PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kittel, RJ; Wichmann, C; Rasse, TM; Fouquet, W; Schmidt, M; Schmid, A; Wagh, DA; Pawlu, C; Kellner, RR; Willig, KI; Hell, SW; Buchner, E; Heckmann, M; Sigrist, SJ				Kittel, RJ; Wichmann, C; Rasse, TM; Fouquet, W; Schmidt, M; Schmid, A; Wagh, DA; Pawlu, C; Kellner, RR; Willig, KI; Hell, SW; Buchner, E; Heckmann, M; Sigrist, SJ			Bruchpilot promotes active zone assembly, Ca2+ channel clustering, and vesicle release	SCIENCE			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; MOTOR-NERVE TERMINALS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC TERMINALS; SYNAPTIC PLASTICITY; TRANSMITTER RELEASE; GLUTAMATE-RECEPTOR; CALCIUM-CHANNEL; DROSOPHILA; PROTEIN	The molecular organization of presynaptic active zones during calcium influx - triggered neurotransmitter release is the focus of intense investigation. The Drosophila coiled-coil domain protein Bruchpilot (BRP) was observed in donut-shaped structures centered at active zones of neuromuscular synapses by using subdiffraction resolution STED ( stimulated emission depletion) fluorescence microscopy. At brp mutant active zones, electron-dense projections (T-bars) were entirely lost, Ca2+ channels were reduced in density, evoked vesicle release was depressed, and short-term plasticity was altered. BRP-like proteins seem to establish proximity between Ca2+ channels and vesicles to allow efficient transmitter release and patterned synaptic plasticity.	Inst Klin Neurobiol, D-97080 Wurzburg, Germany; European Neurosci Inst Gottingen, D-37077 Gottingen, Germany; Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany; Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany	Max Planck Society	Heckmann, M (corresponding author), Inst Klin Neurobiol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	Heckmann_M@klinik.uni-wuerzburg.de; ssigris@gwdg.de	Willig, Katrin/AAH-5418-2020; Kittel, Robert J/G-6404-2015	Willig, Katrin/0000-0002-1860-334X; Kittel, Robert J/0000-0002-9199-4826; Schmidt, Manuela/0000-0003-1972-3519; Heckmann, Manfred/0000-0002-4874-1735				ADLER EM, 1991, J NEUROSCI, V11, P1496; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; ATWOOD HL, 1967, NATURE, V215, P57, DOI 10.1038/215057a0; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bennett MR, 2000, BIOPHYS J, V78, P2201, DOI 10.1016/S0006-3495(00)76769-5; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Dittman JS, 2000, J NEUROSCI, V20, P1374; DUDEL J, 1981, PFLUG ARCH EUR J PHY, V391, P35, DOI 10.1007/BF00580691; Feeney CJ, 1998, J COMP NEUROL, V402, P197, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;197::AID-CNE5&gt;3.0.CO;2-Q; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	37	561	574	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1051	1054		10.1126/science.1126308	http://dx.doi.org/10.1126/science.1126308			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16614170	Green Published			2022-12-28	WOS:000237628800045
J	Petrasek, J; Mravec, J; Bouchard, R; Blakeslee, JJ; Abas, M; Seifertova, D; Wisniewska, J; Tadele, Z; Kubes, M; Covanova, M; Dhonukshe, P; Skupa, P; Benkova, E; Perry, L; Krecek, P; Lee, OR; Fink, GR; Geisler, M; Murphy, AS; Luschnig, C; Zazimalova, E; Friml, J				Petrasek, J; Mravec, J; Bouchard, R; Blakeslee, JJ; Abas, M; Seifertova, D; Wisniewska, J; Tadele, Z; Kubes, M; Covanova, M; Dhonukshe, P; Skupa, P; Benkova, E; Perry, L; Krecek, P; Lee, OR; Fink, GR; Geisler, M; Murphy, AS; Luschnig, C; Zazimalova, E; Friml, J			PIN proteins perform a rate-limiting function in cellular auxin efflux	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TRANSGENIC PLANTS; TRANSPORT; GRADIENTS; GENE; GRAVITROPISM; EXPRESSION; REGULATOR	Intercellular flow of the phytohormone auxin underpins multiple developmental processes in plants. Plant-specific pin-formed ( PIN) proteins and several phosphoglycoprotein (PGP) transporters are crucial factors in auxin transport - related development, yet the molecular function of PINs remains unknown. Here, we show that PINs mediate auxin efflux from mammalian and yeast cells without needing additional plant-specific factors. Conditional gain-of-function alleles and quantitative measurements of auxin accumulation in Arabidopsis and tobacco cultured cells revealed that the action of PINs in auxin efflux is distinct from PGP, rate-limiting, specific to auxins, and sensitive to auxin transport inhibitors. This suggests a direct involvement of PINs in catalyzing cellular auxin efflux.	Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague 6, Czech Republic; Charles Univ, Fac Sci, Dept Plant Physiol, CR-12844 Prague 2, Czech Republic; Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, CH-8007 Zurich, Switzerland; Purdue Univ, Dept Hort, W Lafayette, IN 47907 USA; Agr Univ Vienna, Univ Nat Resources & Appl Life Sci, Inst Appl Genet & Cell Biol, A-1190 Vienna, Austria; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Masaryk Univ, Dept Funct Genom & Proteom, Lab Mol Plant Physiol, Brno 62500, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Charles University Prague; Eberhard Karls University of Tubingen; University of Zurich; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Natural Resources & Life Sciences, Vienna; Nicolaus Copernicus University; University of Bern; Massachusetts Institute of Technology (MIT); Whitehead Institute; Masaryk University Brno	Zazimalova, E (corresponding author), Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague 6, Czech Republic.	eva.zazim@ueb.cas.cz	Petrasek, Jan/C-8240-2009; Petrasek, Jan/AAW-1081-2021; Eva, Zazimalova/G-7432-2014; Skupa, Petr/H-2176-2014; Covanova, Milada/F-7473-2014; Kubes, Martin/F-9761-2014; Wisniewska, Justyna/D-4351-2009; Mravec, Jozef/J-7370-2016; Benkova, Eva/E-2910-2012; Blakeslee, Joshua/G-4420-2011; Friml, Jiri/D-9511-2012; Geisler, Markus M/B-3921-2012	Petrasek, Jan/0000-0002-6719-2735; Petrasek, Jan/0000-0002-6719-2735; Eva, Zazimalova/0000-0002-8325-7092; Mravec, Jozef/0000-0003-0331-3304; Friml, Jiri/0000-0002-8302-7596; Geisler, Markus M/0000-0002-6641-5810; Tadele, Zerihun/0000-0002-3686-3698; Kubes, Martin/0000-0003-2182-4490; Skupa, Petr/0000-0001-9878-0639; Luschnig, Christian/0000-0003-2099-9280				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Kepinski S, 2005, CURR BIOL, V15, pR208, DOI 10.1016/j.cub.2005.03.012; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	22	670	708	9	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					914	918		10.1126/science.1123542	http://dx.doi.org/10.1126/science.1123542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16601150				2022-12-28	WOS:000237452900048
J	Bettelli, E; Carrier, YJ; Gao, WD; Korn, T; Strom, TB; Oukka, M; Weiner, HL; Kuchroo, VK				Bettelli, E; Carrier, YJ; Gao, WD; Korn, T; Strom, TB; Oukka, M; Weiner, HL; Kuchroo, VK			Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells	NATURE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR FOXP3; IL-6-DEFICIENT MICE; TGF-BETA; DISTINCT; DIFFERENTIATION; INTERLEUKIN-17; INFLAMMATION; ACTIVATION	On activation, T cells undergo distinct developmental pathways, attaining specialized properties and effector functions. T-helper (T-H) cells are traditionally thought to differentiate into T(H)1 and T(H)2 cell subsets. T(H)1 cells are necessary to clear intracellular pathogens and T(H)2 cells are important for clearing extracellular organisms(1,2). Recently, a subset of interleukin ( IL)-17-producing T (T(H)17) cells distinct from T(H)1 or T(H)2 cells has been described and shown to have a crucial role in the induction of autoimmune tissue injury(3-5). In contrast, CD4(+) CD25(+) Foxp3(+) regulatory T (T-reg) cells inhibit autoimmunity and protect against tissue injury(6). Transforming growth factor-beta (TGF-beta) is a critical differentiation factor for the generation of T-reg cells(7). Here we show, using mice with a reporter introduced into the endogenous Foxp3 locus, that IL-6, an acute phase protein induced during inflammation(8,9), completely inhibits the generation of Foxp3(+) T-reg cells induced by TGF-beta. We also demonstrate that IL-23 is not the differentiation factor for the generation of T(H)17 cells. Instead, IL-6 and TGF-beta together induce the differentiation of pathogenic T(H)17 cells from naive T cells. Our data demonstrate a dichotomy in the generation of pathogenic (T(H)17) T cells that induce autoimmunity and regulatory (Foxp3(+)) T cells that inhibit autoimmune tissue injury.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Hosp, Transplant Res Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	moukka@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Strom, Terry B./E-9268-2010; Korn, Thomas/AAE-6960-2019	Strom, Terry B./0000-0002-7570-0736; Korn, Thomas/0000-0002-3633-0955				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; BOTTOMLY K, 1988, IMMUNOL TODAY, V9, P268, DOI 10.1016/0167-5699(88)91308-4; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Eugster HP, 2001, EUR J IMMUNOL, V31, P2302, DOI 10.1002/1521-4141(200108)31:8<2302::AID-IMMU2302>3.0.CO;2-#; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirano T, 1998, Int Rev Immunol, V16, P249; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nardelli DT, 2004, CLIN DIAGN LAB IMMUN, V11, P1075, DOI 10.1128/CDLI.11.6.1075-1084.2004; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Okuda Y, 2000, J NEUROIMMUNOL, V105, P120, DOI 10.1016/S0165-5728(00)00192-2; Ozato K, 2002, BIOTECHNIQUES, V33, pS66; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	23	4949	5361	17	438	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					235	238		10.1038/nature04753	http://dx.doi.org/10.1038/nature04753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16648838				2022-12-28	WOS:000237418800050
J	Mangan, PR; Harrington, LE; O'Quinn, DB; Helms, WS; Bullard, DC; Elson, CO; Hatton, RD; Wahl, SM; Schoeb, TR; Weaver, CT				Mangan, PR; Harrington, LE; O'Quinn, DB; Helms, WS; Bullard, DC; Elson, CO; Hatton, RD; Wahl, SM; Schoeb, TR; Weaver, CT			Transforming growth factor-beta induces development of the T(H)17 lineage	NATURE			English	Article							CD4(+) T-CELLS; CITROBACTER-RODENTIUM; AUTOIMMUNE INFLAMMATION; EFFACING PATHOGEN; HELPER TYPE-1; TGF-BETA; CYTOKINE; IL-23; DISTINCT; INFECTION	A new lineage of effector CD4(+) T cells characterized by production of interleukin (IL)-17,the T-helper-17 (T(H)17) lineage, was recently described based on developmental and functional features distinct from those of classical T(H)1 and T(H)2 lineages(1,2). Like T(H)1 and T(H)2, T(H)17 cells almost certainly evolved to provide adaptive immunity tailored to specific classes of pathogens(3), such as extracellular bacteria(4). Aberrant T(H)17 responses have been implicated in a growing list of autoimmune disorders(5-7). T(H)17 development has been linked to IL-23, an IL-12 cytokine family member that shares with IL-12 a common subunit, IL-12p40 (ref. 8). The IL-23 and IL-12 receptors also share a subunit, IL-12R beta 1, that pairs with unique, inducible components, IL-23R and IL-12R beta 2, to confer receptor responsiveness(9). Here we identify transforming growth factor-beta (TGF-beta) as a cytokine critical for commitment to T(H)17 development. TGF-beta acts to upregulate IL-23R expression, thereby conferring responsiveness to IL-23. Although dispensable for the development of IL-17-producing T cells in vitro and in vivo, IL-23 is required for host protection against a bacterial pathogen, Citrobacter rodentium. The action of TGF-beta on naive T cells is antagonized by interferon-gamma and IL-4, thus providing a mechanism for divergence of the T(H)1, T(H)2 and T(H)17 lineages.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama, Dept Genom, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Natl Inst Dent & Craniofacial Dis, Cellular Immunol Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu	Eckhardt, Erik/G-1567-2010; O'Quinn, Darrell/B-3318-2008	Hatton, Robin/0000-0002-4797-9899; Weaver, Casey/0000-0002-2180-1793	NIAID NIH HHS [T32 AI007051] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000046] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Kubo T, 2004, J IMMUNOL, V173, P7249, DOI 10.4049/jimmunol.173.12.7249; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102	26	2447	2627	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					231	234		10.1038/nature04754	http://dx.doi.org/10.1038/nature04754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16648837				2022-12-28	WOS:000237418800049
J	Siegenthaler, M; Spertini, O				Siegenthaler, M; Spertini, O			Spurious platelet count	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CHU Vaudois, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Siegenthaler, M (corresponding author), CHU Vaudois, CH-1011 Lausanne, Switzerland.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1936	1936		10.1056/NEJMicm050107	http://dx.doi.org/10.1056/NEJMicm050107			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672705	Green Published			2022-12-28	WOS:000237239900010
J	Forrest, G; Plumb, C; Sue, Z; Stein, A				Forrest, G; Plumb, C; Sue, Z; Stein, A			Breast cancer in the family - children's perceptions of their mother's cancer and its initial treatment: qualitative of their study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARENTAL CANCER; COMMUNICATION; IMPACT	Objectives To explore how children of mothers newly diagnosed with breast cancer perceive their mothers illness and its initial treatment; to contrast, their accounts with the mothers' perceptions of their children's knowledge. Design Qualitative interview study with thematic analysis. Setting Home based interviews with mothers and children in Oxfordshire, England. Participants 37 mothers with early breast cancer and 31 of their children aged between 6 and 18 years. Results Awareness of cancer as a life threatening illness existed even among Most Of the youngest children interviewed. Children described specific aspects of their mother's treatment as especially stressful (seeing her immediately postoperatively, chemotherapy, and hair loss). Children suspected that something was wrong even before they were told the diagnosis. Parents sometimes misunderstood their children's reactions and Underestimated the emotional impact or did not recognise the children's need for more preparation and age appropriate information about the illness and its treatment. Conclusions As part Of their care, parents newly diagnosed with a life threatening illness need to be supported to think about how they will talk to their children. General practitioners and hospital specialists, as well as nurses, are well placed to be able to hell) with these concerns and if necessary to be involved in discussions with the children. The provision of appropriate information, including recommended websites, should be part of this care. More information specifically designed for young children is needed.	Univ Oxford, Pk Hosp Children, Sect Child & Adolescent Psychiat, Oxford OX3 7LQ, England; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Forrest, G (corresponding author), Univ Oxford, Pk Hosp Children, Sect Child & Adolescent Psychiat, Oxford OX3 7LQ, England.	gillian.forrest@psych.ox.ac.uk		Ziebland, Sue/0000-0002-6496-4859; Stein, Alan/0000-0001-8207-2822				Barnes J, 2000, BRIT MED J, V321, P479, DOI 10.1136/bmj.321.7259.479; Bloom Joan R., 1994, Journal of the National Cancer Institute Monographs, V0, P199; Bluebond-Langner M., 1978, PRIVATE WORLDS DYING; General Medical Council, 2003, TOM DOCT REC UND MED; Keeley D, 2000, BRIT MED J, V321, P462, DOI 10.1136/bmj.321.7259.462; Kroll L, 1998, BRIT MED J, V316, P880, DOI 10.1136/bmj.316.7135.880; MURRAY L, 1908, UNIPOLAR DEPRESSION, P17; OAKLEY A, 1995, BRIT MED J, V310, P1029, DOI 10.1136/bmj.310.6986.1029; *OFF NAT STAT, 1999, HLTH STAT Q, V4, P59; Pope C., 2020, QUALITATIVE RES HLTH; Rutter M, 2000, DEV PSYCHOPATHOL, V12, P375, DOI 10.1017/S0954579400003072; SLAVIN LA, 1982, AM J PSYCHIAT, V139, P179; Visser A, 2004, CANCER TREAT REV, V30, P683, DOI 10.1016/j.ctrv.2004.06.001; Welch AS, 1996, CANCER, V77, P1409, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1409::AID-CNCR28>3.0.CO;2-4	14	72	74	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					998	1001		10.1136/bmj.38793.567801.AE	http://dx.doi.org/10.1136/bmj.38793.567801.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16613935	Green Published, Bronze			2022-12-28	WOS:000237403100014
J	Nicolaou, M; Paes, T; Wakelin, S				Nicolaou, M; Paes, T; Wakelin, S			Blushing: an embarrassing condition, but treatable	LANCET			English	Editorial Material							BOTULINUM-TOXIN; SYMPATHECTOMY; FEAR		Mt Vernon & Hillingdon Hosp NHS Trust, Dept Vasc Surg, Northwood HA6 2RN, Middx, England; St Marys Hosp, Dept Dermatol, London, England	Imperial College London	Paes, T (corresponding author), Mt Vernon & Hillingdon Hosp NHS Trust, Dept Vasc Surg, Northwood HA6 2RN, Middx, England.	trevor.paes@gmail.com						Adair A, 2005, ANN ROY COLL SURG, V87, P358, DOI 10.1308/003588405X60597; DARWIN C, 1979, PORTABLE DARWIN, P364; de Jong PJ, 2005, BEHAV RES THER, V43, P747, DOI 10.1016/j.brat.2004.06.005; Drott C, 2003, CLIN AUTON RES, V13, P26, DOI 10.1007/s10286-003-1109-z; Drott C, 1998, BRIT J DERMATOL, V138, P639; Drott Christer, 2002, J Cosmet Dermatol, V1, P115, DOI 10.1046/j.1473-2165.2002.00047.x; Drummond PD, 2000, PERS INDIV DIFFER, V29, P1123, DOI 10.1016/S0191-8869(99)00259-7; EDELMANN R, 2004, COPING BLUSHING; Furlan AD, 2000, J PAIN, V1, P245, DOI 10.1054/jpai.2000.19408; GAWANDE A, 2003, COMPLICATIONS SURG N, P146; Gerlach AL, 2001, J ABNORM PSYCHOL, V110, P247, DOI 10.1037/0021-843X.110.2.247; Mulkens S, 2001, J ANXIETY DISORD, V15, P413, DOI 10.1016/S0887-6185(01)00073-1; Nicolaou M, 2003, CLIN AUTON RES, V13, P71, DOI 10.1007/s10286-003-1116-0; Ojimba TA, 2004, BRIT J SURG, V91, P264, DOI 10.1002/bjs.4511; Schimel D, 2003, ECOL APPL, V13, P1, DOI 10.1890/1051-0761(2003)013[0001:E]2.0.CO;2; SCHOLING A, 1993, BEHAV RES THER, V31, P155, DOI 10.1016/0005-7967(93)90067-5; Scholing A, 1996, BEHAV MODIF, V20, P338, DOI 10.1177/01454455960203006; Sterodimas A, 2003, CLIN EXP DERMATOL, V28, P592, DOI 10.1046/j.1365-2230.2003.01379.x; Yuraitis M, 2004, DERMATOL SURG, V30, P102, DOI 10.1111/j.1524-4725.2004.30017.x	19	16	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1297	1299		10.1016/S0140-6736(06)68554-1	http://dx.doi.org/10.1016/S0140-6736(06)68554-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037AG	16631894				2022-12-28	WOS:000237118500006
J	Macilwain, C				Macilwain, C			Handle with care	NATURE			English	News Item																		Cyranoski D, 2005, NATURE, V438, P420, DOI 10.1038/438420a; Macilwain C, 2003, NATURE, V422, P111, DOI 10.1038/422111a	2	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					990	991		10.1038/440990a	http://dx.doi.org/10.1038/440990a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625170				2022-12-28	WOS:000236906000012
J	Taylor, JRA; Kier, WM				Taylor, JRA; Kier, WM			A pneumo-hydrostatic skeleton in land crabs - A sophisticated dual support system enables a crab to stay mobile immediately after moulting.	NATURE			English	Editorial Material							IMAGINAL ECDYSIS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Taylor, JRA (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	jataylor@email.unc.edu						BLISS DE, 1968, AM ZOOL, V8, P355; BLISS DE, 1979, AM ZOOL, V19, P385; CHAPMAN G, 1975, J EXP ZOOL, V194, P249, DOI 10.1002/jez.1401940118; CHAPMAN G, 1958, BIOL REV, V33, P338, DOI 10.1111/j.1469-185X.1958.tb01260.x; Clark R. B., 1964, DYNAMICS METAZOAN EV; COTTRELL CB, 1962, J EXP BIOL, V39, P431; Drach P., 1939, Ann Inst oceanogr Paris, V19, P103; HUGHES TD, 1980, PHYSIOL ENTOMOL, V5, P153, DOI 10.1111/j.1365-3032.1980.tb00222.x; Miles CI, 1998, J EXP BIOL, V201, P1785; Passano L., 1960, PHYSIOL CRUSTACEA, P473, DOI DOI 10.1016/B978-0-12-395628-6.50021-X; Reynolds S.E., 1980, Advances in Insect Physiology, V15, P475, DOI 10.1016/S0065-2806(08)60144-7; SKINNER D M, 1985, P43; Taylor JRA, 2003, SCIENCE, V301, P209, DOI 10.1126/science.1085987	13	10	11	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					1005	1005		10.1038/4401005a	http://dx.doi.org/10.1038/4401005a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034DL	16625186				2022-12-28	WOS:000236906000025
J	Benkovic, SJ; Hammes-Schiffer, S				Benkovic, SJ; Hammes-Schiffer, S			Biochemistry - Enzyme motions inside and out	SCIENCE			English	Editorial Material							DIHYDROFOLATE-REDUCTASE; CATALYSIS; DYNAMICS		Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sjb1@psu.edu; shs@chem.psu.edu	Hammes-Schiffer, Sharon/B-7325-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024129, R01GM056207, R01GM024129, R37GM056207] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24129, GM56207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antikainen NM, 2005, BIOCHEMISTRY-US, V44, P16835, DOI 10.1021/bi051378i; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Kiefer PM, 2004, SOLID STATE IONICS, V168, P219, DOI 10.1016/j.ssi.2002.12.001; Kohen A, 1998, ACCOUNTS CHEM RES, V31, P397, DOI 10.1021/ar9701225; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h	12	77	78	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					208	209		10.1126/science.1127654	http://dx.doi.org/10.1126/science.1127654			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614206				2022-12-28	WOS:000236765300032
J	Ashourian, N; Mousdicas, N				Ashourian, N; Mousdicas, N			Pellagra-like dermatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Indiana Univ, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Ashourian, N (corresponding author), Indiana Univ, Indianapolis, IN 46202 USA.								0	15	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1614	1614		10.1056/NEJMicm050641	http://dx.doi.org/10.1056/NEJMicm050641			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611952				2022-12-28	WOS:000236736900010
J	Lange, A; Giller, K; Hornig, S; Martin-Eauclaire, MF; Pongs, O; Becker, S; Baldus, M				Lange, A; Giller, K; Hornig, S; Martin-Eauclaire, MF; Pongs, O; Becker, S; Baldus, M			Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR	NATURE			English	Article							SHAKER K+ CHANNEL; SELECTIVITY FILTER; PEPTIDE INHIBITOR; PROTEIN-STRUCTURE; STRUCTURAL BASIS; SCORPION TOXINS; MUTANT CYCLES; CHARYBDOTOXIN; PORE; VOLTAGE	The active site of potassium (K+) channels catalyses the transport of K+ ions across the plasma membrane(1)-similar to the catalytic function of the active site of an enzyme-and is inhibited by toxins from scorpion venom. On the basis of the conserved structures of K+ pore regions(2) and scorpion toxins(3,4), detailed structures for the K+ channel-scorpion toxin binding interface have been proposed. In these models and in previous solution-state nuclear magnetic resonance (NMR) studies using detergent-solubilized membrane proteins(5,6), scorpion toxins were docked to the extracellular entrance of the K+ channel pore assuming rigid, preformed binding sites(7-13). Using high-resolution solid-state NMR spectroscopy, here we show that high-affinity binding of the scorpion toxin kaliotoxin to a chimaeric K+ channel (KcsA- Kv1.3)(14,15) is associated with significant structural rearrangements in both molecules. Our approach involves a combined analysis of chemical shifts and proton-proton distances and demonstrates that solid-state NMR is a sensitive method for analysing the structure of a membrane protein-inhibitor complex. We propose that structural flexibility of the K+ channel and the toxin represents an important determinant for the high specificity of toxin-K+ channel interactions.	Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; Univ Hamburg, Zentrum Mol Neurobiol, Inst Neurale Signalverarbeitung, D-20251 Hamburg, Germany; Univ Mediterranee, CNRS, Inst Jean Roche, F-13916 Marseille 20, France	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Baldus, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany.	maba@mpibpc.mpg.de	Baldus, Marc/C-2737-2009	Baldus, Marc/0000-0001-7068-5613; Lange, Adam/0000-0002-7534-5973				AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; Aiyar J, 1996, J BIOL CHEM, V271, P31013, DOI 10.1074/jbc.271.49.31013; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; CREUZET F, 1991, SCIENCE, V251, P783, DOI 10.1126/science.1990439; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Lange A, 2005, ANGEW CHEM INT EDIT, V44, P2089, DOI 10.1002/anie.200462516; Lange A, 2002, J AM CHEM SOC, V124, P9704, DOI 10.1021/ja026691b; Legros C, 2000, J BIOL CHEM, V275, P16918, DOI 10.1074/jbc.275.22.16918; Legros C, 2002, BIOCHEMISTRY-US, V41, P15369, DOI 10.1021/bi026264a; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Luca S, 2001, J BIOMOL NMR, V20, P325, DOI 10.1023/A:1011278317489; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Takeuchi K, 2003, STRUCTURE, V11, P1381, DOI 10.1016/j.str.2003.10.003; Yu KQ, 2004, BIOPHYS J, V86, P3542, DOI 10.1529/biophysj.103.039461; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	29	341	346	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					959	962		10.1038/nature04649	http://dx.doi.org/10.1038/nature04649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612389				2022-12-28	WOS:000236736700046
J	Raghoebarsing, AA; Pol, A; van de Pas-Schoonen, KT; Smolders, AJP; Ettwig, KF; Rijpstra, WIC; Schouten, S; Damste, JSS; Op den Camp, HJM; Jetten, MSM; Strous, M				Raghoebarsing, AA; Pol, A; van de Pas-Schoonen, KT; Smolders, AJP; Ettwig, KF; Rijpstra, WIC; Schouten, S; Damste, JSS; Op den Camp, HJM; Jetten, MSM; Strous, M			A microbial consortium couples anaerobic methane oxidation to denitrification	NATURE			English	Article							METHANOTROPHIC ARCHAEA; 16S RDNA; SEDIMENTS; DIVERSITY; AMMONIUM; CARBON; DONOR; SOIL	Modern agriculture has accelerated biological methane and nitrogen cycling on a global scale(1,2). Freshwater sediments often receive increased downward fluxes of nitrate from agricultural runoff and upward fluxes of methane generated by anaerobic decomposition(3). In theory, prokaryotes should be capable of using nitrate to oxidize methane anaerobically, but such organisms have neither been observed in nature nor isolated in the laboratory(4-8). Microbial oxidation of methane is thus believed to proceed only with oxygen or sulphate(9,10). Here we show that the direct, anaerobic oxidation of methane coupled to denitrification of nitrate is possible. A microbial consortium, enriched from anoxic sediments, oxidized methane to carbon dioxide coupled to denitrification in the complete absence of oxygen. This consortium consisted of two microorganisms, a bacterium representing a phylum without any cultured species and an archaeon distantly related to marine methanotrophic Archaea. The detection of relatives of these prokaryotes in different freshwater ecosystems worldwide(11-14) indicates that the reaction presented here may make a substantial contribution to biological methane and nitrogen cycles.	Univ Nijmegen St Radboud Hosp, Inst Water & Wetland Res, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; Univ Nijmegen St Radboud Hosp, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; Dept Marine Biogeochem & Toxicol, Royal Netherlands Inst Sea Res NIOZ, NL-1790 AB Den Burg, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Strous, M (corresponding author), Univ Nijmegen St Radboud Hosp, Inst Water & Wetland Res, Dept Microbiol, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	m.strous@science.ru.nl	Strous, Marc/B-4064-2017; Jetten, Mike/B-8834-2011; Smolders, Alfons J.P./H-2583-2012; Camp, Huub J.M. Op den/F-5114-2011; Damste, Jaap S Sinninghe/F-6128-2011; Ettwig, Katharina F/B-9395-2011	Strous, Marc/0000-0001-9600-3828; Jetten, Mike/0000-0002-4691-7039; Camp, Huub J.M. Op den/0000-0003-1990-9030; Damste, Jaap S Sinninghe/0000-0002-8683-1854; 				Bakermans C, 2002, MICROB ECOL, V44, P95, DOI [10.1007/s00248-002-0005-8, 10.1007/s00248-002-3011-y]; Blumenberg M, 2005, APPL ENVIRON MICROB, V71, P4345, DOI 10.1128/AEM.71.8.4345-4351.2005; Blumenberg M, 2004, P NATL ACAD SCI USA, V101, P11111, DOI 10.1073/pnas.0401188101; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Costa C, 2000, APPL MICROBIOL BIOT, V53, P754, DOI 10.1007/s002530000337; Eisentraeger A, 2001, WATER RES, V35, P2261, DOI 10.1016/S0043-1354(00)00516-9; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Islas-Lima S, 2004, WATER RES, V38, P13, DOI 10.1016/j.watres.2003.08.024; Kasai Y, 2005, ENVIRON MICROBIOL, V7, P806, DOI 10.1111/j.1462-2920.2005.00754.x; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knowles R, 2005, ECOL ENG, V24, P441, DOI 10.1016/j.ecoleng.2005.01.001; Koga Y, 1998, BIOSCI BIOTECH BIOCH, V62, P230, DOI 10.1271/bbb.62.230; Koizumi Y, 2003, FEMS MICROBIOL ECOL, V46, P147, DOI 10.1016/S0168-6496(03)00212-5; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; MASON I, 1977, J WATER POLLUT CON F, V49, P855; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; Shima S, 2005, CURR OPIN MICROBIOL, V8, P643, DOI 10.1016/j.mib.2005.10.002; Stein LY, 2001, ENVIRON MICROBIOL, V3, P10, DOI 10.1046/j.1462-2920.2001.00154.x; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Strous M, 2002, ANTON LEEUW INT J G, V81, P693, DOI 10.1023/A:1020590413079; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; Waki M, 2002, APPL MICROBIOL BIOT, V59, P338, DOI 10.1007/s00253-002-1003-y	28	875	984	47	916	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					918	921		10.1038/nature04617	http://dx.doi.org/10.1038/nature04617			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612380	Green Published			2022-12-28	WOS:000236736700037
J	Tolstrup, J; Jensen, MK; Tjonneland, A; Overvad, K; Mukamal, KJ; Gronbaek, M				Tolstrup, Janne; Jensen, Majken K.; Tjonneland, Anne; Overvad, Kim; Mukamal, Kenneth J.; Gronbaek, Morten			Prospective study of alcohol drinking coronary heart disease in women and patterns and men	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CONTROLLED-TRIAL; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; REGULAR DRINKERS; DANISH MEN; MORTALITY; RISK; CONSUMPTION	Objective To determine the association between alcohol drinking patterns and risk of coronary heart disease in women and men. Design Population based cohort study. Setting Denmark, 1993-2002.. Participants 28 448 women and 25 052 men aged 50-65 years, who were free of cardiovascular disease at entry to the study. Main outcome measures Incidence of coronary heart disease occurring during a median follow-up period of 5.7 years. Results 749 and 1283 coronary heart disease events occurred among women and men. Women who drank alcohol on at least one day a week had a lower risk of coronary heart disease than women who drank alcohol on less than one day a week. Little difference was found, however, between drinking frequency: one day a week (hazard ratio 0.64, 95% confidence interval 0.51 to 0.81), 2-4 days a week (0.63, 0.52 to 0.77), five or six days a week (0.79, 0.61 to 1.03), and seven days a week (0.65, 0.51 to 0.84). For men an inverse association was found between drinking frequency and risk of coronary heart disease across the entire range of drinking frequencies. The lowest risk was observed among men who drank daily (0.59, 0.48 to 0.71) compared with men who drank alcohol on less than one day a week. Conclusions Among women alcohol intake may be the primary determinant of the inverse association between drinking alcohol and risk of coronary heart disease whereas among men, drinking frequency, not alcohol intake, seems more important.	Natl Inst Publ Hlth, Alcohol Res Ctr, DK-1399 Copenhagen, Denmark; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Aarhus Univ Hosp, Cardiovasc Res Ctr, Dept Clin Epidemiol, Aalborg, Denmark; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA	Danish Cancer Society; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center	Tolstrup, J (corresponding author), Natl Inst Publ Hlth, Alcohol Res Ctr, Oster Farimagsgade 5, DK-1399 Copenhagen, Denmark.	jst@niph.dk	Mukamal, Kenneth/GVR-7978-2022	Tolstrup, Janne/0000-0002-9796-3967; Tjonneland, Anne/0000-0003-4385-2097; Jensen, Majken Karoline/0000-0003-4729-7545; Overvad, Kim/0000-0001-6429-7921; Gronbaek, Morten Klocker/0000-0002-8473-6474				Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; BIEN TH, 1990, INT J ADDICT, V25, P1429, DOI 10.3109/10826089009056229; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; Flesch M, 2001, BASIC RES CARDIOL, V96, P128, DOI 10.1007/s003950170062; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GOLDITZ GA, 1987, NEW ENGL J MED, V316, P1105; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Gronbaek M, 2000, EUR J CLIN NUTR, V54, P174, DOI 10.1038/sj.ejcn.1600919; GRUCHOW HW, 1982, ATHEROSCLEROSIS, V43, P393, DOI 10.1016/0021-9150(82)90038-7; HOJNACKI JL, 1991, ATHEROSCLEROSIS, V88, P49, DOI 10.1016/0021-9150(91)90256-3; Juel K, 1999, DAN MED BULL, V46, P354; JURGENSEN HJ, 1986, METHOD INFORM MED, V25, P158; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Mumenthaler MS, 1999, ALCOHOL RES HEALTH, V23, P55; Murray RP, 2002, AM J EPIDEMIOL, V155, P242, DOI 10.1093/aje/155.3.242; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Rakic V, 1998, ATHEROSCLEROSIS, V137, P243, DOI 10.1016/S0021-9150(97)00269-4; Rakic V, 1998, J HYPERTENS, V16, P165, DOI 10.1097/00004872-199816020-00006; Register TC, 2002, ALCOHOL RES HEALTH, V26, P299; SHAPER AG, 1995, BRIT MED J, V310, P325, DOI 10.1136/bmj.310.6975.325; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; Trevisan M, 2004, ADDICTION, V99, P313, DOI 10.1111/j.1360-0443.2003.00630.x; WANNAMETHEE G, 1991, J HUM HYPERTENS, V5, P59	29	125	130	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1244	1247		10.1136/bmj.38831.503113.7C	http://dx.doi.org/10.1136/bmj.38831.503113.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16672312	Green Published, Bronze			2022-12-28	WOS:000237984100017
J	Scaffidi, P; Misteli, T				Scaffidi, P; Misteli, T			Lamin A-dependent nuclear defects in human aging	SCIENCE			English	Article							HUTCHINSON-GILFORD-PROGERIA; ARCHITECTURE; ZMPSTE24	Mutations in the nuclear structural protein lamin A cause the premature aging syndrome Hutchinson-Gilford progeria (HGPS). Whether lamin A plays any role in normal aging is unknown. We show that the same molecular mechanism responsible for HGPS is active in healthy cells. Cell nuclei from old individuals acquire defects similar to those of HGPS patient cells, including changes in histone modifications and increased DNA damage. Age-related nuclear defects are caused by sporadic use, in healthy individuals, of the same cryptic splice site in lamin A whose constitutive activation causes HGPS. Inhibition of this splice site reverses the nuclear defects associated with aging. These observations implicate lamin A in physiological aging.	NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Scaffidi, Paola/GRS-9019-2022	Scaffidi, Paola/0000-0002-3642-4193	NATIONAL CANCER INSTITUTE [Z01BC010309] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [Z01 BC010309-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREW W, 1964, Adv Gerontol Res, V18, P87; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	14	822	865	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1059	1063		10.1126/science.1127168	http://dx.doi.org/10.1126/science.1127168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16645051	Green Accepted			2022-12-28	WOS:000237628800047
J	Akkerman, HB; Blom, PWM; de Leeuw, DM; de Boer, B				Akkerman, HB; Blom, PWM; de Leeuw, DM; de Boer, B			Towards molecular electronics with large-area molecular junctions	NATURE			English	Article							SELF-ASSEMBLED MONOLAYERS; CONDUCTANCE; TRANSPORT; CONTACT; METALS	Electronic transport through single molecules has been studied extensively by academic(1-8) and industrial(9,10) research groups. Discrete tunnel junctions, or molecular diodes, have been reported using scanning probes(11,12), break junctions(13,14), metallic crossbars(6) and nanopores(8,15). For technological applications, molecular tunnel junctions must be reliable, stable and reproducible. The conductance per molecule, however, typically varies by many orders of magnitude(5). Self-assembled monolayers (SAMs) may offer a promising route to the fabrication of reliable devices, and charge transport through SAMs of alkanethiols within nanopores is well understood, with non-resonant tunnelling dominating the transport mechanism(8). Unfortunately, electrical shorts in SAMs are often formed upon vapour deposition of the top electrode(16-18), which limits the diameter of the nanopore diodes to about 45 nm. Here we demonstrate a method to manufacture molecular junctions with diameters up to 100 mu m with high yields (>95 per cent). The junctions show excellent stability and reproducibility, and the conductance per unit area is similar to that obtained for benchmark nanopore diodes. Our technique involves processing the molecular junctions in the holes of a lithographically patterned photoresist, and then inserting a conducting polymer interlayer between the SAM and the metal top electrode. This simple approach is potentially low-cost and could pave the way for practical molecular electronics.	Univ Groningen, Mat Sci Ctr Plus, NL-9747 AG Groningen, Netherlands; Philips Res Labs, NL-5656 AA Eindhoven, Netherlands	University of Groningen; Philips; Philips Research	Akkerman, HB (corresponding author), Univ Groningen, Mat Sci Ctr Plus, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.de.boer@rug.nl	Blom, Paul WM/U-8304-2017; De Leeuw, Dago/AAC-4929-2020; Akkerman, Hylke B/C-3008-2008					AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; Blum AS, 2005, NAT MATER, V4, P167, DOI 10.1038/nmat1309; Chang SC, 2003, APPL PHYS LETT, V83, P3198, DOI 10.1063/1.1616989; Chen Y, 2003, NANOTECHNOLOGY, V14, P462, DOI 10.1088/0957-4484/14/4/311; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Cui XD, 2001, SCIENCE, V294, P571, DOI 10.1126/science.1064354; de Boer B, 2003, LANGMUIR, V19, P4272, DOI 10.1021/la0341052; de Boer B, 2004, LANGMUIR, V20, P1539, DOI 10.1021/la0356349; Engelkes VB, 2004, J AM CHEM SOC, V126, P14287, DOI 10.1021/ja046274u; Haick H, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1854742; Haynie BC, 2003, APPL SURF SCI, V203, P433, DOI 10.1016/S0169-4332(02)00695-5; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Nitzan A, 2003, SCIENCE, V300, P1384, DOI 10.1126/science.1081572; PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Reichert J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176804; Salomon A, 2003, ADV MATER, V15, P1881, DOI 10.1002/adma.200306091; SIMMONS JG, 1963, J APPL PHYS, V34, P1793, DOI 10.1063/1.1702682; Smit RHM, 2002, NATURE, V419, P906, DOI 10.1038/nature01103; Wang WY, 2003, PHYS REV B, V68, DOI [10.1103/PhysRevB.68.035416, 10.1103/PhysRevB.68.184105]; Zhitenev NB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226801; Zhou C, 1997, APPL PHYS LETT, V71, P611, DOI 10.1063/1.120195	23	545	554	5	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					69	72		10.1038/nature04699	http://dx.doi.org/10.1038/nature04699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672966	Green Submitted, Green Published			2022-12-28	WOS:000237248600033
J	Vecchi, GA; Soden, BJ; Wittenberg, AT; Held, IM; Leetmaa, A; Harrison, MJ				Vecchi, GA; Soden, BJ; Wittenberg, AT; Held, IM; Leetmaa, A; Harrison, MJ			Weakening of tropical Pacific atmospheric circulation due to anthropogenic forcing	NATURE			English	Article							COUPLED CLIMATE MODELS; SEA-SURFACE TEMPERATURE; LONG-TERM CHANGES; EL-NINO; WALKER; TRENDS; ENSO	Since the mid-nineteenth century the Earth's surface has warmed(1-3), and models indicate that human activities have caused part of the warming by altering the radiative balance of the atmosphere(1,3). Simple theories suggest that global warming will reduce the strength of the mean tropical atmospheric circulation(4,5). An important aspect of this tropical circulation is a large-scale zonal (east-west) overturning of air across the equatorial Pacific Ocean-driven by convection to the west and subsidence to the east-known as the Walker circulation(6). Here we explore changes in tropical Pacific circulation since the mid-nineteenth century using observations and a suite of global climate model experiments. Observed Indo-Pacific sea level pressure reveals a weakening of the Walker circulation. The size of this trend is consistent with theoretical predictions, is accurately reproduced by climate model simulations and, within the climate models, is largely due to anthropogenic forcing. The climate model indicates that the weakened surface winds have altered the thermal structure and circulation of the tropical Pacific Ocean. These results support model projections of further weakening of tropical atmospheric circulation during the twenty-first century(4,5,7).	NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami	Vecchi, GA (corresponding author), NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA.	Gabriel.A.Vecchi@noaa.gov	Vecchi, Gabriel/A-2413-2008; Soden, Brian/ABC-3659-2021; Wittenberg, Andrew T/G-9619-2013	Vecchi, Gabriel/0000-0002-5085-224X; Wittenberg, Andrew T/0000-0003-1680-8963				Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; BOER GJ, 1993, CLIM DYNAM, V8, P225, DOI 10.1007/BF00198617; CANE MA, 1977, J MAR RES, V35, P395; CARDONE VJ, 1990, J CLIMATE, V3, P113, DOI 10.1175/1520-0442(1990)003<0113:OTIHMW>2.0.CO;2; Clarke AJ, 1996, J CLIMATE, V9, P1020, DOI 10.1175/1520-0442(1996)009<1020:LTCITE>2.0.CO;2; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; DERBER J, 1989, J PHYS OCEANOGR, V19, P1333, DOI 10.1175/1520-0485(1989)019<1333:AGODAS>2.0.CO;2; DESER C, 1990, J CLIMATE, V3, P1254, DOI 10.1175/1520-0442(1990)003<1254:LSACFO>2.0.CO;2; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Harrison DE, 2001, GEOPHYS RES LETT, V28, P1051, DOI 10.1029/1999GL011307; HARRISON DE, 1989, J CLIMATE, V2, P1561, DOI 10.1175/1520-0442(1989)002<1561:PWWITI>2.0.CO;2; HELD IM, IN PRESS J CLIM; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; JULIAN PR, 1978, MON WEATHER REV, V106, P1433, DOI 10.1175/1520-0493(1978)106<1433:ASOTSO>2.0.CO;2; Kaplan A, 2000, J CLIMATE, V13, P2987, DOI 10.1175/1520-0442(2000)013<2987:RSOIOH>2.0.CO;2; KNUTSON TR, 1995, J CLIMATE, V8, P2181, DOI 10.1175/1520-0442(1995)008<2181:TMROTT>2.0.CO;2; KNUTSON TR, IN PRESS J CLIM; RAMAGE CS, 1984, J CLIM APPL METEOROL, V23, P187, DOI 10.1175/1520-0450(1984)023<0187:CSMRSC>2.0.CO;2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Soden BJ, 2005, SCIENCE, V310, P841, DOI 10.1126/science.1115602; Stouffer RJ, 2006, J CLIMATE, V19, P723, DOI 10.1175/JCLI3632.1; Tanaka HL, 2004, TELLUS A, V56, P250, DOI 10.1111/j.1600-0870.2004.00049.x; Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; WHYSALL KDB, 1987, NATURE, V327, P216, DOI 10.1038/327216a0; Wittenberg AT, 2006, J CLIMATE, V19, P698, DOI 10.1175/JCLI3631.1; Worley SJ, 2005, INT J CLIMATOL, V25, P823, DOI 10.1002/joc.1166; [No title captured]	30	741	769	13	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					73	76		10.1038/nature04744	http://dx.doi.org/10.1038/nature04744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672967				2022-12-28	WOS:000237248600034
J	Davis, S				Davis, S			The patient's journey: living with diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Article											Davis, S (corresponding author), Buckingham Grove, Hillingdon UB10 0QZ, Middx, England.	sali@salisplat.co.uk							0	1	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1018	1020		10.1136/bmj.332.7548.1018	http://dx.doi.org/10.1136/bmj.332.7548.1018			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16644829	Green Published			2022-12-28	WOS:000237403100022
J	O'Regan, RM				O'Regan, RM			Chemoprevention of breast cancer	LANCET			English	Editorial Material							SURGICAL ADJUVANT BREAST; SERUM-CHOLESTEROL; RANDOMIZED-TRIAL; TAMOXIFEN; PREVENTION; RALOXIFENE; OUTCOMES; WOMEN		Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University	O'Regan, RM (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	Ruth_ORegan@emoryhealthcare.org						BLACK LJ, 1994, J CLIN INVEST, V93, P63, DOI 10.1172/JCI116985; Clarke M, 1998, LANCET, V351, P1451; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; JORDAN VC, 1976, EUR J CANCER, V12, P419, DOI 10.1016/0014-2964(76)90030-X; Kudchadkar R, 2005, CA-CANCER J CLIN, V55, P145, DOI 10.3322/canjclin.55.3.145; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Powles T, 1998, LANCET, V352, P98; Veronesi U, 2003, J NATL CANCER I, V95, P160, DOI 10.1093/jnci/95.2.160	12	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1382	1383		10.1016/S0140-6736(06)68594-2	http://dx.doi.org/10.1016/S0140-6736(06)68594-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650636				2022-12-28	WOS:000237195600010
J	Antonovics, J; Hood, ME; Baker, CH				Antonovics, J; Hood, ME; Baker, CH			Molecular virology - Was the 1918 flu avian in origin?	NATURE			English	Letter							PANDEMIC INFLUENZA-VIRUS		Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Antonovics, J (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	ja8n@virginia.edu						Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sharp PA, 2005, SCIENCE, V310, P17, DOI 10.1126/science.310.5745.17; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230	7	42	47	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					E9	E9		10.1038/nature04824	http://dx.doi.org/10.1038/nature04824			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641950	Bronze			2022-12-28	WOS:000237080000029
J	Erler, JT; Bennewith, KL; Nicolau, M; Dornhofer, N; Kong, C; Le, QT; Chi, JTA; Jeffrey, SS; Giaccia, AJ				Erler, JT; Bennewith, KL; Nicolau, M; Dornhofer, N; Kong, C; Le, QT; Chi, JTA; Jeffrey, SS; Giaccia, AJ			RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis (Retracted article. See vol. 579, pg. 456, 2020)	NATURE			English	Article; Retracted Publication							GENE-EXPRESSION; CELL INVASION; CANCER; SPECIFICITY; MECHANISMS; MIGRATION; TUMORS; RAS	Metastasis is a multistep process responsible for most cancer deaths, and it can be influenced by both the immediate microenvironment (cell-cell or cell-matrix interactions) and the extended tumour microenvironment (for example vascularization)(1). Hypoxia (low oxygen) is clinically associated with metastasis and poor patient outcome, although the underlying processes remain unclear(2). Microarray studies have shown the expression of lysyl oxidase (LOX) to be elevated in hypoxic human tumour cells(3). Paradoxically, LOX expression is associated with both tumour suppression and tumour progression, and its role in tumorigenesis seems dependent on cellular location, cell type and transformation status(4-9). Here we show that LOX expression is regulated by hypoxia-inducible factor (HIF) and is associated with hypoxia in human breast and head and neck tumours. Patients with high LOX-expressing tumours have poor distant metastasis-free and overall survivals. Inhibition of LOX eliminates metastasis in mice with orthotopically grown breast cancer tumours. Mechanistically, secreted LOX is responsible for the invasive properties of hypoxic human cancer cells through focal adhesion kinase activity and cell to matrix adhesion. Furthermore, LOX may be required to create a niche permissive for metastatic growth. Our findings indicate that LOX is essential for hypoxia-induced metastasis and is a good therapeutic target for preventing and treating metastases.	Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Leipzig, Dept Obstet & Gynecol, D-04103 Leipzig, Germany; Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA	Stanford University; Stanford University; Stanford University; Leipzig University; Duke University	Giaccia, AJ (corresponding author), Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA.	giaccia@stanford.edu	Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X; Jeffrey, Stefanie/0000-0003-4478-2764; Erler, Janine/0000-0001-8675-6527; Le, Quynh Thu/0000-0002-3682-1439	NCI NIH HHS [T32 CA009151] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Cen DZ, 2004, J MED CHEM, V47, P6914, DOI 10.1021/jm049568z; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen YJ, 2004, CANCER RES, V64, P7302, DOI 10.1158/0008-5472.CAN-04-0899; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Csiszar K, 2002, INT J CANCER, V97, P636, DOI 10.1002/ijc.10035; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gilad GM, 2001, EUR J PHARMACOL, V430, P69, DOI 10.1016/S0014-2999(01)01354-1; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kirschmann DA, 2002, CANCER RES, V62, P4478; Krishnamachary B, 2003, CANCER RES, V63, P1138; Leufgen H, 2005, J CELL PHYSIOL, V204, P146, DOI 10.1002/jcp.20289; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Spicher A, 1998, MOL CELL BIOL, V18, P7371, DOI 10.1128/MCB.18.12.7371; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Wang WG, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-13; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122	29	1085	1139	6	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1222	1226		10.1038/nature04695	http://dx.doi.org/10.1038/nature04695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16642001				2022-12-28	WOS:000237080000052
J	Lurie, P; Almeida, CM; Stine, N; Stine, AR; Wolfe, SM				Lurie, P; Almeida, CM; Stine, N; Stine, AR; Wolfe, SM			Financial conflict of interest disclosure and voting patterns at food and drug administration drug advisory committee meetings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUSTRY	Context In January 2002, the US Food and Drug Administration (FDA) issued a draft guidance requiring more detailed financial conflict of interest disclosure at advisory committee meetings. Objectives To characterize financial conflict disclosures at drug-related meetings, and to assess the relationship between conflicts and voting behavior at meetings that considered specific products. Design and Setting Cross-sectional study using agendas and transcripts from all FDA Drug Advisory Committee meetings (2001-2004) listed on the FDA Web site. Main Outcome Measures Conflict rates, type, and size. The relationship between having a conflict and voting in favor of the index drug was described for each voter using Mantel-Haenszel relative risks and Monte Carlo simulations; Spearman rho was used for a meeting-level analysis comparing rates of conflict with voting patterns. The impact of the removal of persons with conflicts of interest on the vote margins was also evaluated. Results A total of 221 meetings held by 16 advisory committees were included in the study. In 73% of the meetings, at least 1 advisory committee member or voting consultant disclosed a conflict; only 1% of advisory committee members were recused. For advisory committee members (n=1957) and voting consultants combined (n=990), 28% (n=825) disclosed a conflict. The most commonly specified conflicts were consulting arrangements, contracts/grants, and investments. Nineteen percent of consulting arrangements involved over $10000, 23% of contracts/grants exceeded $100000, and 30% of investments were over $25000. The meeting-level analysis did not show a statistically significant relationship between conflict rates ("index conflict," "competitor conflict," or "any conflict") and voting patterns, but a weak, statistically significant positive relationship was apparent for competitor conflict and any conflict in the Mantel-Haenszel analyses. The Monte Carlo analyses produced similar findings in the competitor conflict analysis only. In all 3 conflict categories, the exclusion of advisory committee members and voting consultants with conflicts would have produced margins less favorable to the index drug in the majority of meetings, but this would not have changed whether the majority favored or opposed the drug. Conclusions Disclosures of conflicts of interest at drug advisory committee meetings are common, often of considerable monetary value, and rarely result in recusal of advisory committee members. A weak relationship between certain types of conflicts and voting behaviors was detected, but excluding advisory committee members and voting consultants with conflicts would not have altered the overall vote outcome at any meeting studied.	Publ Citizens Hlth Res Grp, Washington, DC 20009 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lurie, P (corresponding author), Publ Citizens Hlth Res Grp, 1600 20th St NW, Washington, DC 20009 USA.	plurie@citizen.org	Stine, Alexander/O-8104-2016	Stine, Alexander/0000-0002-1676-5572; Stine, Nicholas/0000-0001-8811-259X				Cauchon D., 2000, US TODAY        0925, pA1; Harris G., 2005, NY TIMES 0225, pA1; JEWELL NP, 1984, BIOMETRICS, V40, P421, DOI 10.2307/2531395; Lenzer J, 2005, BRIT MED J, V330, P1106, DOI 10.1136/bmj.330.7500.1106-a; Lenzer J, 2003, BRIT MED J, V326, P680, DOI 10.1136/bmj.326.7391.680; McComas Katherine A., CONFLICTS INTEREST F; *OFF INSP GEN, 2003, OEI010100590 US DEP; OHARROW R, 2000, WASHINGTON POST 0912, pA1; Press W., 1992, NUMERICAL RECIPES FO; Saul Stephanie, 2005, N Y Times Web, pC3; Steinbrook R, 2005, NEW ENGL J MED, V353, P116, DOI 10.1056/NEJMp058108; *US FDA, FDA GUID CONFL INT A; *US FDA, CONF FIN DISCL REP S; *US FDA, 2001, BRIEF REP SPEC GOV E; *US FDA, 2002, IN PRESS DRAFT GUID; *VASSARSTATS, VASSARSTATS RAND PRO; WADMAN M, 2001, NATURE, V411, P951; WILLMAN D, 1999, LOS ANGELES TIM 0325, pA1	18	97	99	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1921	1928		10.1001/jama.295.16.1921	http://dx.doi.org/10.1001/jama.295.16.1921			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639051				2022-12-28	WOS:000237059200027
J	Bibring, JP; Langevin, Y; Mustard, JF; Poulet, F; Arvidson, R; Gendrin, A; Gondet, B; Mangold, N; Pinet, P; Forget, F				Bibring, JP; Langevin, Y; Mustard, JF; Poulet, F; Arvidson, R; Gendrin, A; Gondet, B; Mangold, N; Pinet, P; Forget, F		OMEGA team	Global mineralogical and aqueous mars history derived from OMEGA/Mars express data	SCIENCE			English	Article							SURFACE; SPIRIT; IDENTIFICATION; MERIDIANI; DIVERSITY; EVOLUTION; ROVER; CRUST	Global mineralogical mapping of Mars by the Observatoire pour la Mineralogie, l'Eau, les Glaces et l'Activite (OMEGA) instrument on the European Space Agency's Mars Express spacecraft provides new information on Mars' geological and climatic history. Phyllosilicates formed by aqueous alteration very early in the planet's history (the "phyllocian" era) are found in the oldest terrains; sulfates were formed in a second era (the "theiikian" era) in an acidic environment. Beginning about 3.5 billion years ago, the last era (the "siderikian") is dominated by the formation of anhydrous ferric oxides in a slow superficial weathering, without liquid water playing a major role across the planet.	Inst Astrophys Spatiale, F-91405 Orsay, France; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Interact & Dynam Environm Surface, F-91405 Orsay, France; Observ Midi Pyrenees, F-31400 Toulouse, France; Univ Paris 06, Meteorol Dynam Lab, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Brown University; Washington University (WUSTL); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Sorbonne Universite	Bibring, JP (corresponding author), Inst Astrophys Spatiale, Batiment 121,Orsay Campus, F-91405 Orsay, France.		pinet, patrick/ABF-6172-2021; Douté, Sylvain/C-2082-2013; Hauber, Ernst/U-2521-2018; Schmitt, Bernard/A-1064-2009; Bellucci, Giancarlo/ABA-9201-2020; Korablev, Oleg/L-5083-2013; Gomez, cecile/Q-2526-2019; Loizeau, Damien/P-4435-2017; Korablev, Oleg I/K-6770-2017; Gomez, Cécile/B-8473-2012; Fouchet, Thierry/C-6374-2017	pinet, patrick/0000-0002-1933-5631; Hauber, Ernst/0000-0002-1375-304X; Schmitt, Bernard/0000-0002-1230-6627; Bellucci, Giancarlo/0000-0003-0867-8679; Korablev, Oleg/0000-0003-1115-0656; Gomez, cecile/0000-0002-2986-430X; Loizeau, Damien/0000-0001-6001-3880; Korablev, Oleg I/0000-0003-1115-0656; Gomez, Cécile/0000-0002-2986-430X; Fouchet, Thierry/0000-0001-9040-8285; Capaccioni, Fabrizio/0000-0003-1631-4314; Cerroni, Priscilla/0000-0003-0239-2741; Altieri, Francesca/0000-0002-6338-8300; Ignatiev, Nikolay/0000-0002-6358-7094				Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001469; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Bernal J.D., 1951, PHYS BASIS LIFE; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Carr M.H, 1996, WATER MARS; Chassefiere E, 2004, PLANET SPACE SCI, V52, P1039, DOI 10.1016/j.pss.2004.07.002; CHICARRO A, 2004, ESA SPEC PUBL, V1240, P00003; Christensen P.R., 2001, J GEOPHYS RES, V106, P23; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CHRISTENSEN PR, 2001, J GEOPHYS RES, V106, P885; Encrenaz T, 2004, ICARUS, V170, P424, DOI 10.1016/j.icarus.2004.05.008; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Griffith LL, 1997, J GEOPHYS RES-PLANET, V102, P9135, DOI 10.1029/96JE02939; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KAHN R, 1985, ICARUS, V62, P175, DOI 10.1016/0019-1035(85)90116-2; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pieters C., 1993, REMOTE GEOCHEMICAL A, P309; PINET P, 1990, J GEOPHYS RES-SOLID, V95, P14435, DOI 10.1029/JB095iB09p14435; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	33	1149	1164	5	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					400	404		10.1126/science.1122659	http://dx.doi.org/10.1126/science.1122659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627738				2022-12-28	WOS:000236941800040
J	D'Angelo, MA; Anderson, DJ; Richard, E; Hetzer, MW				D'Angelo, MA; Anderson, DJ; Richard, E; Hetzer, MW			Nuclear pores form de novo from both sides of the nuclear envelope	SCIENCE			English	Article							COMPLEX; RAN; ORGANIZATION; STEPS; CYCLE	Nuclear pore complexes are multiprotein channels that span the double lipid bilayer of the nuclear envelope. How new pores are inserted into the intact nuclear envelope of proliferating and differentiating eukaryotic cells is unknown. We found that the Nup107-160 complex was incorporated into assembly sites in the nuclear envelope from both the nucleoplasmic and the cytoplasmic sides. Nuclear pore insertion required the generation of Ran guanosine triphosphate in the nuclear and cytoplasmic compartments. Newly formed nuclear pore complexes did not contain structural components of preexisting pores, suggesting that they can form de novo.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Anderson, Daniel/0000-0002-3249-2439				BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bodoor K, 1999, BIOCHEM CELL BIOL, V77, P321, DOI 10.1139/bcb-77-4-321; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; HETZER M, 2005, ANN REV CELL DEV BIO; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; MAUL GG, 1980, CYTOGENET CELL GENET, V26, P175, DOI 10.1159/000131439; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119	27	170	171	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					440	443		10.1126/science.1124196	http://dx.doi.org/10.1126/science.1124196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627745				2022-12-28	WOS:000236941800051
J	Dey, S; Joshi, A				Dey, S; Joshi, A			Stability via asynchrony in Drosophila metapopulations with low migration rates	SCIENCE			English	Article							SPATIAL POPULATION-DYNAMICS; DISPERSAL; MODELS; HETEROGENEITY; CHAOS	Very few experimental studies have examined how migration rate affects metapopulation dynamics and stability. We studied the dynamics of replicate laboratory metapopulations of Drosophila under different migration rates. Low migration stabilized metapopulation dynamics, while promoting unstable subpopulation dynamics, by inducing asynchrony among neighboring subpopulations. High migration synchronized subpopulation dynamics, thereby destabilizing the meta populations. Contrary to some theoretical predictions, increased migration did not affect average population size. Simulations based on a simple non-species-specific population growth model captured most features of the data, which suggests that our results are generalizable.	Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Evolutionary Biol Lab, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Joshi, A (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Evolutionary Biol Lab, Jakkur PO, Bangalore 560064, Karnataka, India.	ajoshi@incasr.ac.in						ALLEN JC, 1993, NATURE, V364, P229, DOI 10.1038/364229a0; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Brannstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2065, DOI 10.1098/rspb.2005.3185; CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Dey S, 2006, J THEOR BIOL, V238, P78, DOI 10.1016/j.jtbi.2005.05.013; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; GYLLENBERG M, 1993, MATH BIOSCI, V118, P25, DOI 10.1016/0025-5564(93)90032-6; HANSKI I, 1993, J THEOR BIOL, V163, P491, DOI 10.1006/jtbi.1993.1134; Hanski I., 1999, METAPOPULATION ECOLO; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Ives AR, 2004, AM NAT, V163, P375, DOI 10.1086/381942; Kendall BE, 1998, THEOR POPUL BIOL, V54, P11, DOI 10.1006/tpbi.1998.1365; Lecomte J, 2004, J ANIM ECOL, V73, P179, DOI 10.1111/j.1365-2656.2004.00796.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mueller L.D., 2000, STABILITY MODEL POPU; Nachman G, 2000, OIKOS, V91, P51, DOI 10.1034/j.1600-0706.2000.910105.x; NACHMAN G, 1987, J ANIM ECOL, V56, P267, DOI 10.2307/4814; NACHMAN G, 1991, BIOL J LINN SOC, V42, P285, DOI 10.1111/j.1095-8312.1991.tb00564.x; Ranta E, 1998, OIKOS, V83, P376, DOI 10.2307/3546852; Ripa J, 2000, OIKOS, V89, P175, DOI 10.1034/j.1600-0706.2000.890119.x; RUXTON GD, 1994, P ROY SOC B-BIOL SCI, V256, P189, DOI 10.1098/rspb.1994.0069; Ruxton GD, 1996, J ANIM ECOL, V65, P161, DOI 10.2307/5719; Sheeba V, 1998, CURR SCI INDIA, V75, P1406	27	99	100	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					434	436		10.1126/science.1125317	http://dx.doi.org/10.1126/science.1125317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627743				2022-12-28	WOS:000236941800049
J	Hajitou, A; Trepel, M; Lilley, CE; Soghomonyan, S; Alauddin, MM; Marini, FC; Restel, BH; Ozawa, MG; Moya, CA; Rangel, R; Sun, Y; Zaoui, K; Schmidt, M; von Kalle, C; Weitzman, MD; Gelovani, JG; Pasqualini, R; Arap, W				Hajitou, A; Trepel, M; Lilley, CE; Soghomonyan, S; Alauddin, MM; Marini, FC; Restel, BH; Ozawa, MG; Moya, CA; Rangel, R; Sun, Y; Zaoui, K; Schmidt, M; von Kalle, C; Weitzman, MD; Gelovani, JG; Pasqualini, R; Arap, W			A hybrid vector for ligand-directed tumor targeting and molecular imaging	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; KINASE GENE-TRANSFER; ADENOASSOCIATED VIRUS; IN-VIVO; THYMIDINE KINASE; MAMMALIAN-CELLS; LIVING SUBJECTS; EXPRESSION; DELIVERY; THERAPY	Merging tumor targeting and molecular-genetic imaging into an integrated platform is limited by lack of strategies to enable systemic yet ligand-directed delivery and imaging of specific transgenes. Many eukaryotic viruses serve for transgene delivery but require elimination of native tropism for mammalian cells; in contrast, prokaryotic viruses can be adapted to bind to mammalian receptors but are otherwise poor vehicles. Here we introduce a system containing cis-elements from adeno-associated virus (AAV) and single-stranded bacteriophage. Our AAV/phage (AAVP) prototype targets an integrin. We show that AAVP provides superior tumor transduction over phage and that incorporation of inverted terminal repeats is associated with improved fate of the delivered transgene. Moreover, we show that the temporal dynamics and spatial heterogeneity of gene expression mediated by targeted AAVP can be monitored by positron emission tomography. This new class of targeted hybrid viral particles will enable a wide range of applications in biology and medicine.	Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bone Marrow Transplantat, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Freiburg, Ctr Med, Dept Hematol & Oncol, D-79106 Freiburg, Germany; Univ Freiburg, Ctr Med, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Freiburg; University of Freiburg; Salk Institute	Pasqualini, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rpasqual@mdanderson.org; warap@mdanderson.org	Marini, Frank C/L-8018-2016; Rangel, Roberto/AHE-6583-2022	Rangel, Roberto/0000-0002-9088-7957; Soghomonyan, Suren/0000-0001-5930-9051; Hajitou, Amin/0000-0003-1119-5686	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alauddin MM, 2003, J LABELLED COMPD RAD, V46, P285, DOI 10.1002/jlcr.637; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Barbas C.F., 2001, PHAGE DISPLAY LAB MA; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Blasberg RG, 2003, J CLIN INVEST, V111, P1620, DOI 10.1172/JCI200318855; Chen LM, 2004, CHEM BIOL, V11, P1081, DOI 10.1016/j.chembiol.2004.05.019; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; GEIER MR, 1973, NATURE, V246, P221, DOI 10.1038/246221a0; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Gross S, 2005, METHOD ENZYMOL, V399, P512, DOI 10.1016/S0076-6879(05)99035-6; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Hajitou A, 2006, TRENDS CARDIOVAS MED, V16, P80, DOI 10.1016/j.tcm.2006.01.003; Hajitou A, 2001, CANCER RES, V61, P3450; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Hsiao CD, 2001, DEV DYNAM, V220, P323, DOI 10.1002/dvdy.1113; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P463, DOI 10.1016/S0167-4889(98)00163-3; Kang KW, 2005, MOL IMAGING BIOL, V7, P296, DOI 10.1007/s11307-005-0010-7; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Larocca D, 1999, FASEB J, V13, P727, DOI 10.1096/fasebj.13.6.727; Lieber A, 1999, J VIROL, V73, P9314, DOI 10.1128/JVI.73.11.9314-9324.1999; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Mizuguchi H, 2004, HUM GENE THER, V15, P1034, DOI 10.1089/hum.2004.15.1034; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pentz RD, 2005, NAT MED, V11, P1145, DOI 10.1038/nm1105-1145; Piersanti S, 2004, J MOL MED, V82, P467, DOI 10.1007/s00109-004-0543-2; Poul MA, 1999, J MOL BIOL, V288, P203, DOI 10.1006/jmbi.1999.2678; Ray P, 2001, SEMIN NUCL MED, V31, P312, DOI 10.1053/snuc.2001.26209; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Souza GR, 2006, P NATL ACAD SCI USA, V103, P1215, DOI 10.1073/pnas.0509739103; Tai YC, 2005, ANNU REV BIOMED ENG, V7, P255, DOI 10.1146/annurev.bioeng.6.040803.140021; Tjuvajev JG, 1998, CANCER RES, V58, P4333; Tjuvajev JG, 1999, CANCER RES, V59, P5186; Tjuvajev JG, 2003, CANCER CELL, V3, P327, DOI 10.1016/S1535-6108(03)00082-5; Trepel M, 2001, CANCER RES, V61, P8110; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7	45	206	223	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					385	398		10.1016/j.cell.2006.02.042	http://dx.doi.org/10.1016/j.cell.2006.02.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630824	Bronze			2022-12-28	WOS:000237241500026
J	Lee, TI; Jenner, RG; Boyer, LA; Guenther, MG; Levine, SS; Kumar, RM; Chevalier, B; Johnstone, SE; Cole, MF; Isono, K; Koseki, H; Fuchikami, T; Abe, K; Murray, HL; Zucker, JP; Yuan, BB; Bell, GW; Herbolsheimer, E; Hannett, NM; Sun, KM; Odom, DT; Otte, AP; Volkert, TL; Bartel, DP; Melton, DA; Gifford, DK; Jaenisch, R; Young, RA				Lee, TI; Jenner, RG; Boyer, LA; Guenther, MG; Levine, SS; Kumar, RM; Chevalier, B; Johnstone, SE; Cole, MF; Isono, K; Koseki, H; Fuchikami, T; Abe, K; Murray, HL; Zucker, JP; Yuan, BB; Bell, GW; Herbolsheimer, E; Hannett, NM; Sun, KM; Odom, DT; Otte, AP; Volkert, TL; Bartel, DP; Melton, DA; Gifford, DK; Jaenisch, R; Young, RA			Control of developmental regulator's by polycomb in human embryonic stem cells	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; GROUP GENE; MONOCLONAL-ANTIBODIES; MOUSE DEVELOPMENT; RESPONSE ELEMENT; GROUP-COMPLEXES; DROSOPHILA; TRANSCRIPTION; MAINTENANCE; PROTEIN	Polycomb group proteins are essential for early development in metazoans, but their contributions to human development are not well understood. We have mapped the Polycomb Repressive Complex 2 (PRC2) subunit SUZ12 across the entire nonrepeat portion of the genome in human embryonic stem (ES) cells. We found that SUZ12 is distributed across large portions of over two hundred genes encoding key developmental regulators. These genes are occupied by nucleosomes trimethylated at histone H3K27, are transcriptionally repressed, and contain some of the most highly conserved noncoding elements in the genome. We found that PRC2 target genes are preferentially activated during ES cell differentiation and that the ES cell regulators OCT4, SOX2, and NANOG cooccupy a significant subset of these genes. These results indicate that PRC2 occupies a special set of developmental genes in ES cells that must be repressed to maintain pluripotency and that are poised for activation during ES cell differentiation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; RIKEN, Ctr Allergy & Immunol, Dev Genet Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN, Tsukuba Inst, BioResource Ctr, Technol & Dev Team Mammalian Cellular Dynam, Tsukuba, Ibaraki 2300045, Japan; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, CSAIL, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); RIKEN; RIKEN; University of Amsterdam; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Jenner, Richard/J-8683-2012; Koseki, Haruhiko/I-3825-2014	Young, Richard A/0000-0001-8855-8647; Jenner, Richard/0000-0002-2946-6811; Koseki, Haruhiko/0000-0001-8424-5854; Odom, Duncan/0000-0001-6201-5599; Levine, Stuart/0000-0001-7363-562X; Isono, Kyoichi/0000-0002-4609-8985	NHGRI NIH HHS [HG002668, R01 HG002668, R01 HG002668-03] Funding Source: Medline; NIDDK NIH HHS [K25 DK070813, DK070813] Funding Source: Medline; NIGMS NIH HHS [GM069400, R01 GM069400] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK070813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069400] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENDER M, 1987, DEV BIOL, V119, P418, DOI 10.1016/0012-1606(87)90046-7; Birve A, 2001, DEVELOPMENT, V128, P3371; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BOYER LA, 2006, IN PRESS NATURE; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; DENELL RE, 1983, DEV BIOL, V97, P34, DOI 10.1016/0012-1606(83)90061-1; DUNCAN I, 1986, CELL, V47, P297, DOI 10.1016/0092-8674(86)90452-6; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Hamer KM, 2002, HYBRIDOMA HYBRIDOM, V21, P245, DOI 10.1089/153685902760213859; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Kennison JA, 2004, METHOD ENZYMOL, V377, P61; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mayhall EA, 2004, CURR OPIN CELL BIOL, V16, P713, DOI 10.1016/j.ceb.2004.09.007; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIMON J, 1992, DEVELOPMENT, V114, P493; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tie F, 2001, DEVELOPMENT, V128, P275; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang JB, 2002, MAMM GENOME, V13, P493, DOI 10.1007/s00335-002-2182-7; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	66	1792	1871	0	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					301	313		10.1016/j.cell.2006.02.043	http://dx.doi.org/10.1016/j.cell.2006.02.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630818	Bronze, Green Accepted			2022-12-28	WOS:000237241500020
J	Wingham, DJ; Siegert, MJ; Shepherd, A; Muir, AS				Wingham, DJ; Siegert, MJ; Shepherd, A; Muir, AS			Rapid discharge connects Antarctic subglacial lakes	NATURE			English	Article							ICE-SHEET; EAST ANTARCTICA; GLACIER; VOSTOK; MELTWATER; BENEATH; SYSTEM	The existence of many subglacial lakes(1) provides clear evidence for the widespread presence of water beneath the East Antarctic ice sheet, but the hydrology beneath this ice mass is poorly understood(2). Such knowledge is critical to understanding ice flow, basal water transfer to the ice margin, glacial landform development and subglacial lake habitats. Here we present ice-sheet surface elevation changes in central East Antarctica that we interpret to represent rapid discharge from a subglacial lake. Our observations indicate that during a period of 16 months, 1.8 km(3) of water was transferred over 290 km to at least two other subglacial lakes. While viscous deformation of the ice roof above may moderate discharge, the intrinsic instability of such a system(3) suggests that discharge events are a common mode of basal drainage(4). If large lakes, such as Lake Vostok or Lake Concordia(1), are pressurizing, it is possible that substantial discharges could reach the coast(5,6). Our observations conflict with expectations that subglacial lakes have long residence times and slow circulations(2,7,8), and we suggest that entire subglacial drainage basins may be flushed periodically. The rapid transfer of water between lakes would result in large-scale solute and microbe relocation, and drainage system contamination from in situ exploration is, therefore, a distinct risk.	UCL, Dept Space & Climate Phys, Ctr Polar Observat & Modelling, London WC1E 6BT, England; Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Ctr Polar Observat & Modelling, Bristol BS8 1SS, Avon, England; Univ Cambridge, Scott Polar Res Inst, Ctr Polar Observat & Modelling, Cambridge CB2 1ER, England	University of London; University College London; University of Bristol; University of Cambridge	Wingham, DJ (corresponding author), UCL, Dept Space & Climate Phys, Ctr Polar Observat & Modelling, Pearson Bldg,Gower St, London WC1E 6BT, England.	djw@cpom.ucl.ac.uk; m.j.siegert@bristol.ac.uk	Siegert, Martin J/A-3826-2008; Siegert, Martin/M-9939-2019	Siegert, Martin J/0000-0002-0090-4806; Siegert, Martin/0000-0002-0090-4806; Muir, Alan/0000-0001-7754-088X; Shepherd, Andrew/0000-0002-4914-1299				Bell RE, 2002, NATURE, V416, P307, DOI 10.1038/416307a; Bjornsson H, 1998, NATURE, V395, P771, DOI 10.1038/27384; Denton GH, 2005, GEOGR ANN A, V87A, P67, DOI 10.1111/j.0435-3676.2005.00245.x; Fowler AC, 1999, J GLACIOL, V45, P506, DOI 10.3189/S0022143000001362; Gray L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021387; HUYBRECHTS P, 1992, BERICHTE POLARFORSCH, V99, P1; Joughin I, 1996, J GLACIOL, V42, P564, DOI 10.3189/S0022143000003543; KAMB B, 1987, J GEOPHYS RES-SOLID, V92, P9083, DOI 10.1029/JB092iB09p09083; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; McKay CP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017490; Nye J.F., 1976, J GLACIOL, V17, P181, DOI [10.3189/S002214300001354X, DOI 10.3189/S002214300001354X]; Royston-Bishop G, 2004, ANN GLACIOL-SER, V39, P490, DOI 10.3189/172756404781813853; Sawagaki T, 1997, GEOGR ANN A, V79A, P223, DOI 10.1111/1468-0459.00019; Shreve R.L., 1972, J GLACIOL, V11, P205, DOI [DOI 10.3189/S002214300002219X, 10.3189/S002214300002219X]; Sieger MJ, 2005, GLOBAL PLANET CHANGE, V45, P249, DOI 10.1016/j.gloplacha.2004.09.008; Siegert MJ, 2005, ANTARCT SCI, V17, P453, DOI 10.1017/S0954102005002889; Siegert MJ, 2001, NATURE, V414, P603, DOI 10.1038/414603a; Studinger M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019801; VANDERVEEN CJ, 1999, FUNDAMENTALS GLACIER, P1; Wingham DJ, 1998, SCIENCE, V282, P456, DOI 10.1126/science.282.5388.456	20	287	309	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1033	1036		10.1038/nature04660	http://dx.doi.org/10.1038/nature04660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625193				2022-12-28	WOS:000236906000032
J	Dietrich, AJ; Tobin, JN; Cassells, A; Robinson, CM; Greene, MA; Sox, CH; Beach, ML; DuHamel, KN; Younge, RG				Dietrich, AJ; Tobin, JN; Cassells, A; Robinson, CM; Greene, MA; Sox, CH; Beach, ML; DuHamel, KN; Younge, RG			Telephone care management to improve cancer screening among low-income women - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-HEALTH CENTERS; PRACTICAL CLINICAL-TRIALS; TAILORED INTERVENTIONS; PROMOTE MAMMOGRAPHY; RACIAL DISPARITIES; COST-EFFECTIVENESS; BREAST-CANCER; PARTICIPATION; POPULATION; PREVENTION	Background: Minority and low-income women receive fewer cancer screenings than other women. Objective: To evaluate the effect of a telephone support intervention to increase rates of breast, cervical and colorectal cancer screening among minority and low-income women. Design: Randomized, controlled trial conducted between November 2001 and April 2004. Setting: 11 community and migrant health centers in New York city. Patients: 1413 women who were overdue for cancer screening. Intervention: Over 18 months, women assigned to the intervention group received an average of 4 calls from prevention care managers and women assigned to the control group received usual care. Follow-up data were available for 99% of women, and 91 % of the intervention group received at least 1 call. Measurements: Medical record documentation of mammography, Papanicolaou testing, and colorectal cancer screening according to U.S. Preventive Services Task Force recommendations. Results: The proportion of women who had mammography increased from 0.58 to 0.68 with the intervention and decreased from 0.60 to 0.58 with usual care; the proportion who had Papanicolaou testing increased from 0.71 to 0.78 with the intervention and was unchanged with usual care; and the proportion who had colorectal screening increased from 0.39 to 0.63 with the intervention and from 0.39 to 0.50 with usual care. The difference in the change in screening rates between groups was 0.12 for mammography (95% Cl, 0.06 to 0.19), 0.07 for Papanicolaou testing (Cl, 0.01 to 0.12), and 0.13 for colorectal screening (Cl, 0.07 to 0.19). The proportion of women who were up to date for 3 tests increased from 0.21 to 0.43 with the intervention. Limitations: Participants were from 1 city and had access to a regular source of care. Medical records may not have captured all cancer screenings. Conclusions: Telephone support can improve cancer screening rates among women who visit community and migrant health centers. The intervention seems to be well suited to health plans, large medical groups, and other organizations that seek to increase cancer screening rates and to address disparities in care.	Dartmouth Coll, Sch Med, Dept Family & Community Med, Hanover, NH 03755 USA; Dartmouth Coll, Hitchcock Med Ctr, Norris Cotton Canc Ctr, Hanover, NH 03756 USA; Yeshiva Univ Albert Einstein Coll Med, Montefiore Med Grp, Bronx, NY 10461 USA; Fordham Family Practice, Bronx, NY USA; Mt Sinai Sch Med, Clin Directors Network, New York, NY USA; Beth Israel Deaconess Med Ctr, New York, NY 10003 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Harvard University; Beth Israel Deaconess Medical Center	Dietrich, AJ (corresponding author), Dartmouth Coll, Sch Med, Dept Family & Community Med, 7250 Strasenburgh Hall, Hanover, NH 03755 USA.	Allen.J.Dietrich@dartmouth.edu	Tobin, Jonathan N./R-2413-2019	Tobin, Jonathan/0000-0003-4722-539X	NATIONAL CANCER INSTITUTE [R01CA119014, P30CA008748, R01CA087776] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA087776, R01 CA119014, P30 CA008748, R01 CA-87776, R01 CA119014-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AG HEALTHC RES QU, 2003, SCREEN CERV CANC REC; *AG HEALTHC RES QU, 1997, PUT PREV PRACT; [Anonymous], 2005, NAT HEALTHC DISP REP; Barr JK, 2001, AM J MANAG CARE, V7, P887; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Champion V, 2003, PREV MED, V36, P150, DOI 10.1016/S0091-7435(02)00038-5; Cooper GS, 2004, CANCER-AM CANCER SOC, V100, P418, DOI 10.1002/cncr.20014; Crane LA, 2000, CANCER EPIDEM BIOMAR, V9, P923; Dietrich AJ, 1998, ARCH FAM MED, V7, P320, DOI 10.1001/archfami.7.4.320; DIETRICH AJ, 1992, BRIT MED J, V304, P687, DOI 10.1136/bmj.304.6828.687; Duan NH, 2000, AM J PUBLIC HEALTH, V90, P1468, DOI 10.2105/AJPH.90.9.1468; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Friedrich MJ, 2000, JAMA-J AM MED ASSOC, V283, P467, DOI 10.1001/jama.283.4.467; GERONIMUS A, 1993, VALIDITY USING CENSU, P269; Glasgow RE, 2005, MED CARE, V43, P551, DOI 10.1097/01.mlr.0000163645.41407.09; *HLTH RES SERV ADM, 2003, SECT 330 GRANT UN DA; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; LANTZ PM, 1995, AM J PUBLIC HEALTH, V85, P834, DOI 10.2105/AJPH.85.6.834; Levin B, 2002, CANCER-AM CANCER SOC, V95, P1618, DOI 10.1002/cncr.10890; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; *NAT AC PRESS, 2004, UN TREATM CONFR RAC; *NAT CANC I, 2003, CANC HLTH DISP FACT; *NAT CANC I, PAT NAV RES PROGR; *NAT COMM QUAL ASS, HEDIS 2005 SUMM TABL; *NEW YORK CIT HLTH, COL CIT HOSP DOUBL 2; Ogedegbe G, 2005, J NATL MED ASSOC, V97, P162; Prochaska J. O., 1986, TREATING ADDICTIVE B, P3, DOI DOI 10.1007/978-1-4613-2191-0_; Riegel B, 2002, ARCH INTERN MED, V162, P705, DOI 10.1001/archinte.162.6.705; Rimer BK, 1999, PATIENT EDUC COUNS, V37, P125, DOI 10.1016/S0738-3991(98)00122-0; Roetzheim RG, 2005, ANN FAM MED, V3, P109, DOI 10.1370/afm.240; Roetzheim RG, 2004, ANN FAM MED, V2, P294, DOI 10.1370/afm.101; Saywell RM, 2004, J WOMENS HEALTH, V13, P909, DOI 10.1089/jwh.2004.13.909; Schiffman M. H., 1996, CANC EPIDEMIOLOGY PR, P1090; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Taylor CB, 2003, DIABETES CARE, V26, P1058, DOI 10.2337/diacare.26.4.1058; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *US DEP HHS, HLTH PEOPL 2010; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; West DS, 2004, HEALTH EDUC BEHAV, V31, p29S, DOI 10.1177/1090198104266033; Winker MA, 2004, JAMA-J AM MED ASSOC, V292, P1612, DOI 10.1001/jama.292.13.1612; Wood D, 1998, JAMA-J AM MED ASSOC, V279, P29, DOI 10.1001/jama.279.1.29; Woolf SH, 2004, AM J PUBLIC HEALTH, V94, P2078, DOI 10.2105/AJPH.94.12.2078; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	44	137	140	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					563	571		10.7326/0003-4819-144-8-200604180-00006	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035QZ	16618953	Green Accepted			2022-12-28	WOS:000237017900003
J	Mittermaier, A; Kay, LE				Mittermaier, A; Kay, LE			Review - New tools provide new insights in NMR studies of protein dynamics	SCIENCE			English	Review							RELAXATION DISPERSION EXPERIMENTS; MODEL-FREE APPROACH; SH3 DOMAIN MUTANT; CORRELATED MOTIONS; BACKBONE DYNAMICS; BIOLOGICAL MACROMOLECULES; GLOBULAR-PROTEINS; CHEMICAL-EXCHANGE; RESIDUAL DIPOLAR; SPECTROSCOPY	There is growing evidence that structural flexibility plays a central role in the function of protein molecules. Many of the experimental data come from nuclear magnetic resonance ( NMR) spectroscopy, a technique that allows internal motions to be probed with exquisite time and spatial resolution. Recent methodological advancements in NMR have extended our ability to characterize protein dynamics and promise to shed new light on the mechanisms by which these molecules function. Here, we present a brief overview of some of the new methods, together with applications that illustrate the level of detail at which protein motions can now be observed.	McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada; Univ Toronto, Dept Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada	McGill University; University of Toronto; University of Toronto; University of Toronto	Mittermaier, A (corresponding author), McGill Univ, Dept Chem, 801 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	anthony.mittermaier@mcgill.ca; kay@pound.med.utoronto.ca	Mittermaier, Anthony/R-3210-2017	Mittermaier, Anthony/0000-0002-3767-1225				Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Bremi T, 1997, J AM CHEM SOC, V119, P6672, DOI 10.1021/ja9708676; Chou JJ, 2003, J AM CHEM SOC, V125, P8959, DOI 10.1021/ja029972s; Clore GM, 2004, BIOCHEMISTRY-US, V43, P10678, DOI 10.1021/bi049357w; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Ishima R, 2003, J BIOMOL NMR, V25, P243, DOI 10.1023/A:1022851228405; Ishima R, 2001, J MOL BIOL, V305, P515, DOI 10.1006/jmbi.2000.4321; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Korzhnev DM, 2005, J AM CHEM SOC, V127, P15602, DOI 10.1021/ja054550e; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lundstrom P, 2005, P NATL ACAD SCI USA, V102, P16984, DOI 10.1073/pnas.0504361102; Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z; Mittermaier A, 2005, BIOCHEMISTRY-US, V44, P15430, DOI 10.1021/bi051771o; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pelupessy P, 2003, J BIOMOL NMR, V25, P265, DOI 10.1023/A:1023076212536; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tolman JR, 1997, NAT STRUCT BIOL, V4, P292, DOI 10.1038/nsb0497-292; Wang TZ, 2005, J AM CHEM SOC, V127, P828, DOI 10.1021/ja045743p; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; WUTHRICH K, 1978, TRENDS BIOCHEM SCI, V3, P227, DOI 10.1016/S0968-0004(78)94607-8	31	619	628	7	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					224	228		10.1126/science.1124964	http://dx.doi.org/10.1126/science.1124964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614210				2022-12-28	WOS:000236765300036
J	Lesurtel, M; Graf, R; Aleil, B; Walther, DJ; Tian, YH; Jochum, W; Gachet, C; Bader, M; Clavien, PA				Lesurtel, M; Graf, R; Aleil, B; Walther, DJ; Tian, YH; Jochum, W; Gachet, C; Bader, M; Clavien, PA			Platelet-derived serotonin mediates liver regeneration	SCIENCE			English	Article							TRYPTOPHAN-HYDROXYLASE ISOFORM; ENDOTHELIAL-CELL APOPTOSIS; ISCHEMIC RAT-LIVER; REPERFUSION INJURY; 5-HT2B RECEPTOR; GROWTH-FACTOR; ALPHA; THROMBOCYTOPENIA; INFLAMMATION; SYSTEM	The liver can regenerate its volume after major tissue loss. In a mouse model of liver regeneration, thrombocytopenia, or impaired platelet activity resulted in the failure to initiate cellular proliferation in the liver. Platelets are major carriers of serotonin in the blood. In thrombocytopenic mice, a serotonin agonist reconstituted liver proliferation. The expression of 5-HT2A and 2B subtype serotonin receptors in the liver increased after hepatectomy. Antagonists of 5-HT2A and 2B receptors inhibited liver regeneration. Liver regeneration was also blunted in mice lacking tryptophan hydroxylase 1, which is the rate-limiting enzyme for the synthesis of peripheral serotonin. This failure of regeneration was rescued by reloading serotonin-free platelets with a serotonin precursor molecule. These results suggest that platelet-derived serotonin is involved in the initiation of liver regeneration.	Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Zurich, Switzerland; Univ Zurich Hosp, Dept Pathol, Zurich, Switzerland; INSERM, U311, Estab Francais Sang Alsace, Strasbourg, France; Max Planck Inst Mol Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Clavien, PA (corresponding author), Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Zurich, Switzerland.	clavien@chir.unizh.ch	Bader, Michael/K-2124-2013; Gachet, Christian/H-9156-2016; Lesurtel, Mickaël/J-3710-2019	Lesurtel, Mickaël/0000-0003-2397-4599; Bader, Michael/0000-0003-4780-4164; Graf, Rolf/0000-0001-7449-7302				Balasubramanian S, 1998, HEPATOLOGY, V27, P62, DOI 10.1002/hep.510270111; BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P622, DOI 10.1111/j.1476-5381.1995.tb14977.x; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CYWES R, 1993, HEPATOLOGY, V18, P635, DOI 10.1002/hep.1840180324; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eddahibi S, 1997, AM J PHYSIOL-HEART C, V272, pH1173, DOI 10.1152/ajpheart.1997.272.3.H1173; EVENSEN SA, 1968, THROMB DIATH HAEMOST, V19, P570, DOI 10.1055/s-0038-1651236; FANBURG BL, 1997, AM J PHYSIOL, V272, P795; Fiorica-Howells E, 2000, J NEUROSCI, V20, P294, DOI 10.1523/JNEUROSCI.20-01-00294.2000; Gachet C, 2001, THROMB HAEMOSTASIS, V86, P222; Gawaz M., 2001, BLOOD PLATELETS PHYS, V1st ed, pp. 200; George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; JULIUS D, 1990, P NATL ACAD SCI USA, V87, P928, DOI 10.1073/pnas.87.3.928; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; Kohli V, 1999, TRANSPLANTATION, V67, P1099, DOI 10.1097/00007890-199904270-00003; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; Mannaioni PF, 1997, INFLAMM RES, V46, P4, DOI 10.1007/PL00000158; Marcos E, 2004, CIRC RES, V94, P1263, DOI 10.1161/01.RES.0000126847.27660.69; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Moritani C, 1998, CHEST, V113, P452, DOI 10.1378/chest.113.2.452; MULLANE KM, 1985, J CARDIOVASC PHARM, V7, P733, DOI 10.1097/00005344-198507000-00018; MUNRO JM, 1988, LAB INVEST, V58, P249; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P2591, DOI 10.1073/pnas.050282397; Okada Y, 1997, TRANSPLANTATION, V64, P801, DOI 10.1097/00007890-199709270-00002; ROSEN R, 1987, CARDIOVASC RES, V21, P293, DOI 10.1093/cvr/21.4.293; ROUSSEAU G, 1993, AM HEART J, V125, P1553, DOI 10.1016/0002-8703(93)90740-Z; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Selleng K, 2005, AM J HEMATOL, V78, P188, DOI 10.1002/ajh.20305; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; SEUWEN K, 1990, BIOCHEM PHARMACOL, V39, P985, DOI 10.1016/0006-2952(90)90276-Q; Sindram D, 2000, GASTROENTEROLOGY, V118, P183, DOI 10.1016/S0016-5085(00)70427-6; Sindram D, 2001, FASEB J, V15, P1230, DOI 10.1096/fj.00-0554fje; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Welsh DJ, 2004, AM J RESP CRIT CARE, V170, P252, DOI 10.1164/rccm.200302-264OC; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120	41	575	601	6	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					104	107		10.1126/science.1123842	http://dx.doi.org/10.1126/science.1123842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601191				2022-12-28	WOS:000236584400041
J	Konishi, S; Izawa, T; Lin, SY; Ebana, K; Fukuta, Y; Sasaki, T; Yano, M				Konishi, Saeko; Izawa, Takeshi; Lin, Shao Yang; Ebana, Kaworu; Fukuta, Yoshimichi; Sasaki, Takuji; Yano, Masahiro			An SNP caused loss of seed shattering during rice domestication	SCIENCE			English	Article							MADS-BOX GENES; HOMEODOMAIN PROTEIN; HOMEOBOX GENES; DIVERSITY; ARABIDOPSIS; PATTERN; ORIGIN; DISPERSAL; GENETICS; PROMOTER	Loss of seed shattering was a key event in the domestication of major cereals. We revealed that the qSH1 gene, a major quantitative trait locus of seed shattering in rice, encodes a BEL1-type homeobox gene and demonstrated that a single-nucleotide polymorphism ( SNP) in the 5' regulatory region of the qSH1 gene caused loss of seed shattering owing to the absence of abscission layer formation. Haplotype analysis and association analysis in various rice collections revealed that the SNP was highly associated with shattering among japonica subspecies of rice, implying that it was a target of artificial selection during rice domestication.	Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan	National Institute of Agrobiological Sciences - Japan; Japan International Research Center for Agricultural Sciences	Yano, M (corresponding author), Natl Inst Agrobiol Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	myano@nias.affrc.go.jp	Yano, Masahiro/AAC-5441-2019	Yano, Masahiro/0000-0003-1510-4622; Izawa, Takeshi/0000-0001-5109-0024				BAUMLEIN H, 1992, PLANT J, V2, P233; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Ezcurra I, 2000, PLANT J, V24, P57, DOI 10.1046/j.1365-313x.2000.00857.x; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; ICHIKAWA T, 1990, JARQ-JPN AGR RES Q, V24, P37; Ito M, 2002, INT REV CYTOL, V218, P1; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; MACNEISH RS, 1998, 2 SAJOR; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; REISER L, 1995, CELL, V83, P735, DOI 10.1016/0092-8674(95)90186-8; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; SATO YI, 1991, RICE GENET NEWSL, V8, P76; Smith HMS, 2004, CURR BIOL, V14, P812, DOI 10.1016/j.cub.2004.04.032; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200	30	587	663	6	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1392	1396		10.1126/science.1126410	http://dx.doi.org/10.1126/science.1126410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16614172				2022-12-28	WOS:000237961600059
J	Brar, GA; Kiburz, BM; Zhang, Y; Kim, JE; White, F; Amon, A				Brar, Gloria A.; Kiburz, Brendan M.; Zhang, Yi; Kim, Ji-Eun; White, Forest; Amon, Angelika			Rec8 phosphorylation and recombination promote the step-wise loss of cohesins in meiosis	NATURE			English	Article							SISTER-CHROMATID COHESION; POLO-LIKE KINASE; PROTEIN PHOSPHATASE 2A; HOMOLOGOUS CHROMOSOMES; CENTROMERIC COHESION; SPINDLE CHECKPOINT; YEAST MEIOSIS; I DEPENDS; SEGREGATION; MEI-S332	During meiosis, cohesins-protein complexes that hold sister chromatids together-are lost from chromosomes in a step-wise manner(1). Loss of cohesins from chromosome arms is necessary for homologous chromosomes to segregate during meiosis I. Retention of cohesins around centromeres until meiosis II is required for the accurate segregation of sister chromatids. Here we show that phosphorylation of the cohesin subunit Rec8 contributes to step-wise cohesin removal. Our data further implicate two other key regulators of meiotic chromosome segregation, the cohesin protector Sgo1 and meiotic recombination in bringing about the step-wise loss of cohesins and thus the establishment of the meiotic chromosome segregation pattern. Understanding the interplay between these processes should provide insight into the events underlying meiotic chromosome mis-segregation, the leading cause of miscarriages and mental retardation in humans.	MIT, Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Ctr Canc Res, E17-233 40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu		White, Forest/0000-0002-1545-1651; Amon, Angelika/0000-0001-9837-0314	NIGMS NIH HHS [R01 GM062207] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2003, CURR BIOL, V13, P1979, DOI 10.1016/j.cub.2003.10.057; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	28	103	105	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					532	536		10.1038/nature04794	http://dx.doi.org/10.1038/nature04794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16672979				2022-12-28	WOS:000237778900055
J	Harnett, MM				Harnett, MM			B cells spread and gather	SCIENCE			English	Editorial Material							SYNAPSE FORMATION; ACTIVATION		Univ Glasgow, Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow	Harnett, MM (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland.	M.Harnett@bio.gla.ac.uk						Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179	6	7	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					709	710		10.1126/science.1127652	http://dx.doi.org/10.1126/science.1127652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675691				2022-12-28	WOS:000237312100038
J	Both, C; Bouwhuis, S; Lessells, CM; Visser, ME				Both, C; Bouwhuis, S; Lessells, CM; Visser, ME			Climate change and population declines in a long-distance migratory bird	NATURE			English	Article							TIT PARUS-MAJOR; LIFE-HISTORY TRAITS; FICEDULA-HYPOLEUCA; AVIAN REPRODUCTION; WINTER MOTH; PHENOLOGY; TEMPERATURE; SONGBIRDS; RESPONSES; MIGRANT	Phenological responses to climate change differ across trophic levels(1-3), which may lead to birds failing to breed at the time of maximal food abundance. Here we investigate the population consequences of such mistiming in the migratory pied flycatcher, Ficedula hypoleuca(4). In a comparison of nine Dutch populations, we find that populations have declined by about 90% over the past two decades in areas where the food for provisioning nestlings peaks early in the season and the birds are currently mistimed. In areas with a late food peak, early-breeding birds still breed at the right time, and there is, at most, a weak population decline. If food phenology advances further, we also predict population declines in areas with a late food peak, as in these areas adjustment to an advanced food peak is insufficient(4). Mistiming as a result of climate change is probably a widespread phenomenon(1), and here we provide evidence that it can lead to population declines.	NIOO KNAW, Netherlands Inst Ecol, NL-6666 ZG Heteren, Netherlands; Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolut Studies, NL-9750 AA Haren, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Groningen	Both, C (corresponding author), NIOO KNAW, Netherlands Inst Ecol, POB 40, NL-6666 ZG Heteren, Netherlands.	C.Both@rug.nl	Bouwhuis, Sandra/H-5270-2011; Visser, Marcel E/A-9151-2009; Both, Christiaan/E-6459-2011; Lessells, C.M./B-3891-2011	Bouwhuis, Sandra/0000-0003-4023-1578; Visser, Marcel E/0000-0002-1456-1939; Both, Christiaan/0000-0001-7099-9831; van der Heijden, Marianne/0000-0002-0795-3619				Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; Boele Arjan, 2001, Limosa, V74, P103; Both C, 2005, J AVIAN BIOL, V36, P368, DOI 10.1111/j.0908-8857.2005.03484.x; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Brommer JE, 2005, EVOLUTION, V59, P1362; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanz JJ, 1998, ARDEA, V86, P81; Sauer JR, 1996, CONSERV BIOL, V10, P465, DOI 10.1046/j.1523-1739.1996.10020465.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; TINBERGEN JM, 1994, FUNCT ECOL, V8, P563, DOI 10.2307/2389916; VANBALEN JH, 1973, ARDEA, V61, P1; Verboven N, 2001, ARDEA, V89, P387; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; von HAARTMAN LARS, 1954, ACTA ZOOL FENNICA, V83, P1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999	28	972	1025	6	774	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					81	83		10.1038/nature04539	http://dx.doi.org/10.1038/nature04539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672969	Green Published, Green Submitted			2022-12-28	WOS:000237248600036
J	Shalowitz, D; Wendler, D				Shalowitz, D; Wendler, D			Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: An integrated approach	ANNALS OF INTERNAL MEDICINE			English	Article								Researchers have found that implementation of the Health insurance Portability and Accountability Act (HIPAA) Privacy Rule is having a negative impact on clinical research. This impact traces, in part, to many research institutions complying with HIPAA by adding lengthy, complex language to their research consent documents. The addition of extensive language burdens institutional review boards and may undermine participants' understanding of the research in which they take part. Comparative analysis reveals, however, that the addition of lengthy text often is unnecessary. The U.S. federal requirements for informed consent for human subjects research and the HIPAA Privacy Rule's requirements for individual authorization overlap substantially. Hence, consent forms that satisfy the U.S. federal regulations for human subjects research need only minimal additional text to also satisfy the authorization requirements under the HIPAA Privacy Rule.	NIH Clin Ctr, Dept Clin Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Wendler, D (corresponding author), NIH Clin Ctr, Dept Clin Bioeth, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	dwendler@nih.gov	Shalowitz, David/AAS-9591-2021; Shalowitz, David/A-7432-2009	Shalowitz, David/0000-0002-5189-4687; 				BERGLER JH, 1980, CLIN PHARMACOL THER, V27, P435, DOI 10.1038/clpt.1980.60; Breese P, 2004, ANN INTERN MED, V141, P897, DOI 10.7326/0003-4819-141-11-200412070-00034; EHRINGHAUS SH, 2004, ASS GEN COUNS ASS AM; Harth SC, 1995, SOC SCI MED, V41, P1647, DOI 10.1016/0277-9536(95)00058-F; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; *HLTH CAR RES UND, 2004, HIPPA RUL; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610; O'Herrin JK, 2004, ANN SURG, V239, P772, DOI 10.1097/01.sla.0000128307.98274.dc; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; RIECKEN HW, 1982, JAMA-J AM MED ASSOC, V248, P344, DOI 10.1001/jama.248.3.344; *US DEP HHS, STAND PRV IND ID HLT; Weiss BD, 1998, J FAM PRACTICE, V46, P168	13	23	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					685	688		10.7326/0003-4819-144-9-200605020-00012	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039GJ	16670138				2022-12-28	WOS:000237293700008
J	Miller, C				Miller, C			Biophysics - Lonely voltage sensor seeks protons for permeation	SCIENCE			English	Editorial Material							ALVEOLAR EPITHELIAL-CELLS; HYDROGEN-ION CURRENTS; DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; PH		Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	cmiller@brandeis.edu						Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1991, BIOPHYS J, V60, P1243, DOI 10.1016/S0006-3495(91)82158-0; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; RAMSEY LS, 2006, NATURE          0322; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0	12	12	12	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					534	535		10.1126/science.1127186	http://dx.doi.org/10.1126/science.1127186			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645081				2022-12-28	WOS:000237296700028
J	Sfeir, MY; Beetz, T; Wang, F; Huang, LM; Huang, XMH; Huang, MY; Hone, J; O'Brien, S; Misewich, JA; Heinz, TF; Wu, LJ; Zhu, YM; Brus, LE				Sfeir, MY; Beetz, T; Wang, F; Huang, LM; Huang, XMH; Huang, MY; Hone, J; O'Brien, S; Misewich, JA; Heinz, TF; Wu, LJ; Zhu, YM; Brus, LE			Optical spectroscopy of individual single-walled carbon nanotubes of defined chiral structure	SCIENCE			English	Article							DENSITY-OF-STATES; RAMAN-SCATTERING; TRANSITIONS; DEPENDENCE; EXCITONS	We simultaneously determined the physical structure and optical transition energies of individual single-walled carbon nanotubes by combining electron diffraction with Rayleigh scattering spectroscopy. These results test fundamental features of the excited electronic states of carbon nanotubes. We directly verified the systematic changes in transition energies of semiconducting nanotubes as a function of their chirality and observed predicted energy splittings of optical transitions in metallic nanotubes.	Columbia Univ, Dept Chem, New York, NY 10027 USA; Columbia Univ, Dept Phys & Elect Engn, New York, NY 10027 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA	Columbia University; Columbia University; Columbia University; Columbia University; United States Department of Energy (DOE); Brookhaven National Laboratory	Sfeir, MY (corresponding author), Columbia Univ, Dept Chem, 3000 Broadway, New York, NY 10027 USA.	msfeir@bnl.gov	Hone, James C/E-1879-2011; Huang, Limin/J-6211-2014; OBrien, Stephen/O-8814-2019; bartelsdoe, ludwig/F-8008-2011; wang, Feng/I-5727-2015; O'Brien, Stephen/D-7682-2013; Heinz, Tony/K-7797-2015; Sfeir, Matthew/AAE-7390-2019; Huang, Mingyuan/B-4424-2011	Hone, James C/0000-0002-8084-3301; Huang, Limin/0000-0003-3053-0160; OBrien, Stephen/0000-0001-7531-8900; wang, Feng/0000-0001-8369-6194; O'Brien, Stephen/0000-0001-7531-8900; Heinz, Tony/0000-0003-1365-9464; Sfeir, Matthew/0000-0001-5619-5722; 				Ando T, 1997, J PHYS SOC JPN, V66, P1066, DOI 10.1143/JPSJ.66.1066; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Barone V, 2005, NANO LETT, V5, P1830, DOI 10.1021/nl0509733; Chang E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.196401; Fantini C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147406; Gao M, 2003, APPL PHYS LETT, V82, P2703, DOI 10.1063/1.1569418; Huang LM, 2004, J PHYS CHEM B, V108, P16451, DOI 10.1021/jp0474125; Jorio A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075401; Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118; KANE CL, 2004, PHYS REV LETT, V93; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Machon M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035416; Maultzsch J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205438; Maultzsch J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.241402; Meyer JC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.217401; Mintmire JW, 1998, PHYS REV LETT, V81, P2506, DOI 10.1103/PhysRevLett.81.2506; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Popov VN, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/017; Reich S, 2000, PHYS REV B, V62, P4273, DOI 10.1103/PhysRevB.62.4273; Saito R, 2000, PHYS REV B, V61, P2981, DOI 10.1103/PhysRevB.61.2981; Saito R, 1998, PHYS PROPERTIES CARB; Samsonidze GG, 2004, APPL PHYS LETT, V85, P5703, DOI 10.1063/1.1829160; Sfeir MY, 2004, SCIENCE, V306, P1540, DOI 10.1126/science.1103294; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; Telg H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.177401; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Yu ZH, 2001, J PHYS CHEM B, V105, P6831, DOI 10.1021/jp010853t	29	200	203	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					554	556		10.1126/science.1124602	http://dx.doi.org/10.1126/science.1124602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645089				2022-12-28	WOS:000237296700038
J	Ferrara, G; Losi, M; D'Amico, R; Roversi, P; Piro, R; Meacci, M; Meccugni, B; Dori, IM; Andreani, A; Bergamini, BM; Mussini, C; Rumpianesi, F; Fabbri, LM; Richeldi, L				Ferrara, G; Losi, M; D'Amico, R; Roversi, P; Piro, R; Meacci, M; Meccugni, B; Dori, IM; Andreani, A; Bergamini, BM; Mussini, C; Rumpianesi, F; Fabbri, LM; Richeldi, L			Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study	LANCET			English	Article							ENZYME-LINKED IMMUNOSPOT; INTERFERON-GAMMA ASSAY; CELL-BASED ASSAY; SKIN-TEST; ENUMERATION; TRACKING	Background Two commercial blood assays for the diagnosis of latent tuberculosis infection-T-SPOT.TB and QuantiFERON-TB Gold-have been separately compared with the tuberculin skin test. Our aim was to compare the efficacy of all three tests in the same population sample. Methods We did a prospective study in 393 consecutively enrolled patients who were tested simultaneously with T-SPOT.TB and QuantiFERON-TB Gold because of suspected latent or active tuberculosis. 318 patients also had results available for a tuberculin skin test. Findings Overall agreement with the skin test was similar (T-SPOT. TB kappa = 0.508, QuantiFERON-TB Gold kappa = 0.460), but fewer BCG-vaccinated individuals were identified as positive by the two blood assays than by the tuberculin skin test (p = 0.003 for T-SPOT.TB and p < 0.0001 for QuantiFERON-TB Gold). Indeterminate results were significantly more frequent with QuantiFERON-TB Gold (11%, 43 of 383) than with T-SPOT.TB (3%,12 of 383; p < 0.0001) and were associated with immunosuppressive treatments for both tests. Age younger than 5 years was significantly associated with indeterminate results with QuantiFERON-TB Gold (p = 0.003), but not with T-SPOT.TB. Overall, T-SPOT.TB produced significantly more positive results (38%, n = 144, vs 26%, n = 100, with QuantiFERON-TB Gold; p < 0.0001), and close contacts of patients with active tuberculosis were more likely to be positive with T-SPOT.TB than with QuantiFERON-TB Gold (p = 0.0010). Interpretation T-SPOT.TB and QuantiFERON-TB Gold have higher specificity than the tuberculin skin test. Rates of indeterminate and positive results, however, differ between the blood tests, suggesting that they might provide different results in routine clinical practice.	Univ Modena & Reggio Emilia, Dept Oncol Haematol & Resp Dis, Sect Resp Dis, I-41100 Modena, Italy; Univ Modena & Reggio Emilia, Dept Oncol Haematol & Resp Dis, Sect Stat, I-41100 Modena, Italy; Azienda Osped Policlin Modena, Lab Micribiol & Virol, Modena, Italy; Univ Modena & Reggio Emilia, Dept Paediat, Modena, Italy; Univ Modena & Reggio Emilia, Clin Infect & Trop Dis, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Richeldi, L (corresponding author), Univ Modena & Reggio Emilia, Dept Oncol Haematol & Resp Dis, Sect Resp Dis, Via Pozzo 71, I-41100 Modena, Italy.	richeldi.luca@unimore.it	Ferrara, Giovanni/AAC-1237-2020; Richeldi, Luca/ABF-2486-2020; Ferrara, Giovanni/K-9415-2019; Losi, Monica/A-7028-2010; Piro, Roberto/AAA-5572-2021; Mussini, Cristina/K-8672-2016; Bergamini, Barbara Maria/F-4182-2017; D'Amico, Roberto/I-8106-2014; Fabbri, Leonardo M/I-4055-2012; Richeldi, Luca/B-6243-2019	Ferrara, Giovanni/0000-0002-3807-3315; Richeldi, Luca/0000-0001-8594-1448; Piro, Roberto/0000-0003-1046-4848; Mussini, Cristina/0000-0002-6615-4198; Bergamini, Barbara Maria/0000-0003-3681-0921; D'Amico, Roberto/0000-0002-3211-6687; Fabbri, Leonardo M/0000-0001-8894-1689; 				Altman D.G., 1991, PRACTICAL STAT MED R; American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; DeAngelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2793, DOI 10.1001/jama.293.22.2793; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; *I MED, 2000, END NEGL EL TUB US W; Joos Ladina, 2005, Proc Am Thorac Soc, V2, P445, DOI 10.1513/pats.200508-097JS; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Laartz BW, 2002, INFECT CONT HOSP EP, V23, P573, DOI 10.1086/501973; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; MEYERSTEINBRENNER H, 2005, ENV PROTECT EU, V2, P433; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Taylor Z, 2001, AM J RESP CRIT CARE, V163, P1; Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201	32	414	450	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1328	1334		10.1016/S0140-6736(06)68579-6	http://dx.doi.org/10.1016/S0140-6736(06)68579-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631911				2022-12-28	WOS:000237118500027
J	Bassler, BL; Losick, R				Bassler, BL; Losick, R			Bacterially speaking	CELL			English	Review							TO-CELL COMMUNICATION; A-FACTOR; TRANSCRIPTIONAL MODULATION; GENE-EXPRESSION; C-FACTOR; IDENTIFICATION; DIFFERENTIATION; INTERFERENCE; CANNIBALISM; COMPETENCE	Bacteria use a variety of means to communicate with one another and with their eukaryotic hosts. In some cases, social interactions allow bacteria to synchronize the behavior of all of the members of the group and thereby act like multicellular organisms. By contrast, some bacterial social engagements promote individuality among members within the group and thereby foster diversity. Here we explore the molecular mechanisms underpinning some recently discovered bacterial communication systems. These include long- and short-range chemical signaling channels; one-way, two-way, and multi-way communication; contact-mediated and contact-inhibited signaling; and the use and spread of misinformation or, more dramatically, even deadly information.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Harvard University	Bassler, BL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	bbassler@molbio.princeton.edu; losick@mcb.harvard.edu		Bassler, Bonnie/0000-0002-0043-746X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065859, R01GM018568] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 054442] Funding Source: Medline; NIGMS NIH HHS [R01 GM18568, R01 GM065859] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Brady SF, 2004, APPL ENVIRON MICROB, V70, P6865, DOI 10.1128/AEM.70.11.6865-6870.2004; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; KHOKHLOV AS, 1967, DOKL AKAD NAUK SSSR+, V177, P232; KIM SK, 1990, CELL, V61, P19, DOI 10.1016/0092-8674(90)90211-V; KIM SK, 1990, SCIENCE, V249, P926, DOI 10.1126/science.2118274; KIM SK, 1990, P NATL ACAD SCI USA, V87, P3635, DOI 10.1073/pnas.87.10.3635; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; KUSPA A, 1992, J BACTERIOL, V174, P3319, DOI 10.1128/jb.174.10.3319-3326.1992; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lobedanz S, 2003, GENE DEV, V17, P2151, DOI 10.1101/gad.274203; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; Lyon GJ, 2002, J BIOL CHEM, V277, P6247, DOI 10.1074/jbc.M109989200; Manefield M, 2002, MICROBIOL-SGM, V148, P1119, DOI 10.1099/00221287-148-4-1119; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; MULLIGAN JT, 1985, P NATL ACAD SCI USA, V82, P6609, DOI 10.1073/pnas.82.19.6609; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Okada M, 2005, NAT CHEM BIOL, V1, P23, DOI 10.1038/nchembio709; ONAKA H, 1995, J BACTERIOL, V177, P6083, DOI 10.1128/jb.177.21.6083-6092.1995; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Tsui WHW, 2004, CHEM BIOL, V11, P1307, DOI 10.1016/j.chembiol.2004.07.010; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Willey JM, 2006, MOL MICROBIOL, V59, P731, DOI 10.1111/j.1365-2958.2005.05018.x; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000	48	760	811	6	192	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					237	246		10.1016/j.cell.2006.04.001	http://dx.doi.org/10.1016/j.cell.2006.04.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630813	Bronze			2022-12-28	WOS:000237241500015
J	Hegerl, GC; Crowley, TJ; Hyde, WT; Frame, DJ				Hegerl, GC; Crowley, TJ; Hyde, WT; Frame, DJ			Climate sensitivity constrained by temperature reconstructions over the past seven centuries	NATURE			English	Article							MODEL; SOLAR; UNCERTAINTIES; VARIABILITY; SIGNALS; OCEAN; AGES	The magnitude and impact of future global warming depends on the sensitivity of the climate system to changes in greenhouse gas concentrations. The commonly accepted range for the equilibrium global mean temperature change in response to a doubling of the atmospheric carbon dioxide concentration(1), termed climate sensitivity, is 1.5-4.5 K (ref. 2). A number of observational studies(3-10), however, find a substantial probability of significantly higher sensitivities, yielding upper limits on climate sensitivity of 7.7 K to above 9 K (refs 3-8). Here we demonstrate that such observational estimates of climate sensitivity can be tightened if reconstructions of Northern Hemisphere temperature over the past several centuries are considered. We use large-ensemble energy balance modelling and simulate the temperature response to past solar, volcanic and greenhouse gas forcing to determine which climate sensitivities yield simulations that are in agreement with proxy reconstructions. After accounting for the uncertainty in reconstructions and estimates of past external forcing, we find an independent estimate of climate sensitivity that is very similar to those from instrumental data. If the latter are combined with the result from all proxy reconstructions, then the 5-95 per cent range shrinks to 1.5-6.2 K, thus substantially reducing the probability of very high climate sensitivity.	Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA; Univ Oxford, Dept Phys, Climate Dynam Grp, Oxford OX1 3PU, England	Duke University; University of Oxford	Hegerl, GC (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA.	hegerl@duke.edu	Frame, Dave/A-8918-2014; Frame, Dave/R-6169-2016	Frame, Dave/0000-0002-0949-3994; Hegerl, Gabriele/0000-0002-4159-1295				Andronova NG, 2000, GEOPHYS RES LETT, V27, P2137, DOI 10.1029/2000GL006109; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Cook ER, 2004, QUATERNARY SCI REV, V23, P2063, DOI 10.1016/j.quascirev.2004.08.013; Crowley TJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017801; Crowley TJ, 1999, GEOPHYS RES LETT, V26, P1901, DOI 10.1029/1999GL900347; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; FOREST CE, IN PRESS GEOPHYS RES; Frame DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022241; Free M, 1999, J GEOPHYS RES-ATMOS, V104, P19057, DOI 10.1029/1999JD900233; Gregory JM, 2002, J CLIMATE, V15, P3117, DOI [10.1175/1520-0442(2002)015<3117:AOBEOT>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3117:AOBEOT&gt;2.0.CO;2]; Hegerl GC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016635; HEGERL GC, UNPUB J CLIM; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Lean JL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015880; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; LI YH, 1984, TELLUS B, V36, P212, DOI 10.1111/j.1600-0889.1984.tb00243.x; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; NORTH GR, 1983, J GEOPHYS RES-OCEANS, V88, P6576, DOI 10.1029/JC088iC11p06576; SCHNEIDER SH, 1974, REV GEOPHYS, V12, P447, DOI 10.1029/RG012i003p00447; Shindell DT, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004151; SIEGENTHALER U, 1983, J GEOPHYS RES-OCEANS, V88, P3599, DOI 10.1029/JC088iC06p03599; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; STUIVER M, 1993, RADIOCARBON, V35, P137; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; von Storch H, 2004, SCIENCE, V306, P679, DOI 10.1126/science.1096109	30	280	293	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1029	1032		10.1038/nature04679	http://dx.doi.org/10.1038/nature04679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625192				2022-12-28	WOS:000236906000031
J	Steinbrook, R				Steinbrook, R			Private health care in Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinb@attglobal.net						Detsky AS, 2003, NEW ENGL J MED, V349, P804, DOI 10.1056/NEJMhpr035304; ESMAIL N, 2005, WAITING YOUR TURN HO	2	31	31	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1661	1664		10.1056/NEJMp068064	http://dx.doi.org/10.1056/NEJMp068064			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033ZP	16625005				2022-12-28	WOS:000236893900001
J	Bellinger, DC; Trachtenberg, F; Barregard, L; Tavares, M; Cernichiari, E; Daniel, D; McKinlay, S				Bellinger, DC; Trachtenberg, F; Barregard, L; Tavares, M; Cernichiari, E; Daniel, D; McKinlay, S			Neuropsychological and renal effects of dental amalgam in children - A randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MERCURY CONCENTRATIONS; 6-YEAR-OLD CHILDREN; EXPOSURE; HEALTH; LEAD; FILLINGS; URINE; INTELLIGENCE; DISEASE; BLOOD	Context No randomized trials have been published that address the concern that inhalation of mercury vapor released by amalgam dental restorations causes adverse health effects. Objective To compare the neuropsychological and renal function of children whose dental caries were restored using amalgam or mercury-free materials. Design and Setting The New England Children's Amalgam Trial was a 2-group randomized safety trial involving 5 community health dental clinics in Boston, Mass, and 1 in Farmington, Me, between September 1997 and March 2005. Participants and Intervention A total of 534 children aged 6 to 10 years at baseline with no prior amalgam restorations and 2 or more posterior teeth with caries were randomly assigned to receive dental restoration of baseline and incident caries during a 5-year follow-up period using either amalgam ( n= 267) or resin composite ( n = 267) materials. Main Outcome Measures The primary neuropsychological outcome was 5-year change in full-scale IQ scores. Secondary outcomes included tests of memory and visuomotor ability. Renal glomerular function was measured by creatinine-adjusted albumin in urine. Results Children had a mean of 15 tooth surfaces ( median, 14) restored during the 5-year period ( range, 0-55). Assignment to the amalgam group was associated with a significantly higher mean urinary mercury level (0.9 vs 0.6 mu g/g of creatinine at year 5, P <. 001). After adjusting for randomization stratum and other covariates, no statistically significant differences were found between children in the amalgam and composite groups in 5-year change in full-scale IQ score (3.1 vs 2.1, P=. 21). The difference in treatment group change scores was 1.0 (95% confidence interval, - 0.6 to 2.5) full-scale IQ score point. No statistically significant differences were found for 4-year change in the general memory index (8.1 vs 7.2, P=. 34), 4-year change in visuomotor composite (3.8 vs 3.7, P=. 93), or year 5 urinary albumin ( median, 7.5 vs 7.4 mg/g of creatinine, P=. 61). Conclusions In this study, there were no statistically significant differences in adverse neuropsychological or renal effects observed over the 5-year period in children whose caries were restored using dental amalgam or composite materials. Although it is possible that very small IQ effects cannot be ruled out, these findings suggest that the health effects of amalgam restorations in children need not be the basis of treatment decisions when choosing restorative dental materials.	New England Res Inst Inc, Watertown, MA 02472 USA; Childrens Hosp Boston, Dept Neurol, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Gothenburg Univ, Sahlgrenska Univ Hosp & Acad, Dept Occupat & Environm Med, Gothenburg, Sweden; Forsyth Inst, Boston, MA USA; Univ Rochester, Sch Med, Dept Environm Med, Rochester, NY USA; Univ Maine, Dept Psychol, Farmington, CT USA	HealthCore, Inc; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Sahlgrenska University Hospital; University of Gothenburg; Harvard University; Forsyth Institute; University of Rochester	McKinlay, S (corresponding author), New England Res Inst Inc, 9 Galen St, Watertown, MA 02472 USA.	smckinlay@neriscience.com		Tavares, Mary/0000-0003-4705-1238	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE011886] Funding Source: NIH RePORTER; NIDCR NIH HHS [U01 DE11886] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Altmann L, 1998, NEUROTOXICOL TERATOL, V20, P9, DOI 10.1016/S0892-0362(97)00070-6; *AM DENT ASS, 2002, 1999 SURV DENT SERV; Aydin N, 2003, INT DENT J, V53, P85, DOI 10.1111/j.1875-595X.2003.tb00664.x; BARBER TE, 1986, J OCCUP ENVIRON MED, V28, P354; Barregard L, 2005, OCCUP ENVIRON MED, V62, P352, DOI 10.1136/oem.2004.018911; Bates MN, 2004, INT J EPIDEMIOL, V33, P894, DOI 10.1093/ije/dyh164; Bjorkman L, 1996, COMMUNITY DENT ORAL, V24, P260, DOI 10.1111/j.1600-0528.1996.tb00856.x; Dalen K, 2003, J DENT, V31, P487, DOI 10.1016/S0300-5712(03)00086-1; Dye BA, 2005, OCCUP ENVIRON MED, V62, P368, DOI 10.1136/oem.2004.016832; Echeverria D, 1998, FASEB J, V12, P971, DOI 10.1096/fasebj.12.11.971; Echeverria D, 2005, NEUROTOXICOL TERATOL, V27, P781, DOI 10.1016/j.ntt.2005.08.001; Evens CC, 2001, J TOXICOL ENV HEAL A, V64, P521, DOI 10.1080/15287390152627219; Factor-Litvak P, 2003, ENVIRON HEALTH PERSP, V111, P719, DOI 10.1289/ehp.5879; Gabrio T, 2003, GESUNDHEITSWESEN, V65, P327; Grandjean P, 1997, J OCCUP ENVIRON MED, V39, P707, DOI 10.1097/00043764-199708000-00004; GREEN LW, 1970, PUBLIC HEALTH REP, V85, P815, DOI 10.2307/4593972; Hornung R.W., 1990, APPL OCCUP ENV HYG, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Kingman A, 2005, NEUROTOXICOLOGY, V26, P241, DOI 10.1016/j.neuro.2004.09.008; Kingman A, 1998, J DENT RES, V77, P461, DOI 10.1177/00220345980770030501; Levy M, 2004, ENVIRON RES, V94, P283, DOI 10.1016/j.envres.2003.07.004; MAGOS L, 1972, J ASSOC OFF ANA CHEM, V55, P966; McKinlay SM, 2003, CONTROL CLIN TRIALS, V24, P795, DOI 10.1016/S0197-2456(03)00105-3; Mutter J, 2004, NEUROENDOCRINOL LETT, V25, P331; Nerdrum P, 2004, J PSYCHOSOM RES, V57, P103, DOI 10.1016/S0022-3999(03)00542-7; Nitschke I, 2000, Gerodontology, V17, P39, DOI 10.1111/j.1741-2358.2000.00039.x; POCOCK SJ, 1994, BRIT MED J, V309, P1189, DOI 10.1136/bmj.309.6963.1189; Ritchie KA, 2002, OCCUP ENVIRON MED, V59, P287, DOI 10.1136/oem.59.5.287; SAXE SR, 1995, J AM DENT ASSOC, V126, P1495, DOI 10.14219/jada.archive.1995.0078; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schultz CJ, 2000, DIABETIC MED, V17, P7, DOI 10.1046/j.1464-5491.2000.00200.x; SCHWARTZ J, 1994, ENVIRON RES, V65, P42, DOI 10.1006/enrs.1994.1020; Trepka MJ, 1997, ARCH ENVIRON HEALTH, V52, P134, DOI 10.1080/00039899709602877; Walkowiak J, 1998, NEUROTOXICOL TERATOL, V20, P511, DOI 10.1016/S0892-0362(98)00010-5; World Health Organization, 1991, ENV HLTH CRIT, V118; World Health Organization, 2003, 50 WHO	35	162	164	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1775	1783		10.1001/jama.295.15.1775	http://dx.doi.org/10.1001/jama.295.15.1775			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622139				2022-12-28	WOS:000236886900020
J	Herbert, A; Gerry, NP; McQueen, MB; Heid, IM; Pfeufer, A; Illig, T; Wichmann, HE; Meitinger, T; Hunter, D; Hu, FB; Colditz, G; Hinney, A; Hebebrand, J; Koberwitz, K; Zhu, XF; Cooper, R; Ardlie, K; Lyon, H; Hirschhorn, JN; Laird, NM; Lenburg, ME; Lange, C; Christman, MF				Herbert, A; Gerry, NP; McQueen, MB; Heid, IM; Pfeufer, A; Illig, T; Wichmann, HE; Meitinger, T; Hunter, D; Hu, FB; Colditz, G; Hinney, A; Hebebrand, J; Koberwitz, K; Zhu, XF; Cooper, R; Ardlie, K; Lyon, H; Hirschhorn, JN; Laird, NM; Lenburg, ME; Lange, C; Christman, MF			A common genetic variant is associated with adult and childhood obesity	SCIENCE			English	Article							QUANTITATIVE-TRAIT LOCI; BODY-MASS; DISEQUILIBRIUM; POWERFUL; TESTS; RISK	Obesity is a heritable trait and a risk factor for many common diseases such as type 2 diabetes, heart disease, and hypertension. We used a dense whole-genome scan of DNA samples from the Framingham Heart Study participants to identify a common genetic variant near the INSIG2 gene associated with obesity. We have replicated the finding in four separate samples composed of individuals of Western European ancestry, African Americans, and children. The obesity-predisposing genotype is present in 10% of individuals. Our study suggests that common genetic polymorphisms are important determinants of obesity.	Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Forschungszentrum Umwelt & Gesundheit, Inst Human Genet, D-85764 Neuherberg, Germany; Tech Univ Munich, Inst Human Genet, D-81671 Munich, Germany; Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; Brigham & Womens Hosp, Nurses Hlth Study, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Duisburg Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; SeraCare Life Sci, Genom Collaborat, Cambridge, MA USA; Childrens Hosp, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Technical University of Munich; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Duisburg Essen; Loyola University Chicago; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health	Herbert, A (corresponding author), Boston Univ, Sch Med, Dept Genet & Genom, E613,715 Albany St, Boston, MA 02118 USA.	aherbert@bu.edu; mfc@bu.edu	Colditz, Graham/A-3963-2009; Lenburg, Marc/B-8027-2008; Zhu, Xiaofeng/O-6874-2019; Herbert, Alan/AAY-4286-2020; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; McQueen, Matthew/X-5845-2019; Hinney, Anke/D-6953-2011; Pfeufer, Arne/B-6634-2013; Meitinger, Thomas/O-1318-2015; Wichmann, Heinz Erich/AAA-5695-2022	Colditz, Graham/0000-0002-7307-0291; Lenburg, Marc/0000-0002-5760-4708; Hinney, Anke/0000-0001-5659-0706; Herbert, Alan/0000-0002-0093-1572; Meitinger, Thomas/0000-0002-8838-8403; Zhu, Xiaofeng/0000-0003-0037-411X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074166, R01HL066289, U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK067288, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059532] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NHLBI NIH HHS [R01HL074166, U01 HL065899, R01HL66289, R01HL54485, U01HL65899] Funding Source: Medline; NICHD NIH HHS [R01 HD060726] Funding Source: Medline; NIDDK NIH HHS [P30DK46200, K23DK067288] Funding Source: Medline; NIGMS NIH HHS [R01GM046877] Funding Source: Medline; NIMH NIH HHS [R01MH59532] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Cheverud JM, 2004, DIABETES, V53, P3328, DOI 10.2337/diabetes.53.12.3328; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Farooqi IS, 2005, INT J OBESITY, V29, P1149, DOI 10.1038/sj.ijo.0803056; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Hebebrand J, 2003, Obes Rev, V4, P139; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Kannel W B, 2000, J Atheroscler Thromb, V6, P60; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2003, HUM HERED, V56, P10, DOI 10.1159/000073728; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lyon HN, 2005, AM J CLIN NUTR, V82, p215S, DOI 10.1093/ajcn/82.1.215S; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; *NIH, 1998, NIH PUBL; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Setiawan VW, 2004, CANCER EPIDEM BIOMAR, V13, P213, DOI 10.1158/1055-9965.EPI-03-0241; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takaishi K, 2004, P NATL ACAD SCI USA, V101, P7106, DOI 10.1073/pnas.0401715101; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899	34	526	566	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					279	283		10.1126/science.1124779	http://dx.doi.org/10.1126/science.1124779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614226				2022-12-28	WOS:000236765300053
J	Diederichs, C; Tignon, J; Dasbach, G; Ciuti, C; Lemaitre, A; Bloch, J; Roussignol, P; Delalande, C				Diederichs, C; Tignon, J; Dasbach, G; Ciuti, C; Lemaitre, A; Bloch, J; Roussignol, P; Delalande, C			Parametric oscillation in vertical triple microcavities	NATURE			English	Article							COUPLED SEMICONDUCTOR MICROCAVITY; QUANTUM CRYPTOGRAPHY; POLARITON AMPLIFIER; INTERFERENCE; EMISSION; PHOTONS; LASER	Optical parametric oscillation is a nonlinear process that enables coherent generation of 'signal' and 'idler' waves, shifted in frequency from the pump wave(1,2). Efficient parametric conversion is the paradigm for the generation of twin or entangled photons for quantum optics applications such as quantum cryptography(3,4), or for the generation of new frequencies in spectral domains not accessible by existing devices. Rapid development in the field of quantum information requires monolithic, alignment-free sources that enable efficient coupling into optical fibres and possibly electrical injection. During the past decade, much effort has been devoted to the development of integrated devices for quantuminformation(5-7) and to the realization of all-semiconductor parametric oscillators(8,9). Nevertheless, at present optical parametric oscillators typically rely on nonlinear crystals placed into complex external cavities, and pumped by powerful external lasers. Long interaction lengths are typically required and the phase mismatch between the parametric waves propagating at different velocities(2) results in poor parametric conversion efficiencies. Here we report the demonstration of parametric oscillation in a monolithic semiconductor triple microcavity with signal, pump and idler waves propagating along the vertical direction of the nanostructure. Alternatively, signal and idler beams can also be collected at finite angles, allowing the generation of entangled photon pairs. The pump threshold intensity is low enough to envisage the realization of an all-semiconductor electrically pumped micro-parametric oscillator.	Ecole Normale Super, Lab Pierre Aigrain, F-75231 Paris 05, France; CNRS, LPN, F-91460 Marcoussis, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Tignon, J (corresponding author), Ecole Normale Super, Lab Pierre Aigrain, 24 Rue Lhomond, F-75231 Paris 05, France.	Jerome.Tignon@lpa.ens.fr	Bloch, Jacqueline/S-2062-2017; Ciuti, Cristiano/GYR-1331-2022; Ciuti, Cristiano/GYR-1378-2022; Lemaitre, Aristide/B-9899-2009; Ciuti, Cristiano/K-7248-2012	Bloch, Jacqueline/0000-0001-7823-8420; Ciuti, Cristiano/0000-0002-1134-7013; Lemaitre, Aristide/0000-0003-1892-9726; Ciuti, Cristiano/0000-0002-1134-7013; Diederichs, Carole/0000-0002-1383-5598				Armitage A, 1998, PHYS REV B, V57, P14877, DOI 10.1103/PhysRevB.57.14877; ARMSTRONG JA, 1962, PHYS REV, V127, P1918, DOI 10.1103/PhysRev.127.1918; Baudrier-Raybaut M, 2004, NATURE, V432, P374, DOI 10.1038/nature03027; Ciuti C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245304; Ciuti C, 2000, PHYS REV B, V62, pR4825, DOI 10.1103/PhysRevB.62.R4825; Dasbach G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.161308; Diederichs C, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2150282; Fiore A, 1998, NATURE, V391, P463, DOI 10.1038/35091; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Haidar R, 2003, IEEE J QUANTUM ELECT, V39, P569, DOI 10.1109/JQE.2003.809331; Jennewein T, 2000, PHYS REV LETT, V84, P4729, DOI 10.1103/PhysRevLett.84.4729; MERTZ J, 1991, OPT LETT, V16, P1234, DOI 10.1364/OL.16.001234; Michler P, 1997, APPL PHYS LETT, V70, P2073, DOI 10.1063/1.118955; Moreau E, 2001, APPL PHYS LETT, V79, P2865, DOI 10.1063/1.1415346; MYERS LE, 1995, OPT LETT, V20, P52, DOI 10.1364/OL.20.000052; OU ZY, 1988, PHYS REV A, V37, P1607, DOI 10.1103/PhysRevA.37.1607; OU ZY, 1989, PHYS REV LETT, V62, P2941, DOI 10.1103/PhysRevLett.62.2941; Pellandini P, 1997, APPL PHYS LETT, V71, P864, DOI 10.1063/1.119671; Saba M, 2001, NATURE, V414, P731, DOI 10.1038/414731a; Savvidis PG, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075311; Savvidis PG, 2000, PHYS REV LETT, V84, P1547, DOI 10.1103/PhysRevLett.84.1547; Shen YR, 2003, PRINCIPLES NONLINEAR; STANLEY RP, 1994, APPL PHYS LETT, V65, P2093, DOI 10.1063/1.112803; Tanzilli S, 2001, ELECTRON LETT, V37, P26, DOI 10.1049/el:20010009; Teja J, 1998, OPT EXPRESS, V2, P65, DOI 10.1364/OE.2.000065; TIGNON J, 2005, Patent No. 0505708; Vodopyanov KL, 2004, OPT LETT, V29, P1912, DOI 10.1364/OL.29.001912; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314	29	130	131	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2006	440	7086					904	907		10.1038/nature04602	http://dx.doi.org/10.1038/nature04602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612377				2022-12-28	WOS:000236736700034
J	Poston, L; Briley, AL; Seed, PT; Kelly, FJ; Shennan, AH				Poston, L; Briley, AL; Seed, PT; Kelly, FJ; Shennan, AH		VIP Trial Consortium	Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial	LANCET			English	Article							E SUPPLEMENTATION; BIRTH-WEIGHT; DOUBLE-BLIND; DISORDERS; SERUM	Background Oxidative stress could play a part in pre-eclampsia, and there is some evidence to suggest that vitamin C and vitamin E supplements could reduce the risk of the disorder. Our aim was to investigate the potential benefit of these antioxidants in a cohort of women with a range of clinical risk factors. Methods We did a randomised, placebo-controlled trial to which we enrolled 2410 women identified as at increased risk of pre-eclampsia from 25 hospitals. We assigned the women 1000 mg vitamin C and 400 IU vitamin E (RRR alpha tocopherol; n=1199) or matched placebo (n=1205) daily from the second trimester of pregnancy until delivery. Our primary endpoint was pre-eclampsia, and our main secondary endpoints were low birthweight (<2.5 kg) and small size for gestational age (<5th customised birthweight centile). Analyses were by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN 62368611. Findings Of 2404 patients treated, we analysed 2395 (99.6%). The incidence of pre-eclampsia was similar in treatment and placebo groups (15% [n=181] vs 16% [n=187], RR 0.97 [95% CI 0.80-1.17]). More low birthweight babies were born to women who took antioxidants than to controls (28% [n=387] vs 24% [n=335], 1.15 [1.02-1.30]), but small size for gestational age did not differ between groups (21% [n=294] vs 19% [n=259], 1.12 [0.96-1.31]). Interpretation Concomitant supplementation with vitamin C and vitamin E does not prevent pre-eclampsia in women at risk, but does increase the rate of babies born with a low birthweight. As such, use of these high-dose antioxidants is not justified in pregnancy.	St Thomas Hosp, Univ London Kings Coll, Div Reprod Hlth Endocrinol & Dev, Maternal & Fetal Res Unit, London SE1 7EH, England; St Thomas Hosp, Univ London Kings Coll, Pharmaceut Sci Res Div, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Poston, L (corresponding author), St Thomas Hosp, Univ London Kings Coll, Div Reprod Hlth Endocrinol & Dev, Maternal & Fetal Res Unit, London SE1 7EH, England.	lucilla.poston@kcl.ac.uk	Seed, Paul T/C-4435-2008; Briley, Annette/N-1704-2019; Kelly, Frank J/C-6125-2009; Briley, Annette/AAZ-5305-2020	Seed, Paul T/0000-0001-7904-7933; Kelly, Frank J/0000-0003-2558-8392; Briley, Annette/0000-0002-4266-920X; Poston, Lucilla/0000-0003-1100-2821; Williamson, Catherine/0000-0002-6226-7611; Shennan, Andrew/0000-0001-5273-3132	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beazley D, 2005, AM J OBSTET GYNECOL, V192, P520, DOI 10.1016/j.ajog.2004.09.005; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Boskovic R, 2005, REPROD TOXICOL, V20, P85, DOI 10.1016/j.reprotox.2005.01.003; BRION LP, 2003, COCHRANE DB SYST REV, V3; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Chappell LC, 2002, AM J OBSTET GYNECOL, V187, P127, DOI 10.1067/mob.2002.122969; Derksen RHWM, 2004, ARTHRITIS RHEUM-US, V50, P1028, DOI 10.1002/art.20105; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Fraser WD, 2005, BJOG-INT J OBSTET GY, V112, P684, DOI 10.1111/j.1471-0528.2005.00675.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; *I MED, 2000, DIET REF INT VIT C E; IRIYAMA K, 1984, ANAL BIOCHEM, V141, P238, DOI 10.1016/0003-2697(84)90451-2; KELLY FJ, 1990, BRIT J NUTR, V63, P631, DOI 10.1079/BJN19900149; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Lee BE, 2004, EUR J CLIN NUTR, V58, P1365, DOI 10.1038/sj.ejcn.1601976; Lewis G., 2004, WHY MOTHERS DIE 2000; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Raijmakers MTM, 2005, CURR PHARM DESIGN, V11, P711, DOI 10.2174/1381612053381837; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Rumbold A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004227.pub2; RUMBOLD A, 2005, COCHRANE DB SYST REV, V1; RUMBOLD A, 2005, COCHRANE DB SYST REV, V2; Steyn P S, 2003, J Obstet Gynaecol, V23, P150, DOI 10.1080/014436103000074673; WHO, 2005, MAK EV MOTH CHILD CO; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	507	523	1	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1145	1154		10.1016/S0140-6736(06)68433-X	http://dx.doi.org/10.1016/S0140-6736(06)68433-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616557				2022-12-28	WOS:000236673400023
J	Wilson, DS; Teagle, DAH; Alt, JC; Banerjee, NR; Umino, S; Miyashita, S; Acton, GD; Anma, R; Barr, SR; Belghoul, A; Carlut, J; Christie, DM; Coggon, RM; Cooper, KM; Cordier, C; Crispini, L; Durand, SR; Einaudi, F; Galli, L; Gao, YJ; Geldmacher, J; Gilbert, LA; Hayman, NW; Herrero-Bervera, E; Hirano, N; Holter, S; Ingle, S; Jiang, SJ; Kalberkamp, U; Kerneklian, M; Koepke, J; Laverne, C; Vasquez, HLL; Maclennan, J; Morgan, S; Neo, N; Nichols, HJ; Park, SH; Reichow, MK; Sakuyama, T; Sano, T; Sandwell, R; Scheibner, B; Smith-Duque, CE; Swift, SA; Tartarotti, P; Tikku, AA; Tominaga, M; Veloso, EA; Yamasaki, T; Yamazaki, S; Ziegler, C				Wilson, DS; Teagle, DAH; Alt, JC; Banerjee, NR; Umino, S; Miyashita, S; Acton, GD; Anma, R; Barr, SR; Belghoul, A; Carlut, J; Christie, DM; Coggon, RM; Cooper, KM; Cordier, C; Crispini, L; Durand, SR; Einaudi, F; Galli, L; Gao, YJ; Geldmacher, J; Gilbert, LA; Hayman, NW; Herrero-Bervera, E; Hirano, N; Holter, S; Ingle, S; Jiang, SJ; Kalberkamp, U; Kerneklian, M; Koepke, J; Laverne, C; Vasquez, HLL; Maclennan, J; Morgan, S; Neo, N; Nichols, HJ; Park, SH; Reichow, MK; Sakuyama, T; Sano, T; Sandwell, R; Scheibner, B; Smith-Duque, CE; Swift, SA; Tartarotti, P; Tikku, AA; Tominaga, M; Veloso, EA; Yamasaki, T; Yamazaki, S; Ziegler, C			Drilling to gabbro in intact ocean crust	SCIENCE			English	Article							EAST PACIFIC RISE; SEISMIC STRUCTURE; MAGMA CHAMBER; TECTONIC SEGMENTATION; HYDROTHERMAL SYSTEMS; OMAN OPHIOLITE; ROOT ZONES; MELT; CONSTRAINTS; BENEATH	Sampling an intact sequence of oceanic crust through lavas, dikes, and gabbros is necessary to advance the understanding of the formation and evolution of crust formed at mid-ocean ridges, but it has been an elusive goal of scientific ocean drilling for decades. Recent drilling in the eastern Pacific Ocean in Hole 1256D reached gabbro within seismic layer 2, 1157 meters into crust formed at a superfast spreading rate. The gabbros are the crystallized melt lenses that formed beneath a mid-ocean ridge. The depth at which gabbro was reached confirms predictions extrapolated from seismic experiments at modern mid-ocean ridges: Melt lenses occur at shallower depths at faster spreading rates. The gabbros intrude metamorphosed sheeted dikes and have compositions similar to the overlying lavas, precluding formation of the cumulate lower oceanic crust from melt lenses so far penetrated by Hole 1256D.	Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Texas A&M Univ, Integrated Ocean Drilling Program, College Stn, TX 77845 USA; Shizuoka Univ, Dept Biol & Geosci, Shizuoka 4228529, Japan; Niigata Univ, Dept Geol, Niigata 9502181, Japan; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; Inst Sci Terre Environm & Espace Montpellier, Lab Geophys & Hydrodynam Forage, F-34095 Montpellier, France; Ecole Normale Super, Geol Lab, F-75231 Paris, France; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Univ Brest, CNRS, IUEM, UMR Domaines Ocean 6538, F-29280 Plouzane, France; Univ Genoa, Dipartimento Studio Terr & Risorse, I-16132 Genoa, Italy; Florida Int Univ, Dept Earth Sci, Miami, FL 33199 USA; Univ Milan, Dept Earth Sci, I-20133 Milan, Italy; Univ Houston, Dept Geosci, Houston, TX 77204 USA; Leibniz Inst Marine Sci Kiel, Inst Meereskunde, Forsch Zentrums Marien Geowissensch, D-24148 Kiel, Germany; Williams Coll & Myst Seaport, Maritime Studies Program, Mystic, CT 06355 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Geol & Geophys, Honolulu, HI 96822 USA; Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; Univ St Thomas, Dept Geol, St Paul, MN 55105 USA; Florida State Univ, Dept Geol Sci, Tallahassee, FL 32306 USA; Bundesanstalt Geowissensch & Rohstoffe, D-30655 Hannover, Germany; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; Leibniz Univ Hannover, Inst Mineral, D-30167 Hannover, Germany; Univ Aix Marseille 3, Lab Petrol Magmat, F-13397 Marseille 20, France; Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Leeds, Sch Earth Sci, Leeds LS2 9JT, W Yorkshire, England; Polar Res Inst, Inchon 406840, South Korea; Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; Museum Nat Sci, Dept Geol & Paleontol, Tokyo 1690073, Japan; Macquarie Univ, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia; Univ Karlsruhe, Inst Mineral & Geochem, D-76131 Karlsruhe, Germany; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA; Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; Hokkaido Univ, Dept Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan; Boston Univ, Dept Earth Sci, Boston, MA 02215 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; NERC National Oceanography Centre; University of Southampton; University of Michigan System; University of Michigan; Texas A&M University System; Texas A&M University College Station; Shizuoka University; Niigata University; University of California System; University of California Davis; University of Tsukuba; University of Leicester; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Oregon State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Genoa; State University System of Florida; Florida International University; University of Milan; University of Houston System; University of Houston; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Williams College; Duke University; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Tohoku University; University of St Thomas Minnesota; State University System of Florida; Florida State University; Utah System of Higher Education; University of Utah; Leibniz University Hannover; UDICE-French Research Universities; Aix-Marseille Universite; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Cambridge; University of Leeds; Korea Polar Research Institute (KOPRI); University of Tokyo; Macquarie University; Helmholtz Association; Karlsruhe Institute of Technology; Woods Hole Oceanographic Institution; Rensselaer Polytechnic Institute; Texas A&M University System; Texas A&M University College Station; Hokkaido University; Boston University	Wilson, DS (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	dwilson@geol.ucsb.edu	Coggon, Rosalind/M-8816-2017; CARLUT, Julie/F-1662-2017; Koepke, Juergen/A-7114-2008; Cooper, Kari M/G-8261-2012; Maclennan, John/R-1962-2019; Banerjee, Neil/G-5358-2015; jiang, shijun/J-2443-2014; Yamasaki, Toru/L-4415-2018; Hayman, Nicholas/A-1589-2009; Veloso, Eugenio/A-6637-2009; Crispini, Laura/C-1177-2013; Crispini, Laura/N-1580-2019; Maclennan, John/E-6549-2010; Morgan, Sally/F-9496-2019	Coggon, Rosalind/0000-0002-9228-9707; CARLUT, Julie/0000-0002-4493-8530; Maclennan, John/0000-0001-6857-9600; Banerjee, Neil/0000-0001-7471-766X; jiang, shijun/0000-0001-6259-7912; Yamasaki, Toru/0000-0002-9300-0338; Crispini, Laura/0000-0001-5770-8569; Crispini, Laura/0000-0001-5770-8569; Maclennan, John/0000-0001-6857-9600; Hayman, Nicholas/0000-0001-6743-045X; HIRANO, Nobuo/0000-0002-0469-9854; Tartarotti, Paola/0000-0002-2236-2702; Tominaga, Masako/0000-0002-1169-4146; Acton, Gary/0000-0002-3285-4022; Morgan, Sally/0000-0001-7601-3551; Lledo, Haroldo/0000-0002-1418-3392; Cordier, Carole/0000-0002-6100-4393	NERC [NE/D006597/1] Funding Source: UKRI; Natural Environment Research Council [NE/D006597/1, NER/I/S/2002/00609/2, NE/D001277/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alt J., 1996, P ODP SCI RES, V148, P417; Alt J.C., 2004, HYDROGEOLOGY OCEANIC, P456; Alt JC, 2000, GEOL SOC AM SPEC PAP, P273; Banerjee NR, 2000, GEOLOGY, V28, P151; BASCOM W, 1961, HOLE BOTTOM SEA, P352; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Carbotte S, 1998, GEOLOGY, V26, P455, DOI 10.1130/0091-7613(1998)026<0455:IOMSAS>2.3.CO;2; Crawford WC, 2002, EARTH PLANET SC LETT, V203, P117, DOI 10.1016/S0012-821X(02)00831-2; DETRICK R, 1994, NATURE, V370, P288, DOI 10.1038/370288a0; DETRICK RS, 1993, SCIENCE, V259, P499, DOI 10.1126/science.259.5094.499; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; DICK HJB, 1999, P OC DRILL PROGR IN, V176; Dunn RA, 2001, SCIENCE, V291, P1955, DOI 10.1126/science.1057683; *EXP 304 SCI, 2005, IODP PREL REP, V305, DOI DOI 10.2204/IODP.PR.305.2005; *EXP 304 SCI, 2005, IODP PREL REP, V304, DOI DOI 10.2204/IODP.PR.304.2005; *EXP 309 312 SCI, 2006, IODP PREL REP, V312, DOI DOI 10.2204/IODP.PR.312.2006; *EXP 309 SCI, 2005, IODP PREL REP, V309, DOI DOI 10.2204/IODP.PR.309.2005; GARMANY J, 1989, NATURE, V340, P628, DOI 10.1038/340628a0; GILLIS K, 1993, P OC DRILL PROGR IN, V147; Gillis KA, 2005, EARTH PLANET SC LETT, V232, P83, DOI 10.1016/j.epsl.2005.01.008; Hallenborg E, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002400; HENSTOCK TJ, 1993, J GEOPHYS RES-SOL EA, V98, P4143, DOI 10.1029/92JB02661; Karson FA, 2002, ANNU REV EARTH PL SC, V30, P347, DOI 10.1146/annurev.earth.30.091201.141132; Karson JA, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000155; Kelemen PB, 1997, EARTH PLANET SC LETT, V146, P475, DOI 10.1016/S0012-821X(96)00235-X; KELEMEN PB, 2004, P OC DRILL PROGR IN, V209; KENT GM, 1990, NATURE, V344, P650, DOI 10.1038/344650a0; LANGMUIR CH, 1986, NATURE, V322, P422, DOI 10.1038/322422a0; Macdonald KC, 1996, NATURE, V380, P125, DOI 10.1038/380125a0; Maclennan J, 2005, GEOLOGY, V33, P357, DOI 10.1130/G21207.1; MacLeod CJ, 2000, EARTH PLANET SC LETT, V176, P357, DOI 10.1016/S0012-821X(00)00020-0; MUTTER JC, 1988, NATURE, V336, P156, DOI 10.1038/336156a0; Nedimovic MR, 2005, NATURE, V436, P1149, DOI 10.1038/nature03944; NEHLIG P, 1994, J GEOPHYS RES-SOL EA, V99, P4703, DOI 10.1029/93JB02663; PHIPPSMORGAN J, 1993, J GEOPHYS RES, V98, P6283; PURDY GM, 1992, NATURE, V355, P815, DOI 10.1038/355815a0; QUICK JE, 1993, J GEOPHYS RES-SOL EA, V98, P14015, DOI 10.1029/93JB00698; RICHARDSON CJ, 1987, EARTH PLANET SC LETT, V84, P243, DOI 10.1016/0012-821X(87)90089-6; SCHIFFMAN P, 1987, NATURE, V325, P423, DOI 10.1038/325423a0; Singh SC, 1998, NATURE, V394, P874, DOI 10.1038/29740; SINTON JM, 1992, J GEOPHYS RES-SOL EA, V97, P197, DOI 10.1029/91JB02508; SLEEP NH, 1991, J GEOPHYS RES-SOLID, V96, P2375, DOI 10.1029/90JB02335; Teagle DAH, 2003, EARTH PLANET SC LETT, V210, P81, DOI 10.1016/S0012-821X(03)00126-2; Teagle DAH, 1998, EARTH PLANET SC LETT, V155, P167, DOI 10.1016/S0012-821X(97)00209-4; TOOMEY DR, 1990, NATURE, V347, P639, DOI 10.1038/347639a0; Umino S, 2000, GEOLOGY, V28, P503; VERA EE, 1990, J GEOPHYS RES-SOLID, V95, P15529, DOI 10.1029/JB095iB10p15529; White SM, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000571; Wilson DS, 1996, GEOPHYS RES LETT, V23, P3003, DOI 10.1029/96GL02893; WILSON DS, 2003, P ODP IN REPTS OC DR, V206	50	178	183	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1016	1020		10.1126/science.1126090	http://dx.doi.org/10.1126/science.1126090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16627698	Green Published			2022-12-28	WOS:000237628800035
J	Wood, AJJ; Darbyshire, J				Wood, AJJ; Darbyshire, J			Injury to research volunteers - The clinical-research nightmare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Drazen JM, 2005, NEW ENGL J MED, V353, P2809, DOI 10.1056/NEJMe058279; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Stein CM, 2003, CLIN PHARMACOL THER, V74, P511, DOI 10.1016/j.clpt.2003.08.007	3	36	38	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1869	1871		10.1056/NEJMp068082	http://dx.doi.org/10.1056/NEJMp068082			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672696				2022-12-28	WOS:000237239900001
J	Barrett, MP				Barrett, MP			The rise and fall of sleeping sickness	LANCET			English	Editorial Material							DRUGS		Univ Glasgow, Inst Biomed & Life Sci, Div Imfect & Immun, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Barrett, MP (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Imfect & Immun, Glasgow G12 8QQ, Lanark, Scotland.	m.barrett@bio.gla.ac.uk		Barrett, Mike/0000-0001-9447-3519				[Anonymous], 2006, Wkly Epidemiol Rec, V81, P71; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Pharmaceutical R&D Policy Project, 2005, NEW LANDSC NEGL DIS; Sharp D, 2004, LANCET, V364, P1472, DOI 10.1016/S0140-6736(04)17291-7	8	70	70	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 29	2006	367	9520					1377	1378		10.1016/S0140-6736(06)68591-7	http://dx.doi.org/10.1016/S0140-6736(06)68591-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650633				2022-12-28	WOS:000237195600007
J	Sedrakyan, A; Atkins, D; Treasure, T				Sedrakyan, A; Atkins, D; Treasure, T			The risk of aprotinin: a conflict of evidence	LANCET			English	Editorial Material							CARDIAC-SURGERY; CLINICAL-TRIALS; METAANALYSIS		Agcy Healthcare Res & Qual, Rockville, MD 20850 USA; Guys Hosp, Thorac Unit, London SE1 9RT, England	Agency for Healthcare Research & Quality; Guy's & St Thomas' NHS Foundation Trust	Treasure, T (corresponding author), Agcy Healthcare Res & Qual, Rockville, MD 20850 USA.	tom.treasure@ukgateway.net						BIDSTRUP BP, 1993, ANN THORAC SURG, V55, P971, DOI 10.1016/0003-4975(93)90128-5; Deeks J J, 2003, Health Technol Assess, V7, piii; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Henry DA, 2001, COCHRANE DB SYST REV, V1; *ISRCTN, 2006, BLOOD CONS US ANT RA; Levi M, 1999, LANCET, V354, P1940, DOI 10.1016/S0140-6736(99)01264-7; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; OTT E, 2003, ANESTHESIOLOGY, V99, pA254; ROYSTON D, 1987, LANCET, V2, P1289; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	13	20	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1376	1377		10.1016/S0140-6736(06)68590-5	http://dx.doi.org/10.1016/S0140-6736(06)68590-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650632				2022-12-28	WOS:000237195600006
J	Atature, M; Dreiser, J; Badolato, A; Hogele, A; Karrai, K; Imamoglu, A				Atature, M; Dreiser, J; Badolato, A; Hogele, A; Karrai, K; Imamoglu, A			Quantum-dot spin-state preparation with near-unity fidelity	SCIENCE			English	Article							ELECTRON-SPIN; SPECTROSCOPY; MICROCAVITY; EMISSION	We have demonstrated laser cooling of a single electron spin trapped in a semiconductor quantum dot. Optical coupling of electronic spin states was achieved using resonant excitation of the charged quantum dot (trion) transitions along with the heavy-light hole mixing, which leads to weak yet finite rates for spin-flip Raman scattering. With this mechanism, the electron spin can be cooled from 4.2 to 0.020 kelvin, as confirmed by the strength of the induced Pauli blockade of the trion absorption. Within the framework of quantum information processing, this corresponds to a spin-state preparation with a fidelity exceeding 99.8%.	ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; Univ Munich, Ctr Nanosci, D-80539 Munich, Germany; Univ Munich, Sekt Phys, D-80539 Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; University of Munich	Atature, M (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	atature@phys.ethz.ch; imamoglu@phys.ethz.ch	Badolato, Antonio/E-9778-2015; Atature, Mete/ABD-9297-2020; Dreiser, Jan/W-6261-2018; Hogele, Alexander/C-1080-2016	Dreiser, Jan/0000-0001-7480-1271; Atature, Mete/0000-0003-3852-0944; Badolato, Antonio/0000-0001-8266-2902; Hogele, Alexander/0000-0002-0178-9117				Alen B, 2003, APPL PHYS LETT, V83, P2235, DOI 10.1063/1.1609243; BROSSEL J, 1952, J PHYS-PARIS, V13, P668, DOI 10.1051/jphysrad:019520013012066800; Brown SW, 1996, PHYS REV B, V54, P17339, DOI 10.1103/PhysRevB.54.R17339; Calarco T, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.012310; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; DREXLER H, 1994, PHYS REV LETT, V73, P2252, DOI 10.1103/PhysRevLett.73.2252; Dutt MVG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.227403; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Hanson R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196802; Happ TD, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.041303; Hogele A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1940733; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Kiraz A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032305; Kiraz A, 2001, APPL PHYS LETT, V78, P3932, DOI 10.1063/1.1379987; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; LAI CW, IN PRESS PHYS REV LE; Li XQ, 2003, SCIENCE, V301, P809, DOI 10.1126/science.1083800; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Peter E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067401; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Smith JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197402; Warburton RJ, 2000, NATURE, V405, P926, DOI 10.1038/35016030; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Zrenner A, 2002, NATURE, V418, P612, DOI 10.1038/nature00912	27	445	449	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					551	553		10.1126/science.1126074	http://dx.doi.org/10.1126/science.1126074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16601152				2022-12-28	WOS:000237296700037
J	Chen, FS; Hasegawa, H; Schmitt-Ulms, G; Kawarai, T; Bohm, C; Katayama, T; Gu, YJ; Sanjo, N; Glista, M; Rogaeva, E; Wakutani, Y; Pardossi-Piquard, R; Ruan, XY; Tandon, A; Checler, F; Marambaud, P; Hansen, K; Westaway, D; St George-Hyslop, P; Fraser, P				Chen, FS; Hasegawa, H; Schmitt-Ulms, G; Kawarai, T; Bohm, C; Katayama, T; Gu, YJ; Sanjo, N; Glista, M; Rogaeva, E; Wakutani, Y; Pardossi-Piquard, R; Ruan, XY; Tandon, A; Checler, F; Marambaud, P; Hansen, K; Westaway, D; St George-Hyslop, P; Fraser, P			TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; MISSENSE MUTATIONS; P24 PROTEINS; BETA-APP; MEMBRANE; CLEAVAGE; NOTCH; NICASTRIN	The presenilin proteins (PS1 and PS2)(1,2) and their interacting partners nicastrin(3), aph-1 (refs 4, 5) and pen-2 (ref. 5) forma series of high-molecular-mass, membrane-bound protein complexes(6-8) that are necessary for gamma-secretase and epsilon-secretase cleavage of selected type 1 transmembrane proteins, including the amyloid precursor protein(9), Notch(10) and cadherins(11). Modest cleavage activity can be generated by reconstituting these four proteins in yeast and Spodoptera frugiperda (sf9) cells(12-14). However, a critical but unanswered question about the biology of the presenilin complexes is how their activity is modulated in terms of substrate specificity and/or relative activities at the gamma and epsilon sites. A corollary to this question is whether additional proteins in the presenilin complexes might subsume these putative regulatory functions. The hypothesis that additional proteins might exist in the presenilin complexes is supported by the fact that enzymatically active complexes have a mass that is much greater than predicted for a 1:1:1:1 stoichiometric complex (at least 650 kDa observed, compared with about 220 kDa predicted)(6-8). To address these questions we undertook a search for presenilin-interacting proteins that differentially affected gamma- and epsilon-site cleavage events. Here we report that TMP21, a member of the p24 cargo protein family, is a component of presenilin complexes and differentially regulates gamma-secretase cleavage without affecting epsilon-secretase activity.	Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; UNSA, Equipe Labellisee FRM, Inst Pharmacol Mol & Cellulaire, CNRS,UMR6097, F-06560 Valbonne, France; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; N Shore LIJ Inst Med Res, Litwin Zucker Res Ctr, Manhasset, NY 11030 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Hlth Sci Ctr, Proteom Core, Aurora, CO 80045 USA; Univ Hlth Network, Toronto Western Hosp, Res Inst, Dept Med,Div Neurol, Toronto, ON M5G 1Z5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Yeshiva University; Albert Einstein College of Medicine; Northwell Health; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto	St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada.	p.hyslop@utoronto.ca	Checler, Frederic/C-1241-2009; Glista, Michael/F-2907-2011; Kawarai, Toshitaka/C-2822-2013; Pardossi-Piquard, Raphaëlle/ABA-4472-2021; Pardossi-Piquard, Raphaëlle/D-6263-2012	Checler, Frederic/0000-0003-2098-1750; Kawarai, Toshitaka/0000-0003-4547-8131; Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Sanjo, Nobuo/0000-0002-1226-2425; Marambaud, Philippe/0000-0002-8983-1497				Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; HERRANZ H, IN PRESS EMBO REP; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Li KC, 2004, P NATL ACAD SCI USA, V101, P15561, DOI 10.1073/pnas.0402962101; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Trower MK, 1996, P NATL ACAD SCI USA, V93, P1366, DOI 10.1073/pnas.93.4.1366; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	30	250	260	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1208	1212		10.1038/nature04667	http://dx.doi.org/10.1038/nature04667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641999				2022-12-28	WOS:000237080000049
J	Gentner, TQ; Fenn, KM; Margoliash, D; Nusbaum, HC				Gentner, TQ; Fenn, KM; Margoliash, D; Nusbaum, HC			Recursive syntactic pattern learning by songbirds	NATURE			English	Article							EUROPEAN STARLINGS; LANGUAGE; FACULTY	Humans regularly produce new utterances that are understood by other members of the same language community(1). Linguistic theories account for this ability through the use of syntactic rules (or generative grammars) that describe the acceptable structure of utterances(2). The recursive, hierarchical embedding of language units (for example, words or phrases within shorter sentences) that is part of the ability to construct new utterances minimally requires a 'context-free' grammar(2,3) that is more complex than the 'finite-state' grammars thought sufficient to specify the structure of all non-human communication signals. Recent hypotheses make the central claim that the capacity for syntactic recursion forms the computational core of a uniquely human language faculty(4,5). Here we show that European starlings (Sturnus vulgaris) accurately recognize acoustic patterns defined by a recursive, self-embedding, context-free grammar. They are also able to classify new patterns defined by the grammar and reliably exclude agrammatical patterns. Thus, the capacity to classify sequences from recursive, centre-embedded grammars is not uniquely human. This finding opens a new range of complex syntactic processing mechanisms to physiological investigation.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Gentner, TQ (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.	tgentner@ucsd.edu	Galantucci, Bruno/E-5770-2010		NIDCD NIH HHS [F32 DC000389, F32 DC000389-03] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000389] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chomsky N., 2002, JANUA LINGUARUM; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Fitch WT, 2005, COGNITION, V97, P179, DOI 10.1016/j.cognition.2005.02.005; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2002, COGNITION, V86, pB15, DOI 10.1016/S0010-0277(02)00139-7; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Hopcroft J.E., 1979, INTRO AUTOMATA THEOR; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004	13	372	385	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1204	1207		10.1038/nature04675	http://dx.doi.org/10.1038/nature04675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641998	Green Accepted			2022-12-28	WOS:000237080000048
J	Guermah, M; Palhan, VB; Tackett, AJ; Chait, BT; Roeder, RG				Guermah, M; Palhan, VB; Tackett, AJ; Chait, BT; Roeder, RG			Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates	CELL			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR-SII; NF-KAPPA-B; IN-VITRO; SACCHAROMYCES-CEREVISIAE; GENETIC INTERACTIONS; HISTONE CHAPERONE; H2A-H2B DIMERS; FACTOR TFIIS; INITIATION	We have reconstituted a highly purified RNA polymerase II transcription system containing chromatin templates assembled with purified histones and assembly factors, the histone acetyltransferase p300, and components of the general transcription machinery that, by themselves, suffice for activated transcription (initiation and elongation) on DNA templates. We show that this system mediates activator-dependent initiation, but not productive elongation, on chromatin templates. We further report the purification of a chromatin transcription-enabling activity (CTEA) that, in a manner dependent upon p300 and acetyl-CoA, strongly potentiates transcription elongation through several contiguous nucleosomes as must occur in vivo. The transcription elongation factor SII is a major component of CTEA and strongly synergizes with p300 (histone acetylation) at a step subsequent to preinitiation complex formation. The purification of CTEA also identified HMGB2 as a coactivator that, while inactive on its own, enhances SII and p300 functions.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Guermah, M (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	guermam@mail.rockefeller.edu; roeder@mail.rockefeller.edu			NATIONAL CANCER INSTITUTE [R01CA113872] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066496] Funding Source: NIH RePORTER; NCI NIH HHS [CA113872] Funding Source: Medline; NCRR NIH HHS [RR00862] Funding Source: Medline; NIDDK NIH HHS [DK071900] Funding Source: Medline; NIGMS NIH HHS [GM066496] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Chang CH, 1997, J BIOL CHEM, V272, P23427, DOI 10.1074/jbc.272.37.23427; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fukuda A, 2002, P NATL ACAD SCI USA, V99, P1206, DOI 10.1073/pnas.251674198; Gamble MJ, 2005, MOL CELL BIOL, V25, P797, DOI 10.1128/MCB.25.2.797-807.2005; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jiang W, 2000, J BIOL CHEM, V275, P39819, DOI 10.1074/jbc.C000713200; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lennon JC, 1998, MOL CELL BIOL, V18, P5771, DOI 10.1128/MCB.18.10.5771; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Levchenko V, 2005, BIOCHEMISTRY-US, V44, P5357, DOI 10.1021/bi047786o; Levchenko V, 2004, BIOCHEMISTRY-US, V43, P2359, DOI 10.1021/bi035737q; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Malagon F, 2004, GENETICS, V166, P1215, DOI 10.1534/genetics.166.3.1215; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; REINES D, 1989, J BIOL CHEM, V264, P10799; REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SZENTIRMAY MN, 1993, EMBO J, V12, P4677, DOI 10.1002/j.1460-2075.1993.tb06156.x; Tackett AJ, 2005, J CELL BIOL, V169, P35, DOI 10.1083/jcb.200502104; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Ubukata T, 2003, J BIOL CHEM, V278, P8580, DOI 10.1074/jbc.M211384200; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x	64	71	73	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					275	286		10.1016/j.cell.2006.01.055	http://dx.doi.org/10.1016/j.cell.2006.01.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630816	Bronze, Green Submitted			2022-12-28	WOS:000237241500018
J	Hilgenberg, LGW; Su, HL; Gu, HY; O'Dowd, DK; Smith, MA				Hilgenberg, LGW; Su, HL; Gu, HY; O'Dowd, DK; Smith, MA			a3Na(+)/K+-ATPase is a neuronal receptor for Agrin	CELL			English	Article							ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION; SYNAPSE FORMATION; CORTICAL-NEURONS; MESSENGER-RNA; EXPRESSION; DEFICIENT; NA+; MUSCLE; ATPASE	Agrin, through its interaction with the receptor tyrosine kinase MuSK, mediates accumulation of acetylcholine receptors (AChR) at the developing neuromuscular junction. Agrin has also been implicated in several functions in brain. However, the mechanism by which agrin exerts its effects in neural tissue is unknown. Here we present biochemical evidence that agrin binds to the alpha 3 subunit of the Na+/K+-ATPase (NKA) in CNS neurons. Colocalization with agrin binding sites at synapses supports the hypothesis that the alpha 3NKA is a neuronal agrin receptor. Agrin inhibition of alpha 3NKA activity results in membrane depolarization and increased action potential frequency in cortical neurons in culture and acute slice. An agrin fragment that acts as a competitive antagonist depresses action potential frequency, showing that endogenous agrin regulates native alpha 3NKA function. These data demonstrate that, through its interaction with the alpha 3NKA, agrin regulates activity-dependent processes in neurons, providing a molecular framework for agrin action in the CNS.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Smith, MA (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	masmith@uci.edu			NIDA NIH HHS [DA14960] Funding Source: Medline; NINDS NIH HHS [NS33213, NS45540, NS27501] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS027501, R29NS027501, R01NS027501, T32NS045540, R01NS033213] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Bose CM, 2000, J NEUROSCI, V20, P9086; Bouron A, 1996, NEURON, V17, P969, DOI 10.1016/S0896-6273(00)80227-5; BRINES ML, 1995, NEUROSCI LETT, V191, P145, DOI 10.1016/0304-3940(95)11577-J; BRINES ML, 1993, BRAIN RES, V631, P1, DOI 10.1016/0006-8993(93)91179-V; Campagna JA, 1997, EUR J NEUROSCI, V9, P2269, DOI 10.1111/j.1460-9568.1997.tb01645.x; Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623; Cohen NA, 1997, NEUROSCIENCE, V76, P581, DOI 10.1016/S0306-4522(96)00345-4; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; DAVIDSON DLW, 1978, CAN J NEUROL SCI, V5, P405, DOI 10.1017/S0317167100024185; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; FALLON JR, 1985, NATURE, V315, P571, DOI 10.1038/315571a0; Ferreira A, 1999, J CELL SCI, V112, P4729; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GIBBS ME, 1978, PHARMACOL BIOCHEM BE, V8, P271, DOI 10.1016/0091-3057(78)90315-5; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Hilgenberg LGW, 2004, J NEUROBIOL, V61, P289, DOI 10.1002/neu.20049; Hilgenberg LGW, 2002, MOL CELL NEUROSCI, V19, P97, DOI 10.1006/mcne.2001.1056; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hoover CL, 2003, J CELL BIOL, V161, P923, DOI 10.1083/jcb.200301013; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Li Z, 1997, NEUROSCIENCE, V79, P191, DOI 10.1016/S0306-4522(96)00654-9; Liu IH, 2005, GLYCOBIOLOGY, V15, P1320, DOI 10.1093/glycob/cwj014; Mann S, 1996, MOL CELL NEUROSCI, V8, P1, DOI 10.1006/mcne.1996.0039; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OCONNOR LT, 1995, MOL BRAIN RES, V33, P277, DOI 10.1016/0169-328X(95)00147-K; OCONNOR LT, 1994, J NEUROSCI, V14, P1141, DOI 10.1523/JNEUROSCI.14-03-01141.1994; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; Ross ST, 2001, P NATL ACAD SCI USA, V98, P8874, DOI 10.1073/pnas.141042398; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sato T, 2004, PHARMACOL RES, V49, P151, DOI 10.1016/j.phrs.2003.09.006; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Verbeek MM, 1999, AM J PATHOL, V155, P2115, DOI 10.1016/S0002-9440(10)65529-0; Xia SZ, 1997, PHARMACOL BIOCHEM BE, V58, P727, DOI 10.1016/S0091-3057(97)00045-2; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	50	93	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					359	369		10.1016/j.cell.2006.01.052	http://dx.doi.org/10.1016/j.cell.2006.01.052			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630822	Bronze			2022-12-28	WOS:000237241500024
J	Kaplan, DR; Miller, FD				Kaplan, DR; Miller, FD			When a motor goes bad: A kinesin regulates neuronal survival	CELL			English	Editorial Material							ACTIVATION; TRANSCRIPTION; PROMOTES; SIGNAL		Univ Toronto, Hosp Sick Children, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Physiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kaplan, DR (corresponding author), Univ Toronto, Hosp Sick Children, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada.	dkaplan@sickkids.ca						Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Jacobs WB, 2004, NEUROSCIENTIST, V10, P443, DOI 10.1177/1073858404263456; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Middleton G, 2000, J CELL BIOL, V148, P325, DOI 10.1083/jcb.148.2.325; Visochek L, 2005, J NEUROSCI, V25, P7420, DOI 10.1523/JNEUROSCI.0333-05.2005; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	9	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 21	2006	125	2					224	226		10.1016/j.cell.2006.03.031	http://dx.doi.org/10.1016/j.cell.2006.03.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630809	Bronze			2022-12-28	WOS:000237241500011
J	Olsen, B; Munster, VJ; Wallensten, A; Waldenstrom, J; Osterhaus, ADME; Fouchier, RAM				Olsen, B; Munster, VJ; Wallensten, A; Waldenstrom, J; Osterhaus, ADME; Fouchier, RAM			Global patterns of influenza A virus in wild birds	SCIENCE			English	Review							HIGHLY PATHOGENIC H5N1; AVIAN INFLUENZA; NORTH-AMERICA; AQUATIC BIRDS; HONG-KONG; DUCKS; ASIA; ECOLOGY; GENES; TRANSMISSION	The outbreak of highly pathogenic avian influenza of the H5N1 subtype in Asia, which has subsequently spread to Russia, the Middle East, Europe, and Africa, has put increased focus on the role of wild birds in the persistence of influenza viruses. The ecology, epidemiology, genetics, and evolution of pathogens cannot be fully understood without taking into account the ecology of their hosts. Here, we review our current knowledge on global patterns of influenza virus infections in wild birds, discuss these patterns in the context of host ecology and in particular birds' behavior, and identify some important gaps in our current knowledge.	Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands; Kalmar Cty Council, Smedby Hlth Ctr, SE-39471 Kalmar, Sweden; Umea Univ, Dept Infect Dis, SE-90187 Umea, Sweden; Univ Kalmar, Dept Biol & Environm Sci, Sect Zoonot Ecol & Epidemiol, SE-39182 Kalmar, Sweden; Linkoping Univ, Fac Hlth Sci, Dept Mol & Clin Med IMK, Div Virol, SE-58185 Linkoping, Sweden; Lund Univ, Dept Anim Ecol, SE-22362 Lund, Sweden	Erasmus University Rotterdam; Erasmus MC; Umea University; Linnaeus University; University of Kalmar; Linkoping University; Lund University	Fouchier, RAM (corresponding author), Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Munster, Vincent/I-7607-2018; Waldenström, Jonas/E-4460-2013; Fouchier, Ron A/A-1911-2014	Munster, Vincent/0000-0002-2288-3196; Waldenström, Jonas/0000-0002-1152-4235; Fouchier, Ron A/0000-0001-8095-2869; Olsen, Bjorn/0000-0002-4646-691X; Osterhaus, Albert/0000-0002-6074-1172				Alerstam T., 1990, P331; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; AUSTIN FJ, 1993, J WILDLIFE DIS, V29, P568, DOI 10.7589/0090-3558-29.4.568; Brown LH, 1982, BIRDS AFRICA, VI; CHEN H, 2006, P NATL AC SCI US; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Del Hoyo J., 1996, HDB BIRDS WORLD; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gill Robert E. Jr, 1994, Transactions of the North American Wildlife and Natural Resources Conference, V59, P63; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; Hatchette TF, 2004, J GEN VIROL, V85, P2327, DOI 10.1099/vir.0.79878-0; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; KIDA H, 1980, INFECT IMMUN, V30, P547; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Liu JH, 2004, VIRUS GENES, V29, P81, DOI 10.1023/B:VIRU.0000032791.26573.f1; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Martin V, 2006, DEV BIOLOGICALS, V124, P23; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Okazaki K, 2000, ARCH VIROL, V145, P885, DOI 10.1007/s007050050681; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; SCOTT D. A, 1996, PUBL WETLANDS INT, V41; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Spackman E, 2005, VIRUS RES, V114, P89, DOI 10.1016/j.virusres.2005.05.013; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; van de Kam J, 2004, SHOREBIRDS ILLUSTRAT; Wallensten A, 2005, ARCH VIROL, V150, P1685, DOI 10.1007/s00705-005-0543-8; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004	39	1294	1408	20	428	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					384	388		10.1126/science.1122438	http://dx.doi.org/10.1126/science.1122438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627734				2022-12-28	WOS:000236941800035
J	Smith, DJ				Smith, DJ			Predictability and preparedness in influenza control	SCIENCE			English	Editorial Material							TRANSMISSION DYNAMICS; PANDEMIC INFLUENZA; MOUTH EPIDEMIC; PUBLIC-HEALTH; VIRUS; EVOLUTION; IMPACT; FOOT	The threat of pandemic human influenza looms as we survey the ongoing avian influenza pandemic and wonder if and when it will jump species. What are the risks and how can we plan? The nub of the problem ties in the inherent variability of the virus, which makes prediction difficult. However, it is not impossible; mathematical models can help determine and quantify critical parameters and thresholds in the relationships of those parameters, even if the relationships are nonlinear and obscure to simple reasoning. Mathematical models can derive estimates for the levels of drug stockpiles needed to buy time, how and when to modify vaccines, whom to target with vaccines and drugs, and when to enforce quarantine measures. Regardless, the models used for pandemic planning must be tested, and for this we must continue to gather data, not just for exceptional scenarios but also for seasonal influenza.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk	Smith, Derek/Z-3075-2019	Smith, Derek/0000-0002-2393-1890	NIH HHS [DP1-OD000490-01] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Efron B., 1994, MONOGRAPHS STAT APPL; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Hampson AW, 2002, PERSP MED V, V7, P49; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, WHO PAND INFL DRAFT	18	56	62	4	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					392	394		10.1126/science.1122665	http://dx.doi.org/10.1126/science.1122665			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034OZ	16627736				2022-12-28	WOS:000236941800037
J	Tryggvason, K; Pikkarainen, T; Patrakka, J				Tryggvason, K; Pikkarainen, T; Patrakka, J			Nck links nephrin to actin in kidney podocytes	CELL			English	Editorial Material							PHOSPHORYLATION; PROTEIN; PODOCIN		Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Tryggvason, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden.	karl.tryggvason@ki.se	Patrakka, Jaakko/AAG-8796-2019					Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; JONES N, 2006, NATURE; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; VERMA R, 2006, J CLIN INVEST	10	69	74	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 21	2006	125	2					221	224		10.1016/j.cell.2006.04.002	http://dx.doi.org/10.1016/j.cell.2006.04.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630808	Bronze			2022-12-28	WOS:000237241500010
J	Belfort, M				Belfort, M			Umbilical-cord prolapse at 29 weeks' gestation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Marks Hosp, Salt Lake City, UT 84124 USA		Belfort, M (corresponding author), St Marks Hosp, Salt Lake City, UT 84124 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					E15	E15		10.1056/NEJMicm050015	http://dx.doi.org/10.1056/NEJMicm050015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16625004				2022-12-28	WOS:000236893900010
J	Gbesso, S; Decosas, J; Gnahoui-David, B; Sala-Diakanda, F				Gbesso, S; Decosas, J; Gnahoui-David, B; Sala-Diakanda, F			Adolescent sexual health? Let us get real!	LANCET			English	Editorial Material									Plan W Africa Reg Off, Accra, Ghana; Coll Enseignement Gen, Aplahoue, Benin; Plan Benin, Cotonou, Benin; Plan Togo, Lome, Togo		Decosas, J (corresponding author), Plan W Africa Reg Off, Accra, Ghana.	josef.decosas@plan-international.org						Leach F, 2003, INVESTIGATIVE STUDY; 2006, PLAN TOGO SUFFERING	2	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1221	1222		10.1016/S0140-6736(06)68518-8	http://dx.doi.org/10.1016/S0140-6736(06)68518-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	034FC	16631863				2022-12-28	WOS:000236913400007
J	Spilianakis, CG; Flavell, RA				Spilianakis, CG; Flavell, RA			Molecular biology - Managing associations between different chromosomes	SCIENCE			English	Editorial Material							X-INACTIVATION		Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923				Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	9	15	16	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					207	208		10.1126/science.1126689	http://dx.doi.org/10.1126/science.1126689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614205				2022-12-28	WOS:000236765300031
J	White, TD; WoldeGabriel, G; Asfaw, B; Ambrose, S; Beyene, Y; Bernor, RL; Boisserie, JR; Currie, B; Gilbert, H; Haile-Selassie, Y; Hart, WK; Hlusko, LJ; Howell, FC; Kono, RT; Lehmann, T; Louchart, A; Lovejoy, CO; Renne, PR; Saegusa, H; Vrba, ES; Wesselman, H; Suwa, G				White, TD; WoldeGabriel, G; Asfaw, B; Ambrose, S; Beyene, Y; Bernor, RL; Boisserie, JR; Currie, B; Gilbert, H; Haile-Selassie, Y; Hart, WK; Hlusko, LJ; Howell, FC; Kono, RT; Lehmann, T; Louchart, A; Lovejoy, CO; Renne, PR; Saegusa, H; Vrba, ES; Wesselman, H; Suwa, G			Asa Issie, aramis and the origin of Australopithecus	NATURE			English	Article							MIDDLE AWASH VALLEY; ENAMEL THICKNESS; EARLY HOMINID; ALLIA BAY; ISOTOPIC EVIDENCE; AFAR RIFT; MIOCENE; ANAMENSIS; EVOLUTION; KANAPOI	The origin of Australopithecus, the genus widely interpreted as ancestral to Homo, is a central problem in human evolutionary studies. Australopithecus species differ markedly from extant African apes and candidate ancestral hominids such as Ardipithecus, Orrorin and Sahelanthropus. The earliest described Australopithecus species is Au. anamensis, the probable chronospecies ancestor of Au. afarensis. Here we describe newly discovered fossils from the Middle Awash study area that extend the known Au. anamensis range into northeastern Ethiopia. The new fossils are from chronometrically controlled stratigraphic sequences and date to about 4.1-4.2 million years ago. They include diagnostic craniodental remains, the largest hominid canine yet recovered, and the earliest Australopithecus femur. These new fossils are sampled from a woodland context. Temporal and anatomical intermediacy between Ar. ramidus and Au. afarensis suggest a relatively rapid shift from Ardipithecus to Australopithecus in this region of Africa, involving either replacement or accelerated phyletic evolution.	Univ Calif Berkeley, Museum Vertebrate Zool, Human Evolut Res Ctr, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Los Alamos Natl Lab, Hydrol Geochem & Geol Grp, Los Alamos, NM 87545 USA; Rift Valley Res Serv, Addis Ababa, Ethiopia; Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; Minist Youth Sports & Culture, Dept Anthropol & Archaeol, Author Res & Conservat Cultural Heritage, Addis Ababa, Ethiopia; Howard Univ, Coll Med, Dept Anat, Lab Evolutionary Biol, Washington, DC 20059 USA; Museum Natl Hist Nat, Unite Paleobiodivers & Paleoenvironm, CNRS, UMR 5143,Dept Hist Terre,USM 0203, F-75005 Paris, France; Univ Poitiers, UMR 6046, Lab Geobiol Biochronol & Paleontol Humaine, F-86022 Poitiers, France; Miami Univ, Dept Geol, Oxford, OH 45056 USA; Cleveland Museum Nat Hist, Dept Phys Anthropol, Cleveland, OH 44106 USA; Museum Nat Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan; Transvaal Museum, Palaeontol Sect, ZA-0001 Pretoria, South Africa; Univ Lyon 1, Lab Paleoenvironm & Paleobiosphere, UMR 5125, F-69622 Villeurbanne, France; Kent State Univ, Dept Anthropol, Kent, OH 44242 USA; Kent State Univ, Div Biomed Sci, Kent, OH 44242 USA; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Hyogo, Inst Nat & Environm Sci, Yayoigaoka, Sanda 6691546, Japan; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Sierra Coll, Nat Hist Museum, Rocklin, CA 95677 USA; Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Illinois System; University of Illinois Urbana-Champaign; Howard University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Universite de Poitiers; University System of Ohio; Miami University; Cleveland Museum of Natural History; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Berkeley Geochronolgy Center; University of California System; University of California Berkeley; University of Hyogo; Yale University; University of Tokyo	White, TD (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Human Evolut Res Ctr, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	timwhite@berkeley.edu	Rodriguez-Berral, Raul/A-8948-2016; , owen/N-7301-2019	Rodriguez-Berral, Raul/0000-0001-8989-0692; , owen/0000-0003-0053-4523; Louchart, Antoine/0000-0003-3847-6007; Renne, Paul/0000-0003-1769-5235; Hlusko, Leslea/0000-0003-0189-6390; Currie, Brian/0000-0002-5759-3914				[Anonymous], 1991, HETEROCHRONY EVOLUTI; ASFAW B, 1987, J HUM EVOL, V16, P611, DOI 10.1016/0047-2484(87)90016-9; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CERLING TE, 1988, PALAEOGEOGR PALAEOCL, V63, P335, DOI 10.1016/0031-0182(88)90104-6; COFFING K, 1994, AM J PHYS ANTHROPOL, V93, P55, DOI 10.1002/ajpa.1330930104; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Flessa K.W., 2005, GEOLOGICAL RECORD EC; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Haile-Selassie Y, 2004, GEOBIOS-LYON, V37, P536, DOI 10.1016/j.geobios.2003.03.012; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2000, AM J PHYS ANTHROPOL, P170; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; HAILEAB B, 1992, J HUM EVOL, V22, P453, DOI 10.1016/0047-2484(92)90080-S; HALL CM, 1984, NATURE, V308, P26, DOI 10.1038/308026a0; HART WK, 1992, QUATERN INT, V13, P77; Hlusko LJ, 2006, GEOBIOS-LYON, V39, P57, DOI 10.1016/j.geobios.2004.09.001; Hlusko LJ, 2004, AM J PHYS ANTHROPOL, V124, P223, DOI 10.1002/ajpa.10353; Kappelman J, 1996, J HUM EVOL, V30, P139, DOI 10.1006/jhev.1996.0010; KINGSTON JD, 1994, SCIENCE, V264, P955, DOI 10.1126/science.264.5161.955; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Macho GA, 2005, ANAT REC PART A, V283A, P310, DOI 10.1002/ar.a.20175; MALMGREN BA, 1983, PALEOBIOLOGY, V9, P377, DOI 10.1017/S0094837300007843; Ohman JC, 2005, SCIENCE, V307, P845; Pickford M, 2002, C R PALEVOL, V1, P191, DOI 10.1016/S1631-0683(02)00028-3; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Schoeninger MJ, 2003, J ANTHROPOL ARCHAEOL, V22, P200, DOI 10.1016/S0278-4165(03)00034-5; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; SENUT B, 2000, CR HEBD ACAD SCI, V332, P134; Stanley S. M., 1979, MACROEVOLUTION PATTE; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Suwa G, 2005, ANTHROPOL SCI, V113, P273, DOI 10.1537/ase.050118; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Vrba ES, 2005, PALEOBIOLOGY, V31, P157, DOI 10.1666/0094-8373(2005)031[0157:MTAHEI]2.0.CO;2; Wagner PJ, 2000, SYST BIOL, V49, P65, DOI 10.1080/10635150050207393; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; White TD, 2002, CAM S BIO EVOL ANTHR, V33, P407; White TD, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P369; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1993, NATURE, V366, P261, DOI 10.1038/366261a0; WHITE TD, IN PRESS PALEVOL; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058; WOOD B, 1994, NATURE, V371, P280, DOI 10.1038/371280a0; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Wynn JG, 2000, J HUM EVOL, V39, P411, DOI 10.1006/jhev.2000.0431	50	190	197	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					883	889		10.1038/nature04629	http://dx.doi.org/10.1038/nature04629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	031WU	16612373				2022-12-28	WOS:000236736700030
J	Ross, JS; Gross, CP; Desai, MM; Hong, YL; Grant, AO; Daniels, SR; Hachinski, VC; Gibbons, RJ; Gardner, TJ; Krumholz, HM				Ross, JS; Gross, CP; Desai, MM; Hong, YL; Grant, AO; Daniels, SR; Hachinski, VC; Gibbons, RJ; Gardner, TJ; Krumholz, HM			Effect of blinded peer review on abstract acceptance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							EDITORIAL DECISIONS; BIAS	Context Peer review should evaluate the merit and quality of abstracts but may be biased by geographic location or institutional prestige. The effectiveness of blinded peer review at reducing bias is unknown. Objective To evaluate the effect of blinded review on the association between abstract characteristics and likelihood of abstract acceptance at a national research meeting. Design and Setting All abstracts submitted to the American Heart Association's annual Scientific Sessions research meeting from 2000-2004. Abstract review included the author's name and institution (open review) from 2000-2001, and this information was concealed (blinded review) from 2002-2004. Abstracts were categorized by country, primary language, institution prestige, author sex, and government and industry status. Main Outcome Measure Likelihood of abstract acceptance during open and blinded review, by abstract characteristics. Results The mean number of abstracts submitted each year for evaluation was 13 455 and 28.5% were accepted. During open review, 40.8% of US and 22.6% of non-US abstracts were accepted (relative risk [RR], 1.81; 95% confidence interval [CI], 1.75-1.88), whereas during blinded review, 33.4% of US and 23.7% of non-US abstracts were accepted (RR, 1.41; 95% CI, 1.37-1.45; P < .001 for comparison between peer review periods). Among non-US abstracts, during open review, 31.1% from English-speaking countries and 20.9% from non-English-speaking countries were accepted (RR, 1.49; 95% CI, 1.39-1.59), whereas during blinded review, 28.8% and 22.8% of abstracts were accepted, respectively (RR, 1.26; 95% CI, 1.19-1.34; P < .001). Among abstracts from US academic institutions, during open review, 51.3% from highly prestigious and 32.6% from nonprestigious institutions were accepted (RR, 1.57; 95% CI, 1.48-1.67), whereas during blinded review, 38.8% and 29.0% of abstracts were accepted, respectively (RR, 1.34; 95% CI, 1.26-1.41; P < .001). Conclusions This study provides evidence of bias in the open review of abstracts, favoring authors from the United States, English-speaking countries outside the United States, and prestigious academic institutions. Moreover, blinded review at least partially reduced reviewer bias.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Amer Heart Assoc, Dallas, TX USA; Duke Univ, Med Ctr, Dept Internal Med, Div Cardiol, Durham, NC 27710 USA; Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Cardiol, Cincinnati, OH USA; Lawson Hlth Res Inst, Neurosci Program, London, ON, Canada; Mayo Clin, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN USA; Christiana Care Hlth Syst, Ctr Heart & Vasc Hlth, Newark, DE USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Duke University; Cincinnati Children's Hospital Medical Center; Western University (University of Western Ontario); Mayo Clinic; Christiana Care Health System	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Gibbons, Raymond/0000-0003-0704-1350; Desai, Mayur/0000-0001-6616-0945; Ross, Joseph/0000-0002-9218-3320				[Anonymous], 2000, US NEWS WORLD REPORT; Bachand RG, 2003, SERIALS LIBR, V45, P39, DOI 10.1300/J123v45n02_04; Cho MK, 1998, JAMA-J AM MED ASSOC, V280, P243, DOI 10.1001/jama.280.3.243; Eldredge J, 1999, Med Ref Serv Q, V18, P13, DOI 10.1300/J115v18n02_02; FISHER M, 1994, JAMA-J AM MED ASSOC, V272, P143, DOI 10.1001/jama.272.2.143; GARFUNKEL JM, 1994, JAMA-J AM MED ASSOC, V272, P137, DOI 10.1001/jama.272.2.137; GILBERT JR, 1994, JAMA-J AM MED ASSOC, V272, P139, DOI 10.1001/jama.272.2.139; GODLEE F, 2003, PEER REV HLTH SCI, P101; Hojat M, 2003, ADV HEALTH SCI EDUC, V8, P75, DOI 10.1023/A:1022670432373; KASSIRER JP, 1994, JAMA-J AM MED ASSOC, V272, P96, DOI 10.1001/jama.272.2.96; Kliewer MA, 2004, AM J ROENTGENOL, V183, P1545, DOI 10.2214/ajr.183.6.01831545; Link AM, 1998, JAMA-J AM MED ASSOC, V280, P246, DOI 10.1001/jama.280.3.246; *NAT I HLTH, AW DAT; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; *PEARS ED INC, 2004, TIME 2005 ALM	15	122	128	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1675	1680		10.1001/jama.295.14.1675	http://dx.doi.org/10.1001/jama.295.14.1675			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609089	Bronze			2022-12-28	WOS:000236707300023
J	Habashi, JP; Judge, DP; Holm, TM; Cohn, RD; Loeys, BL; Cooper, TK; Myers, L; Klein, EC; Liu, GS; Calvi, C; Podowski, M; Neptune, ER; Halushka, MK; Bedja, D; Gabrielson, K; Rifkin, DB; Carta, L; Ramirez, F; Huso, DL; Dietz, HC				Habashi, JP; Judge, DP; Holm, TM; Cohn, RD; Loeys, BL; Cooper, TK; Myers, L; Klein, EC; Liu, GS; Calvi, C; Podowski, M; Neptune, ER; Halushka, MK; Bedja, D; Gabrielson, K; Rifkin, DB; Carta, L; Ramirez, F; Huso, DL; Dietz, HC			Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome	SCIENCE			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; RECEPTOR; PATHOGENESIS; FIBRILLIN; BLOCKADE; RATS; CONTRIBUTES; DILATATION; ACTIVATION	Aortic aneurysm and dissection are manifestations of Marfan syndrome (MFS), a disorder caused by mutations in the gene that encodes fibrillin-1. Selected manifestations of MFS reflect excessive signaling by the transforming growth factor-beta (TGF-beta) family of cytokines. We show that aortic aneurysm in a mouse model of MFS is associated with increased TGF-beta signaling and can be prevented by TGF-beta antagonists such as TGF-beta-neutralizing antibody or the angiotensin II type 1 receptor (AT1) blocker, losartan. AT1 antagonism also partially reversed noncardiovascular manifestations of MFS, including impaired alveolar septation. These data suggest that losartan, a drug already in clinical use for hypertension, merits investigation as a therapeutic strategy for patients with MFS and has the potential to prevent the major life-threatening manifestation of this disorder.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08903 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; New York University; New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Loeys, Bart/B-3236-2017; Cohn, Ronald/AAC-5835-2021	Loeys, Bart/0000-0003-3703-9518; Halushka, Marc/0000-0002-7112-7389; Judge, Daniel/0000-0002-3407-0248; Steinbach, Erin/0000-0002-6165-8928	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067056] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL067056] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COUCKE PJ, IN PRESS NAT GENET; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EVERETT AD, 1994, HYPERTENSION, V23, P587, DOI 10.1161/01.HYP.23.5.587; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Gadson PF, 1997, EXP CELL RES, V230, P169, DOI 10.1006/excr.1996.3398; Gott VL, 1999, NEW ENGL J MED, V340, P1307, DOI 10.1056/NEJM199904293401702; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jones ES, 2004, J MOL CELL CARDIOL, V37, P1023, DOI 10.1016/j.yjmcc.2004.08.004; Jones KB, 2005, SPINE, V30, P291, DOI 10.1097/01.brs.0000152166.88174.1c; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Nagashima H, 2001, CIRCULATION, V104, pI282; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nollen GJ, 2002, HEART, V87, P470, DOI 10.1136/heart.87.5.470; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SCHLUMBERGER W, 1991, ARTERIOSCLER THROMB, V11, P1660, DOI 10.1161/01.ATV.11.6.1660; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; SPENCE SG, 1995, TERATOLOGY, V51, P367, DOI 10.1002/tera.1420510603; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Visconti RP, 2003, MATRIX BIOL, V22, P109, DOI 10.1016/S0945-053X(03)00014-3; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028	31	1262	1303	7	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					117	121		10.1126/science.1124287	http://dx.doi.org/10.1126/science.1124287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601194	Green Accepted			2022-12-28	WOS:000236584400045
J	Liu, J; Taylor, DW; Krementsova, EB; Trybus, KM; Taylor, KA				Liu, Jun; Taylor, Dianne W.; Krementsova, Elena B.; Trybus, Kathleen M.; Taylor, Kenneth A.			Three-dimensional structure of the myosin V inhibited state by cryoelectron tomography	NATURE			English	Article							UNCONVENTIONAL MYOSIN; TAIL DOMAIN; ELECTRON TOMOGRAPHY; ATPASE ACTIVITY; MOTOR-ACTIVITY; TILT SERIES; ACTIN; RECONSTRUCTION; LOCALIZATION; CALMODULIN	Unconventional myosin V (myoV) is an actin-based molecular motor that has a key function in organelle and mRNA transport, as well as in membrane trafficking(1). MyoV was the first member of the myosin superfamily shown to be processive, meaning that a single motor protein can 'walk' hand-over-hand along an actin filament for many steps before detaching(2-4). Full-length myoV has a low actin-activated MgATPase activity at low [Ca2+], whereas expressed constructs lacking the cargo-binding domain have a high activity regardless of [Ca2+] (refs 5 - 7). Hydrodynamic data and electron micrographs indicate that the active state is extended, whereas the inactive state is compact(8-10). Here we show the first three-dimensional structure of the myoV inactive state. Each myoV molecule consists of two heads that contain an amino-terminal motor domain followed by a lever arm that binds six calmodulins. The heads are followed by a coiled-coil dimerization domain (S2) and a carboxy-terminal globular cargo-binding domain. In the inactive structure, bending of myoV at the head S2 junction places the cargo-binding domain near the motor domain's ATP-binding pocket, indicating that ATPase inhibition might occur through decreased rates of nucleotide exchange. The actin-binding interfaces are unobstructed, and the lever arm is oriented in a position typical of strong actin-binding states. This structure indicates that motor recycling after cargo delivery might occur through transport on actively treadmilling actin filaments rather than by diffusion.	Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	State University System of Florida; Florida State University; University of Vermont	Trybus, KM (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	trybus@physiology.med.uvm.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047421] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047421] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Winkler H, 2003, J STRUCT BIOL, V143, P24, DOI 10.1016/S1047-8477(03)00120-5; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	30	158	162	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					208	211		10.1038/nature04719	http://dx.doi.org/10.1038/nature04719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16625208				2022-12-28	WOS:000238979700049
J	Shu, YS; Hasenstaub, A; Duque, A; Yu, YG; McCormick, DA				Shu, Yousheng; Hasenstaub, Andrea; Duque, Alvaro; Yu, Yuguo; McCormick, David A.			Modulation of intracortical synaptic potentials by presynaptic somatic membrane potential	NATURE			English	Article							CAT VISUAL-CORTEX; UNDERLYING CONTRAST ADAPTATION; NEOCORTICAL PYRAMIDAL NEURONS; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; NERVE-TERMINALS; RAT NEOCORTEX; IN-VIVO; CELLS; CONNECTIONS	Traditionally, neuronal operations in the cerebral cortex have been viewed as occurring through the interaction of synaptic potentials in the dendrite and soma, followed by the initiation of an action potential, typically in the axon(1,2). Propagation of this action potential to the synaptic terminals is widely believed to be the only form of rapid communication of information between the soma and axonal synapses, and hence to postsynaptic neurons. Here we show that the voltage fluctuations associated with dendrosomatic synaptic activity propagate significant distances along the axon, and that modest changes in the somatic membrane potential of the presynaptic neuron modulate the amplitude and duration of axonal action potentials and, through a Ca2+-dependent mechanism, the average amplitude of the postsynaptic potential evoked by these spikes. These results indicate that synaptic activity in the dendrite and soma controls not only the pattern of action potentials generated, but also the amplitude of the synaptic potentials that these action potentials initiate in local cortical circuits, resulting in synaptic transmission that is a mixture of triggered and graded ( analogue) signals.	Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Shu, Yousheng/AAC-3881-2020; Kobelt, Liza/F-5926-2011	Shu, Yousheng/0000-0002-2834-2876; Yu, Yuguo/0000-0003-0603-2890				Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2005, CEREB CORTEX, V15, P152, DOI 10.1093/cercor/bhh118; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Dorval AD, 2001, ANN BIOMED ENG, V29, P897, DOI 10.1114/1.1408929; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Ivanov AI, 2003, J NEUROSCI, V23, P1206, DOI 10.1523/JNEUROSCI.23-04-01206.2003; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; NICHOLLS J, 1978, J PHYSIOL-LONDON, V281, P171, DOI 10.1113/jphysiol.1978.sp012415; Peters A, 1984, CEREBRAL CORTEX, V1; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SHAPIRO E, 1980, P NATL ACAD SCI-BIOL, V77, P629, DOI 10.1073/pnas.77.1.629; SHIMAHARA T, 1975, J PHYSIOL-LONDON, V247, P299, DOI 10.1113/jphysiol.1975.sp010933; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2	31	295	304	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					761	765		10.1038/nature04720	http://dx.doi.org/10.1038/nature04720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16625207				2022-12-28	WOS:000238095100057
J	Wu, SW; Ogawa, N; Ho, W				Wu, S. W.; Ogawa, N.; Ho, W.			Atomic-scale coupling of photons to single-molecule junctions	SCIENCE			English	Article							GROUND-STATE; SPECTROSCOPY; TEMPERATURE; MICROSCOPY	Spatial resolution at the atomic scale has been achieved in the coupling of light to single molecules adsorbed on a surface. Electron transfer to a single molecule induced by green to near-infrared light in the junction of a scanning tunneling microscope (STM) exhibited spatially varying probability that is confined within the molecule. The mechanism involves photo-induced resonant tunneling in which a photoexcited electron in the STM tip is transferred to the molecule. The coupling of photons to the tunneling process provides a pathway to explore molecular dynamics with the combined capabilities of lasers and the STM.	Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ho, W (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	wilsonho@uci.edu	Ogawa, Naoki/B-3626-2013; Wu, Shiwei/F-4542-2010	Wu, Shiwei/0000-0001-9838-9066				Adams DM, 2003, J PHYS CHEM B, V107, P6668, DOI 10.1021/jp0268462; APELL SP, 1992, PHYS REV B, V45, P6757, DOI 10.1103/PhysRevB.45.6757; Bartels L, 2004, SCIENCE, V305, P648, DOI 10.1126/science.1099770; Galperin M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.206802; Grafstrom S, 2002, J APPL PHYS, V91, P1717, DOI 10.1063/1.1432113; Hartschuh A, 2004, PHILOS T R SOC A, V362, P807, DOI 10.1098/rsta.2003.1348; Hecht B, 2000, J CHEM PHYS, V112, P7761, DOI 10.1063/1.481382; Kadish K. M., 2000, PORPHYRIN HDB; KEAY BJ, 1995, PHYS REV LETT, V75, P4102, DOI 10.1103/PhysRevLett.75.4102; Lamprecht B, 1997, APPL PHYS B-LASERS O, V64, P269, DOI 10.1007/s003400050174; Nguyen KA, 2001, J CHEM PHYS, V114, P10757, DOI 10.1063/1.1370064; Nitzan A, 2003, SCIENCE, V300, P1384, DOI 10.1126/science.1081572; Oosterkamp TH, 1997, PHYS REV LETT, V78, P1536, DOI 10.1103/PhysRevLett.78.1536; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; Repp J, 2004, SCIENCE, V305, P493, DOI 10.1126/science.1099557; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; SPANGLER D, 1977, J AM CHEM SOC, V99, P7478, DOI 10.1021/ja00465a014; Stipe BC, 1999, REV SCI INSTRUM, V70, P137, DOI 10.1063/1.1149555; Thon A, 2004, APPL PHYS A-MATER, V78, P189, DOI 10.1007/s00339-003-2314-2; TIEN PK, 1963, PHYS REV, V129, P647, DOI 10.1103/PhysRev.129.647; TRAUTMAN JK, 1994, NATURE, V369, P40, DOI 10.1038/369040a0; WIESENDANGER R, 1998, SCANNING PROBE MICRO; Wu SW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.236802; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361	24	175	177	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1362	1365		10.1126/science.1124881	http://dx.doi.org/10.1126/science.1124881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16627700				2022-12-28	WOS:000237961600050
J	Barrett, G; Cassell, JA; Peacock, JL; Coleman, MP				Barrett, G; Cassell, JA; Peacock, JL; Coleman, MP			National survey of British public's views on use of identifiable medical data by the National Cancer Registry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMED-CONSENT; INFORMATION	Objectives To describe the views of the British public on the use of personal medical data by the National Cancer Registry without individual consent, and to assess the relative importance attached by the public to personal privacy in relation to public health uses of identifiable health data. Design Cross sectional, face to face interview survey. Setting England, Wales, and Scotland. Participants 2872 respondents, 97% of those who took part in the Office for National Statistics' omnibus survey, a national multistage probability sample in March and April 2005 (response rates 62% and 69%, respectively). Results 72% (95% confidence interval 70% to 74%) of all respondents did not consider any of the following to be an invasion of their privacy by the National Cancer Registry: inclusion of postcode, inclusion of name and address, and the receipt of a letter inviting them to a research study on the basis of inclusion in the registry. Only 2% (2% to 3%) of the sample considered all of these to amount to an invasion of privacy. Logistic regression analysis showed that the proportions not concerned about invasion of privacy varied significantly by country, ethnicity, socioeconomic status, and housing tenure, although in all subgroups examined most respondents had no concerns. 81% (79% to 83%) of all respondents said that they would support a law making cancer registration statutory. Conclusions Most of the British public considers the confidential use of personal, identifiable patient information by the National Cancer Registry for the purposes of public health research and surveillance not to be an invasion of privacy.	Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge TW7 5DU, Middx, England; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London WC1E 6BT, England; London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London, England	Brunel University; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Barrett, G (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge TW7 5DU, Middx, England.	geraldine.barrett@brunel.ac.uk	Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807; Peacock, Janet/0000-0002-0310-2518; Barrett, Geraldine/0000-0002-9738-1051; Cassell, Jackie/0000-0003-0777-0385				BOYD P, 2003, J HLTH SERV RES P S1, V8, pS1; *BRIT MED ASS, 2005, CONF PART BIGG PICT; de Vet HCW, 2003, INT J EPIDEMIOL, V32, P1114, DOI 10.1093/ije/dyg314; Department of Health, 2003, CONF NHS COD PRACT; *EUR COMM RES GROU, 2003, DAT PROT; *GEN MED COUNC, 2000, CONF PROT PROV INF; HIGGINS J, 2003, J HLTH SERV RES P S1, V8, pS1; Ingelfinger JR, 2004, NEW ENGL J MED, V350, P1452, DOI 10.1056/NEJMe048027; McKinney PA, 2005, BRIT MED J, V330, P877, DOI 10.1136/bmj.38404.650208.ae; O'Neill O, 2003, J MED ETHICS, V29, P4, DOI 10.1136/jme.29.1.4; *OFF NAT STAT, KS18 TEN CENS 2001 K; Peto J, 2004, BRIT MED J, V328, P1029, DOI 10.1136/bmj.328.7447.1029; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Walley T, 2006, BRIT MED J, V332, P130, DOI 10.1136/bmj.332.7534.130; *WELLC TRUST PUBL, 2004, PUBL HLTH SCI CHALL	15	83	84	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1068	1070A		10.1136/bmj.38805.473738.7C	http://dx.doi.org/10.1136/bmj.38805.473738.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16648132	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000237518400018
J	Lavallo, V; Canac, Y; Donnadieu, B; Schoeller, WW; Bertrand, G				Lavallo, V; Canac, Y; Donnadieu, B; Schoeller, WW; Bertrand, G			Cyclopropenylidenes: From interstellar space to an isolated derivative in the laboratory	SCIENCE			English	Article							FUNCTIONAL CYCLO C-3-DERIVATIVES; HETEROCYCLIC CARBENES; C3H2 ISOMERS; SE REACTIONS; SMALL RINGS; IDENTIFICATION; DIAMINOCARBENES; ATTACK	Like many of the molecular species that have been detected in the interstellar medium, the singlet carbene cyclopropenylidene (C3H2) has been presumed to be too unstable to isolate in the laboratory. However, by appending pi-electron-donating amino groups to the triangular skeleton, we prepared a cyclopropenylidene derivative that is stable at room temperature. In contrast to previously isolated carbenes, this compound does not require a heteroatom adjacent to the electron-deficient carbon to confer stability. Despite the presence of amino groups, the geometric parameters of the cyclic skeleton, revealed by x-ray crystallography, are only slightly perturbed relative to those of the calculated structure of unsubstituted cyclopropenylidene. Stable cyclopropenylidene derivatives might thus serve as models for a better understanding of the formation of carbon-bearing molecules in the interstellar medium.	Univ Calif Riverside, CNRS,Unite Mixte Int 2957, Joint Res Chem Lab, Dept Chem, Riverside, CA 92521 USA; Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany	University of California System; University of California Riverside; University of Bielefeld	Bertrand, G (corresponding author), Univ Calif Riverside, CNRS,Unite Mixte Int 2957, Joint Res Chem Lab, Dept Chem, Riverside, CA 92521 USA.	gbertran@mail.ucr.edu	Schoeller, Wolfgang W/A-5755-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068825] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068825-01A2, R01 GM068825, R01 GM 68825] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alder RW, 2004, ANGEW CHEM INT EDIT, V43, P5896, DOI 10.1002/anie.200400654; Alder RW, 1996, ANGEW CHEM INT EDIT, V35, P1121, DOI 10.1002/anie.199611211; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; ARDUENGO AJ, 1995, J AM CHEM SOC, V117, P11027, DOI 10.1021/ja00149a034; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; BRESLOW R, 1957, J AM CHEM SOC, V79, P5318, DOI 10.1021/ja01576a067; Brinker U.H., 2001, ADV CARBENE CHEM; Driess M, 1996, ANGEW CHEM INT EDIT, V35, P829; Hahn FE, 2006, ANGEW CHEM INT EDIT, V45, P1348, DOI 10.1002/anie.200503858; Halton B, 2005, EUR J ORG CHEM, V2005, P3391, DOI 10.1002/ejoc.200500231; HEINEMANN C, 1994, CHEM PHYS LETT, V217, P11, DOI 10.1016/0009-2614(93)E1360-S; IGAU A, 1988, J AM CHEM SOC, V110, P6463, DOI 10.1021/ja00227a028; Itoh T, 2006, J AM CHEM SOC, V128, P957, DOI 10.1021/ja056575j; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kaiser RI, 2002, CHEM REV, V102, P1309, DOI 10.1021/cr970004v; Kirmse W, 2004, ANGEW CHEM INT EDIT, V43, P1767, DOI 10.1002/anie.200301729; Komatsu K, 2003, CHEM REV, V103, P1371, DOI 10.1021/cr010011q; MAIER G, 1994, J AM CHEM SOC, V116, P2014, DOI 10.1021/ja00084a047; Nyulaszi L, 1998, J MOL STRUC-THEOCHEM, V453, P91, DOI 10.1016/S0166-1280(98)00190-0; OFELE K, 1968, ANGEW CHEM INT EDIT, V7, P950, DOI 10.1002/anie.196809501; Peris E, 2004, COORDIN CHEM REV, V248, P2239, DOI 10.1016/j.ccr.2004.04.014; REISENAUER HP, 1984, ANGEW CHEM INT EDIT, V23, P641, DOI 10.1002/anie.198406411; Schumann H, 1997, ANGEW CHEM INT EDIT, V36, P2232, DOI 10.1002/anie.199722321; Scott NM, 2005, EUR J INORG CHEM, P1815; Seburg RA, 1997, J AM CHEM SOC, V119, P5847, DOI 10.1021/ja9638869; Taatjes CA, 2005, PHYS CHEM CHEM PHYS, V7, P806, DOI 10.1039/b417160h; TAMM M, 1995, J ORGANOMET CHEM, V501, P309, DOI 10.1016/0022-328X(95)05702-Q; THADDEUS P, 1985, ASTROPHYS J, V299, pL63, DOI 10.1086/184581; WEISS R, 1978, ANGEW CHEM INT EDIT, V17, P445, DOI 10.1002/anie.197804451; WEISS R, 1978, ANGEW CHEM INT EDIT, V17, P446, DOI 10.1002/anie.197804461; WEISS R, 1979, ANGEW CHEM INT EDIT, V18, P473, DOI 10.1002/anie.197904731; YOSHIDA Z, 1982, PURE APPL CHEM, V54, P1059, DOI 10.1351/pac198254051059	32	202	202	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					722	724		10.1126/science.1126675	http://dx.doi.org/10.1126/science.1126675			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	039NF	16614171	Green Accepted			2022-12-28	WOS:000237312100043
J	Rudd, CE				Rudd, CE			Focus on research: Disabled receptor signaling and new primary immunodeficiency disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Cambridge, Cambridge, England	University of Cambridge	Rudd, CE (corresponding author), Univ Cambridge, Cambridge, England.		Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019				Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669	1	12	12	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1874	1877		10.1056/NEJMp068062	http://dx.doi.org/10.1056/NEJMp068062			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672698				2022-12-28	WOS:000237239900003
J	O'Brien, PE; Dixon, JB; Laurie, C; Skinner, S; Proietto, J; McNeil, J; Strauss, B; Marks, S; Schachter, L; Chapman, L; Anderson, M				O'Brien, PE; Dixon, JB; Laurie, C; Skinner, S; Proietto, J; McNeil, J; Strauss, B; Marks, S; Schachter, L; Chapman, L; Anderson, M			Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							WEIGHT REDUCING DIETS; QUALITY-OF-LIFE; MORBID-OBESITY; RISK-FACTORS; US ADULTS; PLACEMENT; PREVALENCE; HEALTH; MANAGEMENT; OUTCOMES	Background: Obesity is a major, growing health problem. Observational studies suggest that bariatric surgery is more effective than nonsurgical therapy, but no randomized, controlled trials have confirmed this. Objective: To ascertain whether surgical therapy for obesity achieves better weight loss, health, and quality of life than nonsurgical therapy. Design: Randomized, controlled trial. Setting: University departments of medicine and surgery and an affiliated private hospital. Patients: 80 adults with mild to moderate obesity (body mass index, 30 kg/m(2) to 35 kg/m(2)) from the general community. Interventions: Patients were assigned to a program of very-low-calorie diets, pharmacotherapy, and lifestyle change for 24 months (nonsurgical group) or to placement of a laparoscopic adjustable gastric band (LAP-BAND System, INAMED Health, Santa Barbara, California) (surgical group). Measurements: outcome measures were weight change, presence of the metabolic syndrome, and change in quality of life at 2 years. Results: At 2 years, the surgical group had greater weight loss, with a mean of 21.6% (95% CI, 19.3% to 23.9%) of initial weight lost and 87.2% (CI, 77.7% to 96.6%) of excess weight lost, while the nonsurgical group had a loss of 5.5% (CI, 3.2% to 7.9%) of initial weight and 21.8% (CI, 11.9% to 31.6%) of excess weight (P < 0.001). The metabolic syndrome was initially present in 15 (38%) patients in each group and was present in 8 (24%) nonsurgical patients and 1 (3%) surgical patient at the completion of the study (P < 0.002). Quality of life improved statistically significantly more in the surgical group (8 of 8 subscores of Short Form-36) than in the nonsurgical group (3 of 8 subscores). Limitations: The study included mildly and moderately obese participants, was not powered for comparison of adverse events, and examined outcomes only for 24 months. Conclusions: Surgical treatment using laparoscopic adjustable gastric banding was statistically significantly more effective than nonsurgical therapy in reducing weight, resolving the metabolic syndrome, and improving quality of life during a 24-month treatment program.	Monash Univ, Sch Med, Alfred Hosp, Ctr Obes Res & Educ, Melbourne, Vic 3004, Australia; Univ Melbourne, Melbourne, Vic 3002, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne	O'Brien, PE (corresponding author), Monash Univ, Sch Med, Alfred Hosp, Ctr Obes Res & Educ, Melbourne, Vic 3004, Australia.	paul.obrien@med.monash.edu.au	Strauss, Boyd JG/I-4646-2012; Dixon, John B/A-5318-2011; Proietto, Joe/B-3780-2012; McNeil, John/L-6440-2019	Dixon, John B/0000-0001-5391-4082; McNeil, John/0000-0002-1049-5129				ANDERSEN T, 1984, NEW ENGL J MED, V310, P352, DOI 10.1056/NEJM198402093100604; Angrisani L, 2004, OBES SURG, V14, P415, DOI 10.1381/096089204322917963; Avenell A, 2004, J HUM NUTR DIET, V17, P293, DOI 10.1111/j.1365-277X.2004.00530.x; Avenell A, 2004, J HUM NUTR DIET, V17, P317, DOI 10.1111/j.1365-277X.2004.00531.x; BELACHEW M, 1995, OBES SURG, V5, P66, DOI 10.1381/096089295765558196; Chapman AE, 2004, SURGERY, V135, P326, DOI 10.1016/S0039-6060(03)00392-1; DIGGLE P, 1994, APPL STAT-J ROY ST C, V43, P49; Dixon AFR, 2005, J CLIN ENDOCR METAB, V90, P813, DOI 10.1210/jc.2004-1546; Dixon JB, 2002, AM J SURG, V184, p51S, DOI 10.1016/S0002-9610(02)01181-9; Favretti F, 2002, AM J SURG, V184, p38S, DOI 10.1016/S0002-9610(02)01178-9; Fielding GA, 2003, SURG ENDOSC, V17, P1541, DOI 10.1007/s00464-002-8921-8; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Keller S., 1994, SF36 PHYS MENTAL HLT; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; O'Brien PE, 2005, OBES SURG, V15, P820, DOI 10.1381/0960892054222858; O'Brien PE, 2003, J LAPAROENDOSC ADV A, V13, P265, DOI 10.1089/109264203322333593; O'Brien PE, 2002, OBES SURG, V12, P652, DOI 10.1381/096089202321019639; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Ren CJ, 2002, AM J SURG, V184, p46S, DOI 10.1016/S0002-9610(02)01180-7; Schauer PR, 2000, ANN SURG, V232, P515, DOI 10.1097/00000658-200010000-00007; Scopinaro N, 1998, WORLD J SURG, V22, P936, DOI 10.1007/s002689900497; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; WARE JE, 1997, SF36 HLTH SURVEY MAN; World Health Organization, 2000, WHO TECHN REP SER, V894	29	355	360	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					625	633		10.7326/0003-4819-144-9-200605020-00005	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039GJ	16670131				2022-12-28	WOS:000237293700001
J	Pond, B; McPake, B				Pond, B; McPake, B			The health migration crisis: the role of four Organisation for Economic Cooperation and Development countries	LANCET			English	Article							TRENDS	The crisis of human resources for health that is affecting low-income countries and especially sub-Saharan Africa has been attributed, at least in part, to increasing rates of migration of qualified health staff to high-income countries. We describe the conditions in four Organisation for Economic Cooperation and Development (OECD) health labour markets that have led to increasing rates of immigration. Popular explanations of these trends include ageing populations, growing incomes, and feminisation of the health workforce. Although these explanations form part of the larger picture, analysis of the forces operating in the four countries suggests that specific policy measures largely unrelated to these factors have driven growing demand for health staff. On this basis we argue that specific policy measures are equally capable of reversing these trends and avoiding the exploitation of low-income countries' scarce resources. These policies should seek to ensure local stability in health labour markets so that shortages of staff are not solved via the international brain drain.	Queen Margaret Univ Coll, Inst Int Hlth & Dev, Edinburgh EH12 8TS, Midlothian, Scotland	Queen Margaret University	McPake, B (corresponding author), Queen Margaret Univ Coll, Inst Int Hlth & Dev, Edinburgh EH12 8TS, Midlothian, Scotland.	bmcpake@qmuc.ac.uk	McPake, Barbara/AAE-8655-2021	McPake, Barbara/0000-0002-9904-1077				Aiken LH, 2004, HEALTH AFFAIR, V23, P69, DOI 10.1377/hlthaff.23.3.69; *AMA, 2004, PHYS CHAR DISTR US; [Anonymous], 2004, HUM RES HLTH OV CRIS; *ASS AM MED COLL, 2004, AAMC DAT BOOK 2004; Bach S., 2003, INT MIGRATION HLTH W; BAILEY T, 2004, HUMAN RESOURCES DEV, P234; *BAK, ARZT 1998 2004 BUND; BERLAND Y, 2002, DEMOGRAPHIE PROFESSI; *BRIT BROADC CORP, NHS OV DOCT ICAN BRI; *BRIT BROADC CORP, 1998, MED STUD NUMB BOOST; Buchan J, 2002, BMJ-BRIT MED J, V324, P751, DOI 10.1136/bmj.324.7340.751; Buchan J, 2003, RCN LABOUR MARKET RE; Buchan James, 2004, J Health Serv Res Policy, V9 Suppl 1, P10, DOI 10.1258/135581904322724086; Buchan James, 2003, INT NURSE MOBILITY T; BUERHAUS P, 2004, HLTH AFF        1117; Buerhaus PI, 2002, HEALTH AFFAIR, V21, P123, DOI 10.1377/hlthaff.21.5.123; Buerhaus PI, 1999, HEALTH AFFAIR, V18, P214, DOI 10.1377/hlthaff.18.1.214; Buerhaus PI, 2003, HEALTH AFFAIR, V22, P191, DOI 10.1377/hlthaff.22.6.191; *BUND, 2002, GEH DTSCH GES ARZT A; Bundred PE, 2000, LANCET, V356, P245, DOI 10.1016/S0140-6736(00)02492-2; BUSSE R, HLTH CARE SYSTEMS TR; *C BUDG OFF, 1995, MED GRAD MED ED; Chan BTB, 2002, PERCEIVED SURPLUS PE; COOPER R, 2002, HLTH AFF, V21, P222; COOPER R, 2004, PROGR DIR COUNC MED; COUFFINHAL A, 2001, QUESTIONS EC SANTE, V45, P1; COUFFINHAL A, 2001, QUESTIONS EC SANTE, V44, P1; *COUNC GRAD MED ED, 2002 SUMM REP US C S; *COUNC GRAD MED ED, 2000, EFF BAL BUDG ACT 199; DEMESQUITA JB, INT MIGRATION HLTH W; Diallo K, 2004, B WORLD HEALTH ORGAN, V82, P601; Dovlo D., 1999, HUMAN RESOURCES HLTH, V3, P1; Dumont J.-C., 2004, TRENDS INT MIGRATION; DUPILET C, 2000, DEMOGRAPHIE MED PENU; Forcier Melanie Bourassa, 2004, Hum Resour Health, V2, P12, DOI 10.1186/1478-4491-2-12; GATTUSO C, 2004, NUMERUS CLAUSUS SERA; *GEN MED COUNC, 2002, GMC ANN REV; *GMC, 2004, ANN REV 2003 4 QUAL; *GMC, ANN REV 2004 2005; *GMC, 2002, ANN REP ACC; GRANT H, WP0204 PRAIR CTR EXC; Grumbach K, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.5.13; HALL E, 2004, HUMAN RESOURCES DEV, P522; Healy J, 2002, HEALTH POLICY, V61, P1, DOI 10.1016/S0168-8510(01)00213-5; LANGLOIS J, 2001, DEMOGRAPHIE MED FUTU; LANGLOIS J, 2003, B ORDRE MED, V15, P1; LIESE B, 2004, AFRICA REGIONAL HUMA; MATTEI JF, AUGMENTATION NUMERUS; *MED MARK SERV, BACKGR INF AMA PHYS; Mensah K, 2005, SKILLS DRAIN HLTH PR; *NAT COUN STAT BOA, NURS LIC NCLEX EX ST; *NAT RES MATCH PRO, ADV DAT TABL 2004 RE; *NMC, 2004, STAT AN REG 1 APR 20; *ORG EC COOP DEV, 2002, TRENDS INT MIGR SOPE; PARIS V, PERSPECTIVES DEMOGRA; PETERSON SE, 1983, HEALTH POLICY EDUC, V3, P337, DOI 10.1016/0165-2281(83)90005-X; SAGOE K, 2004, INT ORG MIGR SEM HLT; Samuelson P.A, 1970, EC INTRO ANAL; SANDIER S, HLTH CARE SYSTEMS TR; *SAV CHILDR MED, WHOS CHAR AFR AID NH; SCHNEE M, 1999, DTSCH ARZTEBLATT, V96, pA30; SCHUMACHER E, EARNINGS EMPLOYMENT; *UK DEP HLTH, INT RECR CONS GEN PR; *UK DEP HLTH, ALL STAFF NHS 1994 2; *UK DEP HLTH, 2001, COD PRACT NHS EMPL I; *UK DEP HLTH, 1999, BIGG NURS PAY RIS 10; *UK DEP HLTH, NHS PLAN PLAN INV PL; *UK DEP HLTH, 2004, COD PRACT NHS EMPL I; *UK DEP HLTH, ADV LETT 1995 2004; *UK U COLL ADM SER, APPL ACC PRECL MED S; US Department of Health and Human Services, 2002, PROJ SUPPL DEM SHORT; WHELAN G, 2000, US ASS PROGR DIR INT; WORZ M, 2002, NEWSLETTER EUROPEAN, V4; 2002, ABBILDUNG 10 ENTWICK; GLOBAL ATLAS HLTH WO; 1996, ABBILDUNG 13 ANZAHL	76	52	54	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1448	1455		10.1016/S0140-6736(06)68346-3	http://dx.doi.org/10.1016/S0140-6736(06)68346-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650654				2022-12-28	WOS:000237195600032
J	Gregoor, PJHS				Gregoor, PJHS			Atorvastatin may cause nightmares	BRITISH MEDICAL JOURNAL			English	Article									Albert Schweitzer Hosp, Dept Internal Med, NL-3300 AK Dordrecht, Netherlands	Albert Schweitzer Ziekenhuis	Gregoor, PJHS (corresponding author), Albert Schweitzer Hosp, Dept Internal Med, POB 444, NL-3300 AK Dordrecht, Netherlands.	p.smakgregoor@asz.nl						Boriani G, 2001, ANN PHARMACOTHER, V35, P1292; Farmer JA, 2000, DRUG SAFETY, V23, P197, DOI 10.2165/00002018-200023030-00003	2	10	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 22	2006	332	7547					950	950		10.1136/bmj.332.7547.950	http://dx.doi.org/10.1136/bmj.332.7547.950			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627511	Green Published			2022-12-28	WOS:000237143900018
J	Staab, D; Diepgen, TL; Fartasch, M; Kupfer, J; Lob-Corzilius, T; Ring, J; Scheewe, S; Scheidt, R; Schmid-Ott, G; Schnopp, C; Szczepanski, R; Werfel, T; Wittenmeier, M; Wahn, U; Gieler, U				Staab, D; Diepgen, TL; Fartasch, M; Kupfer, J; Lob-Corzilius, T; Ring, J; Scheewe, S; Scheidt, R; Schmid-Ott, G; Schnopp, C; Szczepanski, R; Werfel, T; Wittenmeier, M; Wahn, U; Gieler, U			Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE; ASTHMA; INTERVENTIONS; IMPROVE; LIFE	Objective To determine the effects of age related, structured educational programmes on the management: of moderate to severe atopic dermatitis ill Childhood and adolescence. Design Multicentre, randomised controlled trial. Setting Seven hospitals in Germany. Participants Parents of children With atopic dermatitis aged 3 months to 7 years (n = 274) and 8-12 years (n = 102), adolescents with atopic dermatitis aged 13-18 years (n = 70), and controls (n = 244, n = 83, and n = 50, respectively). Interventions Group sessions of standardised intervention programmes for atopic dermatitis once weekly for six weeks or no education (control group). Main outcome measures Severity of eczema (scoring of atopic dermatitis scale), subjective severity (standardised questionnaires), and quality of life for parents of affected children aged less than 13 years, over 12 months. Results Significant improvements in severity of eczema and subjective severity were seen in all intervention groups compared with control groups (total score for severity: age 3 months to 7 years - 17.5, 95% confidence intervals - 19.6 to - 15.3 v - 12.2, - 14.3 to - 10.1; age 8-12 years - 16.0, - 20.0 to - 12.0 v - 7.8, - 11.4; - 4.3; and age 13-18 years - 19.7, - 23.7 to - 15.7 v - 5.2, - 10.5 to 0.1). Parents of affected children aged less than 7 years experienced significantly better improvement in all five quality of life subscales, whereas parents of affected children aged 8-12 years experienced significantly better improvement ill three or five quality of life subscales. Conclusion Age related educational programmes for the control of atopic dermatitis ill children and adolescents are effective ill the long term management of the disease.	Univ Hosp Heidelberg, Dept Clin Social Med Occupat & Environm Dermatol, D-69115 Heidelberg, Germany; Humboldt Univ, Charite, Dept Paediat Pulm & Immunol, Berlin, Germany; Univ Erlangen Nurnberg, Dept Dermatol, D-8520 Erlangen, Germany; Univ Giessen, Dept Psychol Med, D-35390 Giessen, Germany; Childrens Hosp, Osnabruck, Germany; Tech Univ Munich, Dept Dermatol & Allergy Biederstein, D-8000 Munich, Germany; Rehabil Clin Children & Adolescents, Sylt, Germany; Hannover Med Sch, Dept Psychosomat, Hannover, Germany; Hannover Med Sch, Dept Dermatol & Allergol, Hannover, Germany; Childrens Hosp Amsterdamer Strasse, Cologne, Germany; Univ Giessen, Dept Psychosomat Med & Psychotherapy, D-35390 Giessen, Germany	Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; Justus Liebig University Giessen; Technical University of Munich; Hannover Medical School; Hannover Medical School; University of Cologne; Justus Liebig University Giessen	Diepgen, TL (corresponding author), Univ Hosp Heidelberg, Dept Clin Social Med Occupat & Environm Dermatol, Thibautstr 3, D-69115 Heidelberg, Germany.	thomas_diepgen@med.uni-heidelberg.de	Ring, Johannes/GLN-4341-2022; Werfel, Thomas/B-6921-2012; Kupfer, JOERG/A-5109-2008	Ring, Johannes/0000-0001-8236-3152; 				BROBERG A, 1990, ACTA DERM-VENEREOL, V70, P495; Chinn DJ, 2002, BRIT J DERMATOL, V146, P432, DOI 10.1046/j.1365-2133.2002.04603.x; CLAUSEN K, 1998, PRAVENTION REHABILIT, V4, P198; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DIEPGEN TL, 2000, EPIDEMIOLOGY ATOPIC, P96; DRAKE LA, 1992, J AM ACAD DERMATOL, V26, P485; EHLERS A, 1995, J CONSULT CLIN PSYCH, V63, P624, DOI 10.1037/0022-006X.63.4.624; Ellis C, 2003, BRIT J DERMATOL, V148, P3, DOI 10.1046/j.1365-2133.148.s63.1.x; Fivenson David, 2002, J Manag Care Pharm, V8, P333; Fox C, 2003, BMJ-BRIT MED J, V327, P1120, DOI 10.1136/bmj.327.7424.1120; Gebert N, 1998, PATIENT EDUC COUNS, V35, P213, DOI 10.1016/S0738-3991(98)00061-5; Guevara JP, 2003, BMJ-BRIT MED J, V326, P1308, DOI 10.1136/bmj.326.7402.1308; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; KUPFER J, 2003, DERMATOL PSYCHOSOM, V4, P79; LOBCORZILIUS T, 2004, DERMATOL PSYCHOSOM, V5, P141; Riemsma RP, 2002, BRIT MED J, V325, P558, DOI 10.1136/bmj.325.7364.558; Staab D, 2002, PEDIAT ALLERG IMM-UK, V13, P84, DOI 10.1034/j.1399-3038.2002.01005.x; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; VONRUDEN U, 1999, Z GESUNDHEITSWISSENS, V4, P335; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Wenninger K, 2000, PATIENT EDUC COUNS, V40, P253, DOI 10.1016/S0738-3991(99)00074-9; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Williams RB, 2002, PSYCHOSOM MED, V64, P552, DOI 10.1097/01.PSY.0000023410.02546.5D	24	273	279	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					933	936		10.1136/bmj.332.7547.933	http://dx.doi.org/10.1136/bmj.332.7547.933			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627509	Bronze, Green Published			2022-12-28	WOS:000237143900012
J	Taylor, CB				Taylor, CB			Panic disorder	BRITISH MEDICAL JOURNAL			English	Review							COGNITIVE-BEHAVIORAL THERAPY; GENERALIZED ANXIETY DISORDERS; PRIMARY-CARE; SUICIDAL IDEATION; TRIAL; COMORBIDITY; MEDICATION; IMPROVE		Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA	Stanford University	Taylor, CB (corresponding author), Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA.	btaylor@stanford.edu		Taylor, C. Barr/0000-0002-4564-6548				Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; *AM PSYCH ASS, 2002, PRACT GUID TREATM PS, P635; Austin David, 2005, Aust Fam Physician, V34, P563; Bandelow B, 2004, CNS SPECTRUMS, V9, P725, DOI 10.1017/S1092852900022379; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; Craske MG, 2005, PSYCHOL MED, V35, P1645, DOI 10.1017/S003329170500557X; Goodwin RD, 2005, EUR NEUROPSYCHOPHARM, V15, P435, DOI 10.1016/j.euroneuro.2005.04.006; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Kaufman J, 2000, DEPRESS ANXIETY, V12, P69, DOI 10.1002/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K; Kenardy JA, 2003, J CONSULT CLIN PSYCH, V71, P1068, DOI 10.1037/0022-006X.71.6.1068; Mayor S, 2006, BRIT MED J, V332, P504, DOI 10.1136/bmj.332.7540.504-b; *NAT I HLTH CLIN E, 22 NAT I HLTH CLIN E; Pilowsky DJ, 2006, DEPRESS ANXIETY, V23, P11, DOI 10.1002/da.20092; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Rollman BL, 2003, GEN HOSP PSYCHIAT, V25, P74, DOI 10.1016/S0163-8343(03)00004-5; Roth WT, 2005, PSYCHOL BULL, V131, P171, DOI 10.1037/0033-2909.131.2.171; Roy-Byrne PP, 2005, ARCH GEN PSYCHIAT, V62, P290, DOI 10.1001/archpsyc.62.3.290; *ROYAL AUSTR NZ CO, 2003, AUST NZ J PSYCHIAT, V37, P642; Sareen J, 2005, J NERV MENT DIS, V193, P450, DOI 10.1097/01.nmd.0000168263.89652.6b; van Boeijen CA, 2005, BRIT J GEN PRACT, V55, P763	20	17	19	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 22	2006	332	7547					951	955		10.1136/bmj.332.7547.951	http://dx.doi.org/10.1136/bmj.332.7547.951			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037JV	16627512	Green Published			2022-12-28	WOS:000237143900019
J	Gruenberg, J; van der Goot, FG				Gruenberg, J; van der Goot, FG			Toxoplasma: Guess who's coming to dinner	CELL			English	Editorial Material							CURVATURE		Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Ctr Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	jean.gruenberg@biochem.unige.ch; gisou.vandergoot@epfl.ch	van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X				Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gruenberg J, 2003, CURR OPIN CELL BIOL, V15, P382, DOI 10.1016/S0955-0674(03)00078-4; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Roy CR, 2006, NAT REV IMMUNOL, V6, P136, DOI 10.1038/nri1775; RUSSELL DG, 1995, TRENDS CELL BIOL, V5, P125, DOI 10.1016/S0962-8924(00)88963-1; Soldati D, 2004, TRENDS PARASITOL, V20, P567, DOI 10.1016/j.pt.2004.09.009	9	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 21	2006	125	2					226	228		10.1016/j.cell.2006.03.029	http://dx.doi.org/10.1016/j.cell.2006.03.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630810	Bronze			2022-12-28	WOS:000237241500012
J	Ronnow, HM; Renner, C; Aeppli, G; Kimura, T; Tokura, Y				Ronnow, HM; Renner, C; Aeppli, G; Kimura, T; Tokura, Y			Polarons and confinement of electronic motion to two dimensions in a layered manganite	NATURE			English	Article							GIANT MAGNETORESISTANCE; QUASI-PARTICLE; CHARGE; SURFACE; BI2SR2CACU2O8+DELTA; INTERFERENCE; TRANSITION; PEROVSKITE; PSEUDOGAP; OXIDES	A remarkable feature of layered transition-metal oxides-most famously, the high-temperature superconductors-is that they can display hugely anisotropic electrical and optical properties (for example, seeming to be insulating perpendicular to the layers and metallic within them), even when prepared as bulk three-dimensional single crystals. This is the phenomenon of 'confinement', a concept at odds with the conventional theory of solids, and recognized(1) as due to magnetic and electron-lattice interactions within the layers that must be overcome at a substantial energy cost if electrons are to be transferred between layers. The associated energy gap, or 'pseudogap', is particularly obvious in experiments where charge is moved perpendicular to the planes, most notably scanning tunnelling microscopy(2) and polarized infrared spectroscopy(3). Here, using the same experimental tools, we show that there is a second family of transition-metal oxides-the layered manganites La(2-2x)Sr(1+2x)Mn(2)O(7)-with even more extreme confinement and pseudogap effects. The data demonstrate quantitatively that because the charge carriers are attached to polarons (lattice- and spin-textures within the planes), it is as difficult to remove them from the planes through vacuum-tunnelling into a conventional metallic tip, as it is for them to move between Mn-rich layers within the material itself.	UCL, London Ctr Nanotechnol, London WC1E 6BT, England; ETH, Neutron Scattering Lab, CH-5232 Villigen, Switzerland; Paul Scherrer Inst, CH-5232 Villigen, Switzerland; UCL, Dept Phys & Astron, London WC1E 6BT, England; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci & Technol Agcy, ERATO, Spin Superstruct Project, Tsukuba, Ibaraki 3050046, Japan	University of London; University College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of London; University College London; Alcatel-Lucent; Lucent Technologies; AT&T; University of Tokyo; Japan Science & Technology Agency (JST)	Renner, C (corresponding author), UCL, London Ctr Nanotechnol, Gower St, London WC1E 6BT, England.	c.renner@ucl.ac.uk	Kimura, Tsuyoshi/F-8090-2018; Renner, Christoph/B-6140-2013; Ronnow, Henrik M/A-4953-2009; Tokura, Yoshinori/C-7352-2009	Renner, Christoph/0000-0001-9882-681X; Ronnow, Henrik M/0000-0002-8832-8865; Tokura, Yoshinori/0000-0002-2732-4983				Abrikosov AA, 2000, PHYS REV B, V61, P7770, DOI 10.1103/PhysRevB.61.7770; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Becker T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.237203; Blanco JM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085405; Campistol JM, 2001, AMYLOID, V8, P65, DOI 10.3109/13506120108993816; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Dagotto E., 2003, SPRINGER SERIES SOLI, V136; Dessau DS, 1998, PHYS REV LETT, V81, P192, DOI 10.1103/PhysRevLett.81.192; Fath M, 1999, SCIENCE, V285, P1540, DOI 10.1126/science.285.5433.1540; Freeland JW, 2005, NAT MATER, V4, P62, DOI 10.1038/nmat1280; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Ishikawa T, 2000, PHYS REV B, V62, P12354, DOI 10.1103/PhysRevB.62.12354; JIN S, 1994, SCIENCE, V264, P413, DOI 10.1126/science.264.5157.413; Kimura T, 2000, ANNU REV MATER SCI, V30, P451, DOI 10.1146/annurev.matsci.30.1.451; Kimura T, 1996, SCIENCE, V274, P1698, DOI 10.1126/science.274.5293.1698; Kittel C, 2007, INTRO SOLID STATE PH, V7th; Konoto M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.107201; Mannella N, 2005, NATURE, V438, P474, DOI 10.1038/nature04273; Millis AJ, 1998, NATURE, V392, P147, DOI 10.1038/32348; Mori S, 1998, NATURE, V392, P473, DOI 10.1038/33105; Moritomo Y, 1996, NATURE, V380, P141, DOI 10.1038/380141a0; Perring TG, 1997, PHYS REV LETT, V78, P3197, DOI 10.1103/PhysRevLett.78.3197; Perring TG, 1998, PHYS REV B, V58, P14693, DOI 10.1103/PhysRevB.58.R14693; Ramirez AP, 1996, PHYS REV LETT, V76, P3188, DOI 10.1103/PhysRevLett.76.3188; Renner C, 2002, NATURE, V416, P518, DOI 10.1038/416518a; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Uchida S, 1996, PHYS REV B, V53, P14558, DOI 10.1103/PhysRevB.53.14558; VONHELMOLT R, 1993, PHYS REV LETT, V71, P2331, DOI 10.1103/PhysRevLett.71.2331; Wei JYT, 1997, PHYS REV LETT, V79, P5150, DOI 10.1103/PhysRevLett.79.5150; Yazdani A, 1999, PHYS REV LETT, V83, P176, DOI 10.1103/PhysRevLett.83.176	31	86	86	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					1025	1028		10.1038/nature04650	http://dx.doi.org/10.1038/nature04650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625191	Green Submitted			2022-12-28	WOS:000236906000030
J	Steinberg, KP; Hudson, LD; Goodman, RB; Hough, CL; Lanken, PN; Hyzy, R; Thompson, BT; Ancukiewicz, M				Steinberg, KP; Hudson, LD; Goodman, RB; Hough, CL; Lanken, PN; Hyzy, R; Thompson, BT; Ancukiewicz, M		Natl Heart Lung Blood Inst Acute R	Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DOSE METHYLPREDNISOLONE; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; SEVERE SEPSIS; CLINICAL-TRIAL; LUNG INJURY; THERAPY; ARDS; MORTALITY; HYDROCORTISONE	BACKGROUND: Persistent acute respiratory distress syndrome (ARDS) is characterized by excessive fibroproliferation, ongoing inflammation, prolonged mechanical ventilation, and a substantial risk of death. Because previous reports suggested that corticosteroids may improve survival, we performed a multicenter, randomized controlled trial of corticosteroids in patients with persistent ARDS. METHODs: We randomly assigned 180 patients with ARDS of at least seven days' duration to receive either methylprednisolone or placebo in a double-blind fashion. The primary end point was mortality at 60 days. Secondary end points included the number of ventilator-free days and organ-failure-free days, biochemical markers of inflammation and fibroproliferation, and infectious complications. RESULTS: At 60 days, the hospital mortality rate was 28.6 percent in the placebo group (95 percent confidence interval, 20.3 to 38.6 percent) and 29.2 percent in the methylprednisolone group (95 percent confidence interval, 20.8 to 39.4 percent; P=1.0); at 180 days, the rates were 31.9 percent (95 percent confidence interval, 23.2 to 42.0 percent) and 31.5 percent (95 percent confidence interval, 22.8 to 41.7 percent; P=1.0), respectively. Methylprednisolone was associated with significantly increased 60- and 180-day mortality rates among patients enrolled at least 14 days after the onset of ARDS. Methylprednisolone increased the number of ventilator-free and shock-free days during the first 28 days in association with an improvement in oxygenation, respiratory-system compliance, and blood pressure with fewer days of vasopressor therapy. As compared with placebo, methylprednisolone did not increase the rate of infectious complications but was associated with a higher rate of neuromuscular weakness. CONCLUSIONS: These results do not support the routine use of methylprednisolone for persistent ARDS despite the improvement in cardiopulmonary physiology. In addition, starting methylprednisolone therapy more than two weeks after the onset of ARDS may increase the risk of death.	Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital	Steinberg, KP (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Box 359762,325 9th Ave, Seattle, WA 98104 USA.	steinkp@u.washington.edu						Annane D, 2004, BMJ-BRIT MED J, V329, P480, DOI 10.1136/bmj.38181.482222.55; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; ASHBAUGH DG, 1985, ARCH SURG-CHICAGO, V120, P530; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BIFFL WL, 1995, AM J SURG, V170, P591, DOI 10.1016/S0002-9610(99)80022-1; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; BONE RC, 1988, CHEST, V94, P448, DOI 10.1016/S0012-3692(16)33495-X; BRAUDE S, 1992, CRIT CARE MED, V20, P1187, DOI 10.1097/00003246-199208000-00021; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Collard HR, 2003, ANN INTERN MED, V138, P494, DOI 10.7326/0003-4819-138-6-200303180-00015; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; HOOPER RG, 1990, CHEST, V97, P138, DOI 10.1378/chest.97.1.138; Keel JBP, 1998, RESPIRATION, V65, P258, DOI 10.1159/000029273; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; LAMY M, 1976, AM REV RESPIR DIS, V114, P267; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; MEDURI GU, 1994, CHEST, V105, P1516, DOI 10.1378/chest.105.5.1516; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; MEDURI GU, 1991, CHEST, V100, P943, DOI 10.1378/chest.100.4.943; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; RAGHU G, 1985, AM REV RESPIR DIS, V131, P281, DOI 10.1164/ajrccm/138.3.703; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; TOMASHEFSKI JF, 1990, CLIN CHEST MED, V11, P593; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEIGELT JA, 1985, ARCH SURG-CHICAGO, V120, P536	38	901	973	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1671	1684						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16625008				2022-12-28	WOS:000236893900004
J	Hampton, T				Hampton, T			Interplay of genes and environment found in adolescents' alcohol abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This study aims to understand the underlying developmental mechanisms that lead to adolescent substance use and abuse. A mutation in the gene encoding aldehyde dehydrogenase 2 that affects alcohol metabolism can cause high levels of toxic aldehyde to build up causing it to affect human behavior.										Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; Wu G, 2000, ALCOHOL ALCOHOLISM, V35, P55, DOI 10.1093/alcalc/35.1.55	2	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1760	+		10.1001/jama.295.15.1760	http://dx.doi.org/10.1001/jama.295.15.1760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622132				2022-12-28	WOS:000236886900003
J	Cromie, MJ; Shi, YX; Latifi, T; Groisman, EA				Cromie, MJ; Shi, YX; Latifi, T; Groisman, EA			An RNA sensor for intracellular Mg2+	CELL			English	Article							CONTROLS GENE-EXPRESSION; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; TRANSCRIPTION ATTENUATION; MAGNESIUM TRANSPORT; BACILLUS-SUBTILIS; PHOP; RIBOSWITCHES; TYPHIMURIUM; BACTERIA	Most RNA molecules require Mg2+ for their structure and enzymatic properties. Here we report the first example of an RNA serving as sensor for cytoplasmic Mg2+. We establish that expression of the Mg2+ transporter MgtA of Salmoneila enterica serovar Typhimurium is controlled by its 51 untranslated region (5'UTR). We show that the 5'UTR of the mgtA gene can adopt different stem-loop structures depending on the Mg2+ levels, which determine whether transcription reads through into the mgtA coding region or stops within the 5'UTR. We could recapitulate the Mg2+-regulated transcription using a defined in vitro transcription system with RNA polymerase as the only protein component. The initiation of mgtA transcription responds to extracytoplasmic Mg2+ and its elongation into the coding region to cytoplasmic Mg2+, providing a singular example in which the same ligand is sensed in different cellular compartments to regulate disparate steps in gene transcription.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, 660 S Euclild Ave,Campus Box 8230, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu			NIAID NIH HHS [AI49561] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; BENNETT GN, 1978, J MOL BIOL, V121, P179, DOI 10.1016/S0022-2836(78)80004-7; Brantl S, 2004, TRENDS MICROBIOL, V12, P473, DOI 10.1016/j.tim.2004.09.008; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Chamnongpol S, 2002, MOL MICROBIOL, V44, P561, DOI 10.1046/j.1365-2958.2002.02917.x; Chamnongpol S, 2000, J MOL BIOL, V300, P291, DOI 10.1006/jmbi.2000.3848; Chamnongpol S, 2003, J MOL BIOL, V325, P795, DOI 10.1016/S0022-2836(02)01268-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS RW, 1980, ADV BACT GENETICS; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; England T E, 1980, Methods Enzymol, V65, P65; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Hilbert F, 1999, J BACTERIOL, V181, P2158, DOI 10.1128/JB.181.7.2158-2165.1999; Jacquier A, 1996, BIOCHIMIE, V78, P474, DOI 10.1016/0300-9084(96)84754-7; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; KNAPP G, 1989, METHOD ENZYMOL, V180, P192; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LANDICK R, 1996, ESCHERICHIA COLI SAL; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; NIYOGI SK, 1981, NUCLEIC ACIDS RES, V9, P2615, DOI 10.1093/nar/9.11.2615; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Tao T, 1998, MICROBIOL-SGM, V144, P655, DOI 10.1099/00221287-144-3-655; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Yamamoto K, 2002, MOL MICROBIOL, V45, P423, DOI 10.1046/j.1365-2958.2002.03017.x; Yanofsky C, 2004, TRENDS GENET, V20, P367, DOI 10.1016/j.tig.2004.06.007; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	49	245	259	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					71	84		10.1016/j.cell.2006.01.043	http://dx.doi.org/10.1016/j.cell.2006.01.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615891	Bronze			2022-12-28	WOS:000237314200015
J	Roozendaal, R; Carroll, MC				Roozendaal, R; Carroll, MC			Emerging patterns in complement-mediated pathogen recognition	CELL			English	Review							SPLENIC MARGINAL ZONE; INNATE IMMUNITY; B-CELL; RECEPTOR; MICE; MACROPHAGES; INFECTION; EVOLUTION; RESPONSES; PATHWAY	Protection from acute infection requires an immediate response by the host innate immune system. Two recent Cell papers, including one in this issue, provide new insight into the role of the complement system in response to blood-borne pathogens.	Harvard Univ, Sch Med, CBR Inst Biomed Res Inc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Carroll, MC (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res Inc, 800 Huntington Ave, Boston, MA 02115 USA.	carroll@cbr.med.harvard.edu						Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Chen YY, 2005, J IMMUNOL, V175, P8173, DOI 10.4049/jimmunol.175.12.8173; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; HOLERS VM, 1992, IMMUNOL TODAY, V13, P231; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Verschoor A, 2003, J IMMUNOL, V171, P5363, DOI 10.4049/jimmunol.171.10.5363	18	51	55	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					29	32		10.1016/j.cell.2006.03.018	http://dx.doi.org/10.1016/j.cell.2006.03.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615887	Bronze			2022-12-28	WOS:000237314200011
J	Whetstine, JR; Nottke, A; Lan, F; Huarte, M; Smolikov, S; Chen, ZZ; Spooner, E; Li, E; Zhang, GY; Colaiacovo, M; Shi, Y				Whetstine, Johnathan R.; Nottke, Amanda; Lan, Fei; Huarte, Maite; Smolikov, Sarit; Chen, Zhongzhou; Spooner, Eric; Li, En; Zhang, Gongyi; Colaiacovo, Monica; Shi, Yang			Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases	CELL			English	Article							DAMAGE-INDUCED APOPTOSIS; RNA-POLYMERASE-II; CAENORHABDITIS-ELEGANS; C-ELEGANS; DNA-DAMAGE; H3 METHYLATION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL ELONGATION; COVALENT MODIFICATIONS; MAMMALIAN CHROMATIN	Histone methylation regulates chromatin structure, transcription, and epigenetic state of the cell. Histone methylation is dynamically regulated by histone methylases and demethylases such as LSD1 and JHDM1, which mediate demethylation of di- and monomethylated histones. It has been unclear whether demethylases exist that reverse lysine trimethylation. We show the JmjC domain-containing protein JMJD2A reversed trimethylated H3-K9/K36 to di- but not mono- or unmethylated products. Overexpression of JMJD2A but not a catalytically inactive mutant reduced H3-K9/K36 trimethylation levels in cultured cells. In contrast, RNAi depletion of the C. elegans JMJD2A homolog resulted in an increase in general H3-K9Me3 and localized H3-K36Me3 levels on meiotic chromosomes and triggered p53-dependent germline apoptosis. Additionally, other human JMJD2 subfamily members also functioned as trimethylation-specific demethylases, converting H3-K9Me3 to H3-K9Me2 and H3-K9Me1, respectively. Our finding that this family of demethylases generates different methylated states at the same lysine residue provides a mechanism for fine-tuning histone methylation.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; MIT, Whitehead Inst, Nine Cambridge Ctr, Cambridge, MA 02142 USA; Novartis Biomed Res Inst, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Massachusetts Institute of Technology (MIT); Whitehead Institute; Novartis	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	chen, zhong/E-3900-2015; Huarte, Maite/J-6903-2014	chen, zhong/0000-0003-1319-9664; Huarte, Maite/0000-0003-3753-6493	NIAID NIH HHS [R37 AI033456] Funding Source: Medline; NIGMS NIH HHS [GM 072551, GM 071004, GM 58012] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, R01GM072551] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; BRENNER S, 1974, GENETICS, V77, P71; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Katoh M, 2004, INT J ONCOL, V24, P1623; Kelly KO, 2000, GENETICS, V156, P617; Kelly WG, 2002, DEVELOPMENT, V129, P479; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; KIM J, 2006, IN PRESS EMBO REP; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; POGRIBNY IP, IN PRESS CARCINOGENE; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reuben M, 2002, DEV BIOL, V245, P71, DOI 10.1006/dbio.2002.0634; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rinaldo C, 1998, MOL GEN GENET, V260, P289, DOI 10.1007/s004380050897; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Schaner CE, 2006, GERMLINE CHROMATIN; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta Gunnar, 2004, Novartis Found Symp, V259, P22; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Takanami T, 1998, DNA Res, V5, P373, DOI 10.1093/dnares/5.6.373; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; THOMAS G, 1972, H-S Z PHYSIOL CHEM, V353, P1423, DOI 10.1515/bchm2.1972.353.2.1423; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yang ZQ, 2000, CANCER RES, V60, P4735; Yeo S, 2005, MOL CELLS, V20, P423; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	88	765	810	2	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					467	481		10.1016/j.cell.2006.03.028	http://dx.doi.org/10.1016/j.cell.2006.03.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16603238	Bronze			2022-12-28	WOS:000237506100014
J	Helenius, J; Brouhard, G; Kalaidzidis, Y; Diez, S; Howard, J				Helenius, J; Brouhard, G; Kalaidzidis, Y; Diez, S; Howard, J			The depolymerizing kinesin MCAK uses lattice diffusion to rapidly target microtubule ends	NATURE			English	Article							CENTROMERE-ASSOCIATED KINESIN; REPRESSOR-OPERATOR INTERACTION; C-TERMINUS; CYTOPLASMIC DYNEIN; DYNAMICS; PROTEIN; TUBULIN; XKCM1; ASSOCIATION; COOPERATE	The microtubule cytoskeleton is a dynamic structure in which the lengths of the microtubules are tightly regulated. One regulatory mechanism is the depolymerization of microtubules by motor proteins in the kinesin-13 family(1). These proteins are crucial for the control of microtubule length in cell division(2-4), neuronal development(5) and interphase microtubule dynamics(6,7). The mechanism by which kinesin-13 proteins depolymerize microtubules is poorly understood. A central question is how these proteins target to microtubule ends at rates exceeding those of standard enzyme-substrate kinetics(8). To address this question we developed a single-molecule microscopy assay for MCAK, the founding member of the kinesin-13 family(9). Here we show that MCAK moves along the microtubule lattice in a one-dimensional (1D) random walk. MCAK-microtubule interactions were transient: the average MCAK molecule diffused for 0.83 s with a diffusion coefficient of 0.38 mu m(2) s(-1). Although the catalytic depolymerization by MCAK requires the hydrolysis of ATP, we found that the diffusion did not. The transient transition from three-dimensional diffusion to 1D diffusion corresponds to a "reduction in dimensionality"(10) that has been proposed as the search strategy by which DNA enzymes find specific binding sites(11). We show that MCAK uses this strategy to target to both microtubule ends more rapidly than direct binding from solution.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Lomonosov Moscow State University	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	howard@mpi-cbg.de	Brouhard, Gary/AAZ-7789-2021; Howard, Jonathon/J-7492-2016; Diez, Stefan/E-8172-2010; Kalaidzidis, Yannis/H-3094-2016; Howard, Jonathon/D-4229-2011	Howard, Jonathon/0000-0003-0086-1196; Diez, Stefan/0000-0002-0750-8515; Kalaidzidis, Yannis/0000-0002-6137-1193; Howard, Jonathon/0000-0003-0086-1196				Adam G., 1968, STRUCTURAL CHEM MOL, P198; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Kalaidzidis YL, 1997, PROGRAM COMPUT SOFT+, V23, P206; Klein GA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108102; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Niederstrasser H, 2002, J MOL BIOL, V316, P817, DOI 10.1006/jmbi.2001.5360; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; RICHTER PH, 1974, BIOPHYS CHEM, V2, P255, DOI 10.1016/0301-4622(74)80050-5; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	30	338	347	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					115	119		10.1038/nature04736	http://dx.doi.org/10.1038/nature04736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672973				2022-12-28	WOS:000237248600044
J	Steinbrook, R				Steinbrook, R			Compensation for injured research subjects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Institute of Medicine, 2003, RESP RES SYST APPR P; LEWIN GROUP, 2005, 2 LEW GROUP; Mello MM, 2003, ANN INTERN MED, V139, P40, DOI 10.7326/0003-4819-139-1-200307010-00011; *PC, 1982, PRESS COMM STUD ETH; Scott LD, 2003, J LAW MED ETHICS, V31, P419, DOI 10.1111/j.1748-720X.2003.tb00104.x	5	31	31	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1871	1873		10.1056/NEJMp068080	http://dx.doi.org/10.1056/NEJMp068080			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672697	Green Submitted			2022-12-28	WOS:000237239900002
J	Wadman, M				Wadman, M			The quiet rise of the clinical contractor	NATURE			English	News Item																		Hopkin M, 2006, NATURE, V440, P855, DOI 10.1038/440855a; 2006, NATURE, V440, P388	2	4	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					22	23		10.1038/441022a	http://dx.doi.org/10.1038/441022a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672945				2022-12-28	WOS:000237248600011
J	Bennett, CL				Bennett, CL			Cosmology from start to finish	NATURE			English	Review							PROBE WMAP OBSERVATIONS; DARK ENERGY; POWER-SPECTRUM; BARYONIC OSCILLATIONS; INFLATIONARY UNIVERSE; GENERAL-RELATIVITY; GALAXY; CONSTRAINTS; EVOLUTION; MATTER	Cosmology is undergoing a revolution. With recent precise measurements of the cosmic microwave background radiation, large galaxy redshift surveys, better measurements of the expansion rate of the Universe and a host of other astrophysical observations, there is now a standard, highly constrained cosmological model. It is not a cosmology that was predicted. Unidentified dark particles dominate the matter content of our Universe, and mysteries surround the processes responsible for the accelerated expansion at its earliest moments (inflation?) and for its recent acceleration (dark energy?). New measurements must address the fundamental questions: what happened at the birth of the Universe, and what is its ultimate fate?	Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Johns Hopkins University	Bennett, CL (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, 3400 N Charles St, Baltimore, MD 21218 USA.	cbennett@jhu.edu		Bennett, Charles/0000-0001-8839-7206				ALBRECHT A, 1982, PHYS REV LETT, V48, P1220, DOI 10.1103/PhysRevLett.48.1220; ALCOCK C, 1979, NATURE, V281, P358, DOI 10.1038/281358a0; Angulo R, 2005, MON NOT R ASTRON SOC, V362, pL25, DOI 10.1111/j.1745-3933.2005.00067.x; Arkani-Hamed N, 2004, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2004/04/001; Arkani-Hamed N, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/05/074; Armendariz-Picon C, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.103510; ASTIER P, 2005, ASTRON ASTROPHYS; Bassett B, 2005, ASTRON GEOPHYS, V46, P26, DOI 10.1111/j.1468-4004.2005.46526.x; Bennett CL, 2005, SCIENCE, V307, P879, DOI 10.1126/science.1106444; Bennett CL, 1996, ASTROPHYS J, V464, pL1, DOI 10.1086/310075; Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Blake C, 2003, ASTROPHYS J, V594, P665, DOI 10.1086/376983; BOYLE LA, 2005, ASTROPH0507455; Carroll SM, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043528; Carroll SM, 1998, PHYS REV LETT, V81, P3067, DOI 10.1103/PhysRevLett.81.3067; Cole S, 2005, MON NOT R ASTRON SOC, V362, P505, DOI 10.1111/j.1365-2966.2005.09318.x; COLES P, 1993, MON NOT R ASTRON SOC, V262, P1065, DOI 10.1093/mnras/262.4.1065; COLGATE SA, 1979, ASTROPHYS J, V232, P404, DOI 10.1086/157300; Deffayet C, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.044023; Dunlop J, 1996, NATURE, V381, P581, DOI 10.1038/381581a0; Dvali G, 2000, PHYS LETT B, V485, P208, DOI 10.1016/S0370-2693(00)00669-9; Einstein A, 1916, ANN PHYS-BERLIN, V49, P769; Eisenstein D, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.103523; Eisenstein DJ, 1998, ASTROPHYS J, V504, pL57, DOI 10.1086/311582; Eisenstein DJ, 1998, ASTROPHYS J, V496, P605, DOI 10.1086/305424; Ellis J, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.095007; Ellis J, 2002, SPACE SCI REV, V100, P235, DOI 10.1023/A:1015834615268; Glazebrook K, 2004, NATURE, V430, P181, DOI 10.1038/nature02667; Glazebrook K, 2005, NEW ASTRON REV, V49, P374, DOI 10.1016/j.newar.2005.08.007; Glazebrook K, 2005, ASTROPHYS J, V631, P1, DOI 10.1086/432497; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; Haiman Z, 2001, ASTROPHYS J, V553, P545, DOI 10.1086/320939; Hill GJ, 2004, P SOC PHOTO-OPT INS, V5492, P251, DOI 10.1117/12.552474; Hinshaw G, 2003, ASTROPHYS J SUPPL S, V148, P135, DOI 10.1086/377225; Hodapp KW, 2004, ASTRON NACHR, V325, P636, DOI 10.1002/asna.200410300; Hu W, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.063004; Hu W, 1997, NATURE, V386, P37, DOI 10.1038/386037a0; Leibundgut B, 2001, ANNU REV ASTRON ASTR, V39, P67, DOI 10.1146/annurev.astro.39.1.67; LINDE AD, 1982, PHYS LETT B, V114, P431, DOI 10.1016/0370-2693(82)90086-7; Linder EV, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.083504; National Research Council, 2003, CONN QUARKS COSM 11; Ostriker JP, 2003, SCIENCE, V300, P1909, DOI 10.1126/science.1085976; Peebles PJE, 2003, REV MOD PHYS, V75, P559, DOI 10.1103/RevModPhys.75.559; PEEBLES PJE, 1970, ASTROPHYS J, V162, P815, DOI 10.1086/150713; PEEBLES PJE, 1988, ASTROPHYS J, V325, pL17, DOI 10.1086/185100; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Randall L, 1999, PHYS REV LETT, V83, P3370, DOI 10.1103/PhysRevLett.83.3370; Refregier A, 2003, ANNU REV ASTRON ASTR, V41, P645, DOI 10.1146/annurev.astro.41.111302.102207; Riess AG, 2004, ASTROPHYS J, V607, P665, DOI 10.1086/383612; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Riess AG, 1996, ASTROPHYS J, V473, P88, DOI 10.1086/178129; Scherrer RJ, 1998, ASTROPHYS J, V504, P607, DOI 10.1086/306113; Seife C, 2003, SCIENCE, V302, P2038, DOI 10.1126/science.302.5653.2038; Seo HJ, 2005, ASTROPHYS J, V633, P575, DOI 10.1086/491599; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Steinhardt PJ, 2005, NEW ASTRON REV, V49, P43, DOI 10.1016/j.newar.2005.01.003; Turner MS, 2003, ANN HENRI POINCARE, V4, pS333, DOI 10.1007/s00023-003-0926-x; Turner MS, 1996, PHYS REV D, V53, P6822, DOI 10.1103/PhysRevD.53.6822; Van Waerbeke L, 2005, ASTRON ASTROPHYS, V429, P75, DOI 10.1051/0004-6361:20041513; WEINBERG S, 1989, REV MOD PHYS, V61, P1, DOI 10.1103/RevModPhys.61.1; WEINBERG S, 1987, PHYS REV LETT, V59, P2607, DOI 10.1103/PhysRevLett.59.2607; WETTERICH C, 1988, NUCL PHYS B, V302, P668, DOI 10.1016/0550-3213(88)90193-9; White M, 2005, ASTROPART PHYS, V24, P334, DOI 10.1016/j.astropartphys.2005.07.007; Will CM, 2004, PRAMANA-J PHYS, V63, P731, DOI 10.1007/BF02705195; Zlatev I, 1999, PHYS REV LETT, V82, P896, DOI 10.1103/PhysRevLett.82.896; 2005, REPORT TASK FORCE CO	73	12	13	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1126	1131		10.1038/nature04803	http://dx.doi.org/10.1038/nature04803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641983				2022-12-28	WOS:000237080000032
J	Rumbold, AR; Crowther, CA; Haslam, RR; Dekker, GA; Robinson, JS				Rumbold, AR; Crowther, CA; Haslam, RR; Dekker, GA; Robinson, JS			Vitamins C and E and the risks of preeclampsia and perinatal complications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-TOCOPHEROL; PREGNANCY; WOMEN; SUPPLEMENTATION; HYPERTENSION; CALCIUM; DISEASE; PLASMA; BIRTH	Background: Supplementation with antioxidant vitamins has been proposed to reduce the risk of preeclampsia and perinatal complications, but the effects of this intervention are uncertain. Methods: We conducted a multicenter, randomized trial of nulliparous women between 14 and 22 weeks of gestation. Women were assigned to daily supplementation with 1000 mg of vitamin C and 400 IU of vitamin E or placebo (microcrystalline cellulose) until delivery. Primary outcomes were the risks of maternal preeclampsia, death or serious outcomes in the infants (on the basis of definitions used by the Australian and New Zealand Neonatal Network), and delivering an infant whose birth weight was below the 10th percentile for gestational age. Results: Of the 1877 women enrolled in the study, 935 were randomly assigned to the vitamin group and 942 to the placebo group. Baseline characteristics of the two groups were similar. There were no significant differences between the vitamin and placebo groups in the risk of preeclampsia (6.0 percent and 5.0 percent, respectively; relative risk, 1.20; 95 percent confidence interval, 0.82 to 1.75), death or serious outcomes in the infant (9.5 percent and 12.1 percent; relative risk, 0.79; 95 percent confidence interval, 0.61 to 1.02), or having an infant with a birth weight below the 10th percentile for gestational age (8.7 percent and 9.9 percent; relative risk, 0.87; 95 percent confidence interval, 0.66 to 1.16). Conclusions: Supplementation with vitamins C and E during pregnancy does not reduce the risk of preeclampsia in nulliparous women, the risk of intrauterine growth restriction, or the risk of death or other serious outcomes in their infants.	Univ Adelaide, Womens & Childrens Hosp, Discipline Obstet & Gynaecol, Adelaide, SA 5006, Australia; Womens & Childrens Hosp, Dept Perinatal Med, Adelaide, SA, Australia	University of Adelaide; Womens & Childrens Hospital Australia; Womens & Childrens Hospital Australia	Crowther, CA (corresponding author), Univ Adelaide, Womens & Childrens Hosp, Discipline Obstet & Gynaecol, 72 King William Rd, Adelaide, SA 5006, Australia.	caroline.crowther@adelaide.edu.au	Pritchard, Margo A/G-5188-2010; Lawrence, Annemarie/I-4180-2013	Pritchard, Margo A/0000-0002-1058-9117; Lawrence, Annemarie/0000-0002-8736-4741				ACOG, 2002, OBSTET GYNECOL, V99, P869; Beazley D, 2005, AM J OBSTET GYNECOL, V192, P520, DOI 10.1016/j.ajog.2004.09.005; Bendich Adrianne, 1993, P411; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; Carr A, 1999, FASEB J, V13, P1007, DOI 10.1096/fasebj.13.9.1007; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; CORRIGAN JJ, 1981, AM J CLIN NUTR, V34, P1701, DOI 10.1093/ajcn/34.9.1701; Crowther CA, 1999, AUST NZ J OBSTET GYN, V39, P12, DOI 10.1111/j.1479-828X.1999.tb03434.x; *DEP HUM SERV, 2003, MAT PER INF MORT S A; Devaraj S, 1997, ARTERIOSCL THROM VAS, V17, P2273, DOI 10.1161/01.ATV.17.10.2273; DONOGHUE DA, 2000, NEONATAL NETWORK SER, V4; Fraser WD, 2005, BJOG-INT J OBSTET GY, V112, P684, DOI 10.1111/j.1471-0528.2005.00675.x; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; HANNAH ME, 1992, NEW ENGL J MED, V327, P368; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402; Hochberg Y., 1987, MULTIPLE COMP PROCED; Holmes VA, 2004, INT J GYNECOL OBSTET, V87, P66, DOI 10.1016/j.ijgo.2004.06.015; Hubel CA, 1996, AM J OBSTET GYNECOL, V174, P975, DOI 10.1016/S0002-9378(96)70336-8; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; MIKHAIL MS, 1994, AM J OBSTET GYNECOL, V171, P150, DOI 10.1016/0002-9378(94)90462-6; *NAT AC SCI, 1989, REC DAIL ALL RDA; POSTON L, 2006, VITAMINS PREECLAMPSI; Roberts CL, 1999, MED J AUSTRALIA, V170, P114, DOI 10.5694/j.1326-5377.1999.tb127678.x; ROBERTS JM, 1993, LANCET, V342, P504; ROBERTS JM, COMBINED ANTIOXIDANT; Rumbold A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004227.pub2; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saugstad OD, 2001, CURR OPIN OBSTET GYN, V13, P147, DOI 10.1097/00001703-200104000-00009; SAUGSTAD OD, 1988, PEDIATR RES, V23, P143, DOI 10.1203/00006450-198802000-00001; SLATER EK, 2004, MATERNAL DEATHS SERI, V1; SPINNATO JA, ANTIOXIDANT THERAPY; WICKENS D, 1981, ANN CLIN BIOCHEM, V18, P158, DOI 10.1177/000456328101800306; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	36	315	326	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1796	1806		10.1056/NEJMoa054186	http://dx.doi.org/10.1056/NEJMoa054186			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641396	Bronze, Green Published			2022-12-28	WOS:000237077100005
J	Bascompte, J; Jordano, P; Olesen, JM				Bascompte, J; Jordano, P; Olesen, JM			Asymmetric coevolutionary networks facilitate biodiversity maintenance	SCIENCE			English	Article							INTERACTION STRENGTH; FOOD WEBS; STABILITY; PATTERNS	The mutualistic interactions between plants and their pollinators or seed dispersers have played a major role in the maintenance of Earth's biodiversity. To investigate how coevolutionary interactions are shaped within species-rich communities, we characterized the architecture of an array of quantitative, mutualistic networks spanning a broad geographic range. These coevolutionary networks are highly asymmetric, so that if a plant species depends strongly on an animal species, the animal depends weakly on the plant. By using a simple dynamical model, we showed that asymmetries inherent in coevolutionary networks may enhance long-term coexistence and facilitate biodiversity maintenance.	CSIC, Estac Biol Donana, Integrat Ecol Grp, E-41080 Seville, Spain; Aarhus Univ, Dept Ecol & Genet, DK-8000 Aarhus, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Aarhus University	Bascompte, J (corresponding author), CSIC, Estac Biol Donana, Integrat Ecol Grp, Apartado 1056, E-41080 Seville, Spain.	bascompte@ebd.csic.es	Bascompte, Jordi/B-7596-2008; Olesen, Jens M/A-3011-2009; Jordano, Pedro/A-5162-2008	Bascompte, Jordi/0000-0002-0108-6411; Olesen, Jens M/0000-0003-1998-1083; Jordano, Pedro/0000-0003-2142-9116; Olesen, Jes/0000-0002-6712-2702				Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FAGAN WF, 1994, ECOLOGY, V75, P2022, DOI 10.2307/1941607; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kokkoris GD, 1999, ECOL LETT, V2, P70, DOI 10.1046/j.1461-0248.1999.22058.x; May R.M., 1973, STABILITY COMPLEXITY; May R. M., 1981, THEOR ECOL-NETH, P78; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1980, J ANIM ECOL, V49, P667; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; RAFFAELLI DG, 1995, FOOD WEBS INTEGRATIO, P185; Ringel MS, 1996, THEOR POPUL BIOL, V50, P281, DOI 10.1006/tpbi.1996.0032; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Thompson J.N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; ULANOWICZ RE, 1991, MATH BIOSCI, V103, P45, DOI 10.1016/0025-5564(91)90090-6; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2	25	801	834	13	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					431	433		10.1126/science.1123412	http://dx.doi.org/10.1126/science.1123412			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627742	Green Submitted			2022-12-28	WOS:000236941800048
J	Naundorf, B; Wolf, F; Volgushev, M				Naundorf, B; Wolf, F; Volgushev, M			Unique features of action potential initiation in cortical neurons	NATURE			English	Article							IN-VIVO; COINCIDENCE DETECTION; PYRAMIDAL NEURONS; VISUAL-CORTEX; THRESHOLD; MECHANISM; KINETICS	Neurons process and encode information by generating sequences of action potentials(1,2). For all spiking neurons, the encoding of single-neuron computations into sequences of spikes is biophysically determined by the cell's action-potential-generating mechanism. It has recently been discovered that apparently minor modifications of this mechanism can qualitatively change the nature of neuronal encoding(3,4). Here we quantitatively analyse the dynamics of action potential initiation in cortical neurons in vivo, in vitro and in computational models. Unexpectedly, key features of the initiation dynamics of cortical neuron action potentials-their rapid initiation and variable onset potential are outside the range of behaviours described by the classical Hodgkin-Huxley theory. We propose a new model based on the cooperative activation of sodium channels that reproduces the observed dynamics of action potential initiation. This new model predicts that Hodgkin-Huxley-type dynamics of action potential initiation can be induced by artificially decreasing the effective density of sodium channels. In vitro experiments confirm this prediction, supporting the hypothesis that cooperative sodium channel activation underlies the dynamics of action potential initiation in cortical neurons.	Univ Gottingen, Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; Univ Gottingen, Dept Phys, D-37073 Gottingen, Germany; Univ Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany; Ruhr Univ Bochum, Dept Neurophysiol, D-44780 Bochum, Germany; Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow 117485, Russia	Max Planck Society; University of Gottingen; University of Gottingen; University of Gottingen; Ruhr University Bochum; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences	Wolf, F (corresponding author), Univ Gottingen, Max Planck Inst Dynam & Self Org, Bunsenstr 10, D-37073 Gottingen, Germany.	fred@chaos.gwdg.de	Wolf, Fred/D-5771-2011; Volgushev, Maxim/AAO-6793-2020	Wolf, Fred/0000-0002-7068-3762; Volgushev, Maxim/0000-0002-8080-1136				ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; BERNSTEIN J, 1868, ARCH GES PHYSL, V1, P173, DOI DOI 10.1007/BF01; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Goldman L, 1995, BIOPHYS J, V69, P2364, DOI 10.1016/S0006-3495(95)80105-0; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; HUXLEY AF, 1972, NOBEL LECT PHYSL MED; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; PATLAK J, 1991, PHYSIOL REV, V71, P1047, DOI 10.1152/physrev.1991.71.4.1047; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Volgushev M, 2002, J PHYSIOL-LONDON, V540, P307, DOI 10.1113/jphysiol.2001.012974; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003	18	240	245	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1060	1063		10.1038/nature04610	http://dx.doi.org/10.1038/nature04610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625198				2022-12-28	WOS:000236906000038
J	Qaseem, A; Snow, V; Fitterman, N; Hornbake, ER; Lawrence, VA; Smetana, GW; Weiss, K; Owens, DK				Qaseem, A; Snow, V; Fitterman, N; Hornbake, ER; Lawrence, VA; Smetana, GW; Weiss, K; Owens, DK		Clinical Efficacy Assessment Subco	Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: A guideline from the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							POSTOPERATIVE COMPLICATIONS; NASOGASTRIC DECOMPRESSION; ANESTHESIA; MORBIDITY; MORTALITY; OUTCOMES; INDEX; HIP	strategies to reduce the perioperative pulmonary risk and focuses on atelectasis, pneumonia, and respiratory failure. The target audience for this guideline is general internists or other clinicians involved in perioperative management of surgical patients. The target patient population is all adult persons undergoing noncardiothoracic surgery.Postoperative pulmonary complications play an important role in the risk for patients undergoing noncardiothoracic surgery. strategies to reduce the perioperative pulmonary risk and focuses on atelectasis, pneumonia, and respiratory failure. The target audience for this guideline is general internists or other clinicians involved in perioperative management of surgical patients. The target patient population is all adult persons undergoing noncardiothoracic surgery.	Amer Coll Physicians, Philadelphia, PA 19106 USA; N Shore Med Grp, Huntington, NY USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Northwestern Univ, Chicago, IL 60611 USA; Hines VA Hosp, Chicago, IL USA; Stanford Univ, Stanford, CA 94305 USA; Palo Alto Hlth Care Syst, Stanford, CA USA	American College of Physicians; University of Texas System; University of Texas Health San Antonio; Harvard University; Beth Israel Deaconess Medical Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseetn@acponline.org						ARCHER C, 1993, CAN J ANAESTH, V40, P1022, DOI 10.1007/BF03009471; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; Bluman LG, 1998, CHEST, V113, P883, DOI 10.1378/chest.113.4.883; CHEATHAM ML, 1995, ANN SURG, V221, P469, DOI 10.1097/00000658-199505000-00004; DETSKY AS, 1987, ANN INTERN MED, V107, P195, DOI 10.7326/0003-4819-107-2-195; DILWORTH JP, 1991, THORAX, V46, P165, DOI 10.1136/thx.46.3.165; ESCARCE JJ, 1995, SURGERY, V117, P156, DOI 10.1016/S0039-6060(05)80079-0; FAN ST, 1987, BRIT J SURG, V74, P408, DOI 10.1002/bjs.1800740530; FUJITA T, 1995, AM J SURG, V169, P304, DOI 10.1016/S0002-9610(99)80163-9; GARIBALDI RA, 1981, AM J MED, V70, P677, DOI 10.1016/0002-9343(81)90595-7; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; Gupta RM, 2001, MAYO CLIN PROC, V76, P897, DOI 10.4065/76.9.897; Hamoui N, 2003, ARCH SURG-CHICAGO, V138, P891, DOI 10.1001/archsurg.138.8.891; Lawrence VA, 2006, ANN INTERN MED, V144, P596, DOI 10.7326/0003-4819-144-8-200604180-00011; Lawrence VA, 2002, ARCH INTERN MED, V162, P2053, DOI 10.1001/archinte.162.18.2053; Manku K, 2003, ANESTH ANALG, V96, P583, DOI 10.1213/01.ANE.0000042501.28843.C4; McHale J E, 2000, Crit Care Nurse, V20, P37; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Nelson R, 2005, BRIT J SURG, V92, P673, DOI 10.1002/bjs.5090; Nelson R, 2005, COCHRANE DB SYST REV; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; PEDERSEN T, 1994, DAN MED BULL, V41, P319; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; ROSEN AK, 1992, MED CARE, V30, P753, DOI 10.1097/00005650-199209000-00001; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Smetana GW, 1999, NEW ENGL J MED, V340, P937, DOI 10.1056/NEJM199903253401207; Sterling R K, 2001, Gastrointest Endosc Clin N Am, V11, P185; Stuhmeier KD, 1996, ANESTHESIOLOGY, V85, P706, DOI 10.1097/00000542-199610000-00004; Thomas EJ, 1997, AM J MED, V102, P277, DOI 10.1016/S0002-9343(96)00451-2; WEBER RS, 1993, LARYNGOSCOPE, V103, P22; WILLIFORD WO, 1991, NEW ENGL J MED, V325, P525; WINDSOR JA, 1988, ANN SURG, V208, P209, DOI 10.1097/00000658-198808000-00013	33	352	397	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					575	580		10.7326/0003-4819-144-8-200604180-00008	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618955				2022-12-28	WOS:000237017900005
J	Smetana, GW; Lawrence, VA; Cornell, JE				Smetana, GW; Lawrence, VA; Cornell, JE			Preoperative pulmonary risk stratification for noncardiothoracic surgery: Systematic review for the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							EARLY POSTOPERATIVE COMPLICATIONS; THORACOABDOMINAL AORTIC-ANEURYSM; UPPER ABDOMINAL-SURGERY; BLOOD-TRANSFUSION; PERIOPERATIVE COMPLICATIONS; INFECTIOUS COMPLICATIONS; NOSOCOMIAL INFECTIONS; MULTIVARIATE-ANALYSIS; RESPIRATORY-FAILURE; PUBLICATION BIAS	Background: The importance of clinical risk factors for postoperative pulmonary complications and the value of preoperative testing to stratify risk are the subject of debate. Purpose: To systematically review the literature on preoperative pulmonary risk stratification before noncardiothoracic surgery. Data Sources: MEDLINE search from 1 January 1980 through 30 June 2005 and hand search of the bibliographies of retrieved articles. Study Selection: English -language studies that reported the effect of patient- and procedure- related risk factors and laboratory predictors on postoperative pulmonary complication rates after noncardiothoracic surgery and that met predefined inclusion criteria. Data Extraction: The authors used standardized abstraction instruments to extract data on study characteristics, hierarchy of research design, study quality, risk factors, and laboratory predictors. Data Synthesis: The authors determined random-effects pooled estimate odds ratios and, when appropriate, trim-and-fill estimates for patient- and procedure- related risk factors from studies that used multivatiable analyses. They assigned summary strength of evidence scores for each factor. Good evidence supports patient-related risk factors for postoperative pulmonary complications, including advanced age, American Society of Anesthesiologists class 2 or higher, functional dependence, chronic obstructive pulmonary disease, and congestive heart failure. Good evidence supports procedure-related risk factors for postoperative pulmonary complications, including aortic aneurysm repair, nonresective thoracic surgery, abdominal surgery, neurosurgery, emergency surgery, general anesthesia, head and neck surgery, vascular surgery, and prolonged surgery. Among laboratory predictors, good evidence exists only for serum albumin level less than 30 g/L. Insufficient evidence supports preoperative spirometry as a tool to stratify risk. Limitations: For certain risk factors and laboratory predictors, the literature provides only unadjusted estimates of risk. Prescreening, variable selection algorithms, and publication bias limited reporting of risk factors among studies using multivariable analysis. Conclusions: Selected clinical and laboratory factors allow risk stratification for postoperative pulmonary complications after noncardiothoracic surgery.	Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Sch Med, Boston, MA 02215 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; S Texas Vet Hlth Care Syst, San Antonio, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Smetana, GW (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Sch Med, 330 Brookline Ave, Boston, MA 02215 USA.	gsmetana@bidmc.harvard.edu						ARCHER C, 1993, CAN J ANAESTH, V40, P1022, DOI 10.1007/BF03009471; Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; ARRIAGA MA, 1990, ANN OTO RHINOL LARYN, V99, P611, DOI 10.1177/000348949009900804; ARVIDSSON S, 1994, ACTA ANAESTH SCAND, V38, P679, DOI 10.1111/j.1399-6576.1994.tb03977.x; Barisione G, 1997, EUR RESPIR J, V10, P1301, DOI 10.1183/09031936.97.10061301; BEARD K, 1986, ANESTHESIOLOGY, V64, P269, DOI 10.1097/00000542-198602000-00026; Blouw Eleanor L, 2003, AANA J, V71, P45; Bluman LG, 1998, CHEST, V113, P883, DOI 10.1378/chest.113.4.883; BRAGA M, 1992, EUR J SURG, V158, P531; Brooks-Brunn J A, 2000, Clin Nurs Res, V9, P27, DOI 10.1177/10547730022158429; Brooks-Brunn J A, 1992, Clin Nurs Res, V1, P180, DOI 10.1177/105477389200100207; Brooks-Brunn JA, 1998, HEART LUNG, V27, P151, DOI 10.1016/S0147-9563(98)90002-4; BrooksBrunn JA, 1997, CHEST, V111, P564, DOI 10.1378/chest.111.3.564; BUCKWALTER JA, 1983, AM J SURG, V146, P613, DOI 10.1016/0002-9610(83)90297-0; CALLIGARO KD, 1993, J VASC SURG, V18, P914, DOI 10.1016/0741-5214(93)90545-W; Canturk NZ, 2002, CLIN NUTR, V21, P431, DOI 10.1054/clnu.2002.0575; Carson JL, 1999, TRANSFUSION, V39, P694, DOI 10.1046/j.1537-2995.1999.39070694.x; CHARASH WE, 1994, J TRAUMA, V37, P667, DOI 10.1097/00005373-199410000-00023; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHOBAN PS, 1995, AM SURGEON, V61, P1001; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; COOPER MH, 1989, ANAESTHESIA, V44, P306, DOI 10.1111/j.1365-2044.1989.tb11283.x; DelgadoRodriguez M, 1997, J HOSP INFECT, V35, P269, DOI 10.1016/S0195-6701(97)90220-6; DeNino LA, 1997, CHEST, V111, P1536, DOI 10.1378/chest.111.6.1536; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIEHL JT, 1983, ANN SURG, V197, P49, DOI 10.1097/00000658-198301001-00008; DILWORTH JP, 1991, THORAX, V46, P165, DOI 10.1136/thx.46.3.165; Duane DT, 1997, J NEUROSURG ANESTH, V9, P263, DOI 10.1097/00008506-199707000-00011; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; EJLERTSEN T, 1989, ACTA CHIR SCAND, V155, P93; Elkouri S, 2004, J VASC SURG, V39, P497, DOI 10.1016/j.jvs.2003.10.018; EPHGRAVE KS, 1993, SURGERY, V114, P815; EPSTEIN SK, 1993, CHEST, V104, P694, DOI 10.1378/chest.104.3.694; ESCARCE JJ, 1995, SURGERY, V117, P156, DOI 10.1016/S0039-6060(05)80079-0; EVALDSON GR, 1992, ACTA OBSTET GYN SCAN, V71, P54, DOI 10.3109/00016349209007948; FAN ST, 1987, BRIT J SURG, V74, P408, DOI 10.1002/bjs.1800740530; FASTH S, 1987, INT J COLORECTAL DIS, V2, P87, DOI 10.1007/BF01647698; FASTH S, 1980, ACTA CHIR SCAND, V146, P519; Ferguson MK, 1997, WORLD J SURG, V21, P599, DOI 10.1007/s002689900279; Ferguson MK, 2002, J THORAC CARDIOV SUR, V123, P661, DOI 10.1067/mtc.2002.120350; FOGH J, 1987, ACTA ANAESTH SCAND, V31, P717, DOI 10.1111/j.1399-6576.1987.tb02651.x; FUJITA T, 1995, AM J SURG, V169, P304, DOI 10.1016/S0002-9610(99)80163-9; Fuso L, 2000, RESP MED, V94, P1171, DOI 10.1053/rmed.2000.0946; GALICIER C, 1985, INFECT CONT HOSP EP, V6, P487, DOI 10.1017/S0195941700063608; GARIBALDI RA, 1981, AM J MED, V70, P677, DOI 10.1016/0002-9343(81)90595-7; Gefke K, 1994, Ann Vasc Surg, V8, P137, DOI 10.1007/BF02018861; GERSON MC, 1990, AM J MED, V88, P101, DOI 10.1016/0002-9343(90)90456-N; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; GILLINGSMITH GL, 1995, BRIT J SURG, V82, P624, DOI 10.1002/bjs.1800820517; Gillinov A M, 1998, Dis Esophagus, V11, P43, DOI 10.1093/dote/11.1.43; Girish M, 2001, CHEST, V120, P1147, DOI 10.1378/chest.120.4.1147; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; GRECO D, 1991, AM J MED, V91, pS164, DOI 10.1016/0002-9343(91)90363-3; Griffin SM, 2002, J AM COLL SURGEONS, V194, P285, DOI 10.1016/S1072-7515(01)01177-2; Gupta RM, 2001, MAYO CLIN PROC, V76, P897, DOI 10.4065/76.9.897; Haga Y, 1999, SURG TODAY, V29, P219, DOI 10.1007/BF02483010; Hajzman Z, 2001, OBES SURG, V11, P220, DOI 10.1381/096089201321577929; Hall J C, 1996, Respirology, V1, P133, DOI 10.1111/j.1440-1843.1996.tb00022.x; HALL JC, 1991, CHEST, V99, P923, DOI 10.1378/chest.99.4.923; Hall JC, 1996, J LAPAROENDOSC SURG, V6, P87, DOI 10.1089/lps.1996.6.87; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; HEISS MM, 1993, LANCET, V342, P1328, DOI 10.1016/0140-6736(93)92247-Q; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLLIER LH, 1988, ARCH SURG-CHICAGO, V123, P871; IWAMOTO K, 1993, INTERNAL MED, V32, P274, DOI 10.2169/internalmedicine.32.274; JAYR C, 1993, CHEST, V103, P1231, DOI 10.1378/chest.103.4.1231; JORGENSEN FS, 1988, ANN CHIR GYNAECOL FE, V77, P47; KABALIN CS, 1995, ARCH INTERN MED, V155, P1379, DOI 10.1001/archinte.155.13.1379; KATZ S, 1992, AM SURGEON, V58, P470; KHURI SF, 1995, J AM COLL SURGEONS, V180, P519; Kinugasa S, 2004, J SURG ONCOL, V88, P71, DOI 10.1002/jso.20137; Kinugasa S, 2001, ANN THORAC SURG, V71, P414, DOI 10.1016/S0003-4975(00)02333-X; KISPERT JF, 1992, AM SURGEON, V58, P491; Kocabas A, 1996, RESP MED, V90, P25, DOI 10.1016/S0954-6111(96)90241-3; KONESS RJ, 1990, AM SURGEON, V56, P280; KROENKE K, 1993, CHEST, V104, P1445, DOI 10.1378/chest.104.5.1445; KROENKE K, 1992, ARCH INTERN MED, V152, P967, DOI 10.1001/archinte.152.5.967; Kuwano H, 1998, EUR J SURG, V164, P581; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Lawrence VA, 2006, ANN INTERN MED, V144, P596, DOI 10.7326/0003-4819-144-8-200604180-00011; Lawrence VA, 1996, CHEST, V110, P744, DOI 10.1378/chest.110.3.744; Lawrence VA, 2002, ARCH INTERN MED, V162, P2053, DOI 10.1001/archinte.162.18.2053; LAWRENCE VA, 1989, ARCH INTERN MED, V149, P280, DOI 10.1001/archinte.149.2.280; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Leung JM, 2001, J AM GERIATR SOC, V49, P1080, DOI 10.1046/j.1532-5415.2001.49212.x; LIEDMAN BL, 1995, EUR J SURG, V161, P173; Liu LL, 2000, J AM GERIATR SOC, V48, P405, DOI 10.1111/j.1532-5415.2000.tb04698.x; Manku K, 2003, ANESTH ANALG, V96, P583, DOI 10.1213/01.ANE.0000042501.28843.C4; Manninen PH, 1999, CAN J ANAESTH, V46, P7, DOI 10.1007/BF03012507; MATSUMATA T, 1987, SURGERY, V102, P493; McAlister FA, 2005, AM J RESP CRIT CARE, V171, P514, DOI 10.1164/rccm.200408-1069OC; McHale J E, 2000, Crit Care Nurse, V20, P37; Melendez JA, 1998, CHEST, V114, P69, DOI 10.1378/chest.114.1.69; MELLORS JW, 1988, AM SURGEON, V54, P558; Midorikawa Y, 1999, SURGERY, V126, P484, DOI 10.1067/msy.2099.99573; Mitchell CK, 1998, ARCH SURG-CHICAGO, V133, P194, DOI 10.1001/archsurg.133.2.194; Moller AM, 2001, ACTA ANAESTH SCAND, V45, P345, DOI 10.1034/j.1399-6576.2001.045003345.x; MONEY SR, 1994, AM J SURG, V168, P152, DOI 10.1016/S0002-9610(94)80057-X; NIELSEN PH, 1989, CHEST, V96, P1133, DOI 10.1378/chest.96.5.1133; O'Brien MM, 2002, KIDNEY INT, V62, P585, DOI 10.1046/j.1523-1755.2002.00486.x; Onate-Ocana LF, 2000, ANN SURG ONCOL, V7, P281, DOI 10.1007/s10434-000-0281-9; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Palda VA, 1997, ANN INTERN MED, V127, P309, DOI 10.7326/0003-4819-127-4-199708150-00012; PATRICK JA, 1990, ANAESTHESIA, V45, P390, DOI 10.1111/j.1365-2044.1990.tb14784.x; PEDERSEN T, 1994, DAN MED BULL, V41, P319; PEDERSEN T, 1992, ACTA ANAESTH SCAND, V36, P812, DOI 10.1111/j.1399-6576.1992.tb03570.x; PEDERSEN T, 1990, ACTA ANAESTH SCAND, V34, P144, DOI 10.1111/j.1399-6576.1990.tb03059.x; PEREIRA ED, 1999, SAO PAULO MED J, V117, P151, DOI DOI 10.1590/S1516-31801999000400003; PIEN LC, 1988, J ALLERGY CLIN IMMUN, V82, P696, DOI 10.1016/0091-6749(88)90985-2; PINTO V, 1991, TRANSFUSION, V31, P114, DOI 10.1046/j.1537-2995.1991.31291142940.x; POE RH, 1982, AM J MED SCI, V283, P57, DOI 10.1097/00000441-198203000-00002; POE RH, 1988, AM J MED SCI, V295, P29, DOI 10.1097/00000441-198801000-00007; Polanczyk CA, 2001, JAMA-J AM MED ASSOC, V286, P309, DOI 10.1001/jama.286.3.309; Polanczyk CA, 2001, ANN INTERN MED, V134, P637, DOI 10.7326/0003-4819-134-8-200104170-00008; Reilly DF, 1999, ARCH INTERN MED, V159, P2185, DOI 10.1001/archinte.159.18.2185; ROBERTS J, 1988, HEART LUNG, V17, P166; Rose DK, 1996, CAN J ANAESTH, V43, P333, DOI 10.1007/BF03011710; ROSEN AK, 1992, MED CARE, V30, P753, DOI 10.1097/00005650-199209000-00001; SALES BO, 1992, EUR J SURG, V158, P105; Schwilk B, 1997, ACTA ANAESTH SCAND, V41, P348, DOI 10.1111/j.1399-6576.1997.tb04697.x; SEYMOUR DG, 1989, AGE AGEING, V18, P316, DOI 10.1093/ageing/18.5.316; SEYMOUR DG, 1983, GERONTOLOGY, V29, P262, DOI 10.1159/000213125; Smetana GW, 1999, NEW ENGL J MED, V340, P937, DOI 10.1056/NEJM199903253401207; Smetana GW, 2003, MED CLIN N AM, V87, P7, DOI 10.1016/S0025-7125(02)00147-5; *STAT PR, 2003, STAT US GUID REL 8; Sterling R K, 2001, Gastrointest Endosc Clin N Am, V11, P185; Stuhmeier KD, 1996, ANESTHESIOLOGY, V85, P706, DOI 10.1097/00000542-199610000-00004; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; SVENSSON LG, 1991, J VASC SURG, V14, P271; TARTTER PI, 1988, BRIT J SURG, V75, P789, DOI 10.1002/bjs.1800750822; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Thomas EJ, 1997, AM J MED, V102, P277, DOI 10.1016/S0002-9343(96)00451-2; Verdeil X, 1990, Ann Vasc Surg, V4, P553, DOI 10.1016/S0890-5096(06)60838-8; VODINH J, 1989, SURGERY, V105, P360; Warner DO, 1996, ANESTHESIOLOGY, V85, P460, DOI 10.1097/00000542-199609000-00003; WARREN CPW, 1980, CAN J SURG, V23, P384; WEBER RS, 1993, LARYNGOSCOPE, V103, P22; WILLIAMSRUSSO P, 1992, ARCH INTERN MED, V152, P1209, DOI 10.1001/archinte.152.6.1209; WINDSOR J A, 1988, Australian and New Zealand Journal of Surgery, V58, P711, DOI 10.1111/j.1445-2197.1988.tb01101.x; WINDSOR JA, 1988, ANN SURG, V208, P209, DOI 10.1097/00000658-198808000-00013; WIREN JE, 1983, ACTA ANAESTH SCAND, V27, P476, DOI 10.1111/j.1399-6576.1983.tb01990.x; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013; Yamashita S, 2004, RESP MED, V98, P760, DOI 10.1016/j.rmed.2004.01.011; Yamashita S, 2000, ANESTH ANALG, V91, P1176, DOI 10.1097/00000539-200011000-00025; ZELCER J, 1987, ANAESTH INTENS CARE, V15, P168, DOI 10.1177/0310057X8701500209; Ziser A, 1999, ANESTHESIOLOGY, V90, P42, DOI 10.1097/00000542-199901000-00008	149	477	518	1	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					581	595		10.7326/0003-4819-144-8-200604180-00009	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00009			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618956				2022-12-28	WOS:000237017900006
J	Koglin, A; Mofid, MR; Lohr, F; Schafer, B; Rogov, VV; Blum, MM; Mittag, T; Marahiel, MA; Bernhard, F; Dotsch, V				Koglin, A; Mofid, MR; Lohr, F; Schafer, B; Rogov, VV; Blum, MM; Mittag, T; Marahiel, MA; Bernhard, F; Dotsch, V			Conformational switches modulate protein interactions in peptide antibiotic synthetases	SCIENCE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID SYNTHASE; MUTATIONAL ANALYSIS; TRANSFERASES; RECOGNITION; DYNAMICS; SFP; ARCHITECTURE; SUPERFAMILY; RESOLUTION	Protein dynamics plays an important role in protein function. Many functionally important motions occur on the microsecond and low millisecond time scale and can be characterized by nuclear magnetic resonance relaxation experiments. We describe the different states of a peptidyl carrier protein (PCP) that play a crucial role in its function as a peptide shuttle in the nonribosomal peptide synthetases of the tyrocidine A system. Both apo-PCP ( without the bound 4'-phosphopantetheine cofactor) and holo-PCP exist in two different stable conformations. We show that one of the apo conformations and one of the holo conformations are identical, whereas the two remaining conformations are only detectable by nuclear magnetic resonance spectroscopy in either the apo or holo form. We further demonstrate that this conformational diversity is an essential prerequisite for the directed movement of the 4'-PP cofactor and its interaction with externally acting proteins such as thioesterases and 4'-PP transferase.	Univ Frankfurt, BMRZ, Inst Biophys Chem, D-60439 Frankfurt, Germany; Univ Marburg, Fachbereich Chem Biochem, D-35032 Marburg, Germany; Inst Prot Res, Pushchino, Russia	Goethe University Frankfurt; Philipps University Marburg	Dotsch, V (corresponding author), Univ Frankfurt, BMRZ, Inst Biophys Chem, Marie Curie Str, D-60439 Frankfurt, Germany.	vdoetsch@em.uni-frankfurt.de	Blum, Marc-Michael/M-7691-2014; Doetsch, Volker/D-5697-2011	Blum, Marc-Michael/0000-0003-1856-2071; Bernhard, Frank/0000-0002-4860-1783; mofid, mohammad reza/0000-0002-0347-8152; Dotsch, Volker/0000-0001-5720-212X; Mittag, Tanja/0000-0002-1827-3811				ANDREC M, 1995, PROTEIN SCI, V4, P983; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Finking R, 2004, BIOCHEMISTRY-US, V43, P8946, DOI 10.1021/bi0496891; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Mittag T, 2003, BIOCHEMISTRY-US, V42, P11128, DOI 10.1021/bi0347499; Mofid MR, 2004, BIOCHEMISTRY-US, V43, P4128, DOI 10.1021/bi036013h; Mofid MR, 2002, J BIOL CHEM, V277, P17023, DOI 10.1074/jbc.M200120200; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; VANGUNSTEREN WF, 1995, COMPUT PHYS COMMUN, V91, P305, DOI 10.1016/0010-4655(95)00055-K; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	27	122	125	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					273	276		10.1126/science.1122928	http://dx.doi.org/10.1126/science.1122928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614225				2022-12-28	WOS:000236765300051
J	Krasner, CN; Roche, M; Horowitz, NS; Supko, JG; Lee, SI; Oliva, E; Harris, NL; Fuller, AF				Krasner, CN; Roche, M; Horowitz, NS; Supko, JG; Lee, SI; Oliva, E; Harris, NL; Fuller, AF			Case 11-2006: A 54-year-old woman with a mass in the pelvis - Mixed high-grade serous papillary and transitional-cell carcinoma of the fallopian tube, FIGO stage IIIC.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GYNECOLOGIC-ONCOLOGY-GROUP; EPITHELIAL OVARIAN-CANCER; PRIMARY CYTOREDUCTIVE SURGERY; INTRAPERITONEAL CISPLATIN; CLINICOPATHOLOGICAL ANALYSIS; RANDOMIZED-TRIAL; PACLITAXEL; CARBOPLATIN; SURVIVAL; WOMEN		Massachusetts Gen Hosp, Ctr Canc, Gillette Ctr Womens Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc, Clin Pharmacol Lab, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Krasner, CN (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Gillette Ctr Womens Canc, Boston, MA 02114 USA.			Lee, Susanna I/0000-0003-2195-2943				Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; AlvaradoCabrero I, 1997, INT J GYNECOL PATHOL, V16, P189, DOI 10.1097/00004347-199707000-00001; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bookman MA, 2003, INT J GYNECOL CANCER, V13, P735, DOI 10.1111/j.1525-1438.2003.13602.x; Brown DL, 2001, RADIOLOGY, V219, P213, DOI 10.1148/radiology.219.1.r01ap28213; BUCHSBAUM HJ, 1989, SURG GYNECOL OBSTET, V169, P226; Chi DS, 2001, GYNECOL ONCOL, V82, P532, DOI 10.1006/gyno.2001.6328; Colgan TJ, 2003, INT J GYNECOL PATHOL, V22, P109, DOI 10.1097/00004347-200304000-00001; DEDRICK RL, 1978, CANCER TREAT REP, V62, P1; Eisenkop SM, 1998, GYNECOL ONCOL, V69, P103, DOI 10.1006/gyno.1998.4955; EISENKOP SM, 1992, GYNECOL ONCOL, V47, P203, DOI 10.1016/0090-8258(92)90107-T; Elit L, 2002, GYNECOL ONCOL, V87, P260, DOI 10.1006/gyno.2002.6834; Fennelly D, 1997, J CLIN ONCOL, V15, P187, DOI 10.1200/JCO.1997.15.1.187; Fujiwara K, 2005, J CLIN ONCOL, V23, p465S; Georgiadis MS, 1997, CLIN CANCER RES, V3, P449; GIANNI L, 1995, J CLIN ONCOL, V13, P180, DOI 10.1200/JCO.1995.13.1.180; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; GREEN TH, 1962, CLIN OBSTET GYNECOL, V5, P886, DOI 10.1097/00003081-196209000-00022; GRIFFITHS CT, 1975, NATL CANCER I MONOGR, P101; HACKER NF, 1983, OBSTET GYNECOL, V61, P413; HELEWA ME, 1986, AM J OBSTET GYNECOL, V154, P282, DOI 10.1016/0002-9378(86)90656-3; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974, DOI 10.1016/S0002-9378(94)70090-7; HOSKINS WJ, 1992, GYNECOL ONCOL, V47, P159, DOI 10.1016/0090-8258(92)90100-W; HU CY, 1950, AM J OBSTET GYNECOL, V59, P58, DOI 10.1016/0002-9378(50)90341-3; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; Kawamoto S, 1999, RADIOGRAPHICS, V19, pS85, DOI 10.1148/radiographics.19.suppl_1.g99oc10s85; Le T, 1997, GYNECOL ONCOL, V67, P208, DOI 10.1006/gyno.1997.4839; Makhija S, 2001, GYNECOL ONCOL, V81, P77, DOI 10.1006/gyno.2000.6108; MALKASIAN GD, 1988, AM J OBSTET GYNECOL, V159, P341, DOI 10.1016/S0002-9378(88)80081-4; MARKMAN M, 1993, GYNECOL ONCOL, V50, P100, DOI 10.1006/gyno.1993.1171; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; MARKMAN M, 1991, J CLIN ONCOL, V9, P1801, DOI 10.1200/JCO.1991.9.10.1801; Markman M, 2003, LANCET ONCOL, V4, P277, DOI 10.1016/S1470-2045(03)01074-X; Markman M, 2003, J CLIN ONCOL, V21, P2460, DOI 10.1200/JCO.2003.07.013; MAYER AR, 1992, GYNECOL ONCOL, V47, P223, DOI 10.1016/0090-8258(92)90110-5; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Milojkovic Miodrag, 2004, Archives of Gynecology and Obstetrics, V269, P176, DOI 10.1007/s00404-002-0411-7; Narod SA, 2001, LANCET, V357, P1467, DOI 10.1016/S0140-6736(00)04642-0; Navani SS, 1996, GYNECOL ONCOL, V63, P371, DOI 10.1006/gyno.1996.0338; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; PFEIFFER P, 1990, GYNECOL ONCOL, V36, P306, DOI 10.1016/0090-8258(90)90131-4; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Piek JMJ, 2001, LANCET, V358, P844, DOI 10.1016/S0140-6736(01)05992-X; PIVER MS, 1976, OBSTET GYNECOL, V48, P312; Puls LE, 1997, SOUTHERN MED J, V90, P1097; ROSEN A, 1993, BRIT J CANCER, V68, P605, DOI 10.1038/bjc.1993.394; Rosenblatt KA, 1996, CANCER EPIDEM BIOMAR, V5, P933; Sakuragi N, 2000, GYNECOL ONCOL, V79, P420, DOI 10.1006/gyno.2000.5979; Sengupta PS, 1999, BRIT J CANCER, V80, P444, DOI 10.1038/sj.bjc.6690376; STIVER W, 2005, CHEMOTHERAPY BIOTHER, P53; Szklaruk J, 2003, RADIOGRAPHICS, V23, P403, DOI 10.1148/rg.232025089; Vasey PA, 2004, JNCI-J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; Walker JL, 2006, GYNECOL ONCOL, V100, P27, DOI 10.1016/j.ygyno.2005.11.013; Woodman C, 1997, BRIT J OBSTET GYNAEC, V104, P135, DOI 10.1111/j.1471-0528.1997.tb11032.x; WOOLAS R, 1994, INT J GYNECOL CANCER, V4, P384, DOI 10.1046/j.1525-1438.1994.04060384.x; WU PC, 1986, AM J OBSTET GYNECOL, V155, P1103, DOI 10.1016/0002-9378(86)90359-5; YOUNG RC, 1983, JAMA-J AM MED ASSOC, V250, P3072, DOI 10.1001/jama.250.22.3072	57	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1615	1625		10.1056/NEJMcpc069002	http://dx.doi.org/10.1056/NEJMcpc069002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611953				2022-12-28	WOS:000236736900012
J	Reich, PB; Hobbie, SE; Lee, T; Ellsworth, DS; West, JB; Tilman, D; Knops, JMH; Naeem, S; Trost, J				Reich, PB; Hobbie, SE; Lee, T; Ellsworth, DS; West, JB; Tilman, D; Knops, JMH; Naeem, S; Trost, J			Nitrogen limitation constrains sustainability of ecosystem response to CO2	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; ELEVATED CO2; PLANT DIVERSITY; GRASSLAND RESPONSES; FOREST ECOSYSTEMS; FERTILE GRASSLAND; LONG-TERM; SOIL; PHOTOSYNTHESIS; GROWTH	Enhanced plant biomass accumulation in response to elevated atmospheric CO2 concentration could dampen the future rate of increase in CO2 levels and associated climate warming. However, it is unknown whether CO2-induced stimulation of plant growth and biomass accumulation will be sustained or whether limited nitrogen (N) availability constrains greater plant growth in a CO2-enriched world(1-9). Here we show, after a six-year field study of perennial grassland species grown under ambient and elevated levels of CO2 and N, that low availability of N progressively suppresses the positive response of plant biomass to elevated CO2. Initially, the stimulation of total plant biomass by elevated CO2 was no greater at enriched than at ambient N supply. After four to six years, however, elevated CO2 stimulated plant biomass much less under ambient than enriched N supply. This response was consistent with the temporally divergent effects of elevated CO2 on soil and plant N dynamics at differing levels of N supply. Our results indicate that variability in availability of soil N and deposition of atmospheric N are both likely to influence the response of plant biomass accumulation to elevated atmospheric CO2. Given that limitations to productivity resulting from the insufficient availability of N are widespread in both unmanaged and managed vegetation(5,7-9), soil N supply is probably an important constraint on global terrestrial responses to elevated CO2.	Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Wisconsin, Dept Biol, Eau Claire, WI 54701 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; Columbia University	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	preich@umn.edu	Knops, Johannes/AAA-8546-2020; Tilman, David/ABD-5309-2021; West, Jason B/G-8833-2012	Reich, Peter/0000-0003-4424-662X; Ellsworth, David/0000-0002-9699-2272; Trost, Jared/0000-0003-0431-2151; Lee, Tali/0000-0002-3933-6607; West, Jason/0000-0002-7811-8020; Hobbie, Sarah/0000-0001-5159-031X				Cannell MGR, 1998, GLOBAL CHANGE BIOL, V4, P431, DOI 10.1046/j.1365-2486.1998.00167.x; Craine JM, 2001, GLOBAL CHANGE BIOL, V7, P947, DOI 10.1046/j.1354-1013.2001.00455.x; Dijkstra FA, 2005, PLANT SOIL, V272, P41, DOI 10.1007/s11104-004-3848-6; Finzi AC, 2003, ECOSYSTEMS, V6, P444, DOI 10.1007/s10021-003-0205-1; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Hungate BA, 2004, SCIENCE, V304, P1291, DOI 10.1126/science.1095549; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Lee TD, 2001, NEW PHYTOL, V150, P405, DOI 10.1046/j.1469-8137.2001.00095.x; Lloyd J, 1996, FUNCT ECOL, V10, P4, DOI 10.2307/2390258; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; LUO Y, 1994, PLANT CELL ENVIRON, V17, P1195, DOI 10.1111/j.1365-3040.1994.tb02017.x; Luscher A, 2000, GLOB CHANGE BIOL, V6, P655, DOI 10.1046/j.1365-2486.2000.00345.x; McMurtrie RE, 2000, PLANT SOIL, V224, P135, DOI 10.1023/A:1004711707787; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; OWENSBY CE, 1994, PLANT SOIL, V165, P105, DOI 10.1007/BF00009967; Peterson AG, 1999, GLOB CHANGE BIOL, V5, P331, DOI 10.1046/j.1365-2486.1999.00234.x; Rastetter EB, 1997, ECOL APPL, V7, P444; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Schneider MK, 2004, GLOBAL CHANGE BIOL, V10, P1377, DOI 10.1111/j.1365-2486.2004.00803.x; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Williams MA, 2000, PLANT SOIL, V227, P127, DOI 10.1023/A:1026590001307; Zak DR, 2003, ECOL APPL, V13, P1508, DOI 10.1890/03-5055; Zak DR, 2000, ECOL APPL, V10, P47, DOI 10.2307/2640985; Zanetti S, 1997, OECOLOGIA, V112, P17, DOI 10.1007/s004420050278	29	664	744	20	505	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2006	440	7086					922	925		10.1038/nature04486	http://dx.doi.org/10.1038/nature04486			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612381	Green Published			2022-12-28	WOS:000236736700038
J	Kumar, R; Jha, P; Arora, P; Mony, P; Bhatia, P; Millson, P; Dhingra, N; Bhattacharya, M; Remis, RS; Nagelkerke, N				Kumar, R; Jha, P; Arora, P; Mony, P; Bhatia, P; Millson, P; Dhingra, N; Bhattacharya, M; Remis, RS; Nagelkerke, N		ISHA Investigators	Trends in HIV-1 in young adults in south India from 2000 to 2004: a prevalence study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; COMMUNITY PREVALENCE; PREGNANT-WOMEN; INFECTION; HIV/AIDS; CLINICS; IMPACT; MEN; SEX	Background Major increases in HIV-1 prevalence in India have been predicted. Incident infections need to be tracked to understand the epidemic's course, especially in some southern states of India where the epidemic is more advanced. To estimate incidence, we investigated the prevalence of HIV-1 in young people attending antenatal and sexually transmitted infection (STI) clinics in India. Methods We analysed unlinked, anonymous HIV-1 prevalence data from 294050 women attending 216 antenatal clinics and 58 790 men attending 132 STI clinics in 2000-04. Southern and northern states were analysed separately. Findings The age-standardised HIV-1 prevalence in women aged 15-24 years in southern states fell from 1.7% to 1.1% in 2000-04 (relative reduction 35%; p(trend)<0.0001, yearly reduction 11%), but did not fall significantly in women aged 25-34 years. Reductions in women aged 15-24 years were seen in key demographic groups and were similar in sites tested continuously or in all sites. Prevalence in the north was about a fifth of that in the south, with no significant decreases (or increases) in 2000-04. Prevalence fell in men aged 20-29 years attending STI clinics in the south (p(trend)<0.0001), including those with ulcerative STIs (P-trend=0.0008), but reductions were more modest in their northern counterparts. Interpretation A reduction of more than a third in HIV-1 prevalence in 2000-04 in young women in south India seems realistic, and is not easily attributable to bias or to mortality. This fall is probably due to rising condom use by men and female sex workers in south India, and thus reduced transmission to wives. Expansion of peer-based condom and education programmes for sex workers remains a top priority to control HIV-1 in India.	Univ Toronto, Toronto, ON M5C 1N8, Canada; Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; St Johns Natl Acad Hlth Sci, Inst Populat Hlth & Clin Res, Bangalore, Karnataka, India; Osmania Med Coll & Hosp, Hyderabad, Andhra Pradesh, India; Natl Inst Hlth & Family Welfare, New Delhi, India; United Arab Emirates Univ, Al Ain, U Arab Emirates	University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences; United Arab Emirates University	Jha, P (corresponding author), Univ Toronto, Toronto, ON M5C 1N8, Canada.	prabhat.jha@utoronto.ca	Mony, Prem K./GRF-4752-2022	Mony, Prem K./0000-0002-1399-0520				*AIDS PREV CONTR P, 2005, VOL HLTH SERV EX SUM; [Anonymous], 2019, NATL FAMILY HLTH SUR; *AV SOC, 2004, BEH SURV SURV MAH WA, V2; Bhore AV, 2003, INT J STD AIDS, V14, P37, DOI 10.1258/095646203321043246; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Go VF, 2004, JAIDS-J ACQ IMM DEF, V35, P314, DOI 10.1097/00126334-200403010-00014; Hira SK, 2003, NATL MED J INDIA, V16, P126; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hunter SC, 2003, J BIOSOC SCI, V35, P189, DOI 10.1017/S0021932003001895; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Kang G, 2005, NATL MED J INDIA, V18, P15; KUMAR R, 2005, COMMISSION MACROECON, P58; *NACO, 2001, NAT BAS GEN POP BEH; *NACO, 2000, HIV TEST MAN LAB DIA; *NACO, 2004, ANN REP 2002 2003 20, P1; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; National Intelligence Council, 2002, NEXT WAV HIV AIDS NI; Nicoll A, 1998, AIDS, V12, P1861, DOI 10.1097/00002030-199814000-00018; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Rao JVRP, 2004, LANCET, V364, P1296, DOI 10.1016/S0140-6736(04)17205-X; Risbud A, 2005, INDIAN J MED RES, V121, P369; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; SHEFALEE V, 2004, INDIA TODAY     0926, P26; Thomas K, 2002, NATL MED J INDIA, V15, P135; Venkataramana CBS, 2001, TROP MED INT HEALTH, V6, P1040, DOI 10.1046/j.1365-3156.2001.00814.x; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014; WAWAR M, 2005, 12 C RETR OPP INF BO; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020	30	87	89	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1164	1172		10.1016/S0140-6736(06)68435-3	http://dx.doi.org/10.1016/S0140-6736(06)68435-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616559				2022-12-28	WOS:000236673400025
J	Thore, S; Leibundgut, M; Ban, NN				Thore, Stephane; Leibundgut, Marc; Ban, Nenad			Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand	SCIENCE			English	Article							BACTERIAL GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; CRYSTAL-STRUCTURE; HAMMERHEAD RIBOZYME; TRANSCRIPTION; METABOLISM; MECHANISM; CATALYSIS; ELEMENTS; DOMAIN	Riboswitches are untranslated regions of messenger RNA, which adopt alternate structures, depending on the binding of specific metabolites. Such conformational switching regulates the expression of proteins involved in the biosynthesis of riboswitch substrates. Here, we present the 2.9 angstrom-resolution crystal structure of the eukaryotic Arobidopsis thaliana thiamine pyrophosphate (TPP)-specific riboswitch in complex with its natural ligand. The riboswitch specifically recognizes the TIPP via conserved residues located within two highly distorted parallel "sensor" helices. The structure provides the basis for understanding the reorganization of the riboswitch fold upon TPP binding and explains the mechanism of resistance to the antibiotic pyrithiamine.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, NN (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mot.biol.ethz.ch	Thore, stéphane/M-7759-2014; Thore, Stephane/AAW-6482-2020	Thore, stéphane/0000-0001-7058-3887; Thore, Stephane/0000-0001-7058-3887				Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; CARLISLE CH, 1969, ACTA CRYSTALL B-STRU, VB 25, P1359, DOI 10.1107/S0567740869004043; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; Doudna JA, 2005, NAT STRUCT MOL BIOL, V12, P395, DOI 10.1038/nsmb932; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; MORAS D, 1985, J BIOMOL STRUCT DYN, V3, P479, DOI 10.1080/07391102.1985.10508436; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Soukup JK, 2004, CURR OPIN STRUC BIOL, V14, P344, DOI 10.1016/j.sbi.2004.04.007; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yamauchi T, 2005, FEBS LETT, V579, P2583, DOI 10.1016/j.febslet.2005.03.074	28	260	279	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1208	1211		10.1126/science.1128451	http://dx.doi.org/10.1126/science.1128451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16675665				2022-12-28	WOS:000237957400052
J	Roux, A; Uyhazi, K; Frost, A; De Camilli, P				Roux, Aurelien; Uyhazi, Katherine; Frost, Adam; De Camilli, Pietro			GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission	NATURE			English	Article							MECHANOCHEMICAL ENZYME; INVAGINATION; TUBULATION; CURVATURE; CORTACTIN; RINGS	Dynamin, a crucial factor in endocytosis(1-3), is a member of a family of GTPases that participates in membrane fission(4-6). It was initially proposed to act as a machine that constricts and cuts the neck of nascent vesicles in a GTP-hydrolysis-dependent reaction(4,5), but subsequent studies suggested alternative models(2,7,8). Here we monitored the effect of nucleotides on dynamin-coated lipid tubules in real time. Addition of GTP, but not of GDP or GTP-gamma S, resulted in twisting of the tubules and supercoiling, suggesting a rotatory movement of the helix turns relative to each other during GTP hydrolysis. Rotation was confirmed by the movement of beads attached to the tubules. Twisting activity produced a longitudinal tension that was released by tubule breakage when both ends of the tubule were anchored. Fission also occurred when dynamin and GTP were added to lipid tubules that had been generated from liposomes by the motor activity of kinesin on microtubules. No fission events were observed in the absence of longitudinal tension. These findings demonstrate a mechanoenzyme activity of dynamin in endocytosis, but also imply that constriction is not sufficient for fission. At the short necks of endocytic vesicles, other factors(6,9,10) leading to tension may cooperate with the constricting activity of dynamin to induce fission(11-13).	Yale Univ, Sch Med, Kavli Inst Neurosci, Howard Hughes Med Inst,Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Biochem & Mol Biophys, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, Howard Hughes Med Inst,Dept Cell Biol, 333 Cedar St, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021	Roux, Aurelien R/0000-0002-6088-0711; Uyhazi, Katherine/0000-0002-4280-1397; Frost, Adam/0000-0003-2231-2577				Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Thompson HM, 2001, CURR BIOL, V11, pR850, DOI 10.1016/S0960-9822(01)00513-9; Tsafrir I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138102; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	30	358	372	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					528	531		10.1038/nature04718	http://dx.doi.org/10.1038/nature04718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16648839				2022-12-28	WOS:000237778900054
J	Huang, Y; Fang, J; Bedford, MT; Zhang, Y; Xu, RM				Huang, Y; Fang, J; Bedford, MT; Zhang, Y; Xu, RM			Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A	SCIENCE			English	Article							BINDING; CHROMODOMAIN; BROMODOMAIN; PROTEIN; FAMILY; 53BP1; TAIL; DNA	Biological responses to histone methylation critically depend on the faithful readout and transduction of the methyl-lysine signal by "effector'' proteins, yet our understanding of methyl-lysine recognition has so far been limited to the study of histone binding by chromodomain and WD40-repeat proteins. The double tudor domain of JMJD2A, a Jmjc domain - containing histone demethylase, binds methylated histone H3-K4 and H4-K20. We found that the double tudor domain has an interdigitated structure, and the unusual fold is required for its ability to bind methylated histone tails. The cocrystal structure of the JMJD2A double tudor domain with a trimethylated H3-K4 peptide reveals that the trimethyl-K4 is bound in a cage of three aromatic residues, two of which are from the tudor-2 motif, whereas the binding specificity is determined by side-chain interactions involving amino acids from the tudor-1 motif. Our study provides mechanistic insights into recognition of methylated histone tails by tudor domains and reveals the structural intricacy of methyl-lysine recognition by two closely spaced effector domains.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ Texas, MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX 78957 USA	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center	Xu, RM (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Struct Biol Program, New York, NY 10016 USA.	rmxu@saturn.med.nyu.edu	Bedford, Mark T/E-7856-2011; xu, rui/GRX-5734-2022; Huang, Ying/AFM-0838-2022	Huang, Ying/0000-0002-2806-2874; Fang, Jia/0000-0001-8583-1652; Zhang, Yi/0000-0002-2789-0811	NIDDK NIH HHS [DK62248] Funding Source: Medline; NIGMS NIH HHS [GM68804, GM 63718] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, R01DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005	18	352	370	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					748	751		10.1126/science.1125162	http://dx.doi.org/10.1126/science.1125162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16601153				2022-12-28	WOS:000237312100051
J	Kinsella, JP; Greenough, A; Abman, SH				Kinsella, JP; Greenough, A; Abman, SH			Bronchopulmonary dysplasia	LANCET			English	Review							CHRONIC LUNG-DISEASE; INHALED NITRIC-OXIDE; LOW-BIRTH-WEIGHT; NECROSIS-FACTOR-ALPHA; FREQUENCY OSCILLATORY VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; HYALINE-MEMBRANE DISEASE; HEALTH-CARE UTILIZATION; PULMONARY-FUNCTION; PRETERM INFANTS	Bronchopulmonary dysplasia is a chronic lung disease that affects premature babies and contributes to their morbidity and mortality. Improved survival of very immature infants has led to increased numbers of infants with this disorder. This increase puts a heavy burden on health resources since these infants need frequent re-admission to hospital in the first 2 years after birth and, even as adolescents, have lung-function abnormalities and persistent respiratory symptoms. Unlike the original description of the disease in 1967, premature infants can develop chronic oxygen dependency without severe, acute respiratory distress; this "new bronchopulmonary dysplasia" could be the result of impaired postnatal lung growth. Whether such infants subsequently have catch-up lung growth, especially if given corticosteroids postnatally, is unknown. No safe and effective preventive therapy has been identified, but promising new treatments directed either at reducing lung injury or improving lung growth are under study.	Univ Colorado, Sch Med, Dept Paediat, Denver, CO USA; Kings Coll London, Sch Med, Div Asthma Allergy & Lung Biol, London, England	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of London; King's College London	Kinsella, JP (corresponding author), Childrens Hosp, Div Neonatol, Denver, CO 80218 USA.	john.kinsella@uchsc.edu		Greenough, Anne/0000-0002-8672-5349	NCRR NIH HHS [M01-RR00069] Funding Source: Medline; NHLBI NIH HHS [UO10HL064857] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL064857] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABMAN SH, 1985, PEDIATRICS, V75, P80; ABMAN SH, 2000, LUNG BIOL HEALTH DIS, V137, P619; Ahmed MN, 2003, AM J RESP CRIT CARE, V167, P400, DOI 10.1164/rccm.200202-108OC; ANDERSON AH, 1993, AM J PERINAT, V10, P190; APKON M, 2000, LUNG BIOL HEALTH DIS, V137, P321; AVERY ME, 1987, PEDIATRICS, V79, P26; BAGCHI A, 1994, PEDIATR RES, V36, P244, DOI 10.1203/00006450-199408000-00017; BANCALARI E, 1979, J PEDIATR-US, V95, P819, DOI 10.1016/S0022-3476(79)80442-4; BANCALARI E, 2000, CHRONIC LUNG DIS EAR; Banks BA, 1999, PEDIATRICS, V103, P610, DOI 10.1542/peds.103.3.610; Baraldi E, 1997, AM J RESP CRIT CARE, V155, P149, DOI 10.1164/ajrccm.155.1.9001304; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Bjorklund LJ, 1997, PEDIATR RES, V42, P348; Blackmon LR, 2002, PEDIATRICS, V109, P330; BLAND RD, 2000, CHRONIC LUNG DIS EAR; Bollen CW, 2003, AM J RESP CRIT CARE, V168, P1150, DOI 10.1164/rccm.200306-721CP; BONIKOS DS, 1976, AM J PATHOL, V85, P623; BRYAN MH, 1973, PEDIATRICS, V52, P169; CARLTON DP, 1990, J APPL PHYSIOL, V69, P577, DOI 10.1152/jappl.1990.69.2.577; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Charafeddine L, 1999, PEDIATRICS, V103, P759, DOI 10.1542/peds.103.4.759; CLARK DA, 1982, JAMA-J AM MED ASSOC, V248, P1868, DOI 10.1001/jama.248.15.1868; COALSON JJ, 2000, LUNG BIOL HEALTH DIS, V137, P85; Cole CH, 1999, NEW ENGL J MED, V340, P1005, DOI 10.1056/NEJM199904013401304; Cook AJ, 1996, EUR RESPIR J, V9, P1907, DOI 10.1183/09031936.96.09091907; Courtney SE, 2002, NEW ENGL J MED, V347, P643, DOI 10.1056/NEJMoa012750; CRAPO JD, 1978, LAB INVEST, V39, P640; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; CROWTHER CA, 2004, COCHRANE DB SYST REV, V2, P19; Darlow BA, 2002, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000501, 10.1002/14651858.CD000501]; Davis JM, 2003, PEDIATRICS, V111, P469, DOI 10.1542/peds.111.3.469; DAVIS JM, 1993, J APPL PHYSIOL, V74, P2234, DOI 10.1152/jappl.1993.74.5.2234; Doyle LW, 2005, PEDIATRICS, V115, P655, DOI 10.1542/peds.2004-1238; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Dugas MA, 2005, PEDIATRICS, V115, pE566, DOI 10.1542/peds.2004-0951; Ellsbury DL, 2002, J PEDIATR-US, V140, P247, DOI 10.1067/mpd.2002.121933; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; FOURON JC, 1980, PEDIATRICS, V65, P529; Garland JS, 1999, PEDIATRICS, V104, P91, DOI 10.1542/peds.104.1.91; GERHARDT T, 1987, J PEDIATR-US, V110, P448, DOI 10.1016/S0022-3476(87)80516-4; Ghezzi F, 1998, EUR J OBSTET GYN R B, V78, P5, DOI 10.1016/S0301-2115(97)00236-4; GOLDMAN SL, 1983, J PEDIATR-US, V102, P613, DOI 10.1016/S0022-3476(83)80202-9; Gonzalez A, 1996, J PEDIATR-US, V128, P470, DOI 10.1016/S0022-3476(96)70356-6; GOODMAN G, 1988, J PEDIATR-US, V112, P67, DOI 10.1016/S0022-3476(88)80125-2; Greenough A, 2004, ARCH DIS CHILD, V89, P673, DOI 10.1136/adc.2003.036129; Greenough A, 1999, BRIT J RADIOL, V72, P530, DOI 10.1259/bjr.72.858.10560333; Greenough A, 2001, ARCH DIS CHILD, V85, P463, DOI 10.1136/adc.85.6.463; GREENOUGH A, 2004, COCHRANE DB SYST REV, V3; GRONECK P, 1995, ARCH DIS CHILD-FETAL, V73, pF1, DOI 10.1136/fn.73.1.F1; GROSECLOSE EE, 1984, PEDIATR RES, V18, P240; Halliday HL, 1999, BIOL NEONATE, V76, P29, DOI 10.1159/000047044; HALLIDAY HL, 1980, PEDIATRICS, V65, P536; HALLMAN M, 1982, J CLIN INVEST, V70, P673, DOI 10.1172/JCI110662; Hallman Mikko, 2003, Semin Neonatol, V8, P19, DOI 10.1016/S1084-2756(02)00196-3; Hartnoll G, 2000, ARCH DIS CHILD-FETAL, V82, pF19, DOI 10.1136/fn.82.1.F19; Hitti J, 1997, AM J OBSTET GYNECOL, V177, P50, DOI 10.1016/S0002-9378(97)70437-X; HODSON WA, 2000, LUNG BIOL HEALTH DIS, V137, P173; HOWLETT A, 2003, COCHRANE DB SYST REV, V4; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jacob SV, 1998, J PEDIATR-US, V133, P193, DOI 10.1016/S0022-3476(98)70220-3; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Jobe AH, 2004, NEW ENGL J MED, V350, P1349, DOI 10.1056/NEJMe048031; Jobe AH, 2000, AM J OBSTET GYNECOL, V182, P401, DOI 10.1016/S0002-9378(00)70231-6; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00001; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jobe Alan H, 2003, Semin Neonatol, V8, P9, DOI 10.1016/S1084-2756(02)00188-4; Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; Jones CA, 1996, PEDIATR RES, V39, P966, DOI 10.1203/00006450-199606000-00007; Kavvadia V, 2000, ARCH DIS CHILD-FETAL, V83, pF91, DOI 10.1136/fn.83.2.F91; Kinsella JP, 1997, PEDIATR RES, V41, P457, DOI 10.1203/00006450-199704000-00002; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; KOJIMA T, 1993, LANCET, V342, P1023, DOI 10.1016/0140-6736(93)92880-3; Kotecha S, 1996, PEDIATR RES, V40, P250, DOI 10.1203/00006450-199608000-00010; Koumbourlis AC, 1996, PEDIATR PULM, V21, P28, DOI 10.1002/(SICI)1099-0496(199601)21:1<28::AID-PPUL5>3.0.CO;2-M; KRAYBILL EN, 1989, J PEDIATR-US, V115, P115, DOI 10.1016/S0022-3476(89)80345-2; Kumar VH, 2004, FRONT BIOSCI-LANDMRK, V9, P464, DOI 10.2741/1245; Lewis BA, 2002, J COMMUN DISORD, V35, P393, DOI 10.1016/S0021-9924(02)00085-0; LISTER P, 1999, COCHRANE DB SYST REV, V4; Makri V, 2002, EUR J PEDIATR, V161, P604, DOI 10.1007/s00431-002-1046-1; MARKESTAD T, 1981, J PEDIATR-US, V98, P597, DOI 10.1016/S0022-3476(81)80774-3; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; MIRRO R, 1990, AM J DIS CHILD, V144, P160, DOI 10.1001/archpedi.1990.02150260038022; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Mourani PM, 2004, AM J RESP CRIT CARE, V170, P1006, DOI 10.1164/rccm.200310-1483oc; Munshi UK, 1997, PEDIATR PULM, V24, P331; Murch SH, 1996, PEDIATR RES, V40, P484, DOI 10.1203/00006450-199609000-00019; NICKERSON BG, 1980, PEDIATRICS, V65, P1140; NILSSON R, 1978, PEDIATR RES, V12, P249, DOI 10.1203/00006450-197804000-00001; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Ogihara T, 1996, PEDIATR RES, V39, P117, DOI 10.1203/00006450-199601000-00017; Ozdemir A, 1997, PEDIATR PULM, V23, P292, DOI 10.1002/(SICI)1099-0496(199704)23:4<292::AID-PPUL7>3.0.CO;2-O; Park HG, 2003, BIOTECHNOL BIOPROC E, V8, P1, DOI 10.1007/BF02932891; Peltoniemi O, 2005, J PEDIATR-US, V146, P632, DOI 10.1016/j.jpeds.2004.12.040; PIERCE MR, 1995, PEDIATR PULM, V19, P371, DOI 10.1002/ppul.1950190611; Polk DH, 1997, AM J OBSTET GYNECOL, V176, P308, DOI 10.1016/S0002-9378(97)70490-3; Ramsay PL, 1998, PEDIATRICS, V102, P927, DOI 10.1542/peds.102.4.927; ROJAS MA, 1995, J PEDIATR-US, V126, P605, DOI 10.1016/S0022-3476(95)70362-4; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; SHAH P, 2001, COCHRANE DB SYST REV, V3; SHAH V, 2000, COCHRANE DB SYST REV, V1; SHANKARAN S, 1984, CHEST, V86, P607, DOI 10.1378/chest.86.4.607; SHEPARD F, 1964, J PEDIATR-US, V65, P1078, DOI 10.1016/S0022-3476(64)80070-6; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Smith VC, 2005, J PEDIATR-US, V146, P469, DOI 10.1016/j.jpeds.2004.12.023; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; TEPPER RS, 1988, J PEDIAT, V109, P1040; Thomas M, 2003, EUR J PEDIATR, V162, P65, DOI 10.1007/s00431-002-0914-z; Thomas M, 2003, ARCH DIS CHILD-FETAL, V88, P329; Thomas MR, 2004, AM J RESP CRIT CARE, V169, P868, DOI 10.1164/rccm.200310-1425OC; TOMASHEFSKI J F JR, 1984, Pediatric Pathology, V2, P469; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; TSCHANZ SA, 1995, BIOL NEONATE, V68, P229; Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; WALTHER FJ, 1992, PEDIATRICS, V90, P899; WANG EEL, 1995, J PEDIATR-US, V127, P640, DOI 10.1016/S0022-3476(95)70130-3; Watterberg KL, 2004, PEDIATRICS, V114, P1649, DOI 10.1542/peds.2004-1159; Watterberg KL, 1996, PEDIATRICS, V97, P210; WHEATER M, 1994, ARCH DIS CHILD-FETAL, V71, pF210, DOI 10.1136/fn.71.3.F210; WHITE CW, 1991, J CLIN INVEST, V87, P2162, DOI 10.1172/JCI115249; WISPE JR, 1992, J BIOL CHEM, V267, P23937; WOLFSON MR, 1984, J PEDIATR-US, V104, P752, DOI 10.1016/S0022-3476(84)80961-0; WOODGATE PG, 2001, COCHRANE DB SYST REV, V2; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; YODER MC, 1991, AM REV RESPIR DIS, V143, P1044, DOI 10.1164/ajrccm/143.5_Pt_1.1044; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; YUKSEL B, 1994, RESP MED, V88, P281, DOI 10.1016/0954-6111(94)90057-4; ZIMMERMAN JJ, 1995, CLIN PERINATOL, V22, P429	131	350	370	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1421	1431		10.1016/S0140-6736(06)68615-7	http://dx.doi.org/10.1016/S0140-6736(06)68615-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650652				2022-12-28	WOS:000237195600030
J	Bonacci, TM; Mathews, JL; Yuan, CJ; Lehmann, DM; Malik, S; Wu, DQ; Font, JL; Bidlack, JM; Smrcka, AV				Bonacci, TM; Mathews, JL; Yuan, CJ; Lehmann, DM; Malik, S; Wu, DQ; Font, JL; Bidlack, JM; Smrcka, AV			Differential targeting of G beta gamma-subunit signaling with small molecules	SCIENCE			English	Article							PROTEIN; RECEPTORS; BINDING	G protein beta gamma subunits have potential as a target for therapeutic treatment of a number of diseases. We performed virtual docking of a small-molecule library to a site on G beta gamma subunits that mediates protein interactions. We hypothesized that differential targeting of this surface could allow for selective modulation of G beta gamma subunit functions. Several compounds bound to G beta gamma subunits with affinities from 0.1 to 60 mu M and selectively modulated functional G beta gamma-protein-protein interactions in vitro, chemotactic peptide signaling pathways in HL-60 leukocytes, and opioid receptor-dependent analgesia in vivo. These data demonstrate an approach for modulation of G protein-coupled receptor signaling that may represent an important therapeutic strategy.	Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Rochester; University of Rochester; University of Connecticut	Smrcka, AV (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	Alan_Smrcka@URMC.rochester.edu		Lehmann, David/0000-0003-0174-344X	NATIONAL CANCER INSTITUTE [R01CA132317] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007949, R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597, R01GM060286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000360, T32DA007232] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA132317] Funding Source: Medline; NHLBI NIH HHS [HL080706, HL-T3207949, R01 HL080706, R01 HL080706-10, R01 HL080706-11] Funding Source: Medline; NIDA NIH HHS [K05-DA00360, T32DA07232] Funding Source: Medline; NIGMS NIH HHS [R01 GM054597-09, R01 GM054597, GM60286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Clark RD, 2002, J MOL GRAPH MODEL, V20, P281, DOI 10.1016/S1093-3263(01)00125-5; Cochran AG, 2001, CURR OPIN CHEM BIOL, V5, P654, DOI 10.1016/S1367-5931(01)00262-9; Connor M, 1999, CLIN EXP PHARMACOL P, V26, P493, DOI 10.1046/j.1440-1681.1999.03049.x; DAAKA Y, 2004, SCI STKE, pRE2; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Iaccarino G, 1999, P NATL ACAD SCI USA, V96, P3945, DOI 10.1073/pnas.96.7.3945; Iaccarino G, 2003, ASSAY DRUG DEV TECHN, V1, P347, DOI 10.1089/154065803321204484; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Rane MJ, 1997, J IMMUNOL, V159, P5070; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385	24	181	190	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					443	446		10.1126/science.1120378	http://dx.doi.org/10.1126/science.1120378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627746				2022-12-28	WOS:000236941800052
J	Dunne, M				Dunne, M			Laser-driven particle accelerators	SCIENCE			English	Editorial Material							ELECTRON-BEAMS		Rutherford Appleton Lab, Cent Laser Facil, Didcot OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Dunne, M (corresponding author), Rutherford Appleton Lab, Cent Laser Facil, Didcot OX11 0QX, Oxon, England.	m.dunne@rl.ac.uk	Dunne, Mike/B-4318-2014	Dunne, Mike/0000-0001-8740-3870; Dunne, Mike/0000-0002-4978-5166				Faure J, 2004, NATURE, V431, P541, DOI 10.1038/nature02963; Fuchs J, 2006, NAT PHYS, V2, P48, DOI 10.1038/nphys199; Geddes CGR, 2004, NATURE, V431, P538, DOI 10.1038/nature02900; Hegelich BM, 2006, NATURE, V439, P441, DOI 10.1038/nature04400; Mangles SPD, 2004, NATURE, V431, P535, DOI 10.1038/nature02939; Patel PK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.125004; Romagnani L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.195001; Schwoerer H, 2006, NATURE, V439, P445, DOI 10.1038/nature04492; Toncian T, 2006, SCIENCE, V312, P410, DOI 10.1126/science.1124412	9	27	49	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					374	376		10.1126/science.1126051	http://dx.doi.org/10.1126/science.1126051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627728				2022-12-28	WOS:000236941800029
J	Goldman, AS; Roy, AH; Huang, Z; Ahuja, R; Schinski, W; Brookhart, M				Goldman, AS; Roy, AH; Huang, Z; Ahuja, R; Schinski, W; Brookhart, M			Catalytic alkane metathesis by tandem alkane dehydrogenation olefin metathesis	SCIENCE			English	Article							IMIDO ALKYLIDENE COMPLEXES; PINCER COMPLEXES; IRIDIUM; MOLYBDENUM	With petroleum supplies dwindling, there is increasing interest in selective methods for transforming other carbon feedstocks into hydrocarbons suitable for transportation fuel. We report the development of highly productive, well-defined, tandem catalytic systems for the metathesis of n-alkanes. Each system comprises one molecular catalyst ( a "pincer''-ligated iridium complex) that effects alkane dehydrogenation and olefin hydrogenation, plus a second catalyst ( molecular or solid-phase) for olefin metathesis. The systems all show complete selectivity for linear (n-alkane) product. We report one example that achieves selectivity with respect to the distribution of product molecular weights, in which n-decane is the predominant high-molecular-weight product of the metathesis of two moles of n-hexane.	Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Chevron Res & Technol Co, Richmond, CA 94802 USA	Rutgers State University New Brunswick; University of North Carolina; University of North Carolina Chapel Hill; Chevron	Goldman, AS (corresponding author), Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA.	agoldman@rutchem.rutgers.edu; brookhar@email.unc.edu	Goldman, Alan/D-9521-2011	Huang, Zheng/0000-0001-7524-098X; Goldman, Alan/0000-0002-2774-710X; MacArthur, Amy/0000-0002-5828-4208				Astruc D, 2005, NEW J CHEM, V29, P42, DOI 10.1039/b412198h; Basset JM, 2005, J AM CHEM SOC, V127, P8604, DOI 10.1021/ja051679f; BURNETT RL, 1973, J CATAL, V31, P55, DOI 10.1016/0021-9517(73)90270-4; Dry ME, 2002, J CHEM TECHNOL BIOT, V77, P43, DOI 10.1002/jctb.527; Gottker-Schnetmann I, 2004, J AM CHEM SOC, V126, P9330, DOI 10.1021/ja048393f; Gottker-Schnetmann I, 2004, J AM CHEM SOC, V126, P1804, DOI 10.1021/ja0385235; Grubbs RH, 2004, TETRAHEDRON, V60, P7117, DOI 10.1016/j.tet.2004.05.124; Gupta M, 1997, J AM CHEM SOC, V119, P840, DOI 10.1021/ja962560x; Gupta M, 1996, CHEM COMMUN, P2083, DOI 10.1039/cc9960002083; Levenspiel O, 2005, IND ENG CHEM RES, V44, P5073, DOI 10.1021/ie040169b; Liu FC, 1999, J AM CHEM SOC, V121, P4086, DOI 10.1021/ja983460p; Murphy M.J., 2004, COMPENDIUM EXPT CETA, DOI [10.2172/1086353, DOI 10.2172/1086353]; Pariya C, 1998, COORDIN CHEM REV, V168, P1, DOI 10.1016/S0010-8545(97)00066-0; Roux E. L., 2005, ANGEW CHEM INT EDIT, V44, P6755; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Schrock RR, 2005, CHEM COMMUN, P2773, DOI 10.1039/b504541j; SCHROCK RR, 1990, J AM CHEM SOC, V112, P3875, DOI 10.1021/ja00166a023; SCOTT S, 2005, 229 ACS NAT M AM CHE; Szybist JP, 2005, ENERG FUEL, V19, P1484, DOI 10.1021/ef049702q; Thieuleux C, 2004, J MOL CATAL A-CHEM, V213, P47, DOI 10.1016/j.molcata.2003.11.028; Vidal V, 1997, SCIENCE, V276, P99, DOI 10.1126/science.276.5309.99; Xu WW, 1997, CHEM COMMUN, P2273, DOI 10.1039/a705105k; Zhu KM, 2004, J AM CHEM SOC, V126, P13044, DOI 10.1021/ja047356l	23	441	450	10	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					257	261		10.1126/science.1123787	http://dx.doi.org/10.1126/science.1123787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	032HK	16614220				2022-12-28	WOS:000236765300046
J	Berggren, RE; Curiel, TJ				Berggren, RE; Curiel, TJ			After the storm - Health care infrastructure in post-Katrina New Orleans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tulane Univ, Hlth Sci Ctr, Sect Adult Infect Dis, New Orleans, LA 70118 USA; Tulane Univ, Hlth Sci Ctr, Sect Hematol & Med Oncol, New Orleans, LA 70118 USA	Tulane University; Tulane University	Berggren, RE (corresponding author), Tulane Univ, Hlth Sci Ctr, Sect Adult Infect Dis, New Orleans, LA 70118 USA.								0	65	65	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1549	1552		10.1056/NEJMp068039	http://dx.doi.org/10.1056/NEJMp068039			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	031WW	16611946	Bronze			2022-12-28	WOS:000236736900001
J	Johnston, SL; Blasi, F; Black, PN; Martin, RJ; Farrell, DJ; Nieman, RB				Johnston, SL; Blasi, F; Black, PN; Martin, RJ; Farrell, DJ; Nieman, RB		TELICAST Investigators	The effect of telithromycin in acute exacerbations of asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO ACTIVITY; MYCOPLASMA-PNEUMONIAE; CHLAMYDIA-PNEUMONIAE; HMR 3647; KETOLIDE	BACKGROUND: We conducted a double-blind, randomized, placebo-controlled study to evaluate the efficacy of telithromycin in patients with acute exacerbations of asthma. METHODS: A total of 278 adults with diagnosed asthma were enrolled within 24 hours after an acute exacerbation of asthma requiring short-term medical care. The patients were randomly assigned to receive 10 days of oral treatment with telithromycin (at a dose of 800 mg daily) or placebo in addition to usual care. Primary efficacy end points were a change from baseline over the treatment period in symptoms (as recorded by patients in a diary card) and in the peak expiratory flow in the morning at home. The presence of Chlamydophila pneumoniae or Mycoplasma pneumoniae was ascertained by serologic analysis, polymerase chain reaction, and culture. RESULTS: Of the two prespecified primary outcomes, only asthma symptoms showed a significantly greater reduction among patients receiving telithromycin than among those receiving placebo. Mean (+/-SD) scores on a test of asthma symptoms (on a 7-point scale, with 0 denoting no symptoms and 6 denoting severe symptoms) were 3.0+/-1.4 at baseline and 1.7+/-1.1 at the end of treatment for the telithromycin group and 2.8+/-1.3 at baseline and 2.0+/-1.0 at the end of treatment for the placebo group. The mean decrease in symptom scores during the treatment period was 1.3 for telithromycin and 1.0 for placebo (mean difference, -0.3; 95 percent confidence interval, -0.5 to -0.1; P=0.004). There was no significant treatment effect on the other primary outcome measure, a change in morning peak expiratory flow. Nausea was more common among patients in the telithromycin group than in the placebo group (P=0.01). Although 61 percent of patients had evidence of infection with C. pneumoniae, M. pneumoniae, or both, there was no relationship between bacteriologic status and the response to asthma treatment. CONCLUSIONS: This study provides evidence of the benefit of telithromycin in patients with acute exacerbations of asthma; the mechanisms of benefit remain unclear.	Natl Heart & Lung Inst, Imperial Coll London, London W2 1PG, England; GR Micro, London, England; Univ Milan, Ist Ric & Cura Carattere Sci Policlin, Milan, Italy; Univ Auckland, Auckland 1, New Zealand; Natl Jewish Med & Res Ctr, Denver, CO USA; Sanofi Aventis, Bridgewater, NJ USA	Imperial College London; GR Micro Ltd.; University of Milan; University of Auckland; National Jewish Health; Sanofi-Aventis	Johnston, SL (corresponding author), Natl Heart & Lung Inst, Imperial Coll London, Norfolk Pl, London W2 1PG, England.	s.johnston@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012; BLASI, FRANCESCO B/O-5885-2017	Johnston, Sebastian Lennox/0000-0003-3009-9200; BLASI, FRANCESCO B/0000-0002-2285-9970				Ackermann G, 2003, J ANTIMICROB CHEMOTH, V51, P497, DOI 10.1093/jac/dkg123; Altman LC, 1998, J ALLERGY CLIN IMMUN, V102, P50, DOI 10.1016/S0091-6749(98)70054-5; Araujo FG, 2002, ANTIMICROB AGENTS CH, V46, P3327, DOI 10.1128/AAC.46.10.3327-3330.2002; Biscione GL, 2004, EUR RESPIR J, V24, P745, DOI 10.1183/09031936.04.00049004; Black PN, 2001, AM J RESP CRIT CARE, V164, P536, DOI 10.1164/ajrccm.164.4.2011040; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Carbon C, 2003, INFECTION, V31, P308, DOI 10.1007/s15010-003-3142-1; CLAY KD, IN PRESS ANN INTERN; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Dowell SF, 2001, CLIN INFECT DIS, V33, P492, DOI 10.1086/322632; *FDA, 2003, IN PRESS FDA ANT DRU, P96; FitzGerald JM, 2004, THORAX, V59, P550, DOI 10.1136/thx.2003.014936; *FOOD DRUG ADM, QUEST ANSW TEL MARK; GRAHAM V, 2001, COCHRANE DB SYST REV, V3; Hammerschlag MR, 2001, J ANTIMICROB CHEMOTH, V48, P25, DOI 10.1093/jac/48.suppl_2.25; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; NICOLAU DP, 2003, CLIN MICROBIOL INFEC, V9, P397; Roblin PM, 1998, ANTIMICROB AGENTS CH, V42, P1515, DOI 10.1128/AAC.42.6.1515; Santanello NC, 1997, EUR RESPIR J, V10, P646; Wark PAB, 2002, EUR RESPIR J, V20, P834, DOI 10.1183/09031936.02.00192002; Yamaguchi T, 2000, ANTIMICROB AGENTS CH, V44, P1381, DOI 10.1128/AAC.44.5.1381-1382.2000	23	208	222	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1589	1600		10.1056/NEJMoa044080	http://dx.doi.org/10.1056/NEJMoa044080			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611950				2022-12-28	WOS:000236736900007
J	Van Wassenbergh, S; Herrel, A; Adriaens, D; Huysentruyt, F; Devaere, S; Aerts, P				Van Wassenbergh, S; Herrel, A; Adriaens, D; Huysentruyt, F; Devaere, S; Aerts, P			A catfish that can strike its prey on land	NATURE			English	Article							CAPTURE		Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	University of Antwerp; Ghent University; Ghent University	Van Wassenbergh, S (corresponding author), Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium.	sam.vanwassenbergh@ua.ac.be	Huysentruyt, Frank/F-2809-2010; Herrel, Anthony/C-3712-2013; Adriaens, Dominique/G-1587-2010	Herrel, Anthony/0000-0003-0991-4434; Adriaens, Dominique/0000-0003-3610-2773; Aerts, Peter/0000-0002-6867-5421; Van Wassenbergh, Sam/0000-0001-5746-4621				Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; Bramble D.M., 1985, P230; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Huysentruyt F, 2004, BELG J ZOOL, V134, P41; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; SPONDER DL, 1981, J ZOOL, V193, P517; Summers AP, 1998, J EXP ZOOL, V281, P280, DOI 10.1002/(SICI)1097-010X(19980701)281:4<280::AID-JEZ4>3.0.CO;2-K; Van Wassenbergh S, 2005, J EXP BIOL, V208, P4627, DOI 10.1242/jeb.01919	9	33	34	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					881	881		10.1038/440881a	http://dx.doi.org/10.1038/440881a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612372				2022-12-28	WOS:000236736700028
J	Wooding, S; Bufe, B; Grassi, C; Howard, MT; Stone, AC; Vazquez, M; Dunn, DM; Meyerhof, W; Weiss, RB; Bamshad, MJ				Wooding, S; Bufe, B; Grassi, C; Howard, MT; Stone, AC; Vazquez, M; Dunn, DM; Meyerhof, W; Weiss, RB; Bamshad, MJ			Independent evolution of bitter-taste sensitivity in humans and chimpanzees	NATURE			English	Article							RECEPTOR GENE; STATISTICAL-METHOD; NATURAL-SELECTION; DIVERSITY; PHENYLTHIOCARBAMIDE; FAMILIES; TAS2R16; BONOBOS; LOCUS; TRAIT	It was reported over 65 years ago that chimpanzees, like humans, vary in taste sensitivity to the bitter compound phenylthiocarbamide (PTC)(1). This was suggested to be the result of a shared balanced polymorphism, defining the first, and now classic, example of the effects of balancing selection in great apes. In humans, variable PTC sensitivity is largely controlled by the segregation of two common alleles at the TAS2R38 locus, which encode receptor variants with different ligand affinities(2-4). Here we show that PTC taste sensitivity in chimpanzees is also controlled by two common alleles of TAS2R38; however, neither of these alleles is shared with humans. Instead, a mutation of the initiation codon results in the use of an alternative downstream start codon and production of a truncated receptor variant that fails to respond to PTC in vitro. Association testing of PTC sensitivity in a cohort of captive chimpanzees confirmed that chimpanzee TAS2R38 genotype accurately predicts taster status in vivo. Therefore, although Fisher et al.'s observations(1) were accurate, their explanation was wrong. Humans and chimpanzees share variable taste sensitivity to bitter compounds mediated by PTC receptor variants, but the molecular basis of this variation has arisen twice, independently, in the two species.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; German Inst Human Nutr Potsdam Rehbruecke, D-14558 Nuthetal, Germany; SW Fdn Biomed Res, Dept Comparat Med, San Antonio, TX 78245 USA; Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA	Utah System of Higher Education; University of Utah; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Texas Biomedical Research Institute; Arizona State University; Arizona State University-Tempe	Wooding, S (corresponding author), Univ Utah, Dept Human Genet, 15 N 2030 E, Salt Lake City, UT 84112 USA.	swooding@genetics.utah.edu; mbamshad@u.washington.edu	Stone, Anne C/B-5719-2009; Bufe, Bernd/N-6685-2018	Bufe, Bernd/0000-0003-1610-0658; Stone, Anne/0000-0001-8021-8314				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P506, DOI 10.1093/ajcn/62.3.506; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; KAPLAN AR, 1964, NATURE, V202, P1366, DOI 10.1038/2021366a0; Kim JK, 2004, REAL-TIME SYST, V26, P199, DOI 10.1023/B:TIME.0000016130.91111.75; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Parry CM, 2004, P NATL ACAD SCI USA, V101, P14830, DOI 10.1073/pnas.0404894101; Schneider JA, 2003, MECH AGEING DEV, V124, P17, DOI 10.1016/S0047-6374(02)00165-3; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Ueda T, 2003, J NEUROSCI, V23, P7376; Wang XX, 2004, HUM MOL GENET, V13, P2671, DOI 10.1093/hmg/ddh289; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yu N, 2003, GENETICS, V164, P1511	30	97	102	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					930	934		10.1038/nature04655	http://dx.doi.org/10.1038/nature04655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612383				2022-12-28	WOS:000236736700040
J	Monnier, L; Mas, E; Ginet, C; Michel, F; Villon, L; Cristol, JP; Colette, C				Monnier, L; Mas, E; Ginet, C; Michel, F; Villon, L; Cristol, JP; Colette, C			Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VIVO FORMATION; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; POSTPRANDIAL HYPERGLYCEMIA; MACROVASCULAR DISEASE; ISOPROSTANE FORMATION; PLATELET ACTIVATION; MASS-SPECTROMETRY; METABOLIC-CONTROL; BLOOD-GLUCOSE	Context Glycemic disorders, one of the main risk factors for cardiovascular disease, are associated with activation of oxidative stress. Objective To assess the respective contributions of sustained chronic hyperglycemia and of acute glucose fluctuations to oxidative stress in type 2 diabetes. Design, Setting, and Participants Case-control study of 21 patients with type 2 diabetes (studied 2003-2005) compared with 21 age- and sex-matched controls (studied in 2001) in Montpellier, France Main Outcome Measures Oxidative stress, estimated from 24-hour urinary excretion rates of free 8-iso prostaglandin F-2 alpha (8-iso PGF(2 alpha)). Assessment of glucose fluctuations was obtained from continuous glucose monitoring system data by calculating the mean amplitude of glycemic excursions (MAGE). Postprandial contribution to glycemic instability was assessed by determining the postprandial increment of glucose level above preprandial values (mean postprandial incremental area under the curve [AUCpp]). Long-term exposure to glucose was estimated from hemoglobin A(1c), from fasting glucose levels, and from mean glucose concentrations over a 24-hour period. Results Mean (SD) urinary 8-iso PGF(2 alpha) excretion rates were higher in the 21 patients with diabetes (482 [206] pg/mg of creatinine) compared with controls (275 [ 85] pg/mg of creatinine). In univariate analysis, only MAGE (r = 0.86; P < .001) and AUCpp (r = 0.55; P = .009) showed significant correlations with urinary 8-iso PGF(2 alpha) excretion rates. Relationships between 8-iso PGF(2 alpha) excretion rates and either MAGE or AUCpp remained significant after adjustment for the other markers of diabetic control in multiple linear regression analysis (multiple R-2 = 0.72 for the model including MAGE and multiple R-2 = 0.41 for the model including AUCpp). Standardized regression coefficients were 0.830 (P < .001) for MAGE and 0.700 (P = .003) for AUCpp. Conclusions Glucose fluctuations during postprandial periods and, more generally, during glucose swings exhibited a more specific triggering effect on oxidative stress than chronic sustained hyperglycemia. The present data suggest that interventional trials in type 2 diabetes should target not only hemoglobin A(1c) and mean glucose concentrations but also acute glucose swings.	Univ Montpellier, Lapeyronie Hosp, Dept Metab Dis, F-34295 Montpellier 5, France; Univ Montpellier, Univ Inst Clin Res, Lab Human Nutr & Atherogenesis, F-34295 Montpellier 5, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Monnier, L (corresponding author), Univ Montpellier, Lapeyronie Hosp, Dept Metab Dis, 371 Ave Doyen Giraud, F-34295 Montpellier 5, France.	l-monnier@chu-montpellier.fr						[Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1995, DIABETES, V44, P968; Basu S, 2005, ANTIOXID REDOX SIGN, V7, P221, DOI 10.1089/ars.2005.7.221; Basu S, 1998, FEBS LETT, V428, P32, DOI 10.1016/S0014-5793(98)00481-5; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bessard J, 2001, J CHROMATOGR B, V754, P333, DOI 10.1016/S0378-4347(00)00621-6; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Ceriello A, 2003, DIABETOLOGIA, V46, pM9, DOI 10.1007/s00125-002-0931-5; Ceriello A, 2002, DIABETES CARE, V25, P1439, DOI 10.2337/diacare.25.8.1439; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Davi G, 2003, CIRCULATION, V107, P3199, DOI 10.1161/01.CIR.0000074205.17807.D0; Davi G, 1999, CIRCULATION, V99, P224; Davi G, 1997, ARTERIOSCL THROM VAS, V17, P3230, DOI 10.1161/01.ATV.17.11.3230; Desideri G, 2003, J CLIN ENDOCR METAB, V88, P5341, DOI 10.1210/jc.2003-030724; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Fava D, 2002, DIABETIC MED, V19, P752, DOI 10.1046/j.1464-5491.2002.00762.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Guerci B, 2003, DIABETES CARE, V26, P582, DOI 10.2337/diacare.26.3.582; Jokl R, 1997, DIABETES REV, V5, P316; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; Laakso M, 1997, DIABETES REV, V5, P294; Lyons TJ, 1997, DIABETES REV, V5, P365; Metzger M, 2002, DIABETES CARE, V25, P1185, DOI 10.2337/diacare.25.7.1185; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Monnier L, 2004, EUR J CLIN INVEST, V34, P37, DOI 10.1111/j.1365-2362.2004.01280.x; Monnier L, 2002, DIABETES CARE, V25, P737, DOI 10.2337/diacare.25.4.737; MONNIER LH, 1984, DIABETES, V33, P907, DOI 10.2337/diabetes.33.9.907; Monsod TP, 2002, DIABETES CARE, V25, P889, DOI 10.2337/diacare.25.5.889; Montero A, 2000, KIDNEY INT, V58, P1963, DOI 10.1111/j.1523-1755.2000.00368.x; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Patrono C, 2005, CURR OPIN PHARMACOL, V5, P198, DOI 10.1016/j.coph.2004.11.003; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Sampson MJ, 2002, DIABETES CARE, V25, P537, DOI 10.2337/diacare.25.3.537; Schwedhelm E, 2003, CLIN CHEM LAB MED, V41, P1552, DOI 10.1515/CCLM.2003.238; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; SERVICE FJ, 1987, DIABETES CARE, V10, P225, DOI 10.2337/diacare.10.2.225; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-00036; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; TROVATI M, 1991, DIABETOLOGIA, V34, P662, DOI 10.1007/BF00400996; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zar J.H., 1996, BIOSTAT ANAL	55	1612	1806	5	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1681	1687		10.1001/jama.295.14.1681	http://dx.doi.org/10.1001/jama.295.14.1681			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609090	Bronze			2022-12-28	WOS:000236707300024
J	Shelton, JD; Halperin, DT; Wilson, D				Shelton, JD; Halperin, DT; Wilson, D			Has global HIV incidence peaked?	LANCET			English	Editorial Material							PARTNER REDUCTION; PREVENTION; PREVALENCE; AFRICA		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA; US Agcy Int Dev, So Africa Reg HIV AIDS Program, Mbabane, Swaziland; World Bank, Global HIV AIDS Program, Washington, DC 20433 USA	United States Agency for International Development (USAID); United States Agency for International Development (USAID); The World Bank	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	JShelton@usaid.gov						Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; BELLO GA, IN PRESS SEX TRANSMI; CHELUGET B, IN PRESS SEX TRANS S; GAILALRD EM, IN PRESS SEX TRANS S; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; HLADIK W, IN PRESS SEX TRANS S; KAYIRINGWA E, IN PRESS SEX TRANSMI; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; MAHOMVA A, IN PRESS SEX TRANS S; NELSON KE, 1996, NEW ENGL J MED, V335, P343; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; The Ministry of Health of the People's Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, 2006, 2005 UPD HIV AIDS EP; *UNAIDS WHO, 2005, AIDS EP UPD SPEC REP; *US BUR CENS, 2004, HIV AIDS SURV DAT BA; Wilson D, 2004, BRIT MED J, V328, P848, DOI 10.1136/bmj.328.7444.848	15	30	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2006	367	9517					1120	1122		10.1016/S0140-6736(06)68436-5	http://dx.doi.org/10.1016/S0140-6736(06)68436-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030ZH	16616543				2022-12-28	WOS:000236673400005
J	Lawrence, KT; Liu, ZH; Herbert, TD				Lawrence, KT; Liu, ZH; Herbert, TD			Evolution of the eastern tropical Pacific through Plio-Pleistocene glaciation	SCIENCE			English	Article							ATLANTIC REGION; CLIMATE; PLIOCENE; OCEAN; THERMOCLINE; INTENSIFICATION; STRATIFICATION; CALIBRATION; WARMTH; SHIFTS	A tropical Pacific climate state resembling that of a permanent El Nino is hypothesized to have ended as a result of a reorganization of the ocean heat budget similar to 3 million years ago, a time when large ice sheets appeared in the high latitudes of the Northern Hemisphere. We report a high-resolution alkenone reconstruction of conditions in the heart of the eastern equatorial Pacific (EEP) cold tongue that reflects the combined influences of changes in the equatorial thermocline, the properties of the thermocline's source waters, atmospheric greenhouse gas content, and orbital variations on sea surface temperature (SST) and biological productivity over the past 5 million years. Our data indicate that the intensification of Northern Hemisphere glaciation similar to 3 million years ago did not interrupt an almost monotonic cooling of the EEP during the Plio-Pleistocene. SST and productivity in the eastern tropical Pacific varied in phase with global ice volume changes at a dominant 41,000-year (obliquity) frequency throughout this time. Changes in the Southern Hemisphere most likely modulated most of the changes observed.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Lawrence, KT (corresponding author), Brown Univ, Dept Geol Sci, Box 1846, Providence, RI 02912 USA.	kira_lawrence@brown.edu	Liu, Zhonghui/D-3163-2009	Liu, Zhonghui/0000-0002-2168-8305				Budziak D, 2000, PALEOCEANOGRAPHY, V15, P307, DOI 10.1029/1999PA000433; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Cortese G, 2004, EARTH PLANET SC LETT, V224, P509, DOI 10.1016/j.epsl.2004.05.035; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; Haywood AM, 2000, GLOBAL PLANET CHANGE, V25, P239, DOI 10.1016/S0921-8181(00)00028-X; Haywood AM, 2004, EARTH PLANET SC LETT, V218, P363, DOI 10.1016/S0012-821X(03)00685-X; IMBRIE J, 1984, MILANKOVITCH CLIMA 1; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Lisiecki LE, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000733; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; Maslin MA, 1996, GEOL RUNDSCH, V85, P452, DOI 10.1007/BF02369002; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P839, DOI 10.2973/odp.proc.sr.138.160.1995; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Rickaby REM, 2005, SCIENCE, V307, P1948, DOI 10.1126/science.1104666; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Sicre MA, 2001, ORG GEOCHEM, V32, P981, DOI 10.1016/S0146-6380(01)00061-4; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Spero HJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000814; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; TSUCHIYA M, 1989, PROG OCEANOGR, V23, P101, DOI 10.1016/0079-6611(89)90012-8; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	33	253	267	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					79	83		10.1126/science.1120395	http://dx.doi.org/10.1126/science.1120395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601186				2022-12-28	WOS:000236584400033
J	Teo, HL; Gill, DJ; Sun, J; Perisic, O; Veprintsev, DB; Vallis, Y; Emr, SD; Williams, RL				Teo, HL; Gill, DJ; Sun, J; Perisic, O; Veprintsev, DB; Vallis, Y; Emr, SD; Williams, RL			ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes	CELL			English	Article							MULTIVESICULAR BODY PATHWAY; ENDOSOME-ASSOCIATED COMPLEX; SORTING COMPLEX; PROTEIN-TRANSPORT; UBIQUITIN; TSG101; BINDING; YEAST; RECOGNITION; HRS	ESCRT complexes form the main machinery driving protein sorting from endosomes to lysosomes. Currently, the picture regarding assembly of ESCRTs on endosomes is incomplete. The structure of the conserved heterotrimeric ESCRT-I core presented here shows a fan-like arrangement of three helical hairpins, each corresponding to a different subunit. Vps23/Tsg101 is the central hairpin sandwiched between the other subunits, explaining the critical role of its "steadiness box" in the stability of ESCRT-I. We show that yeast ESCRT-I links directly to ESCRT-II, through a tight interaction of Vps28 (ESCRT-I) with the yeast-specific zinc-finger insertion within the GLUE domain of Vps36 (ESCRT-II). The crystal structure of the GLUE domain missing this insertion reveals it is a split PH domain, with a noncanonical lipid binding pocket that binds Ptdlns3P. The simultaneous and reinforcing interactions of ESCRT-II GLUE domain with membranes, ESCRT-II, and ubiquitin are critical for ubiquitinated cargo progression from early to late endosomes.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Ctr Prot Engn, Cambridge CB2 2QH, England; Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	MRC Laboratory Molecular Biology; University of Cambridge; Howard Hughes Medical Institute; University of California System; University of California San Diego	Teo, HL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hlt@mrc-lmb.cam.ac.uk; rlw@mrc-lmb.cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Gill, David/H-7691-2013	Veprintsev, Dmitry B/0000-0002-3583-5409; Gill, David/0000-0002-0937-9737; Perisic, Olga/0000-0002-3842-2896; Teo, Hsiang Ling/0000-0002-3849-809X; Williams, Roger/0000-0001-7754-4207	MRC [MC_U105184308, MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795, MC_U105184308] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Di Lello P, 2005, BIOCHEMISTRY-US, V44, P7678, DOI 10.1021/bi050099s; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Feng GH, 2000, CANCER RES, V60, P1736; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Johnson MC, 2005, J VIROL, V79, P3775, DOI 10.1128/JVI.79.6.3775-3786.2005; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Puertollano R, 2005, J BIOL CHEM, V280, P9258, DOI 10.1074/jbc.M412481200; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schug S A, 1993, Pharmacoeconomics, V3, P260, DOI 10.2165/00019053-199303040-00002; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	65	157	161	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					99	111		10.1016/j.cell.2006.01.047	http://dx.doi.org/10.1016/j.cell.2006.01.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615893	Bronze			2022-12-28	WOS:000237314200017
J	Vilenkin, A				Vilenkin, Alexander			The vacuum energy crisis	SCIENCE			English	Editorial Material									Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA	Tufts University	Vilenkin, A (corresponding author), Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.	vilenkin@cosmos.phy.tufts.edu						Bludman SA, 2000, NUCL PHYS A, V663, p865C, DOI 10.1016/S0375-9474(99)00733-2; EFSTATHIOU G, 1995, MON NOT R ASTRON SOC, V274, pL73, DOI 10.1093/mnras/274.1.L73; Garriga J, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.023503; LINDE AD, 1987, 300 YEARS GRAVITATIO; Livio M, 2005, SCIENCE, V309, P1022, DOI 10.1126/science.1111446; Martel H, 1998, ASTROPHYS J, V492, P29, DOI 10.1086/305016; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Steinhardt PJ, 2006, SCIENCE, V312, P1180, DOI 10.1126/science.1126231; Steinhardt PJ, 2002, SCIENCE, V296, P1436, DOI 10.1126/science.1070462; VILENKIN A, 1995, PHYS REV LETT, V74, P846, DOI 10.1103/PhysRevLett.74.846; WEINBERG S, 1987, PHYS REV LETT, V59, P2607, DOI 10.1103/PhysRevLett.59.2607	13	7	7	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1148	1149		10.1126/science.1128570	http://dx.doi.org/10.1126/science.1128570			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16675664	Green Submitted			2022-12-28	WOS:000237957400031
J	Boyer, LA; Plath, K; Zeitlinger, J; Brambrink, T; Medeiros, LA; Lee, TI; Levine, SS; Wernig, M; Tajonar, A; Ray, MK; Bell, GW; Otte, AP; Vidal, M; Gifford, DK; Young, RA; Jaenisch, R				Boyer, LA; Plath, K; Zeitlinger, J; Brambrink, T; Medeiros, LA; Lee, TI; Levine, SS; Wernig, M; Tajonar, A; Ray, MK; Bell, GW; Otte, AP; Vidal, M; Gifford, DK; Young, RA; Jaenisch, R			Polycomb complexes repress developmental regulators in murine embryonic stem cells	NATURE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; DNA METHYLATION; EARLY EMBRYOGENESIS; MOUSE DEVELOPMENT; GENE-EXPRESSION; PROTEIN; EZH2; ENHANCER; OCT-3/4	The mechanisms by which embryonic stem (ES) cells self-renew while maintaining the ability to differentiate into virtually all adult cell types are not well understood. Polycomb group (PcG) proteins are transcriptional repressors that help to maintain cellular identity during metazoan development by epigenetic modification of chromatin structure(1). PcG proteins have essential roles in early embryonic development(2-6) and have been implicated in ES cell pluripotency(2), but few of their target genes are known in mammals. Here we show that PcG proteins directly repress a large cohort of developmental regulators in murine ES cells, the expression of which would otherwise promote differentiation. Using genome-wide location analysis in murine ES cells, we found that the Polycomb repressive complexes PRC1 and PRC2 co-occupied 512 genes, many of which encode transcription factors with important roles in development. All of the co-occupied genes contained modified nucleosomes (trimethylated Lys 27 on histone H3). Consistent with a causal role in gene silencing in ES cells, PcG target genes were de-repressed in cells deficient for the PRC2 component Eed, and were preferentially activated on induction of differentiation. Our results indicate that dynamic repression of developmental pathways by Polycomb complexes may be required for maintaining ES cell pluripotency and plasticity during embryonic development.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; CSIC, Dev & Cell Biol Ctr Invest Biol, E-28040 Madrid, Spain; MIT, Comp Sci Lab, Cambridge, MA 02139 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Young, Richard A/F-6495-2012; Vidal, Miguel/M-8861-2016	Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X; Vidal, Miguel/0000-0003-4374-6761; Plath, Kathrin/0000-0001-7796-3372	NHGRI NIH HHS [R01 HG002668, R01 HG002668-03] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100	26	1928	2014	4	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					349	353		10.1038/nature04733	http://dx.doi.org/10.1038/nature04733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16625203				2022-12-28	WOS:000237593200048
J	Zhu, M; Yu, XB; Wang, W; Zhao, WJ; Jia, LT				Zhu, M; Yu, XB; Wang, W; Zhao, WJ; Jia, LT			A primitive fish provides key characters bearing on deep osteichthyan phylogeny	NATURE			English	Article							LUNGFISH; AUSTRALIA; COSMINE	Osteichthyans, or bony vertebrates, include actinopterygians (teleosts and their relatives) and sarcopterygians (coelacanths, lungfishes and tetrapods). Despite features found in basal actinopterygians (for example, Dialipina and Ligulalepis)(1-3) and basal sarcopterygians (for example, Psarolepis and Achoania)(4,5), the morphological gap between the two lineages remains wide and how sarcopterygians developed a dermal surface covering known as cosmine (composed of a pore-canal network and a single layer of odontodes and enamel) is still poorly known(6-10). Here we describe a primitive fossil fish, Meemannia eos gen. et sp. nov., that possesses an actinopterygian-like skull roof and a cosmine-like dermal surface combining a pore-canal network (found in various fossil sarcopterygians) with superimposed layers of odontodes and enamel (previously known in actinopterygians and some acanthodians(11-13)). This 405-million-year-old fish from the Lower Devonian of Yunnan (China) demonstrates that cosmine in many fossil sarcopterygians arose step by step through the acquisition of a pore-canal network followed by the subsequently developed ability to resorb previous generations of odontodes and enamel. Meemannia provides key characters for studying deep osteichthyan phylogeny and indicates a possible morphotype for the common ancestor of actinopterygians and sarcopterygians.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Kean Univ, Dept Biol Sci, Union, NJ 07083 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhumin@ivpp.ac.cn	Zhu, Min/E-8728-2012; Yu, Xiaobo/G-7160-2011; min, zhu/AAL-6712-2021	Zhu, Min/0000-0002-4786-0898; Yu, Xiaobo/0000-0001-9600-7888; Zhao, Wenjin/0000-0002-9649-2171				Arratia Gloria, 1996, P165; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; BEMIS WE, 1992, ACTA ZOOL-STOCKHOLM, V73, P115, DOI 10.1111/j.1463-6395.1992.tb00956.x; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Gross W., 1971, Palaeontographica A, V136, P1; GROSS WALTER, 1956, K SVENSKA VETENSKAPSAKAD HANDL, V5, P1; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jessen HL, 1975, C INT CTR NATIONAL R, V218, P213; Long M., 1988, U HAWAII WORKING PAP, V7, P1; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Meinke D.K., 1984, Journal of Vertebrate Paleontology, V4, P457; MEINKE D K, 1987, P133; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; ORVIG T, 1969, LETHAIA, V2, P241, DOI 10.1111/j.1502-3931.1969.tb01850.x; PEARSON D M, 1979, Transactions of the Royal Society of Edinburgh, V70, P337; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; SCHULTZE HP, 1992, FOSSIL FISHES LIVING, P233; SMITH MM, 1990, BIOL REV, V65, P277, DOI 10.1111/j.1469-185X.1990.tb01427.x; SWOFFORD DL, 2003, PAUP PHYLOGENETIC AN; Taverne Louis, 1997, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V67, P57; Thomson K.S., 1975, Bulletin Peabody Mus nat Hist, VNo. 40, P1; Thomson KS, 1977, PROBLEMS VERTEBRATE, P247; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078	30	74	78	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					77	80		10.1038/nature04563	http://dx.doi.org/10.1038/nature04563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672968				2022-12-28	WOS:000237248600035
J	Feder, S; Matheny, RL; Loveless, RS; Rea, TD				Feder, S; Matheny, RL; Loveless, RS; Rea, TD			Withholding resuscitation: A new approach to prehospital end-of-life decisions	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIAC-ARREST	Background: Emergency medical services (EMS) personnel often are not permitted to honor requests to withhold resuscitation at the end of life, particularly if there is no written do-not-resuscitate (DNR) order. Objective: To determine whether EMS personnel from agencies implementing new guidelines would be more likely to withhold resuscitation from persons having out-of-hospital cardiac arrests than would personnel from agencies that did not implement the guidelines. Design: Observational study in which 16 of 35 local EMS agencies volunteered to implement new guidelines for withholding resuscitation. Setting: King County, Washington. Patients: 2770 patients with EMS-attended cardiac arrest. Intervention: New guidelines adopted by participating agencies permitted EMS personnel to withhold resuscitation if the patient had a terminal condition and if the patient, family, or caregivers indicated, in writing or verbally, that no resuscitation was desired. Measurements: Proportion of resuscitations withheld in agencies that implemented new guidelines compared with those that did not. Results: Emergency medical services personnel from agencies implementing new guidelines withheld resuscitation in 11.8% of patients (99 of 841 patients) having cardiac arrests, compared with an average of 5.3% (range, 4.2% to 5.9%) of patients (103 of 1929 patients) in 3 historical and contemporary control groups. Honoring verbal requests alone accounted for 53% of withheld resuscitations in the intervention group (52 of 99 patients) compared with an average of 8% (range, 7% to 9%) in the control groups (8 of 103 patients). Limitations: The study was not a randomized, controlled trial; individual agencies chose whether to implement the guidelines. Conclusions: Implementation of new guidelines was associated with an increase in the number of resuscitations withheld by EMS personnel. This increase was primarily due to honoring verbal requests.			Feder, S (corresponding author), King Cty Med 1,7064 S 220th St, Kent, WA 98032 USA.	sylvia_feder@kcfiremed.org						Becker Linda J, 2003, Prehosp Emerg Care, V7, P303, DOI 10.1080/10903120390936464; DULL SM, 1994, ANN EMERG MED, V23, P997, DOI 10.1016/S0196-0644(94)70093-1; Guru V, 1999, CAN MED ASSOC J, V161, P1251; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Marco CA, 2003, J EMERG MED, V24, P101, DOI 10.1016/S0736-4679(02)00688-1; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Sabatino CP, 1999, J LAW MED ETHICS, V27, P297, DOI 10.1111/j.1748-720X.1999.tb01465.x; Silveira MJ, 2003, J AM GERIATR SOC, V51, P1435, DOI 10.1046/j.1532-5415.2003.51462.x	9	35	36	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					634	640		10.7326/0003-4819-144-9-200605020-00006	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	039GJ	16670132				2022-12-28	WOS:000237293700002
J	Steensma, DP				Steensma, DP			Working against the grain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Steensma, DP (corresponding author), Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA.	Steensma.david@mayo.edu		Steensma, David/0000-0001-5130-9284					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					697	698		10.7326/0003-4819-144-9-200605020-00016	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039GJ	16670142				2022-12-28	WOS:000237293700012
J	King, AW; Gunderson, CA; Post, WM; Weston, DJ; Wullschleger, SD				King, AW; Gunderson, CA; Post, WM; Weston, DJ; Wullschleger, SD			Atmosphere - Plant respiration in a warmer world	SCIENCE			English	Editorial Material							CARBON-CYCLE; TEMPERATURE; CLIMATE; ACCLIMATION; Q(10); MODEL		Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	King, AW (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	kingaw@ornl.gov	Weston, David/A-9116-2011; Post, Wilfred M/B-8959-2012; Wullschleger, Stan D/B-8297-2012	Weston, David/0000-0002-4794-9913; Wullschleger, Stan D/0000-0002-9869-0446; Post, Wilfred/0000-0002-1410-8499				Amthor Jeffrey S., 1994, P501; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DEVRIES FWT, 1975, ANN BOTANY, V39, P77; Forward D. F, 1960, ENCY PLANT PHYSL, P234; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Wythers KR, 2005, GLOBAL CHANGE BIOL, V11, P435, DOI 10.1111/j.1365-2486.2005.00922.x	12	105	115	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					536	537		10.1126/science.1114166	http://dx.doi.org/10.1126/science.1114166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645083				2022-12-28	WOS:000237296700030
J	Manning, SW; Ramsey, CB; Kutschera, W; Higham, T; Kromer, B; Steier, P; Wild, EM				Manning, SW; Ramsey, CB; Kutschera, W; Higham, T; Kromer, B; Steier, P; Wild, EM			Chronology for the Aegean Late Bronze Age 1700-1400 BC	SCIENCE			English	Article							TREE-RINGS; RADIOCARBON CALIBRATION; MINOAN ERUPTION; SANTORINI; C-14; RECORDS; PROVIDE	Radiocarbon (carbon-14) data from the Aegean Bronze Age 1700-1400 B.C. show that the Santorini (Thera) eruption must have occurred in the late 17th century B.C. By using carbon-14 dates from the surrounding region, cultural phases, and Bayesian statistical analysis, we established a chronology for the initial Aegean Late Bronze Age cultural phases (Late Minoan IA, IB, and II). This chronology contrasts with conventional archaeological dates and cultural synthesis: stretching out the Late Minoan IA, IB, and II phases by similar to 100 years and requiring reassessment of standard interpretations of associations between the Egyptian and Near Eastern historical dates and phases and those in the Aegean and Cyprus in the mid-second millennium B.C.	Cornell Univ, Dept Classics, Ithaca, NY 14853 USA; Univ Reading, Sch Human & Environm Sci, Dept Archaeol, Reading RG6 6AB, Berks, England; Univ Oxford, Oxford Radiocarbon Accelerator Unit, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; Univ Vienna, Vienna Environm Res Accelerator Lab, Inst Isotopenforsch & Kernphys, A-1090 Vienna, Austria; Heidelberg Univ, Inst Umweltphys, Heidelberger Akad Wissensch, D-69120 Heidelberg, Germany	Cornell University; University of Reading; University of Oxford; University of Vienna; Ruprecht Karls University Heidelberg	Manning, SW (corresponding author), Cornell Univ, Dept Classics, 120 Goldwin Smith Hall, Ithaca, NY 14853 USA.	sm456@cornell.edu	Ramsey, Christopher Bronk/A-3277-2012; Ramsey, Christopher Bronk/AAQ-2227-2021; Steier, Peter/AAZ-6043-2020; Higham, Tom/Y-2707-2019	Ramsey, Christopher Bronk/0000-0002-8641-9309; Ramsey, Christopher Bronk/0000-0002-8641-9309; Higham, Tom/0000-0002-5949-598X				BAILLIE MGL, 1988, NATURE, V332, P344, DOI 10.1038/332344a0; BETANCOURT PP, 1987, ARCHAEOMETRY, V29, P45, DOI 10.1111/j.1475-4754.1987.tb00396.x; BETANCOURT PP, 1976, AM J ARCHAEOL, V80, P329, DOI 10.2307/503574; BIETAK M, 2001, SYNCHRONISATION CIVI, V2, P23; BRUNS M, 1980, RADIOCARBON, V22, P532, DOI 10.1017/S0033822200009851; CADOGAN G, 1978, ARCHAEOMETRY, V20, P209, DOI 10.1111/j.1475-4754.1978.tb00234.x; Clausen HB, 1997, J GEOPHYS RES-OCEANS, V102, P26707, DOI 10.1029/97JC00587; Doumas C. D, 1992, WALL PAINTINGS THERA; Friedrich WL, 2006, SCIENCE, V312, P548, DOI 10.1126/science.1125087; FRIEDRICH WL, 1990, THERA AEGEAN WORLD 3, P188; Grudd H, 2000, GEOPHYS RES LETT, V27, P2957, DOI 10.1029/1999GL010852; HAMMER CU, 1987, NATURE, V328, P517, DOI 10.1038/328517a0; HAMMER CU, 2001, SYNCHRONISATION CIVI, V2, P87; HARDY DA, 1990, THERA AEGEAN WORLD 3; Housley R. A., 1990, THERA AEGEAN WORLD, V3, P207; HUBBERTON HW, 1990, THERA AEGEAN WORLD 3, P179; Kitchen K. A., 2000, SYNCHRONISATION CIVI, P39; LAMARCHE VC, 1984, NATURE, V307, P121, DOI 10.1038/307121a0; Manning S. W., 1999, TEST TIME VOLCANO TH; MANNING SW, 1990, ARCHAEOMETRY, V32, P91, DOI 10.1111/j.1475-4754.1990.tb01085.x; Manning SW, 2002, RADIOCARBON, V44, P739, DOI 10.1017/S0033822200032197; Manning SW, 2001, SCIENCE, V294, P2532, DOI 10.1126/science.1066112; MANNING SW, 1992, ANTIQUITY, V66, P636, DOI 10.1017/S0003598X00039351; Manning SW, 2001, ANTIQUITY, V75, P328, DOI 10.1017/S0003598X00060981; MANNING SW, 2001, SYNCHRONISATION CIVI, V2, P111; Oren E. D., 1997, HYKSOS NEW HIST ARCH; Pasquier-Cardin A, 1999, J VOLCANOL GEOTH RES, V92, P195, DOI 10.1016/S0377-0273(99)00076-1; Pearce NJG, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000672; Ramsey CB, 2004, RADIOCARBON, V46, P325, DOI 10.1017/S0033822200039631; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Sigurdsson H, 1990, THERA AEGEAN WORLD 3, V3, P100; Southon J, 2004, RADIOCARBON, V46, P1239, DOI 10.1017/S0033822200033129; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; von Beckerath J, 1997, CHRONOLOGIE PHARAONI; WARREN P, 1984, NATURE, V308, P492, DOI 10.1038/308492a0; Warren Peter, 1989, AEGEAN BRONZE AGE CH; WARREN PM, 1987, ARCHAEOMETRY, V29, P205, DOI 10.1111/j.1475-4754.1987.tb00412.x; WARREN PM, 2006, TIMELINES STUDIES HO, V2, P305; WARREN PM, 1998, STUDIES SARDINIAN AR, V5, P323; WARREN PM, 1999, MELETEMATA STUDIES A, P893; WIENER MH, 2006, TIMELINES STUDIES HO, V3, P317; WIENER MH, 2003, METRON MEASURING AEG, P363; Zielinski GA, 1998, J ARCHAEOL SCI, V25, P279, DOI 10.1006/jasc.1997.0227	45	136	139	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					565	569		10.1126/science.1125682	http://dx.doi.org/10.1126/science.1125682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	039HN	16645092				2022-12-28	WOS:000237296700042
J	Dloniak, SM; French, JA; Holekamp, KE				Dloniak, SM; French, JA; Holekamp, KE			Rank-related maternal effects of androgens on behaviour in wild spotted hyaenas	NATURE			English	Article							HYENA CROCUTA-CROCUTA; SOCIAL-STATUS; FETAL LIFE; TESTOSTERONE; MASCULINIZATION; YOLK; REPRODUCTION; AGGRESSION; DOMINANCE; FEMALES	Within any hierarchical society, an individual's social rank can have profound effects on its health and reproductive success(1,2), and rank-related variation in these traits is often mediated by variation in endocrine function(2). Maternal effects mediated by prenatal hormone exposure are potentially important for non-genetic inheritance of phenotypic traits related to social rank(3), and thus for shaping individual variation in behaviour and social structure. Here we show that androgen concentrations in wild female spotted hyaenas (Crocuta crocuta) are higher during late gestation in dominant females than in subordinate females. Furthermore, both male and female cubs born to mothers with high concentrations of androgens in late pregnancy exhibit higher rates of aggression and mounting behaviour than cubs born to mothers with lower androgen concentrations. Both behaviours are strongly affected in other mammals by organizational effects of androgens(4), and both have important effects on fitness in hyaenas. Therefore, our results suggest that rank-related maternal effects of prenatal androgen exposure can adaptively influence offspring phenotype in mammals, as has previously been shown to occur in birds. They also suggest an organizational mechanism for the development of female dominance and aggressiveness in spotted hyaenas, traits that may offset the costs of extreme virilization.	Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; Univ Nebraska, Dept Psychol, Omaha, NE 68182 USA; Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Michigan State University; University of Nebraska System; University of Nebraska System	Dloniak, SM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	dloniak@kenyaweb.co	Holekamp, Kay E/G-6054-2010; French, Jeffrey/F-1779-2011	French, Jeffrey/0000-0001-5304-1592				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Becker JB., 2002, BEHAV ENDOCRINOLOGY, P1; Clutton-Brock T. H., 1988, REPROD SUCCESS; Dloniak SM, 2004, GEN COMP ENDOCR, V135, P51, DOI 10.1016/j.ygcen.2003.08.011; Drea CM, 2002, P ROY SOC B-BIOL SCI, V269, P1981, DOI 10.1098/rspb.2002.2109; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Frank Laurence G., 1996, P78; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; FRANK LG, 1995, NATURE, V377, P584, DOI 10.1038/377584b0; GOY RW, 1988, HORM BEHAV, V22, P552, DOI 10.1016/0018-506X(88)90058-X; Goymann W, 1999, GEN COMP ENDOCR, V114, P340, DOI 10.1006/gcen.1999.7268; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; KRUUK H, 1972, SPOTTED HYENA; Licht P, 1998, J REPROD FERTIL, V113, P105; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Marchlewska-Koj A, 2003, PHYSIOL BEHAV, V79, P671, DOI 10.1016/S0031-9384(03)00168-9; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; SMALE L, 1993, ANIM BEHAV, V46, P467, DOI 10.1006/anbe.1993.1215; Szykman M, 2003, AGGRESSIVE BEHAV, V29, P457, DOI 10.1002/ab.10065; Whittingham LA, 2002, ANIM BEHAV, V63, P63, DOI 10.1006/anbe.2001.1889; YALCINKAYA TM, 1993, SCIENCE, V260, P1929, DOI 10.1126/science.8391165	27	134	138	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1190	1193		10.1038/nature04540	http://dx.doi.org/10.1038/nature04540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641996				2022-12-28	WOS:000237080000045
J	Itkis, ME; Borondics, F; Yu, AP; Haddon, RC				Itkis, ME; Borondics, F; Yu, AP; Haddon, RC			Bolometric infrared photoresponse of suspended single-walled carbon nanotube films	SCIENCE			English	Article							TRANSPARENT; SENSORS; PHOTOCONDUCTIVITY; EXCITONS	The photoresponse in the electrical conductivity of a single-walled carbon nanotube (SWNT) film is dramatically enhanced when the nanotube film is suspended in vacuum. We show here that the change in conductivity is bolometric (caused by heating of the SWNT network). Electron-phonon interactions lead to ultrafast relaxation of the photoexcited carriers, and the energy of the incident infrared OR) radiation is efficiently transferred to the crystal lattice. It is not the presence of photoexcited holes and electrons, but a rise in temperature, that results in a change in resistance, thus, photoconductivity experiments cannot be used to support the band picture over the exciton model of excited states in carbon nanotubes. The photoresponse of suspended SWNT films is sufficiently high that they may function as the sensitive element of an IR bolometric detector.	Univ Calif Riverside, Dept Chem, Ctr Nanoscale Sci & Engn, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Environm Chem & Engn, Ctr Nanoscale Sci & Engn, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Haddon, RC (corresponding author), Univ Calif Riverside, Dept Chem, Ctr Nanoscale Sci & Engn, Riverside, CA 92521 USA.	haddon@ucr.edu	Soleil, SMIS/I-3166-2014; Haddon, Robert C/A-2528-2008; Borondics, Ferenc/A-7616-2008	Haddon, Robert C/0000-0002-7903-5139; Borondics, Ferenc/0000-0001-9975-4301				Ajayan PM, 2002, SCIENCE, V296, P705, DOI 10.1126/science.296.5568.705; Ando T, 1997, J PHYS SOC JPN, V66, P1066, DOI 10.1143/JPSJ.66.1066; Artukovic E, 2005, NANO LETT, V5, P757, DOI 10.1021/nl050254o; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Bekyarova E, 2005, J AM CHEM SOC, V127, P5990, DOI 10.1021/ja043153l; Bekyarova E, 2004, J PHYS CHEM B, V108, P19717, DOI 10.1021/jp0471857; Collins PG, 2000, APPL PHYS LETT, V76, P894, DOI 10.1063/1.125621; Dresselhaus M.S., 2001, CARBON NANOTUBES SYN, V80; Freitag M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.076803; Fujiwara A, 2004, CARBON, V42, P919, DOI 10.1016/j.carbon.2003.12.063; Henini M., 2002, HDB INFRARED DETECTI; Hennrich F, 2002, PHYS CHEM CHEM PHYS, V4, P2273, DOI 10.1039/b201570f; HERR SL, 1986, PHYS REV B, V33, P8851, DOI 10.1103/PhysRevB.33.8851; ITKIS ME, 1984, JETP LETT+, V39, P448; Itkis ME, 2003, NANO LETT, V3, P309, DOI 10.1021/nl025926e; Itkis ME, 2002, NANO LETT, V2, P155, DOI 10.1021/nl0156639; Kaempgen M, 2005, APPL SURF SCI, V252, P425, DOI 10.1016/j.apsusc.2005.01.020; Matsuoka Y, 2003, SCI TECHNOL ADV MAT, V4, P47, DOI 10.1016/S1468-6996(03)00005-6; Misewich JA, 2003, SCIENCE, V300, P783, DOI 10.1126/science.1081294; Mohite A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1863447; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Qiu XH, 2005, NANO LETT, V5, P749, DOI 10.1021/nl050227y; Sheng CX, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.125427; Snow ES, 2005, SCIENCE, V307, P1942, DOI 10.1126/science.1109128; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; Star A, 2004, ADV MATER, V16, P2049, DOI 10.1002/adma.200400322; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Wang F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.177401; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311	30	394	416	4	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					413	416		10.1126/science.1125695	http://dx.doi.org/10.1126/science.1125695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627739				2022-12-28	WOS:000236941800043
J	Navarro, L; Dunoyer, P; Jay, F; Arnold, B; Dharmasiri, N; Estelle, M; Voinnet, O; Jones, JDG				Navarro, L; Dunoyer, P; Jay, F; Arnold, B; Dharmasiri, N; Estelle, M; Voinnet, O; Jones, JDG			A plant miRNA contributes to antibacterial resistance by repressing auxin signaling	SCIENCE			English	Article							BOX PROTEIN TIR1; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MICRORNAS; IDENTIFICATION; RECEPTOR; DICER-LIKE-4; SUPPRESSORS; BIOGENESIS	Plants and animals activate defenses after perceiving pathogen-associated molecular patterns (PAMPs) such as bacterial flagellin. In Arabidopsis, perception of flagellin increases resistance to the bacterium Pseudomonas syringae, although the molecular mechanisms involved remain elusive. Here, we show that a flagellin-derived peptide induces a plant microRNA (miRNA) that negatively regulates messenger RNAs for the F-box auxin receptors TIR1, AFB2, and AFB3. Repression of auxin signaling restricts P. syringae growth, implicating auxin in disease susceptibility and miRNA-mediated suppression of auxin signaling in resistance.	CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Indiana University System; Indiana University Bloomington	Voinnet, O (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr; jonathan.jones@sainsbury-laboratory.ac.uk	Jones, Jonathan DG/J-5129-2012; Estelle, Mark/ABD-6742-2021	Jones, Jonathan DG/0000-0002-4953-261X; JAY, Florence/0000-0001-7353-8299; Voinnet, Olivier/0000-0001-6982-9544				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Glickmann E, 1998, MOL PLANT MICROBE IN, V11, P156, DOI 10.1094/MPMI.1998.11.2.156; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YAMADA T, 1991, MOLECULAR STRATEGIES OF PATHOGENS AND HOST PLANTS, P83	26	1283	1410	9	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					436	439		10.1126/science.1126088	http://dx.doi.org/10.1126/science.1126088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627744				2022-12-28	WOS:000236941800050
J	Williams, D; Baverstock, K				Williams, D; Baverstock, K			Too soon for a final diagnosis	NATURE			English	Editorial Material							BOMB SURVIVORS; CANCER-RISKS; RADIATION; CHERNOBYL		Strangeways Res Lab, Thyroid Carcinogenesis Res Grp, Cambridge CB1 8RN, England; Univ Kuopio, Dept Environm Sci, FIN-70211 Kuopio, Finland	University of Eastern Finland	Williams, D (corresponding author), Strangeways Res Lab, Thyroid Carcinogenesis Res Grp, Worts Causeway, Cambridge CB1 8RN, England.							BAVERSTOCK K, 1992, NATURE, V359, P21, DOI 10.1038/359021b0; Brenner DJ, 2006, RADIAT ENVIRON BIOPH, V44, P253, DOI 10.1007/s00411-006-0029-4; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; *INT AT EN AG, 1991, INT CHERN PROJ TECH; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; PUKKALA E, 2006, INT J CANC; SHIMIZU Y, 1992, RADIAT RES, V130, P249, DOI 10.2307/3578283; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Williams D, 2002, NAT REV CANCER, V2, P543, DOI 10.1038/nrc845	9	19	20	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					993	994		10.1038/440993a	http://dx.doi.org/10.1038/440993a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034DL	16625177				2022-12-28	WOS:000236906000017
J	Comerio, MC				Comerio, MC			Earthquake anniversary - Can buildings be made earthquake-safe?	SCIENCE			English	Editorial Material									Univ Calif Berkeley, Dept Architecture, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Comerio, MC (corresponding author), Univ Calif Berkeley, Dept Architecture, Berkeley, CA 94720 USA.	mcomerio@berkeley.edu						Comerio M.C., 1998, DISASTER HITS HOME N; *EARTHQ ENG RES I, 2006, WORLD HOUS ENCY; Fajfar P., 2004, PERFORMANCE BASED SE; Tobriner Stephen, 2006, BRACING DISASTER EAR; TOUAILLON J, 1970, Patent No. 99973	5	6	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					204	206		10.1126/science.1126302	http://dx.doi.org/10.1126/science.1126302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HK	16614203				2022-12-28	WOS:000236765300029
J	Savage, VM; White, EP; Moses, ME; Ernest, SKM; Enquist, BJ; Charnov, EL				Savage, VM; White, EP; Moses, ME; Ernest, SKM; Enquist, BJ; Charnov, EL			Comment on "The illusion of invariant quantities in life histories"	SCIENCE			English	Editorial Material							ANIMALS; SIZE; SEX		Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Utah State Univ, Dept Biol, Logan, UT 84322 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	Harvard University; Utah System of Higher Education; Utah State University; University of New Mexico; University of Arizona	Savage, VM (corresponding author), Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA.	vsavage@cgr.harvard.edu	Ernest, Morgan/A-4355-2008; Enquist, Brian J/B-6436-2008; Ernest, S.K. Morgan/O-2532-2015; White, Ethan P/A-2936-2008	Ernest, Morgan/0000-0002-6026-8530; Enquist, Brian J/0000-0002-6124-7096; Ernest, S.K. Morgan/0000-0002-6026-8530; White, Ethan/0000-0001-6728-7745				Allsop DJ, 2003, NATURE, V425, P783, DOI 10.1038/425783a; Beverton R.J.H., 1959, CIBA FDN C AGEING, V5, P142, DOI DOI 10.1002/9780470715253.CH10; Calder WA., 1984, SIZE FUNCTION LIFE H; Charnov Eric L., 1993, P1; Cipriani R, 2005, J EVOLUTION BIOL, V18, P1613, DOI 10.1111/j.1420-9101.2005.00949.x; de Jong G, 2005, SCIENCE, V309, P1193, DOI 10.1126/science.1117591; Gardner A, 2005, AM NAT, V165, P551, DOI 10.1086/429526; Nee S, 2005, SCIENCE, V309, P1236, DOI 10.1126/science.1114488	8	21	21	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					198B	+		10.1126/science.1123679	http://dx.doi.org/10.1126/science.1123679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614200				2022-12-28	WOS:000236765300023
J	Yoshizawa, M; Tamura, M; Fujita, M				Yoshizawa, M; Tamura, M; Fujita, M			Diels-alder in aqueous molecular hosts: Unusual regioselectivity and efficient catalysis	SCIENCE			English	Article							ACCELERATION; PRODUCTS; CAPSULE	Self-assembled, hollow molecular structures are appealing as synthetic hosts for mediating chemical reactions. However, product binding has inhibited catalytic turnover in such systems, and selectivity has rarely approached the levels observed in more structurally elaborate natural enzymes. We found that an aqueous organopalladium cage induces highly unusual regioselectivity in the Diels-Alder coupling of anthracene and phthalimide guests, promoting reaction at a terminal rather than central anthracene ring. Moreover, a similar bowl-shaped host attains efficient catalytic turnover in coupling the same substrates ( although with the conventional regiochemistry), most likely because the product geometry inhibits the aromatic stacking interactions that attract the planar reagents to the host.	Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci & Technol Agcy, CREST, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Fujita, M (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp	Fujita, Makoto/E-6350-2012; Yoshizawa, Michito/A-4631-2013	Yoshizawa, Michito/0000-0002-0543-3943; Fujita, Makoto/0000-0001-6105-7340				BRESLOW R, 1991, ACCOUNTS CHEM RES, V24, P159, DOI 10.1021/ar00006a001; Chen J, 2002, ORG LETT, V4, P327, DOI 10.1021/ol0168115; Cheng MF, 2003, CHEM PHYS LETT, V368, P630, DOI 10.1016/S0009-2614(02)01955-3; Cram D.J., 1994, CONTAINER MOL THEIR, DOI 10.1039/9781847550620-00107; Fiedler D, 2004, ANGEW CHEM INT EDIT, V43, P6748, DOI 10.1002/anie.200461776; Fringuelli F., 2002, DIELS ALDER REACTION; FUJITA M, 1995, NATURE, V378, P469, DOI 10.1038/378469a0; Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G; Jencks W. P., 1969, CATALYSIS CHEM ENZYM; Kaanumalle LS, 2005, J AM CHEM SOC, V127, P3674, DOI 10.1021/ja0425381; KANG J, 1997, NATURE, V385, P508; Kang JM, 1998, J AM CHEM SOC, V120, P7389, DOI 10.1021/ja980927n; KLANDERM.BH, 1965, J AM CHEM SOC, V87, P4649, DOI 10.1021/ja00948a049; Kusukawa T, 2003, CHEM LETT, V32, P284, DOI 10.1246/cl.2003.284; Kusukawa T, 2001, ANGEW CHEM INT EDIT, V40, P1879; Kusukawa T, 1999, J AM CHEM SOC, V121, P1397, DOI 10.1021/ja9837295; Marty M, 1998, CHEM COMMUN, P2265, DOI 10.1039/a806070c; Merlau ML, 2001, ANGEW CHEM INT EDIT, V40, P4239, DOI 10.1002/1521-3773(20011119)40:22<4239::AID-ANIE4239>3.0.CO;2-E; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; PAULING L, 1948, Am Sci, V36, P51; RIGAUDY J, 1981, TETRAHEDRON, V37, P2585, DOI 10.1016/S0040-4020(01)98961-6; Steed J.W., 2022, SUPRAMOL CHEM; Stuhlmann F, 2002, J AM CHEM SOC, V124, P3238, DOI 10.1021/ja0167405; Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688; Yoshizawa M, 2004, J AM CHEM SOC, V126, P6846, DOI 10.1021/ja048860t; Yoshizawa M, 2001, J AM CHEM SOC, V123, P10454, DOI 10.1021/ja010875t; Yu SY, 2000, J AM CHEM SOC, V122, P2665, DOI 10.1021/ja994014k	27	966	973	12	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					251	254		10.1126/science.1124985	http://dx.doi.org/10.1126/science.1124985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	032HK	16614218				2022-12-28	WOS:000236765300044
J	Christakis, DA				Christakis, DA			The hidden and potent effects of television advertising	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN		Univ Washington, Inst Child Hlth, Seattle, WA 98115 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Christakis, DA (corresponding author), Univ Washington, Inst Child Hlth, 6200 NE 74th St 210, Seattle, WA 98115 USA.	dachris@u.washington.edu						*AM ASS ADV AG ASS, 2002, 2001 TEL COMM MON RE; Christakis DA, 2004, J PEDIATR-US, V145, P652, DOI 10.1016/j.jpeds.2004.06.078; Comstock G., 1991, TELEVISION AM CHILD; COTUGNA N, 1988, J NUTR EDUC, V20, P125; GALLO AE, 1998, FOOD ADVERTISING US; GENTILE G, 2005, PLAYING GAMES MORE Y; GOLDBERG ME, 1990, J MARKETING RES, V27, P445, DOI 10.2307/3172629; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Jordan AB, 2006, ARCH PEDIAT ADOL MED, V160, P446, DOI 10.1001/archpedi.160.4.446; KUNKEL D, 2001, HDB CHILDREN MEDIA, P765; Salas Jo, 2005, NOTE WHAT WE MEAN DI, P1; Snyder LB, 2006, ARCH PEDIAT ADOL MED, V160, P18, DOI 10.1001/archpedi.160.1.18; Strasburger V. C., 2001, HDB CHILDREN MEDIA, P415; Stroebele N, 2004, APPETITE, V42, P111, DOI 10.1016/j.appet.2003.09.001; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436; [No title captured]	16	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1698	1699		10.1001/jama.295.14.1698	http://dx.doi.org/10.1001/jama.295.14.1698			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16615175				2022-12-28	WOS:000236707300026
J	Laxminarayan, R; Mills, AJ; Breman, JG; Measham, AR; Alleyne, G; Claeson, M; Jha, P; Musgrove, P; Chow, J; Shahid-Salles, S; Jamison, DT				Laxminarayan, R; Mills, AJ; Breman, JG; Measham, AR; Alleyne, G; Claeson, M; Jha, P; Musgrove, P; Chow, J; Shahid-Salles, S; Jamison, DT			Advancement of global health: key messages from the Disease Control Priorities Project	LANCET			English	Article							ANTIMICROBIAL RESISTANCE; DEVELOPING-COUNTRIES	The Disease Control Priorities Project (DCPP), a joint project of the Fogarty International Center of the US National Institutes of Health, the WHO, and The World Bank, was launched in 2001 to identify policy changes and intervention strategies for the health problems of low-income and middle-income countries. Nearly 500 experts worldwide compiled and reviewed the scientific research on a broad range of diseases and conditions, the results of which are published this week. A major product of DCPP, Disease Control Priorities in Developing Countries, 2nd edition (DCP2), focuses on the assessment of the cost-effectiveness of health-improving strategies (or interventions) for the conditions responsible for the greatest burden of disease. DCP2 also examines crosscutting issues crucial to the delivery of quality health services, including the organisation, financial support, and capacity of health systems. Here, we summarise the key messages of the project.	Resources Future Inc, Washington, DC 20036 USA; London Sch Hyg & Trop Med, London WC1, England; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Pan Amer Hlth Org, Washington, DC USA; World Bank, Washington, DC 20433 USA; Univ Toronto, Toronto, ON, Canada; St Michaels Hosp, McLaughlin Ctr Mol Med, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; Global Hlth, Hlth Affairs, Bethesda, MD USA; Populat Reference Bur, Washington, DC USA	Resources for the Future; University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Pan American Health Organization; The World Bank; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Laxminarayan, R (corresponding author), Resources Future Inc, 1616 P St NW Suite 600, Washington, DC 20036 USA.	ramanan@rff.org	Laxminarayan, Ramanan/ABD-5050-2021	Mills, Anne/0000-0001-9863-9950				Becker G. S., 2003, AM ECON REV, V95, P277; Bourguignon F, 2002, AM ECON REV, V92, P727, DOI 10.1257/00028280260344443; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Deaton A, 2004, 10669 NAT BUR EC RES; Easterlin R. A, 1996, GROWTH TRIUMPHANT 21; JAMISON D, 2004, WHY INFANT MORTALITY, P21; Jamison D.T., 1993, DIS CONTROL PRIORITI; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jamison DT, 2006, PRIORITIES HLTH; Levine R, 2004, WHAT WORKS WORKING G; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MASON JB, 2003, 1 DCPP; Mulligan J, 2003, 9 DCPP; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; World Bank, 1993, WORLD DEV REP INV HL	17	208	211	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1193	1208		10.1016/S0140-6736(06)68440-7	http://dx.doi.org/10.1016/S0140-6736(06)68440-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616562				2022-12-28	WOS:000236673400028
J	Chave, J; Alonso, D; Etienne, RS				Chave, J; Alonso, D; Etienne, RS			Theoretical biology - Comparing models of species abundance	NATURE			English	Letter							BIODIVERSITY; DIVERSITY; TREE		Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR5174, F-31062 Toulouse, France; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Groningen, Community & Conservat Ecol Grp, NL-9750 AA Haren, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Michigan System; University of Michigan; University of Groningen	Chave, J (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR5174, F-31062 Toulouse, France.	chave@cict.fr	Etienne, Rampal S./F-5835-2012; Alonso, David/A-5406-2008	Etienne, Rampal S./0000-0003-2142-7612; Alonso, David/0000-0002-8888-1644				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Diserud OH, 2000, AM NAT, V155, P497, DOI 10.1086/303339; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Hubbell Stephen P., 2001, V32, pi; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030	10	50	50	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					E1	E1		10.1038/nature04826	http://dx.doi.org/10.1038/nature04826			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672928	Green Published			2022-12-28	WOS:000237248600026
J	Kwok, TCY; Ricker, N; Fraser, R; Chan, AW; Burns, A; Stanley, EF; McCourt, P; Cutler, SR; Roy, PJ				Kwok, TCY; Ricker, N; Fraser, R; Chan, AW; Burns, A; Stanley, EF; McCourt, P; Cutler, SR; Roy, PJ			A small-molecule screen in C-elegans yields a new calcium channel antagonist	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EGG-LAYING BEHAVIOR; SEROTONIN; MORPHOGENESIS; IMIPRAMINE; DOPAMINE; EGL-19; STATES; CCA-1	Small-molecule inhibitors of protein function are powerful tools for biological analysis(1) and can lead to the development of new drugs. However, a major bottleneck in generating useful small-molecule tools is target identification. Here we show that Caenorhabditis elegans can provide a platform for both the discovery of new bioactive compounds and target identification. We screened 14,100 small molecules for bioactivity in wild-type worms and identified 308 compounds that induce a variety of phenotypes. One compound that we named nemadipine-A induces marked defects in morphology and egg-laying. Nemadipine-A resembles a class of widely prescribed anti-hypertension drugs called the 1,4-dihydropyridines (DHPs) that antagonize the alpha(1)-subunit of L-type calcium channels(2,3). Through a genetic suppressor screen, we identified egl-19 as the sole candidate target of nemadipine-A, a conclusion that is supported by several additional lines of evidence. egl-19 encodes the only L-type calcium channel alpha(1)-subunit in the C. elegans genome(4,5). We show that nemadipine-A can also antagonize vertebrate L-type calcium channels, demonstrating that worms and vertebrates share the orthologous protein target. Conversely, FDA-approved DHPs fail to elicit robust phenotypes, making nemadipine-A a unique tool to screen for genetic interactions with this important class of drugs. Finally, we demonstrate the utility of nemadipine- A by using it to reveal redundancy among three calcium channels in the egg-laying circuit. Our study demonstrates that C. elegans enables rapid identification of new small-molecule tools and their targets.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 3E1, Canada; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Univ Toronto, Collaborat Program Dev Biol, Toronto, ON M5S 3G5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Roy, PJ (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 160 Coll St, Toronto, ON M5S 3E1, Canada.	peter.roy@utoronto.ca	Cutler, Sean R/D-6617-2011; Chan, Allen/AAF-4718-2020; Roy, Peter/G-5357-2014	Ricker, Nicole/0000-0001-5706-5399; Roy, Peter/0000-0003-2959-2276				BRENNER S, 1974, GENETICS, V77, P71; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; HARROLD M, 2002, FOYES PRINCIPLES MED, P533; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LEWIS JA, 1995, CAENORHABDITIS ELEGA; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LOEV B, 1972, J PHARM PHARMACOL, V24, P917, DOI 10.1111/j.2042-7158.1972.tb08919.x; Mathews EA, 2003, J NEUROSCI, V23, P6537; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Roy PJ, 2000, DEVELOPMENT, V127, P755; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schafer WR, 1996, GENETICS, V143, P1219; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; TRENT C, 1983, GENETICS, V104, P619; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Weinshenker D, 1999, J NEUROSCI, V19, P9831; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	28	217	236	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					91	95		10.1038/nature04657	http://dx.doi.org/10.1038/nature04657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672971				2022-12-28	WOS:000237248600039
J	Trollope-Kumar, K; Guyatt, G				Trollope-Kumar, K; Guyatt, G			Syndromic approach for treatment of STIs: time for a change	LANCET			English	Editorial Material							SEXUALLY-TRANSMITTED INFECTIONS; VAGINAL DISCHARGE; LOW-PREVALENCE; WOMEN; MANAGEMENT		McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; W End Clin, Hamilton, ON, Canada; McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McMaster University; McMaster University	Trollope-Kumar, K (corresponding author), McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada.	kumarak@mcmaster.ca						Bogaerts J, 1999, SEX TRANSM INFECT, V75, P437, DOI 10.1136/sti.75.6.437; Chalamilla G, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-22; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; Hawkes S, 2002, SEX TRANSM INFECT, V78, pI31, DOI 10.1136/sti.78.suppl_1.i31; Koenig M., 1998, Reproductive Health Matters, V6, P84, DOI 10.1016/S0968-8080(98)90085-4; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Pepin J, 2004, SEX TRANSM INFECT, V80, P230, DOI 10.1136/sti.2003.007534; Trollope-Kumar K, 2001, TROP MED INT HEALTH, V6, P260, DOI 10.1046/j.1365-3156.2001.00699.x	9	12	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1380	1381		10.1016/S0140-6736(06)68593-0	http://dx.doi.org/10.1016/S0140-6736(06)68593-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650635				2022-12-28	WOS:000237195600009
J	van den Heuvel, EPJ				van den Heuvel, EPJ			Astronomy - Pulsar magnetospheres and pulsar death	SCIENCE			English	Editorial Material							RADIATION		Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Univ Amsterdam, Ctr High Energy Astrophys, NL-1098 SJ Amsterdam, Netherlands; Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	University of Amsterdam; University of Amsterdam; University of California System; University of California Santa Barbara	van den Heuvel, EPJ (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1098 SJ Amsterdam, Netherlands.	edvdh@science.uva.nl	van den Heuvel, Edward P.J./C-1262-2018					GOLD T, 1968, NATURE, V218, P731, DOI 10.1038/218731a0; GOLDREICH P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; GUNN JE, 1969, NATURE, V221, P454, DOI 10.1038/221454a0; Kramer M, 2006, SCIENCE, V312, P549, DOI 10.1126/science.1124060; KRAMER M, 2006, SCIENCE         0223; OORT JH, 1956, B ASTRON I NETH, V12, P285; PACINI F, 1967, NATURE, V216, P567, DOI 10.1038/216567a0; STURROCK PA, 1970, NATURE, V227, P465, DOI 10.1038/227465a0; STURROCK PA, 1971, ASTROPHYS J, V164, P529, DOI 10.1086/150865	9	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					539	540		10.1126/science.1125934	http://dx.doi.org/10.1126/science.1125934			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645085				2022-12-28	WOS:000237296700032
J	Masgrau, L; Roujeinikova, A; Johannissen, LO; Hothi, P; Basran, J; Ranaghan, KE; Mulholland, AJ; Sutcliffe, MJ; Scrutton, NS; Leys, D				Masgrau, L; Roujeinikova, A; Johannissen, LO; Hothi, P; Basran, J; Ranaghan, KE; Mulholland, AJ; Sutcliffe, MJ; Scrutton, NS; Leys, D			Atomic description of an enzyme reaction dominated by proton tunneling	SCIENCE			English	Article							AROMATIC AMINE DEHYDROGENASE; THERMOPHILIC ALCOHOL-DEHYDROGENASE; HYDRIDE-TRANSFER REACTIONS; TRANSITION-STATE THEORY; HYDROGEN BOND-CLEAVAGE; METHYLAMINE DEHYDROGENASE; TEMPERATURE-DEPENDENCE; ELECTRON-TRANSFER; CATALYSIS; SIMULATIONS	We present an atomic-level description of the reaction chemistry of an enzyme-catalyzed reaction dominated by proton tunneling. By solving structures of reaction intermediates at near-atomic resolution, we have identified the reaction pathway for tryptamine oxidation by aromatic amine dehydrogenase. Combining experiment and computer simulation, we show proton transfer occurs predominantly to oxygen O2 of Asp(128)beta in a reaction dominated by tunneling over similar to 0.6 angstroms. The role of long-range coupled motions in promoting tunneling is controversial. We show that, in this enzyme system, tunneling is promoted by a short-range motion modulating proton-acceptor distance and no long-range coupled motion is required.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M60 1QD, Lancs, England; Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M60 1QD, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Bristol; University of Manchester; University of Manchester; University of Manchester; University of Leicester	Leys, D (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	adrian.mulholland@bristol.ac.uk; michael.sutcliffe@manchester.ac.uk; nigel.scrutton@manchester.ac.uk; david.leys@manchester.ac.uk	Masgrau, Laura/ABA-9339-2020; Ranaghan, Kara/H-1190-2013; Masgrau, Laura/O-1214-2015; Ranaghan, Kara/B-3825-2015	Masgrau, Laura/0000-0003-4495-508X; Ranaghan, Kara/0000-0002-6391-6601; Masgrau, Laura/0000-0003-4495-508X; Roujeinikova, Anna/0000-0001-8478-4751; Mulholland, Adrian/0000-0003-1015-4567; Sutcliffe, Mike/0000-0003-0414-1700	BBSRC [BB/D01963X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/R86119/01] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, B19724/2, BB/C511305/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Agrawal N, 2004, BIOCHEMISTRY-US, V43, P1998, DOI 10.1021/bi036124g; Alhambra C, 2002, CHEM PHYS LETT, V355, P388, DOI 10.1016/S0009-2614(02)00057-X; Alhambra C, 2001, CHEM PHYS LETT, V347, P512, DOI 10.1016/S0009-2614(01)00921-6; Alhambra C, 2000, J AM CHEM SOC, V122, P8197, DOI 10.1021/ja001476l; Antoniou D, 2001, J PHYS CHEM B, V105, P5553, DOI 10.1021/jp004547b; Ball P, 2004, NATURE, V431, P396, DOI 10.1038/431396a; Basran J, 2003, J BIOL CHEM, V278, P43973, DOI 10.1074/jbc.M305983200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Basran J, 1999, BIOCHEMISTRY-US, V38, P3218, DOI 10.1021/bi982719d; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Caratzoulas S, 2002, J AM CHEM SOC, V124, P3270, DOI 10.1021/ja017146y; Doll KM, 2003, J AM CHEM SOC, V125, P10877, DOI 10.1021/ja030120h; Doll KM, 2003, INORG CHEM, V42, P4849, DOI 10.1021/ic0300722; Faulder PF, 2001, J AM CHEM SOC, V123, P8604, DOI 10.1021/ja016219a; Francisco WA, 2002, J AM CHEM SOC, V124, P8194, DOI 10.1021/ja025758s; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; GOVINDARAJ S, 1994, J BACTERIOL, V176, P2922, DOI 10.1128/JB.176.10.2922-2929.1994; Harris RJ, 2000, BIOCHEMISTRY-US, V39, P1189, DOI 10.1021/bi991941v; Hatcher E, 2004, J AM CHEM SOC, V126, P5763, DOI 10.1021/ja039606o; Hothi P, 2005, FEBS J, V272, P5894, DOI 10.1111/j.1742-4658.2005.04990.x; HUSKEY WP, 1983, J AM CHEM SOC, V105, P5704, DOI 10.1021/ja00355a038; Hwang JK, 1996, J AM CHEM SOC, V118, P11745, DOI 10.1021/ja962007f; HWANG JK, 1991, J PHYS CHEM-US, V95, P8445, DOI 10.1021/j100175a009; HYUN YL, 1995, BBA-PROTEIN STRUCT M, V1251, P198, DOI 10.1016/0167-4838(95)00117-D; HYUN YL, 1995, BIOCHEMISTRY-US, V34, P12249, DOI 10.1021/bi00038a020; Klinman J P, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P415; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Masgrau L, 2004, ARCH BIOCHEM BIOPHYS, V428, P41, DOI 10.1016/j.abb.2004.03.013; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; Olsson MHM, 2004, J AM CHEM SOC, V126, P2820, DOI 10.1021/ja037233l; Pu JZ, 2005, J PHYS CHEM B, V109, P8551, DOI 10.1021/jp051184c; Ridder L, 2002, J AM CHEM SOC, V124, P9926, DOI 10.1021/ja0256360; Siebrand W, 2004, J PHYS CHEM B, V108, P4185, DOI 10.1021/jp030575t; Tresadern G, 2003, MOL PHYS, V101, P2775, DOI 10.1080/0026897031000121271; Truhlar D. G., 1985, THEORY CHEM REACTION, P65; Truhlar DG, 2004, INT J QUANTUM CHEM, V100, P1136, DOI 10.1002/qua.20205; Truhlar DG, 1996, J PHYS CHEM-US, V100, P12771, DOI 10.1021/jp953748q; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1989, SCIENCE, V246, P112, DOI 10.1126/science.2675313; WARSHEL A, 2006, ISOTOPE EFFECTS CHEM, P621	47	248	257	7	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					237	241		10.1126/science.1126002	http://dx.doi.org/10.1126/science.1126002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614214				2022-12-28	WOS:000236765300040
J	Psaty, BM; Weiss, NS; Furberg, CD				Psaty, BM; Weiss, NS; Furberg, CD			Recent trials in hypertension - Compelling science or commercial speech?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH OUTCOMES; 1ST-LINE AGENTS; CLINICAL-TRIAL; BETA-BLOCKADE; PREVENTION; METAANALYSIS; AMLODIPINE; INHIBITORS; MORTALITY; COMMITTEE		Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068639, R01HL060739, R01HL074745, R01HL043201] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderman MH, 2005, HYPERTENSION, V46, P1, DOI 10.1161/01.HYP.0000168924.37091.58; [Anonymous], 1991, JAMA, V265, P3255; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P43, DOI 10.1001/jama.292.1.43-c; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Veterans Administration Cooperative Study Group on Antihypertensive Agents, 1967, JAMA-J AM MED ASSOC, V202, P116, DOI DOI 10.1001/JAMA.1967.03130150084015; Whelton PK, 2005, ARCH INTERN MED, V165, P1401, DOI 10.1001/archinte.165.12.1401; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Yki-Jarvinen H, 2005, LANCET, V366, P1241, DOI 10.1016/S0140-6736(05)67504-6	24	35	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1704	1706		10.1001/jama.295.14.1704	http://dx.doi.org/10.1001/jama.295.14.1704			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609093				2022-12-28	WOS:000236707300028
J	Gross, R; Webb, P				Gross, R; Webb, P			Wasting time for wasted children: severe child undernutrition must be resolved in non-emergency settings	LANCET			English	Editorial Material							COMPLEX EMERGENCIES		UNICEF, Nutr Sect, Program Div, New York, NY 10017 USA; Tufts Univ, Friedman Sch Nutr, Boston, MA 02111 USA	UNICEF; Tufts University	Webb, P (corresponding author), UNICEF, Nutr Sect, Program Div, New York, NY 10017 USA.	patrick.webb@tufts.edu	Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354				[Anonymous], 2004, 2004 REP GLOB AIDS E; *EM FOOD SEC NUTR, 2005, PROV REP; GILLESPIE S, 2005, P INT C HIV AIDS FOO; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; *UN, 2005, NIG 2005 MAY SEPT FL; *UNICEF, 2004, STAT WORLDS CHILDR; *UNICEF, 2003, DROUGHT HIV AIDS C 1; *WHO UNICEF UNHCR, 1999, FOOD NUTR NEEDS EM; *WORLD BANK, 2003, COMB MALN TIM ACT; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3	10	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1209	1211		10.1016/S0140-6736(06)68509-7	http://dx.doi.org/10.1016/S0140-6736(06)68509-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616563				2022-12-28	WOS:000236673400029
J	Peter, JV; Moran, JL; Phillips-Hughes, J; Graham, P; Bersten, AD				Peter, JV; Moran, JL; Phillips-Hughes, J; Graham, P; Bersten, AD			Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACUTE RESPIRATORY-FAILURE; CONGESTIVE-HEART-FAILURE; AIRWAY PRESSURE; FACE MASK; MYOCARDIAL-INFARCTION; SUPPORT VENTILATION; OXYGEN-THERAPY; BILEVEL; PUBLICATION	Background Non-invasive positive pressure ventilation (NIPPY), using continuous positive airway pressure (CPAP) or bilevel ventilation, has been shown to reduce the need for invasive mechanical ventilation in patients with acute cardiogenic pulmonary oedema. We assessed additional benefits of NIPPY in a meta-analysis. Methods Meta-analysis comparison in acute cardiogenic pulmonary oedema was undertaken to compare (1) CPAP with standard therapy (oxygen by face-mask, diuretics, nitrates, and other supportive care), (2) bilevel ventilation with standard therapy, and (3) bilevel ventilation with CPAP, incorporating randomised controlled trials identified by electronic and hand search (1966-May, 2005). In 23 trials that fulfilled inclusion criteria, we assessed the effect of NIPPY on hospital mortality and mechanical ventilation, estimated as relative risks. Findings CPAP was associated with a significantly lower mortality rate than standard therapy (relative risk 0.59, 95% CI 0.38-0.90, p=0.015). A non-significant trend towards reduced mortality was seen in the comparison between bilevel ventilation and standard therapy (0.63, 0.37-1.10, p=0.11). We recorded no substantial difference in mortality risk between bilevel ventilation and CPAP (p=0.38). The need for mechanical ventilation was reduced with CPAP (0.44, 0.29-0.66, p=0.0003) and with bilevel ventilation (0.50, 0.27-0.90, p=0.02), compared with standard therapy; but no significant difference was seen between CPAP and bilevel ventilation (p=0.86). Weak evidence of an increase in the incidence of new myocardial infarction with bilevel ventilation versus CPAP was recorded (1.49, 0.92-2.42, p=0.11). Heterogeneity of treatment effects was not evident for mortality or mechanical ventilation across patients' groups. Interpretation In patients with acute cardiogenic pulmonary oedema, CPAP and bilevel ventilation reduces the need for subsequent mechanical ventilation. Compared with standard therapy, CPAP reduces mortality; our results also suggest a trend towards reduced mortality after bilevel NIPPV.	Queen Elizabeth Hosp, Dept Intens Care Med, Woodville S, SA 5011, Australia; CSIRO Math & Informat Sci, N Ryde, NSW, Australia; Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; Flinders Univ S Australia, Flinders Med Ctr, Dept Crit Care Med, Adelaide, SA 5001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Flinders University South Australia; Flinders Medical Centre; Flinders University South Australia	Moran, JL (corresponding author), Queen Elizabeth Hosp, Dept Intens Care Med, Woodville S, SA 5011, Australia.	john.moran@nwahs.sa.gov.au	Graham, Petra/V-8136-2019; Peter, John Victor/R-7700-2019	Graham, Petra/0000-0003-2890-2447; Bersten, Andrew/0000-0001-9908-394X; Peter, John Victor/0000-0002-3423-1830				BARATZ DM, 1992, CHEST, V102, P1397, DOI 10.1378/chest.102.5.1397; Baudouin S, 2002, THORAX, V57, P192; Bellone A, 2005, INTENS CARE MED, V31, P807, DOI 10.1007/s00134-005-2649-6; Bellone A, 2004, CRIT CARE MED, V32, P1860, DOI 10.1097/01.CCM.0000139694.47326.B6; Beltrame J F, 1998, J Card Fail, V4, P271, DOI 10.1016/S1071-9164(98)90232-9; BERSTEN AD, 1991, CRIT CARE MED, V19, P266, DOI 10.1097/00003246-199102000-00024; Bersten AD, 2003, AM J RESP CRIT CARE, V168, P1406, DOI 10.1164/rccm.2309016; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; BOLLAERT PE, 2002, AM J RESP CRIT CARE, V165, pB57; Bradburn M, 1998, STATA TECH B REPRINT, V8, P86; Chadda K, 2002, CRIT CARE MED, V30, P2457, DOI 10.1097/00003246-200211000-00009; Cotter G, 1998, LANCET, V351, P389, DOI 10.1016/S0140-6736(97)08417-1; Crane SD, 2004, EMERG MED J, V21, P155, DOI 10.1136/emj.2003.005413; Cross AM, 2003, EMERG MED J, V20, P531, DOI 10.1136/emj.20.6.531; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P1438, DOI 10.1164/rccm.200301-072OC; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; GOLDBERGER JJ, 1986, ARCH INTERN MED, V146, P489, DOI 10.1001/archinte.146.3.489; HAO CX, 2002, ACTA ACAD MED JIANGX, V42, P50; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsu J., 1996, MULTIPLE COMP THEORY, DOI DOI 10.1007/978-1-4899-7180-7; *INT CONS C INT CA, 2001, AM J RESP CRIT CARE, V163, P283; Keenan SP, 2003, ANN INTERN MED, V138, P861, DOI 10.7326/0003-4819-138-11-200306030-00007; Kelly CA, 2002, EUR HEART J, V23, P1379, DOI 10.1053/euhj.2001.3156; L'Her E, 2004, INTENS CARE MED, V30, P882, DOI 10.1007/s00134-004-2183-y; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lenique F, 1997, AM J RESP CRIT CARE, V155, P500, DOI 10.1164/ajrccm.155.2.9032185; Levitt MA, 2001, J EMERG MED, V21, P363, DOI 10.1016/S0736-4679(01)00385-7; LIESCHING TN, 2003, AM J RESP CRIT CARE, V167, pA864; LIN M, 1995, CHEST, V107, P1379, DOI 10.1378/chest.107.5.1379; Lofaso F, 1996, AM J RESP CRIT CARE, V153, P1591, DOI 10.1164/ajrccm.153.5.8630607; MARTINBERMUDEZ R, 2002, INTENS CARE MED, V28, pA255; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; McIntosh MW, 1996, STAT MED, V15, P1713, DOI 10.1002/(SICI)1097-0258(19960830)15:16<1713::AID-SIM331>3.0.CO;2-D; Mehta S, 1997, CRIT CARE MED, V25, P620, DOI 10.1097/00003246-199704000-00011; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540, DOI 10.1164/ajrccm.163.2.9906116; Nava S, 2003, AM J RESP CRIT CARE, V168, P1432, DOI 10.1164/rccm.200211-1270OC; Pang D, 1998, CHEST, V114, P1185, DOI 10.1378/chest.114.4.1185; Park M, 2004, CRIT CARE MED, V32, P2407, DOI 10.1097/01.CCM.0000147770.20400.10; Park M, 2001, Arq Bras Cardiol, V76, P221; Peter John V, 2004, Ann Intern Med, V141, pW78; PLOTNICK GD, 1982, SOUTH MED J, V75, P565, DOI 10.1097/00007611-198205000-00015; RASANEN J, 1985, AM J CARDIOL, V55, P296, DOI 10.1016/0002-9149(85)90364-9; SASSOON CSH, 1992, AM REV RESPIR DIS, V145, P1219, DOI 10.1164/ajrccm/145.5.1219; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; SHARP S, 1998, STATA TECH B, V7, P148; Steichen T, 1998, STATA TECHNICAL B RE, V41, P9; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Takeda S, 1997, ANESTH ANALG, V84, P1091, DOI 10.1097/00000539-199705000-00025; Takeda S, 1998, JPN CIRC J, V62, P553, DOI 10.1253/jcj.62.553	52	256	281	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1155	1163		10.1016/S0140-6736(06)68506-1	http://dx.doi.org/10.1016/S0140-6736(06)68506-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616558				2022-12-28	WOS:000236673400024
J	Berger, C; Song, ZM; Li, XB; Wu, XS; Brown, N; Naud, C; Mayou, D; Li, TB; Hass, J; Marchenkov, AN; Conrad, EH; First, PN; de Heer, WA				Berger, Claire; Song, Zhimin; Li, Xuebin; Wu, Xiaosong; Brown, Nate; Naud, Cecile; Mayou, Didier; Li, Tianbo; Hass, Joanna; Marchenkov, Atexei N.; Conrad, Edward H.; First, Phillip N.; de Heer, Wait A.			Electronic confinement and coherence in patterned epitaxial graphene	SCIENCE			English	Article							HETEROEPITAXIAL GRAPHITE; CARBON NANOTUBES; SILICON-CARBIDE; BERRYS PHASE; GAS; CONDUCTION; STATE; FILMS	Ultrathin epitaxial graphite was grown on single-crystal silicon carbide by vacuum graphitization. The material can be patterned using standard nanolithography methods. The transport properties, which are closely related to those of carbon nanotubes, are dominated by the single epitaxial graphene layer at the silicon carbide interface and reveal the Dirac nature of the charge carriers. Patterned structures show quantum confinement of electrons and phase coherence lengths beyond 1 micrometer at 4 kelvin, with mobilities exceeding 2.5 square meters per volt-second. All-graphene electronically coherent devices and device architectures are envisaged.	Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; CNRS, Etud Proprietes Elect Solides Lab, F-38042 Grenoble 9, France	University System of Georgia; Georgia Institute of Technology; Centre National de la Recherche Scientifique (CNRS)	de Heer, WA (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	walt.deheer@physics.gatech.edu	Wu, Xiaosong/B-1902-2014	Wu, Xiaosong/0000-0001-9224-9871				Ando T, 1998, J PHYS SOC JPN, V67, P2857, DOI 10.1143/JPSJ.67.2857; Beenakker C. W. J., 1991, QUANTUM TRANSPORT SE, V44; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; BERGGREN KF, 1988, PHYS REV B, V37, P10118, DOI 10.1103/PhysRevB.37.10118; Charrier A, 2002, J APPL PHYS, V92, P2479, DOI 10.1063/1.1498962; Datta S., 1997, ELECT TRANSPORT MESO; Forbeaux I, 1998, PHYS REV B, V58, P16396, DOI 10.1103/PhysRevB.58.16396; Fujita M, 1996, J PHYS SOC JPN, V65, P1920, DOI 10.1143/JPSJ.65.1920; Kelly B.T., 1981, PHYS GRAPHITE; LIFSHITZ IM, 1956, SOV PHYS JETP-USSR, V2, P636; Lin JJ, 2002, J PHYS-CONDENS MAT, V14, pR501, DOI 10.1088/0953-8984/14/18/201; Luk'yanchuk IA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166402; NAKANO T, 1996, J JPN SOC ORAL TUMOR, V8, P54; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Poncharal P, 2002, J PHYS CHEM B, V106, P12104, DOI 10.1021/jp021271u; Ramachandran V, 1998, J ELECTRON MATER, V27, P308, DOI 10.1007/s11664-998-0406-7; Sharapov SG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075104; SOULE DE, 1958, PHYS REV, V1, P708; SOULE DE, 1964, PHYS REV A, V134, P453; VISSCHER PB, 1971, PHYS REV B-SOLID ST, V3, P2541, DOI 10.1103/PhysRevB.3.2541; WAKABAYASHI K, 2001, PHYS REV B, V64, P12; WALLACE PR, 1947, PHYS REV, V71, P622, DOI 10.1103/PhysRev.71.622; Zhang YB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176803; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	26	4777	4969	51	2324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1191	1196		10.1126/science.1125925	http://dx.doi.org/10.1126/science.1125925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16614173				2022-12-28	WOS:000237957400047
J	Zhang, JW; Grindley, JC; Yin, T; Jayasinghe, S; He, XC; Ross, JT; Haug, JS; Rupp, D; Porter-Westpfahl, KS; Wiedemann, LM; Wu, H; Li, LH				Zhang, Jiwang; Grindley, Justin C.; Yin, Tong; Jayasinghe, Sachintha; He, Xi C.; Ross, Jason T.; Haug, Jeffrey S.; Rupp, Dawn; Porter-Westpfahl, Kimberly S.; Wiedemann, Leanne M.; Wu, Hong; Li, Linheng			PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention	NATURE			English	Article							BONE-MARROW NICHE; SELF-RENEWAL; PROGENITOR CELLS; IDENTIFICATION; GENE; PHOSPHORYLATION; DIFFERENTIATION; RECRUITMENT; QUIESCENCE; COMMITMENT	Haematopoietic stem cells (HSCs) must achieve a balance between quiescence and activation that fulfils immediate demands for haematopoiesis without compromising long-term stem cell maintenance, yet little is known about the molecular events governing this balance(1-3). Phosphatase and tensin homologue ( PTEN) functions as a negative regulator of the phosphatidylinositol-3-OH kinase (PI(3)K)-Akt pathway, which has crucial roles in cell proliferation, survival, differentiation and migration(4,5). Here we show that inactivation of PTEN in bone marrow HSCs causes their short-term expansion, but long-term decline, primarily owing to an enhanced level of HSC activation. PTEN-deficient HSCs engraft normally in recipient mice, but have an impaired ability to sustain haematopoietic reconstitution, reflecting the dysregulation of their cell cycle and decreased retention in the bone marrow niche. Mice with PTEN-mutant bone marrow also have an increased representation of myeloid and T-lymphoid lineages and develop myeloproliferative disorder (MPD)(6). Notably, the cell populations that expand in PTEN mutants match those that become dominant in the acute myeloid/lymphoid leukaemia that develops in the later stages of MPD. Thus, PTEN has essential roles in restricting the activation of HSCs, in lineage fate determination, and in the prevention of leukaemogenesis.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Zhang, Jiwang/AAG-2706-2021; Wiedemann, Leanne/E-3316-2010	Li, Linheng/0000-0001-9963-430X; Jayasinghe, Sachintha/0000-0002-3254-4892; Wiedemann, Leanne/0000-0002-0964-4676				Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	639	685	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					518	522		10.1038/nature04747	http://dx.doi.org/10.1038/nature04747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16633340				2022-12-28	WOS:000237778900052
J	Arriola, DJ; Carnahan, EM; Hustad, PD; Kuhlman, RL; Wenzel, TT				Arriola, DJ; Carnahan, EM; Hustad, PD; Kuhlman, RL; Wenzel, TT			Catalytic production of olefin block copolymers via chain shuttling polymerization	SCIENCE			English	Article							ALPHA-OLEFINS; SYSTEMS; GROWTH; ZINC; POLYMERS	We report a catalytic system that produces olefin block copolymers with alternating semicrystalline and amorphous segments, achieved by varying the ratio of alpha-olefin to ethylene in the two types of blocks. The system uses a chain shuttling agent to transfer growing chains between two distinct catalysts with different monomer selectivities in a single polymerization reactor. The block copolymers simultaneously have high melting temperatures and low glass transition temperatures, and therefore they maintain excellent elastomeric properties at high temperatures. Furthermore, the materials are effectively produced in economically favorable, continuous polymerization processes.	Dow Chem Co USA, Midland, MI 48674 USA; Dow Chem Co USA, Freeport, TX 77541 USA	Dow Chemical Company; Dow Chemical Company	Arriola, DJ (corresponding author), Dow Chem Co USA, Bldg 1702, Midland, MI 48674 USA.	djarriola@dow.com; ecarnahan@dow.com; pdhustad@dow.com; kuhlmarl@dow.com; wenzeltt@dow.com						ARRIOLA DJ, 2005, Patent No. 2005090427; Bogaert S, 2002, J MOL CATAL A-CHEM, V190, P207, DOI 10.1016/S1381-1169(02)00219-4; BOOR J, 1979, ZIEGLERNATTA CATALYS; Britovsek GJP, 2004, J AM CHEM SOC, V126, P10701, DOI 10.1021/ja0485560; Britovsek GJP, 2002, ANGEW CHEM INT EDIT, V41, P489, DOI 10.1002/1521-3773(20020201)41:3<489::AID-ANIE489>3.0.CO;2-C; Chien JCW, 1997, MACROMOLECULES, V30, P3447, DOI 10.1021/ma961726b; Coates GW, 2002, ANGEW CHEM INT EDIT, V41, P2236, DOI 10.1002/1521-3773(20020703)41:13<2236::AID-ANIE2236>3.0.CO;2-3; COATES GW, 1995, SCIENCE, V267, P217, DOI 10.1126/science.267.5195.217; Coates GW, 2000, CHEM REV, V100, P1223, DOI 10.1021/cr990286u; DOTSON NA, 1996, POLYM PROCESS MODELI, P262; FRAZIER KA, 2004, Patent No. 20040220050; Furuyama R, 2005, MACROMOLECULES, V38, P1546, DOI 10.1021/ma0481104; Gibson VC, 2003, CHEM REV, V103, P283, DOI 10.1021/cr980461r; Hamley I. W., 1998, PHYS BLOCK COPOLYMER; Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u; Hsieh H. L., 1996, ANIONIC POLYM PRINCI; Kamigaito M, 2001, CHEM REV, V101, P3689, DOI 10.1021/cr9901182; Lieber S, 2000, MACROMOLECULES, V33, P9192, DOI 10.1021/ma000691j; Makio H, 2002, ADV SYNTH CATAL, V344, P477, DOI 10.1002/1615-4169(200207)344:5<477::AID-ADSC477>3.0.CO;2-6; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; MATYJASZEWSKI K, 2006, CATIONIC POLYM MECH; McKnight AL, 1998, CHEM REV, V98, P2587, DOI 10.1021/cr940442r; Murphy V, 2002, CHEM REC, V2, P278, DOI 10.1002/tcr.10025; NATTA G, 1959, ADV CATAL, V11, P1, DOI 10.1016/S0360-0564(08)60416-2; Pelletier J-F, 1996, [No title captured], Patent No. [EP 736,536, 736536]; Pelletier JF, 1996, ANGEW CHEM INT EDIT, V35, P1854, DOI 10.1002/anie.199618541; SAMSEL EG, 1993, Patent No. 0539876; SAMSEL EG, 2002, Patent No. 6444867; van Meurs M, 2005, J AM CHEM SOC, V127, P9913, DOI 10.1021/ja050100a; Zhang YH, 2003, J AM CHEM SOC, V125, P9062, DOI 10.1021/ja029780x	30	700	770	19	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					714	719		10.1126/science.1125268	http://dx.doi.org/10.1126/science.1125268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675694				2022-12-28	WOS:000237312100041
J	Gibson, VC				Gibson, VC			Shuttling polyolefins to a new materials dimension	SCIENCE			English	Editorial Material							POLYETHYLENE CHAIN GROWTH; OLEFIN POLYMERIZATION; ETHYLENE; CATALYSTS; SYSTEMS; ZINC		Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England	Imperial College London	Gibson, VC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, Exhibit Rd, London SW7 2AZ, England.	v.gibson@imperial.com.uk						Arriola DJ, 2006, SCIENCE, V312, P714, DOI 10.1126/science.1125268; Britovsek GJP, 2004, J AM CHEM SOC, V126, P10701, DOI 10.1021/ja0485560; BRITOVSEK GJP, 2003, Patent No. 0314046; Gibson VC, 2003, CHEM REV, V103, P283, DOI 10.1021/cr980461r; Ittel SD, 2000, CHEM REV, V100, P1169, DOI 10.1021/cr9804644; Pelletier JF, 1996, ANGEW CHEM INT EDIT, V35, P1854, DOI 10.1002/anie.199618541; Saito J, 2001, ANGEW CHEM INT EDIT, V40, P2918, DOI 10.1002/1521-3773(20010803)40:15<2918::AID-ANIE2918>3.0.CO;2-S; Samsel E. G., 1993, [No title captured], Patent No. [EP 0574854, 0574854]; Tian J, 2001, J AM CHEM SOC, V123, P5134, DOI 10.1021/ja0157189; van Meurs M, 2005, J AM CHEM SOC, V127, P9913, DOI 10.1021/ja050100a; ZIEGLER K, 1955, ANGEW CHEM INT EDIT, V67, P541, DOI 10.1002/ange.19550671902	11	55	58	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					703	704		10.1126/science.1127258	http://dx.doi.org/10.1126/science.1127258			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675687				2022-12-28	WOS:000237312100034
J	Nelson, HD; Vesco, KK; Haney, E; Fu, RW; Nedrow, A; Miller, J; Nicolaidis, C; Walker, M; Humphrey, L				Nelson, HD; Vesco, KK; Haney, E; Fu, RW; Nedrow, A; Miller, J; Nicolaidis, C; Walker, M; Humphrey, L			Nonhormonal therapies for menopausal hot flashes - Systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							STANDARDIZED SOY EXTRACT; DOUBLE-BLIND TRIAL; POSTMENOPAUSAL WOMEN; BREAST-CANCER; VASOMOTOR SYMPTOMS; PLACEBO; FLUSHES; CLONIDINE; PHYTOESTROGENS; MULTICENTER	Context Concern regarding the adverse effects of estrogen and other hormones for treating menopausal symptoms has led to demand for other options; however, the efficacy and adverse effects of nonhormonal therapies are unclear. Objective To assess the efficacy and adverse effects of nonhormonal therapies for menopausal hot flashes by reviewing published randomized controlled trials. Data Sources MEDLINE ( 1966-October 2005), PsycINFO (1974-October 2005), and the Cochrane Controlled Clinical Trials Register Database (1966-October 2005) were searched for relevant trials that provided data on treatment of menopausal hot flashes using 1 or more nonhormonal therapies. Study Selection All English-language, published, randomized, double-blind, placebo-controlled trials of oral nonhormonal therapies for treating hot flashes in menopausal women measuring and reporting hot flash frequency or severity outcomes. Data Extraction Trials were identified, subjected to inclusion and exclusion criteria, and reviewed. Data on participants, interventions, and outcomes were extracted and trials were rated for quality based on established criteria. A meta-analysis was conducted for therapies with sufficient trials reporting hot flash frequency outcomes. Data Synthesis From 4249 abstracts, 43 trials met inclusion criteria, including 10 trials of antidepressants, 10 trials of clonidine, 6 trials of other prescribed medications, and 17 trials of isoflavone extracts. The number of daily hot flashes decreased compared with placebo in meta-analyses of 7 comparisons of selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) ( mean difference, - 1.13; 95% confidence interval [CI], - 1.70 to - 0.57), 4 trials of clonidine (- 0.95; 95% CI, - 1.44 to - 0.47), and 2 trials of gabapentin (- 2.05; 95% CI, - 2.80 to - 1.30). Frequency was not reduced in meta-analysis of trials of red clover isoflavone extracts and results were mixed for soy isoflavone extracts. Evidence of the efficacy of other therapies is limited due to the small number of trials and their deficiencies. Trials do not compare different therapies head-to-head and relative efficacy cannot be determined. Conclusion The SSRIs or SNRIs, clonidine, and gabapentin trials provide evidence for efficacy; however, effects are less than for estrogen, few trials have been published and most have methodological deficiencies, generalizability is limited, and adverse effects and cost may restrict use for many women. These therapies may be most useful for highly symptomatic women who cannot take estrogen but are not optimal choices for most women.	Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Ctr Womens Hlth, Portland, OR 97201 USA; Providence Hlth Syst, Women & Childrens Hlth Res Ctr, Portland, OR USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Hosp & Specialty Med, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Oregon Evidence Based Practice Ctr, BICC 504,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu	Nicolaidis, Christina/CAC-0028-2022; Nicolaidis, Christina/X-6468-2019	Nicolaidis, Christina/0000-0002-9394-5956; Nicolaidis, Christina/0000-0002-9394-5956				ANDERSEN O, 1986, ACTA OBSTET GYN SCAN, V65, P405, DOI 10.3109/00016348609157373; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; ARKINSON C, 2004, BREAST CANCER RES, V6, pR170; Baber R J, 1999, Climacteric, V2, P85, DOI 10.3109/13697139909025571; BALK E, 2005, AHRQ PUBL; BERGMANS MGM, 1987, MATURITAS, V9, P227, DOI 10.1016/0378-5122(87)90005-3; BLATT MHG, 1953, ARCH INTERN MED, V91, P792, DOI 10.1001/archinte.1953.00240180101012; BOLLI P, 1975, NEW ZEAL MED J, V82, P196; Carpenter JS, 1998, CANCER-AM CANCER SOC, V82, P1682, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.3.CO;2-8; CASPER RF, 1985, CLIN ENDOCRINOL, V22, P293, DOI 10.1111/j.1365-2265.1985.tb03243.x; CLAYDEN JR, 1974, BRIT MED J, V1, P409, DOI 10.1136/bmj.1.5905.409; *CONSORT, STRENGTH SCI SOUND E; Crisafulli A, 2004, MENOPAUSE, V11, P400, DOI 10.1097/01.GME.0000109314.11228.E5; DAVID A, 1988, AM J OBSTET GYNECOL, V158, P1107, DOI 10.1016/0002-9378(88)90230-X; Duffy R, 2003, PHARMACOL BIOCHEM BE, V75, P721, DOI 10.1016/S0091-3057(03)00116-3; EDINGTON RF, 1980, CAN MED ASSOC J, V123, P23; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans ML, 2005, OBSTET GYNECOL, V105, P161, DOI 10.1097/01.AOG.0000147840.06947.46; Faure ED, 2002, MENOPAUSE, V9, P329, DOI 10.1097/00042192-200209000-00005; Freedman RR, 1999, AM J OBSTET GYNECOL, V181, P66, DOI 10.1016/S0002-9378(99)70437-0; FREEDMAN RR, 1995, J CLIN ENDOCR METAB, V80, P2354, DOI 10.1210/jc.80.8.2354; Fugate SE, 2004, ANN PHARMACOTHER, V38, P1482, DOI 10.1345/aph.1D610; Goldberg, 1996, J CLIN ONCOL, V14, P2411, DOI 10.1200/JCO.1996.14.8.2411; GOLDBERG RM, 1994, J CLIN ONCOL, V12, P155, DOI 10.1200/JCO.1994.12.1.155; GREENE JG, 1976, J PSYCHOSOM RES, V20, P425, DOI 10.1016/0022-3999(76)90005-2; Guttuso T, 2003, OBSTET GYNECOL, V101, P337, DOI 10.1016/S0029-7844(02)02712-6; HAMMOND MG, 1984, J CLIN ENDOCR METAB, V58, P1158, DOI 10.1210/jcem-58-6-1158; Han KK, 2002, OBSTET GYNECOL, V99, P389, DOI 10.1016/S0029-7844(01)01744-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jeri AR, 2002, FEMALE PATIENT, V27, P35; Knight D C, 1999, Climacteric, V2, P79, DOI 10.3109/13697139909025570; Knight DC, 1996, OBSTET GYNECOL, V87, P897; Krebs EE, 2004, OBSTET GYNECOL, V104, P824, DOI 10.1097/01.AOG.0000140688.71638.d3; LINDSAY R, 1978, MATURITAS, V1, P21, DOI 10.1016/0378-5122(78)90006-3; Loprinzi CL, 2002, J CLIN ONCOL, V20, P1578, DOI 10.1200/JCO.20.6.1578; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; MacGregor CA, 2005, EUR J CANCER, V41, P708, DOI 10.1016/j.ejca.2005.01.005; MACLENNAN A, 2002, ORAL OESTROGEN REPLA; MELIS GB, 1988, OBSTET GYNECOL, V72, P688; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; NAGAMANI M, 1987, AM J OBSTET GYNECOL, V156, P561, DOI 10.1016/0002-9378(87)90050-0; Nappi C, 1991, ACTA OBSTET GYN SCAN, V70, P435, DOI 10.3109/00016349109007156; NELSON H, 2005, 120 AG HEALTHC RES Q; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; NESHEIM BI, 1981, EUR J CLIN PHARMACOL, V20, P413, DOI 10.1007/BF00542092; Newton KM, 2002, OBSTET GYNECOL, V100, P18, DOI 10.1016/S0029-7844(02)02005-7; Nikander E, 2003, OBSTET GYNECOL, V101, P1213, DOI 10.1016/S0029-7844(03)00232-1; Pandya KJ, 2005, LANCET, V366, P818, DOI 10.1016/S0140-6736(05)67215-7; Pandya KJ, 2000, ANN INTERN MED, V132, P788, DOI 10.7326/0003-4819-132-10-200005160-00004; Penotti M, 2003, FERTIL STERIL, V79, P1112, DOI 10.1016/S0015-0282(03)00158-4; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salmi T, 1979, Int J Gynaecol Obstet, V16, P422; Scambia G, 2000, MENOPAUSE, V7, P105, DOI 10.1097/00042192-200007020-00006; Secreto G, 2004, MATURITAS, V47, P11, DOI 10.1016/S0378-5122(03)00219-6; Slavin Robert E., 1986, EDUC RESEARCHER, V15, P5, DOI [10.3102/0013189X015009005, DOI 10.3102/0013189X015009005]; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stearns V, 2005, J CLIN ONCOL, V23, P6919, DOI 10.1200/JCO.2005.10.081; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Stearns V, 2003, JAMA-J AM MED ASSOC, V289, P2827, DOI 10.1001/jama.289.21.2827; Suvanto-Luukkonen E, 2005, MENOPAUSE, V12, P18, DOI 10.1097/00042192-200512010-00006; Tarim E, 2002, ADV THER, V19, P258, DOI 10.1007/BF02853171; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tice JA, 2003, JAMA-J AM MED ASSOC, V290, P207, DOI 10.1001/jama.290.2.207; Unfer V, 2004, FERTIL STERIL, V82, P145, DOI 10.1016/j.fertnstert.2003.11.041; Upmalis DH, 2000, MENOPAUSE, V7, P236, DOI 10.1097/00042192-200007040-00005; van de Weijer PHM, 2002, MATURITAS, V42, P187, DOI 10.1016/S0378-5122(02)00080-4; Whitehead A., 2002, METAANALYSIS CONTROL; WREN BG, 1986, MED J AUSTRALIA, V144, P369, DOI 10.5694/j.1326-5377.1986.tb115924.x; *WYETH PHARM, GO LOW PREMPR; ZICHELLA L, 1986, MATURITAS, V8, P229, DOI 10.1016/0378-5122(86)90030-7	75	455	490	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2057	2071		10.1001/jama.295.17.2057	http://dx.doi.org/10.1001/jama.295.17.2057			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038MF	16670414				2022-12-28	WOS:000237225100022
J	Daddario-DiCaprio, KM; Geisbert, TW; Stroher, U; Geisbert, JB; Grolla, A; Fritz, EA; Fernando, L; Kagan, E; Jahrling, PB; Hensley, LE; Jones, SM; Feldmann, H				Daddario-DiCaprio, KM; Geisbert, TW; Stroher, U; Geisbert, JB; Grolla, A; Fritz, EA; Fernando, L; Kagan, E; Jahrling, PB; Hensley, LE; Jones, SM; Feldmann, H			Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment	LANCET			English	Article							REPLICATION-COMPETENT; GUINEA-PIGS; INFECTION; VACCINATION; EBOLA; GLYCOPROTEINS; PROPHYLAXIS; ANTIBODIES; RESPONSES; SMALLPOX	Background Effective countermeasures are urgently needed to prevent and treat infections caused by highly pathogenic and biological threat agents such as Marburg virus (MARV). We aimed to test the efficacy of a replication-competent vaccine based on attenuated recombinant vesicular stomatitis virus (rVSV), as a postexposure treatment for MARV haemorrhagic fever. Methods We used a rhesus macaque model of MARV haemorrhagic fever that produced 100% lethality. We administered rVSV vectors expressing the MARV Musoke strain glycoprotein to five macaques 20-30 min after a high-dose lethal injection of homologous MARV. Three animals were MARV-positive controls and received nonspecific rVSV vectors. We tested for viraemia, undertook analyses for haematology and serum biochemistry, and measured humoral and cellular immune responses. Findings All five rhesus monkeys that were treated with the rVSV MARV vectors as a postexposure treatment survived a high-dose lethal challenge of MARV for at least 80 days. None of these five animals developed clinical symptoms consistent with MARV haemorrhagic fever. All the control animals developed fulminant disease and succumbed to the MARV challenge by day 12. MARV disease in the controls was indicated by: high titres of MARV (10(3)-10(5) plaque-forming units per mL); development of leucocytosis with concurrent neutrophilia at end-stage disease; and possible damage to the liver, kidney, and pancreas. Interpretation Postexposure protection against MARV in non-human primates provides a paradigm for the treatment of MARV haemorrhagic fever. indeed, these data suggest that rVSV-based filoviral vaccines might not only have potential as preventive vaccines, but also could be equally useful for postexposure treatment of filoviral infections.	USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; NIAID, Integrated Res Facil, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Public Health Agency of Canada; University of Manitoba; University of Manitoba; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Geisbert, TW (corresponding author), USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.	tom.geisbert@amedd.army.mil		Hensley, Lisa/0000-0003-1188-4342				Agafonova OA, 1997, VOP VIRUSOL+, V42, P109; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bachmann MF, 1996, IMMUNOL TODAY, V17, P553, DOI 10.1016/S0167-5699(96)10066-9; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Fehr T, 1996, CELL IMMUNOL, V168, P184, DOI 10.1006/cimm.1996.0065; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; GONCHAR NI, 1991, VOP VIRUSOL+, V36, P435; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; IGNATYEV GM, 1994, VOP VIRUSOL+, V39, P169; Ignatyev GM, 1996, J BIOTECHNOL, V44, P111, DOI 10.1016/0168-1656(95)00104-2; Ignatyev GM, 1996, VOP VIRUSOL+, V41, P206; *INT SOC INF DIS, 2004, EB VIR LAB ACC US MA; International Society for Infectious Diseases, 2004, EB LAB ACC DEATH RUS; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kahn JS, 2001, J VIROL, V75, P11079, DOI 10.1128/JVI.75.22.11079-11087.2001; Kolokol'tsov AA, 2001, B EXP BIOL MED+, V132, P686, DOI 10.1023/A:1012540614713; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; LEFRANCOIS L, 1984, J VIROL, V51, P208, DOI 10.1128/JVI.51.1.208-214.1984; MARTINI GA, 1968, DEUT MED WOCHENSCHR, V93, P559, DOI 10.1055/s-0028-1105098; Massoudi MS, 2003, J INFECT DIS, V188, P973, DOI 10.1086/378357; Mortimer PP, 2003, CLIN INFECT DIS, V36, P622, DOI 10.1086/374054; Noble S, 2004, VACCINE, V22, P3018, DOI 10.1016/j.vaccine.2004.02.013; Rupprecht CE, 2004, NEW ENGL J MED, V351, P2626, DOI 10.1056/NEJMcp042140; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Sergeev A N, 1995, Antibiot Khimioter, V40, P24; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; SMITH DH, 1982, LANCET, V1, P816; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; SzomolanyiTsuda E, 1996, J EXP MED, V183, P403, DOI 10.1084/jem.183.2.403; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P158; Yu Andy S, 2004, Clin Liver Dis, V8, P283, DOI 10.1016/j.cld.2004.02.010	35	136	145	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1399	1404		10.1016/S0140-6736(06)68546-2	http://dx.doi.org/10.1016/S0140-6736(06)68546-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650649				2022-12-28	WOS:000237195600027
J	Panosian, C; Coates, TJ				Panosian, C; Coates, TJ			Becoming a physician: The new medical "missionaries" - Grooming the next generation of global health workers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Div Infect Dis, Program Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Panosian, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA.		Panossian, Alexander/AAK-8720-2021	Panossian, Alexander/0000-0002-8467-4525				*ASS AM MED COLL, 1984, 1984 MED STUD GRAD Q; Gupta AR, 1999, AM J TROP MED HYG, V61, P1019, DOI 10.4269/ajtmh.1999.61.1019; Merits School, 2003, INTERNAL REPORT; Mullan Fitzhugh, 2005, HEALERS ABROAD AM RE	4	89	89	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1771	1773		10.1056/NEJMp068035	http://dx.doi.org/10.1056/NEJMp068035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641393				2022-12-28	WOS:000237077100002
J	Treydte, KS; Schleser, GH; Helle, G; Frank, DC; Winiger, M; Haug, GH; Esper, J				Treydte, KS; Schleser, GH; Helle, G; Frank, DC; Winiger, M; Haug, GH; Esper, J			The twentieth century was the wettest period in northern Pakistan over the past millennium	NATURE			English	Article							HEMISPHERE TEMPERATURES; TREE-RINGS; PRECIPITATION; DENDROCLIMATOLOGY; HYDROGEN; CLIMATE; OXYGEN	Twentieth-century warming could lead to increases in the moisture-holding capacity of the atmosphere, altering the hydrological cycle and the characteristics of precipitation(1). Such changes in the global rate and distribution of precipitation may have a greater direct effect on human well-being and ecosystem dynamics than changes in temperature itself(2,3). Despite the co-variability of both of these climate variables(3), attention in long-term climate reconstruction has mainly concentrated on temperature changes(4-8). Here we present an annually resolved oxygen isotope record from tree-rings, providing a millennial-scale reconstruction of precipitation variability in the high mountains of northern Pakistan. The climatic signal originates mainly from winter precipitation, and is robust over ecologically different sites. Centennial-scale variations reveal dry conditions at the beginning of the past millennium and through the eighteenth and early nineteenth centuries, with precipitation increasing during the late nineteenth and the twentieth centuries to yield the wettest conditions of the past 1,000 years. Comparison with other long-term precipitation reconstructions indicates a large-scale intensification of the hydrological cycle coincident with the onset of industrialization and global warming, and the unprecedented amplitude argues for a human role.	Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; Forschungszentrum Julich, ICGV, D-52425 Julich, Germany; Univ Bonn, D-53115 Bonn, Germany; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Helmholtz Association; Research Center Julich; University of Bonn; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Treydte, KS (corresponding author), Swiss Fed Res Inst WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland.	kerstin.treydte@wsl.ch	treydte, kerstin/B-4714-2012; Frank, David/C-7764-2013; Esper, Jan/O-3127-2018; Helle, Gerd/G-5380-2013	Esper, Jan/0000-0003-3919-014X; Treydte, Kerstin/0000-0001-8399-6517; Helle, Gerhard/0000-0001-9988-6638; Frank, David/0000-0001-5463-5640				Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; BOEHNER J, IN PRESS BOREAS; Brauning A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020793; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Briffa KR, 2002, SCIENCE, V295, P2227, DOI 10.1126/science.1069486; COOK ER, 1994, INT J CLIMATOL, V14, P379, DOI 10.1002/joc.3370140404; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Emori S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023272; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; ESPER J, IN PRESS MOUNT RES D; Esper J., 2004, EOS, V85, P113, DOI DOI 10.1029/2004EO120002; Hughes M., 1995, CLIMATE AD 1500, P415; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; LEAVITT SW, 1984, NATURE, V311, P145, DOI 10.1038/311145a0; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; New M, 2001, INT J CLIMATOL, V21, P1899, DOI 10.1002/joc.680; Pederson N, 2001, J CLIMATE, V14, P872, DOI 10.1175/1520-0442(2001)014<0872:HRFNMD>2.0.CO;2; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; ROZANSKI K, 1992, SCIENCE, V258, P981, DOI 10.1126/science.258.5084.981; Sheppard PR, 2004, CLIM DYNAM, V23, P869, DOI 10.1007/s00382-004-0473-2; Singh J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004855; Tang KL, 2001, EARTH PLANET SC LETT, V185, P355, DOI 10.1016/S0012-821X(00)00385-X; TETT SFB, UNPUB CLIM DYN; Trenberth KE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022760; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilson RJS, 2005, INT J CLIMATOL, V25, P611, DOI 10.1002/joc.1150; Yang B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014485	30	455	473	6	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1179	1182		10.1038/nature04743	http://dx.doi.org/10.1038/nature04743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641993	Green Submitted			2022-12-28	WOS:000237080000042
J	Bernstein, BE; Mikkelsen, TS; Xie, XH; Kamal, M; Huebert, DJ; Cuff, J; Fry, B; Meissner, A; Wernig, M; Plath, K; Jaenisch, R; Wagschal, A; Feil, R; Schreiber, SL; Lander, ES				Bernstein, BE; Mikkelsen, TS; Xie, XH; Kamal, M; Huebert, DJ; Cuff, J; Fry, B; Meissner, A; Wernig, M; Plath, K; Jaenisch, R; Wagschal, A; Feil, R; Schreiber, SL; Lander, ES			A bivalent chromatin structure marks key developmental genes in embryonic stem cells	CELL			English	Article							TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; POLYCOMB; METHYLATION; BINDING; HUMAN-CHROMOSOME-21; TRANSCRIPTION; RECRUITMENT; TRITHORAX; ISLANDS	The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development. We explored this by examining histone methylation in mouse embryonic stem (ES) cells across 56 large HCNE-rich loci. We identified a specific modification pattern, termed "bivalent domains," consisting of large regions of H3 lysine 27 methylation harboring smaller regions of H3 lysine 4 methylation. Bivalent domains tend to coincide with TF genes expressed at low levels. We propose that bivalent domains silence developmental genes in ES cells while keeping them poised for activation. We also found striking correspondences between genome sequence and histone methylation in ES cells, which become notably weaker in differentiated cells. These results highlight the importance of DNA sequence in defining the initial epigenetic landscape and suggest a novel chromatin-based mechanism for maintaining pluripotency.	Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; CNRS, Inst Genet Mol, UMR 5535, Montpellier, France; Univ Montpellier 2, Montpellier, France; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Harvard University; Howard Hughes Medical Institute	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	bbernstein@partners.org	Mikkelsen, Tarjei S/A-1306-2007; Feil, Robert P/D-2087-2013	Mikkelsen, Tarjei S/0000-0002-8133-3135; Feil, Robert P/0000-0002-5671-5860; Plath, Kathrin/0000-0001-7796-3372; Xie, Xiaohui/0000-0002-5479-6345; Cuff, James/0000-0003-0570-4106	NCI NIH HHS [CA84198] Funding Source: Medline; NICHD NIH HHS [HD045022] Funding Source: Medline; NIGMS NIH HHS [GM38627] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038627, R37GM038627] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnaud P, 2000, MOL CELL BIOL, V20, P3434, DOI 10.1128/MCB.20.10.3434-3441.2000; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Greally JM, 2002, P NATL ACAD SCI USA, V99, P327, DOI 10.1073/pnas.012539199; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; Kosak ST, 2004, SCIENCE, V306, P644, DOI 10.1126/science.1103864; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mogass M, 2004, BIOCHEM BIOPH RES CO, V325, P124, DOI 10.1016/j.bbrc.2004.10.004; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Perry P, 2004, CELL CYCLE, V3, P1645; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sado T, 2005, HUM MOL GENET, V14, pR59, DOI 10.1093/hmg/ddi117; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schraets D, 2003, ONCOGENE, V22, P3655, DOI 10.1038/sj.onc.1206438; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	59	3830	3952	9	411	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					315	326		10.1016/j.cell.2006.02.041	http://dx.doi.org/10.1016/j.cell.2006.02.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630819	Bronze			2022-12-28	WOS:000237241500021
J	Rubin, GM				Rubin, GM			Janelia Farm: An experiment in scientific culture	CELL			English	Editorial Material									Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Rubin, GM (corresponding author), Howard Hughes Med Inst, Janella Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	rubing@jfrc.hhmi.org		Rubin, Gerald/0000-0001-8762-8703					0	14	14	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 21	2006	125	2					209	212		10.1016/j.cell.2006.04.005	http://dx.doi.org/10.1016/j.cell.2006.04.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630805	Bronze			2022-12-28	WOS:000237241500007
J	Sengoku, T; Nureki, O; Nakamura, A; Satoru, KI; Yokoyama, S				Sengoku, T; Nureki, O; Nakamura, A; Satoru, KI; Yokoyama, S			Structural basis for RNA unwinding by the DEAD-box protein Drosophila vasa	CELL			English	Article							INITIATION-FACTOR 4A; CRYSTAL-STRUCTURE; HELICASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; TERMINAL DOMAIN; OSKAR PROTEIN; Q-MOTIF; ATP; TRANSLATION; BINDING	DEAD-box RNA helicases, which regulate various processes involving RNA, have two RecA-like domains as a catalytic core to alter higher-order RNA structures. We determined the 2.2 angstrom resolution structure of the core of the Drosophila DEAD-box protein Vasa in complex with a single-stranded RNA and an ATP analog. The ATP analog intensively interacts with both of the domains, thereby bringing them into the closed form, with many interdomain interactions of conserved residues. The bound RNA is sharply bent, avoiding a clash with a conserved alpha helix in the N-terminal domain. This "wedge" helix should disrupt base pairs by bending one of the strands when a duplex is bound. Mutational analyses indicated that the interdomain interactions couple ATP hydrolysis to RNA unwinding, probably through fine positioning of the duplex relative to the wedge helix. This mechanism, which differs from those for canonical translocating helicases, may enable the targeted modulation of intricate RNA structures.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Okazaki Natl Res Inst, Ctr Integrat Biosci, Okazaki, Aichi 4448585, Japan; RIKEN, SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan	University of Tokyo; RIKEN; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Japan Synchrotron Radiation Research Institute; RIKEN	Yokoyama, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Nakamura, Akira/V-6869-2019; Yokoyama, Shigeyuki/N-6911-2015; Sengoku, Toru/E-4304-2013	Nakamura, Akira/0000-0001-6506-9146; Yokoyama, Shigeyuki/0000-0003-3133-7338; Sengoku, Toru/0000-0001-9461-8714				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; BESSMAN MJ, 1963, METHOD ENZYMOL, V6, P166, DOI 10.1016/0076-6879(63)06160-7; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carmel AB, 2004, RNA, V10, P66, DOI 10.1261/rna.5134304; Carrera P, 2000, MOL CELL, V5, P181, DOI 10.1016/S1097-2765(00)80414-1; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diges CM, 2005, BIOCHEMISTRY-US, V44, P7903, DOI 10.1021/bi050033x; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; FULLERPACE FV, 1993, EMBO J, V12, P3619, DOI 10.1002/j.1460-2075.1993.tb06035.x; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kurimoto K, 2005, J STRUCT BIOL, V150, P58, DOI 10.1016/j.jsb.2005.01.006; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LIANG L, 1994, DEVELOPMENT, V120, P1201; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Markussen FH, 1997, COLD SPRING HARB SYM, V62, P13; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; NICOL SM, 1995, P NATL ACAD SCI USA, V92, P11681, DOI 10.1073/pnas.92.25.11681; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sengoku T, 2004, ACTA CRYSTALLOGR D, V60, P320, DOI 10.1107/S0907444903025897; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465; Styhler S, 1998, DEVELOPMENT, V125, P1569; Svitkin YV, 2001, RNA, V7, P1743; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinker R, 1998, DEV BIOL, V199, P1, DOI 10.1006/dbio.1998.8941; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Zhao CY, 2004, J ARID ENVIRON, V56, P1, DOI 10.1016/S0140-1963(03)00005-3	61	432	440	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					287	300		10.1016/j.cell.2006.01.054	http://dx.doi.org/10.1016/j.cell.2006.01.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630817	Bronze			2022-12-28	WOS:000237241500019
J	Lawrence, VA; Cornell, JE; Smetana, GW				Lawrence, VA; Cornell, JE; Smetana, GW			Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: Systematic review for the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED TRIAL; MAJOR ABDOMINAL-SURGERY; EPIDURAL-ANESTHESIA; PARENTERAL-NUTRITION; INCENTIVE SPIROMETRY; NASOGASTRIC DECOMPRESSION; CHEST PHYSIOTHERAPY; ADMINISTRATIVE DATA; HOSPITAL STAY; ANALGESIA	Background: Postoperative pulmonary complications are as frequent and clinically important as cardiac complications in terms of morbidity, mortality, and length of stay. However, there has been much less research and no previous systematic reviews of the evidence of interventions to prevent pulmonary complications. Purpose: To systematically review the literature on interventions to prevent postoperative pulmonary complications after noncardiothoracic surgery. Data Sources: MEDLINE English -language literature search, 1 January 1980 through 30 June 2005, plus bibliographies of retrieved publications. Study Selection: Randomized, controlled trials (RCTs); systematic reviews; or meta-analyses that met predefined inclusion criteria. Data Extraction: Using standardized forms, the authors abstracted data on study methods, quality, intervention and control groups, patient characteristics, surgery, postoperative pulmonary complications, and adverse events. Data Synthesis: The authors qualitatively synthesized, without meta-analysis, evidence from eligible studies. Good evidence (2 systematic reviews, 5 additional RCTs) indicates that lung expansion interventions (for example, incentive spirometry, deep breathing exercises, and continuous positive airway pressure) reduce pulmonary risk. Fair evidence suggests that selective, rather than routine, use of nasogastric tubes after abdominal surgery (2 meta-analyses) and short-acting rather than long-acting intraciperative neuromuscular blocking agents (1 RCT) reduce risk. The evidence is conflicting or insufficient for preoperative smoking cessation (1 RCT), epidural anesthesia (2 meta-analyses), epidural analgesia (6 RCTs, 1 meta-analysis), and laparoscopic (vs. open) operations (1 systematic review, 1 meta-analysis, 2 additional RCTs), although laparoscopic operations reduce pain and pulmonary compromise as measured by spirometry. While malnutrition is associated with increased pulmonary risk, routine total enteral or parenteral nutrition does not reduce risk (1 meta-analysis, 3 additional RCTs). Enteral formulations designed to improve immune status (immunonutrition) may prevent postoperative pneumonia (1 meta-analysis, 1 additional RCT). Limitations: The overall quality of the literature was fair: Ten of 20 RCTs and 6 of 11 systematic reviews were good quality. Conclusions: Few interventions have been shown to clearly or possibly reduce postoperative pulmonary complications.	Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA; S Texas Vet Hlth Care Syst, San Antonio, TX USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lawrence, VA (corresponding author), Univ Texas, Hlth Sci Ctr, 7703 Floyd Curl Dr,Mail Code 7879, San Antonio, TX 78229 USA.	vlawrence@uthscsa.edu						Abraham NS, 2004, BRIT J SURG, V91, P1111, DOI 10.1002/bjs.4640; Amar D, 2002, ANESTHESIOLOGY, V97, P1029, DOI 10.1097/00000542-200210000-00051; Ballantyne JC, 1998, ANESTH ANALG, V86, P598, DOI 10.1097/00000539-199803000-00032; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; Bluman LG, 1998, CHEST, V113, P883, DOI 10.1378/chest.113.4.883; Bohner H, 2002, LANGENBECK ARCH SURG, V387, P21, DOI 10.1007/s00423-002-0281-2; Bozzetti F, 2001, LANCET, V358, P1487, DOI 10.1016/S0140-6736(01)06578-3; CHEATHAM ML, 1995, ANN SURG, V221, P469, DOI 10.1097/00000658-199505000-00004; Chumillas S, 1998, ARCH PHYS MED REHAB, V79, P5, DOI 10.1016/S0003-9993(98)90198-8; CUSCHIERI RJ, 1985, BRIT J SURG, V72, P495, DOI 10.1002/bjs.1800720631; DETSKY AS, 1987, ANN INTERN MED, V107, P195, DOI 10.7326/0003-4819-107-2-195; ESCARCE JJ, 1995, SURGERY, V117, P156, DOI 10.1016/S0039-6060(05)80079-0; Fleron MH, 2003, ANESTH ANALG, V97, P2, DOI 10.1213/01.ANE.0000066355.07482.0C; Gianotti L, 2002, GASTROENTEROLOGY, V122, P1763, DOI 10.1053/gast.2002.33587; Guller U, 2003, ARCH SURG-CHICAGO, V138, P1179, DOI 10.1001/archsurg.138.11.1179; HALL JC, 1991, LANCET, V337, P953, DOI 10.1016/0140-6736(91)91580-N; Hall JC, 1996, BRIT MED J, V312, P148; HALL JC, 1996, BMJ-BRIT MED J, V312, P152; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Higham H, 2001, BRIT MED J, V322, P1182; Horlocker TT, 2001, THROMB RES, V101, pV141; Karanikolas M, 2002, ANESTHESIOLOGY, V97, P1027, DOI 10.1097/00000542-200210000-00048; Karayiannakis AJ, 1996, BRIT J ANAESTH, V77, P448, DOI 10.1093/bja/77.4.448; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Lawrence VA, 2002, ARCH INTERN MED, V162, P2053, DOI 10.1001/archinte.162.18.2053; Litz RJ, 2001, ANESTHESIOLOGY, V95, P1031, DOI 10.1097/00000542-200110000-00039; Liu SS, 2002, ANESTHESIOLOGY, V97, P1025, DOI 10.1097/00000542-200210000-00044; Mann C, 2000, ANESTHESIOLOGY, V92, P433, DOI 10.1097/00000542-200002000-00025; McCulloch TJ, 2001, BRIT MED J, V322, P1182, DOI 10.1136/bmj.322.7295.1182; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Nelson R, 2005, BRIT J SURG, V92, P673, DOI 10.1002/bjs.5090; Nelson R, 2005, COCHRANE DB SYST REV; Norris EJ, 2002, ANESTHESIOLOGY, V97, P1029, DOI 10.1097/00000542-200210000-00052; Norris EJ, 2001, ANESTHESIOLOGY, V95, P1054, DOI 10.1097/00000542-200111000-00006; Olsen MF, 1997, BRIT J SURG, V84, P1535, DOI 10.1002/bjs.1800841111; Overend TJ, 2001, CHEST, V120, P971, DOI 10.1378/chest.120.3.971; Pacelli F, 2001, ARCH SURG-CHICAGO, V136, P933, DOI 10.1001/archsurg.136.8.933; Park WY, 2001, ANN SURG, V234, P560; PEDERSEN T, 1994, DAN MED BULL, V41, P319; Peyton PJ, 2003, ANESTH ANALG, V96, P548, DOI 10.1097/00000539-200302000-00046; Polanczyk CA, 2001, JAMA-J AM MED ASSOC, V286, P309, DOI 10.1001/jama.286.3.309; Porterfield WR, 1997, J CLIN ANESTH, V9, P74, DOI 10.1016/S0952-8180(96)00205-X; PRONOVOST PJ, 2001, ACP J CLUB, V135, P1; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Romano PS, 2002, AM J MED QUAL, V17, P145, DOI 10.1177/106286060201700404; Romano PS, 2002, MED CARE, V40, P856, DOI 10.1097/00005650-200210000-00004; ROSEN AK, 1992, MED CARE, V30, P753, DOI 10.1097/00005650-199209000-00001; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Thomas EJ, 1997, AM J MED, V102, P277, DOI 10.1016/S0002-9343(96)00451-2; THOMAS JA, 1994, PHYS THER, V74, P3, DOI 10.1093/ptj/74.1.3; THOMAS JA, 1994, PHYS THER, V74, P10; Todd MM, 2001, ANESTHESIOLOGY, V95, P1051, DOI 10.1097/00000542-200111000-00005; Urwin SC, 2000, BRIT J ANAESTH, V84, P450, DOI 10.1093/oxfordjournals.bja.a013468; Vignali A, 2004, DIS COLON RECTUM, V47, P1686, DOI 10.1007/s10350-004-0653-5; Walder B, 2001, ACTA ANAESTH SCAND, V45, P795, DOI 10.1034/j.1399-6576.2001.045007795.x; Warner DO, 2000, ANESTHESIOLOGY, V92, P1467, DOI 10.1097/00000542-200005000-00037; WILLIFORD WO, 1991, NEW ENGL J MED, V325, P525; WILMORE DW, 1988, SURGERY, V104, P917; Zacks SL, 2002, AM J GASTROENTEROL, V97, P334; [No title captured]	65	275	297	1	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					596	608		10.7326/0003-4819-144-8-200604180-00011	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00011			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618957				2022-12-28	WOS:000237017900007
J	Tunved, P; Hansson, HC; Kerminen, VM; Strom, J; Dal Maso, M; Lihavainen, H; Viisanen, Y; Aalto, PP; Komppula, M; Kulmala, M				Tunved, P; Hansson, HC; Kerminen, VM; Strom, J; Dal Maso, M; Lihavainen, H; Viisanen, Y; Aalto, PP; Komppula, M; Kulmala, M			High natural aerosol loading over boreal forests	SCIENCE			English	Article							PARTICLE FORMATION EVENTS; ATMOSPHERIC PARTICLES; SIZE DISTRIBUTION; ORGANIC AEROSOLS; BOUNDARY-LAYER; GROWTH; EMISSIONS; CLIMATE; CO2	Aerosols play a key role in the radiation balance of the atmosphere. Here, we present evidence that the European boreal region is a substantial source of both aerosol mass and aerosol number. The investigation supplies a straightforward relation between emissions of monoterpenes and gas-to-particle formation over regions substantially lacking in anthropogenic aerosol sources. Our results show that the forest provides an aerosol population of 1000 to 2000 particles of climatically active sizes per cubic centimeter during the late spring to early fall period. This has important implications for radiation budget estimates and relevancy for the evaluation of feedback loops believed to determine our future climate.	Dept Appl Environm Sci, Air Pollut Lab, SE-10691 Stockholm, Sweden; Finnish Meteorol Inst, FI-00101 Helsinki, Finland; Univ Helsinki, Dept Phys Sci, FI-00014 Helsinki, Finland	Finnish Meteorological Institute; University of Helsinki	Tunved, P (corresponding author), Dept Appl Environm Sci, Air Pollut Lab, Frescativagen 54, SE-10691 Stockholm, Sweden.	peter.tunved@itm.su.se	Komppula, Mika/AAC-2571-2021; Aalto, Pasi P/A-1539-2009; Kerminen, Veli-Matti/M-9026-2014; Dal Maso, Miikka/A-7980-2008; Lihavainen, Heikki/N-4840-2014; Viisanen, Yrjö/CAG-3818-2022; Kulmala, Markku T/I-7671-2016	Komppula, Mika/0000-0002-4550-3061; Aalto, Pasi P/0000-0001-8826-9108; Dal Maso, Miikka/0000-0003-3040-3612; Viisanen, Yrjö/0000-0002-9660-3281; Kulmala, Markku T/0000-0003-3464-7825				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Boy M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003838; CIAIS P, 1995, J GEOPHYS RES-ATMOS, V100, P5051, DOI 10.1029/94JD02847; DRAXLER R, 1997, ARL224 ERL NOAA; Guenther A, 1997, ECOL APPL, V7, P34, DOI 10.1890/1051-0761(1997)007[0034:SASVIN]2.0.CO;2; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Heintzenberg J, 2000, TELLUS B, V52, P1104, DOI 10.1034/j.1600-0889.2000.00136.x; Janson R, 2001, TELLUS B, V53, P423, DOI 10.1034/j.1600-0889.2001.d01-30.x; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kavouras IG, 1998, NATURE, V395, P683, DOI 10.1038/27179; KERMINEN VM, 2005, GEOPHYS RES LETT, V32; Komppula M, 2003, BOREAL ENVIRON RES, V8, P395; Kulmala M, 1998, TELLUS B, V50, P449, DOI 10.1034/j.1600-0889.1998.t01-4-00004.x; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2001, TELLUS B, V53, P324, DOI 10.1034/j.1600-0889.2001.d01-24.x; LINDFORD V, 1999, BIOGENIC VOC EMISSIO, pCH10; Makela JM, 1997, GEOPHYS RES LETT, V24, P1219, DOI 10.1029/97GL00920; Makela Jyrki M., 2000, Boreal Environment Research, V5, P299; NOVAKOV T, 1993, NATURE, V365, P823, DOI 10.1038/365823a0; O'Dowd CD, 2002, NATURE, V416, P497, DOI 10.1038/416497a; Odum JR, 1996, ENVIRON SCI TECHNOL, V30, P2580, DOI 10.1021/es950943+; Spanke J, 2001, TELLUS B, V53, P406, DOI 10.1034/j.1600-0889.2001.d01-29.x; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; Tunved P, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005085; Tunved P, 2003, ATMOS CHEM PHYS, V3, P2183, DOI 10.5194/acp-3-2183-2003; Vehkamaki H, 2004, ATMOS CHEM PHYS, V4, P2015, DOI 10.5194/acp-4-2015-2004	27	326	330	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					261	263		10.1126/science.1123052	http://dx.doi.org/10.1126/science.1123052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614221				2022-12-28	WOS:000236765300047
J	Berggren, RE				Berggren, RE			Adaptations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Char HIV Outpatient Clin, New Orleans, LA USA		Berggren, RE (corresponding author), Char HIV Outpatient Clin, New Orleans, LA USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1550	1551		10.1056/NEJMp068040	http://dx.doi.org/10.1056/NEJMp068040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611947				2022-12-28	WOS:000236736900002
J	Kinoshita, T; Wenger, T; Weiss, DS				Kinoshita, T; Wenger, T; Weiss, DS			A quantum Newton's cradle	NATURE			English	Article							TONKS-GIRARDEAU GAS; IMPENETRABLE BOSONS; SCATTERING	It is a fundamental assumption of statistical mechanics that a closed system with many degrees of freedom ergodically samples all equal energy points in phase space. To understand the limits of this assumption, it is important to find and study systems that are not ergodic, and thus do not reach thermal equilibrium. A few complex systems have been proposed that are expected not to thermalize because their dynamics are integrable(1,2). Some nearly integrable systems of many particles have been studied numerically, and shown not to ergodically sample phase space(3). However, there has been no experimental demonstration of such a system with many degrees of freedom that does not approach thermal equilibrium. Here we report the preparation of out-of-equilibrium arrays of trapped one-dimensional (1D) Bose gases, each containing from 40 to 250 (87)Rb atoms, which do not noticeably equilibrate even after thousands of collisions. Our results are probably explainable by the well-known fact that a homogeneous 1D Bose gas with point-like collisional interactions is integrable. Until now, however, the time evolution of out-of-equilibrium 1D Bose gases has been a theoretically unsettled issue(4-6), as practical factors such as harmonic trapping and imperfectly point-like interactions may compromise integrability. The absence of damping in 1D Bose gases may lead to potential applications in force sensing and atom interferometry.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Weiss, DS (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	dsweiss@phys.psu.edu	Weiss, David S/B-7886-2010					Berman GP, 2005, CHAOS, V15, DOI 10.1063/1.1855036; Berman GP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.030404; Carusotto I, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.093202; Dunjko V, 2001, PHYS REV LETT, V86, P5413, DOI 10.1103/PhysRevLett.86.5413; Fallani L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140406; Gangardt DM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.010401; GIRARDEAU M, 1960, J MATH PHYS, V1, P516, DOI 10.1063/1.1703687; Girardeau MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.050403; Gustavson TL, 2000, CLASSICAL QUANT GRAV, V17, P2385, DOI 10.1088/0264-9381/17/12/311; HERRMANN F, 1981, AM J PHYS, V49, P761, DOI 10.1119/1.12407; Kinoshita T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190406; Kinoshita T, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011602; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; Miesner HJ, 1998, SCIENCE, V279, P1005, DOI 10.1126/science.279.5353.1005; Minguzzi A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.240404; Moore MG, 2004, J PHYS IV, V116, P69, DOI 10.1051/jp4:2004116003; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; OLSHANII M, 2005, INTERFEROMETRY DENSE; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Pedri P, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.043601; PROUKAKIS NP, 2005, QUASICONDENSATE GROW; Raman C, 1999, PHYS REV LETT, V83, P2502, DOI 10.1103/PhysRevLett.83.2502; Rigol M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.240403; Tabor M, 1989, CHAOS INTEGRABILITY; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Wang YJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090405; Wu H, 1996, J PHYS B-AT MOL OPT, V29, pL321, DOI 10.1088/0953-4075/29/8/003; Wu SJ, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.043602	30	1404	1407	0	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2006	440	7086					900	903		10.1038/nature04693	http://dx.doi.org/10.1038/nature04693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612376				2022-12-28	WOS:000236736700033
J	Trunz, BB; Fine, PEM; Dye, C				Trunz, BB; Fine, PEM; Dye, C			Effect of BCG vaccination on childhood tuberculous meningitis and miliarytuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness	LANCET			English	Article							ANNUAL RISK; MYCOBACTERIUM-TUBERCULOSIS; MILIARY TUBERCULOSIS; PREVALENCE SURVEY; INFECTION; CHILDREN; EFFICACY; INFANTS; PREVENTION; MORTALITY	Background BCG vaccine has shown consistently high efficacy against childhood tuberculous meningitis and miliary tuberculosis, but variable efficacy against adult pulmonary tuberculosis and other mycobacterial diseases. We assess and compare the costs and effects of BCG as an intervention against severe childhood tuberculosis in different regions of the world. Methods We calculated the number of tuberculous meningitis and miliary tuberculosis cases that have been and will be prevented in all children born in 2002, by combining estimates of the annual risk of tuberculosis infection, the proportion of infections that lead to either of these diseases in unvaccinated children, the number of children vaccinated, and BCG efficacy. Findings We estimated that the 100.5 million BCG vaccinations given to infants in 2002 will have prevented 29729 cases of tuberculous meningitis (5th-95th centiles, 24063-36192) in children during their first 5 years of life, or one case for every 3435 vaccinations (2771-4177), and 11486 cases of miliary tuberculosis (7304-16280), or one case for every 9314 vaccinations (6172-13 729). The numbers of cases prevented would be highest in South East Asia (46%), sub-Saharan Africa (27%), the western Pacific region (15%), and where the risk of tuberculosis infection and vaccine coverage are also highest. At US$2-3 per dose, BCG vaccination costs US$206 (150-272) per year of healthy life gained. Interpretation BCG vaccination is a highly cost-effective intervention against severe childhood tuberculosis; it should be retained in high-incidence countries as a strategy to supplement the chemotherapy of active tuberculosis.	WHO, HIV AIDS TB & Malaria, CH-1211 Geneva 27, Switzerland; London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Dye, C (corresponding author), WHO, HIV AIDS TB & Malaria, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022					[Anonymous], 2001, Wkly Epidemiol Rec, V76, P33; Arnadottir T, 2001, INT J TUBERC LUNG D, V5, P391; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Awasthi S, 1999, Indian Pediatr, V36, P455; BARNUM HN, 1986, SOC SCI MED, V23, P847, DOI 10.1016/0277-9536(86)90212-1; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Bhattacharjee J., 1993, Journal of Communicable Diseases, V25, P71; CAMARGOS PAM, 1988, INT J EPIDEMIOL, V17, P193, DOI 10.1093/ije/17.1.193; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P569; Chen XY, 2004, LANCET, V364, P417; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMSTOCK GW, 1994, CONTROL CLIN TRIALS, V15, P247, DOI 10.1016/0197-2456(94)90042-6; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; COSTA MCN, 1991, B OFICINA SANIT PANA, V110, P26; de Ribes GC, 1997, B SOC PATHOL EXOT, V90, P349; DEMARCHAYUELA P, 1994, TUBERCLE LUNG DIS, V75, P423, DOI 10.1016/0962-8479(94)90115-5; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; DYE C, IN PRESS DIS CONTROL; EGWAGA SM, 2003, TANZANIAN NATL TUBER, V2, P107; El Ibiary S, 1999, INT J TUBERC LUNG D, V3, P294; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Fine P, 2005, BRIT MED J, V331, P647, DOI 10.1136/bmj.331.7518.647; Fine P. E. M., 2001, TUBERCULOSIS COMPREH; FINE PEM, 1999, WHOVB9923, P1; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; Garly ML, 2001, VACCINE, V20, P468, DOI 10.1016/S0264-410X(01)00339-5; Hong YP, 1998, INT J TUBERC LUNG D, V2, P27; HUSSEY G, 1991, PEDIATR INFECT DIS J, V10, P832, DOI 10.1097/00006454-199111000-00008; *INT UN TUB LUNG D, 1994, TUBERCLE LUNG DIS, V75, P179; Jamison D.T., 1993, DIS CONTROL PRIORITI; JAMISON DT, 1993, DIS CONTROL PRIORITI, P3; Lobato MN, 1998, PEDIATR INFECT DIS J, V17, P407, DOI 10.1097/00006454-199805000-00012; MICELI I, 1988, INT J EPIDEMIOL, V17, P629, DOI 10.1093/ije/17.3.629; *MIN HLTH PEOPL RE, 2000, REP NAT RAND SURV EP; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Mittal S. K., 1996, Indian Journal of Pediatrics, V63, P659, DOI 10.1007/BF02730815; MURRAY CJL, 1991, LANCET, V338, P1305, DOI 10.1016/0140-6736(91)92600-7; MURTAGH K, 1980, LANCET, V1, P423; MYINT TT, 1987, ANN TROP PAEDIATR, V7, P159, DOI 10.1080/02724936.1987.11748499; *NAT CTR TUB LEPR, 2005, NAT TUB PREV SURV 20; Odhiambo JA, 1999, AM J PUBLIC HEALTH, V89, P1078, DOI 10.2105/AJPH.89.7.1078; Pathania VS, 1999, VACCINE, V17, P1926, DOI 10.1016/S0264-410X(98)00462-9; PONNIGHAUS JM, 1992, LANCET, V339, P636, DOI 10.1016/0140-6736(92)90794-4; PUTRALI J, 1983, P E REG TUBERC C INT, V99, P194; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; ROMANUS V, 1992, TUBERCLE LUNG DIS, V73, P150, DOI 10.1016/0962-8479(92)90149-E; ROMANUS V, 1995, TUBERCLE LUNG DIS, V76, P300, DOI 10.1016/S0962-8479(05)80028-0; Roth A, 2004, PEDIATR INFECT DIS J, V23, P544, DOI 10.1097/01.inf.0000129693.81082.a0; Salaniponi FML, 2004, INT J TUBERC LUNG D, V8, P718; SCHAAF HS, 2004, CLIN TUBERCULOSIS, P154; SHARMA R S, 1989, Journal of Communicable Diseases, V21, P200; SNIDER DE, 1988, PEDIATR INFECT DIS J, V7, P271, DOI 10.1097/00006454-198804000-00008; Spyridis P, 2003, INT J TUBERC LUNG D, V7, P248; Styblo K, 1969, Bull Int Union Tuberc, V42, P1; STYBLO K, 1982, Bulletin of the International Union Against Tuberculosis, V57, P133; Styblo K, 2001, INT J TUBERC LUNG D, V5, P103; Styblo K., 1985, B INT UNION TUBERC, V60, P117; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Thilothammal N, 1996, ARCH DIS CHILD, V74, P144, DOI 10.1136/adc.74.2.144; TRNKA L, 1994, TUBERCLE LUNG DIS, V75, P348, DOI 10.1016/0962-8479(94)90080-9; Tupasi TE, 2000, INT J TUBERC LUNG D, V4, P216; Tupasi TE, 1999, INT J TUBERC LUNG D, V3, P471; *UN POP DIV, 2002, WORLD POP PROSP 2002; *WHO, VACC IMM BIOL STAT G; *WHO, 2005, GLOB TUB CONTR SURV, P247; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; World Health Organization, 2004, WORLD HLTH REP 2004; WUNSCH V, 1990, B WORLD HEALTH ORGAN, V68, P69; WUNSCHFILHO V, 1993, INT J EPIDEMIOL, V22, P149, DOI 10.1093/ije/22.1.149; YAMADA N, 2005, NATL TB SURVEY 2002, P40; Zodpey S P, 1996, J Indian Med Assoc, V94, P338	74	721	758	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1173	1180		10.1016/S0140-6736(06)68507-3	http://dx.doi.org/10.1016/S0140-6736(06)68507-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030ZH	16616560				2022-12-28	WOS:000236673400026
J	Tugwell, P; Petticrew, M; Robinson, V; Kristjansson, E; Maxwell, L				Tugwell, P; Petticrew, M; Robinson, V; Kristjansson, E; Maxwell, L		Cochrane Equity Field Editorial Te	Cochrane and Campbell Collaborations, and health equity	LANCET			English	Editorial Material							INEQUALITIES; SMOKING; CHILD		Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Tugwell, P (corresponding author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	elacasse@uottawa.ca	Tugwell, Peter/AFD-8076-2022; Petticrew, Mark/AAY-6274-2021	Tugwell, Peter/0000-0001-5062-0556; Welch, Vivian/0000-0002-5238-7097	Medical Research Council [MC_U130059812] Funding Source: Medline; Chief Scientist Office [SPHSU1] Funding Source: Medline; MRC [MC_U130059812] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arblaster L, 1996, J Health Serv Res Policy, V1, P93; Bambas L, 2004, COURSE READER HLTH E; Barnes J, 2005, J CHILD PSYCHOL PSYC, V46, P952, DOI 10.1111/j.1469-7610.2004.00392.x; *COCHR COLL, 2006, CAMPBELL COCHRA 0309; GWATKIN D, 2001, LEADERSHIP FORUM REA; Koolman X, 2004, HEALTH ECON, V13, P649, DOI 10.1002/hec.884; Mackenbach JP, 2003, J EPIDEMIOL COMMUN H, V57, P162, DOI 10.1136/jech.57.3.162; Milanovic B, 1997, ECON LETT, V56, P45, DOI 10.1016/S0165-1765(97)00101-8; Moser KA, 2005, BRIT MED J, V331, P1180, DOI 10.1136/bmj.38659.588125.79; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Thomas J, 2004, BRIT MED J, V328, P1010, DOI 10.1136/bmj.328.7446.1010; Thomson H, 2001, BRIT MED J, V323, P187, DOI 10.1136/bmj.323.7306.187; Tsikata S, 2003, 11 COCHR C BARC SPAI; Tugwell P, 2006, BMJ-BRIT MED J, V332, P358, DOI 10.1136/bmj.332.7537.358; WAGSTAFF A, 1991, J HEALTH ECON, V10, P21, DOI 10.1016/0167-6296(91)90015-F; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Wiltshire S, 2001, BRIT MED J, V323, P203, DOI 10.1136/bmj.323.7306.203; Woodall AA, 2005, BRIT MED J, V331, P488, DOI 10.1136/bmj.38576.467292.EB; *WORLD BANK, 2004, ROUND 1 COUNTR REP H; YASBECK AS, 2005, REACHING POOR HLTH N	20	32	32	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1128	1130		10.1016/S0140-6736(06)68490-0	http://dx.doi.org/10.1016/S0140-6736(06)68490-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030ZH	16616547				2022-12-28	WOS:000236673400009
J	Kislinger, T; Cox, B; Kannan, A; Chung, C; Hu, PZ; Ignatchenko, A; Scott, MS; Gramolini, AO; Morris, Q; Hallett, MT; Rossant, J; Hughes, TR; Frey, B; Emili, A				Kislinger, T; Cox, B; Kannan, A; Chung, C; Hu, PZ; Ignatchenko, A; Scott, MS; Gramolini, AO; Morris, Q; Hallett, MT; Rossant, J; Hughes, TR; Frey, B; Emili, A			Global survey of organ and organelle protein expression in mouse: Combined proteomic and transcriptomic profiling	CELL			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; SPECTROMETRY-BASED PROTEOMICS; YEAST PROTEOME; MEMBRANE PROTEINS; GENE-EXPRESSION; SCALE; IDENTIFICATION; ABUNDANCE; GENOME; LOCATIONS	Organs and organelles represent core biological systems in mammals, but the diversity in protein composition remains unclear. Here, we combine subcellular fractionation with exhaustive tandem mass spectrometry-based shotgun sequencing to examine the protein content of four major organellar compartments (cytosol, membranes [microsomes], mitochondria, and nuclei) in six organs (brain, heart, kidney, liver, lung, and placenta) of the laboratory mouse, Mus musculus. Using rigorous statistical filtering and machine-learning methods, the subcellular localization of 3274 of the 4768 proteins identified was determined with high confidence, including 1503 previously uncharacterized factors, while tissue selectivity was evaluated by comparison to previously reported mRNA expression patterns. This molecular compendium, fully accessible via a searchable web-browser interface, serves as a reliable reference of the expressed tissue and organelle proteomes of a leading model mammal.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Dept Dev Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; McGill Univ, Ctr Bioinformat, Montreal, PQ H3A 2B4, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University	Emili, A (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St,Room 914, Toronto, ON M5S 3E1, Canada.	andrew.emili@utoronto.ca	Morris, Quaid/ABE-8343-2020; Scott, Michelle/C-7445-2013; Kislinger, Thomas/A-5934-2008	Scott, Michelle/0000-0001-6231-7714; Hallett, Michael/0000-0001-6738-6786; Morris, Quaid/0000-0002-2760-6999; Ignatchenko, Alexandr/0000-0002-6083-941X; Hu, Pingzhao/0000-0002-9546-2245; Kislinger, Thomas/0000-0003-3525-5540				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Brunet S, 2003, TRENDS CELL BIOL, V13, P629, DOI 10.1016/j.tcb.2003.10.006; Cai YD, 2004, BIOINFORMATICS, V20, P1151, DOI 10.1093/bioinformatics/bth054; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HECHENBICHLER K, 2004, 399 SFB; Huang Y, 2004, BIOINFORMATICS, V20, P21, DOI 10.1093/bioinformatics/btg366; IMAOKA S, 1995, ARCH BIOCHEM BIOPHYS, V321, P255, DOI 10.1006/abbi.1995.1393; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Krapfenbauer K, 2003, ELECTROPHORESIS, V24, P1847, DOI 10.1002/elps.200305401; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mott R, 2002, GENOME RES, V12, P1168, DOI 10.1101/gr.96802; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nielsen PA, 2005, MOL CELL PROTEOMICS, V4, P402, DOI 10.1074/mcp.T500002-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	50	384	402	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					173	186		10.1016/j.cell.2006.01.044	http://dx.doi.org/10.1016/j.cell.2006.01.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615898	Bronze			2022-12-28	WOS:000237314200022
J	Moreau, CS; Bell, CD; Vila, R; Archibald, SB; Pierce, NE				Moreau, CS; Bell, CD; Vila, R; Archibald, SB; Pierce, NE			Phylogeny of the ants: Diversification in the age of angiosperms	SCIENCE			English	Article							HYMENOPTERA; ORIGIN; FORMICIDAE	We present a large-scale molecular phylogeny of the ants (Hymenoptera: Formicidae), based on 4.5 kilobases of sequence data from six gene regions extracted from 139 of the 288 described extant genera, representing 19 of the 20 subfamilies. All but two subfamilies are recovered as monophyletic. Divergence time estimates calibrated by minimum age constraints from 43 fossils indicate that most of the subfamilies representing extant ants arose much earlier than previously proposed but only began to diversify during the Late Cretaceous to Early Eocene. This period also witnessed the rise of angiosperms and most herbivorous insects.	Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Florida State Univ, Sch Computat Sci, Dirac Sci Lib 150R, Tallahassee, FL 32306 USA	Harvard University; State University System of Florida; Florida State University	Moreau, CS (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	cmoreau@oeb.harvard.edu	Vila, Roger/A-1817-2012; Moreau, Corrie S/B-2889-2011	Vila, Roger/0000-0002-2447-4388; Moreau, Corrie/0000-0003-1139-5792				Astruc C, 2004, MOL PHYLOGENET EVOL, V31, P880, DOI 10.1016/j.ympev.2003.10.024; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bolton B., 2003, SYNOPSIS CLASSIFICAT; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Crozier RH, 1997, NATURWISSENSCHAFTEN, V84, P22, DOI 10.1007/s001140050341; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; Dlussky G.M.., 1997, PALEONTOL J+, V31, P616; Dlussky G. M., 2003, RUSS ENTOMOL J, V11, P411; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Grimaldi David, 1997, American Museum Novitates, V3208, P1; Grimaldi David, 2005, pi; Holldobler B., 1990, pi; Nel A., 2004, Geologica Acta, V2, P23; Ohnishi H, 2003, GENES GENET SYST, V78, P419, DOI 10.1266/ggs.78.419; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; SHATTUCK SO, 1992, SYST ENTOMOL, V17, P199, DOI 10.1111/j.1365-3113.1992.tb00332.x; TAYLOR RW, 1978, SCIENCE, V201, P979, DOI 10.1126/science.201.4360.979; Tobin John E., 1994, P279; URBANI CB, 1992, SYST ENTOMOL, V17, P301, DOI 10.1111/j.1365-3113.1992.tb00553.x; Ward Philip S., 2005, Myrmecologische Nachrichten, V7, P87; WARD PS, 1994, SYST ENTOMOL, V19, P159, DOI 10.1111/j.1365-3113.1994.tb00585.x; Ward PS, 2003, INVERTEBR SYST, V17, P361, DOI 10.1071/IS02046; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102	28	609	634	2	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					101	104		10.1126/science.1124891	http://dx.doi.org/10.1126/science.1124891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601190				2022-12-28	WOS:000236584400040
J	Wodtke, AM				Wodtke, AM			Chemistry in a computer: Advancing the in silico dream	SCIENCE			English	Editorial Material							DENSITY-FUNCTIONAL THEORY		Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Wodtke, AM (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	wodtke@chem.ucsb.edu	Wodtke, Alec M/I-4848-2012	Wodtke, Alec/0000-0002-6509-2183				Behler J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036104; Chao SD, 2002, J CHEM PHYS, V117, P8341, DOI 10.1063/1.1504083; Diekhoner L, 2002, J CHEM PHYS, V117, P5018, DOI 10.1063/1.1498476; EYRING H, 1935, Z PHYS CHEM B LPZ, V12, P4; Hellman A, 2003, SURF SCI, V532, P126, DOI 10.1016/S0039-6028(03)00111-0; Huang YH, 2000, SCIENCE, V290, P111, DOI 10.1126/science.290.5489.111; Jacobsen CJH, 2002, J CATAL, V205, P382, DOI 10.1006/jcat.2001.3442; Kohn W, 1996, J PHYS CHEM-US, V100, P12974, DOI 10.1021/jp960669l; Nieto P, 2006, SCIENCE, V312, P86, DOI 10.1126/science.1123057; White JD, 2005, NATURE, V433, P503, DOI 10.1038/nature03213	10	9	9	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					64	65		10.1126/science.1124924	http://dx.doi.org/10.1126/science.1124924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601182	Green Submitted			2022-12-28	WOS:000236584400028
J	Heal, C; Buettner, P; Raasch, B; Browning, S; Graham, D; Bidgood, R; Campbell, M; Cruikshank, R				Heal, C; Buettner, P; Raasch, B; Browning, S; Graham, D; Bidgood, R; Campbell, M; Cruikshank, R			Can sutures get wet? Prospective randomised controlled trial of wound management in general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFECTION; SURGERY	Objective To compare standard management of keeping wounds dry and covered with allowing wounds to be uncovered and wet in the first 48 hours after minor skin excision. Design Prospective, randomised controlled, multicentre trial testing for equivalence of infection rates. Setting Primary care in regional centre, Queensland, Australia. Participants 857 patients randomised to either keep their wound dry and covered (n = 442) or remove the dressing and wet the wound (n = 4 15). Results The incidence of infection ill the intervention group (8.4%) was not inferior to the incidence ill the control group (8.9%) (P < 0.05). The one sided 95% confidence interval for the difference of infection rates was infinity to 0.028. Conclusion Wounds can be uncovered and allowed to get wet in the first 48 hours after minor skin excision without increasing the incidence of infection.	James Cook Univ, Townsville, Qld, Australia	James Cook University	Heal, C (corresponding author), 10 Sunset Beach Court,Shoal Point, Mackay, Qld 4750, Australia.	clarshel@hotmail.com	Heal, Clare/D-3786-2015	Heal, Clare/0000-0002-5041-2666				AJAO OG, 1977, J TROP MED HYG, V80, P192; AJOA OG, J TROP MED HYG, V80, P192; *AUSTR GOV, CHIM AV MACK MO; BRITT H, 2005, GEN PRACTICE SERIES, V18; Bruce J, 2001, J HOSP INFECT, V49, P99, DOI 10.1053/jhin.2001.1045; Carragee EJ, 1996, SPINE, V21, P2160, DOI 10.1097/00007632-199609150-00020; COLEBROOK L, 1948, LANCET, V252, P682, DOI 10.1016/S0140-6736(48)91114-3; CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; EDLICH RF, 1992, WOUND HEALING, P581; GOLDBERG HM, 1981, AM J SURG, V141, P358, DOI 10.1016/0002-9610(81)90196-3; LATHLEAN S, 1999, AUST FAM PHYS S1, V28; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Merei JM, 2004, J PEDIATR SURG, V39, P1871, DOI 10.1016/j.jpedsurg.2004.08.017; NAGACHINTA T, 1987, J INFECT DIS, V156, P967, DOI 10.1093/infdis/156.6.967; Neues C, 2000, CHIRURG, V71, P234, DOI 10.1007/s001040050040; NOE JM, 1988, PLAST RECONSTR SURG, V81, P82; THOMAS S, 1990, WOUND MANAGEMENT DRE, P9; WEISS Y, 1983, INT SURG, V68, P237	18	60	59	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1053	1054B		10.1136/bmj.38800.628704.AE	http://dx.doi.org/10.1136/bmj.38800.628704.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16636023	Green Published, Bronze			2022-12-28	WOS:000237518400012
J	Young, R; Sweeting, H; West, P				Young, R; Sweeting, H; West, P			Prevalence of deliberate self harm and attempted suicide within contemporary Goth youth subculture: longitudinal cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To investigate whether deliberate self harm is associated with contemporary Goth youth subculture. Design Longitudinal cohort study. Setting School and community based study of young people living in the Central Clydeside Conurbation, Scotland. Participants 1258 people aged 19, surveyed in 2002-4 and followed-up since age 11 (1994). Main outcome measures Lifetime prevalence of self harm and attempted suicide and their association with Goth youth subculture, before and after adjusting for confounders. Results Identification as belonging to the Goth Subculture was strongly associated with lifetime self harm and attempted suicide, with a prevalence of 53% and 47%, respectively among the most highly identified group, and evidence for a dose-response relation. Adjusting for potential confounders did not significantly attenuate this association. Analysis of other youth subcultures showed that this effect was primarily associated with Goth subculture. Conclusions Identification as belonging to the Goth subculture was the best predictor of self harm and attempted suicide. Although based on small numbers, additional longitudinal analysis suggests both selection and modelling mechanisms are involved, selection mechanisms possibly being more likely.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Young, R (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	robert@msoc.mrc.gla.ac.uk			Medical Research Council [MC_U130059818] Funding Source: Medline; MRC [MC_U130059818] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Hawton K, 2005, BRIT MED J, V330, P891, DOI 10.1136/bmj.330.7496.891; Hodkinson Paul, 2002, GOTH IDENTITY STYLE; KANDEL DB, 1982, ARCH GEN PSYCHIAT, V39, P1205; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Skegg K, 2003, AM J PSYCHIAT, V160, P541, DOI 10.1176/appi.ajp.160.3.541; West P, 2003, J AM ACAD CHILD PSY, V42, P941, DOI 10.1097/01.CHI.0000046907.27264.E4; West P, 2001, SOCIOLOGY, V35, P539, DOI 10.1177/S0038038501000268; 2002, BEYOND PALE	9	81	84	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1058	1061		10.1136/bmj.38790.495544.7C	http://dx.doi.org/10.1136/bmj.38790.495544.7C			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16613936	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000237518400014
J	Lim, W; Dentali, F; Eikelboom, JW; Crowther, MA				Lim, W; Dentali, F; Eikelboom, JW; Crowther, MA			Meta-analysis: Low-molecular-weight heparin and bleeding in patients with severe renal insufficiency	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE-CORONARY-SYNDROME; INTRAVENOUS UNFRACTIONATED HEPARIN; GLOMERULAR-FILTRATION-RATE; UNSTABLE ANGINA PATIENTS; DEEP VENOUS THROMBOSIS; ELDERLY-PATIENTS; ANTI-XA; RECEIVING ENOXAPARIN; PULMONARY-EMBOLISM; CONTROLLED-TRIALS	Background: Dose adjustment or laboratory monitoring of low-molecular-weight heparin (LMWH) is commonly recommended for patients with severe renal insufficiency (creatinine clearance :530 mL/min), but the basis for this recommendation is unclear. Purpose: To compare levels of anti-Xa heparin and risk for major bleeding in LMWH-treated patients with a creatinine clearance of 30 mL/min or less versus those with a creatinine clearance greater than 30 mL/min by using standard weight-adjusted therapeutic doses, empirically adjusted doses, or prophylactic doses of LMWH. Data Sources: Electronic databases (MEDLINE, EMBASE, and the Cochrane Library) searched to December 2005 with no language restrictions. The authors also searched reference lists and contacted experts. Study Selection: Observational or subgroups of randomized studies that included non-dialysis-de pendent patients with varying degrees of renal function who were treated with LMWH and reported creatinine clearance and anti-Xa levels or major bleeding. Data Extraction: Two reviewers independently selected studies and extracted data on patient characteristics, renal function, LMWH treatment, anti-Xa levels, and major bleeding. The pooled odds ratio of major bleeding in patients with a creatinine clearance of 30 mL/min or less was calculated by using the Peto method. Data Synthesis: Eighteen studies using 3 preparations of LMWH (15 studies using enoxaparin, 2 using tinzaparin, and 1 using dalte-parin) were included. Peak anti-Xa levels measured 4 hours after a subcutaneous injection were statistically significantly higher in patients with a creatinine clearance of 30 mL/min or less compared with those with a creatinine clearance greater than 30 mL/min in studies that used a standard therapeutic dose of enoxaparin (4 studies) but not in studies of empirically dose-adjusted enoxaparin (3 studies). Data were insufficient to assess the relationship between anti-Xa and renal function for prophylactic doses of enoxaparin and therapeutic doses of tinzaparin or dalteparin. In 12 studies involving 4971 patients, LMWH was associated with a statistically significant increase in the risk for major bleeding in patients with a creatinine clearance of 30 mL/min or less compared with those with a creatinine clearance greater than 30 mL/min (5.0% vs. 2.4%; odds ratio, 2.25 [95% CI, 1.19 to 4.27]; P= 0.013). When analyzed according to LAAWH preparation, major bleeding was increased when a standard therapeutic dose of enoxaparin was used (8.3% vs. 2.4%; odds ratio, 3.88 [CI, 1.78 to 8.45]) but may not be increased when an empirically adjusted dose of enoxaparin is used (0.9% vs. 1.9%; odds ratio, 0.58 [CI, 0.09 to 3.78]; P = 0.23 for heterogeneity). There were insufficient studies to assess the risk for major bleeding with tinzaparin, dalteparin, and prophylactic doses of enoxaparin. Limitations: The data for tinzaparin and dalteparin were limited. Data are observational, and the potential for confounding cannot be excluded. Conclusions: Non-dialysis-dependent patients with a creatinine clearance of 30 mL/min or less who are treated with standard therapeutic doses of enoxaparin have elevated levels of anti-Xa and an increased risk for major bleeding. Empirical dose adjustment of enoxaparin may reduce the risk for bleeding and merits additional evaluation. No conclusions can be made regarding other LMWHs.	McMaster Univ, Hamilton, ON L8S 4L8, Canada; Hamilton Gen Hosp, Hamilton, ON, Canada; Univ Insubria, Varese, Italy	McMaster University; McMaster University; University of Insubria	Lim, W (corresponding author), St Josephs Hosp, 50 Charlton Ave E,Room L208, Hamilton, ON L8N 4A6, Canada.	limwp@mcmaster.ca	Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285				Barrett JS, 2001, INT J CLIN PHARM TH, V39, P431; Bazinet A, 2005, THROMB RES, V116, P41, DOI 10.1016/j.thromres.2004.10.004; Becker RC, 2002, AM HEART J, V143, P753, DOI 10.1067/mhj.2002.120774; Boneu B, 1990, Baillieres Clin Haematol, V3, P531, DOI 10.1016/S0950-3536(05)80017-4; Brophy DF, 2004, AM J KIDNEY DIS, V44, P270, DOI 10.1053/j.ajkd.2004.04.032; Brophy DF, 2001, PHARMACOTHERAPY, V21, P169, DOI 10.1592/phco.21.2.169.34113; Bruno R, 2003, BRIT J CLIN PHARMACO, V56, P407, DOI 10.1046/j.1365-2125.2003.01904.x; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Busby LT, 2001, AM J HEMATOL, V67, P54, DOI 10.1002/ajh.1077; CADROY Y, 1991, THROMB RES, V63, P385, DOI 10.1016/0049-3848(91)90141-I; Cestac P, 2003, DRUG SAFETY, V26, P197, DOI 10.2165/00002018-200326030-00005; Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7; Chow SL, 2003, J CLIN PHARMACOL, V43, P586, DOI 10.1177/0091270003253420; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collet JP, 2005, EUR HEART J, V26, P2285, DOI 10.1093/eurheartj/ehi337; Collet JP, 2003, J AM COLL CARDIOL, V41, P8, DOI 10.1016/S0735-1097(02)02664-5; Collet JP, 2001, INT J CARDIOL, V80, P81, DOI 10.1016/S0167-5273(01)00455-7; Cornelli U, 1999, SEMIN THROMB HEMOST, V25, P57; Desjardins L, 2004, ARCH PATHOL LAB MED, V128, P519; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farooq V, 2004, AM J KIDNEY DIS, V43, P531, DOI 10.1053/j.ajkd.2003.11.012; FOLLEA G, 1986, HAEMOSTASIS, V16, P147; Frydman A, 1996, HAEMOSTASIS, V26, P24; Gerlach AT, 2000, PHARMACOTHERAPY, V20, P771, DOI 10.1592/phco.20.9.771.35210; Gibson CM, 2004, EUR HEART J, V25, P1998, DOI 10.1016/j.ehj.2004.08.016; GOUDABLE C, 1991, NEPHRON, V59, P543, DOI 10.1159/000186641; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; Green B, 2005, BRIT J CLIN PHARMACO, V59, P281, DOI 10.1111/j.1365-2125.2004.02253.x; Harenberg J, 2004, J THROMB HAEMOST, V2, P547, DOI 10.1111/j.1538-7933.2004.00647.x; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; HORY B, 1991, THROMB RES, V63, P311, DOI 10.1016/0049-3848(91)90134-I; Hulot JS, 2005, CLIN PHARMACOL THER, V77, P542, DOI 10.1016/j.clpt.2005.02.012; Hulot JS, 2004, THER DRUG MONIT, V26, P305, DOI 10.1097/00007691-200406000-00015; Kane-Gill SL, 2005, J CLIN PHARM THER, V30, P207, DOI 10.1111/j.1365-2710.2005.00634.x; Khazan M, 2003, PHARMACOTHERAPY, V23, P651, DOI 10.1592/phco.23.5.651.32208; Kovacs MJ, 2000, THROMB HAEMOSTASIS, V84, P138; Kruse MW, 2004, AM HEART J, V148, P582, DOI 10.1016/j.ahj.2004.04.015; Laposata M, 1998, ARCH PATHOL LAB MED, V122, P799; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Ma JM, 2004, ANN PHARMACOTHER, V38, P1576, DOI 10.1345/aph.1E096; Macie C, 2004, CHEST, V125, P1616, DOI 10.1378/chest.125.5.1616; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; Mahe I, 2002, PATHOPHYSIOL HAEMO T, V32, P134, DOI 10.1159/000065216; Mismetti P, 1998, THROMB HAEMOSTASIS, V79, P1162; Montalescot G, 2004, CIRCULATION, V110, P392, DOI 10.1161/01.CIR.0000136830.65073.C7; Nagge J, 2002, ARCH INTERN MED, V162, P2605, DOI 10.1001/archinte.162.22.2605; Pautas E, 2002, DRUG SAFETY, V25, P725, DOI 10.2165/00002018-200225100-00005; Pautas E, 2001, REV MED INTERNE, V22, P120, DOI 10.1016/S0248-8663(00)00301-5; Peng Yan Ghee, 2004, Journal of Pharmacy Practice and Research, V34, P14; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Sanderink GJCM, 2002, THROMB RES, V105, P225, DOI 10.1016/S0049-3848(02)00031-2; Shprecher AR, 2005, PHARMACOTHERAPY, V25, P817, DOI 10.1592/phco.2005.25.6.817; Siguret V, 2000, THROMB HAEMOSTASIS, V84, P800; Spinler SA, 2003, AM HEART J, V146, P33, DOI 10.1016/S0002-8703(03)00121-2; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thorevska N, 2004, CHEST, V125, P856, DOI 10.1378/chest.125.3.856	56	323	343	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					673	684		10.7326/0003-4819-144-9-200605020-00011	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00011			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039GJ	16670137				2022-12-28	WOS:000237293700007
J	Carroll, SM				Carroll, SM			Is our Universe natural?	NATURE			English	Review							INFLATIONARY UNIVERSE; COSMOLOGY; SCENARIO; FLATNESS; HORIZON; THEOREM	It goes without saying that we are stuck with the Universe we have. Nevertheless, we would like to go beyond simply describing our observed Universe, and try to understand why it is that way rather than some other way. When considering both the state in which we find our current Universe, and the laws of physics it obeys, we discover features that seem remarkably unnatural to us. Physicists and cosmologists have been exploring increasingly ambitious ideas in an attempt to explain how surprising aspects of our Universe can arise from simple dynamical principles.	Univ Chicago, Enrico Fermi Inst, Dept Phys, Chicago, IL 60637 USA; Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Carroll, SM (corresponding author), Univ Chicago, Enrico Fermi Inst, Dept Phys, 5640 S Ellis Ave, Chicago, IL 60637 USA.	carroll@theory.uchicago.edu	Carroll, Sean/C-5972-2015	Carroll, Sean/0000-0002-4226-5758				Adams A, 2005, J HIGH ENERGY PHYS; Aguirre A, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.103525; AGUIRRE A, 2005, ARXIVASTROPH0506519; AGUIRRE A, 2005, ARXIVGRQC0512034; Alberghi GL, 1999, J HIGH ENERGY PHYS; ALBERGHI GL, ARXIVHEPTH9906047; ALBRECHT A, 1982, PHYS REV LETT, V48, P1220, DOI 10.1103/PhysRevLett.48.1220; ALBRECHT A, 2004, ARXIVHEPTH0405270; Arkani-Hamed N, 2005, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2005/06/073; Arkani-Hamed N., 2005, ARXIVHEPTH0501082; Ashok SK, 2004, J HIGH ENERGY PHYS; Banks T, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/01/031; BARDEEN JM, 1983, PHYS REV D, V28, P679, DOI 10.1103/PhysRevD.28.679; Bousso R, 2000, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2000/06/006; CARDY JL, 1988, PHYS LETT B, V215, P749, DOI 10.1016/0370-2693(88)90054-8; Carroll Sean M, 2001, Living Rev Relativ, V4, P1, DOI 10.12942/lrr-2001-1; Chen, 2004, ARXIVHEPTH0410270; DIJKGRAAF R, ARXIVHEPTH0504221; Dine M, 2005, J HIGH ENERGY PHYS; Douglas MR, 2003, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2003/05/046; Dutta S, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.083507; Dyson L, 2002, J HIGH ENERGY PHYS; EASTHER R, 2005, ARXIVASTROPH0511233; FARHI E, 1990, NUCL PHYS B, V339, P417, DOI 10.1016/0550-3213(90)90357-J; Feng JL, 2001, NUCL PHYS B, V602, P307, DOI 10.1016/S0550-3213(01)00097-9; FISCHLER W, 1990, PHYS REV D, V42, P4042, DOI 10.1103/PhysRevD.42.4042; FISCHLER W, 1990, PHYS REV D, V41, P2638, DOI 10.1103/PhysRevD.41.2638; FOX PJ, 2005, ARXIVHEPTH0503249; FREIVOGEL B, 2005, ARXIVHEPTH0510046; Gaite J, 1996, PHYS REV D, V54, P5163, DOI 10.1103/PhysRevD.54.5163; Garriga J, 1998, PHYS REV D, V57, P2230, DOI 10.1103/PhysRevD.57.2230; GARRIGA J, 2005, ARXIVHEPTH0509184; Goncharov A. S., 1987, International Journal of Modern Physics A, V2, P561, DOI 10.1142/S0217751X87000211; Graesser ML, 2004, PHYS LETT B, V600, P15, DOI 10.1016/j.physletb.2004.08.061; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; GUTH AH, 1982, PHYS REV LETT, V49, P1110, DOI 10.1103/PhysRevLett.49.1110; HAWKING SW, 1982, PHYS LETT B, V115, P295, DOI 10.1016/0370-2693(82)90373-2; HELLEMAN S, 2005, ARXIVHEPTH0405041; Hollands S, 2002, GEN RELAT GRAVIT, V34, P2043, DOI 10.1023/A:1021175216055; HOLMAN R, ARXIVHEPTH0511102; Kachru S, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.046005; LINDE A, 1992, NUCL PHYS B, V372, P421, DOI 10.1016/0550-3213(92)90326-7; LINDE A, ARXIVHEPTH0211048; LINDE AD, 1982, PHYS LETT B, V108, P389, DOI 10.1016/0370-2693(82)91219-9; LINDE AD, 1986, PHYS LETT B, V175, P395, DOI 10.1016/0370-2693(86)90611-8; LINDE AD, 1983, PHYS LETT B, V129, P177, DOI 10.1016/0370-2693(83)90837-7; Martel H, 1998, ASTROPHYS J, V492, P29, DOI 10.1086/305016; McGreevy J, 2005, J HIGH ENERGY PHYS; PENROSE R, 1989, EMPERORS NEW MIND, pCH7; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; POGOSIAN L, 2004, JCAP, V407; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; STAROBINSKY AA, 1982, PHYS LETT B, V117, P175, DOI 10.1016/0370-2693(82)90541-X; Tegmark M, 1998, ASTROPHYS J, V499, P526, DOI 10.1086/305673; TEGMARK M, 2005, ARXIVASTROPH0511774; THOOFT G, 1980, NATO ADV STUDY I S B, V59; Vachaspati T, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.023502; VILENKIN A, 1988, PHYS REV D, V37, P888, DOI 10.1103/PhysRevD.37.888; VILENKIN A, 1995, PHYS REV LETT, V74, P846, DOI 10.1103/PhysRevLett.74.846; VILENKIN A, 1983, PHYS REV D, V27, P2848, DOI 10.1103/PhysRevD.27.2848; VILENKIN A, 1995, ARXIVGRQC9512031; WEINBERG S, 1987, PHYS REV LETT, V59, P2607, DOI 10.1103/PhysRevLett.59.2607	68	30	30	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1132	1136		10.1038/nature04804	http://dx.doi.org/10.1038/nature04804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641984	Green Submitted			2022-12-28	WOS:000237080000033
J	Iwahara, J; Clore, GM				Iwahara, J; Clore, GM			Detecting transient intermediates in macromolecular binding by paramagnetic NMR	NATURE			English	Article							HOMEODOMAIN-DNA COMPLEX; RELAXATION ENHANCEMENT; ANTENNAPEDIA HOMEODOMAIN; ASSOCIATION; PROTEINS; REFINEMENT; RATES	Macromolecular complex formation is governed by two opposing constraints of specificity and speed(1,2). Kinetic(3-6) and theoretical considerations suggest that significant rate enhancement can be achieved either by reducing the dimensionality of the search process(1,7) or by the creation of a short-range attractive potential around the target site(2). This implies the existence of transient intermediates involving non-specific binding modes. Here we show that intermolecular paramagnetic relaxation enhancement (PRE) provides a means of directly detecting the presence of, and investigating the nature of, low population transient intermediates under equilibrium conditions. Applying this approach, we characterize the search process whereby a sequence-specific transcription factor (the homeodomain of HOXD9) binds to non-cognate DNA sites as a means of enhancing the rate of specific association. The PRE data in the fast exchange regime reveal the presence of transient intermediates formed in a stochastic manner at non-cognate sites whose structure is similar to that of the specific complex. Two distinct search processes involving intra- as well as intermolecular translocations can be delineated. The intermolecular PRE method is general and can be readily applied to investigations of transient intermediates in many other macromolecular binding processes.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Iwahara, Junji/0000-0003-4732-2173	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029023, ZIADK029023, Z01DK029039] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam G., 1968, STRUCTURAL CHEM MOL, P198; AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Dvoretsky A, 2002, FEBS LETT, V528, P189, DOI 10.1016/S0014-5793(02)03297-0; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Lewin B., 2000, GENES; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Zhou HX, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178101	27	309	310	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1227	1230		10.1038/nature04673	http://dx.doi.org/10.1038/nature04673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16642002				2022-12-28	WOS:000237080000053
J	Sha, SH; Qiu, JH; Schacht, J				Sha, SH; Qiu, JH; Schacht, J			Aspirin to prevent gentamicin-induced hearing loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							INDUCED OTOTOXICITY		Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; Fourth Mil Med Univ, Xian 710032, Peoples R China	University of Michigan System; University of Michigan; Air Force Military Medical University	Sha, SH (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.	schacht@umich.edu						Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; GOVAERTS PJ, 1990, TOXICOL LETT, V52, P227, DOI 10.1016/0378-4274(90)90033-I; Sha SH, 1999, LAB INVEST, V79, P807; *WHO, 2005, WHOHTM2005349	4	123	139	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1856	1857		10.1056/NEJMc053428	http://dx.doi.org/10.1056/NEJMc053428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641409				2022-12-28	WOS:000237077100037
J	Gostin, LO				Gostin, LO			Physician-assisted suicide - A legitimate medical practice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*AM MED ASS, 1993, COD MED ETH PHYS ASS; [Anonymous], 2001, FED REG, V66, P56; Bloche MG, 2006, NEW ENGL J MED, V354, P993, DOI 10.1056/NEJMp068019; Gostin LO, 1997, JAMA-J AM MED ASSOC, V278, P1523, DOI 10.1001/jama.278.18.1523; Gostin LO, 2005, JAMA-J AM MED ASSOC, V294, P842, DOI 10.1001/jama.294.7.842; Greenhouse Linda, 2006, NY TIMES, pA1; LANE C, 2006, WASH POST       0221, pA1; *OR DEP HUM SERV, 2006, 8 OR DEP HUM SERV; Pew Research Center, 2006, STRONG PUBL SUPP RIG; VOGEL N, 2005, LOS ANGELES TIM 0524, pA1	10	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1941	1943		10.1001/jama.295.16.1941	http://dx.doi.org/10.1001/jama.295.16.1941			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639054				2022-12-28	WOS:000237059200030
J	Gordon, G; Chu, V				Gordon, G; Chu, V			Medical professionalism in Laos	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Lao Luxembourg Heart Inst, Dept Cardiol, Viangchan, Laos	Harvard University; Harvard Medical School	Gordon, G (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA.	gregory_gordon@vmed.org						American Board of Internal Medicine, 1995, PROJ PROF; Olness K, 2001, AMBUL CHILD HLTH, V7, P109; Swick HM, 2000, ACAD MED, V75, P612, DOI 10.1097/00001888-200006000-00010; *UN DEV PROGR, 2003, HUM DEV REP 2003 IND; *WORLD HEART FED, 2006, WORLD HEART DAY WORL	5	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 22	2006	367	9519					1302	1304		10.1016/S0140-6736(06)68557-7	http://dx.doi.org/10.1016/S0140-6736(06)68557-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631897				2022-12-28	WOS:000237118500009
J	Holmes, JM; Clarke, MP				Holmes, JM; Clarke, MP			Amblyopia	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; PARENTAL NON-CONCORDANCE; COST-UTILITY ANALYSIS; VISUAL-ACUITY; OCCLUSION THERAPY; DIABETIC-RETINOPATHY; INFANTILE CATARACT; FOLLOW-UP; VISION; CHILDREN	Results from recent randomised clinical trials in amblyopia should change our approach to screening for and treatment of amblyopia. Based on the current evidence, if one screening session is used, screening at school entry could be the most reasonable time. Clinicians should preferably use age-appropriate LogMAR acuity tests, and treatment should only be considered for children who are clearly not in the typical range for their age. Any substantial refractive error should be corrected before further treatment is considered and the child should be followed in spectacles until no further improvement is recorded, which can take up to 6 months. Parents and carers should then be offered an informed choice between patching and atropine drops. Successful patching regimens can last as little as 1 h or 2 h a day, and successful atropine regimens as little as one drop twice a week. Intense and extended regimens might not be needed in initial therapy.	Mayo Clin, Coll Med, Dept Ophthalmol, Rochester, MN 55905 USA; Newcastle Univ, Dept Ophthalmol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Mayo Clinic; Newcastle University - UK	Holmes, JM (corresponding author), Mayo Clin, Coll Med, Dept Ophthalmol, Rochester, MN 55905 USA.	holmes.jonathan@mayo.edu		Holmes, Jonathan/0000-0002-7663-2034	NEI NIH HHS [EY011751, EY015799] Funding Source: Medline; NATIONAL EYE INSTITUTE [U10EY011751, R01EY015799] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams GGW, 1999, BRIT J OPHTHALMOL, V83, P380; ALLEN HF, 1957, AM J OPHTHALMOL, V44, P38, DOI 10.1016/0002-9394(57)91953-0; *AM AC OPHTH, 2002, PED EYE EV PREF PRAC; ATKINSON J, 1983, ACTA OPHTHALMOL, P18; Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Awan M, 2005, INVEST OPHTH VIS SCI, V46, P1435, DOI 10.1167/iovs.04-0971; BALDONE JA, 1963, J LA STATE MED SOC, V116, P420; Beck R W, 1998, J AAPOS, V2, P255, DOI 10.1016/S1091-8531(98)90079-9; Beck RW, 2003, OPHTHALMOLOGY, V110, P2075, DOI 10.1016/S0161-6420(03)01023-6; Beck RW, 2003, AM J OPHTHALMOL, V135, P194, DOI 10.1016/S0002-9394(02)01825-1; Berg AO, 2004, ANN FAM MED, V2, P263, DOI 10.1370/afm.193; BROWDER JA, 1974, CLIN PEDIATR, V13, P983, DOI 10.1177/000992287401301111; CAMPBELL FW, 1978, BRIT J OPHTHALMOL, V62, P748, DOI 10.1136/bjo.62.11.748; Campos EC, 1997, DOC OPHTHALMOL, V93, P247, DOI 10.1007/BF02569065; CAMPOS EC, 1995, GRAEF ARCH CLIN EXP, V233, P307, DOI 10.1007/BF00177654; Choong YF, 2004, EYE, V18, P369, DOI 10.1038/sj.eye.6700647; Chua B, 2004, BRIT J OPHTHALMOL, V88, P1119, DOI 10.1136/bjo.2004.041863; CLARKE M, 2003, 9 M INT STRAB ASS SY, P167; Clarke MP, 2003, BMJ-BRIT MED J, V327, P1251, DOI 10.1136/bmj.327.7426.1251; Cole SR, 2001, J AAPOS, V5, P250, DOI 10.1067/mpa.2001.117097; Cotter S, 2003, AM J OPHTHALMOL, V136, P630, DOI 10.1016/S0002-9394(03)00458-6; Davis AP, 2003, INVEST OPHTH VIS SCI, V44, P610, DOI 10.1167/iovs.02-0240; Eastgate RM, 2006, EYE, V20, P370, DOI 10.1038/sj.eye.6701882; El Mallah MK, 2000, BRIT J OPHTHALMOL, V84, P952, DOI 10.1136/bjo.84.9.952; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Getz LM, 1996, INVEST OPHTH VIS SCI, V37, P180; Glaser SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P268; Goodyear BG, 2000, J NEUROPHYSIOL, V84, P1907, DOI 10.1152/jn.2000.84.4.1907; GOTTLOB I, 1990, INVEST OPHTH VIS SCI, V31, P776; GOTTLOB I, 1995, GRAEF ARCH CLIN EXP, V233, P407, DOI 10.1007/BF00180943; GOTTLOB I, 1992, INVEST OPHTH VIS SCI, V33, P2722; Gregson R, 2002, EYE, V16, P461, DOI 10.1038/sj.eye.6700102; Hartmann EE, 2000, PEDIATRICS, V106, P1105, DOI 10.1542/peds.106.5.1105; Hazell CD., 1995, BR ORTHOPT J, V52, P8; Holmes JM, 2003, OPHTHAL EPIDEMIOL, V10, P67, DOI 10.1076/opep.10.2.67.13894; Holmes JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1625; Holmes JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1345; Hrisos S, 2004, OPHTHALMOLOGY, V111, P1550, DOI 10.1016/j.ophtha.2003.12.059; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P507; KAY H, 1983, BRIT J OPHTHALMOL, V67, P131, DOI 10.1136/bjo.67.2.131; Keech RV, 2002, OPHTHALMOLOGY, V109, P2261, DOI 10.1016/S0161-6420(02)01282-4; Konig H H, 2000, Strabismus, V8, P79, DOI 10.1076/0927-3972(200006)8:2;1-2;FT079; Konig HH, 2004, PEDIATRICS, V113, P95, DOI 10.1542/peds.113.2.e95; LAM GC, 1993, OPHTHALMOLOGY, V100, P1751; Leguire LE, 2002, J PEDIAT OPHTH STRAB, V39, P326, DOI 10.3928/0191-3913-20021101-05; Lempert P, 2004, OPHTHALMOLOGY, V111, P304, DOI 10.1016/j.ophtha.2003.05.020; Lempert P, 2000, J AAPOS, V4, P258, DOI 10.1067/mpa.2000.106963; Loudon SE, 2005, STRABISMUS, V13, P93, DOI 10.1080/09273970590949818; Loudon S E, 2002, Strabismus, V10, P79, DOI 10.1076/stra.10.2.79.8143; Loudon SE, 2004, GRAEF ARCH CLIN EXP, V242, P736, DOI 10.1007/s00417-004-0896-9; Loudon SE, 2003, GRAEF ARCH CLIN EXP, V241, P176, DOI 10.1007/s00417-002-0570-z; LOUDON SE, 2003, INVEST OPHTH VIS SCI, V44, P4246; MCGRAW PV, 1993, OPHTHAL PHYSL OPT, V13, P400, DOI 10.1111/j.1475-1313.1993.tb00499.x; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Membreno JH, 2002, OPHTHALMOLOGY, V109, P2265, DOI 10.1016/S0161-6420(02)01286-1; Mintz-Hittner HA, 2000, ARCH OPHTHALMOL-CHIC, V118, P1535; Morrison DG, 2005, J PEDIAT OPHTH STRAB, V42, P52; Moseley MJ, 2002, OPHTHAL PHYSL OPT, V22, P296, DOI 10.1046/j.1475-1313.2002.00034.x; National Eye Institute, 1984, VA IMP SURV PIL STUD; Newsham D, 2000, BRIT J OPHTHALMOL, V84, P957, DOI 10.1136/bjo.84.9.957; Newsham D, 2002, BRIT J OPHTHALMOL, V86, P787, DOI 10.1136/bjo.86.7.787; OLIVER M, 1986, AM J OPHTHALMOL, V102, P340, DOI 10.1016/0002-9394(86)90008-5; Park KH, 2004, EYE, V18, P571, DOI 10.1038/sj.eye.6700671; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Rahi JS, 1999, BRIT MED J, V318, P362, DOI 10.1136/bmj.318.7180.362; Rahi JS, 2002, LANCET, V360, P621, DOI 10.1016/S0140-6736(02)09775-1; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Repka MS, 2004, OPHTHALMOLOGY, V111, P2076, DOI 10.1016/j.ophtha.2004.04.032; Repka MX, 2005, J AAPOS, V9, P129, DOI 10.1016/j.jaapos.2004.12.014; Repka MX, 2005, ARCH OPHTHALMOL-CHIC, V123, P149; Repka MX, 2002, ARCH OPHTHALMOL-CHIC, V120, P281; Rice ML, 2004, AM J OPHTHALMOL, V137, P278, DOI 10.1016/j.ajo.2003.08.016; Richardson SR, 2005, INVEST OPHTH VIS SCI, V46, P150, DOI 10.1167/iovs.04-0672; Rydberg A, 1999, Strabismus, V7, P1, DOI 10.1076/stra.7.1.1.656; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; Schmidt P, 2005, INVEST OPHTH VIS SCI, V46, P2639, DOI 10.1167/iovs.05-0141; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Searle A, 2002, EYE, V16, P150, DOI 10.1038/sj/EYE/6700086; Simons K, 1999, BRIT J OPHTHALMOL, V83, P582, DOI 10.1136/bjo.83.5.582; Simons K, 1997, OPHTHALMOLOGY, V104, P2143, DOI 10.1016/S0161-6420(97)30048-7; Simons K, 2005, SURV OPHTHALMOL, V50, P123, DOI 10.1016/j.survophthal.2004.12.005; Snowdon SK, 1997, HEALTH TECHNOL ASSES, V1, P1; Stewart C., 2000, BR ORTHOPT J, V57, P32; Stewart CE, 2005, INVEST OPHTH VIS SCI, V46, P3152, DOI 10.1167/iovs.05-0357; Stewart CE, 2004, BRIT J OPHTHALMOL, V88, P1552, DOI 10.1136/bjo.2004.044214; Stewart CE, 2004, INVEST OPHTH VIS SCI, V45, P3048, DOI 10.1167/iovs.04-0250; Stewart CE, 2005, INVESET OPHTHALMOL V, V46, P3595; Swanson J, 2003, PEDIATRICS, V111, P902; Tan JHY, 2003, BRIT J OPHTHALMOL, V87, P291, DOI 10.1136/bjo.87.3.291; TOMMILA V, 1981, BRIT J OPHTHALMOL, V65, P575, DOI 10.1136/bjo.65.8.575; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; VONNOORDEN GK, 1992, INVEST OPHTH VIS SCI, V33, P2729; VONNOORDEN GK, 1979, T OPHTHAL SOC UK, V99, P442; Waddingham PE, 2006, EYE, V20, P375, DOI 10.1038/sj.eye.6701883; Wallace David K, 2005, Am Orthopt J, V55, P76, DOI 10.3368/aoj.55.1.76; Williams C, 2002, BMJ-BRIT MED J, V324, P1549, DOI 10.1136/bmj.324.7353.1549; Williams C, 2001, Ophthalmic Epidemiol, V8, P279; WILLIAMS C, 1995, BRIT J OPHTHALMOL, V79, P218, DOI 10.1136/bjo.79.3.218; WOODRUFF G, 1994, EYE, V8, P627, DOI 10.1038/eye.1994.157; WRIGHT KW, 1986, ARCH OPHTHALMOL-CHIC, V104, P549	101	272	279	1	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1343	1351		10.1016/S0140-6736(06)68581-4	http://dx.doi.org/10.1016/S0140-6736(06)68581-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631913				2022-12-28	WOS:000237118500029
J	Coppens, I; Dunn, JD; Romano, JD; Pypaert, M; Zhang, H; Boothroyd, JC; Joiner, KA				Coppens, I; Dunn, JD; Romano, JD; Pypaert, M; Zhang, H; Boothroyd, JC; Joiner, KA			Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space	CELL			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PARASITOPHOROUS VACUOLE; MEMBRANE; CHOLESTEROL; PROTEINS; PLASMODIUM; MECHANISMS; SECRETION; FISSION; NETWORK	The intracellular compartment harboring Toxoplasma gondii satisfies the parasite's nutritional needs for rapid growth in mammalian cells. We demonstrate that the parasitophorous vacuole (PV) of T. gondii accumulates material coming from the host mammalian cell via the exploitation of the host endo-lysosomal system. The parasite actively recruits host microtubules, resulting in selective attraction of endo-lysosomes to the PV. Microtubule-based invaginations of the PV membrane serve as conduits for the delivery of host endo-lysosomes within the PV. These tubular conduits are decorated by a parasite coat, including the tubulogenic protein GRA7, which acts like a garrote that sequesters host endocytic organelles in the vacuolar space. These data define an unanticipated process allowing the parasite intimate and concentrated access to a diverse range of low molecular weight components produced by the endo-lysosomal system. More generally, they identify a unique mechanism for unidirectional transport and sequestration of host organelles.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Univ Arizona, Coll Med, Arizona Hlth Sci Ctr, Tucson, AZ 85724 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; Yale University; University of Arizona; University of Arizona Health Sciences	Coppens, I (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	icoppens@jhsph.edu	Joiner, Keith/AAH-1059-2021	Boothroyd, John C./0000-0001-9719-745X; Joiner, Keith/0000-0003-3062-823X; Dunn, Joe Dan/0000-0002-5091-4527; Romano, Julia/0000-0001-8956-7377	NIAID NIH HHS [AI488443, AI45057, AI060767] Funding Source: Medline; NIGMS NIH HHS [T32 GM07276] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045057, R01AI060767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Haldar K, 2001, INT J PARASITOL, V31, P1393, DOI 10.1016/S0020-7519(01)00251-X; Hall S, 2001, TOXOPLASMOSIS COMPRE, P58; HALONEN SK, 1994, J EUKARYOT MICROBIOL, V41, P65, DOI 10.1111/j.1550-7408.1994.tb05936.x; Holopainen JM, 2000, EUR J BIOCHEM, V267, P6231, DOI 10.1046/j.1432-1327.2000.01708.x; Infante AS, 2000, J CELL SCI, V113, P3907; Jacobs D, 1998, MOL BIOCHEM PARASIT, V91, P237, DOI 10.1016/S0166-6851(97)00204-1; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; Kaneko T, 1998, J MOL BIOL, V284, P1671, DOI 10.1006/jmbi.1998.2251; Karsten V, 2004, J BIOL CHEM, V279, P26052, DOI 10.1074/jbc.M400480200; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kozlov MM, 2001, TRAFFIC, V2, P51, DOI 10.1034/j.1600-0854.2001.020107.x; Labruyere E, 1999, MOL BIOCHEM PARASIT, V102, P311, DOI 10.1016/S0166-6851(99)00092-4; Lange Y, 2002, J LIPID RES, V43, P198; Lingelbach K, 1998, J CELL SCI, V111, P1467; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; RUSSELL DG, 1995, TRENDS CELL BIOL, V5, P125, DOI 10.1016/S0962-8924(00)88963-1; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Sinai AP, 1997, J CELL SCI, V110, P2117	29	230	236	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 21	2006	125	2					261	274		10.1016/j.cell.2006.01.056	http://dx.doi.org/10.1016/j.cell.2006.01.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630815	Bronze			2022-12-28	WOS:000237241500017
J	Mosimann, C; Hausmann, G; Basler, K				Mosimann, C; Hausmann, G; Basler, K			Parafibromin/hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/armadillo	CELL			English	Article							RNA-POLYMERASE-II; TUMOR-SUPPRESSOR GENE; CATENIN-TCF COMPLEX; LONG-RANGE ACTION; HISTONE METHYLATION; SIGNALING PATHWAY; PAF1 COMPLEX; CHROMATIN-STRUCTURE; WINGLESS SIGNAL; DROSOPHILA	The Wnt pathway controls cell fates, tissue homeostasis, and cancer. Its activation entails the association of beta-catenin with nuclear TCF/LEF proteins and results in transcriptional activation of target genes. The mechanism by which nuclear beta-catenin controls transcription is largely unknown. Here we genetically identify a novel Wnt/Wg pathway component that mediates the transcriptional outputs of beta-catenin/Armadillo. We show that Drosophila Hyrax and its human ortholog, Parafibromin, components of the Polymerase-Associated Factor 1 (PAF1) complex, are required for nuclear transduction of the Wnt/Wg signal and bind directly to the C-terminal region of beta-catenin/Armadillo. Moreover, we find that the transactivation potential of Parafibromin/Hyrax depends on the recruitment of Pygopus to beta-catenin/Armadillo. Our results assign to the tumor suppressor Parafibromin an unexpected role in Wnt signaling and provide a molecular mechanism for Wnt target gene control, in which the nuclear Wnt signaling complex directly engages the PAF1 complex, thereby controlling transcriptional initiation and elongation by RNA Polymerase II.	Univ Zurich, Inst Mol Biol, Natl Res Ctr Frontiers Genet, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Natl Res Ctr Frontiers Genet, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.uniz.ch		Mosimann, Christian/0000-0002-0749-2576; Basler, Konrad/0000-0003-3534-1529				Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cox RT, 1999, GENETICS, V153, P319; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Geuking P, 2005, GENETICS, V171, P1683, DOI 10.1534/genetics.105.045534; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hahn MA, 2005, ONCOGENE, V24, P6241, DOI 10.1038/sj.onc.1208778; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hendy G N, 2000, Rev Endocr Metab Disord, V1, P297, DOI 10.1023/A:1026518502081; Hoeck H. N., 1990, GRZIMEKS ENCY MAMMAL, P535; Hoffmans R, 2004, DEVELOPMENT, V131, P4393, DOI 10.1242/dev.01296; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Parker DS, 2002, DEVELOPMENT, V129, P2565; PEIFER M, 1994, DEVELOPMENT, V120, P369; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sivasankaran R, 2000, MECH DEVELOP, V91, P427, DOI 10.1016/S0925-4773(99)00313-5; Stadeli R, 2005, MECH DEVELOP, V122, P1171, DOI 10.1016/j.mod.2005.07.004; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wang PF, 2005, HORM METAB RES, V37, P380, DOI 10.1055/s-2005-870150; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615	51	249	255	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					327	341		10.1016/j.cell.2006.01.053	http://dx.doi.org/10.1016/j.cell.2006.01.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630820	Bronze			2022-12-28	WOS:000237241500022
J	Farmer, A				Farmer, A			Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study - Commentary: Metabolic syndrome and mortality	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE; RISK		Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Farmer, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	andrew.farmer@dphpc.ox.ac.uk						Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Girman CJ, 2004, AM J CARDIOL, V93, P136, DOI 10.1016/j.amjcard.2003.09.028; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F	5	5	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 15	2006	332	7546					882	882		10.1136/bmj.332.7546.882	http://dx.doi.org/10.1136/bmj.332.7546.882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16613961	Green Published, Bronze			2022-12-28	WOS:000237132100015
J	Xie, XS; Yu, J; Yang, WY				Xie, XS; Yu, J; Yang, WY			Perspective - Living cells as test tubes	SCIENCE			English	Editorial Material							STOKES-RAMAN SCATTERING; SINGLE-MOLECULE; GENE-EXPRESSION; RNA-POLYMERASE; IN-VIVO; KINESIN; MICROSCOPY; LOCALIZATION; TRANSPORT; MOVEMENT	The combination of specific probes and advanced optical microscopy now allows quantitative probing of biochemical reactions in living cells. On selected systems, one can detect and track a particular protein with single-molecule sensitivity, nanometer spatial precision, and millisecond time resolution. Metabolites, usually difficult to detect, can be imaged and monitored in living cells with coherent anti-Stokes Raman scattering microscopy. Here, we describe the application of these techniques in studying gene expression, active transport, and lipid metabolism.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Yang, Wei Yuan/B-4474-2011					ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; Babcock HP, 2004, BIOPHYS J, V87, P2749, DOI 10.1529/biophysj.104.042234; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; GANIKHANOV G, IN PRESS OPT LETT; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Nan XL, 2005, J PHYS CHEM B, V109, P24220, DOI 10.1021/jp056360w; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Schoenheimer R, 1938, SCIENCE, V87, P221, DOI 10.1126/science.87.2254.221; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; THORNETJOMSLAND G, 2003, MOL BIOL CELL, V14, pA104; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	31	200	213	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					228	230		10.1126/science.1127566	http://dx.doi.org/10.1126/science.1127566			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HK	16614211				2022-12-28	WOS:000236765300037
J	Frank, M				Frank, M			Access to the scientific literature - A difficult balance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Amer Physiol Soc, Bethesda, MD USA; Washington DC Principles Coalit, Washington, DC USA		Frank, M (corresponding author), Amer Physiol Soc, Bethesda, MD USA.							Bergstrom TC, 2001, J ECON PERSPECT, V15, P183, DOI 10.1257/jep.15.4.183; DAVIS PM, 2004, CUL TASK FORC OP ACC; FRANK M, 2004, SERIALS REV, V30, P281; MCCABE M, 1999, ARL BIMONTHLY REPORT, V207; Willinsky J., 2006, ACCESS PRINCIPLE CAS	5	15	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1552	1555		10.1056/NEJMp068004	http://dx.doi.org/10.1056/NEJMp068004			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	031WW	16611948				2022-12-28	WOS:000236736900003
J	Gruber, T; Freeley, M; Thuille, N; Heit, I; Shaw, S; Long, A; Baier, G				Gruber, T; Freeley, M; Thuille, N; Heit, I; Shaw, S; Long, A; Baier, G			Comment on "PDK1 nucleates T cell receptor-induced signaling complex for NF-kappa B activation"	SCIENCE			English	Editorial Material							PROTEIN-KINASE-C; PKC-THETA; PHOSPHORYLATION		Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; Royal Coll Surgeons Ireland, Dept Biochem, Dublin 2, Ireland; AltanaPharma, Constance, Germany; NCI, Expt Immunol Branch, Bethesda, MD 20892 USA	Medical University of Innsbruck; Royal College of Surgeons - Ireland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Baier, G (corresponding author), Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria.	gottfried.baier@i-med.ac.at	Baier, Gottfried/E-8755-2012	Gruber, Thomas/0000-0002-5796-7090; Baier, Gottfried/0000-0002-2085-8325; Thuille, Nikolaus/0000-0002-2253-3946; Freeley, Michael/0000-0002-5763-6582				Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Thuille N, 2005, EMBO J, V24, P3869, DOI 10.1038/sj.emboj.7600856; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200	9	13	13	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770								10.1126/science.1122000	http://dx.doi.org/10.1126/science.1122000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601177				2022-12-28	WOS:000236584400020
J	Hastings, MH				Hastings, MH			Hibernation proteins: Preparing for life in the freezer	CELL			English	Editorial Material							PHOTOPERIODIC REGULATION; RECEPTOR; HAMSTER	Hibernation is an extreme response to a seasonal environment, yet we know almost nothing about how it is timed or how vital cellular functions are sustained in the face of plummeting body temperature. In this issue of Cell, Kondo et al. (2006) identify a liver-derived protein complex as an essential coordinator of this adaptation to the depredations of winter.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham NG7 2UH, England	MRC Laboratory Molecular Biology; University of Nottingham	Hastings, MH (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mha@mrc-lmb.cam.ac.uk	Ebling, Francis/A-1900-2013	Ebling, Francis/0000-0002-7316-9582; Hastings, Michael Harvey/0000-0001-8576-6651	Medical Research Council [MC_U105170643] Funding Source: Medline; MRC [MC_U105170643] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dibb KM, 2005, AM J PHYSIOL-REG I, V288, pR607, DOI 10.1152/ajpregu.00612.2004; Lincoln GA, 2005, ENDOCRINOLOGY, V146, P3782, DOI 10.1210/en.2005-0132; Osborne PG, 2006, BEHAV BRAIN RES, V168, P208, DOI 10.1016/j.bbr.2005.11.007; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Ross AW, 2004, ENDOCRINOLOGY, V145, P13, DOI 10.1210/en.2003-0838; Ruby NF, 1998, BRAIN RES, V782, P63, DOI 10.1016/S0006-8993(97)01263-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	9	4	6	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					21	23		10.1016/j.cell.2006.03.019	http://dx.doi.org/10.1016/j.cell.2006.03.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615885	Bronze			2022-12-28	WOS:000237314200009
J	Ruddiman, WF				Ruddiman, WF			Nicholas J. Shackleton (1937-2006)	SCIENCE			English	Biographical-Item									Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA	University of Virginia	Ruddiman, WF (corresponding author), Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA.	wfr5c@virginia.edu						*CLIMAP PROJ MEMB, 1981, MAP CHART SER GEOL S; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; SHACKLETON N, PUBLICATION LIST	4	0	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					711	711		10.1126/science.1126255	http://dx.doi.org/10.1126/science.1126255			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675692				2022-12-28	WOS:000237312100039
J	Fallon, M; Hanks, G; Cherny, N				Fallon, M; Hanks, G; Cherny, N			ABC of palliative care - Principles of control of cancer pain	BRITISH MEDICAL JOURNAL			English	Editorial Material									Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Bristol, Bristol BS8 1TH, Avon, England; Shaare Zedek Med Ctr, Jerusalem, Israel	University of Edinburgh; University of Bristol; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Fallon, M (corresponding author), Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland.			Cherny, Nathan/0000-0003-1976-8952; Fallon, Marie/0000-0001-9214-0091					0	34	38	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 29	2006	332	7548					1022	1024		10.1136/bmj.332.7548.1022	http://dx.doi.org/10.1136/bmj.332.7548.1022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16644831	Green Submitted, Green Published			2022-12-28	WOS:000237403100024
J	Shortridge, KF				Shortridge, KF			Influenza pandemic preparedness: gauging from EU plans	LANCET			English	Editorial Material							VIRUS		Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	University of Hong Kong; University of Auckland	Shortridge, KF (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kennedyfs@xtra.co.nz						Belshe RB, 1998, LANCET, V351, P460, DOI 10.1016/S0140-6736(98)22007-1; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Shortridge KF, 2003, J APPL MICROBIOL, V94, p70S; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778	9	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1374	1375		10.1016/S0140-6736(06)68512-7	http://dx.doi.org/10.1016/S0140-6736(06)68512-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650631				2022-12-28	WOS:000237195600005
J	Friedrich, WL; Kromer, B; Friedrich, M; Heinemeier, J; Pfeiffer, T; Talamo, S				Friedrich, WL; Kromer, B; Friedrich, M; Heinemeier, J; Pfeiffer, T; Talamo, S			Santorini eruption radiocarbon dated to 1627-1600 BC	SCIENCE			English	Article									Aarhus Univ, Dept Earth Sci, DK-8000 Aarhus, Denmark; Heidelberger Akad Wissensch, Inst Umweltphys, D-69120 Heidelberg, Germany; Univ Hohenheim, Inst Bot, D-70593 Stuttgart, Germany; Aarhus Univ, Dept Phys & Astron, Accelerator Mass Spectrometry 14C Dating Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Ruprecht Karls University Heidelberg; University Hohenheim; Aarhus University	Friedrich, WL (corresponding author), Aarhus Univ, Dept Earth Sci, CF Moellers Alle 1120, DK-8000 Aarhus, Denmark.	walter@geo.au.dk	Friedrich, Walter/A-2788-2014; Talamo, Sahra/AAD-1774-2022	Talamo, Sahra/0000-0002-2406-3132; Friedrich, Michael/0000-0003-1614-0959				BIETAK M, 2003, SYNCHRONISATION CIVI, P23; Doumas C. D, 1992, WALL PAINTINGS THERA; Manning S. W., 1999, TEST TIME VOLCANO TH; PFEIFFER T, 2003, THESIS AARHUS U; Ramsey CB, 2004, RADIOCARBON, V46, P325, DOI 10.1017/S0033822200039631; Ramsey CB, 2001, RADIOCARBON, V43, P381	6	245	251	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					548	548		10.1126/science.1125087	http://dx.doi.org/10.1126/science.1125087			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645088				2022-12-28	WOS:000237296700035
J	Dumville, JC; Torgerson, DJ; Hewitt, CE				Dumville, JC; Torgerson, DJ; Hewitt, CE			Research methods - Reporting attrition in randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOCATION; IMBALANCE; INTENTION		Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England	University of York - UK	Dumville, JC (corresponding author), Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England.	jd34@york.ac.uk	Dumville, Jo C/O-7867-2014; Torgerson, David/L-4566-2019	Dumville, Jo C/0000-0002-6546-3685; Torgerson, David/0000-0002-1667-4275; Hewitt, Catherine Elizabeth/0000-0002-0415-3536				ALTMAN DG, 1985, STATISTICIAN, V34, P125; ALTMAN DG, 2005, ENCY BIOSTATISTICS, P1273, DOI DOI 10.1002/0470011815.B2A01015; BIRKS YF, 2001, OSTEOPOROSIS INT, V15, P701; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Roberts C, 1999, BRIT MED J, V319, P185, DOI 10.1136/bmj.319.7203.185; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; SENN SJ, 1989, STAT MED, V8, P467, DOI 10.1002/sim.4780080410; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300	11	245	247	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					969	971		10.1136/bmj.332.7547.969	http://dx.doi.org/10.1136/bmj.332.7547.969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627519	Green Published			2022-12-28	WOS:000237143900025
J	Iso, H; Date, C; Wakai, K; Fukui, M; Tamakoshi, A				Iso, H; Date, C; Wakai, K; Fukui, M; Tamakoshi, A		JACC Study Grp	The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults	ANNALS OF INTERNAL MEDICINE			English	Article							COFFEE CONSUMPTION; EPIGALLOCATECHIN GALLATE; MELLITUS; PREVALENCE; TOLERANCE	Background: in western populations, coffee consumption is associated with a reduced risk for type 2 diabetes; however, the effect of green, black, and oolong teas is unclear. Objective: To examine the relationship between consumption of these beverages and risk for diabetes. Design: Retrospective cohort study. Setting: 25 communities across Japan. Participants: A total of 17 413 persons (6727 men and 10 686 women; 49% of the original study population) who were 40 to 65 years of age; had no history of type 2 diabetes, cardiovascular disease, or cancer at the baseline lifestyle survey; and completed the 5-year follow-up questionnaire. There was no difference in body mass index levels at baseline between respondents and non-respondents. Measurements: Questionnaire on consumption of coffee; black, green, and oolong teas; and physician-diagnosed diabetes. Results: During the 5-year follow-up, there were 444 self-reported new cases of diabetes in 231 men and 213 women (5-year event rates, 3.4% and 2.0%, respectively). Consumption of green tea and coffee was inversely associated with risk for diabetes after adjustment for age, sex, body mass index, and other risk factors. Multivariable odds ratios for diabetes among participants who frequently drank green tea and coffee ( :6 cups of green tea per day and 3 cups of coffee per day) were 0.67 (95% Cl, 0.47 to 0.94) and 0.58 (Cl, 0.37 to 0.90), respectively, compared with those who drank less than I cup per week. No association was found between consumption of black or oolong teas and the risk for diabetes. Total caffeine intake from these beverages was associated with a 33% reduced risk for diabetes. These inverse associations were more pronounced in women and in overweight men. Limitations: Diabetes was self-reported, no data were available on consumption of soda, and the follow-up rate was low. Conclusions: Consumption of green tea, coffee, and total caffeine was associated with a reduced risk for type 2 diabetes.	Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth, Suita, Osaka 5650871, Japan; Osaka City Univ, Osaka 558, Japan; Nara Womens Univ, Nara 630, Japan; Aichi Canc Ctr, Nagoya, Aichi 464, Japan; Nagoya Univ, Nagoya, Aichi, Japan	Osaka University; Osaka Metropolitan University; Nara Womens University; Aichi Cancer Center; Nagoya University	Iso, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	iso@pbhei.med.osaka-u-ac.jp	Tamakoshi, Akiko/D-5105-2012; Wakai, Kenji/I-7248-2014	Wakai, Kenji/0000-0001-7388-7157; Iso, Hiroyasu/0000-0002-9241-7289; TOKUDOME, SHINKAN/0000-0001-7311-2458				ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759; Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185; Date C, 2005, J EPIDEMIOL, V15, pS9, DOI 10.2188/jea.15.S9; Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; Ohno Y, 2001, J Epidemiol, V11, P144; Resource Council Science and Technology Agency the Government of Japan, 2000, STAND TABL FOOD COMP; ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124; Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Sasazuki S, 2004, CANCER CAUSE CONTROL, V15, P483, DOI 10.1023/B:CACO.0000036449.68454.42; Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881; SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891; Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200	22	331	354	0	49	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					554	562		10.7326/0003-4819-144-8-200604180-00005	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618952				2022-12-28	WOS:000237017900002
J	Breban, R; Blower, S				Breban, R; Blower, S			Role of parametric resonance in virological failure during HIV treatment interruption therapy	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; STRUCTURED TREATMENT INTERRUPTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; DYNAMICS IN-VIVO; T-CELL DYNAMICS; VIRAL DYNAMICS; INTERMITTENT; INFECTION; TOXICITY	We present a novel hypothesis that could explain virological failure to structured treatment interruptions (STI). We analysed a classic mathematical model of HIV within-host viral dynamics and found that non-linear parametric resonance occurs when STI are added to the model; resonance is observed as virological failure. We simulated clinical trial data and calculated patient-specific resonant spectra. We gained two important insights. First, within an STI trial, patients who begin with similar viral loads can be expected to show very different virological responses as a result of resonance. Second, and more importantly, virological failure is not simply due to STI or patients' characteristics; instead it is the result of complex interaction between STI and the patient's viral dynamics. Hence, our analyses show that no universal regimen with periodic interruptions will be effective for all patients.	Semel Inst Neurosci & Human Behav, Dept Biomath, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, AIDS Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Blower, S (corresponding author), Semel Inst Neurosci & Human Behav, Dept Biomath, Los Angeles, CA 90024 USA.	sblower@mednet.ucla.edu		Breban, Romulus/0000-0002-5821-8139	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041935] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041935] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agur Z., 1995, Journal of Biological Systems, V3, P241, DOI 10.1142/S021833909500023X; AGUR Z, 1989, LANCET, V2, P1400; AGUR Z, 1987, ANN NY ACAD SCI, V504, P274, DOI 10.1111/j.1749-6632.1987.tb48738.x; AGUR Z, 1991, EXP HEMATOL, V19, P364; AGUR Z, 1985, J THEOR BIOL, V112, P677, DOI 10.1016/S0022-5193(85)80053-9; Agur Z., 1998, COMPUT MATH METHOD M, V1, P237; Altfeld M, 2001, NAT MED, V7, P881, DOI 10.1038/90901; Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Austin DJ, 1998, J THEOR BIOL, V194, P313, DOI 10.1006/jtbi.1997.0438; BERGE P, 1986, ORDER WITHIN CHAOS; BREBAN R, ROLE PARAMETRIC RESO; Butikov EI, 1999, COMPUT SCI ENG, V1, P76, DOI 10.1109/5992.764219; CHARLENE L, 2004, MEDSCAPE TODAY  0713; Clark DR, 1999, ADV IMMUNOL, V73, P301, DOI 10.1016/S0065-2776(08)60789-0; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2003, J INFECT DIS, V188, P388, DOI 10.1086/376535; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Garcia F, 2001, AIDS, V15, pF29, DOI 10.1097/00002030-200106150-00002; GUCKENHEIMER J, 1997, NONLINEAR OSCILLATIO; Howe L, 2002, J VIROL, V76, P10588, DOI 10.1128/JVI.76.21.10588-10597.2002; Lori F, 2000, LANCET, V355, P287, DOI 10.1016/S0140-6736(99)03515-1; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Nowak MA., 2000, VIRUS DYNAMICS MATH; Ortiz GM, 2001, P NATL ACAD SCI USA, V98, P13288, DOI 10.1073/pnas.221452198; Papasavvas E, 2004, PLOS MED, V1, P218, DOI 10.1371/journal.pmed.0010064; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Swierniak A, 1996, CELL PROLIFERAT, V29, P117, DOI 10.1046/j.1365-2184.1996.00995.x	35	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1285	1289		10.1016/S0140-6736(06)68543-7	http://dx.doi.org/10.1016/S0140-6736(06)68543-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631884				2022-12-28	WOS:000236913400033
J	Ellsworth, WL				Ellsworth, WL			Earthquake anniversary - Halfway through Reid's cycle and counting	SCIENCE			English	Editorial Material									US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Ellsworth, WL (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	ellsworth@usgs.gov						Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; Hickman S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020688; Jordan TH, 2006, SEISMOL RES LETT, V77, P3, DOI 10.1785/gssrl.77.1.3; Klett M., 2006, RUINS 1906 2006 REPH; LAWSON AC, 1908, CARNEGIE I WASHINGTO, V87; National Research Council, 2006, IMPR SEISM MON IMPR; *WORK GROUP CAL EA, 2003, 03214 US GEOL SURV W; Zoback ML, 2006, GSA TODAY, V16, P4	8	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					203	204		10.1126/science.1124890	http://dx.doi.org/10.1126/science.1124890			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614202				2022-12-28	WOS:000236765300028
J	Sun, YR; Giebink, NC; Kanno, H; Ma, BW; Thompson, ME; Forrest, SR				Sun, YR; Giebink, NC; Kanno, H; Ma, BW; Thompson, ME; Forrest, SR			Management of singlet and triplet excitons for efficient white organic light-emitting devices	NATURE			English	Article							TRANSIENT ANALYSIS; BLUE; ELECTROPHOSPHORESCENCE; PHOSPHORESCENCE; DOPANT; DIODES; LAYERS	Lighting accounts for approximately 22 per cent of the electricity consumed in buildings in the United States, with 40 per cent of that amount consumed by inefficient (similar to 15 lm W-1) incandescent lamps(1,2). This has generated increased interest in the use of white electroluminescent organic light-emitting devices, owing to their potential for significantly improved efficiency over incandescent sources combined with low-cost, high-throughput manufacturability. The most impressive characteristics of such devices reported to date have been achieved in all-phosphor-doped devices, which have the potential for 100 per cent internal quantum efficiency(2): the phosphorescent molecules harness the triplet excitons that constitute three-quarters of the bound electron-hole pairs that form during charge injection, and which (unlike the remaining singlet excitons) would otherwise recombine non-radiatively. Here we introduce a different device concept that exploits a blue fluorescent molecule in exchange for a phosphorescent dopant, in combination with green and red phosphor dopants, to yield high power efficiency and stable colour balance, while maintaining the potential for unity internal quantum efficiency. Two distinct modes of energy transfer within this device serve to channel nearly all of the triplet energy to the phosphorescent dopants, retaining the singlet energy exclusively on the blue fluorescent dopant. Additionally, eliminating the exchange energy loss to the blue fluorophore allows for roughly 20 per cent increased power efficiency compared to a fully phosphorescent device. Our device challenges incandescent sources by exhibiting total external quantum and power efficiencies that peak at 18.7 +/- 0.5 per cent and 37.6 +/- 0.6 lm W-1, respectively, decreasing to 18.4 +/- 0.5 per cent and 23.8 +/- 0.5 lm W-1 at a high luminance of 500 cd m(-2).	Princeton Univ, Dept Elect Engn, Princeton Inst Sci & Technol Mat PRISM, Princeton, NJ 08544 USA; Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Princeton University; University of Southern California	Forrest, SR (corresponding author), Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA.	forrest@princeton.edu	Ma, Biwu/B-6943-2012; Ma, Biwu/B-6924-2019; Thompson, Mark/F-4062-2018	Ma, Biwu/0000-0003-1573-8019; Giebink, Noel/0000-0002-3798-5830; Thompson, Mark/0000-0002-7764-4096				Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; Adachi C, 2002, IEEE J SEL TOP QUANT, V8, P372, DOI 10.1109/2944.999192; Adamovich V, 2002, NEW J CHEM, V26, P1171, DOI 10.1039/b204301g; Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Baldo MA, 2000, PHYS REV B, V62, P10967, DOI 10.1103/PhysRevB.62.10967; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Baldo MA, 2000, PHYS REV B, V62, P10958, DOI 10.1103/PhysRevB.62.10958; D'Andrade BW, 2004, ADV MATER, V16, P1585, DOI 10.1002/adma.200400684; D'Andrade BW, 2004, ADV MATER, V16, P624, DOI 10.1002/adma.200306670; D'Andrade BW, 2003, J APPL PHYS, V94, P3101, DOI 10.1063/1.1597942; Forrest SR, 2003, ADV MATER, V15, P1043, DOI 10.1002/adma.200302151; Holmes RJ, 2003, APPL PHYS LETT, V83, P3818, DOI 10.1063/1.1624639; Hosokawa C, 1995, APPL PHYS LETT, V67, P3853, DOI 10.1063/1.115295; Kalinowski J, 2004, CHEM PHYS, V297, P39, DOI 10.1016/j.chemphys.2003.09.041; Kawamura Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862777; Murata H, 2002, APPL PHYS LETT, V80, P189, DOI 10.1063/1.1432109; Qin DS, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1879108; Reufer M, 2005, NAT MATER, V4, P340, DOI 10.1038/nmat1354; Segal M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075211; Sokolik I, 1996, APPL PHYS LETT, V69, P4168, DOI 10.1063/1.116974; Tokito S, 2003, APPL PHYS LETT, V83, P2459, DOI 10.1063/1.1611620; TUNG YJ, 2004, P SOC INFORM DISPLAY, V35, P48; *US DEP EN, 2001, NAT LIGHT INV EN CON, V1	23	2068	2149	28	1001	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					908	912		10.1038/nature04645	http://dx.doi.org/10.1038/nature04645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612378	Green Published			2022-12-28	WOS:000236736700035
J	Phanish, MK; Andrews, PA				Phanish, MK; Andrews, PA			A rare and reversible cause of anaemia and renal impairment	LANCET			English	Editorial Material							ACQUIRED HYPOTHYROIDISM; FAILURE		St Helier Hosp, SW Thames Renal & Transplantat Unit, Carshalton SM5 1AA, Surrey, England	St Helier Hospital	Andrews, PA (corresponding author), St Helier Hosp, SW Thames Renal & Transplantat Unit, Carshalton SM5 1AA, Surrey, England.	peter.andrews@epsom-sthelier.nhs.uk		phanish, mysore/0000-0001-8402-8286				Al-Fifi S, 1999, ACTA PAEDIATR, V88, P715; Birewar Sonali, 2004, S D J Med, V57, P109; Camacho GD, 2003, PEDIATR NEPHROL, V18, P290, DOI 10.1007/s00467-002-1033-9; Nakahama H, 2001, NEPHRON, V88, P264, DOI 10.1159/000046000; PAGLIACCI MC, 1987, NEPHRON, V46, P225, DOI 10.1159/000184359	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1212	1212		10.1016/S0140-6736(06)68510-3	http://dx.doi.org/10.1016/S0140-6736(06)68510-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616564				2022-12-28	WOS:000236673400030
J	Gisin, N				Gisin, N			New additions to the Schrodinger cat family	SCIENCE			English	Editorial Material									Univ Geneva, Appl Phys Grp, Ecole Med 20, CH-1211 Geneva, Switzerland	University of Geneva	Gisin, N (corresponding author), Univ Geneva, Appl Phys Grp, Ecole Med 20, CH-1211 Geneva, Switzerland.	nicolas.gisin@physics.unige.ch						Auffeves A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.230405; BOUWMEESTER D, 2000, PHYS QUANTUM INFORMA; Ourjoumtsev A, 2006, SCIENCE, V312, P83, DOI 10.1126/science.1122858	3	4	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					63	64		10.1126/science.1125584	http://dx.doi.org/10.1126/science.1125584			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601181				2022-12-28	WOS:000236584400027
J	Hallem, EA; Carlson, JR				Hallem, EA; Carlson, JR			Coding of odors by a receptor repertoire	CELL			English	Article							OLFACTORY RECEPTOR; ANTENNAL LOBE; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; ORGANIZATION; REPRESENTATIONS; NEURONS; MAP; DISCRIMINATION; IDENTIFICATION	We provide a systematic analysis of how odor quality, quantity, and duration are encoded by the odorant receptor repertoire of the Drosophila antenna. We test the receptors with a panel of over 100 odors and find that strong responses are sparse, with response density dependent on chemical class. Individual receptors range along a continuum from narrowly tuned to broadly tuned. Broadly tuned receptors are most sensitive to structurally similar odorants. Strikingly, inhibitory responses are widespread among receptors. The temporal dynamics of the receptor repertoire provide a rich representation of odor quality, quantity, and duration. Receptors with similar odor sensitivity often map to widely dispersed glomeruli in the antennal lobe. We construct a multidimensional "odor space" based on the responses of each individual receptor and find that the positions of odors depend on their chemical class, concentration, and molecular complexity. The space provides a basis for predicting behavioral responses to odors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Hallem, Elissa/0000-0003-0260-3174	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729, R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC04729, DC02174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bichao H, 2003, J COMP PHYSIOL A, V189, P203, DOI 10.1007/s00369-003-0391-5; BOECKH J, 1965, COLD SPRING HARB SYM, V30, P263, DOI 10.1101/SQB.1965.030.01.028; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; CAIN WS, 1977, SCIENCE, V195, P796, DOI 10.1126/science.836592; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOTY RL, 1992, HUMAN SENSE SMELL, P95; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Elmore T, 2003, J NEUROSCI, V23, P9906; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Meister M, 2001, J NEUROSCI, V21, P1351; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; SANCHEZ MGD, 2005, J COMP PHYSIOL A, V191, P189; Schneider D., 1968, Symposia of the Zoological Society of London, VNo. 23, P279; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; *TNO, 2004, VOL COMP FOOD QUAL Q; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	62	787	836	5	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					143	160		10.1016/j.cell.2006.01.050	http://dx.doi.org/10.1016/j.cell.2006.01.050			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615896	Bronze			2022-12-28	WOS:000237314200020
J	Hirokawa, N; Tanaka, Y; Okada, Y; Takeda, S				Hirokawa, N; Tanaka, Y; Okada, Y; Takeda, S			Nodal flow and the generation of left-right asymmetry	CELL			English	Review							RIGHT AXIS DETERMINATION; INTRAFLAGELLAR TRANSPORT PROTEINS; SYMMETRY-BREAKING; RETINOIC ACID; EMBRYONIC-DEVELOPMENT; ZEBRAFISH EMBRYO; KUPFFERS VESICLE; SONIC HEDGEHOG; SITUS-INVERSUS; MOUSE EMBRYOS	The establishment of left-right asymmetry in mammals is a good example of how multiple cell biological processes coordinate in the formation of a basic body plan. The leftward movement of fluid at the ventral node, called nodal flow, is the central process in symmetry breaking on the left-right axis. Nodal flow is autonomously generated by the rotation of cilia that are tilted toward the posterior on cells of the ventral node. These cilia are built by transport via the KIF3 motor complex. How nodal flow is interpreted to create left-right asymmetry has been a matter of debate. Recent evidence suggests that the leftward movement of membrane-sheathed particles, called nodal vesicular parcels (NVPs), may result in the activation of the noncanonical Hedgehog signaling pathway, an asymmetric elevation in intracellular Ca2+ and changes in gene expression.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Okada, Yasushi/N-5067-2015; Takeda, Sen/I-8462-2012	Okada, Yasushi/0000-0003-2601-3689; Takeda, Sen/0000-0001-7090-2139; Tanaka, Yosuke/0000-0001-5376-5726				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bellomo D, 1996, DEV DYNAM, V205, P471, DOI 10.1002/(SICI)1097-0177(199604)205:4<471::AID-AJA10>3.0.CO;2-4; Brokaw CJ, 2005, CELL MOTIL CYTOSKEL, V60, P35, DOI 10.1002/cm.20046; Buceta J, 2005, BIOPHYS J, V89, P2199, DOI 10.1529/biophysj.105.063743; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Cartwright JHE, 2004, P NATL ACAD SCI USA, V101, P7234, DOI 10.1073/pnas.0402001101; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Delmas P, 2004, CELL, V118, P145, DOI 10.1016/j.cell.2004.07.007; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Harvey RP, 1998, CELL, V94, P273, DOI 10.1016/S0092-8674(00)81468-3; Hensen V., 1876, Z ANAT ENTW GESCH, V1, P353; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; HOGAN B, 1986, MANIPULATIONG MOUSE; Hou J, 2004, DEV DYNAM, V229, P373, DOI 10.1002/dvdy.10450; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hummel K. P., 1959, Journal of Heredity, V50, P9; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Sampath K, 1997, DEVELOPMENT, V124, P3293; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; SAUSEDO RA, 1994, ANAT REC, V239, P103, DOI 10.1002/ar.1092390112; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; SLEIGH MA, 1982, SYM SOC EXP BIOL, P139; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; TANAKA Y, 1995, J CELL SCI, V108, P1883; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Tsang TE, 1999, CELL MOL BIOL, V45, P493; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Viebahn C, 2001, GENESIS, V29, P96, DOI 10.1002/1526-968X(200102)29:2<96::AID-GENE1010>3.0.CO;2-H; YANG YT, 1999, GENE DEV, V13, P2527; YOST HJ, 1991, CIBA F SYMP, V162, P165; Yost HJ, 1999, CURR OPIN GENET DEV, V9, P422; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	73	403	413	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					33	45		10.1016/j.cell.2006.03.002	http://dx.doi.org/10.1016/j.cell.2006.03.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615888	Bronze			2022-12-28	WOS:000237314200012
J	Kondo, N; Sekijima, T; Kondo, J; Takamatsu, N; Tohya, K; Ohtsu, T				Kondo, N; Sekijima, T; Kondo, J; Takamatsu, N; Tohya, K; Ohtsu, T			Circannual control of hibernation by HP complex in the brain	CELL			English	Article							FATTY-ACID OXIDATION; GROUND-SQUIRRELS; MAMMALIAN HIBERNATION; BINDING GLOBULIN; MYOCARDIUM; CHIPMUNKS; HYPOTHERMIA; PROTEINS; GENE; IDENTIFICATION	Seasonal hibernation in mammals is under a unique adaptation system that protects organisms from various harmful events, such as lowering of body temperature (Tb), during hibernation. However, the precise factors controlling hibernation remain unknown. We have previously demonstrated a decrease in hibernation-specific protein (HP) complex in the blood of chipmunks during hibernation. Here, HP is identified as a candidate hormone for hibernation. In chipmunks kept in constant cold and darkness, HP is regulated by an individual free-running circannual rhythm that correlates with hibernation. The level of HP complex in the brain increases coincident with the onset of hibernation. Such HP regulation proceeds independently of Tb changes in constant warmth, and Tb decreases only when brain HP is increased in the cold. Blocking brain HP activity using an antibody decreases the duration of hibernation. We suggest that HP, a target of endogenously generated circannual rhythm, carries hormonal signals essential for hibernation to the brain.	Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; KAST, Machida, Tokyo 1948511, Japan; Mitsubishi Toky Pharmaceut Inc, Yokohama Res Ctr, Kanagawa 2270033, Japan; Kitasato Univ, Sch Sci, Dept Biosci, Kanagawa 2288555, Japan; Kansai Coll Oriental Med, Dept Anat, Osaka 5900482, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kitasato University	Kondo, N (corresponding author), Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan.	nkondo@libra.ls.m-kagaku.co.jp						AMORESE DA, 1982, P NATL ACAD SCI-BIOL, V79, P6375, DOI 10.1073/pnas.79.20.6375; Aschoff J., 1981, HDB BEHAVIORAL NEURO, V4, P475; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P725, DOI 10.1016/S0145-305X(01)00033-7; BRONSON FH, 1989, MAMMALIAM REPROD BIO; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gwinner E, 1996, J EXP BIOL, V199, P39; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; Harlow HJ, 2001, NATURE, V409, P997, DOI 10.1038/35059165; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Holzer M, 2002, NEW ENGL J MED, V346, P549; KEMPER GB, 1982, COMP BIOCHEM PHYS C, V73, P445, DOI 10.1016/0306-4492(82)90151-4; Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9; Kojima M, 2001, EUR J BIOCHEM, V268, P5997, DOI 10.1046/j.0014-2956.2001.02572.x; Kondo Jun, 1996, P351; KONDO N, 1992, J BIOL CHEM, V267, P473; KONDO N, 1986, CIRC RES, V59, P221, DOI 10.1161/01.RES.59.2.221; KONDO N, 1988, BRIT J PHARMACOL, V95, P1287, DOI 10.1111/j.1476-5381.1988.tb11766.x; KONDO N, 1987, EXPERIENTIA, V43, P873, DOI 10.1007/BF01951645; KONDO N, 1984, SCIENCE, V225, P641, DOI 10.1126/science.6740332; KONDO N, 1986, EXPERIENTIA, V42, P1220, DOI 10.1007/BF01946394; Kondo Nobuaki, 1992, P89; Kondo Noriaki, 1993, P467; PAKHOTIN PI, 1990, NEUROSCIENCE, V38, P591, DOI 10.1016/0306-4522(90)90053-7; Pengelley E.T., 1974, P95; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Sambrook J., 2002, MOL CLONING LAB MANU; SHARAPOV VM, 1983, MYCOPATHOLOGIA, V84, P77; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; Takamatsu N, 1997, GENE, V204, P127, DOI 10.1016/S0378-1119(97)00532-5; TAKAMATSU N, 1993, MOL CELL BIOL, V13, P1516, DOI 10.1128/MCB.13.3.1516; Wang L.C.H., 1982, P206; Wang L.C.H., 1988, Advances in Comparative and Environmental Physiology, V2, P1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	36	88	100	1	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					161	172		10.1016/j.cell.2006.03.017	http://dx.doi.org/10.1016/j.cell.2006.03.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615897	Bronze			2022-12-28	WOS:000237314200021
J	Ironside, JW; Bishop, MT; Connolly, K; Hegazy, D; Lowrie, S; Le Grice, M; Ritchie, DL; McCardle, LM; Hilton, DA				Ironside, JW; Bishop, MT; Connolly, K; Hegazy, D; Lowrie, S; Le Grice, M; Ritchie, DL; McCardle, LM; Hilton, DA			Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study	BRITISH MEDICAL JOURNAL			English	Article							ACCUMULATION; VCJD; KURU	Objective To perform prion protein gene (PRNP) codon 129 analysis in DNA extracted from appendix tissue samples that had tested positive for disease associated prion protein. Design Reanalysis of positive cases identified in a retrospective anonymised unlinked prevalence study of variant Creutzfeldt-Jakob disease (vCJD) in the United Kingdom. Study samples Three positive appendix tissue samples out of 12 674 samples of appendix and tonsil tested for disease associated prion protein. The patients from whom these samples were obtained were aged 20-29 years at the time of surgery, which took place in 1996-9. Setting Pathology departments in two tertiary centres in England and Scotland. Results Adequate DNA was available for analysis in two of the three specimens, both of which were homozygous for valine at codon 129 in the PRNP. Conclusions This is the first indication that the valine homozygous subgroup at codon 129 in the PRNP is susceptible to vCJD infection. All tested clinical cases of vCJD have so far occurred in the methionine homozygous subgroup, and a single case of probable iatrogenic vCJD infection has been identified in one patient who was a methionine/valine heterozygote at this genetic locus. People infected with vCJD with a valine homozygous codon 129 PRNP genotype may have a prolonged incubation period, during which horizontal spread of the infection could occur either from blood donations or from contaminated surgical instruments used on these individuals during the asymptomatic phase of the illness.	Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis, Edinburgh EH4 2XU, Midlothian, Scotland; Derriford Hosp, Dept Histopathol, Plymouth PL6 8DSH, Devon, England	University of Edinburgh; Derriford Hospital	Ironside, JW (corresponding author), Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis, Edinburgh EH4 2XU, Midlothian, Scotland.			Ironside, James/0000-0001-5869-2108	Medical Research Council [G0600953, G0900580] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bird SM, 2004, LANCET, V364, P1362, DOI 10.1016/S0140-6736(04)17194-8; Ersdal C, 2005, VET PATHOL, V42, P258, DOI 10.1354/vp.42-3-258; Goldfarb LG, 2004, CURR MOL MED, V4, P375, DOI 10.2174/1566524043360627; HAINFELLNER JA, 1997, BRAIN PATHOL, V7, P574; Hilton DA, 2002, BRIT MED J, V325, P633, DOI 10.1136/bmj.325.7365.633; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; McLean CA, 1998, BRAIN PATHOL, V8, P429; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6	9	108	109	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1186	1188		10.1136/bmj.38804.511644.55	http://dx.doi.org/10.1136/bmj.38804.511644.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16606639	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000237935300017
J	Padoa-Schioppa, C; Assad, JA				Padoa-Schioppa, C; Assad, JA			Neurons in the orbitofrontal cortex encode economic value	NATURE			English	Article							ORBITAL PREFRONTAL CORTEX; REWARD PREFERENCE; EXPECTED REWARD; MONKEYS; SIGNALS; CINGULATE; RESPONSES; BEHAVIOR; LESIONS	Economic choice is the behaviour observed when individuals select one among many available options. There is no intrinsically 'correct' answer: economic choice depends on subjective preferences. This behaviour is traditionally the object of economic analysis(1) and is also of primary interest in psychology(2). However, the underlying mental processes and neuronal mechanisms are not well understood. Theories of human and animal choice(1-3) have a cornerstone in the concept of 'value'. Consider, for example, a monkey offered one raisin versus one piece of apple: behavioural evidence suggests that the animal chooses by assigning values to the two options(4). But where and how values are represented in the brain is unclear. Here we show that, during economic choice, neurons in the orbitofrontal cortex(5-18) (OFC) encode the value of offered and chosen goods. Notably, OFC neurons encode value independently of visuospatial factors and motor responses. If a monkey chooses between A and B, neurons in the OFC encode the value of the two goods independently of whether A is presented on the right and B on the left, or vice versa. This trait distinguishes the OFC from other brain areas in which value modulates activity related to sensory or motor processes(19-25). Our results have broad implications for possible psychological models, suggesting that economic choice is essentially choice between goods rather than choice between actions. In this framework, neurons in the OFC seem to be a good candidate network for value assignment underlying economic choice.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Padoa-Schioppa, C (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	camillo@alum.mit.edu		Padoa-Schioppa, Camillo/0000-0002-7519-8790	NINDS NIH HHS [R01 NS041000-01, R01 NS041000] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041000] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BUTTER CM, 1969, SCIENCE, V164, P1306, DOI 10.1126/science.164.3885.1306; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; HODGES JR, 2001, NEUROLOGY S4, V56, P6; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Kagel John H., 1995, EC CHOICE THEORY EXP; Kahneman D, 2000, CHOICES VALUES FRAME; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, COGNITION, V99, pB1, DOI 10.1016/j.cognition.2005.04.008; Pasquier F, 1997, EUR NEUROL, V38, P1, DOI 10.1159/000112894; Pinker S., 1997, MIND WORKS; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; RALEIGH MJ, 1981, EXP NEUROL, V73, P378, DOI 10.1016/0014-4886(81)90273-9; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; SAMUELSON P. A., 1947, FDN EC ANAL; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Simon HA, 1982, P AM PHILOS SOC, V106, P467; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; ZIGMOND MJ, 1999, FUNDAMENTAL NEUROSCI, pCH53	30	1002	1017	7	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					223	226		10.1038/nature04676	http://dx.doi.org/10.1038/nature04676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16633341	Green Accepted			2022-12-28	WOS:000237418800047
J	Ahimastos, AA; Lawler, A; Reid, CM; Blombery, PA; Kingwell, BA				Ahimastos, AA; Lawler, A; Reid, CM; Blombery, PA; Kingwell, BA			RETRACTED: Brief communication: Ramipril markedly improves walking ability in patients with peripheral arterial disease - A randomized trial (Retracted article)	ANNALS OF INTERNAL MEDICINE			English	Article; Retracted Publication							CONVERTING ENZYME-INHIBITION; INTERMITTENT CLAUDICATION; BLOOD-FLOW; HYPERTENSION; MULTICENTER; CAPTOPRIL; THERAPY	Background: Peripheral arterial disease (PAD) affects up to 12% of adults older than 50 years of age. Conventional therapies have only modest effects in improving symptoms. Objective: To examine the effects of angiotensin-converting enzyme inhibition on walking ability in patients with PAD. Design: Randomized, double-blind, placebo-controlled trial initiated in March 2003 and completed in January 2005. Setting: The Alfred Hospital, Melbourne, Australia. Participants: 40 older adults with symptomatic PAD and no history of diabetes or hypertension. Intervention: 10 mg of ramipril (n = 20) or placebo (n = 20) once daily for 24 weeks. All patients completed the trial. Measurements: Pain-free and maximum walking time were recorded during a standard treadmill test, and the standard Walking Impairment Questionnaire was administered. Results: After adjustment for the baseline pain-free walking time, mean pain-free walking time after ramipril treatment was 227 seconds (95% Cl, 175 seconds to 278 seconds; P < 0.001) longer than that after placebo treatment. Similarly, maximum walking time improved by 451 seconds in the ramipril group (CI, 367 seconds to 536 seconds; P < 0.001) but did not change in the placebo group. Ramipril improved the Walking Impairment Questionnaire median distance score from 5% (range, 1% to 39%) to 21% (range, 12% to 58%; P < 0.001), speed score from 3% (range, 3% to 39%) to 18% (range, 8% to 50%; P < 0.001), and stair-climbing score from 17% (range, 4% to 80%) to 67% (range, 38% to 88%; P < 0.001). No adverse events were reported. Limitations: The sample size is modest and the strict inclusion criteria limit the applicability of the results to patients with claudication and infrainguinall disease and those without diabetes. Conclusion: Ramipril improved pain-free and maximum walking time in some adults with symptomatic PAD.	Alfred Hosp, Baker Heart Res Inst, Melbourne, Vic 8008, Australia; Monash Univ, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University	Kingwell, BA (corresponding author), Baker Heart Res Inst, Alfred & Baker Med Unit, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	b.kingwell@alfred.org.au	Blombery, Peter/AAR-1849-2020; Reid, Christopher M/AAP-8135-2021	Reid, Christopher/0000-0001-9173-3944				Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; BERNARDI D, 1988, ANGIOLOGY, V39, P942, DOI 10.1177/000331978803901103; BREWSTER DC, 2000, DIREST RECONSTRUCTIO; Dawson DL, 2000, AM J MED, V109, P523, DOI 10.1016/S0002-9343(00)00569-6; Fabre JE, 1999, CIRCULATION, V99, P3043, DOI 10.1161/01.CIR.99.23.3043; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; HIATT WR, 1995, CIRCULATION, V92, P614, DOI 10.1161/01.CIR.92.3.614; Higashi Y, 2000, J AM COLL CARDIOL, V35, P284, DOI 10.1016/S0735-1097(99)00561-6; Mancini GBJ, 1996, CIRCULATION, V94, P258, DOI 10.1161/01.CIR.94.3.258; Nehler MR, 1999, ANN VASC SURG, V13, P109, DOI 10.1007/s100169900228; Newman AB, 2000, J AM GERIATR SOC, V48, P1157; O'Keefe JH, 2001, J AM COLL CARDIOL, V37, P1, DOI 10.1016/S0735-1097(00)01044-5; Regensteiner JG, 1990, J VASC MED BIOL, V2, P142; ROBERTS DH, 1992, ANGIOLOGY, V43, P748, DOI 10.1177/000331979204300905; Silvestre JS, 2001, CIRC RES, V89, P678, DOI 10.1161/hh2001.097691; SONECHA TN, 1990, INT ANGIOL, V9, P22; SUMNER DS, 1969, SURGERY, V65, P763; VANDEVEN LLM, 1994, VASA-J VASCULAR DIS, V23, P357; Yusuf S, 2000, NEW ENGL J MED, V342, P145	19	66	69	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					660	664		10.7326/0003-4819-144-9-200605020-00009	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039GJ	16670135				2022-12-28	WOS:000237293700005
J	Bazin, E; Glemin, S; Galtier, N				Bazin, E; Glemin, S; Galtier, N			Population size does not influence mitochondrial genetic diversity in animals	SCIENCE			English	Article							SELECTION; DRIFT; DNA; POLYMORPHISM; EVOLUTION	Within-species genetic diversity is thought to reflect population size, history, ecology, and ability to adapt. Using a comprehensive collection of polymorphism data sets covering 3000 animal species, we show that the widely used mitochondria) DNA (mtDNA) marker does not reflect species abundance or ecology: mtDNA diversity is not higher in invertebrates than in vertebrates, in marine than in terrestrial species, or in small than in large organisms. Nuclear loci, in contrast, fit these intuitive expectations. The unexpected mitochondria( diversity distribution is explained by recurrent adaptive evolution, challenging the neutral theory of molecular evolution and questioning the relevance of mtDNA in biodiversity and conservation studies.	Univ Montpellier 2, CNRS, UMR Genome Populat Interact Adaptat 5171, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Galtier, N (corresponding author), Univ Montpellier 2, CNRS, UMR Genome Populat Interact Adaptat 5171, F-34095 Montpellier 5, France.	galtier@univ-montp2.fr	Bazin, Eric/A-4033-2010					Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Bazin E, 2005, NUCLEIC ACIDS RES, V33, pD481, DOI 10.1093/nar/gki076; CABALLERO A, 1992, GENETICS, V131, P493; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Cherry JL, 2003, GENETICS, V163, P421; Foltz DW, 2003, J MOL EVOL, V57, P607, DOI 10.1007/s00239-003-2495-5; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Gillespie JH, 2001, EVOLUTION, V55, P2161; Gillespie JH, 2000, GENETICS, V155, P909; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hedrick P, 2005, EVOLUTION, V59, P1596; Hudson RR, 2003, EVOLUTION, V57, P182; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Iizuka M, 2002, GENETICS, V161, P381; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Nevo E., 1984, Lecture Notes in Biomathematics, V53, P13; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Roze D, 2005, GENETICS, V170, P1385, DOI 10.1534/genetics.104.039495; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031	29	665	677	2	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					570	572		10.1126/science.1122033	http://dx.doi.org/10.1126/science.1122033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645093				2022-12-28	WOS:000237296700043
J	Linder, P; Lasko, P				Linder, P; Lasko, P			Bent out of shape: RNA unwinding by the DEAD-Box helicase vasa	CELL			English	Editorial Material							PROTEIN		Univ Geneva, Ctr Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Geneva; McGill University	Linder, P (corresponding author), Univ Geneva, Ctr Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland.	patrick.linder@medecine.unige.ch	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501				Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X	9	50	51	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					219	221		10.1016/j.cell.2006.03.030	http://dx.doi.org/10.1016/j.cell.2006.03.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630807	Bronze			2022-12-28	WOS:000237241500009
J	McGuire, AL; Gibbs, RA				McGuire, AL; Gibbs, RA			No longer de-identified	SCIENCE			English	Editorial Material							GENOMIC DATA PRIVACY; PROTECTING PRIVACY; TECHNOLOGY		Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, 1 Baylor Plaza,Suite 310D, Houston, TX 77030 USA.	amcguire@bcm.edu						Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; *HHS, 2004, RES REP DAT HIPAA PR; HUGO Ethics Committee, 2002, STAT HUM GEN DAT; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Malin B, 2004, J BIOMED INFORM, V37, P179, DOI 10.1016/j.jbi.2004.04.005; Malin BA, 2005, J AM MED INFORM ASSN, V12, P28, DOI 10.1197/jamia.M1603; McWilliams R, 2003, JAMA-J AM MED ASSOC, V290, P360, DOI 10.1001/jama.290.3.360; *NCI, 1999, CONF DAT SEC CANC RE; *NHGRI, 1996, GUID HUM SUBJ ISS LA; NHGRI, 2003, REAFF EXT NHGRI RAP; *OFF HUM RES PROT, 2004, GUID RES INV COD PRI; Roche PA, 2005, SCIENCE, V307, P1200; Rothstein MA, 2005, J LAW MED ETHICS, V33, P89, DOI 10.1111/j.1748-720X.2005.tb00213.x; Sweeney L, 1997, J LAW MED ETHICS, V25, P98, DOI 10.1111/j.1748-720X.1997.tb01885.x; SWEENEY L, 2004, ACM COMPUT SOC, V34; Wylie JE, 2003, TRENDS BIOTECHNOL, V21, P113, DOI 10.1016/S0167-7799(02)00039-2	17	138	140	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					370	371		10.1126/science.1125339	http://dx.doi.org/10.1126/science.1125339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627725				2022-12-28	WOS:000236941800026
J	Regoes, RR; Bonhoeffer, S				Regoes, RR; Bonhoeffer, S			Emergence of drug-resistant influenza virus: Population dynamical considerations	SCIENCE			English	Editorial Material							NEURAMINIDASE INHIBITORS; ADAMANTANE RESISTANCE; A VIRUSES; IN-VITRO; OSELTAMIVIR; ZANAMIVIR; ANTIVIRALS; CHILDREN; MUTATION; SPREAD	Given the considerable challenges to the rapid development of an effective vaccine against influenza, antiviral agents wilt play an important role as a first-tine defense if a new pandemic occurs. The large-scale use of drugs for chemoprophylaxis and treatment wilt impose strong selection for the evolution of drug-resistant strains. The ensuing transmission of those strains could substantially limit the effectiveness of the drugs as a first-tine defense. Summarizing recent data on the rate at which the treatment of influenza infection generates resistance de novo and on the transmission fitness of resistant virus, we discuss possible implications for the epidemiological spread of drug resistance in the context of an established population dynamic model.	ETH, ETH Zentrum CHN, Inst Intergrat Biol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bonhoeffer, S (corresponding author), ETH, ETH Zentrum CHN, Inst Intergrat Biol, K12-1,Univ Str 16, CH-8092 Zurich, Switzerland.	sebastian.bonhoeffer@env.ethz.ch	Regoes, Roland R/A-6538-2008; Bonhoeffer, Sebastian/A-2735-2008	Regoes, Roland R/0000-0001-8319-5293; Bonhoeffer, Sebastian/0000-0001-8052-3925				ANDERSON R M, 1991; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; HAY AJ, 1996, ANTIVIRAL DRUG RESIS, P43; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Heymann DL, 2006, CELL, V124, P671, DOI 10.1016/j.cell.2006.02.009; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jackson HC, 2000, CLIN DRUG INVEST, V20, P447, DOI 10.2165/00044011-200020060-00007; Jefferson T., 2004, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001169.pub2, DOI 10.1002/14651858.CD001169.PUB2]; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Monto AS, 2003, VACCINE, V21, P1796, DOI 10.1016/S0264-410X(03)00075-6; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Roberts NA, 2001, PHILOS T ROY SOC B, V356, P1895, DOI 10.1098/rstb.2001.1002; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; WHO, 2021, REP IND ALL VACC GRO; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005	35	144	151	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					389	391		10.1126/science.1122947	http://dx.doi.org/10.1126/science.1122947			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034OZ	16627735				2022-12-28	WOS:000236941800036
J	Levitan, DR; Ferrell, DL				Levitan, DR; Ferrell, DL			Selection on gamete recognition proteins depends on sex, density, and genotype frequency	SCIENCE			English	Article							STRONGYLOCENTROTUS-FRANCISCANUS; SPERM LIMITATION; URCHINS; EVOLUTION; CONFLICT; FERTILIZATION; BINDIN; SPECIATION; TRAITS; SEQUENCE	Gamete recognition proteins can evolve at astonishing rates and lie at the heart of reproductive isolation and speciation in diverse taxa. However, the source of selection driving this evolution remains unknown. We report on how the sperm bindin genotype influences reproductive success under natural conditions. An interaction between genotype frequency and spawning density determines how sperm bindin genotype influences reproductive success. Common genotypes are selected under sperm-limited conditions, whereas rare genotypes are selected under conditions of intense sperm competition and sexual conflict. Variation in the evolutionary rates of bindin may reflect historic differences in sperm availability.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Levitan, DR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	levitan@bio.fsu.edu; ferrell@bio.fsu.edu						Biermann CH, 1998, MOL BIOL EVOL, V15, P1761, DOI 10.1093/oxfordjournals.molbev.a025902; Debenham P, 2000, J MOL EVOL, V51, P481, DOI 10.1007/s002390010111; Doebeli M, 2005, J EVOLUTION BIOL, V18, P1587, DOI 10.1111/j.1420-9101.2005.00897.x; Ebert TA, 2003, FISH B-NOAA, V101, P915; GAO B, 1986, P NATL ACAD SCI USA, V83, P8634, DOI 10.1073/pnas.83.22.8634; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Haygood R, 2004, EVOLUTION, V58, P1414; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Kamei N, 2003, GENE DEV, V17, P2502, DOI 10.1101/gad.1133003; Levitan D, 1998, EVOLUTION, V52, P1043, DOI 10.2307/2411235; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; Levitan DR, 2004, AM NAT, V164, P298, DOI 10.1086/423150; LEVITAN DR, 1993, AM NAT, V141, P517, DOI 10.1086/285489; Mah SA, 2005, MOL BIOL EVOL, V22, P533, DOI 10.1093/molbev/msi037; McCartney MA, 2004, MOL BIOL EVOL, V21, P732, DOI 10.1093/molbev/msh071; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Payne RJH, 1997, EVOLUTION, V51, P1, DOI 10.1111/j.1558-5646.1997.tb02382.x; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439	21	136	139	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					267	269		10.1126/science.1122183	http://dx.doi.org/10.1126/science.1122183			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614223				2022-12-28	WOS:000236765300049
J	Gostin, L				Gostin, L			Public health strategies for pandemic influenza - ethics and the law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, L (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*APPL BOD, 2001, WTDS135ABR APPL BOD; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Blendon RJ, 2006, HEALTH AFFAIR, V25, pW15, DOI 10.1377/hlthaff.25.w15; Centers for Disease Control and Prevention, PUBL HLTH GUID COMM; *DEP HLTH HUM SERV, FISC YEAR 2005 BUDG; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FIDLER DP, IN PRESS J LAW MED E; Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229; Gostin LO, 2001, AM J PUBLIC HEALTH, V91, P1388, DOI 10.2105/AJPH.91.9.1388; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; *I MED, 2005, QUAR STAT PORTS ENTR; John RKS, 2005, EMERG INFECT DIS, V11, P6, DOI 10.3201/eid1101.040835; Kimura A. C., 2005, Morbidity and Mortality Weekly Report, V54, P196; Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043; *PUBL HLTH ASS, 1918, JAMA-J AM MED ASSOC, V71, P2068; *USDA, 2005, QUEST ANSW AV INFL; *WHO, 2003, HOSP INF CONTR GUID; *WHO, H5N1 AV INFL TIM; WHO World Health Organization, 2004, WHO SARS RISK ASS PR; *WORLD BANK, 2005, AV HUM INFL FIN NEED; 2005, FED REG         1130, V70, P71892	26	75	77	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1700	1704		10.1001/jama.295.14.1700	http://dx.doi.org/10.1001/jama.295.14.1700			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609092				2022-12-28	WOS:000236707300027
J	Lindheimer, MD; Sibai, BM				Lindheimer, MD; Sibai, BM			Antioxidant supplementation in pre-eclampsia	LANCET			English	Editorial Material							TRIAL		Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Cincinnati, Dept Obstet & Gynecol, Cincinnati, OH USA	University of Chicago; University of Chicago; University System of Ohio; University of Cincinnati	Lindheimer, MD (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA.	mlindhei@medicine.bsd.uchicago.edu						FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; Lindheimer M D, 1996, Curr Opin Nephrol Hypertens, V5, P452, DOI 10.1097/00041552-199609000-00013; Lindheimer MD, 2005, AM J OBSTET GYNECOL, V193, P3, DOI 10.1016/j.ajog.2005.03.017; Lindheimer MD, 2004, SEMIN NEPHROL, V24, P537; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; RUSH D, 1980, PEDIATRICS, V65, P683; Sibai BM, 1998, AM J OBSTET GYNECOL, V179, P1275, DOI 10.1016/S0002-9378(98)70146-2; Villar J, 2006, AM J OBSTET GYNECOL, V194, P639, DOI 10.1016/j.ajog.2006.01.068; Villar J, 2004, SEMIN NEPHROL, V24, P607, DOI 10.1016/S0270-9295(04)00132-9	9	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1119	1120		10.1016/S0140-6736(06)68434-1	http://dx.doi.org/10.1016/S0140-6736(06)68434-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616542				2022-12-28	WOS:000236673400004
J	Adami, C				Adami, C			Reducible complexity	SCIENCE			English	Editorial Material							EVOLUTION		Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA	Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Adami, C (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA.	adami@kgi.edu	Adami, Chris/A-9675-2011; Adami, Christoph/A-5181-2009	Adami, Chris/0000-0002-2915-9504; 				Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Behe MJ, 2004, PROTEIN SCI, V13, P2651, DOI 10.1110/ps.04802904; BEHE MJ, 1994, DARWINS BLACK BOX BI; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Darwin C, 1872, ORIGIN SPECIES; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568	6	16	16	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					61	63		10.1126/science.1126559	http://dx.doi.org/10.1126/science.1126559			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601180				2022-12-28	WOS:000236584400026
J	Foster, LJ; de Hoog, CL; Zhang, YL; Zhang, Y; Xie, XH; Mootha, VK; Mann, M				Foster, LJ; de Hoog, CL; Zhang, YL; Zhang, Y; Xie, XH; Mootha, VK; Mann, M			A mammalian organelle map by protein correlation profiling	CELL			English	Article							LARGE-SCALE ANALYSIS; SUBCELLULAR-LOCALIZATION; PROTEOMIC ANALYSIS; GENE-EXPRESSION; GLOBAL ANALYSIS; GENOMICS; YEAST; PROTEASOME; ARGININE; COMPLEX	Protein localization to membrane-enclosed organelles is a central feature of cellular organization. Using protein correlation profiling, we have mapped 1,404 proteins to ten subcellular locations in mouse liver, and these correspond with enzymatic assays, marker protein profiles, and confocal microscopy. These localizations allowed assessment of the specificity in published organellar proteomic inventories and demonstrate multiple locations for 39% of all organellar proteins. Integration of proteomic and genomic data enabled us to identify networks of coexpressed genes, cis-regulatory motifs, and putative transcriptional regulators involved in organelle biogenesis., Our analysis ties biochemistry, cell biology, and genomics into a common framework for organelle analysis.	Univ So Denmark, Dept Biochem & Mol Biol, CEBI, DK-5230 Odense, Denmark; Univ British Columbia, Dept Biochem & Mol Biol, Ctr Proteom, Vancouver, BC V6T 1Z4, Canada; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany; Chinese Acad Sci, Beijing Inst Genom, Beijing 101300, Peoples R China; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Syst Biol, Boston, MA 02115 USA	University of Southern Denmark; University of British Columbia; Max Planck Society; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Mann, M (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, CEBI, Campusvej 55, DK-5230 Odense, Denmark.	mmann@biochem.mpg.de	Mann, Matthias/A-3454-2013	Mann, Matthias/0000-0003-1292-4799; Xie, Xiaohui/0000-0002-5479-6345				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Agaton C, 2003, MOL CELL PROTEOMICS, V2, P405, DOI 10.1074/mcp.M300022-MCP200; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Azarani A, 1998, BIOCHEM J, V333, P439, DOI 10.1042/bj3330439; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Hoog CL, 2004, ANNU REV GENOM HUM G, V5, P267, DOI 10.1146/annurev.genom.4.070802.110305; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gaucher SP, 2004, J PROTEOME RES, V3, P495, DOI 10.1021/pr034102a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glaser P, 2004, CURR OPIN MICROBIOL, V7, P489, DOI 10.1016/j.mib.2004.08.016; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; PETERS JM, 1994, J BIOL CHEM, V269, P7709; RAPPSILBER J, 2003, 51 C MASS SPECTR ALL; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Tulp A, 1998, ELECTROPHORESIS, V19, P1288, DOI 10.1002/elps.1150190812; Wiemann S, 2004, GENOME RES, V14, P2136, DOI 10.1101/gr.2576704; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	43	439	452	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					187	199		10.1016/j.cell.2006.03.022	http://dx.doi.org/10.1016/j.cell.2006.03.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615899	Bronze			2022-12-28	WOS:000237314200023
J	Tomita, K; Cooper, JP				Tomita, K; Cooper, JP			The meiotic chromosomal bouquet: SUN collects flowers	CELL			English	Editorial Material							FISSION YEAST; RECOMBINATION; MOVEMENT; POMBE	In the early stages of meiosis, all the telomeres in the cell attach to the nuclear envelope and gather near the centrosome. This polarized chromosomal array is known as the bouquet, as the clustered telomeres resemble the gathered stems of a floral arrangement. In this issue of Cell, Chikashige et al. (2006) provide intriguing clues about the molecular details underlying this conserved meiotic event.	Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England	Cancer Research UK	Cooper, JP (corresponding author), Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England.	julie.cooper@cancer.org.uk	Tomita, Kazunori/P-6363-2019	Tomita, Kazunori/0000-0003-1096-6725; cooper, julia promisel/0000-0003-2171-2587				CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; DEVEAUX LC, 1992, GENETICS, V130, P251; Goto B, 2001, J CELL SCI, V114, P2427; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Martin-Castellanos C, 2005, CURR BIOL, V15, P2056, DOI 10.1016/j.cub.2005.10.038; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; Scherthan H, 2006, COLD SPRING HARB MON, V45, P225; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233	8	33	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					19	21		10.1016/j.cell.2006.03.020	http://dx.doi.org/10.1016/j.cell.2006.03.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615884	Bronze			2022-12-28	WOS:000237314200008
J	Weinberger, SE; Smith, LG; Collier, VU				Weinberger, Steven E.; Smith, Lawrence G.; Collier, Virginia U.		Educ Comm Am Coll Phys	Redesigning training for internal medicine	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE; RESIDENCY PROGRAMS; NEW-MODEL; EDUCATION; FUTURE; GAP	The American College of Physicians supports the need for reform throughout the continuum of training in internal medicine. Today's internists must have the necessary knowledge, skills, and attitudes to meet the challenges of an expanding body of medical knowledge and a rapidly evolving system of health care delivery. Suggested priorities for undergraduate medical education include redesigning curricular experiences to afford students earlier and more exposure to career opportunities in internal medicine, improving ambulatory education, exposing students to outstanding faculty role models in internal medicine, and incorporating educational experiences during the fourth year that optimize its value and relevance to the student's future career plans in internal medicine. Internal medicine residency training should remain a 3-year experience, with a component of core education common to all trainees and a component of customized training in the third year targeted toward the resident's career goals. Residency programs should be designed around educational rather than institutional service needs. The ambulatory component of training requires substantial reform in its structure, sites, content, and timing. Team-based models should be used both for patient care and for flexibility in design of residency training. Better faculty models must be developed that build on the concept of a "core faculty," improve the rewards for teaching faculty, and provide appropriate faculty development focusing on a necessary set of educator competencies.	Amer Coll Physicians, Customer Serv, Philadelphia, PA 19106 USA	American College of Physicians	Weinberger, SE (corresponding author), Amer Coll Physicians, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Arora V, 2005, AM J MED, V118, P680, DOI 10.1016/j.amjmed.2005.03.022; *ASS AM MED COLL, 2005, MED ED COSTS STUD DE; Association of American Medical Colleges, 2006, COMP RES PHYS THEIR; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Charap MH, 2005, AM J MED, V118, P1042, DOI 10.1016/j.amjmed.2005.06.009; Collier VU, 2002, ANN INTERN MED, V136, P384, DOI 10.7326/0003-4819-136-5-200203050-00011; *COUNC GRAD MED ED, 2000, FIN GRAD MED ED CHAN; Ferrer RL, 2005, ANN INTERN MED, V142, P691, DOI 10.7326/0003-4819-142-8-200504190-00037; Fincher RE, 2004, NEW ENGL J MED, V351, P630, DOI 10.1056/NEJMp048054; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Fuster V, 2004, J AM COLL CARDIOL, V44, P267, DOI 10.1016/j.jacc.2004.05.027; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Goldman L, 2004, AM J MED, V117, P133, DOI 10.1016/j.amjmed.2004.05.001; Goroll AH, 2004, ANN INTERN MED, V140, P902, DOI 10.7326/0003-4819-140-11-200406010-00012; Keating RJ, 2005, AM J MED, V118, P788, DOI 10.1016/j.amjmed.2005.04.014; Larson EB, 2004, ANN INTERN MED, V140, P639, DOI 10.7326/0003-4819-140-8-200404200-00011; Ludmerer KM, 2005, JAMA-J AM MED ASSOC, V294, P1083, DOI 10.1001/jama.294.9.1083; PECKHAM C, 2005, POINT COUNTERPOINT F; Schwartz MD, 2005, ANN INTERN MED, V142, P715, DOI 10.7326/0003-4819-142-8-200504190-00040; Smith LG, 2005, AM J MED, V118, P439, DOI 10.1016/j.amjmed.2005.01.021; Smith LG, 2004, AM J MED, V116, P648, DOI 10.1016/j.amjmed.2004.02.015; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Whitcomb ME, 2004, NEW ENGL J MED, V351, P710, DOI 10.1056/NEJMsb045003	23	117	120	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					927	932		10.7326/0003-4819-144-12-200606200-00124	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00124			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16601254				2022-12-28	WOS:000238555500008
J	Purandare, N; Burns, A; Daly, KJ; Hardicre, J; Morris, J; Macfarlane, G; McCollum, C				Purandare, Nitin; Burns, Alistair; Daly, Kevin J.; Hardicre, Jayne; Morris, Julie; Macfarlane, Gary; McCollum, Charles			Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATENT FORAMEN OVALE; TRANSCRANIAL DOPPLER; MICROEMBOLIC SIGNALS; STROKE PATIENTS; ULTRASOUND; PREVALENCE; ROTTERDAM; STENOSIS; CRITERIA; BYPASS	Objective To compare the occurrence of spontaneous cerebral emboli and venous to arterial circulation shunts in patients with Alzheimer's disease or vascular dementia and controls without dementia. Design Cross sectional case-control study. Setting Secondary care old age psychiatry services, Manchester. Participants 170 patients with dementia (85 with Alzheimer's disease, 85 with vascular dementia) and 150 age and sex matched controls. Patients on anticoagulant treatment, patients with severe dementia, and controls with marked cognitive impairment were excluded. Main outcome measures Frequencies of detection of spontaneous cerebral emboli during one hour monitoring of the middle cerebral arteries with transcranial Doppler and venous to arterial circulation shunts by a transcranial Doppler technique using intravenous microbubbles as an ultrasound contrast. Results Spontaneous cerebral emboli were detected in 32 (40%) of patients with Alzheimer's disease and 31 (37%) of those with vascular dementia compared with just 12 each (15% and 14%) of their controls, giving significant odds ratios adjusted for vascular risk factors of 2.70 (95% confidence interval 1.18 to 6.21) for Alzheimer's disease and 5.36 (1.24 to 23.18) for vascular dementia. These spontaneous cerebral emboli were not caused by carotid disease, which was equally frequent in dementia patients and their controls. A venous to arterial circulation shunt indicative of patent foramen ovale was found in 27 (32%) Alzheimer's disease patients and 25 (29%) vascular dementia patients compared with 19 (22%) and 17 (20%) controls, giving non-significant odds ratios of 1.57 (0.80 to 3.07) and 1.67 (0.81 to 3.41). Conclusion Spontaneous cerebral emboli were significantly associated with both Alzheimer's disease and vascular dementia. They may represent a potentially preventable or treatable cause of dementia.	Univ Manchester, Sch Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Dept Psychiat, Manchester, Lancs, England; Univ Manchester, Acad Surg Unit, Manchester M13 9PL, Lancs, England; S Manchester Univ Hosp NHS Trust, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Macfarlane, G (corresponding author), Univ Manchester, Sch Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England.	cnmcc@manchester.ac.uk	Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314; Burns, Alistair/0000-0002-9837-0645; hardicre, jayne/0000-0002-4047-9779	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anzola Gian Paolo, 2002, Eur J Ultrasound, V16, P11, DOI 10.1016/S0929-8266(02)00043-5; Deklunder G, 1998, STROKE, V29, P1821, DOI 10.1161/01.STR.29.9.1821; DITULLIO M, 1993, STROKE, V24, P1020, DOI 10.1161/01.STR.24.7.1020; Droste DW, 2000, STROKE, V31, P1640, DOI 10.1161/01.STR.31.7.1640; Fearn SJ, 2001, J THORAC CARDIOV SUR, V121, P1150, DOI 10.1067/mtc.2001.114099; FOISTEIN MF, 1975, J PSYCHIATR RES, V12, P189; Folstein MF., 1975, J PSYCHIATR RES, V12, P189, DOI [DOI 10.1016/0022-3956(75)90026-6, 10.1016/0022-3956(75)90026-6]; HAGAN PT, 1984, MAYO CLIN P, V59, P17; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hutchinson S, 2002, STROKE, V33, P685, DOI 10.1161/hs0302.104166; Jauss M, 2000, CEREBROVASC DIS, V10, P490, DOI 10.1159/000016119; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meier B, 2005, HEART, V91, P444, DOI 10.1136/hrt.2004.052258; Meier B, 2003, CIRCULATION, V107, P5, DOI 10.1161/01.CIR.0000046073.34261.C1; Nygren T, 1998, CLIN PHYSIOL, V18, P327; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Purandare N, 2005, INT J GERIATR PSYCH, V20, P12, DOI 10.1002/gps.1202; Riding G, 2001, BRIT J SURG, V88, P745; Ringelstein EB, 1998, STROKE, V29, P725; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Russell D, 2002, J NEUROL SCI, V203, P211, DOI 10.1016/S0022-510X(02)00293-9; SASTRY S, 2002, HEART, V88, P32; Sidhu PS, 1997, CLIN RADIOL, V52, P654, DOI 10.1016/S0009-9260(97)80027-X; Skoog I, 1999, ALZ DIS ASSOC DIS, V13, pS106, DOI 10.1097/00002093-199912003-00016; SLIWKA U, 1995, STROKE, V26, P2067, DOI 10.1161/01.STR.26.11.2067; SPENCER MP, 1995, STROKE, V26, P1123, DOI 10.1161/01.STR.26.6.1123; Stewart R, 1999, AUST NZ J PSYCHIAT, V33, P809, DOI 10.1046/j.1440-1614.1999.00657.x; Stork JL, 2002, STROKE, V33, P2014, DOI 10.1161/01.STR.0000021002.17394.7F; Stygall J, 2003, HEALTH PSYCHOL, V22, P579, DOI 10.1037/0278-6133.22.6.579; WEBSTER MWI, 1988, LANCET, V2, P11	31	90	105	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1119	1122		10.1136/bmj.38814.696493.AE	http://dx.doi.org/10.1136/bmj.38814.696493.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044OT	16648133	Green Published, Bronze			2022-12-28	WOS:000237682700015
J	Rieux-Laucat, F; Hivroz, C; Lim, A; Mateo, V; Pellier, I; Selz, F; Fischer, A; Le Deist, F				Rieux-Laucat, F; Hivroz, C; Lim, A; Mateo, V; Pellier, I; Selz, F; Fischer, A; Le Deist, F			Brief report: Inherited and somatic CD3 zeta mutations in a patient with T-cell deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IN-VIVO REVERSION; WISKOTT-ALDRICH-SYNDROME; PROTEIN-TYROSINE KINASE; ANTIGEN RECEPTOR; MICE LACKING; ZETA-CHAIN; GENE; MOSAICISM; LYMPHOCYTES	A four-month-old boy with primary immunodeficiency was found to have a homozygous germ-line mutation of the gene encoding the CD3 zeta subunit of the T-cell receptor - CD3 complex. CD3 zeta is necessary for the development and function of T cells. Some of the patient's T cells had low levels of the T-cell receptor - CD3 complex and carried the Q70X mutation in both alleles of CD3 zeta, whereas other T cells had normal levels of the complex and bore the Q70X mutation on only one allele of CD3 zeta, plus one of three heterozygous somatic mutations of CD3 zeta on the other allele, allowing expression of poorly functional T-cell receptor - CD3 complexes.	Univ Paris 05, Hop Necker, Unite 768, INSERM, F-75015 Paris, France; Univ Paris 05, Hop Necker, Fac Med, F-75015 Paris, France; Univ Paris 05, Hop Necker, Unite Immunol Hematol Pediat, F-75015 Paris, France; Inst Pasteur, INSERM, Unite 520, F-75724 Paris, France; Inst Pasteur, INSERM, Inst Curie, F-75724 Paris, France; Inst Pasteur, INSERM, Unite 668, F-75724 Paris, France; Inst Pasteur, INSERM, Unite Immunite Antivirale Biotherapies & Vaccin, F-75724 Paris, France; Ctr Hosp Univ St Justine, Dept Microbiol & Immunol, Montreal, PQ, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Rieux-Laucat, F (corresponding author), Univ Paris 05, Hop Necker, Unite 768, INSERM, 149 Rue Sevres, F-75015 Paris, France.	rieux@necker.fr	Hivroz, Claire/H-2711-2014; Rieux-Laucat, Frédéric/A-7916-2017; Mateo, Véronique/AAD-1379-2019; isabelle, pellier/L-5683-2015; Mateo, Véronique/O-9738-2017	Hivroz, Claire/0000-0002-6794-2890; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Mateo, Véronique/0000-0002-9327-1277; Mateo, Véronique/0000-0002-9327-1277				Andre-Schmutz I, 2002, TRANSPLANT P, V34, P2927, DOI 10.1016/S0041-1345(02)03491-7; Ariga T, 1998, BLOOD, V92, P699, DOI 10.1182/blood.V92.2.699; Ariga T, 2001, J IMMUNOL, V166, P5245, DOI 10.4049/jimmunol.166.8.5245; ARNAIZVILLENA A, 1992, NEW ENGL J MED, V327, P529, DOI 10.1056/NEJM199208203270805; Arredondo-Vega FX, 2002, BLOOD, V99, P1005, DOI 10.1182/blood.V99.3.1005; Bonnerot C, 1998, EMBO J, V17, P4606, DOI 10.1093/emboj/17.16.4606; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Dadi HK, 2003, NEW ENGL J MED, V349, P1821, DOI 10.1056/NEJMoa031178; Dadi HK, 2004, NEW ENGL J MED, V350, P1803; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; Dumont C, 2002, J IMMUNOL, V169, P1705, DOI 10.4049/jimmunol.169.4.1705; Fischer A, 2004, NAT IMMUNOL, V5, P23, DOI 10.1038/ni1023; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; HIRSCHHORN R, 1994, AM J HUM GENET, V55, P59; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; Kung C, 2000, NAT MED, V6, P343; Lim A, 2002, J IMMUNOL METHODS, V261, P177, DOI 10.1016/S0022-1759(02)00004-2; Lin SY, 1997, J EXP MED, V185, P707, DOI 10.1084/jem.185.4.707; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; Nishikomori R, 2004, BLOOD, V103, P4565, DOI 10.1182/blood-2003-10-3655; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; PANNETIER C, 1997, ANTIGEN T CELL RECEP, P287; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Rieux-Laucat F, 1999, BLOOD, V94, P2575; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x	36	75	81	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1913	1921		10.1056/NEJMoa053750	http://dx.doi.org/10.1056/NEJMoa053750			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672702				2022-12-28	WOS:000237239900007
J	Eichholzer, M; Tonz, T; Zimmermann, R				Eichholzer, M; Tonz, T; Zimmermann, R			Folic acid: a public-health challenge	LANCET			English	Review							NEURAL-TUBE DEFECTS; CELL FOLATE CONCENTRATIONS; FOOD FORTIFICATION; VITAMIN INTERVENTION; PERICONCEPTIONAL USE; HOMOCYSTEINE LEVELS; SERUM HOMOCYSTEINE; WESTERN-AUSTRALIA; REPRODUCTIVE AGE; PREVALENCE RATES	Despite worldwide public-health campaigns recommending periconceptional daily supplementation of synthetic folic acid to reduce the risk of neural tube defects, many women are not following these recommendations. At the same time, in most European countries no decline in defects has been recorded in recent years. Vulnerable groups are those with a low standard of education, young people, and women with unplanned pregnancies. Furthermore, in most countries without mandatory fortification, the general population is not consuming the recommended 0.4 mg of food folate per day. Voluntary fortification improves the situation, but does not reach all parts of the population. In the USA, Canada, and Chile, mandatory fortification of flour substantially improved folate and homocysteine status, and neural tube defects rates fell by between 31% and 78%. Nevertheless, many countries do not choose mandatory folic acid fortification, in part because expected additional health benefits are not yet scientifically proven in clinical trials, in part because of feared health risks, and because of the issue of freedom of choice. Thus, additional creative public-health approaches need to be developed to prevent neural tube defects and improve the folate status of the general population.	Univ Zurich, Inst Social & Prevent Med, Hirschengraben 84, CH-8001 Zurich, Switzerland; Childrens Hosp, Luzern, Switzerland; Univ Zurich Hosp, Dept Obstet, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Eichholzer, M (corresponding author), Univ Zurich, Inst Social & Prevent Med, Hirschengraben 84, CH-8001 Zurich, Switzerland.	eichholz@ifspm.unizh.ch						[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; [Anonymous], 1998, DIETARY REFERENCE IN; BAERLOCHER K, 2002, MEASURES PREVENT NEU; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Bailey LB, 2003, J NUTR, V133, p1961S, DOI 10.1093/jn/133.6.1961S; Barkai G, 2003, LANCET, V361, P1331, DOI 10.1016/S0140-6736(03)13080-2; Beitz R, 2002, EUR J CLIN NUTR, V56, P539, DOI 10.1038/sj.ejcn.1601346; Benchalal M, 2002, ANN ONCOL, V13, P480, DOI 10.1093/annonc/mdf023; Berry RJ, 2005, BMJ-BRIT MED J, V330, P815, DOI 10.1136/bmj.38369.437789.82; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bostom AG, 2001, ANN INTERN MED, V135, P133, DOI 10.7326/0003-4819-135-2-200107170-00014; Botto LD, 2004, AM J MED GENET C, V125C, P12, DOI 10.1002/ajmg.c.30004; Botto LD, 2005, BMJ-BRIT MED J, V330, P571, DOI 10.1136/bmj.38336.664352.82; Bower C, 2004, AUST NZ J PUBL HEAL, V28, P458, DOI 10.1111/j.1467-842X.2004.tb00028.x; Bower C, 2004, BIRTH DEFECTS RES A, V70, P842, DOI 10.1002/bdra.20074; Bower C, 2004, PAEDIATR PERINAT EP, V18, P277, DOI 10.1111/j.1365-3016.2004.00567.x; Braekke K, 2003, ACTA OBSTET GYN SCAN, V82, P620, DOI 10.1034/j.1600-0412.2003.00180.x; Busby A, 2005, REPROD TOXICOL, V20, P393, DOI 10.1016/j.reprotox.2005.03.009; BUTTERWORTH CE, 1992, AM J OBSTET GYNECOL, V166, P803, DOI 10.1016/0002-9378(92)91337-A; Campbell NRC, 1996, ARCH INTERN MED, V156, P1638, DOI 10.1001/archinte.156.15.1638; CASASBECERRA L, 1997, REPRODUCTIVE HLTH MA, V9, P29; Castilla EE, 2003, AM J MED GENET A, V123A, P123, DOI 10.1002/ajmg.a.20230; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P962; Chacko MR, 2003, PEDIATRICS, V112, P536, DOI 10.1542/peds.112.3.536; Chan A, 2001, MED J AUSTRALIA, V174, P631, DOI 10.5694/j.1326-5377.2001.tb143471.x; Charles D, 2004, BMJ-BRIT MED J, V329, P1375, DOI 10.1136/bmj.329.7479.1375; CHILDERS JM, 1995, CANCER EPIDEM BIOMAR, V4, P155; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Choumenkovitch SF, 2001, J NUTR, V131, P3277, DOI 10.1093/jn/131.12.3277; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke Robert, 2005, Semin Vasc Med, V5, P215, DOI 10.1055/s-2005-872407; Coll O, 2004, EUR J OBSTET GYN R B, V115, P173, DOI 10.1016/j.ejogrb.2003.12.009; *COMM ASP FOOD POL, 2000, 50 COMM ASP FOOD POL; Cornel MC, 2005, REPROD TOXICOL, V20, P411, DOI 10.1016/j.reprotox.2005.03.015; CRANE JMG, 2001, J SOC OBSTET GYNAECO, V23, P510; Cuskelly GJ, 1999, AM J CLIN NUTR, V70, P234; Czeizel A. E., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P175; Czeizel AE, 2005, NUTRITION, V21, P698, DOI 10.1016/j.nut.2004.10.017; Czeizel AE, 1998, EUR J OBSTET GYN R B, V78, P151, DOI 10.1016/S0301-2115(98)00061-X; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Czeizel Andrew E, 2004, Int J Med Sci, V1, P50; Czernichow Sebastien, 2005, Semin Vasc Med, V5, P156, DOI 10.1055/s-2005-872400; *DACH GERM NUTR SO, 2000, REF VAL NUTR INT; Daly S, 1997, LANCET, V350, P1666, DOI 10.1016/S0140-6736(97)07247-4; de Jong-van den Berg LTW, 2005, AM J OBSTET GYNECOL, V192, P121, DOI 10.1016/j.ajog.2004.05.085; de Walle HEK, 1999, BRIT MED J, V319, P291, DOI 10.1136/bmj.319.7205.291; de Walle HEK, 2002, TERATOLOGY, V66, P40, DOI 10.1002/tera.10078; de Walle HEK, 2002, PREV MED, V35, P65, DOI 10.1006/pmed.2002.1040; De Wals P, 2003, BIRTH DEFECTS RES A, V67, P919, DOI 10.1002/bdra.10124; *DEP HHS US, 2004, PREV REP; Eichholzer M, 2001, SWISS MED WKLY, V131, P539; Eichholzer M, 2002, Praxis (Bern 1994), V91, P7; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; Fletcher RJ, 2004, P NUTR SOC, V63, P605, DOI 10.1079/PNS2004391; Food Administration (FDA) D, 1996, FED REGISTER, V61, P8781; *FOOD STAND AG, 2006, AG BOARD DISC FOL HL; Food Standards Agency, 2002, BOARD REACH CONCL FO; French AE, 2003, CLIN PHARMACOL THER, V74, P288, DOI 10.1016/S0009-9236(03)00200-5; Garcia A, 2004, CAN MED ASSOC J, V171, P897, DOI 10.1503/cmaj.1031586; Hertrampf E, 2003, J NUTR, V133, P3166, DOI 10.1093/jn/133.10.3166; Hirsch S, 2002, J NUTR, V132, P289, DOI 10.1093/jn/132.2.289; *HLTH CAN, 1997, CANADA GAZETTE 1, V131, P3702; Husler M, 2002, Ther Umsch, V59, P641, DOI 10.1024/0040-5930.59.12.641; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kadir RA, 2002, CAN MED ASSOC J, V167, P255; Kallen B, 2005, EARLY HUM DEV, V81, P469, DOI 10.1016/j.earlhumdev.2005.03.004; Katz J, 2001, INT J EPIDEMIOL, V30, P802, DOI 10.1093/ije/30.4.802; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Kim YI, 2004, AM J CLIN NUTR, V80, P1123, DOI 10.1093/ajcn/80.5.1123; Knudsen VK, 2004, PUBLIC HEALTH NUTR, V7, P843, DOI 10.1079/PHN2004630; KOLETZKO B, 2004, DTSCH ARZTEBL, V101, P1670; Koren G, 1997, CAN FAM PHYSICIAN, V43, P851; Kotsopoulos J, 2005, CARCINOGENESIS, V26, P1603, DOI 10.1093/carcin/bgi117; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Larson RJ, 2005, J NATL CANCER I, V97, P693, DOI 10.1093/jnci/dji117; Li Z, 2003, LANCET, V361, P380, DOI 10.1016/S0140-6736(03)12390-2; LIU S, EVALUATION FOOD FORT; Liu Shiliang, 2004, BMC Pregnancy Childbirth, V4, P20, DOI 10.1186/1471-2393-4-20; Lopez-Camelo JS, 2005, AM J MED GENET A, V135A, P120, DOI 10.1002/ajmg.a.30651; Lucock M, 2005, NAT REV GENET, V6, P235, DOI 10.1038/nrg1558; LUMLEY J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001056.pub2, 10.1002/14651858.CD001056, DOI 10.1002/14651858.CD001056]; Martin J A, 1999, Natl Vital Stat Rep, V47, P1; McDonald Sarah D, 2003, J Obstet Gynaecol Can, V25, P115; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Mills JL, 2003, AM J CLIN NUTR, V77, P1474, DOI 10.1093/ajcn/77.6.1474; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Munoz-Moran E, 1998, LANCET, V352, P1120, DOI 10.1016/S0140-6736(05)79761-0; Myers MF, 2001, AM J EPIDEMIOL, V154, P1051, DOI 10.1093/aje/154.11.1051; *NHMRC, 1993, REV STAT REL DIET FO; Nydhal M, 2003, J Nutr Health Aging, V7, P67; Oakley GP, 2004, BIRTH DEFECTS RES A, V70, P838, DOI 10.1002/bdra.20059; Oakley GP, 2004, BRIT MED J, V329, P41, DOI 10.1136/bmj.329.7456.41; Persad VL, 2002, CAN MED ASSOC J, V167, P241; Planells E, 2003, EUR J CLIN NUTR, V57, P777, DOI 10.1038/sj.ejcn.1601610; Postma MJ, 2002, PHARM WORLD SCI, V24, P8, DOI 10.1023/A:1014848928212; Quadagno D, 1997, AIDS EDUC PREV, V9, P359; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Rader JI, 2000, FOOD CHEM, V70, P275, DOI 10.1016/S0308-8146(00)00116-3; Ray JG, 2005, OBSTET GYNECOL, V105, P261, DOI 10.1097/01.AOG.0000151988.84346.3e; Ray JG, 2005, AM J MED, V118, P444, DOI 10.1016/j.amjmed.2004.10.024; Ray JG, 2002, LANCET, V360, P2047, DOI 10.1016/S0140-6736(02)11994-5; Ray JG, 2004, BJOG-INT J OBSTET GY, V111, P399, DOI 10.1111/j.1471-0528.2004.00115.x; Ray JG, 2003, J PEDIATR-US, V143, P805, DOI 10.1067/S0022-3476(03)00495-5; Ray JG, 2003, AM J MED GENET A, V120A, P309, DOI 10.1002/ajmg.a.20161; Ray JG, 2002, EPIDEMIOLOGY, V13, P238, DOI 10.1097/00001648-200203000-00026; Ray JG, 2002, CAN J PUBLIC HEALTH, V93, P249, DOI 10.1007/BF03405010; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Relton CL, 2005, PUBLIC HEALTH NUTR, V8, P338, DOI 10.1079/PHN2004690; Rosano A, 1999, J EPIDEMIOL COMMUN H, V53, P630, DOI 10.1136/jech.53.10.630; Rosenberg IH, 2005, AM J CLIN NUTR, V82, P279, DOI 10.1093/ajcn/82.2.279; Salvi VS, 2005, LANCET, V366, P871, DOI 10.1016/S0140-6736(05)67294-7; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Shane B, 2003, AM J CLIN NUTR, V77, P8, DOI 10.1093/ajcn/77.1.8; Shaw GM, 2003, AM J MED GENET A, V119A, P137, DOI 10.1002/ajmg.a.20145; Signore C, 2005, OBSTET GYNECOL, V105, P757, DOI 10.1097/01.AOG.0000154886.40318.5e; Sillender M, 2000, J Obstet Gynaecol, V20, P271; SISK ER, 2002, J NUTR HEALTH AGING, V8, P140; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Stevenson RE, 2000, PEDIATRICS, V106, P677, DOI 10.1542/peds.106.4.677; SUTER P, 2002, NUTR CHECKLIST; Taylor MJ, 2004, J PSYCHOPHARMACOL, V18, P251, DOI 10.1177/0269881104042630; Thompson JR, 2001, LANCET, V358, P1935, DOI 10.1016/S0140-6736(01)06959-8; TONZ O, 2002, FORUM MED SUISSE, V13, P303; TONZ O, 2005, 5 FED OFF PUBL HLTH; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; *US FDA, 1996, FOL CAN HELP PREV BI; van der Pal-de Bruin KM, 2000, PAEDIATR PERINAT EP, V14, P111; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Virtanen JK, 2005, EUR J CARDIOV PREV R, V12, P369, DOI 10.1097/01.hjr.0000160834.75466.b0; Vollset SE, 2005, EPIDEMIOLOGY, V16, P201, DOI 10.1097/01.ede.0000152914.84962.13; Voutilainen S, 2004, AM J CLIN NUTR, V80, P317, DOI 10.1093/ajcn/80.2.317; Waller DK, 2003, PAEDIATR PERINAT EP, V17, P378, DOI 10.1046/j.1365-3016.2003.00511.x; Ward M, 2004, Ir Med J, V97, P274; Werler MM, 1997, AM J MED GENET, V71, P93; *WHO, 2003, WHOTECHN REP DIET NU; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060	136	209	218	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1352	1361		10.1016/S0140-6736(06)68582-6	http://dx.doi.org/10.1016/S0140-6736(06)68582-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631914				2022-12-28	WOS:000237118500030
J	Burtsev, M; Turchin, P				Burtsev, M; Turchin, P			Evolution of cooperative strategies from first principles	NATURE			English	Article							KIN-SELECTION; STRONG RECIPROCITY; POPULATIONS; ALTRUISM; GAME	One of the greatest challenges in the modern biological and social sciences is to understand the evolution of cooperative behaviour. General outlines of the answer to this puzzle are currently emerging as a result of developments in the theories of kin selection(1-7), reciprocity(8-10), multilevel selection(11-15) and cultural group selection(16,17). The main conceptual tool used in probing the logical coherence of proposed explanations has been game theory, including both analytical models and agent-based simulations(6,7,9,18-24). The game-theoretic approach yields clear-cut results but assumes, as a rule, a simple structure of payoffs and a small set of possible strategies. Here we propose a more stringent test of the theory by developing a computer model with a considerably extended spectrum of possible strategies. In our model, agents are endowed with a limited set of receptors, a set of elementary actions and a neural net in between. Behavioural strategies are not predetermined; instead, the process of evolution constructs and reconstructs them from elementary actions. Two new strategies of cooperative attack and defence emerge in simulations, as well as the well-known dove, hawk and bourgeois strategies. Our results indicate that cooperative strategies can evolve even under such minimalist assumptions, provided that agents are capable of perceiving heritable external markers of other agents.	RAS, MV Keldysh Appl Math Inst, Dept Nonlinear Dynam, Moscow 125047, Russia; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	Russian Academy of Sciences; Keldysh Institute of Applied Mathematics; University of Connecticut	Burtsev, M (corresponding author), RAS, MV Keldysh Appl Math Inst, Dept Nonlinear Dynam, Moscow 125047, Russia.	mbur@narod.ru	Burtsev, Mikhail S/G-6293-2010	Burtsev, Mikhail S/0000-0003-1614-1695				[Anonymous], 2018, HIST DYNAMICS WHY ST, DOI DOI 10.23943/PRINCETON/9780691180779.001.0001; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, 2004, EVOLUTION, V58, P1833; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Bowles S., 2001, SOCIAL DYNAMICS, P155; Boyd R., 1985, CULTURE EVOLUTIONARY; Burtsev MS, 2004, ARTIF LIFE, V10, P397, DOI 10.1162/1064546041766415; Epstein J.M., 1996, GROWING ARTIFICIAL S; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; Matthiopoulos J, 2002, ECOL MODEL, V147, P291, DOI 10.1016/S0304-3800(01)00420-3; MAYNARDSMITH J, 1974, J THEOR BIOL, V47, P209, DOI DOI 10.1016/0022-5193(74)90110-6; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; MICHOD RE, 1980, SCIENCE, V210, P667, DOI 10.1126/science.210.4470.667; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI 10.1111/j.1558-5646.1992.tb02045.x; Richerson P.J., 1998, INDOCTRINABILITY IDE, P71; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Sober Elliott, 1998, OTHERS EVOLUTION PSY; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wilson David Sloan, 1997, American Naturalist, V150, P122	29	44	50	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1041	1044		10.1038/nature04470	http://dx.doi.org/10.1038/nature04470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625195				2022-12-28	WOS:000236906000034
J	Kupfer, A; Muller, H; Antoniazzi, MM; Jared, C; Greven, H; Nussbaum, RA; Wilkinson, M				Kupfer, A; Muller, H; Antoniazzi, MM; Jared, C; Greven, H; Nussbaum, RA; Wilkinson, M			Parental investment by skin feeding in a caecilian amphibian	NATURE			English	Article							REPRODUCTIVE MODES; GYMNOPHIONA; BIOLOGY; BALANCE	Although the initial growth and development of most multicellular animals depends on the provision of yolk, there are many varied contrivances by which animals provide additional or alternative investment in their offspring(1). Providing offspring with additional nutrition should be favoured by natural selection when the consequent increased fitness of the young offsets any corresponding reduction in fecundity(2). Alternative forms of nutrition may allow parents to delay and potentially redirect their investment. Here we report a remarkable form of parental care and mechanism of parent-offspring nutrient transfer in a caecilian amphibian. Boulengerula taitanus is a direct-developing, oviparous caecilian(3), the skin of which is transformed in brooding females to provide a rich supply of nutrients for the developing offspring. Young animals are equipped with a specialized dentition, which they use to peel and eat the outer layer of their mother's modified skin. This new form of parental care provides a plausible intermediate stage in the evolution of viviparity in caecilians. At independence, offspring of viviparous and of oviparous dermatotrophic caecilians are relatively large despite being provided with relatively little yolk. The specialized dentition of skin-feeding (dermatophagous) caecilians may constitute a pre-adaptation to the fetal feeding on the oviduct lining of viviparous caecilians.	Nat Hist Museum, Dept Zool, London SW7 5BD, England; Leiden Univ, Inst Biol, NL-2311 GP Leiden, Netherlands; Inst Butantan, Lab Biol Celular, BR-05503900 Sao Paulo, Brazil; Univ Dusseldorf, Inst Zoomorphol & Zellbiol, D-40225 Dusseldorf, Germany; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Ecol & Evolut Biol, Ann Arbor, MI 48109 USA	Natural History Museum London; Leiden University; Leiden University - Excl LUMC; Instituto Butantan; Heinrich Heine University Dusseldorf; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wilkinson, M (corresponding author), Nat Hist Museum, Dept Zool, Cromwell Rd, London SW7 5BD, England.	mw@bmnh.org	Mueller, Hendrik/B-4979-2010; Wilkinson, Mark/J-2026-2014; Kupfer, Alexander/B-5417-2010; Antoniazzi, Marta/A-3495-2017; Jared, Carlos/D-3299-2012; Antoniazzi, Marta Maria/AAF-1942-2021	Mueller, Hendrik/0000-0001-6764-7376; Wilkinson, Mark/0000-0002-9459-8976; Jared, Carlos/0000-0002-9117-6276; Antoniazzi, Marta Maria/0000-0002-0575-7921				Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; Exbrayat J. M., 2000, GYMNOPHIONES CURIEUX; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; HIMSTEDT W, 1996, BLINDWUHLEN; Kupfer A, 2004, BIOL J LINN SOC, V83, P207, DOI 10.1111/j.1095-8312.2004.00382.x; Lehtinen RM, 2003, REPROD BIOL PHYLOGEN, V2, P343; Loader SP, 2003, J ZOOL, V259, P93, DOI 10.1017/S0952836902003060; Malonza PK, 2005, TROP ZOOL, V18, P49, DOI 10.1080/03946975.2005.10531214; Muller H, 2005, ZOOMORPHOLOGY, V124, P171, DOI 10.1007/s00435-005-0005-6; Muller M., 1977, ZOOL JB ANAT, V97, P532; Nussbaum RA, 2003, REPROD BIOL PHYLOGEN, V1, P527; NUSSBAUM RA, 1994, COPEIA, P750; O'Reilly J. C., 1998, American Zoologist, V38, p187A; PARKER HW, 1956, NATURE, V178, P250, DOI 10.1038/178250a0; PARKER HW, 1964, COPEIA, P75; Pennisi E, 1999, SCIENCE, V283, P623, DOI 10.1126/science.283.5402.623; Romeis B., 1989, MIKROSKOPISCHE TECHN; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Taylor E. H., 1968, CAECILIANS WORLD; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; TOLEDO RC, 1993, COMP BIOCHEM PHYS A, V105, P593, DOI 10.1016/0300-9629(93)90259-7; Wake MH, 1998, J EXP ZOOL, V282, P477; WELDON PJ, 1993, J HERPETOL, V27, P219, DOI 10.2307/1564942; Wilkinson M, 1998, J NAT HIST, V32, P1403, DOI 10.1080/00222939800770701; Wilkinson Mark, 2003, African Journal of Herpetology, V52, P83	28	83	91	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					926	929		10.1038/nature04403	http://dx.doi.org/10.1038/nature04403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612382	Green Published			2022-12-28	WOS:000236736700039
J	Robins, JH; Ross, HA; Allen, MS; Matisoo-Smith, E				Robins, JH; Ross, HA; Allen, MS; Matisoo-Smith, E			Taxonomy - Sus bucculentus revisited	NATURE			English	Editorial Material							DNA		Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; Univ Auckland, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand; Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; Massey University; University of Auckland; University of Auckland; University of Auckland	Robins, JH (corresponding author), Univ Auckland, Dept Anthropol, Private Bag 92019, Auckland 1, New Zealand.	j.robins@auckland.ac.nz	Allen, Melinda S/AAB-7224-2021; Ross, Howard/D-2978-2009	Allen, Melinda S/0000-0001-5041-5106; Matisoo-Smith, Elizabeth/0000-0002-3500-8307				Groves Colin P., 2000, P261; Groves CP, 1997, NATURE, V386, P335, DOI 10.1038/386335a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KIRCH PV, 1982, TIKOPIA PREHISTORY E, P100; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN	9	14	15	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086								10.1038/nature04770	http://dx.doi.org/10.1038/nature04770			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612336				2022-12-28	WOS:000236736700029
J	Gurerk, O; Irlenbusch, B; Rockenbach, B				Gurerk, O; Irlenbusch, B; Rockenbach, B			The competitive advantage of sanctioning institutions	SCIENCE			English	Article							STRONG RECIPROCITY; ALTRUISTIC PUNISHMENT; PUBLIC GOOD; COOPERATION; EVOLUTION; ENFORCEMENT; HUMANS; NORMS; BEHAVIOR	Understanding the fundamental patterns and determinants of human cooperation and the maintenance of social order in human societies is a challenge across disciplines. The existing empirical evidence for the higher levels of cooperation when altruistic punishment is present versus when it is absent systematically ignores the institutional competition inherent in human societies. Whether punishment would be deliberately adopted and would similarly enhance cooperation when directly competing with nonpunishment institutions is highly controversial in light of recent findings on the detrimental effects of punishment. We show experimentally that a sanctioning institution is the undisputed winner in a competition with a sanction-free institution. Despite initial aversion, the entire population migrates successively to the sanctioning institution and strongly cooperates, whereas the sanction-free society becomes fully depopulated. The findings demonstrate the competitive advantage of sanctioning institutions and exemplify the emergence and manifestation of social order driven by institutional selection.	Univ Erfurt, D-99089 Erfurt, Germany; London Sch Econ, London WC2A 2AE, England	University of Erfurt; University of London; London School Economics & Political Science	Rockenbach, B (corresponding author), Univ Erfurt, Nordhauser Str 63, D-99089 Erfurt, Germany.	bettina.rockenbach@uni-erfurt.de	Gürerk, Özgür/H-5514-2019; Rockenbach, Bettina/AAI-8072-2021; Irlenbusch, Bernd/J-3064-2015; Rockenbach, Bettina/B-5447-2016	Gürerk, Özgür/0000-0001-7971-7319; Rockenbach, Bettina/0000-0003-2624-1964; Rockenbach, Bettina/0000-0003-2624-1964; Irlenbusch, Bernd/0000-0002-3433-2826				Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; [Anonymous], 1987, EVOLUTION HUMAN SOC; Binmore K, 2005, NATURAL JUSTICE; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Hammerstein P., 2003, GENETIC CULTURAL EVO; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; MAHDI NQ, 1986, ETHOL SOCIOBIOL, V7, P295, DOI 10.1016/0162-3095(86)90055-5; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Rege M, 2004, J PUBLIC ECON, V88, P1625, DOI 10.1016/S0047-2727(03)00021-5; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Wiessner P, 2005, HUM NATURE-INT BIOS, V16, P115, DOI 10.1007/s12110-005-1000-9; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252	30	515	519	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					108	111		10.1126/science.1123633	http://dx.doi.org/10.1126/science.1123633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	029SJ	16601192				2022-12-28	WOS:000236584400042
J	Galindo-Cuspinera, V; Winnig, M; Bufe, B; Meyerhof, W; Breslin, PAS				Galindo-Cuspinera, V; Winnig, M; Bufe, B; Meyerhof, W; Breslin, PAS			A TAS1R receptor-based explanation of sweet 'water-taste'	NATURE			English	Article							BITTER TASTE; INHIBITION; SACCHARIN	Water-tastes' are gustatory after-impressions elicited by water following the removal of a chemical solution from the mouth, akin to colour after-images appearing on 'white' paper after fixation on coloured images. Unlike colour after-images, gustatory aftereffects are poorly understood(1). One theory posits that 'water-tastes' are adaptation phenomena, in which adaptation to one taste solution causes the water presented subsequently to act as a taste stimulus(2,3). An alternative hypothesis is that removal of the stimulus upon rinsing generates a receptor-based, positive, off-response in taste-receptor cells, ultimately inducing a gustatory perception(4). Here we show that a sweet 'water-taste' is elicited when sweet-taste inhibitors are rinsed away. Responses of cultured cells expressing the human sweetener receptor directly parallel the psychophysical responses - water rinses remove the inhibitor from the heteromeric sweetener receptor TAS1R2 - TAS1R3, which activates cells and results in the perception of strong sweetness from pure water. This 'rebound' activity occurs when equilibrium forces on the two-state allosteric sweet receptors result in their coordinated shift to the activated state upon being released from inhibition by rinsing(5-7).	Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; German Inst Human Nutr Potsdam Rehbrucke, D-14558 Nuthetal, Germany	Monell Chemical Senses Center; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Breslin, PAS (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	breslin@monell.org	Bufe, Bernd/N-6685-2018	Bufe, Bernd/0000-0003-1610-0658; Breslin, Paul/0000-0001-5988-8401; Winnig, Marcel/0000-0002-5306-5778				BARTOSHUK LM, 1968, PERCEPT PSYCHOPHYS, V3, P69, DOI 10.3758/BF03212715; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; COOPERMAN BS, 2004, ENCY BIOL CHEM, P68; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; DALZIEL K, 1968, Febs Letters, V1, P346, DOI 10.1016/0014-5793(68)80150-4; DuBois GE, 2004, P NATL ACAD SCI USA, V101, P13972, DOI 10.1073/pnas.0405991101; GENT JF, 1978, PERCEPT PSYCHOPHYS, V23, P171, DOI 10.3758/BF03208298; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Horne J, 2002, CHEM SENSES, V27, P31, DOI 10.1093/chemse/27.1.31; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kenakin T, 2004, RECEPTOR CHANNEL, V10, P51, DOI 10.1080/10606820490464316; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; MCBURNEY DH, 1973, PHYSIOL BEHAV, V10, P1101, DOI 10.1016/0031-9384(73)90194-7; MCBURNEY DH, 1972, OLFACTION TASTE, V4, P329; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; SCHIFFMAN SS, 1993, NEUROSCI BIOBEHAV R, V17, P313, DOI 10.1016/S0149-7634(05)80015-6; Schiffman SS, 1999, CHEM SENSES, V24, P439, DOI 10.1093/chemse/24.4.439; SCHIFFMAN SS, 1995, BRAIN RES BULL, V36, P505, DOI 10.1016/0361-9230(94)00225-P; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	30	96	100	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					354	357		10.1038/nature04765	http://dx.doi.org/10.1038/nature04765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16633339				2022-12-28	WOS:000237593200049
J	Yamane, K; Toumazou, C; Tsukada, Y; Erdjument-Bromage, H; Tempst, P; Wong, JM; Zhang, Y				Yamane, Kenichi; Toumazou, Charalambos; Tsukada, Yu-ichi; Erdjument-Bromage, Hediye; Tempst, Paul; Wong, Jiemin; Zhang, Yi			JHDM2A, a JmjC-containing H3K9 dernethylase, facilitates transcription activation by androgen receptor	CELL			English	Article							HISTONE LYSINE METHYLATION; OXIDATIVE DEMETHYLATION; ARGININE METHYLATION; ESCHERICHIA-COLI; HORMONE-RECEPTOR; COMPLEX; METHYLTRANSFERASE; CHROMATIN; GENES; REPRESSION	Covalent modification of histones plays an important role in regulating chromatin dynamics and transcription. Histone methylation was thought to be an irreversible modification until recently. Using a biochemical assay coupled with chromatography, we have purified a JmjC domain-containing protein, JHDM2A, which specifically demethylates mono- and dimethyl-H3K9. Similar to JHDM1, JHDM2A-mediated histone demethylation requires cofactors Fe(II) and a-ketoglutarate. Mutational studies indicate that a JmjC domain and a zinc finger present in JHDM2A are required for its enzymatic activity. Overexpression of JHDM2A greatly reduced the H3K9 methylation level in vivo. Knockdown of JHDM2A results in an increase in the dimethyl-K9 levels at the promoter region of a subset of genes concomitant with decrease in their expression. Finally, JHDM2A exhibits hormone-dependent recruitment to androgen-receptor target genes, resulting in H3K9 demethylation and transcriptional activation. Thus, our work identifies a histone demethylase and links its function to hormone-dependent transcriptional activation.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Hu, Ruogu/B-2203-2008	Zhang, Yi/0000-0002-2789-0811; Tempst, Paul/0000-0002-6680-3987; Wong, Jiemin/0000-0002-5311-842X; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIDDK NIH HHS [DK065264] Funding Source: Medline; NIGMS NIH HHS [GM68804] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V152, P887, DOI 10.1016/0003-9861(72)90286-X; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HOOG C, 1991, MOL REPROD DEV, V30, P173, DOI 10.1002/mrd.1080300302; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	43	612	648	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					483	495		10.1016/j.cell.2006.03.027	http://dx.doi.org/10.1016/j.cell.2006.03.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16603237	Green Submitted, Bronze			2022-12-28	WOS:000237506100015
J	George, JN				George, JN			Thrombotic thrombocytopenic purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; PLASMA-EXCHANGE; ESCHERICHIA-COLI; ADAMTS-13; PREGNANCY; DIAGNOSIS; OUTCOMES; TRANSPLANTATION		Univ Oklahoma, Hlth Sci Ctr, Hematol Oncol Sect, Dept Med, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	George, JN (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Hematol Oncol Sect, Dept Med, Rm CHB 358,POB 26901, Oklahoma City, OK 73190 USA.	james-george@ouhsc.edu						Allford SL, 2003, BRIT J HAEMATOL, V120, P556, DOI 10.1046/j.1365-2141.2003.04049.x; AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Bohm M, 2005, BRIT J HAEMATOL, V129, P644, DOI 10.1111/j.1365-2141.2005.05512.x; Bonnardeaux A, 2003, LANCET, V362, P1514, DOI 10.1016/S0140-6736(03)14777-0; BRAIN MC, 1962, BRIT J HAEMATOL, V8, P358, DOI 10.1111/j.1365-2141.1962.tb06541.x; Burns ER, 2004, AM J HEMATOL, V75, P18, DOI 10.1002/ajh.10450; Clark WF, 2003, JAMA-J AM MED ASSOC, V290, P1351, DOI 10.1001/jama.290.10.1351; Cohen JA, 1998, J CLIN APHERESIS, V13, P16, DOI 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C; Crowther MA, 1996, ANN INTERN MED, V125, P294, DOI 10.7326/0003-4819-125-4-199608150-00006; Dundas S, 1999, LANCET, V354, P1327, DOI 10.1016/S0140-6736(99)01251-9; Fakhouri F, 2005, BLOOD, V106, P1932, DOI 10.1182/blood-2005-03-0848; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; George JN, 2006, J CLIN APHERESIS, V21, P49, DOI 10.1002/jca.20091; George JN, 2004, TRANSFUSION, V44, P294, DOI 10.1111/j.1537-2995.2004.00700.x; George JN, 2004, SEMIN HEMATOL, V41, P60, DOI 10.1053/j.seminhematol.2003.10.001; George JN, 2003, CURR OPIN HEMATOL, V10, P339, DOI 10.1097/00062752-200309000-00003; Ho VT, 2005, BIOL BLOOD MARROW TR, V11, P571, DOI 10.1016/j.bbmt.2005.06.001; Howard MA, 2006, TRANSFUSION, V46, P154, DOI 10.1111/j.1537-2995.2006.00687.x; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kojouri K, 2001, ANN INTERN MED, V135, P1047, DOI 10.7326/0003-4819-135-12-200112180-00008; Lammle B, 2005, J THROMB HAEMOST, V3, P1663, DOI 10.1111/j.1538-7836.2005.01425.x; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; McMinn JR, 2001, J CLIN APHERESIS, V16, P202, DOI 10.1002/jca.10005; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Peyvandi F, 2004, BRIT J HAEMATOL, V127, P433, DOI 10.1111/j.1365-2141.2004.05217.x; Raife TJ, 2006, TRANSFUSION, V46, P74, DOI 10.1111/j.1537-2995.2005.00674.x; Richardson MW, 2002, THROMB HAEMOSTASIS, V88, P900, DOI 10.1055/s-0037-1613332; ROCK G, 1992, TRANSFUSION, V32, P710, DOI 10.1046/j.1537-2995.1992.32893032096.x; Rock G, 1996, BRIT J HAEMATOL, V94, P383, DOI 10.1046/j.1365-2141.1996.d01-1800.x; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Sadler J Evan, 2004, Hematology Am Soc Hematol Educ Program, P407; Smith JW, 2003, TRANSFUSION, V43, P820, DOI 10.1046/j.1537-2995.2003.00397.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Terrell DR, 2005, J THROMB HAEMOST, V3, P1432, DOI 10.1111/j.1538-7836.2005.01436.x; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vesely SK, 2004, TRANSFUSION, V44, P1149, DOI 10.1111/j.1537-2995.2004.03422.x; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; Veyradier A, 2005, J THROMB HAEMOST, V3, P2420, DOI 10.1111/j.1538-7836.2005.01350.x; Zeigler ZR, 2001, J CLIN APHERESIS, V16, P19, DOI 10.1002/jca.1003; ZHENG X, 2006, CLIN HEMATOLOGY, P802; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035; Ziman A, 2005, TRANSFUSION, V45, P41, DOI 10.1111/j.1537-2995.2005.03146.x; [No title captured]	50	391	417	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1927	1935		10.1056/NEJMcp053024	http://dx.doi.org/10.1056/NEJMcp053024			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672704				2022-12-28	WOS:000237239900009
J	Vert, G; Chory, J				Vert, G; Chory, J			Downstream nuclear events in brassinosteroid signalling	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; BETA-CATENIN; ARABIDOPSIS; KINASE; RECEPTOR; GROWTH; PATHWAY; BZR1; TRANSDUCTION	Brassinosteroids (BRs) are steroid hormones that control many aspects of plant growth and development(1,2). BRs bind to the plasma membrane receptor kinase BRI1, and act through a signalling pathway that involves a glycogen synthase kinase-3-like kinase (BIN2) and a serine/threonine phosphatase (BSU1)(3-5). Previous models proposed that BIN2 negatively regulates BR signalling by controlling the stability and subcellular localization of the related transcription factors BES1 and BZR1 by phosphorylation, in a manner reminiscent of the canonical Wnt signalling pathway of metazoans(6-9). Here we present strong evidence for a different mode of regulation of BR signalling. We show that BES1 is localized constitutively to the nucleus, where its activity is modulated by nuclear-localized BIN2 kinase. BIN2-mediated phosphorylation of BES1 inhibits its DNA-binding activity on BR-responsive target promoters and its transcriptional activity through impaired multimerization. Our observations demonstrate that phosphorylation-dependent inhibition of DNA binding and trans-activation is the key primary mechanism of BES1 regulation.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu		Vert, Greg/0000-0002-0844-9991				Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li JM, 2002, SCIENCE, V295, P1299; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Peng P, 2003, J PLANT GROWTH REGUL, V22, P298, DOI 10.1007/s00344-003-0059-y; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhao J, 2002, PLANT PHYSIOL, V130, P1221, DOI 10.1104/pp.102.010918	27	264	281	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					96	100		10.1038/nature04681	http://dx.doi.org/10.1038/nature04681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672972				2022-12-28	WOS:000237248600040
J	Newman, AB; Simonsick, EM; Naydeck, BL; Boudreau, RM; Kritchevsky, SB; Nevitt, MC; Pahor, M; Satterfield, S; Brach, JS; Studenski, SA; Harris, TB				Newman, AB; Simonsick, EM; Naydeck, BL; Boudreau, RM; Kritchevsky, SB; Nevitt, MC; Pahor, M; Satterfield, S; Brach, JS; Studenski, SA; Harris, TB			Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-RATE RECOVERY; FUNCTIONING OLDER-ADULTS; PHYSICAL FUNCTION; BODY-COMPOSITION; RESPIRATORY-DISEASE; EXERCISE CAPACITY; 6-MINUTE WALK; HEALTH; PREDICTOR; FAILURE	Context Aerobic fitness, an important predictor of cardiovascular disease and mortality, is difficult to assess by maximal exercise testing in older adults. Extended walking tests have been examined as outcome predictors in medically ill populations but not in community-dwelling older adults. Objective To determine whether an extended walking test predicts poor outcomes in older adults. Design, Setting, and Participants Observational cohort study enrolling 3075 community-dwelling adults aged 70 to 79 years living in Pittsburgh, Pa, or Memphis, Tenn. Of those participating in the Health, Aging, and Body Composition Study, 1584 (52%) were women and 1281 (42%) were black. Participants enrolled from March 1997 to April 1998. Ability to complete the long-distance corridor walk and total performance time was assessed at the baseline examination. Main Outcome Measures Total mortality, incident cardiovascular disease, incident mobility limitation, and mobility disability were ascertained after a mean (SD) of 4.9 (0.9) years. Results Among patients eligible to exercise, 351 died, 308 had episodes of incident cardiovascular disease, 1116 had occurrences of mobility limitation, and 509 had occurrences of mobility disability. Inability to complete walking 400 m tended to be associated with a higher risk of mortality and incident cardiovascular disease and, after accounting for potential confounders, was associated with incident mobility limitation (212.6 vs 79.1 events/1000 person-years; adjusted hazard ratio [HR], 1.86; 95% confidence interval [CI], 1.58-2.18; P <. 001) andmobility disability (85.2 vs 28.8 events/1000 person-years; adjusted HR, 1.95; 95% CI, 1.56- 2.44; P <. 001). Of those who completed 400 m, each additional minute of performance time was associated with an adjusted HR of 1.29 ( 95% CI, 1.12-1.48) for mortality, 1.20 ( 95% CI, 1.01-1.42) for incident cardiovascular disease, 1.52 ( 95% CI, 1.41-1.63) for mobility limitation, and 1.52 ( 95% CI, 1.37-1.70) for disability after adjustment for demographics, health behaviors, clinical and subclinical disease, and cardiovascular disease risk factors. Findings were consistent in both men and women and blacks and whites. Among participants who completed the test and after adjusting for potential confounders, those in the poorest quartile of functional capacity ( walk time > 362 seconds) had a higher risk of death than those in the best quartile ( walk time < 290 seconds; adjusted HR, 3.23; 95% CI, 2.11-4.94; P <. 001). Conclusions Older adults in the community who reported no difficulty walking had a wide range of performance on this extended walking test. Ability to do the test and performance were important prognostic factors for total mortality, cardiovascular disease, mobility limitation, and mobility disability in persons in their eighth decade.	Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Geriatr Med, Pittsburgh, PA 15213 USA; NIA, Intramural Res Program, Baltimore, MD 21224 USA; Wake Forest Univ, Sch Med, Dept Internal Med, Div Gerontol & Geriatr Med, Winston Salem, NC 27109 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Florida, Coll Med, Dept Aging & Geriatr Res, Gainesville, FL USA; Univ Tennessee, Dept Prevent Med, Memphis, TN 38163 USA; NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wake Forest University; University of California System; University of California San Francisco; State University System of Florida; University of Florida; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Newman, AB (corresponding author), Univ Pittsburgh, Dept Epidemiol, 130 N Bellefield St,Room 532, Pittsburgh, PA 15213 USA.	newmana@edc.pitt.edu	Simonsick, Eleanor/W-6864-2019; Newman, Anne B./C-6408-2013; Brach, Jennifer/A-6912-2009	Newman, Anne B./0000-0002-0106-1150; Boudreau, Robert/0000-0003-0162-5187; Brach, Jennifer/0000-0002-7793-2004; Kritchevsky, Stephen/0000-0003-3336-6781	Intramural NIH HHS Funding Source: Medline; NIA NIH HHS [N01-AG-6-2103, N01-AG-6-2101, N01-AG-6-2106] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [N01AG062103, N01AG062106, N01AG062101, Z01AG007390] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Brach JS, 2004, J AM GERIATR SOC, V52, P502, DOI 10.1111/j.1532-5415.2004.52154.x; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; FURBERG CD, 1992, AM J CARDIOL, V69, P1329, DOI 10.1016/0002-9149(92)91231-R; Gibbons RJ, 2002, LANCET, V359, P1536, DOI 10.1016/S0140-6736(02)08525-2; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Lucas C, 1999, AM HEART J, V138, P618, DOI 10.1016/S0002-8703(99)70174-2; MCGAVIN CR, 1978, BRIT MED J, V2, P241, DOI 10.1136/bmj.2.6132.241; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Newman AB, 2003, J GERONTOL A-BIOL, V58, P715; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Peeters P, 1996, J GERONTOL A-BIOL, V51, pM147, DOI 10.1093/gerona/51A.4.M147; Peloquin L, 1998, J AGING PHYS ACTIV, V6, P36, DOI 10.1123/japa.6.1.36; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Pober DM, 2002, CAN J APPL PHYSIOL, V27, P575, DOI 10.1139/h02-033; Sayers SP, 2004, J AM GERIATR SOC, V52, P2099, DOI 10.1111/j.1532-5415.2004.52571.x; SAYERS SP, IN PRESS AGING CLIN; Schwartz PJ, 1998, EUR HEART J, V19, pF72; Simonsick EM, 2000, AGING-CLIN EXP RES, V12, P274, DOI 10.1007/BF03339847; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Simonsick EM, 2006, J AM GERIATR SOC, V54, P127, DOI 10.1111/j.1532-5415.2005.00530.x; Simonsick EM, 2001, J AM GERIATR SOC, V49, P1544, DOI 10.1046/j.1532-5415.2001.4911247.x; SWERTS PMJ, 1990, PHYS THER, V70, P439, DOI 10.1093/ptj/70.7.439; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7	33	650	656	1	33	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2018	2026		10.1001/jama.295.17.2018	http://dx.doi.org/10.1001/jama.295.17.2018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038MF	16670410	Bronze			2022-12-28	WOS:000237225100018
J	Riehle, MM; Markianos, K; Niare, O; Xu, JN; Li, J; Toure, AM; Podiougou, B; Oduol, F; Diawara, S; Diallo, M; Coulibaly, B; Ouatara, A; Kruglyak, L; Traore, SF; Vernick, KD				Riehle, MM; Markianos, K; Niare, O; Xu, JN; Li, J; Toure, AM; Podiougou, B; Oduol, F; Diawara, S; Diallo, M; Coulibaly, B; Ouatara, A; Kruglyak, L; Traore, SF; Vernick, KD			Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCI; REFRACTORINESS; RESISTANCE; MOSQUITOS	We surveyed an Anopheles gambiae population in a West African malaria transmission zone for naturally occurring genetic loci that control mosquito infection with the human malaria parasite, Plasmodium falciparum. The strongest Plasmodium resistance loci cluster in a small region of chromosome 2L and each locus explains at least 89% of parasite-free mosquitoes in independent pedigrees. Together, the clustered loci form a genomic Plasmodium-resistance island that explains most of the genetic variation for malaria parasite infection of mosquitoes in nature. Among the candidate genes in this chromosome region, RNA interference knockdown assays confirm a role in Plasmodium resistance for Anopheles Plasmodium-responsive leucine-rich repeat 1 (APL1), encoding a leucine-rich repeat protein that is similar to molecules involved in natural pathogen resistance mechanisms in plants and mammals.	Univ Minnesota, Ctr Microbial & Plant Genom, St Paul, MN 55108 USA; Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98109 USA; Univ Bamako, Dept Epidemiol Affectat Parasitaires, Bamako, Mali; Princeton Univ, Carl Icahn Lab, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; University of Bamako; Princeton University; Princeton University	Vernick, KD (corresponding author), Univ Minnesota, Ctr Microbial & Plant Genom, St Paul, MN 55108 USA.	kvernick@umn.edu		Markianos, Kyriacos/0000-0003-0214-6014				Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dworkin I, 2005, GENETICS, V169, P2115, DOI 10.1534/genetics.104.035766; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Graham MA, 2002, GENETICS, V162, P1961; Hahn MW, 2004, CURR BIOL, V14, pR264, DOI 10.1016/j.cub.2004.03.018; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Macdonald SJ, 2004, GENETICS, V167, P2127, DOI 10.1534/genetics.104.026732; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Zheng LB, 1996, GENETICS, V143, P941; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	16	211	216	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					577	579		10.1126/science.1124153	http://dx.doi.org/10.1126/science.1124153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645095				2022-12-28	WOS:000237296700045
J	Roberts, JM; Wheeler, AJ; Freiwald, A				Roberts, JM; Wheeler, AJ; Freiwald, A			Reefs of the deep: The biology and geology of cold-water coral ecosystems	SCIENCE			English	Review							NORTHEAST ATLANTIC; LOPHELIA-PERTUSA; SEA CORALS; ROCKALL TROUGH; NE ATLANTIC; MOUNDS; OCEAN; SCLERACTINIA; VENTILATION; IMPACTS	Coral reefs are generally associated with shallow tropical seas; however, recent deep-ocean exploration using advanced acoustics and submersibles has revealed unexpectedly widespread and diverse coral ecosystems in deep waters on continental shelves, slopes, seamounts, and ridge systems around the world. Advances reviewed here include the use of corals as paleoclimatic archives and their biogeological functioning, biodiversity, and biogeography. Threats to these fragile, long-lived, and rich ecosystems are mounting: The impacts of deep-water trawling are already widespread, and effects of ocean acidification are potentially devastating.	Scottish Assoc Marine Sci, Dunstaffnage Marine Lab, Oban PA37 1QA, Argyll, Scotland; Natl Univ Ireland Univ Coll Cork, Dept Geol, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; Erlangen Univ, Inst Paleontol, D-91054 Erlangen, Germany	UHI Millennium Institute; University College Cork; University College Cork; University of Erlangen Nuremberg	Roberts, JM (corresponding author), Scottish Assoc Marine Sci, Dunstaffnage Marine Lab, Oban PA37 1QA, Argyll, Scotland.		Freiwald, Andre/C-2061-2018; Roberts, Murray/D-8299-2013	Freiwald, Andre/0000-0002-2335-4042; Roberts, Murray/0000-0003-1688-5133; Wheeler, Andrew/0000-0001-7107-2229				Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; Adkins JF, 2004, EARTH PLANET SC LETT, V227, P481, DOI 10.1016/j.epsl.2004.08.022; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; CAIRNS SD, UNPUB; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Dorschel B, 2005, EARTH PLANET SC LETT, V233, P33, DOI 10.1016/j.epsl.2005.01.035; Duineveld GCA, 2004, MAR ECOL PROG SER, V277, P13, DOI 10.3354/meps277013; *EXP SCI, 2005, 307 IODP; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Freiwald A., 2004, COLD WATER CORAL REE; GASS SE, IN PRESS MAR POLLUT, DOI DOI 10.1016/J.MARPOLBUL.2005.10.002; Goldstein SJ, 2001, EARTH PLANET SC LETT, V193, P167, DOI 10.1016/S0012-821X(01)00494-0; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Hovland M, 2003, MAR GEOL, V198, P83, DOI 10.1016/S0025-3227(03)00096-3; Huvenne VAI, 2005, ERLANGEN EARTH C SER, P535, DOI 10.1007/3-540-27673-4_27; Kenyon NH, 2003, MAR GEOL, V195, P5, DOI 10.1016/S0025-3227(02)00680-1; Kiriakoulakis K, 2005, ERLANGEN EARTH C SER, P715, DOI 10.1007/3-540-27673-4_37; Kiriakoulakis K, 2004, DEEP-SEA RES PT I, V51, P1937, DOI 10.1016/j.dsr.2004.07.010; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Mangini A, 1998, NATURE, V392, P347, DOI 10.1038/32804; Masson DG, 2003, MAR GEOL, V194, P159, DOI 10.1016/S0025-3227(02)00704-1; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Roberts JM, 2005, CORAL REEFS, V24, P654, DOI 10.1007/s00338-005-0049-6; Roberts JM, 2005, ERLANGEN EARTH C SER, P483, DOI 10.1007/3-540-27673-4_24; Roberts JM, 2003, MAR POLLUT BULL, V46, P7, DOI 10.1016/S0025-326X(02)00259-X; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Royal Society, 2005, OC AC DUE INCR ATM C; Schroder-Ritzrau A, 2005, ERLANGEN EARTH C SER, P157, DOI 10.1007/3-540-27673-4_8; Schroder-Ritzrau A, 2003, EARTH PLANET SC LETT, V216, P399, DOI 10.1016/S0012-821X(03)00511-9; Sherwood OA, 2005, ERLANGEN EARTH C SER, P1061, DOI 10.1007/3-540-27673-4_53; Sherwood OA, 2005, MAR ECOL PROG SER, V301, P129, DOI 10.3354/meps301129; Smith JE, 2000, PALAIOS, V15, P25, DOI 10.2307/3515589; Spiro B, 2000, RAPID COMMUN MASS SP, V14, P1332, DOI 10.1002/1097-0231(20000815)14:15<1332::AID-RCM996>3.3.CO;2-R; Thresher R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018869; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Waller RG, 2005, CORAL REEFS, V24, P514, DOI 10.1007/s00338-005-0501-7; Wheeler AJ, 2005, AM FISH S S, V41, P807; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25	44	676	696	50	1511	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					543	547		10.1126/science.1119861	http://dx.doi.org/10.1126/science.1119861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645087				2022-12-28	WOS:000237296700034
J	Brunini, A				Brunini, A			RETRACTED: Origin of the obliquities of the giant planets in mutual interactions in the early Solar System (Retracted Article. See vol 443, pg 1013, 2006)	NATURE			English	Article; Retracted Publication							URANUS GREAT COLLISION; ANGULAR-MOMENTUM; ORBIT; PLANETESIMALS; ACCRETION; COMPONENT; ROTATION	The origin of the spin-axis orientations (obliquities) of the giant planets is a fundamental issue because if the obliquities resulted from tangential collisions with primordial Earth-sized protoplanets, then they are related to the masses of the largest planetesimals out of which the planets form(1-7). A problem with this mechanism, however, is that the orbital planes of regular satellites would probably be uncorrelated with the obliquities, contrary to observations(6,7). Alternatively, they could have come from an external twist that affected the orientation of the Solar System plane(2); but in this model, the outer planets must have formed too rapidly, before the event that produced the twist(8). Moreover, the model cannot be quantitatively tested. Here I show that the present obliquities of the giant planets were probably achieved when Jupiter and Saturn crossed the 1:2 orbital resonance(9) during a specific migration process: different migration scenarios cannot account for the large observed obliquities. The existence of the regular satellites of the giant planets does not represent a problem in this model because, although they formed soon after the planetary formation, they can follow the slow evolution of the equatorial plane it produces.	Natl Univ La Plata, Fac Ciencias Astron & Geofis, RA-1900 La Plata, Argentina; Consejo Nacl Invest Cient & Tecn, Inst Astrofis La Plata, RA-1900 La Plata, Argentina	National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Brunini, A (corresponding author), Natl Univ La Plata, Fac Ciencias Astron & Geofis, Paseo Bosque S-N, RA-1900 La Plata, Argentina.	abrunini@fcaglp.unlp.edu.ar						ARTYMOWICZ P, 1993, ASTROPHYS J, V419, P166, DOI 10.1086/173470; BRUNINI A, 1995, PLANET SPACE SCI, V43, P1019, DOI 10.1016/0032-0633(95)00009-T; COLOMBO G, 1971, ICARUS, V15, P186, DOI 10.1016/0019-1035(71)90073-X; DONES L, 1993, ICARUS, V103, P67, DOI 10.1006/icar.1993.1059; FERNANDEZ JA, 1984, ICARUS, V58, P109, DOI 10.1016/0019-1035(84)90101-5; GOLDREICH P, 1965, ASTRON J, V70, P5, DOI 10.1086/109673; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; KORYCANSKY DG, 1990, ICARUS, V84, P528, DOI 10.1016/0019-1035(90)90051-A; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LISSAUER JJ, 1991, ICARUS, V94, P126, DOI 10.1016/0019-1035(91)90145-J; Lissauer JJ, 1997, ICARUS, V127, P65, DOI 10.1006/icar.1997.5689; LISSAUER JJ, 1991, ICARUS, V93, P288, DOI 10.1016/0019-1035(91)90213-D; MALHOTRA R, 1993, NATURE, V365, P819, DOI 10.1038/365819a0; MIKI S, 1982, PROG THEOR PHYS, V67, P1053, DOI 10.1143/PTP.67.1053; Parisi MG, 1997, PLANET SPACE SCI, V45, P181, DOI 10.1016/S0032-0633(96)00076-1; Petit JM, 1999, ICARUS, V141, P367, DOI 10.1006/icar.1999.6166; PRESS WH, 1989, NUMERICAL RECIPES, P718; SAFRONOV VS, 1969, EVOLUTION PROTOPLANE, P113; Thommes EW, 2003, ICARUS, V161, P431, DOI 10.1016/S0019-1035(02)00043-X; TREMAINE S, 1991, ICARUS, V89, P85, DOI 10.1016/0019-1035(91)90089-C; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Ward WR, 2004, ASTRON J, V128, P2501, DOI 10.1086/424533; WARD WR, 1988, ICARUS, V73, P330, DOI 10.1016/0019-1035(88)90103-0	23	12	12	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1163	1165		10.1038/nature04577	http://dx.doi.org/10.1038/nature04577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641989				2022-12-28	WOS:000237080000038
J	Gould, PA; Krahn, AD				Gould, PA; Krahn, AD		Canadian Heart Rhythm Soc Working	Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; HEART-FAILURE; SUDDEN-DEATH; INFECTIONS; MANAGEMENT; PACEMAKER; AMIODARONE; THERAPY; RECALLS; TRIAL	Context Recent implantable cardioverter-defibrillator (ICD) advisories and recalls have caused management dilemmas for physicians, particularly because there are no specific guidelines or data on outcomes from current management strategies. The risk of ICD generator replacement has not been assessed in this population. Objective To determine the complication rate associated with ICD generator replacement for the current ICD advisories. Design and Setting Seventeen ICD implanting centers in Canada were surveyed to assess complication rates as a result of generator replacements because of ICD advisories from October 2004 to October 2005. Main Outcome Measure Complications associated with elective ICD generator replacement for current device advisories. Results At the 17 surveyed centers, 2915 patients had recall devices, including 533 (18.3%) who had advisory ICDs replaced a mean (SD) of 26.5 (11.5) months after their initial implant. Of these patients, 66% had a secondary prevention ICD, and 45% had received a previous appropriate shock. During a mean (SD) of 2.7 (2.8) months' follow-up after ICD generator replacement, complications occurred in 43 patients (8.1%). Major complications attributable to advisory device replacement requiring reoperation occurred in 31 patients (5.8%), with death in 2 patients after extraction for pocket infection. Minor complications occurred in 12 patients (2.3%). There were 3 (0.1%) advisory-related device malfunctions reported, without clinical consequences. Conclusions ICD generator replacement in patients with advisory devices is associated with a substantial rate of complications, including death. These complications need to be considered in the development of guidelines determining the appropriate treatment of patients with advisory devices.	Univ Western Ontario, Div Cardiol, Dept Med, London, ON, Canada	Western University (University of Western Ontario)	Krahn, AD (corresponding author), London Hlth Sci Ctr, Arythmia Serv, 339 Windermere Rd, London, ON N6A 5A5, Canada.	akrahn@uwo.ca	Gould, Paul/M-6911-2013					Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Byrd CL, 1999, PACE, V22, P1348, DOI 10.1111/j.1540-8159.1999.tb00628.x; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Goldman BS, 1996, PACE, V19, P7, DOI 10.1111/j.1540-8159.1996.tb04785.x; Gornick CC, 2005, HEART RHYTHM, V2, P681, DOI 10.1016/j.hrthm.2005.05.014; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; Higgins SL, 1999, AM J CARDIOL, V83, p79D; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Lai KK, 1998, CLIN INFECT DIS, V27, P265, DOI 10.1086/514673; Maisel WH, 2004, PACE, V27, P437, DOI 10.1111/j.1540-8159.2004.00460.x; Maisel WH, 2001, JAMA-J AM MED ASSOC, V286, P793, DOI 10.1001/jama.286.7.793; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; *MEDTR, 2005, MARQ PAT MAN INF; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Newman D, 2004, PACE, V27, P435, DOI 10.1111/j.1540-8159.2004.00459.x; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Smith PN, 1998, PACE, V21, P42, DOI 10.1111/j.1540-8159.1998.tb01060.x; Tang ASL, 2001, CIRCULATION, V103, P3081, DOI 10.1161/01.CIR.103.25.3081; TRAPPE HJ, 1995, BRIT HEART J, V73, P20; 2005, P DOC POL C PAC ICD; 2005, GUIDANT ADVISORY UPD	23	187	189	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1907	1911		10.1001/jama.295.16.1907	http://dx.doi.org/10.1001/jama.295.16.1907			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639049	Bronze			2022-12-28	WOS:000237059200025
J	Muller, ME; van der Velde, N; Krulder, JWM; van der Cammen, TJM				Muller, ME; van der Velde, N; Krulder, JWM; van der Cammen, TJM			Lesson of the week - Syncope and falls due to timolol eye drops	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPOTENSION; MEDICATIONS; GLAUCOMA		Erasmus MC, Dept Geriatr Med, NL-3000 CA Rotterdam, Netherlands; Albert Schweitzer Hosp, Dept Geriatr Med, NL-3300 AK Dordrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Albert Schweitzer Ziekenhuis	van der Cammen, TJM (corresponding author), Erasmus MC, Dept Geriatr Med, Room D442,POB 2040, NL-3000 CA Rotterdam, Netherlands.	t.vandercammen@erasmusmc.nl		van der Velde, Nathalie/0000-0002-6477-6209				EVERITT DE, 1990, ANN INTERN MED, V112, P120, DOI 10.7326/0003-4819-112-2-120; Grubb BP, 1998, PACE, V21, P652, DOI 10.1111/j.1540-8159.1998.tb00120.x; HIGGINBOTHAM MB, 1986, CIRC RES, V58, P281, DOI 10.1161/01.RES.58.2.281; LEIER CV, 1986, ANN INTERN MED, V104, P197, DOI 10.7326/0003-4819-104-2-197; LESAR TS, 1987, CLIN PHARMACY, V6, P451; NELSON WL, 1986, AM J OPHTHALMOL, V102, P606, DOI 10.1016/0002-9394(86)90532-5; Novack GD, 2002, J AM GERIATR SOC, V50, P956, DOI 10.1046/j.1532-5415.2002.50226.x; SHELL JW, 1982, SURV OPHTHALMOL, V26, P207, DOI 10.1016/0039-6257(82)90081-9; Vander Zanden JA, 2001, ANN PHARMACOTHER, V35, P1633, DOI 10.1345/1542-6270(2001)035<1633:SAEOOB>2.0.CO;2; Weih LM, 2000, ARCH OPHTHALMOL-CHIC, V118, P264; Weiss A, 2002, ARCH INTERN MED, V162, P2369, DOI 10.1001/archinte.162.20.2369	11	31	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					960	961		10.1136/bmj.332.7547.960	http://dx.doi.org/10.1136/bmj.332.7547.960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627515	Green Published			2022-12-28	WOS:000237143900022
J	Gibbons, FK; Branda, JA; Shepard, JO; Howell, MD; Hales, CA; Harris, NL				Gibbons, FK; Branda, JA; Shepard, JO; Howell, MD; Hales, CA; Harris, NL			Case 12-2006: A 37-year-old man with hemoptysis and a pulmonary infiltrate - Tuberculosis, primary, pulmonary.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LUNG; CT; FLUOROQUINOLONES; MANIFESTATIONS; LYMPHOMA		Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Gibbons, FK (corresponding author), Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA.		Howell, Michael/B-8065-2009; Branda, John/ABD-5620-2020	Howell, Michael/0000-0001-7003-6971; 				American Cancer Society, 2005, CANC FACTS FIG 2005; Beigelman C, 2000, EUR RADIOL, V10, P699, DOI 10.1007/s003300050989; BERGER HW, 1974, CHEST, V65, P522, DOI 10.1378/chest.65.5.522; BUCKNER CB, 1990, J THORAC IMAG, V5, P28, DOI 10.1097/00005382-199004000-00006; Cartwright RA, 2004, HEMATOL ONCOL, V22, P11, DOI 10.1002/hon.723; Centers for Disease Control, 2004, REP TUB US 2003; Chambliss ML, 1999, ARCH FAM MED, V8, P168, DOI 10.1001/archfami.8.2.168; CHANG SC, 1987, CHEST, V91, P230, DOI 10.1378/chest.91.2.230; Gadgeel SM, 1999, CHEST, V115, P1232, DOI 10.1378/chest.115.5.1232; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Ginsburg AS, 2003, CLIN INFECT DIS, V37, P1448, DOI 10.1086/379328; Harisinghani MG, 2000, RADIOGRAPHICS, V20, P449, DOI 10.1148/radiographics.20.2.g00mc12449; HOLLAND EA, 1991, J THORAC IMAG, V6, P74, DOI 10.1097/00005382-199109000-00015; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; Jacobs MR, 2004, CURR PHARM DESIGN, V10, P3213, DOI 10.2174/1381612043383296; Johnson JL, 2002, POSTGRAD MED, V112, P101, DOI 10.3810/pgm.2002.10.1335; Jose B Oliapuram, 2005, J Ky Med Assoc, V103, P15; Kiani B, 2003, ANN THORAC SURG, V76, P967, DOI 10.1016/S0003-4975(03)00140-1; Kim HY, 2001, RADIOGRAPHICS, V21, P839, DOI 10.1148/radiographics.21.4.g01jl06839; LEE KS, 1995, AM J ROENTGENOL, V164, P1361, DOI 10.2214/ajr.164.6.7754873; Leung AN, 1999, RADIOLOGY, V210, P307, DOI 10.1148/radiology.210.2.r99ja34307; LEWIS ER, 1991, AM J ROENTGENOL, V156, P711, DOI 10.2214/ajr.156.4.2003430; Nakata M, 2002, CHEST, V121, P1464, DOI 10.1378/chest.121.5.1464; NASH DR, 1980, CHEST, V77, P32, DOI 10.1378/chest.77.1.32; PARMAR MS, 1967, AM REV RESPIR DIS, V96, P310; Pfyffer GE, 2003, MANUAL CLIN MICROBIO, P532; Reisz G, 1997, Mo Med, V94, P633; SEGARRA F, 1963, AM REV RESPIR DIS, V87, P37; Sterling TR, 2004, INT J TUBERC LUNG D, V8, P1396; Viera AJ, 2003, AM FAM PHYSICIAN, V67, P1019; VINCENT V, 2003, MANUAL CLIN MICROBIO, P560; *WHO, 2004, TUB FACT SHEET; [No title captured]; 2004, MMWR MORB MORTAL WKL, V53, P209; 2004, MMWR MORB MORTAL WKL, V53, P246	35	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1729	1737		10.1056/NEJMcpc069003	http://dx.doi.org/10.1056/NEJMcpc069003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16625012				2022-12-28	WOS:000236893900011
J	Haynes, RB; Cotoi, C; Holland, J; Walters, L; Wilczynski, N; Jedraszewski, D; McKinlay, J; Parrish, R; McKibbon, KA				Haynes, RB; Cotoi, C; Holland, J; Walters, L; Wilczynski, N; Jedraszewski, D; McKinlay, J; Parrish, R; McKibbon, KA		McMaster PLUS Project	Second-order peer review of the medical literature for clinical practitioners	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERAL-PRACTICE; JOURNALS; CARE	Context Most articles in clinical journals are not appropriate for direct application by individual clinicians. Objective To create a second order of clinical peer review for journal articles to determine which articles are most relevant for specific clinical disciplines. Design and Setting A 2-stage prospective observational study in which research staff reviewed all issues of over 110 ( number has varied slightly as new journals were added or discarded from review but number has always been over 110) clinical journals and selected each article that met critical appraisal criteria from January 2003 through the present. Practicing physicians were recruited from around the world, excluding Northern Ontario, to the McMaster Online Rating of Evidence ( MORE) system and registered as raters according to their clinical disciplines. An automated system assigned each qualifying article to raters for each pertinent clinical discipline, and recorded their online assessments of the articles on 7-point scales ( highest score, 7) of relevance and newsworthiness ( defined as useful new information for physicians). Rated articles fed an online alerting service, the McMaster Premium Literature Service ( PLUS). Physicians from Northern Ontario were invited to register with PLUS and then receive e-mail alerts about articles according to MORE system peer ratings for their own discipline. Online access by PLUS users of PLUS alerts, raters' comments, article abstracts, and full-text journal articles was automatically recorded. Main Outcome Measures Clinical rater recruitment and performance. Relevance and newsworthiness of journal articles to clinical practice in the discipline of the rating physician. Results Through October 2005, MORE had 2139 clinical raters, and PLUS had 5892 articles with 45 462 relevance ratings and 44 724 newsworthiness ratings collected since 2003. On average, clinicians rated systematic review articles higher for relevance to practice than articles with original evidence and lower for useful new information. Primary care physicians rated articles lower than did specialists ( P <. 05). Of the 98 physicians who registered for PLUS, 88 (90%) used it on 3136 occasions during an 18-month test period. Conclusions This demonstration project shows the feasibility and use of a post-publication clinical peer review system that differentiates published journal articles according to the interests of a broad range of clinical disciplines.	McMaster Univ, Hlth Informat Res Unit, Michael G DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada	McMaster University	Haynes, RB (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, 1200 Main St W,Room 2C10B, Hamilton, ON L8N 3Z5, Canada.	bhaynes@mcmaster.ca		Parrish, Rick/0000-0002-3809-6015; Haynes, Robert Brian/0000-0002-1453-3196				Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Coiera E, 2000, J AM MED INFORM ASSN, V7, P215, DOI 10.1136/jamia.2000.0070215; ELY JW, 2002, BMJ-BRIT MED J, V324, P1; HAYNES RB, 1990, ANN INTERN MED, V113, P724, DOI 10.7326/0003-4819-113-9-724; HAYNES RB, 2004, ACP J CLUB, V140, pA13; McAlister FA, 1999, J GEN INTERN MED, V14, P236, DOI 10.1046/j.1525-1497.1999.00323.x; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; McKibbon KA, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-33; Putnam W, 2002, CAN MED ASSOC J, V166, P1525; Wilczynski NL, 2001, STUD HEALTH TECHNOL, V84, P390; Wilson P, 2001, QUAL HEALTH CARE, V10, P83, DOI 10.1136/qhc.10.2.83; Young JM, 2001, J EVAL CLIN PRACT, V7, P201, DOI 10.1046/j.1365-2753.2001.00294.x	12	65	66	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1801	1808		10.1001/jama.295.15.1801	http://dx.doi.org/10.1001/jama.295.15.1801			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622142	Bronze			2022-12-28	WOS:000236886900023
J	Cummings, JE; Schweikert, RA; Saliba, WI; Burkhardt, JD; Kilikaslan, F; Saad, E; Natale, A				Cummings, JE; Schweikert, RA; Saliba, WI; Burkhardt, JD; Kilikaslan, F; Saad, E; Natale, A			Brief communication: Atrial-esophageal fistulas after radiofrequency ablation	ANNALS OF INTERNAL MEDICINE			English	Article							CATHETER ABLATION; FIBRILLATION	Background: Ablation of atrial fibrillation is generally considered safe and effective. However, atrial-esophageal fistulas have recently been reported as a rare but fatal complication. Objective: To describe 9 patients with atrial-esophageal fistulas after ablation for atrial fibrillation. Design: Retrospective case series. Setting: Institutions where cardiologists performed atrial fibrillation ablation procedures. Patients: 9 patients with atrial-esophageal fistulas after atrial fibrillation ablation. Measurements: Demographic characteristics, mortality, presenting signs and symptoms, and days to presentation. Results: Patients presented a mean of 12.3 days (range, 10 to 16 days) after their procedures. Nonspecific symptoms included fever, leukocytosis, and neurologic abnormalities. All patients died. Only 4 patients received correct diagnoses before death, although all patients presented to a physician. In 3 patients, surgical repair was attempted. Limitations: Few physicians reported cases, and only approximate numbers of procedures performed by the physicians are known. Thus, the authors could not estimate the incidence of atrial-esophageal fistulas after ablation. Conclusions: Formation of atrial-esophageal fistulas is a rare but potentially devastating complication of atrial fibrillation ablation. This disorder may have an indolent presentation and may mimic other disease states, such as stroke or sepsis.	Cleveland Clin Fdn, Dept Cardiovasc Med, Sect Electrophysiol & Pacing, Cleveland, OH 44195 USA; Hosp Procardiaco, Rio De Janeiro, Brazil	Cleveland Clinic Foundation	Cummings, JE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Sect Electrophysiol & Pacing, 9500 Euclid Ave Desk F-15, Cleveland, OH 44195 USA.							Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Cummings JE, 2005, CIRCULATION, V112, P459, DOI 10.1161/CIRCULATIONAHA.104.509612; Doll N, 2003, J THORAC CARDIOV SUR, V125, P836, DOI 10.1067/mtc.2003.165; Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1239, DOI 10.1067/mtc.2001.118041; Pappone C, 2004, CIRCULATION, V109, P2724, DOI 10.1161/01.CIR.0000131866.44650.46; Scanavacca MI, 2004, J CARDIOVASC ELECTR, V15, P960, DOI 10.1046/j.1540-8167.2004.04083.x	6	158	165	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					572	574		10.7326/0003-4819-144-8-200604180-00007	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618954				2022-12-28	WOS:000237017900004
J	Maynard, A; Street, A				Maynard, A; Street, A			Health service reform - Seven years of feast, seven years of famine: boom to bust in the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Service improvements in the NHS have not kept pace with the dramatic increase in expenditure. As expenditure growth slows, attention must focus on reforming the incentives faced by NHS staff and institutions rather than on indulging in yet another reorganisation.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Maynard, A (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	akm3@york.ac.uk		Street, Andrew David/0000-0002-2540-0364				BLOOR K, IN PRESS J R STAT SO; Dawson D., 2005, 6 CTR HLTH EC; Department of Health, 2005, HEALTHC OUTP PROD AC; Department of Health, 2005, CHIEF EX REP NHS; Department of Health, 2006, IMPL PAYM RES TECHN; Department of Health, 2002, REF NHS FIN FLOWS IN; Dixon Sheila, 2004, Health Stat Q, P23; HARDING M, 2006, HLTH SERV J     0223, P10; HARRISON A, 2000, HLTH CARE UK, V4, P52; *HM TREAS, 2005, STRAT CONT CSR07; *HM TREAS DEP HLTH, 2000, MOD NHS FAIRN FAM CO; *LAB PART, 1997, 1997 EL MAN; Lee P., 2006, PUBLIC SERVICE PRODU; Mannion R, 2005, HLTH POLICY MATTERS, V11, P1; MANNION R, 2006, PAYMENT RESULTS DEMA; Maynard A, 2004, BMJ-BRIT MED J, V329, P227, DOI 10.1136/bmj.329.7459.227; Maynard A, 2002, LANCET, V360, P576, DOI 10.1016/S0140-6736(02)09736-2; Maynard A., 2005, 9 INT MED WORKF C ME; *NHS EX, 1997, NEW NHS MOD DEP; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; Street A, 2004, PUBLIC MONEY MANAGE, V24, P301, DOI 10.1111/j.1467-9302.2004.00438.x; Street A, 2004, HANDBOOK OF PUBLIC POLICY IN EUROPE: BRITAIN, FRANCE AND GERMANY, P277; Sussex J, 2004, ACTIVITY BASED FUNDI; The King's Fund, 2005, IND AUD NHS LAB 1997; TIMMINS N, 2006, FINANCIAL TIMES 0117, P1; Wanless, 2002, SECURING OUR FUTURE; WEBSTER R, 2005, 9 INT MED WORKF C ME; WILLIAMS A, 2004, WHAT COULD BE NICER; 2005, LANCET, V366, P1673	29	28	28	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2006	332	7546					906	908		10.1136/bmj.332.7546.906	http://dx.doi.org/10.1136/bmj.332.7546.906			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16613969	Green Published			2022-12-28	WOS:000237132100025
J	Macilwain, C				Macilwain, C			University challenge	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2006	440	7086					867	867		10.1038/440867a	http://dx.doi.org/10.1038/440867a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612354				2022-12-28	WOS:000236736700012
J	Coudreuse, DYM; Roel, G; Betist, MC; Destree, O; Korswagen, HC				Coudreuse, DYM; Roel, G; Betist, MC; Destree, O; Korswagen, HC			Wnt gradient formation requires retromer function in Wnt-producing cells	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; XENOPUS EMBRYOS; EXPRESSION; WINGLESS; POLARITY; MIGRATION; HOMOLOG; ENDODERM; RECEPTOR	Wnt proteins function as morphogens that can form long-range concentration gradients to pattern developing tissues. Here, we show that the retromer, a multiprotein complex involved in intracellular protein trafficking, is required for long-range signaling of the Caenorhabditis elegans Wnt ortholog EGL-20. The retromer functions in EGL-20-producing cells to allow the formation of an EGL-20 gradient along the anteroposterior axis. This function is evolutionarily conserved, because Wnt target gene expression is also impaired in the absence of the retromer complex in vertebrates. These results demonstrate that the ability of Wnt to regulate long-range patterning events is dependent on a critical and conserved function of the retromer complex within Wnt-producing cells.	Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Korswagen, HC (corresponding author), Hubrecht Lab, Uppslalaan 8, NL-3584 CT Utrecht, Netherlands.	rkors@niob.knaw.nl	Korswagen, Hendrik/I-8782-2012	Coudreuse, Damien/0000-0003-2534-1621				Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Harris J, 1996, DEVELOPMENT, V122, P3117; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; NOORDERMEER J, 1989, NUCLEIC ACIDS RES, V17, P11, DOI 10.1093/nar/17.1.11; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Whangbo J, 2000, DEVELOPMENT, V127, P4587; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9	23	191	209	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					921	924		10.1126/science.1124856	http://dx.doi.org/10.1126/science.1124856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16645052				2022-12-28	WOS:000237452900050
J	Schillinger, M; Sabeti, S; Loewe, C; Dick, P; Amighi, J; Mlekusch, W; Schlager, O; Cejna, M; Lammer, J; Minar, E				Schillinger, M; Sabeti, S; Loewe, C; Dick, P; Amighi, J; Mlekusch, W; Schlager, O; Cejna, M; Lammer, J; Minar, E			Calloon angioplasty versus implantation of nitinol stents in the superficial femoral artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FEMOROPOPLITEAL ANGIOPLASTY; BALLOON ANGIOPLASTY; POPLITEAL ARTERIES; PRIMARY PATENCY; CT; PLACEMENT; DISEASE; OBSTRUCTIONS; ANGIOGRAPHY; PTA	BACKGROUND: Because stent implantation for disease of the superficial femoral artery has been associated with high rates of late clinical failure, percutaneous transluminal angioplasty is preferred for endovascular treatment, and stenting is recommended only in the event of suboptimal technical results. We evaluated whether primary implantation of a self-expanding nitinol (nickel-titanium) stent yielded anatomical and clinical benefits superior to those afforded by percutaneous transluminal angioplasty with optional secondary stenting. METHODS: We randomly assigned 104 patients who had severe claudication or chronic limb ischemia due to stenosis or occlusion of the superficial femoral artery to undergo primary stent implantation (51 patients) or angioplasty (53 patients). Restenosis and clinical outcomes were assessed at 6 and 12 months. RESULTS: The mean (+/-SD) length of the treated segment was 132+/-71 mm in the stent group and 127+/-55 mm in the angioplasty group. Secondary stenting was performed in 17 of 53 patients (32 percent) in the angioplasty group, in most cases because of a suboptimal result after angioplasty. At 6 months, the rate of restenosis on angiography was 24 percent in the stent group and 43 percent in the angioplasty group (P=0.05); at 12 months the rates on duplex ultrasonography were 37 percent and 63 percent, respectively (P=0.01). Patients in the stent group were able to walk significantly farther on a treadmill at 6 and 12 months than those in the angioplasty group. CONCLUSIONS: In the intermediate term, treatment of superficial-femoral-artery disease by primary implantation of a self-expanding nitinol stent yielded results that were superior to those with the currently recommended approach of balloon angioplasty with optional secondary stenting.	Med Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna Gen Hosp, A-1090 Vienna, Austria; Med Univ Vienna, Dept Angiog & Intervent Radiol, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Schillinger, M (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna Gen Hosp, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	martin.schillinger@meduniwien.ac.at	Mlekusch, Wolfgang/M-6238-2014; Loewe, Christian/GSI-8660-2022	Mlekusch, Wolfgang/0000-0002-2833-6038; Loewe, Christian/0000-0003-2502-0676				Adriaensen MEAPM, 2004, RADIOLOGY, V233, P385, DOI 10.1148/radiol.2331031595; Becquemin JP, 2003, J VASC SURG, V37, P487, DOI 10.1067/mva.2003.155; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; CAPEK P, 1991, CIRCULATION, V83, P70; Catalano C, 2004, RADIOLOGY, V231, P555, DOI 10.1148/radiol.2312020920; Cejna M, 2001, J VASC INTERV RADIOL, V12, P23, DOI 10.1016/S1051-0443(07)61397-9; Duda SH, 2005, J VASC INTERV RADIOL, V16, P331, DOI 10.1097/01.RVI.0000151260.74519.CA; Duda SH, 2002, CIRCULATION, V106, P1505, DOI 10.1161/01.CIR.0000029746.10018.36; Grimm J, 2001, J VASC INTERV RADIOL, V12, P935, DOI 10.1016/S1051-0443(07)61572-3; Henry M, 1996, J ENDOVASC SURG, V3, P369, DOI 10.1583/1074-6218(1996)003<0369:CEWANN>2.0.CO;2; JOHNSTON KW, 1992, RADIOLOGY, V183, P767, DOI 10.1148/radiology.183.3.1294068; Letourneau-Guillon L, 2004, J VASC INTERV RADIOL, V15, P615, DOI 10.1097/01.RVI.0000127898.23424.01; Lugmayr HF, 2002, RADIOLOGY, V222, P37, DOI 10.1148/radiol.2221010268; Martin ML, 2003, AM J ROENTGENOL, V180, P1085, DOI 10.2214/ajr.180.4.1801085; Minar E, 2000, CIRCULATION, V102, P2694, DOI 10.1161/01.CIR.102.22.2694; RANKE C, 1992, ULTRASOUND MED BIOL, V18, P433, DOI 10.1016/0301-5629(92)90082-L; Sabeti S, 2005, J ENDOVASC THER, V12, P6, DOI 10.1583/04-1359.1; Sabeti S, 2004, RADIOLOGY, V232, P516, DOI 10.1148/radiol.2322031345; Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026; SMOUSE HB, 2004, ANN M MIDW I INT THE; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Vroegindeweij D, 1997, CARDIOVASC INTER RAD, V20, P420, DOI 10.1007/s002709900186; Zdanowski Z, 1999, INT ANGIOL, V18, P251	23	912	995	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1879	1888		10.1056/NEJMoa051303	http://dx.doi.org/10.1056/NEJMoa051303			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672699	Bronze			2022-12-28	WOS:000237239900004
J	Sakimoto, T; Rosenblatt, MI; Azar, DT				Sakimoto, T; Rosenblatt, MI; Azar, DT			Laser eye surgery for refractive errors	LANCET			English	Review							IN-SITU KERATOMILEUSIS; DIFFUSE LAMELLAR KERATITIS; ASSISTED SUBEPITHELIAL KERATECTOMY; EC-5000 EXCIMER-LASER; PHOTOREFRACTIVE KERATECTOMY; EPITHELIAL KERATOMILEUSIS; HYPEROPIC ASTIGMATISM; MODERATE MYOPIA; FOLLOW-UP; HANSATOME MICROKERATOME	Several laser and non-laser refractive surgical procedures have been used to modify the shape of the cornea and correct myopia, hyperopia, astigmatism, and presbyopia. Introduction of the excimer laser to reshape the cornea has resulted in remarkable developments in the correction of these refractive errors. Combined with other advanced ophthalmological instruments, laser refractive eye surgery has resulted in a substantial rise in the safety, efficacy, and predictability of surgical outcomes. Despite these advances, certain limitations and complications persist. In this review, we describe the history; preoperative assessment, surgical techniques, outcomes, and complications of laser refractive surgery.	Massachusetts Eye & Ear Infirm, Cornea Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Azar, DT (corresponding author), Massachusetts Eye & Ear Infirm, Cornea Serv, 243 Charles St, Boston, MA 02114 USA.	dazar@meei.harvard.edu			NATIONAL EYE INSTITUTE [R01EY010101, R29EY010101] Funding Source: NIH RePORTER; NEI NIH HHS [EY10101] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albarran-Diego C, 2004, J CATARACT REFR SURG, V30, P1471, DOI 10.1016/j.jcrs.2003.11.054; Alio JL, 2004, J CATARACT REFR SURG, V30, P2303, DOI 10.1016/j.jcrs.2004.04.048; Asano-Kato N, 2002, AM J OPHTHALMOL, V134, P801, DOI 10.1016/S0002-9394(02)01757-9; Autrata R, 2003, J CATARACT REFR SURG, V29, P2105, DOI 10.1016/S0886-3350(03)00415-2; Azar DT, 2001, OPHTHALMOLOGY, V108, P239, DOI 10.1016/S0161-6420(00)00393-6; Barraquer J., 1949, ESTUDIOS INFORMACION, V2, P10; Barraquer J.I., 1964, ARCH SOC AM OFTALMOL, V5, P27; BARRAQUER JI, 1970, QUERATOPLASTIA REFRA; Bauerberg JM, 1999, J REFRACT SURG, V15, P66; Buratto L, 1993, Refract Corneal Surg, V9, P12; Calvillo MP, 2004, INVEST OPHTH VIS SCI, V45, P3991, DOI 10.1167/iovs.04-0561; Cantu R, 2004, J REFRACT SURG, V20, pS711; Chang MA, 2004, SURV OPHTHALMOL, V49, P269, DOI 10.1016/j.survophthal.2004.02.007; Claringbold TV, 2002, J CATARACT REFR SURG, V28, P18, DOI 10.1016/S0886-3350(01)01234-2; Cobo-Soriano R, 2002, J CATARACT REFR SURG, V28, P1530, DOI 10.1016/S0886-3350(02)01367-6; Davidorf JM, 1998, J REFRACT SURG, V14, P114; DAVINCI L, 1508, CODEX EYE MANUSCRIPT; Dhaliwal DK, 2001, AM J OPHTHALMOL, V131, P506, DOI 10.1016/S0002-9394(00)00811-4; Donders FC, 1864, ANOMALIES ACCOMMODAT; Durnev V.V., 1981, SURG ANOMALIES OCULA, P33; El Danasoury MA, 1999, OPHTHALMOLOGY, V106, P411, DOI 10.1016/S0161-6420(99)90084-2; El Danasoury MA, 2002, OPHTHALMOLOGY, V109, P955, DOI 10.1016/S0161-6420(02)00964-8; El-Maghraby A, 1999, OPHTHALMOLOGY, V106, P447, DOI 10.1016/S0161-6420(99)90102-1; Esquenazi S, 2004, J REFRACT SURG, V20, P356; FABER E, 1895, NED TIJDSCHR GENEES, V31, P495; Gimbel HV, 1999, OPHTHALMOLOGY, V106, P1461, DOI 10.1016/S0161-6420(99)90438-4; Hammond MD, 2005, OPHTHALMOLOGY, V112, P184, DOI 10.1016/j.ophtha.2004.08.014; Handzel A, 2003, J REFRACT SURG, V19, pS241; Hashemi H, 2004, J REFRACT SURG, V20, P217; Hersh PS, 1998, OPHTHALMOLOGY, V105, P1512, DOI 10.1016/S0161-6420(98)98038-1; Hoffman RS, 2003, J CATARACT REFR SURG, V29, P451, DOI 10.1016/S0886-3350(02)01835-7; Jackson WB, 1998, OPHTHALMOLOGY, V105, P1727, DOI 10.1016/S0161-6420(98)99045-5; Jain S, 2001, OPHTHALMOLOGY, V108, P1430, DOI 10.1016/S0161-6420(01)00647-9; Johnson JD, 2001, J CATARACT REFR SURG, V27, P1560, DOI 10.1016/S0886-3350(01)00958-0; Kapadia MS, 2000, CORNEA, V19, P180, DOI 10.1097/00003226-200003000-00011; Kasparova EA, 2003, J REFRACT SURG, V19, pS250, DOI 10.3928/1081-597X-20030302-17; Kaya V, 2004, J REFRACT SURG, V20, P223; Kenyon KR, 2004, OPHTHALMOLOGY, V111, P11, DOI 10.1016/j.ophtha.2002.10.001; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Kim JK, 2004, J CATARACT REFR SURG, V30, P1405, DOI 10.1016/j.jcrs.2003.12.053; Kim TI, 2004, J REFRACT SURG, V20, P432; Klyce SD, 2004, OPHTHALMOLOGY, V111, P1, DOI 10.1016/j.ophtha.2003.09.021; Knorz MC, 2000, OPHTHALMOLOGY, V107, P2072, DOI 10.1016/S0161-6420(00)00373-0; Kohnen T, 2004, J CATARACT REFR SURG, V30, P123, DOI 10.1016/S0886-3350(03)00657-6; L'Esperance F A Jr, 1988, Trans Am Ophthalmol Soc, V86, P208; Lans L.J., 1898, GRAEFES ARCH CLIN EX, V45, P117, DOI 10.1007/BF01991319; Laube T, 2004, J CATARACT REFR SURG, V30, P1998, DOI 10.1016/j.jcrs.2004.01.040; Lee HK, 2005, AM J OPHTHALMOL, V139, P56, DOI 10.1016/j.ajo.2004.08.049; Lee JB, 2001, JPN J OPHTHALMOL, V45, P487, DOI 10.1016/S0021-5155(01)00406-3; Lee JB, 2001, J CATARACT REFR SURG, V27, P565, DOI 10.1016/S0886-3350(00)00880-4; Lin JM, 2005, ACTA OPHTHALMOL SCAN, V83, P40, DOI 10.1111/j.1600-0420.2005.00385.x; Lin RT, 1999, AM J OPHTHALMOL, V127, P129, DOI 10.1016/S0002-9394(98)00320-1; Lindstrom R L, 1999, Trans Am Ophthalmol Soc, V97, P241; LUCCIOLA T, 1886, ARCH OPHTHALMOL-CHIC, V16, P630; MacRae SM, 2000, J REFRACT SURG, V16, P122; Maeda N, 2002, CORNEA, V21, pS75, DOI 10.1097/01.ico.0000263123.53521.4d; Malecaze FJ, 2002, OPHTHALMOLOGY, V109, P1622, DOI 10.1016/S0161-6420(02)01164-8; MCDONALD MB, 1989, ARCH OPHTHALMOL-CHIC, V107, P641, DOI 10.1001/archopht.1989.01070010659013; Melki SA, 2001, SURV OPHTHALMOL, V46, P95, DOI 10.1016/S0039-6257(01)00254-5; Miranda D, 2004, J REFRACT SURG, V20, P325; Nagy ZZ, 2002, J REFRACT SURG, V18, pS620; Nagy ZZ, 2002, J REFRACT SURG, V18, P542; Nagy ZZ, 2001, J REFRACT SURG, V17, P441; Nakano K, 2004, J REFRACT SURG, V20, pS723; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Noda-Tsuruya T, 2004, J REFRACT SURG, V20, P72; Norouzi H, 2003, J REFRACT SURG, V19, P416; PALLIKARIS IG, 1990, LASER SURG MED, V10, P463; Pallikaris LG, 2003, J CATARACT REFR SURG, V29, P1496, DOI 10.1016/S0886-3350(03)00348-1; Partal AE, 2004, J CATARACT REFR SURG, V30, P2138, DOI 10.1016/j.jcrs.2004.02.083; Pop M, 2000, OPHTHALMOLOGY, V107, P251, DOI 10.1016/S0161-6420(99)00043-3; Price FW, 2001, OPHTHALMOLOGY, V108, P1236, DOI 10.1016/S0161-6420(01)00624-8; Rad AS, 2004, J REFRACT SURG, V20, pS718, DOI 10.3928/1081-597X-20040903-18; Rashad KM, 2001, J REFRACT SURG, V17, P113; RUIZ L, 1988, INVEST OPHTH VIS SCI, V29, pS392; Salz JJ, 2002, OPHTHALMOLOGY, V109, P1647, DOI 10.1016/S0161-6420(02)01133-8; Sato T., 1942, ACTA SOC OPHTHALMOL, V46, P469; SCHIOTZ HA, 1885, ARCH AUGENHEILKD, V15, P179; Schwiegerling J, 2000, SURV OPHTHALMOL, V45, P139, DOI 10.1016/S0039-6257(00)00145-4; SEILER T, 1986, OPHTHALMOLOGICA, V192, P65, DOI 10.1159/000309615; Sekundo W, 2003, J CATARACT REFR SURG, V29, P1152, DOI 10.1016/S0886-3350(03)00062-2; Shah MN, 2000, J CATARACT REFR SURG, V26, P1312, DOI 10.1016/S0886-3350(00)00570-8; Shah S, 2002, J CATARACT REFR SURG, V28, P682, DOI 10.1016/S0886-3350(01)01351-7; Steinert R F, 1998, Trans Am Ophthalmol Soc, V96, P197; Stulting RD, 2004, CORNEA, V23, P680, DOI 10.1097/01.ico.0000127477.14304.de; Stulting RD, 1999, OPHTHALMOLOGY, V106, P13, DOI 10.1016/S0161-6420(99)90000-3; TABOADA J, 1981, P AER MED ASS 52 ANN, P8; Taneri S, 2004, J CATARACT REFR SURG, V30, P2130, DOI 10.1016/j.jcrs.2004.02.070; Tekwani NH, 2002, AM J OPHTHALMOL, V134, P311, DOI 10.1016/S0002-9394(02)01597-0; Telandro A, 2004, J REFRACT SURG, V20, pS714; Thammano P, 2003, J CATARACT REFR SURG, V29, P1962, DOI 10.1016/S0886-3350(03)00515-7; Thom SB, 1997, J CATARACT REFR SURG, V23, P1324, DOI 10.1016/S0886-3350(97)80110-1; Tole DM, 2001, J REFRACT SURG, V17, P46; TROKEL SL, 1983, AM J OPHTHALMOL, V96, P710, DOI 10.1016/S0002-9394(14)71911-7; *US FDA, 1999, VISX STAR S2 EXC LAS; *US FDA, 2001, VISX STAR S2 S3 EXC; *US FDA, 2002, TECHNOLAS 217A EXC L; *US FDA, 2000, LADARVISION EXC LAS; *US FDA, 2003, BAUSCH LOMB TECHNOLA; *US FDA, 2004, STAR S4 EXC LAS SYST; *US FDA, 2000, NID EC5000 EXC LAS S; *US FDA, 2003, WAVELIGHT ALLEGRETTO; *US FDA, 2003, TECHNOLAS 217A EXC L; *US FDA, 2003, STAR S4 ACT TRAK EXC; *US FDA, ALCON AP AP PLUS; *US FDA, 2000, TECHNOLAS 217A EXC L; Varley GA, 2004, OPHTHALMOLOGY, V111, P1604, DOI 10.1016/j.ophtha.2004.05.016; Vesaluoma M, 2000, INVEST OPHTH VIS SCI, V41, P369; *VISX TECHN, 2005, NEWS EV; Walker MB, 2000, CORNEA, V19, P170, DOI 10.1097/00003226-200003000-00009; Wang MY, 2000, AM J OPHTHALMOL, V129, P746, DOI 10.1016/S0002-9394(00)00357-3; Waring G. O., 1984, CORNEAL DISORDERS CL, P3; Williams DK, 2000, OPHTHALMOLOGY, V107, P72, DOI 10.1016/S0161-6420(99)00028-7; WILSON SE, 1990, OPHTHALMOLOGY, V97, P734; YEH PC, 2004, SMOLIN THOFTS CORNEA, P1257; Yeh Shu-I, 2004, Ophthalmol Clin North Am, V17, P247, DOI 10.1016/j.ohc.2004.03.003; Yildirim R, 2001, EUR J OPHTHALMOL, V11, P328, DOI 10.1177/112067210101100402; Zaldivar R, 1999, J REFRACT SURG, V15, P299	118	110	113	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1432	1447		10.1016/S0140-6736(06)68275-5	http://dx.doi.org/10.1016/S0140-6736(06)68275-5			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650653				2022-12-28	WOS:000237195600031
J	Biddlecom, A; Bankole, A; Patterson, K				Biddlecom, A; Bankole, A; Patterson, K			Vaccine for cervical cancer: reaching adolescents in sub-Saharan Africa	LANCET			English	Editorial Material									Alan Guttmacher Inst, Div Res, New York, NY 10005 USA		Biddlecom, A (corresponding author), Alan Guttmacher Inst, Div Res, 120 Wall St, New York, NY 10005 USA.	abiddlecom@guttmacher.org						[Anonymous], INJ PRACT RAP ASS RE; Bankole A., 2004, RISK PROTECTION YOUT; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; *GLAX, 2006, MARK APPL CERV GSKS; *GUTTM I, IN PRESS SPEC TAB 20; Hewett P. C., 2005, CHANGING TRANSITIONS, P84, DOI [10.17226/11524, DOI 10.17226/11524]; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; *MERCK CO, 2006, GARDASIL MERCKS INV; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009; Speizer IS, 2003, J ADOLESCENT HEALTH, V33, P324, DOI 10.1016/S1054-139X(02)00535-9; World Health Organization, 2000, WORLD HLTH REP 2000	12	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1299	1300		10.1016/S0140-6736(06)68555-3	http://dx.doi.org/10.1016/S0140-6736(06)68555-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631895				2022-12-28	WOS:000237118500007
J	Chuah, JL; Ghosh, YK; Richards, D; Shun-Shin, GA				Chuah, JL; Ghosh, YK; Richards, D; Shun-Shin, GA			Ocular ischaemic syndrome: a medical emergency	LANCET			English	Editorial Material									Wolverhampton Eye Infirm, Wolverhampton WV3 9QR, England		Chuah, JL (corresponding author), Wolverhampton Eye Infirm, Wolverhampton WV3 9QR, England.	jooleong919@doctors.org.uk						Bennett L W, 1997, J Am Optom Assoc, V68, P250; KEARNS THOMAS P., 1963, PROC STAFF MEETINGS MAYO CLIN, V38, P304; Malhotra R, 2000, BRIT J OPHTHALMOL, V84, P1428, DOI 10.1136/bjo.84.12.1428; Sivalingham A, 1990, INT OPHTHALMOL, V13, P187	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1370	1370		10.1016/S0140-6736(06)68585-1	http://dx.doi.org/10.1016/S0140-6736(06)68585-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631917				2022-12-28	WOS:000237118500033
J	Domek, GJ				Domek, GJ			Social consequences of antiretroviral therapy: preparing for the unexpected futures of HIV-positive children	LANCET			English	Editorial Material							PSYCHOSOCIAL ISSUES; HIV/AIDS; ADOLESCENTS; CARE; AIDS; DISCLOSURE; EFFICACY; ACCESS; HAART; LIFE		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Domek, GJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	gretchen_domek@hms.harvard.edu						Abadia-Barrero CE, 2006, SOC SCI MED, V62, P1219, DOI 10.1016/j.socscimed.2005.07.006; Abadia-Barrero CE, 2006, AIDS PATIENT CARE ST, V20, P36, DOI 10.1089/apc.2006.20.36; Abadia-Barrero César Ernesto, 2002, Interface (Botucatu), V6, P55, DOI 10.1590/S1414-32832002000200005; Atwine B, 2005, SOC SCI MED, V61, P555, DOI 10.1016/j.socscimed.2004.12.018; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; BRAZARSH J, 2004, COMM INF INSP TEAM J; Brown LK, 2000, J CHILD PSYCHOL PSYC, V41, P81, DOI 10.1111/1469-7610.00550; COHEN J, 1989, PEDIATRICS, V100, P8; DOMEK GJ, 2005, THESIS U OXFORD I; Drew RS, 1998, AIDS CARE, V10, pS9, DOI 10.1080/09540129850124325; Foster G, 1996, AIDS CARE, V8, P389, DOI 10.1080/09540129650125597; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Ledlie SW, 2001, AIDS PATIENT CARE ST, V15, P231, DOI 10.1089/10872910152050748; Lee CL, 1999, AIDS PATIENT CARE ST, V13, P41, DOI 10.1089/apc.1999.13.41; Loening-Voysey H, 2001, APPROACHES CARING CH; Matida Luiza Harunari, 2004, Braz J Infect Dis, V8, P419, DOI 10.1590/S1413-86702004000600005; Mialky E, 2001, AIDS PATIENT CARE ST, V15, P575, DOI 10.1089/108729101753287667; O'Hare BAM, 2005, AIDS CARE, V17, P443, DOI 10.1080/09540120412331291779; Pillay AL, 1997, SOC SCI MED, V45, P1493, DOI 10.1016/S0277-9536(97)00079-8; Piot P, 2004, SCIENCE, V304, P1909, DOI 10.1126/science.1101137; Puthanakit T, 2005, CLIN INFECT DIS, V41, P100, DOI 10.1086/430714; Ruiz P, 2000, AM J PSYCHIAT, V157, P110, DOI 10.1176/ajp.157.1.110; Selwyn PA, 1998, ANN INTERN MED, V129, P899, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00012; Shetty Avinash K, 2003, Semin Pediatr Infect Dis, V14, P25, DOI 10.1053/spid.2003.127214; Sowell RL, 1998, AIDS PATIENT CARE ST, V12, P33, DOI 10.1089/apc.1998.12.33; Tramarin A, 2004, AIDS CARE, V16, P213, DOI 10.1080/09540120410001641057; *UNAIDS, 2005, AIDS EP UPD DEC 2005; *UNAIDS, 2001, INV OUR FUT PSYCH SU; Wilfert C, 1999, PEDIATRICS, V103, P164	31	32	32	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1367	1369		10.1016/S0140-6736(06)68584-X	http://dx.doi.org/10.1016/S0140-6736(06)68584-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037AG	16631916				2022-12-28	WOS:000237118500032
J	Enoch, S; Grey, JE; Harding, KG				Enoch, S; Grey, JE; Harding, KG			ABC of wound healing - Recent advances and emerging treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Wound Healing Res Unit, Cardiff, S Glam, Wales; Univ Wales Hosp, Cardiff & Vale NHS Trust, Cardiff CF4 4XW, S Glam, Wales	Cardiff University; Cardiff University	Enoch, S (corresponding author), Cardiff Univ, Wound Healing Res Unit, Cardiff, S Glam, Wales.	joseph.grey@cardiffandvale.wales.nhs.uk	Harding, Keith/J-5605-2013	Harding, Keith/0000-0003-0048-3279				Enoch S, 2005, J MED ETHICS, V31, P2, DOI 10.1136/jme.2003.005272; Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160; Jones JE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001737.pub2; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006	4	83	85	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					962	965		10.1136/bmj.332.7547.962	http://dx.doi.org/10.1136/bmj.332.7547.962			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627516	Green Published			2022-12-28	WOS:000237143900023
J	Johnston, SC; Rootenberg, JD; Katrak, S; Smith, WS; Elkins, JS				Johnston, SC; Rootenberg, JD; Katrak, S; Smith, WS; Elkins, JS			Effect of a US National Institutes of Health programme of clinical trials on public health and costs	LANCET			English	Article							SPINAL-CORD-INJURY; CAROTID-ENDARTERECTOMY; RANDOMIZED-TRIAL; RECTAL DIAZEPAM; DOUBLE-BLIND; ECONOMIC EVALUATIONS; REPETITIVE SEIZURES; PREVENTION; PLACEBO; METHYLPREDNISOLONE	Background Few attempts have been made to estimate the public return on investment in medical research. The total costs and benefits to society of a clinical trial, the final step in testing an intervention, can be estimated by evaluating the effect of trial results on medical care and health. Methods All phase III randomised trials funded by the US National Institute of Neurological Disorders and Stroke before Jan 1, 2000, were included. Pertinent publications on use, cost to society, and health effects for each studied intervention were identified by systematic review, supplemented with data from other public and proprietary sources. Regardless of whether a trial was positive or negative, information on use of tested therapies was integrated with published per-use data on costs and health effect (converted to 2004 US$) to generate 10-year projections for the US population. Findings 28 trials with a total cost of $335 million were included. Six trials (21%) resulted in measurable improvements in health, and four (14%) resulted in cost savings to society. At 10 years, the programme of trials resulted in an estimated additional 470 000 quality-adjusted life years at a total cost of $3.6 billion (including costs of all trials and additional health-care and other expenditures). Valuing a quality-adjusted life year at per-head gross domestic product, the projected net benefit to society at 10-years was $15.2 billion. 95% CIs did not include a net loss at 10 years. Implications For this institute, the public return on investment in clinical trials has been substantial. Although results led to increases in health-care expenditures, health gains were large and valuable.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnston, SC (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	clay.johnston@ucsfmedctr.org			NINDS NIH HHS [NS 02254] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; ABRAMSON NS, 1995, CRIT CARE MED, V23, P178; Agency for Healthcare Research and Quality, HCUPNET HEALTHC COST; *AM HEART ASS, 2004, HEART DIS STROK STAT; [Anonymous], 1998, JAMA, V279, P1265; [Anonymous], SCI OPP PUBL NEEDS I; Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Blackshear JL, 1996, LANCET, V348, P633; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Buxton M, 2004, B WORLD HEALTH ORGAN, V82, P733; Cereghino JJ, 1998, NEUROLOGY, V51, P1274, DOI 10.1212/WNL.51.5.1274; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cronenwett JL, 1997, J VASC SURG, V25, P298, DOI 10.1016/S0741-5214(97)70351-3; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Derdeyn CP, 2000, J NUCL MED, V41, P800; Devinsky O, 2002, SEIZURE-EUR J EPILEP, V11, P371, DOI 10.1053/seiz.2001.0669; Dreifus FE, 1998, NEW ENGL J MED, V338, P1869, DOI 10.1056/NEJM199806253382602; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Fang MC, 2004, ARCH INTERN MED, V164, P55, DOI 10.1001/archinte.164.1.55; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fleurence RL, 2004, HEALTH POLICY, V69, P1, DOI 10.1016/j.healthpol.2003.11.002; Frist WH, 2002, JAMA-J AM MED ASSOC, V287, P1722, DOI 10.1001/jama.287.13.1722; Fuster V, 1999, CIRCULATION, V99, P2064, DOI 10.1161/01.CIR.99.16.2064; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; *GLOB ALL VACC IMM, GAVI HLTH IMM EC GRO; Gold MR, 1996, COST EFFECTIVENESS H; Gross CP, 2000, JAMA-J AM MED ASSOC, V284, P2886, DOI 10.1001/jama.284.22.2886; Haines SJ, 2002, J CLIN NEUROSCI, V9, P411, DOI 10.1054/jocn.2002.1120; HALEY EC, 1994, J NEUROSURG, V80, P788, DOI 10.3171/jns.1994.80.5.0788; Halm EA, 2003, STROKE, V34, P1464, DOI 10.1161/01.STR.0000072514.79745.7D; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; *HLTH INF RES UN M, SEARCH STRAT MEDLINE; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; *IMS HLTH, 2005, ANN SAL IFNB 1A; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2809, DOI 10.1001/jama.287.21.2809; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Kresowik TF, 2001, J VASC SURG, V33, P227, DOI 10.1067/mva.2001.111881; Kuntz KM, 1996, CIRCULATION, V94, P194; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Meltzer D, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P206; MENT LR, 1994, PEDIATRICS, V93, P543; Moya MP, 2002, ANN PHARMACOTHER, V36, P218; *NIH, NIH ALM APPR SECT 2; *NIH, EST FUND VAR DIS CON; *NIH, NIH PUBL ACC BACKGR; O'Dell C, 2004, ANN NEUROL, V56, pS109; Osterkamp E, 1998, Z GERMANISTIK, V8, P7; PETERSEN P, 1989, LANCET, V1, P175; PETITTI D, 1994, META ANAL DECISION A; POLLACK A, 2002, NY TIMES        0419, pC1; Polsky D, 2005, MED DECIS MAKING, V25, P605, DOI 10.1177/0272989X05283136; Prosser LA, 2004, VALUE HEALTH, V7, P554, DOI 10.1111/j.1524-4733.2004.75007.x; Reinhardt UE, 2001, HEALTH AFFAIR, V20, P136, DOI 10.1377/hlthaff.20.5.136; Reinhardt UE, 1997, SOC SCI MED, V45, P555, DOI 10.1016/S0277-9536(96)00396-6; Report of the Advisory Committee on Cultural Diplomacy, 2005, CAS STUD ENV MED NIT, P1; Ritter FJ, 2000, NEUROLOGY, V54, pA295; Scott P, 1996, STROKE, V27, P1453; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Silver AA, 2001, J CLIN PSYCHIAT, V62, P707, DOI 10.4088/JCP.v62n0908; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0; Sudlow M, 1998, LANCET, V352, P1167, DOI 10.1016/S0140-6736(98)01401-9; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Topel R, 2003, MEASURING GAINS MED; *US DEP LAB, BUR LAB STAT DAT PRI; Vitek JL, 2003, ANN NEUROL, V53, P558, DOI 10.1002/ana.10517; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Wooding S, 2005, RHEUMATOLOGY, V44, P1145, DOI 10.1093/rheumatology/keh708; 2005, NAT NEUROSCI, V8, P1273	80	103	106	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1319	1327		10.1016/S0140-6736(06)68578-4	http://dx.doi.org/10.1016/S0140-6736(06)68578-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037AG	16631910				2022-12-28	WOS:000237118500026
J	Low, A; Low, A				Low, A; Low, A			Health economics - Importance of relative measures in policy on health inequalities	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEW-LABOR		Chopwell, Newcastle Upon Tyne NE17 7AY, Tyne & Wear, England; Derwentside Dist Council & Primary Care Trust, Consett, County Durham, England		Low, A (corresponding author), Chopwell, Newcastle Upon Tyne NE17 7AY, Tyne & Wear, England.	alow@btinternet.com						Acheson D., 1998, INDEPENDENT INQUIRY; *DEP HLTH, 2005, TACKL HLTH IN STAT R; *DEP HLTH, 2004, TECHN NOT SPEND REV; Department of Health, 2003, TACKL HLTH IN PROGR; Department of Health, 2004, NAT STAND LOC ACT HL; Dorling D, 2006, BRIT MED J, V332, P662, DOI 10.1136/bmj.332.7542.662; FLEMING M, 2005, MENDING HEARTS INEQU; *HEALTHC COMM, 2006, ASS NEW NAT TARG; JOHNSON M, 2003, CHALLENGE TACKLING H; Low A, 2005, BRIT MED J, V330, P1507, DOI 10.1136/bmj.330.7506.1507; Low A, 2004, J PUBLIC HEALTH-UK, V26, P388, DOI 10.1093/pubmed/fdh175; LOW A, 2002, THESIS U YORK; Shaw M, 2005, BRIT MED J, V330, P1507, DOI 10.1136/bmj.330.7506.1507-b; Shaw M, 2005, BMJ-BRIT MED J, V330, P1016, DOI 10.1136/bmj.330.7498.1016; Wanless D., 2004, SECURING GOOD HLTH W; WANLESS D, 2003, SECURING GOOD HLTH W	16	29	29	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 22	2006	332	7547					967	969		10.1136/bmj.332.7547.967	http://dx.doi.org/10.1136/bmj.332.7547.967			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037JV	16627518	Green Published			2022-12-28	WOS:000237143900024
J	Velev, OD				Velev, OD			Self-assembly of unusual nanoparticle crystals	SCIENCE			English	Editorial Material							COLLOIDAL CRYSTALS		N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Velev, OD (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	odvelev@unity.ncsu.edu	Velev, Orlin D/A-2853-2008	Velev, Orlin D/0000-0003-0473-8056				Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Velev OD, 2000, CURR OPIN COLLOID IN, V5, P56, DOI 10.1016/S1359-0294(00)00039-X	7	57	57	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					376	377		10.1126/science.1125800	http://dx.doi.org/10.1126/science.1125800			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627729				2022-12-28	WOS:000236941800030
J	Prud'homme, B; Gompel, N; Rokas, A; Kassner, VA; Williams, TM; Yeh, SD; True, JR; Carroll, SB				Prud'homme, B; Gompel, N; Rokas, A; Kassner, VA; Williams, TM; Yeh, SD; True, JR; Carroll, SB			Repeated morphological evolution through cis-regulatory changes in a pleiotropic gene	NATURE			English	Article							MELANOGASTER SPECIES GROUP; BAYESIAN-INFERENCE; YELLOW GENE; PHYLOGENY; DIVERGENCE; DIPTERA; NUCLEAR	The independent evolution of morphological similarities is widespread(1,2). For simple traits, such as overall body colour, repeated transitions by means of mutations in the same gene may be common(3-5). However, for more complex traits, the possible genetic paths may be more numerous; the molecular mechanisms underlying their independent origins and the extent to which they are constrained to follow certain genetic paths are largely unknown. Here we show that a male wing pigmentation pattern involved in courtship display has been gained and lost multiple times in a Drosophila clade. Each of the cases we have analysed (two gains and two losses) involved regulatory changes at the pleiotropic pigmentation gene yellow. Losses involved the parallel inactivation of the same cis-regulatory element (CRE), with changes at a few nucleotides sufficient to account for the functional divergence of one element between two sibling species. Surprisingly, two independent gains of wing spots resulted from the co-option of distinct ancestral CREs. These results demonstrate how the functional diversification of the modular CREs of pleiotropic genes contributes to evolutionary novelty and the independent evolution of morphological similarities.	Univ Wisconsin, Madison, WI 53706 USA; Howard Hughes Med Inst, Bock Labs, Madison, WI 53706 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Cambridge; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carroll, SB (corresponding author), Univ Wisconsin, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551; Yeh, Shu-Dan/0000-0003-0488-1418; Gompel, Nicolas/0000-0003-3358-7963; True, John/0000-0001-5124-5495				Bock IR., 1972, U TEXAS PUBLS, V7, P1; Conway Morris S, 2005, LIFES SOLUTION INEVI; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Goto SG, 2001, MOL PHYLOGENET EVOL, V18, P404, DOI 10.1006/mpev.2000.0893; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kopp A, 2002, SYST BIOL, V51, P786, DOI 10.1080/10635150290102410; Lakovaara S., 1982, Genetics and Biology of Drosophila, V3b, P1; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; O'Grady PM, 2002, MOL PHYLOGENET EVOL, V22, P442, DOI 10.1006/mpev.2001.1053; O'Grady PM, 1999, MOL PHYLOGENET EVOL, V12, P124, DOI 10.1006/mpev.1998.0598; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schawaroch V, 2002, BIOL J LINN SOC, V76, P21, DOI 10.1111/j.1095-8312.2002.tb01711.x; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; West-Eberhard Mary Jane, 2003, pi; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; YEH SD, IN PRESS HEREDITY	29	358	364	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1050	1053		10.1038/nature04597	http://dx.doi.org/10.1038/nature04597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625197				2022-12-28	WOS:000236906000036
J	Derbyshire, SWG				Derbyshire, SWG			Controversy - Can fetuses feel pain?	BRITISH MEDICAL JOURNAL			English	Article							FETAL PAIN; STRESS-RESPONSE; INFANTS; ANESTHESIA; AFFERENTS; ANALGESIA; NEONATE; SURGERY; RAT		Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Derbyshire, SWG (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	s.w.derbyshire@bham.ac.uk		Derbyshire, Stuart/0000-0002-2766-3424				ANAND KJS, 1992, NEW ENGL J MED, V326, P1, DOI 10.1056/NEJM199201023260101; ANAND KJS, 1987, LANCET, V1, P243; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; ANDREWS K, 1994, PAIN, V56, P95, DOI 10.1016/0304-3959(94)90154-6; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Chugani H T, 1998, Pediatrics, V102, P1225; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Collett Teresa Stanton, 2003, Pepperdine Law Rev, V30, P161; CRAIG KD, 1993, PAIN, V52, P287, DOI 10.1016/0304-3959(93)90162-I; Cunningham N, 1999, PAIN FORUM, V8, P93; Derbyshire SWG, 2004, NEUROIMAGE, V23, P392, DOI 10.1016/j.neuroimage.2004.04.033; Derbyshire SWG, 1999, BIOETHICS, V13, P1, DOI 10.1111/1467-8519.00129; Fisk NM, 2001, ANESTHESIOLOGY, V95, P828, DOI 10.1097/00000542-200110000-00008; FITZGERALD M, 1987, J PHYSIOL-LONDON, V383, P79; FITZGERALD M, 1987, J COMP NEUROL, V261, P98, DOI 10.1002/cne.902610108; GIANNAKOULOPOULOS X, 1994, LANCET, V344, P77, DOI 10.1016/S0140-6736(94)91279-3; Glover V, 1999, BRIT J OBSTET GYNAEC, V106, P881, DOI 10.1111/j.1471-0528.1999.tb08424.x; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; Goodman MB, 2003, TRENDS NEUROSCI, V26, P643, DOI 10.1016/j.tins.2003.09.013; Herschkowitz N, 2000, BRAIN DEV-JPN, V22, P411, DOI 10.1016/S0387-7604(00)00185-6; Hevner RF, 2000, J NEUROPATH EXP NEUR, V59, P385, DOI 10.1093/jnen/59.5.385; Hobson Peter., 2002, CRADLE THOUGHT EXPLO; James D, 1998, BRIT MED J, V316, P1580, DOI 10.1136/bmj.316.7144.1580; Kostovic I, 2002, ANAT RECORD, V267, P1, DOI 10.1002/ar.10069; LARROCHE JC, 1981, ANAT EMBRYOL, V162, P301, DOI 10.1007/BF00299974; LEE E, LATE ABORTION REV EV; Lee SJ, 2005, JAMA-J AM MED ASSOC, V294, P947, DOI 10.1001/jama.294.8.947; MALIK K, 2000, MAN BEAST ZOMBIE; McGrath PJ, 2002, CLIN PERINATOL, V29, P555, DOI 10.1016/S0095-5108(02)00021-0; Mellor DJ, 2005, BRAIN RES REV, V49, P455, DOI 10.1016/j.brainresrev.2005.01.006; MERSKEY H, 1991, European Psychiatry, V6, P153; Piaget J., 1923, LANGUAGE THOUGHT CHI; ROGERS MC, 1992, NEW ENGL J MED, V326, P55, DOI 10.1056/NEJM199201023260109; Slater R, 2006, J NEUROSCI, V26, P3662, DOI 10.1523/JNEUROSCI.0348-06.2006; Ulfig N, 2000, HISTOL HISTOPATHOL, V15, P771, DOI 10.14670/HH-15.771; Vygotsky L.S., 1980, MIND SOC; 2001, REPORT MRC EXPERT GR	37	46	48	1	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 15	2006	332	7546					909	912B		10.1136/bmj.332.7546.909	http://dx.doi.org/10.1136/bmj.332.7546.909			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037FK	16613970	Green Published			2022-12-28	WOS:000237132100026
J	Gaya, DR; Russell, RK; Nimmo, ER; Satsangi, J				Gaya, DR; Russell, RK; Nimmo, ER; Satsangi, J			New genes in inflammatory bowel disease: lessons for complex diseases?	LANCET			English	Review							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; MAJOR HISTOCOMPATIBILITY COMPLEX; GENOTYPE-PHENOTYPE ANALYSIS; CATION TRANSPORTER GENES; HUMAN MONOCYTIC CELLS; CROHNS-DISEASE; ULCERATIVE-COLITIS; NOD2 GENE	The chronic inflammatory bowel diseases Crohn's disease and ulcerative colitis are common causes of gastrointestinal disease in northern Europe, affecting as many as one in 250 people. Although mortality is low, morbidity associated with these diseases is substantial. We review the recent advances in the genetics of inflammatory bowel disease, with particular emphasis on the data that have been generated since the discovery of the CARD15 (NOD2) gene in 2001.	Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Satsangi, J (corresponding author), Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	j.satsangi@ed.ac.uk			Wellcome Trust [072789/Z/03/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abreu MT, 2002, GASTROENTEROLOGY, V123, P679, DOI 10.1053/gast.2002.35393; Ahmad T, 2004, GASTROENTEROLOGY, V126, P1533, DOI 10.1053/j.gastro.2004.01.061; Ahmad T, 2003, TISSUE ANTIGENS, V62, P527, DOI 10.1046/j.1399-0039.2003.00129.x; Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Ahmad T, 2001, ALIMENT PHARM THER, V15, P731, DOI 10.1046/j.1365-2036.2001.00981.x; Annese V, 2005, AM J GASTROENTEROL, V100, P84, DOI 10.1111/j.1572-0241.2005.40705.x; [Anonymous], ONL MEND INH MAN; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Armuzzi A, 2003, GUT, V52, P1133, DOI 10.1136/gut.52.8.1133; Arnott IDR, 2004, GENES IMMUN, V5, P417, DOI 10.1038/sj.gene.6364111; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bairead E, 2003, EUR J HUM GENET, V11, P237, DOI 10.1038/sj.ejhg.5200954; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Brant SR, 2003, AM J HUM GENET, V73, P1282, DOI 10.1086/379927; Brant SR, 2003, INFLAMM BOWEL DIS, V9, P281, DOI 10.1097/00054725-200309000-00001; Buning C, 2005, WORLD J GASTROENTERO, V11, P407; Buning C, 2004, ALIMENT PHARM THER, V19, P1073, DOI 10.1111/j.1365-2036.2004.01967.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Crawford N, 2003, GASTROENTEROLOGY, V124, pA48, DOI 10.1016/S0016-5085(03)80237-8; Croucher PJP, 2003, GASTROENTEROLOGY, V125, P1919, DOI 10.1053/j.gastro.2003.05.016; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; Cummings JRF, 2005, GUT, V54, pA95; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Daly MJ, 2005, EUR J HUM GENET, V13, P835, DOI 10.1038/sj.ejhg.5201403; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dechairo B, 2001, EUR J HUM GENET, V9, P627, DOI 10.1038/sj.ejhg.5200687; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; FARMER RG, 1980, CLIN GASTROENTEROL, V9, P271; Fisher SA, 2002, EUR J HUM GENET, V10, P259, DOI 10.1038/sj.ejhg.5200792; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Freeman HJ, 2002, J CLIN GASTROENTEROL, V35, P9, DOI 10.1097/00004836-200207000-00004; Friedrichs F, 2006, HUM GENET, V119, P305, DOI 10.1007/s00439-006-0133-1; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; GERWITZ AT, 2005, GASTROENTEROLOGY S2, V128, pA388; Giallourakis C, 2003, AM J HUM GENET, V73, P205, DOI 10.1086/376417; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Glas J, 2004, GASTROENTEROLOGY, V126, P367, DOI 10.1053/j.gastro.2003.08.045; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayward PAR, 1996, QJM-MON J ASSOC PHYS, V89, P713; Hehlio T, 2003, GUT, V52, P558, DOI 10.1136/gut.52.4.558; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Ho GT, 2005, GASTROENTEROLOGY, V128, P288, DOI 10.1053/j.gastro.2004.11.019; Ho GT, 2003, GUT, V52, P759, DOI 10.1136/gut.52.5.759; Ho GT, 2006, HUM MOL GENET, V15, P797, DOI 10.1093/hmg/ddi494; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Idestrom M, 2005, J PEDIATR GASTR NUTR, V40, P456, DOI 10.1097/01.MPG.0000150423.38210.2E; Iizasa H, 2003, J PHARM SCI, V92, P569, DOI 10.1002/jps.10326; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Inoue N, 2002, GASTROENTEROLOGY, V123, P86, DOI 10.1053/gast.2002.34155; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; KILDEBO S, 1990, SCAND J GASTROENTERO, V25, P890, DOI 10.3109/00365529008997609; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kugathasan S, 2004, CLIN GASTROENTEROL H, V2, P1003, DOI 10.1016/S1542-3565(04)00452-5; Lakatos PL, 2005, WORLD J GASTROENTERO, V11, P1489; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lapidus A, 1997, GUT, V41, P480, DOI 10.1136/gut.41.4.480; Leong RWL, 2003, ALIMENT PHARM THER, V17, P1465, DOI 10.1046/j.1365-2036.2003.01607.x; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mascheretti S, 2002, PHARMACOGENETICS, V12, P509, DOI 10.1097/00008571-200210000-00002; McGovern DPB, 2003, AM J HUM GENET, V73, P1465, DOI 10.1086/379745; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Mendoza JL, 2003, SCAND J GASTROENTERO, V38, P1235, DOI 10.1080/00365520310006612; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Mirza MM, 2003, AM J HUM GENET, V72, P1018, DOI 10.1086/373880; Mizoguchi E, 2003, GASTROENTEROLOGY, V125, P148, DOI 10.1016/S0016-5085(03)00665-6; MONSEN U, 1991, SCAND J GASTROENTERO, V26, P302, DOI 10.3109/00365529109025046; Moodie F, 2004, GASTROENTEROLOGY, V126, pA303; Negoro K, 2003, GUT, V52, P541, DOI 10.1136/gut.52.4.541; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Neurath MF, 1998, ANN NY ACAD SCI, V859, P149, DOI 10.1111/j.1749-6632.1998.tb11119.x; Newman B, 2005, GASTROENTEROLOGY, V128, P260, DOI 10.1053/j.gastro.2004.11.056; Newman WG, 2006, HUM MUTAT, V27, P353, DOI 10.1002/humu.20301; Noble CL, 2005, GASTROENTEROLOGY, V129, P1854, DOI 10.1053/j.gastro.2005.09.025; Noble CL, 2005, GUT, V54, P1416, DOI 10.1136/gut.2005.066621; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oostenbrug LE, 2005, INFLAMM BOWEL DIS, V11, P567, DOI 10.1097/01.MIB.0000161305.81198.0f; Orchard TR, 2002, GASTROENTEROLOGY, V123, P714, DOI 10.1053/gast.2002.35396; Orchard TR, 2000, GASTROENTEROLOGY, V118, P274, DOI 10.1016/S0016-5085(00)70209-5; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Ouburg S, 2005, GUT, V54, P439; Panwala CM, 1998, J IMMUNOL, V161, P5733; Parkes M, 2000, AM J HUM GENET, V67, P1605, DOI 10.1086/316905; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Peeters M, 1997, GASTROENTEROLOGY, V113, P802, DOI 10.1016/S0016-5085(97)70174-4; Peeters M, 1996, GASTROENTEROLOGY, V111, P597, DOI 10.1053/gast.1996.v111.pm8780562; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Pierik M, 2005, INFLAMM BOWEL DIS, V11, P1, DOI 10.1097/00054725-200501000-00001; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Potocnik U, 2004, GENES IMMUN, V5, P530, DOI 10.1038/sj.gene.6364123; PROBERT CSJ, 1993, GUT, V34, P1547, DOI 10.1136/gut.34.11.1547; Radlmayr M, 2002, GASTROENTEROLOGY, V122, P2091, DOI 10.1053/gast.2002.34020; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RANKIN GB, 1979, GASTROENTEROLOGY, V77, P914; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Roussomoustakaki M, 1997, GASTROENTEROLOGY, V112, P1845, DOI 10.1053/gast.1997.v112.pm9178675; Russell RK, 2005, INFLAMM BOWEL DIS, V11, P955, DOI 10.1097/01.MIB.0000183423.38037.f3; Russell RK, 2004, BEST PRACT RES CL GA, V18, P525, DOI 10.1016/j.bpg.2003.12.006; RUSSELL RK, 2005, J PEDIAT GASTROENTER, V40, P641; RUSSELL RK, 2006, GUT             0209, DOI DOI 10.1136/GUT.2005082107; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Satsangi J, 1996, GUT, V38, P738, DOI 10.1136/gut.38.5.738; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schroder JM, 1999, CELL MOL LIFE SCI, V56, P32, DOI 10.1007/s000180050004; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Silverberg MS, 2003, INFLAMM BOWEL DIS, V9, P1, DOI 10.1097/00054725-200301000-00001; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sugimura K, 2003, AM J HUM GENET, V72, P509, DOI 10.1086/367848; Sun LP, 2003, J PEDIATR GASTR NUTR, V37, P492, DOI 10.1097/00005176-200310000-00017; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tenesa A, 2006, EUR J HUM GENET, V14, P259, DOI 10.1038/sj.ejhg.5201516; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Thjodleifsson B, 2003, GASTROENTEROLOGY, V124, P1728, DOI 10.1016/S0016-5085(03)00383-4; THOMPSON NP, 1996, BMJ-BRIT MED J, V312, P985; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Trachtenberg EA, 2000, HUM IMMUNOL, V61, P326, DOI 10.1016/S0198-8859(99)00134-2; Traub S, 2004, J BIOL CHEM, V279, P8694, DOI 10.1074/jbc.M310556200; Trinh TT, 2005, GASTROENTEROLOGY, V129, P2106, DOI 10.1053/j.gastro.2005.10.056; Trinh TT, 2005, GUT, V54, P1354, DOI 10.1136/gut.2005.070920; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; van der Linde K, 2003, AM J GASTROENTEROL, V98, P613, DOI 10.1016/S0002-9270(02)06009-4; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; van Heel DA, 2005, EUR J IMMUNOL, V35, P2471, DOI 10.1002/eji.200526296; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; Van Limbergen J, 2006, GUT, V55, pA10; Vavassori P, 2002, DIGEST LIVER DIS, V34, P153, DOI 10.1016/S1590-8658(02)80249-3; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Vermeire S, 2002, GASTROENTEROLOGY, V123, P106, DOI 10.1053/gast.2002.34172; Vermeire S, 2005, GASTROENTEROLOGY, V129, P1845, DOI 10.1053/j.gastro.2005.10.006; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; WALLER S, 2005, GUT             1216, DOI DOI 10.1136/GUT.2005084574; Watanabe T, 2005, GUT, V54, P1515, DOI 10.1136/gut.2005.071795; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Weissenbach J, 1998, CLIN CHEM LAB MED, V36, P511, DOI 10.1515/CCLM.1998.086; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Winstanley C, 1997, MICROBIOL-SGM, V143, P3071, DOI 10.1099/00221287-143-10-3071; Yamamoto-Furusho JK, 2003, HUM IMMUNOL, V64, P119, DOI 10.1016/S0198-8859(02)00772-3; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517; Yang H, 1999, GUT, V44, P519, DOI 10.1136/gut.44.4.519; Yang SH, 2001, INFECT IMMUN, V69, P2045, DOI 10.1128/IAI.69.4.2045-2053.2001; Zouali H, 2003, GUT, V52, P71, DOI 10.1136/gut.52.1.71	188	186	194	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1271	1284		10.1016/S0140-6736(06)68345-1	http://dx.doi.org/10.1016/S0140-6736(06)68345-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631883				2022-12-28	WOS:000236913400032
J	Spengler, D; van Roermund, HLM; Drury, MR; Ottolini, L; Mason, PRD; Davies, GR				Spengler, D; van Roermund, HLM; Drury, MR; Ottolini, L; Mason, PRD; Davies, GR			Deep origin and hot melting of an Archaean orogenic peridotite massif in Norway	NATURE			English	Article							WESTERN GNEISS REGION; MANTLE ROCKS; GARNET PERIDOTITES; METAMORPHIC ROCKS; MAJORITIC GARNET; HIGH-PRESSURE; RARE-EARTH; LITHOSPHERE; EXHUMATION; XENOLITHS	The buoyancy and strength of sub-continental lithospheric mantle is thought to protect the oldest continental crust (cratons) from destruction by plate tectonic processes. The exact origin of the lithosphere below cratons is controversial, but seems clearly to be a residue remaining after the extraction of large amounts of melt(1,2). Models to explain highly melt-depleted but garnet-bearing rock compositions require multi-stage processes with garnet and clinopyroxene possibly of secondary origin(1,3). Here we report on orogenic peridotites (fragments of cratonic mantle incorporated into the crust during continent-continent plate collision(4)) from Otroy, western Norway. We show that the peridotites underwent extensive melting during upwelling from depths of 350 kilometres or more, forming a garnet-bearing cratonic root in a single melting event. These peridotites appear to be the residue after Archaean aluminium depleted komatiite magmatism.	Univ Utrecht, Fac Geowetenschappen, NL-3584 CD Utrecht, Netherlands; IGG Sede Pavia, CNR, I-27100 Pavia, Italy; Free Univ Amsterdam, Fac Aarden Levenswetenschappen, NL-1081 HV Amsterdam, Netherlands	Utrecht University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Vrije Universiteit Amsterdam	Spengler, D (corresponding author), Univ Utrecht, Fac Geowetenschappen, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	spengler@geo.uu.nl	Mason, Paul/AAN-8131-2020; Drury, Martyn R/H-9997-2013	Mason, Paul/0000-0001-7569-5917; Drury, Martyn R/0000-0002-2246-2009; Davies, Gareth Rees/0000-0002-6136-9202				Beyer EE, 2004, GEOLOGY, V32, P609, DOI 10.1130/G20366.1; Brueckner HK, 2002, EARTH PLANET SC LETT, V203, P805, DOI 10.1016/S0012-821X(02)00919-6; Brueckner HK, 2000, J METAMORPH GEOL, V18, P123; Burgess SR, 2004, J PETROL, V45, P609, DOI 10.1093/petrology/egg095; Carlson, 2003, TREATISE GEOCHEMISTR, V2, P363, DOI DOI 10.1016/B0-08-043751-6/02008-9; Carswell D. A., 1968, LITHOS, V1, P322, DOI 10.1016/S0024-4937(68)80014-3; CARSWELL DA, 1973, EARTH PLANET SC LETT, V20, P347, DOI 10.1016/0012-821X(73)90009-5; De Smet J, 2000, TECTONOPHYSICS, V322, P19, DOI 10.1016/S0040-1951(00)00055-X; Dobrzhinetskaya LF, 2004, TERRA NOVA, V16, P325, DOI 10.1111/j.1365-3121.2004.00569.x; DOBRZHINETSKAYA LF, 1995, GEOLOGY, V23, P597, DOI 10.1130/0091-7613(1995)023<0597:MIHGMR>2.3.CO;2; Drury MR, 2001, J PETROL, V42, P131, DOI 10.1093/petrology/42.1.131; FEI Y, 1999, GEOCHEM SOC SPEC PUB, V6, P189; Gasparik T., 2003, ATLAS EARTHS INTERIO, DOI [10.1007/978-3-540-38352-9, DOI 10.1007/978-3-540-38352-9]; Green HW, 2000, J GEODYN, V30, P61, DOI 10.1016/S0264-3707(99)00027-7; Griffin WL, 1999, J PETROL, V40, P705; HAGGERTY SE, 1990, SCIENCE, V248, P993, DOI 10.1126/science.248.4958.993; Hellebrand E, 2002, J PETROL, V43, P2305, DOI 10.1093/petrology/43.12.2305; Herzberg C, 2004, J PETROL, V45, P2507, DOI 10.1093/petrology/egh039; Ionov D, 2004, J PETROL, V45, P343, DOI 10.1093/petrology/egg090; Johnson KTM, 1998, CONTRIB MINERAL PETR, V133, P60, DOI 10.1007/s004100050437; Pearson D.G., 2004, TREATISE GEOCHEMISTR, P171, DOI DOI 10.1016/B0-08-043751-6/02005-3; RINGWOOD AE, 1994, PHYS EARTH PLANET IN, V86, P5, DOI 10.1016/0031-9201(94)05058-9; Schmidberger SS, 2001, J PETROL, V42, P1095, DOI 10.1093/petrology/42.6.1095; Song SG, 2004, AM MINERAL, V89, P1330, DOI 10.2138/am-2004-8-922; Stachel T, 1998, EARTH PLANET SC LETT, V159, P1, DOI 10.1016/S0012-821X(98)00064-8; TAKAHASHI E, 1990, J GEOPHYS RES-SOLID, V95, P15941, DOI 10.1029/JB095iB10p15941; Terry MP, 2000, AM MINERAL, V85, P1637; Van Orman JA, 2002, CONTRIB MINERAL PETR, V142, P416, DOI 10.1007/s004100100304; van Roermund HLM, 1998, TERRA NOVA, V10, P295; van Roermund HLM, 2002, GEOLOGY, V30, P959, DOI 10.1130/0091-7613(2002)030<0959:MIAMGW>2.0.CO;2; Van Roermund HLM, 2001, J PETROL, V42, P117, DOI 10.1093/petrology/42.1.117; Ye K, 2000, NATURE, V407, P734, DOI 10.1038/35037566	32	115	132	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					913	917		10.1038/nature04644	http://dx.doi.org/10.1038/nature04644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612379				2022-12-28	WOS:000236736700036
J	Knight, ZA; Gonzalez, B; Feldman, ME; Zunder, ER; Goldenberg, DD; Williams, O; Loewith, R; Stokoe, D; Balla, A; Toth, B; Balla, T; Weiss, WA; Williams, RL; Shokat, KM				Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.			A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling	CELL			English	Article							PHOSPHOINOSITIDE 3-KINASE INHIBITORS; DEPENDENT PROTEIN-KINASE; P85 REGULATORY SUBUNIT; CATALYTIC SUBUNIT; EMBRYONIC LETHALITY; TYROSINE KINASE; MICE; ACTIVATION; ATM; INSIGHTS	Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined. We describe here an approach to pharmacologically interrogate the PI3-K family. A chemically diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochemically enumerated, revealing cryptic homologies across targets and chemotypes. Crystal structures of three inhibitors bound to p110 gamma identify a conformationally mobile region that is uniquely exploited by selective compounds. This chemical array was then used to define the PI3-K isoforms required for insulin signaling. We find that p110 alpha is the primary insulin-responsive PI3-K in cultured cells, whereas p110 beta is dispensable but sets a phenotypic threshold for p110 alpha activity. Compounds targeting p110 alpha block the acute effects of insulin treatment in vivo, whereas a p110 beta inhibitor has no effect. These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; NICHHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; MRC Laboratory Molecular Biology; University of Geneva; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu	Gonzalez, Beatriz/M-1219-2014; Toth, Balazs/B-4252-2012; Loewith, Robbie J/S-6289-2016	Gonzalez, Beatriz/0000-0002-0710-0202; Loewith, Robbie J/0000-0002-2482-603X; Williams, Roger/0000-0001-7754-4207; Balla, Tamas/0000-0002-9077-3335; Balla, Andras/0000-0002-6450-2793; Weiss, William/0000-0003-2230-9132; Zunder, Eli/0000-0002-0356-1685; Knight, Zachary/0000-0001-7621-1478	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Medical Research Council [MC_U105184308] Funding Source: Medline; NIAID NIH HHS [R01 AI044009-06, R01 AI044009, AI44009] Funding Source: Medline; MRC [MC_U105184308] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alaimo PJ, 2005, BIOORGAN MED CHEM, V13, P2825, DOI 10.1016/j.bmc.2005.02.021; Asano T, 2000, J BIOL CHEM, V275, P17671, DOI 10.1074/jbc.M910391199; Barvian N.C., 2004, PCT Int. Appl., Patent No. [04052373, WO 04 052373]; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Bruce I., 2003, [No title captured], Patent No. [WO 03072557, 03072557, WO 03 072557]; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; HALBROOK J, 2002, Patent No. 0220500; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; HAYAKAWA M, 2003, Patent No. 1277754; HAYAKAWA M, 2003, Patent No. 1277738; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jackson S., 2004, PCT Int. Appl., Patent No. [WO 04 016607, 04016607]; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2004, BIOORGAN MED CHEM, V12, P4749, DOI 10.1016/j.bmc.2004.06.022; Lakshmanan Jaganathan, 2003, Methods Mol Med, V83, P97; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; MADHUSUDAN T, 1994, PROTEIN SCI, V3, P176; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; ROBERTSON AJ, 2001, Patent No. 0153266; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sadhu C, 2001, [No title captured], Patent No. [WO0181346, 0181346]; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; SHIMADA M, 2004, Patent No. 04029058; SMITH GC, 2003, Patent No. 03070726; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Ward S, 2003, CHEM BIOL, V10, P207, DOI 10.1016/S1074-5521(03)00048-6; Yart A, 2002, J BIOL CHEM, V277, P21167, DOI 10.1074/jbc.M110411200; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	50	907	1038	2	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					733	747		10.1016/j.cell.2006.03.035	http://dx.doi.org/10.1016/j.cell.2006.03.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16647110	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000237886000018
J	Giampieri, G; Dougherty, MK; Smith, EJ; Russell, CT				Giampieri, G; Dougherty, MK; Smith, EJ; Russell, CT			A regular period for Saturn's magnetic field that may track its internal rotation	NATURE			English	Article							MAGNETOSPHERE; VOYAGER-1; RADIO; ORBIT	The rotation rate of a planet is one of its fundamental properties. Saturn's rotation, however, is difficult to determine because there is no solid surface from which to time it, and the alternative 'clock'-the magnetic field-is nearly symmetrically aligned with the rotation axis(1-7). Radio emissions, thought to provide a proxy measure of the rotation of the magnetic field, have yielded estimates of the rotation period between 10 h 39 min 22 s and 10 h 45 min 45 s (refs 8-10). Because the period determined from radio measurements exhibits large time variations, even on time-scales of months, it has been uncertain whether the radio-emission periodicity coincides with the inner rotation rate of the planet. Here we report magnetic field measurements that revealed a time-stationary magnetic signal with a period of 10 h 47 min 6 s +/-40 s. The signal appears to be stable in period, amplitude and phase over 14 months of observations, pointing to a close connection with the conductive region inside the planet, although its interpretation as the 'true' inner rotation period is still uncertain.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90025 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Imperial College London; University of California System; University of California Los Angeles	Giampieri, G (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	giacomo.giampieri@jpl.nasa.gov	Russell, Christopher T/E-7745-2012	Russell, Christopher T/0000-0003-1639-8298				ACNA MH, 1981, NATURE, V292, P721; ACUNA MH, 1980, SCIENCE, V207, P444, DOI 10.1126/science.207.4429.444; CASSINIHUYGENS, 2005, CASSINIHUYGENS OPERA; Cecconi B, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011085; CONNERNEY JEP, 1982, NATURE, V298, P44, DOI 10.1038/298044a0; CONNERNEY JEP, 1983, J GEOPHYS RES-SPACE, V88, P8779, DOI 10.1029/JA088iA11p08779; Davies M., 1996, CELESTIAL MECH, V63, P127, DOI DOI 10.1007/BF00693410; DESCH MD, 1981, GEOPHYS RES LETT, V8, P253, DOI 10.1029/GL008i003p00253; Dougherty MK, 2005, SCIENCE, V307, P1266, DOI 10.1126/science.1106098; Espinosa SA, 2000, GEOPHYS RES LETT, V27, P2785, DOI 10.1029/2000GL000048; Espinosa SA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2001JA005084; Galopeau PHM, 2000, J GEOPHYS RES-SPACE, V105, P13089, DOI 10.1029/1999JA005089; Giampieri G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020194; Giampieri G, 2004, ANN GEOPHYS-GERMANY, V22, P653, DOI 10.5194/angeo-22-653-2004; Gurnett DA, 2005, SCIENCE, V307, P1255, DOI 10.1126/science.1105356; NESS NF, 1981, SCIENCE, V212, P211, DOI 10.1126/science.212.4491.211; Press W.H., 1992, NUMERICAL RECIPES AR, V2nd; Russell CT, 2001, GEOPHYS RES LETT, V28, P1911, DOI 10.1029/2001GL012917; SMITH EJ, 1980, SCIENCE, V207, P407, DOI 10.1126/science.207.4429.407; SMITH EJ, 1980, J GEOPHYS RES-SPACE, V85, P5655, DOI 10.1029/JA085iA11p05655; STEVENSON DJ, 1980, SCIENCE, V208, P746, DOI 10.1126/science.208.4445.746	21	98	98	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					62	64		10.1038/nature04750	http://dx.doi.org/10.1038/nature04750			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672964				2022-12-28	WOS:000237248600031
J	Khalid, SK; Jassim, O				Khalid, SK; Jassim, O			Scrofula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Khalid, SK (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					E18	E18		10.1056/NEJMicm050819	http://dx.doi.org/10.1056/NEJMicm050819			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672695				2022-12-28	WOS:000237239900011
J	Banks, J; Marmot, M; Oldfield, Z; Smith, JP				Banks, J; Marmot, M; Oldfield, Z; Smith, JP			Disease and disadvantage in the United States and in England	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; SOCIOECONOMIC-STATUS; HEALTH; FIBRINOGEN; CHILDHOOD; PROSTATE; RISK	Context The United States spends considerably more money on health care than the United Kingdom, but whether that translates to better health outcomes is unknown. Objective To assess the relative heath status of older individuals in England and the United States, especially how their health status varies by important indicators of socioeconomic position. Design, Setting, and Participants We analyzed representative samples of residents aged 55 to 64 years from both countries using 2002 data from the US Health and Retirement Survey ( n= 4386) and the English Longitudinal Study of Aging ( n= 3681), which were designed to have directly comparable measures of health, income, and education. This analysis is supplemented by samples of those aged 40 to 70 years from the 1999-2002 waves of National Health and Nutrition Examination Survey ( n= 2097) and the 2003 wave of the Health Survey for England ( n= 5526). These surveys contain extensive and comparable biological disease markers on respondents, which are used to determine whether differential propensities to report illness can explain these health differences. To ensure that health differences are not solely due to health issues in the black or Latino populations in the United States, the analysis is limited to non-Hispanic whites in both countries. Main Outcome Measure Self-reported prevalence rates of several chronic diseases related to diabetes and heart disease, adjusted for age and health behavior risk factors, were compared between the 2 countries and across education and income classes within each country. Results The US population in late middle age is less healthy than the equivalent British population for diabetes, hypertension, heart disease, myocardial infarction, stroke, lung disease, and cancer. Within each country, there exists a pronounced negative socioeconomic status (SES) gradient with self-reported disease so that health disparities are largest at the bottom of the education or income variants of the SES hierarchy. This conclusion is generally robust to control for a standard set of behavioral risk factors, including smoking, overweight, obesity, and alcohol drinking, which explain very little of these health differences. These differences between countries or across SES groups within each country are not due to biases in self-reported disease because biological markers of disease exhibit exactly the same patterns. To illustrate, among those aged 55 to 64 years, diabetes prevalence is twice as high in the United States and only one fifth of this difference can be explained by a common set of risk factors. Similarly, among middle-aged adults, mean levels of C-reactive protein are 20% higher in the United States compared with England and mean high-density lipoprotein cholesterol levels are 14% lower. These differences are not solely driven by the bottom of the SES distribution. In many diseases, the top of the SES distribution is less healthy in the United States as well. Conclusion Based on self-reported illnesses and biological markers of disease, US residents are much less healthy than their English counterparts and these differences exist at all points of the SES distribution.	UCL, Dept Epidemiol, London WC1E 6BT, England; RAND Corp, Santa Monica, CA USA; Inst Fiscal Studies, London, England	University of London; University College London; RAND Corporation; University of London; London School Economics & Political Science	Marmot, M (corresponding author), UCL, Dept Epidemiol, 1-19 Torrington Pl, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	BANKS, JAMES/C-2022-2008; Marmot, M G/Y-3920-2019	BANKS, JAMES/0000-0002-9726-8921; Marmot, M G/0000-0002-2431-6419	Medical Research Council [G19/35, G0100222, G8802774] Funding Source: Medline; NIA NIH HHS [2R01AG7644-01A1, R37 AG012394, U01AG009740, P01 AG008291-13, 2R01AG017644, R01 AG040165, P01 AG008291] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG017644, R01AG040165, R37AG012394, P01AG008291, U01AG009740, R01AG013196] Funding Source: NIH RePORTER; Economic and Social Research Council [RES-544-28-5001] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		AYANIAN JZ, 2000, JAMA-J AM MED ASSOC, V285, P2061; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; Banks J, 2003, J HUM RESOUR, V38, P241, DOI 10.2307/1558745; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Case A, 2002, AM ECON REV, V92, P1308, DOI 10.1257/000282802762024520; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DEATON A, 2002, HLTH AFF MILLWOOD, V21, P3; Hemingway H, 2005, CIRCULATION, V111, P3071, DOI 10.1161/CIRCULATIONAHA.104.497347; Institute of Medicine (US), 2002, CAR COV TOO LITTL TO; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Marmot M., 2004, STATUS SYNDROME, DOI 10.1111/J.1740-9713.2004.00058.X; Marmot M., 2005, PUBLIC HEALTH; Marmot M, 2003, HLTH WEALTH LIFESTYL; Melia J, 2004, BJU INT, V94, P51, DOI 10.1111/j.1464-4096.2004.04832.x; Mendall MA, 1996, BRIT MED J, V312, P1061; *NAT CTR HLTH STAT, 2004, NHANES AN GUID JUN 2; *NAT HEART LUNG BL, 1997, NIH PUBL; *ORG EC COOP DEV, 2005, OECD HLTH DAT 2005 S; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith JP, 2004, POPUL DEV REV, V30, P108; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; SPROSTON K, 2003, HLTH SURVEY ENGLAND, V3; Steptoe A, 2003, PSYCHOSOM MED, V65, P137, DOI 10.1097/01.PSY.0000039755.23250.A7; Steptoe A, 2004, POPUL DEV REV, V30, P133; *UN DEV PROGR, 2005, INT COOP CROSSR; Wadsworth MEJ, 1997, PAEDIATR PERINAT EP, V11, P2, DOI 10.1046/j.1365-3016.1997.d01-7.x	28	513	515	0	62	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2037	2045		10.1001/jama.295.17.2037	http://dx.doi.org/10.1001/jama.295.17.2037			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038MF	16670412	Green Published			2022-12-28	WOS:000237225100020
J	Sirovich, BE; Gottlieb, DJ; Welch, HG; Fisher, ES				Sirovich, BE; Gottlieb, DJ; Welch, HG; Fisher, ES			Regional variations in health care intensity and physician perceptions of quality of care	ANNALS OF INTERNAL MEDICINE			English	Article							MANAGED CARE; MEDICARE; EXPENDITURES; SATISFACTION; GUIDELINES; EDUCATION; OUTCOMES; SYSTEM; RATES; TOO	Background: Research has documented dramatic differences in health care utilization and spending across U.S. regions with similar levels of patient illness. Although patient outcomes and quality of care have been found to be no better in regions of high health care intensity, it is unknown whether physicians in these regions feel more capable of providing good patient care than those in low-intensity regions. Objective: To determine whether physicians in high-intensity regions feel better able to care for patients than physicians in low-intensity regions. Design: Physician telephone survey Setting: 51 metropolitan and 9 nonmetropolitan areas of the United States and a supplemental national sample. Participants: 10577 physicians who provided care to adults in 1998 or 1999 were surveyed for the Community Tracking Study (response rate, 61%). Measurements: The End-of-Life Expenditure Index, a measure of spending that reflects differences in the overall quantity of medical services provided rather than differences in illness or price, was used to determine health care intensity in the physicians' community. Outcomes included physicians' perceived availability of clinical services, ability to provide high-quality care to patients, and career satisfaction. Results: Although the highest-intensity regions have substantially more hospital beds and specialists per capita, physicians in these regions reported more difficulty obtaining needed services for their patients. The proportion of physicians who felt able to obtain elective hospital admissions ranged from 50% in high-intensity regions to 64% in the lowest-intensity region (P < 0.001 for the relationship between intensity and perceived ability to obtain hospital admissions); the proportion of physicians who felt able to obtain high-quality specialist referrals ranged from 64% in high-intensity regions to 79% in low-intensity regions (P < 0.001). Compared with low-intensity regions, fewer physicians in high-intensity regions felt able to maintain good ongoing patient relationships (range, 62% to 70%; P < 0.001) or able to provide high-quality care (range, 72% to 77%; P = 0.009). In most cases, differences persisted but were attenuated in magnitude after adjustment for physician attributes, practice characteristics, and local market factors (for example, managed care penetration); the difference in perceived ability to provide high-quality care was no longer statistically significant (P = 0.099). Limitations: The cross-sectional design prevented demonstration of a causal relationship between intensity and physician perceptions of quality. Conclusion: Despite more resources, physicians in regions of high health care intensity did not report greater ease in obtaining needed services or greater ability to provide high-quality care.	Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Coll, Ctr Evaluat Clin Sci, Hanover, NH 03755 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College	Sirovich, BE (corresponding author), Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, 111B, White River Jct, VT 05009 USA.	brenda.sirovich@dartmouth.edu			NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG19783, P01 AG019783-06, P01 AG019783] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Baicker K, 2004, HLTH AFF MILLWOOD, P184; Bodenheimer T, 1999, JAMA-J AM MED ASSOC, V281, P2045, DOI 10.1001/jama.281.21.2045; CANTOR JC, 1993, JAMA-J AM MED ASSOC, V270, P1035, DOI 10.1001/jama.270.9.1035; Carrick SE, 1998, MED J AUSTRALIA, V169, P300, DOI 10.5694/j.1326-5377.1998.tb140280.x; Cleland JGF, 2003, J AM COLL CARDIOL, V42, P1234, DOI 10.1016/S0735-1097(03)00948-3; Cooper, 2003, DARTMOUTH ATLAS HLTH; Cooper RA, 2004, ANN INTERN MED, V141, P705, DOI 10.7326/0003-4819-141-9-200411020-00012; *CTR STUD HLTH, TECHN PUBL CTR STUD, V27; *CTR STUD HLTH SYS, 2002, COMM TRACK STUD PHYS; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Frank E, 1996, ARCH FAM MED, V5, P215, DOI 10.1001/archfami.5.4.215; Garber AM, 2004, ANN INTERN MED, V141, P732, DOI 10.7326/0003-4819-141-9-200411020-00018; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Kessler DP, 2000, Q J ECON, V115, P577, DOI 10.1162/003355300554863; Krakauer H, 1996, HEALTH SERV RES, V31, P191; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, P442, DOI 10.1001/jama.289.4.442; LePore P, 2000, Eff Clin Pract, V3, P62; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; Martin AB, 2001, HEALTH CARE FINANC R, V22, P111; *MED PAYM ADV COMM, 2003, REP C VAR INN MED WA; METCALF CE, 1996, SITE DEFINITION SAMP; Phelps CE, 2003, ANN INTERN MED, V138, P348, DOI 10.7326/0003-4819-138-4-200302180-00016; POTTER F, 2001, TECHNICAL PUBLICATIO, V32; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Reschovsky J, 2001, MED CARE, V39, P254, DOI 10.1097/00005650-200103000-00006; Shah BV, 1997, SUDAAN USERS MANUAL; SHEA S, 1990, J GEN INTERN MED, V5, P327, DOI 10.1007/BF02600401; Shine KI, 2003, ANN INTERN MED, V138, P347, DOI 10.7326/0003-4819-138-4-200302180-00015; Skinner J, 1997, NATL TAX J, V50, P413; St Peter RF, 1999, NEW ENGL J MED, V341, P1980, DOI 10.1056/NEJM199912233412606; Stoddard JJ, 2001, J GEN INTERN MED, V16, P675, DOI 10.1111/j.1525-1497.2001.01206.x; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WENNBERG J, 2000, DARTMOUTH ATLAS HLTH; WENNBERG JE, 2002, HELTH AFF; Wennberg JE, 1998, DARTMOUTH ATLAS HLTH; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH; Zuger A, 2004, NEW ENGL J MED, V350, P69, DOI 10.1056/NEJMsr031703	41	86	88	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					641	649		10.7326/0003-4819-144-9-200605020-00007	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	039GJ	16670133				2022-12-28	WOS:000237293700003
J	Patel, K; Muir, AJ; McHutchison, JG				Patel, K; Muir, AJ; McHutchison, JG			Diagnosis and treatment of chronic hepatitis C infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMBINATION THERAPY; PLUS RIBAVIRIN; ADHERENCE		Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27707 USA	Duke University	McHutchison, JG (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27707 USA.	mchut001@mc.duke.edu						Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Dienstag JL, 2002, HEPATOLOGY, V36, pS152, DOI 10.1053/jhep.2002.36381; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; McHutchison JG, 2006, J HEPATOL, V44, P411, DOI 10.1016/j.jhep.2005.12.001; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Sethi Amrita, 2005, Clin Liver Dis, V9, P453, DOI 10.1016/j.cld.2005.05.002; *WHO, 2000, 164 WHO	12	58	61	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1013	1017		10.1136/bmj.332.7548.1013	http://dx.doi.org/10.1136/bmj.332.7548.1013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16644828	Green Published			2022-12-28	WOS:000237403100021
J	Waxman, SW; Morey, AF				Waxman, SW; Morey, AF			Management of urethral strictures	LANCET			English	Editorial Material							FREE TONGUE GRAFT; URETHROPLASTY; VERMILION		Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army	Morey, AF (corresponding author), Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA.	allen.morey@amedd.army.mil						Andrich DE, 2001, J UROLOGY, V165, P1131, DOI 10.1016/S0022-5347(05)66447-6; Barbagli G, 1996, BRIT J UROL, V78, P929, DOI 10.1046/j.1464-410X.1996.23121.x; BURGER RA, 1992, J UROLOGY, V147, P662, DOI 10.1016/S0022-5347(17)37340-8; COHEN SR, 1991, PLAST RECONSTR SURG, V88, P613, DOI 10.1097/00006534-199110000-00008; ELKASABY AW, 1993, J UROLOGY, V149, P276, DOI 10.1016/S0022-5347(17)36054-8; Fenton AS, 2005, UROLOGY, V65, P1055, DOI 10.1016/j.urology.2004.12.018; Fenton AS, 2004, J UROLOGY, V171, P64, DOI 10.1016/S0022-5347(18)37506-2; GUERREROSANTOS J, 1985, PLAST RECONSTR SURG, V76, P451, DOI 10.1097/00006534-198509000-00024; Meneghini A, 2001, EUR UROL, V39, P264, DOI 10.1159/000052450; NAKAYAMA Y, 1987, ANN PLAS SURG, V19, P75, DOI 10.1097/00000637-198707000-00013; Simonato A, 2006, J UROLOGY, V175, P589, DOI 10.1016/S0022-5347(05)00166-7; VECCHIONE TR, 1992, PLAST RECONSTR SURG, V89, P1179, DOI 10.1097/00006534-199206000-00042; Wessells H, 2002, UROL CLIN N AM, V29, P381, DOI 10.1016/S0094-0143(02)00029-0	13	57	65	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1379	1380		10.1016/S0140-6736(06)68592-9	http://dx.doi.org/10.1016/S0140-6736(06)68592-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650634				2022-12-28	WOS:000237195600008
J	Centanni, M; Gargano, L; Canettieri, G; Viceconti, N; Franchi, A; Delle Fave, G; Annibale, B				Centanni, M; Gargano, L; Canettieri, G; Viceconti, N; Franchi, A; Delle Fave, G; Annibale, B			Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATROPHIC BODY GASTRITIS; IRON-DEFICIENCY ANEMIA; ACID-SECRETION; HYPOTHYROIDISM; LEVOTHYROXINE; ABSORPTION; MALABSORPTION; WOMEN; AGE; METABOLISM	Background: Malabsorption of thyroxine has been described in patients treated with drugs that modify an acidic environment. We determined whether there is an increased need for thyroxine in patients with euthyroid multinodular goiter and impaired secretion of gastric acid. Methods: We assessed the dose of thyroxine required to obtain a low level of thyrotropin (0.05 to 0.20 mU per liter) in 248 patients with multinodular goiter. Of these 248 patients, 53 also had Helicobacter pylori-related gastritis and 60 had atrophic gastritis of the body of the stomach (31 with evidence of H. pylori infection and 29 without such evidence). The reference group comprised 135 patients with multinodular goiter and no gastric disorders. In addition, variation in the level of serum thyrotropin was prospectively studied in 11 patients treated with thyroxine before and after H. pylori infection and both before and during treatment with omeprazole in 10 patients treated with thyroxine who had gastroesophageal reflux. Results: The daily requirement of thyroxine was higher (by 22 to 34 percent) in patients with H. pylori-related gastritis, atrophic gastritis, or both conditions than in the reference group. In prospective studies, the occurrence of H. pylori infection in the 11 patients treated with thyroxine led to an increase in the level of serum thyrotropin (P=0.002), an effect that was nearly reversed on eradication of H. pylori infection. In a similar way, omeprazole treatment was associated with an increase in the level of serum thyrotropin in all 10 patients treated with thyroxine, an effect that was reversed by an increase in the thyroxine dose by 37 percent. Conclusions: Patients with impaired acid secretion require an increased dose of thyroxine, suggesting that normal gastric acid secretion is necessary for effective absorption of oral thyroxine.	Univ La Sapienza, Dept Expt Med & Pathol, Endocrinol Unit, Latina, Italy; Univ Roma La Sapienza, Sant Andrea Hosp, Dept Digest & Liver Dis, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Centanni, M (corresponding author), Policlin Umberto 1, Dept Expt Med & Pathol, Viale Regina Elena 324, I-00161 Rome, Italy.	marco.centanni@uniroma1.it	Annibale, Bruno/A-5372-2008	Annibale, Bruno/0000-0001-9120-5957; CANETTIERI, Gianluca/0000-0001-6694-2613; CENTANNI, Marco/0000-0003-0661-1649				Alexander EK, 2004, NEW ENGL J MED, V351, P241, DOI 10.1056/NEJMoa040079; Annibale B, 1997, HELICOBACTER, V2, P57, DOI 10.1111/j.1523-5378.1997.tb00060.x; Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625; Annibale B, 2001, AM J MED, V111, P439, DOI 10.1016/S0002-9343(01)00883-X; Arafah BM, 2001, NEW ENGL J MED, V344, P1743, DOI 10.1056/NEJM200106073442302; BENVENGA S, 1995, THYROID, V5, P249, DOI 10.1089/thy.1995.5.249; Capurso G, 2001, ALIMENT PHARM THER, V15, P1753, DOI 10.1046/j.1365-2036.2001.01101.x; Capurso G, 2000, DIGEST LIVER DIS, V32, P119, DOI 10.1016/S1590-8658(00)80397-7; CENTANNI M, 1987, J CLIN INVEST, V80, P1068, DOI 10.1172/JCI113162; Centanni M, 1999, ARCH INTERN MED, V159, P1726, DOI 10.1001/archinte.159.15.1726; Figura N, 1999, J PHYSIOL PHARMACOL, V50, P817; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; HAYS MT, 1994, THYROID, V4, P55, DOI 10.1089/thy.1994.4.55; HELFAND M, 1990, ANN INTERN MED, V113, P450, DOI 10.7326/0003-4819-113-6-450; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; Kabadi UM, 1997, SOUTHERN MED J, V90, P920, DOI 10.1097/00007611-199709000-00012; Krohn K, 2005, ENDOCR REV, V26, P504, DOI 10.1210/er.2004-0005; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; LIEL Y, 1994, ANN INTERN MED, V120, P619, DOI 10.7326/0003-4819-120-7-199404010-00017; Marignani M, 1999, AM J GASTROENTEROL, V94, P766; MCQUAID KR, 2002, SLESENGER FORDTRANS, V1, P102; Nedrud JG, 2002, HELICOBACTER, V7, P24, DOI 10.1046/j.1523-5378.7.s1.4.x; Sachs G, 2000, ALIMENT PHARM THER, V14, P1383, DOI 10.1046/j.1365-2036.2000.00837.x; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Seppel T, 1996, EXP CLIN ENDOCR DIAB, V104, P180, DOI 10.1055/s-0029-1211442; SHERMAN SI, 1994, AM J MED, V96, P531, DOI 10.1016/0002-9343(94)90093-0; Singh N, 2000, JAMA-J AM MED ASSOC, V283, P2822, DOI 10.1001/jama.283.21.2822; Siraj ES, 2003, ARCH INTERN MED, V163, P1367, DOI 10.1001/archinte.163.11.1367; Smout AJPM, 1998, SCAND J GASTROENTERO, V33, P32, DOI 10.1080/003655298750027191; TOFT AD, 1994, NEW ENGL J MED, V331, P1035; Utiger RD, 2001, NEW ENGL J MED, V344, P1784, DOI 10.1056/NEJM200106073442310; Vanderpump MPJ, 1996, BMJ-BRIT MED J, V313, P539; Wiersinga WM, 2001, HORM RES, V56, P74, DOI 10.1159/000048140; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200	35	215	220	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1787	1795		10.1056/NEJMoa043903	http://dx.doi.org/10.1056/NEJMoa043903			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641395				2022-12-28	WOS:000237077100004
J	Pepys, MB; Hirschfield, GM; Tennent, GA; Gallimore, JR; Kahan, MC; Bellotti, V; Hawkins, PN; Myers, RM; Smith, MD; Polara, A; Cobb, AJA; Ley, SV; Aquilina, JA; Robinson, CV; Sharif, I; Gray, GA; Sabin, CA; Jenvey, MC; Kolstoe, SE; Thompson, D; Wood, SP				Pepys, MB; Hirschfield, GM; Tennent, GA; Gallimore, JR; Kahan, MC; Bellotti, V; Hawkins, PN; Myers, RM; Smith, MD; Polara, A; Cobb, AJA; Ley, SV; Aquilina, JA; Robinson, CV; Sharif, I; Gray, GA; Sabin, CA; Jenvey, MC; Kolstoe, SE; Thompson, D; Wood, SP			Targeting C-reactive protein for the treatment of cardiovascular disease	NATURE			English	Article							AMYLOID-P-COMPONENT; ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; SERUM; SENSITIVITY; COMPLEMENT; ACTIVATION; ARTERIES; BINDING; RAT	Complement-mediated inflammation exacerbates the tissue injury of ischaemic necrosis in heart attacks and strokes, the most common causes of death in developed countries. Large infarct size increases immediate morbidity and mortality and, in survivors of the acute event, larger non-functional scars adversely affect long-term prognosis. There is thus an important unmet medical need for new cardioprotective and neuroprotective treatments. We have previously shown that human C-reactive protein (CRP), the classical acute-phase protein that binds to ligands exposed in damaged tissue and then activates complement(1), increases myocardial and cerebral infarct size in rats subjected to coronary or cerebral artery ligation, respectively(2,3). Rat CRP does not activate rat complement, whereas human CRP activates both rat and human complement(4). Administration of human CRP to rats is thus an excellent model for the actions of endogenous human CRP2,3. Here we report the design, synthesis and efficacy of 1,6-bis(phosphocholine)-hexane as a specific small-molecule inhibitor of CRP. Five molecules of this palindromic compound are bound by two pentameric CRP molecules, crosslinking and occluding the ligand-binding B-face of CRP and blocking its functions. Administration of 1,6-bis(phosphocholine)-hexane to rats undergoing acute myocardial infarction abrogated the increase in infarct size and cardiac dysfunction produced by injection of human CRP. Therapeutic inhibition of CRP is thus a promising new approach to cardioprotection in acute myocardial infarction, and may also provide neuroprotection in stroke. Potential wider applications include other inflammatory, infective and tissue-damaging conditions characterized by increased CRP production, in which binding of CRP to exposed ligands in damaged cells may lead to complement-mediated exacerbation of tissue injury.	UCL, Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Edinburgh, Ctr Cardiovasc Sci, Endothelial Cell & Mol Cardiol Grp, Edinburgh EH16 4TJ, Midlothian, Scotland; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of London; University College London; University of Cambridge; University of Edinburgh; University of London; University College London; University of Southampton	Pepys, MB (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Rowland Hill St, London NW3 2PF, England.	m.pepys@medsch.ucl.ac.uk	Cobb, Alexander/Q-5702-2016; Ley, Steven V/O-7712-2016; Wood, Stephen P/B-1438-2009; Kolstoe, Simon/O-4996-2019; Sabin, Caroline/C-2464-2008; Hawkins, Philip N/C-5573-2008; Aquilina, J. Andrew/A-5366-2013; Aquilina, John Andrew/AGF-4013-2022; Hirschfield, Gideon M/M-2143-2015; Bellotti, Vittorio/A-6201-2014; Gray, Gillian A/B-4058-2014	Cobb, Alexander/0000-0002-3397-9636; Ley, Steven V/0000-0002-7816-0042; Kolstoe, Simon/0000-0003-1472-3966; Sabin, Caroline/0000-0001-5173-2760; Hirschfield, Gideon M/0000-0002-6736-2255; Bellotti, Vittorio/0000-0001-8678-662X; Gray, Gillian A/0000-0003-3104-3305; robinson, carol/0000-0001-7829-5505	Medical Research Council [G7900510] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G7900510] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Clapp BR, 2005, CIRCULATION, V111, P1530, DOI 10.1161/01.CIR.0000159336.31613.31; DEBEER FC, 1982, IMMUNOLOGY, V45, P55; DEBEER FC, 1982, BRIT HEART J, V47, P239; DeLano W.L, PYMOL MOL GRAPHICS S; Denvir MA, 2005, J AM SOC ECHOCARDIOG, V18, P155, DOI 10.1016/j.echo.2004.09.001; Eda S, 1998, J CLIN LAB ANAL, V12, P137, DOI 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Gray GA, 2000, BRIT J PHARMACOL, V130, P1735, DOI 10.1038/sj.bjp.0703503; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; KUSHNER I, 1978, J CLIN INVEST, V61, P235, DOI 10.1172/JCI108932; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Miller AA, 2000, BRIT J PHARMACOL, V131, P29, DOI 10.1038/sj.bjp.0703528; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Pepys MB, 2005, ARTERIOSCL THROM VAS, V25, P1091, DOI 10.1161/01.ATV.0000169644.88847.28; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 2005, CIRC RES, V97, pE97, DOI 10.1161/01.RES.0000193595.03608.08; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Taylor KE, 2005, ARTERIOSCL THROM VAS, V25, P1225, DOI 10.1161/01.ATV.0000164623.41250.28; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9	23	520	563	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1217	1221		10.1038/nature04672	http://dx.doi.org/10.1038/nature04672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16642000	Green Submitted			2022-12-28	WOS:000237080000051
J	Miller, PM; Gavrilets, S; Rice, WR				Miller, PM; Gavrilets, S; Rice, WR			Sexual conflict via maternal-effect genes in ZW species	SCIENCE			English	Article							EVOLUTION; CHROMOSOME; SELECTION		Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Tennessee, Dept Math, Knoxville, TN 37996 USA	University of California System; University of California Santa Barbara; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Miller, PM (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	pmiller@lifesci.ucsb.edu		Miller, Paige/0000-0002-5419-8601	NIGMS NIH HHS [GM56693] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056693] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DOMBROWSKI SM, NCBI HDB NATL LIB ME, pCH20; Gavrilets S, 1998, GENETICS, V149, P1147; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; RICE WR, 1987, GENETICS, V116, P161; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Spencer HG, 2003, GENETICS, V164, P1689; Spencer HG, 2000, ANNU REV GENET, V34, P457, DOI 10.1146/annurev.genet.34.1.457	8	22	22	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					73	73		10.1126/science.1123727	http://dx.doi.org/10.1126/science.1123727			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601185				2022-12-28	WOS:000236584400031
J	Norden, C; Mendoza, M; Dobbelaere, J; Kotwaliwale, CV; Biggins, S; Barral, Y				Norden, C; Mendoza, M; Dobbelaere, J; Kotwaliwale, CV; Biggins, S; Barral, Y			The NoCut pathway links completion of cytokinesis to spindle midzone funiction to prevent chromosome breakage	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEIN-KINASE; MITOTIC SPINDLE; CELL-DIVISION; SEGREGATION; CHECKPOINT; ANAPHASE; COMPARTMENTALIZATION; PHOSPHORYLATION	During anaphase, spindle elongation pulls sister chromatids apart until each pair is fully separated. In turn, cytokinesis cleaves the cell between the separated chromosomes. What ensures that cytokinesis proceeds only after that all chromosome arms are pulled out of the cleavage plane was unknown. Here, we show that a signaling pathway, which we call NoCut, delays the completion of cytokinesis in cells with spindle-midzone defects. NoCut depends on the Aurora kinase Ipl1 and the anillin-related proteins Boi1 and Boi2, which localize to the site of cleavage in an Ipl1-dependent manner and act as abscission inhibitors. Inactivation of NoCut leads to premature abscission and chromosome breakage by the cytokinetic machinery and is lethal in cells with spindle-elongation defects. We propose that NoCut monitors clearance of chromatin from the midzone to ensure that cytokinesis completes only after all chromosomes have migrated to the poles.	ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Fred Hutchinson Cancer Center	Barral, Y (corresponding author), ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch	Mendoza, Manuel/AAE-8987-2021; Norden, Caren/I-3918-2014	Mendoza, Manuel/0000-0001-5522-4878; Biggins, Susan/0000-0002-4499-6319; Norden, Caren/0000-0001-8835-1451; Barral, Yves/0000-0002-0989-3373; Dobbelaere, Jeroen/0000-0002-6727-532X				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; CIRNINI D, 2002, J CELL SCI, V115, P507; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Fraschini R, 2001, MOL GENET GENOMICS, V266, P115, DOI 10.1007/s004380100533; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hallett MA, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-16; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Korinek WS, 2000, CURR BIOL, V10, P947, DOI 10.1016/S0960-9822(00)00626-6; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; McCollum D, 2004, CURR BIOL, V14, pR953, DOI 10.1016/j.cub.2004.10.040; Melo JA, 2001, GENE DEV, V15, P2809; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Tolliday N, 2001, CURR OPIN MICROBIOL, V4, P690, DOI 10.1016/S1369-5274(01)00270-3; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7	46	218	221	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					85	98		10.1016/j.cell.2006.01.045	http://dx.doi.org/10.1016/j.cell.2006.01.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615892	Bronze			2022-12-28	WOS:000237314200016
J	Ferguson, NM; Cummings, DAT; Fraser, C; Cajka, JC; Cooley, PC; Burke, DS				Ferguson, Neil M.; Cummings, Derek A. T.; Fraser, Christophe; Cajka, James C.; Cooley, Philip C.; Burke, Donald S.			Strategies for mitigating an influenza pandemic	NATURE			English	Article							TRANSMISSION DYNAMICS; ANTIVIRAL DRUG; MOUTH EPIDEMIC; HONG-KONG; IMPACT; SARS; INFECTIONS; HOUSEHOLD; SPREAD; FOOT	Development of strategies for mitigating the severity of a new influenza pandemic is now a top global public health priority. Influenza prevention and containment strategies can be considered under the broad categories of antiviral, vaccine and non-pharmaceutical ( case isolation, household quarantine, school or workplace closure, restrictions on travel) measures(1). Mathematical models are powerful tools for exploring this complex landscape of intervention strategies and quantifying the potential costs and benefits of different options(2-5). Here we use a large-scale epidemic simulation(6) to examine intervention options should initial containment(6,7) of a novel influenza outbreak fail, using Great Britain and the United States as examples. We find that border restrictions and/or internal travel restrictions are unlikely to delay spread by more than 2 - 3 weeks unless more than 99% effective. School closure during the peak of a pandemic can reduce peak attack rates by up to 40%, but has little impact on overall attack rates, whereas case isolation or household quarantine could have a significant impact, if feasible. Treatment of clinical cases can reduce transmission, but only if antivirals are given within a day of symptoms starting. Given enough drugs for 50% of the population, household-based prophylaxis coupled with reactive school closure could reduce clinical attack rates by 40 - 50%. More widespread prophylaxis would be even more logistically challenging but might reduce attack rates by over 75%. Vaccine stockpiled in advance of a pandemic could significantly reduce attack rates even if of low efficacy. Estimates of policy effectiveness will change if the characteristics of a future pandemic strain differ substantially from those seen in past pandemics.	Imperial Coll London, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; RTI Int Inc, Res Triangle Pk, NC 27709 USA	Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Research Triangle Institute	Ferguson, NM (corresponding author), Imperial Coll London, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Fahimifar, Sepideh/M-5303-2019; Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; /0000-0002-5704-8094; Cajka, James/0000-0001-9800-6627				ANDERSON R M, 1991; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Coombes R, 2005, BRIT MED J, V330, P495, DOI 10.1136/bmj.330.7490.495; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; *OAKR NAT LAB, 2003, LANDSC GLOB POP DAT; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; World Health Organization (WHO), 2005, WHO GLOB INFL PREP P	23	1410	1456	5	351	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					448	452		10.1038/nature04795	http://dx.doi.org/10.1038/nature04795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16642006	Green Published, Bronze			2022-12-28	WOS:000239278900042
J	Ortlepp, T; Ariando; Mielke, O; Verwijs, CJM; Foo, KFK; Rogalla, H; Uhlmann, FH; Hilgenkamp, H				Ortlepp, T.; Ariando; Mielke, O.; Verwijs, C. J. M.; Foo, K. F. K.; Rogalla, H.; Uhlmann, F. H.; Hilgenkamp, H.			Flip-flopping fractional flux quanta	SCIENCE			English	Article							PAIRING SYMMETRY; JUNCTION; SUPERCONDUCTORS; CIRCUITS	The d-wave pairing symmetry in high - critical temperature superconductors makes it possible to realize superconducting rings with built-in pi phase shifts. Such rings have a twofold degenerate ground state that is characterized by the spontaneous generation of fractional magnetic flux quanta with either up or down polarity. We have incorporated pi phase - biased superconducting rings in a logic circuit, a flip-flop, in which the fractional flux polarity is controllably toggled by applying single flux quantum pulses at the input channel. The integration of pi rings into conventional rapid single flux quantum logic as natural two-state devices should alleviate the need for bias current lines, improve device symmetry, and enhance the operation margins.	Univ Technol Ilmenau, Inst Informat Technol, RSFQ Design Grp, D-98684 Ilmenau, Germany; Univ Twente, Inst nanotechnol, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands; Univ Twente, Inst nanotechnol, MESA, NL-7500 AE Enschede, Netherlands	Technische Universitat Ilmenau; University of Twente; University of Twente	Ortlepp, T (corresponding author), Univ Technol Ilmenau, Inst Informat Technol, RSFQ Design Grp, POB 100565, D-98684 Ilmenau, Germany.	thomas.ortlepp@tu-ilmenau.de	Ortlepp, Thomas/G-3250-2012; , Ariando/F-8953-2012; Ortlepp, Thomas/C-5426-2009	, Ariando/0000-0002-0598-426X; Hilgenkamp, Hans/0000-0001-6109-8804; ROGALLA, HORST/0000-0003-3946-0891				Brock DK, 2000, IEEE SPECTRUM, V37, P40, DOI 10.1109/6.887595; Hilgenkamp H, 2003, NATURE, V422, P50, DOI 10.1038/nature01442; Kirtley JR, 1997, PHYS REV B, V56, P886, DOI 10.1103/PhysRevB.56.886; Kontos T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137007; Likharev KK, 1991, IEEE T APPL SUPERCON, V1, P3, DOI 10.1109/77.80745; Polonsky SV, 1993, IEEE T APPL SUPERCON, V3, P2566, DOI 10.1109/77.233530; Ryazanov VV, 2001, PHYS REV LETT, V86, P2427, DOI 10.1103/PhysRevLett.86.2427; Schulz RR, 2000, APPL PHYS LETT, V76, P912, DOI 10.1063/1.125627; Smilde HJH, 2002, APPL PHYS LETT, V80, P4579, DOI 10.1063/1.1485305; Terzioglu E, 1998, IEEE T APPL SUPERCON, V8, P48, DOI 10.1109/77.678441; TSUEI CC, 1994, PHYS REV LETT, V73, P593, DOI 10.1103/PhysRevLett.73.593; Ustinov AV, 2003, J APPL PHYS, V94, P5405, DOI 10.1063/1.1604964	13	96	97	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1495	1497		10.1126/science.1126041	http://dx.doi.org/10.1126/science.1126041			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16627699				2022-12-28	WOS:000238124100039
J	Paredez, AR; Somerville, CR; Ehrhardt, DW				Paredez, Alexander R.; Somerville, Christopher R.; Ehrhardt, David W.			Visualization of cellulose synthase demonstrates functional association with microtubules	SCIENCE			English	Article							CORTICAL MICROTUBULES; PLASMA-MEMBRANE; MICROFIBRIL ALIGNMENT; CELL; DISRUPTION; DEPOSITION; RESISTANCE; COMPLEXES; MECHANISM; EXPANSION	Expression of a functional yellow fluorescent protein fusion to cellulose synthase (CESA) in transgenic Arabidopsis plants allowed the process of cellulose deposition to be visualized in living cells. Spinning disk confocal microscopy revealed that CESA complexes in the plasma membrane moved at constant rates in linear tracks that were aligned and were coincident with cortical microtubules. Within each observed linear track, complex movement was bidirectional. Inhibition of microtubule polymerization changed the fine-scale distribution and pattern of moving CESA complexes in the membrane, indicating a relatively direct mechanism for guidance of cellulose deposition by the cytoskeleton.	Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Ehrhardt, DW (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	ehrhardt@stanford.edu	Somerville, Christopher R/A-4048-2009; Paredez, Alexander R/B-9799-2009; Paredez, Alexander/E-7171-2014	Somerville, Christopher R/0000-0003-4647-0094; Paredez, Alexander R/0000-0002-9298-3264; Paredez, Alexander/0000-0002-9298-3264				Alberts B., 2008, MOL BIOL CEL, V5th ed.; Baskin TI, 2004, PLANT PHYSIOL, V135, P2279, DOI 10.1104/pp.104.040493; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Emons AMC, 2000, TRENDS PLANT SCI, V5, P35, DOI 10.1016/S1360-1385(99)01507-1; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Giddings T.H., 1991, CYTOSKELETAL BASIS P, P85; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HAIGLER CH, 1986, PROTOPLASMA, V134, P111, DOI 10.1007/BF01275709; HEATH IB, 1974, J THEOR BIOL, V48, P445, DOI 10.1016/S0022-5193(74)80011-1; HEPLER PK, 1974, ANNU REV PLANT PHYS, V25, P309, DOI 10.1146/annurev.pp.25.060174.001521; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; LLOYD CW, 1984, INT REV CYTOL, V86, P1, DOI 10.1016/S0074-7696(08)60176-X; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; REISS HD, 1984, PLANTA, V160, P428, DOI 10.1007/BF00429759; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; ROBINSON DG, 1981, EUR J CELL BIOL, V25, P278; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Wasteneys GO, 2004, CURR OPIN PLANT BIOL, V7, P651, DOI 10.1016/j.pbi.2004.09.008; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050	30	891	928	10	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1491	1495		10.1126/science.1126551	http://dx.doi.org/10.1126/science.1126551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16627697				2022-12-28	WOS:000238124100038
J	Posfai, G; Plunkett, G; Feher, T; Frisch, D; Keil, GM; Umenhoffer, K; Kolisnychenko, V; Stahl, B; Sharma, SS; de Arruda, M; Burland, V; Harcum, SW; Blattner, FR				Posfai, G; Plunkett, G; Feher, T; Frisch, D; Keil, GM; Umenhoffer, K; Kolisnychenko, V; Stahl, B; Sharma, SS; de Arruda, M; Burland, V; Harcum, SW; Blattner, FR			Emergent properties of reduced-genome Escherichia coli	SCIENCE			English	Article							D-CYCLOSERINE; MUTANTS; CELLS; K-12	With the use of synthetic biology, we reduced the Escherichia coli K-12 genome by making planned, precise deletions. The multiple-deletion series (MDS) strains, with genome reductions up to 15%, were designed by identifying nonessential genes and sequences for elimination, including recombinogenic or mobile DNA and cryptic virulence genes, while preserving good growth profiles and protein production. Genome reduction also led to unanticipated beneficial properties: high electroporation efficiency and accurate propagation of recombinant genes and plasmids that were unstable in other strains. Eradication of stress-induced transposition evidently stabilized the MDS genomes and provided some of the new properties.	Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary; Scarab Genom LLC, Madison, WI 53713 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; Friedrich Loeffler Inst, Inst Mol Biol, Fed Res Ctr Virus Dis Anim, D-17493 Greifswald, Germany; Clemson Univ, Dept Chem & Biomol Engn, Clemson, SC 29634 USA; Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Friedrich Loeffler Institute; Clemson University; Clemson University	Posfai, G (corresponding author), Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary.	posfaigy@nucleus.szbk.u-szeged.hu; fred@genome.wisc.edu	Plunkett, Guy/B-8058-2009; Feher, Tamas/AAH-4479-2019; Harcum, Sarah Waterman/AAG-5431-2021	Plunkett, Guy/0000-0003-1422-469X; Feher, Tamas/0000-0001-9318-3640; Harcum, Sarah Waterman/0000-0001-9417-0489	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035682] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35682] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; CHATTERJEE SK, COMMUNICATION; Feher T, 2006, MUTAT RES-FUND MOL M, V595, P184, DOI 10.1016/j.mrfmmm.2005.11.004; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hall BG, 1998, MOL BIOL EVOL, V15, P1; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; HAYASHI K, 2006, MOL SYST BIOL, V2, pE1, DOI [DOI 10.1038/MSB4100049, 10.1038/MSB4100049]; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KISS A, COMMUNICATION; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; RUSSELL RRB, 1972, J BACTERIOL, V111, P622, DOI 10.1128/JB.111.2.622-624.1972; Santat L, 2005, P NATL ACAD SCI USA, V102, P11053, DOI 10.1073/pnas.0502902102; Sekine Y, 1997, GENE, V191, P183, DOI 10.1016/S0378-1119(97)00057-7; Serres MH, 2004, NUCLEIC ACIDS RES, V32, pD300, DOI 10.1093/nar/gkh087; WARGEL RJ, 1971, J BACTERIOL, V105, P1028, DOI 10.1128/JB.105.3.1028-1035.1971; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740	19	483	538	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1044	1046		10.1126/science.1126439	http://dx.doi.org/10.1126/science.1126439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16645050				2022-12-28	WOS:000237628800043
J	Barber, K; Falvey, S; Hamilton, C; Collett, D; Rudge, C				Barber, Kerri; Falvey, Sue; Hamilton, Claire; Collett, Dave; Rudge, Chris			Potential for organ donation in the United Kingdom: audit of intensive care records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UK; ENGLAND	Objectives To determine the true potential for solid organ donation from deceased heartbeating donors and the reasons for non-donation from potential donors. Design An audit of all deaths in intensive care units, 1 April 2003 to 31 March 2005. The study was hierarchic, in that information was sought on whether or not brain stem testing was carried out; if so, whether or not organ donation was considered; if so whether or not the next of kin were approached; if so, whether or not consent was given; if so, whether or not organ donation took place. Setting 341 intensive care units in 284 hospitals in the United Kingdom. Participants 46 801 dead patients, leading to 2740 potential heartbeating solid organ donors and 1244 actual donors. Main outcome measures Proportion of potential deceased heartbeating donors considered for organ donation, proportion of families who denied consent, and proportion of potential donors who became organ donors. Results Over the two years of the study, 41% of the families of potential donors denied consent The refusal rate for families of potential donors from ethnic minorities was twice that for white potential donors, but the age and sex of the potential donor did not affect the refusal rate. In 15% of families of potential donors there was no record of the next of kin being approached for permission for organ donation. Conclusions Intensive care units are extremely good in considering possible organ donation from suitable patients. The biggest obstacle to improving the organ donation rate is the high proportion of relatives who deny consent.	NHS Blood & Transplant, UK Transplant, Bristol BS34 8RR, Avon, England		Rudge, C (corresponding author), NHS Blood & Transplant, UK Transplant, Bristol BS34 8RR, Avon, England.	chris.rudge@uktransplant.nhs.uk		Collett, David/0000-0003-4861-7627				Barber KM, 2005, TRANSPLANT P, V37, P568, DOI 10.1016/j.transproceed.2004.12.088; Briggs JD, 1997, NEPHROL DIAL TRANSPL, V12, P2251, DOI 10.1093/ndt/12.11.2251; GORE SM, 1992, BRIT MED J, V304, P349, DOI 10.1136/bmj.304.6823.349; GORE SM, 1989, BRIT MED J, V299, P1193, DOI 10.1136/bmj.299.6709.1193; Langone AJ, 2003, NEW ENGL J MED, V349, P704, DOI 10.1056/NEJMe038117; MATESANZ R, 2005, TRANSPLANTATION COMP; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; *UK TRANSPL, TRANSPL ACT REP 2004; Wight J, 2004, NEPHROL DIAL TRANSPL, V19, P963, DOI 10.1093/ndt/gfg618; 2005, COUNCIL EUROPE TRANS, V10, P1	10	132	134	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1124	1126A		10.1136/bmj.38804.658183.55	http://dx.doi.org/10.1136/bmj.38804.658183.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16641118	Green Published, Bronze			2022-12-28	WOS:000237682700017
J	Lee, K; Cho, S; Park, SH; Heeger, AJ; Lee, CW; Lee, SH				Lee, K; Cho, S; Park, SH; Heeger, AJ; Lee, CW; Lee, SH			Metallic transport in polyaniline	NATURE			English	Article							CONDUCTING POLYMERS; INSULATOR-TRANSITION; DOPED POLYACETYLENE; POLYPYRROLE; BOUNDARY; ACID	Despite nearly three decades of materials development, the transport properties in the 'metallic state' of the so-called conducting polymers are still not typical of conventional metals(1-7). The hallmark of metallic resistivity-a monotonic decrease in resistivity with temperature-has not been obtained at temperatures over the full range below room temperature; and a frequency dependent conductivity, sigma(omega), typical of metals has also not been observed. In contrast, the low-temperature behaviour of 'metallic' polymers has, in all previous cases, exhibited an increase in resistivity as temperature is further decreased, as a result of disorder-induced localization of the charge carriers(1-4). This disorder-induced localization also changes the infrared response such that sigma(omega) deviates from the prediction of Drude theory(5-7). Here we report classic metallic transport data obtained from truly metallic polymers. With polyaniline samples prepared using self-stabilized dispersion polymerization(8), we find that for samples having room-temperature conductivities in excess of 1,000 S cm(-1), the resistivity decreases monotonically as the temperature is lowered down to 5 K, and that the infrared spectra are characteristic of the conventional Drude model even at the lowest frequencies measured.	Pusan Natl Univ, Dept Phys, Pusan 609735, South Korea; Univ Calif Santa Barbara, Ctr Polymers & Organ Solids, Santa Barbara, CA 93106 USA; Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea	Pusan National University; University of California System; University of California Santa Barbara; Ajou University	Lee, K (corresponding author), Pusan Natl Univ, Dept Phys, Pusan 609735, South Korea.	kwhlee@pusan.ac.kr; hyja@ajou.ac.kr	Cho, Shinuk/B-9530-2008	Cho, Shinuk/0000-0002-6855-833X				Anderson P. W., 1970, Comments on Solid State Physics, V2, P193; Ashcroft N.W., 1976, SOLID STATE PHYS; Chapman B, 1999, PHYS REV B, V60, P13479, DOI 10.1103/PhysRevB.60.13479; FITE C, 1990, SOLID STATE COMMUN, V73, P607, DOI 10.1016/0038-1098(90)90248-A; Heeger AJ, 2002, PHYS SCRIPTA, VT102, P30, DOI 10.1238/Physica.Topical.102a00030; Heeger AJ, 2001, REV MOD PHYS, V73, P681, DOI 10.1103/RevModPhys.73.681; Kaiser AB, 2001, ADV MATER, V13, P927, DOI 10.1002/1521-4095(200107)13:12/13<927::AID-ADMA927>3.0.CO;2-B; Kiebooms R., 2001, HDB ADV ELECT PHOTON, V8, P1, DOI DOI 10.1016/B978-012513745-4/50064-0; Kohlman RS, 1997, PHYS REV LETT, V78, P3915, DOI 10.1103/PhysRevLett.78.3915; KOHLMAN RS, 1996, PHYSICAL PROPERTIES, P453; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; Lee K, 2002, SYNTHETIC MET, V128, P279, DOI 10.1016/S0379-6779(02)00006-1; LEE K, 2004, ENCY NANOSCIENCE NAN, V5, P537; LEE KH, 1993, PHYS REV B, V48, P14884, DOI 10.1103/PhysRevB.48.14884; Lee KH, 1998, ADV MATER, V10, P456, DOI 10.1002/(SICI)1521-4095(199804)10:6<456::AID-ADMA456>3.0.CO;2-M; Lee SH, 2005, ADV FUNCT MATER, V15, P1495, DOI 10.1002/adfm.200400467; MACDIARMID AG, 1995, SYNTHETIC MET, V69, P85, DOI 10.1016/0379-6779(94)02374-8; MOSES D, 1980, SOLID STATE COMMUN, V36, P219, DOI 10.1016/0038-1098(80)90264-1; Mott N.F., 1990, METAL INSULATOR TRAN; Park YW, 1998, SYNTHETIC MET, V96, P81, DOI 10.1016/S0379-6779(98)00078-2; PINES ID, 1966, THEORY QUANTUM LIQUI; REGHU M, 1993, PHYS REV B, V47, P1758, DOI 10.1103/PhysRevB.47.1758; Tzamalis G, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085202; WANG ZH, 1992, PHYS REV B, V45, P4190, DOI 10.1103/PhysRevB.45.4190; Yan H, 2001, MACROMOL MATER ENG, V286, P139, DOI 10.1002/1439-2054(20010301)286:3<139::AID-MAME139>3.3.CO;2-6; YOON CO, 1994, PHYS REV B, V49, P10851, DOI 10.1103/PhysRevB.49.10851; [No title captured]	27	732	754	10	342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					65	68		10.1038/nature04705	http://dx.doi.org/10.1038/nature04705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672965				2022-12-28	WOS:000237248600032
J	Anton, RF; O'Malley, SS; Ciraulo, DA; Cisler, RA; Couper, D; Donovan, DM; Gastfriend, DR; Hosking, JD; Johnson, BA; LoCastro, JS; Longabaugh, R; Mason, BJ; Mattson, ME; Miller, WR; Pettinati, HM; Randall, CL; Swift, R; Weiss, RD; Williams, LD; Zweben, A				Anton, RF; O'Malley, SS; Ciraulo, DA; Cisler, RA; Couper, D; Donovan, DM; Gastfriend, DR; Hosking, JD; Johnson, BA; LoCastro, JS; Longabaugh, R; Mason, BJ; Mattson, ME; Miller, WR; Pettinati, HM; Randall, CL; Swift, R; Weiss, RD; Williams, LD; Zweben, A		COMBINE Study Res Grp	Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; NALTREXONE TREATMENT; RELAPSE PREVENTION; DOUBLE-BLIND; ACAMPROSATE; MAINTENANCE; EFFICACY; ABUSE; INSTRUMENT; THERAPY	Context Alcohol dependence treatment may include medications, behavioral therapies, or both. It is unknown how combining these treatments may impact their effectiveness, especially in the context of primary care and other nonspecialty settings. Objectives To evaluate the efficacy of medication, behavioral therapies, and their combinations for treatment of alcohol dependence and to evaluate placebo effect on overall outcome. Design, Setting, and Participants Randomized controlled trial conducted January 2001-January 2004 among 1383 recently alcohol-abstinent volunteers ( median age, 44 years) from 11 US academic sites with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, diagnoses of primary alcohol dependence. Interventions Eight groups of patients received medical management with 16 weeks of naltrexone ( 100 mg/d) or acamprosate ( 3 g/d), both, and/or both placebos, with or without a combined behavioral intervention ( CBI). A ninth group received CBI only ( no pills). Patients were also evaluated for up to 1 year after treatment. Main Outcome Measures Percent days abstinent from alcohol and time to first heavy drinking day. Results All groups showed substantial reduction in drinking. During treatment, patients receiving naltrexone plus medical management (n= 302), CBI plus medical management and placebos ( n= 305), or both naltrexone and CBI plus medical management ( n= 309) had higher percent days abstinent (80.6, 79.2, and 77.1, respectively) than the 75.1 in those receiving placebos and medical management only ( n= 305), a significant naltrexone x behavioral intervention interaction ( P=. 009). Naltrexone also reduced risk of a heavy drinking day ( hazard ratio, 0.72; 97.5% CI, 0.53-0.98; P=. 02) over time, most evident in those receiving medical management but not CBI. Acamprosate showed no significant effect on drinking vs placebo, either by itself or with any combination of naltrexone, CBI, or both. During treatment, those receiving CBI without pills or medical management ( n= 157) had lower percent days abstinent (66.6) than those receiving placebo plus medical management alone ( n= 153) or placebo plus medical management and CBI ( n= 156) (73.8 and 79.8, respectively; P <. 001). One year after treatment, these between-group effects were similar but no longer significant. Conclusions Patients receiving medical management with naltrexone, CBI, or both fared better on drinking outcomes, whereas acamprosate showed no evidence of efficacy, with or without CBI. No combination produced better efficacy than naltrexone or CBI alone in the presence of medical management. Placebo pills and meeting with a health care professional had a positive effect above that of CBI during treatment. Naltrexone with medical management could be delivered in health care settings, thus serving alcohol-dependent patients who might otherwise not receive treatment.	Med Univ S Carolina, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA; Brown Univ, Roger Williams Med Ctr, Providence, RI 02912 USA; Boston Univ, Sch Med, Vet Affairs Boston Healthcare Syst, Boston, MA 02118 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Washington, Addict Treatment Ctr, Seattle, WA 98195 USA; Univ N Carolina, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; Univ Wisconsin, Milwaukee, WI 53201 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Yale Univ, Sch Med, Subst Abuse Treatment Unit, New Haven, CT USA; Harvard Univ, McLean Hosp, Belmont, MA 02178 USA; Univ Penn, Treatment & Res Ctr, Philadelphia, PA 19104 USA; Univ New Mexico, Ctr Alcoholism Subst Abuse & Addict, Albuquerque, NM 87131 USA; NIAAA, Bethesda, MD USA; Univ Miami, Sch Med, Miami, FL USA	Medical University of South Carolina; Brown University; Roger Williams Medical Center; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Texas System; University of Texas Health San Antonio; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Milwaukee; Boston University; Yale University; Harvard University; McLean Hospital; University of Pennsylvania; University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Miami	Anton, RF (corresponding author), Med Univ S Carolina, Ctr Drug & Alcohol Programs, 67 President St,POB 250861, Charleston, SC 29425 USA.	antonr@musc.edu	Mason, Barbara J/P-6604-2016	Donovan, Dennis/0000-0003-2237-4292; Couper, David/0000-0002-4313-9235; Ciraulo, Domenic/0000-0001-7706-8765	NIAAA NIH HHS [K05AA014715, K05AA00133, K23AA00329, U10AA11715] Funding Source: Medline; NIDA NIH HHS [K02DA00326] Funding Source: Medline; PHS HHS [11756, 11799, 11777, 11787, 11716, 11776, 11727, 11721, 11768, 11773, 11783] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA000133, U10AA011715, K23AA000329, K05AA014715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000326] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anton R, 2003, ALCOHOL CLIN EXP RES, V27, P1107, DOI 10.1097/01.alc.0000086765.46408.64; Anton R, 2003, ALCOHOL CLIN EXP RES, V27, P1123, DOI 10.1097/01.ALC.0000078020.92938.0B; Anton RF, 2003, AM J ADDICTION, V12, pS53, DOI 10.1111/j.1521-0391.2003.tb00496.x; Anton RF, 2002, ALCOHOL CLIN EXP RES, V26, P1215, DOI 10.1097/01.ALC.0000023986.42254.F5; Anton RF, 2001, J CLIN PSYCHOPHARM, V21, P72, DOI 10.1097/00004714-200102000-00013; Anton RF, 1996, ARCH GEN PSYCHIAT, V53, P225; Anton RF, 2001, CLIN CHEM, V47, P1769; AZRIN NH, 1982, J BEHAV THER EXP PSY, V13, P105, DOI 10.1016/0005-7916(82)90050-7; Berglund M, 2003, ALCOHOL CLIN EXP RES, V27, P1645, DOI 10.1097/01.ALC.0000090144.99832.19; Blount A, 1998, INTEGRATED PRIMARY CARE, P1; Carroll KM, 1997, MED CLIN N AM, V81, P927, DOI 10.1016/S0025-7125(05)70556-3; Cisler RA, 1999, ALCOHOL CLIN EXP RES, V23, P263, DOI 10.1111/j.1530-0277.1999.tb04109.x; Committee on Treatment of Alcohol Problems, 1990, BROAD BAS TREATM ALC; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Fiellin DA, 2000, AM J MED, V108, P227, DOI 10.1016/S0002-9343(99)00448-9; Finney JW, 1996, J STUD ALCOHOL, V57, P229, DOI 10.15288/jsa.1996.57.229; First M. B., 1997, STRUCTURED CLIN INTE; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Hanson GR, 2003, JAMA-J AM MED ASSOC, V289, P1031, DOI 10.1001/jama.289.8.1031; Johnson BA, 2005, J STUD ALCOHOL, P157, DOI 10.15288/jsas.2005.s15.157; Johnson BA, 2003, J CLIN PSYCHOPHARM, V23, P281, DOI 10.1097/00004714-200306000-00009; Kadden R., 1995, COGNITIVE BEHAV COPI; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kiefer F, 2004, ALCOHOL ALCOHOLISM, V39, P542, DOI 10.1093/alcalc/agh093; Kiefer F, 2003, ARCH GEN PSYCHIAT, V60, P92, DOI 10.1001/archpsyc.60.1.92; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Kranzler HR, 2001, ALCOHOL CLIN EXP RES, V25, P1335, DOI 10.1097/00000374-200109000-00014; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Latt NC, 2002, MED J AUSTRALIA, V176, P530, DOI 10.5694/j.1326-5377.2002.tb04550.x; LEVINE J, 1986, PSYCHOPHARMACOL BULL, V22, P343; Littleton J, 2003, AM J ADDICTION, V12, pS3, DOI 10.1111/j.1521-0391.2003.tb00492.x; Longabaugh R, 2005, J STUD ALCOHOL, P179, DOI 10.15288/jsas.2005.s15.179; Mann K, 2004, ALCOHOL CLIN EXP RES, V28, P51, DOI 10.1097/01.ALC.0000108656.81563.05; Mason B J, 2000, CNS Spectr, V5, P58; Mason BJ, 2005, J STUD ALCOHOL, P148, DOI 10.15288/jsas.2005.s15.148; Mason BJ, 2003, EUR NEUROPSYCHOPHARM, V13, P469, DOI 10.1016/j.euroneuro.2003.08.009; Mason BJ, 2001, J CLIN PSYCHIAT, V62, P42; MASON BJ, IN PRESS J PSYCHIAT; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Meyers R.J., 1995, CLIN GUIDE ALCOHOL T; Miller W., 1994, MOTIVATIONAL ENHANCE; Miller W., 2004, COMBINED BEHAV INTER; Miller W., 1996, FORM 90 STRUCTURED A; Miller WR, 2001, J STUD ALCOHOL, V62, P211, DOI 10.15288/jsa.2001.62.211; Miller WR, 2005, J STUD ALCOHOL, P188, DOI 10.15288/jsas.2005.s15.188; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; MILLER WR, 1991, BRIT J ADDICT, V86, P43; Miller WR, 1995, DRINKER INVENTORY CO; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nowinski J, 1995, 12 STEP FACILITATION; O'Malley SS, 2003, ARCH INTERN MED, V163, P1695, DOI 10.1001/archinte.163.14.1695; OMalley SS, 1996, ALCOHOL CLIN EXP RES, V20, pA17, DOI 10.1111/j.1530-0277.1996.tb01185.x; Pettinati H. M., 2004, MED MANAGEMENT MM TR; Pettinati HM, 2005, J STUD ALCOHOL, P170, DOI 10.15288/jsas.2005.s15.170; PETTINATI HM, 2005, COMBINE STUDY CONCEP; Roberts JS, 1999, ALCOHOL CLIN EXP RES, V23, P1484, DOI 10.1111/j.1530-0277.1999.tb04671.x; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Streeton C, 2001, ALCOHOL ALCOHOLISM, V36, P544, DOI 10.1093/alcalc/36.6.544; Swift R, 2005, J STUD ALCOHOL, P141, DOI 10.15288/jsas.2005.s15.141; Thomsen OO, 1998, NEW ENGL J MED, V339, P370, DOI 10.1056/NEJM199808063390603; Tonigan JS, 1997, J STUD ALCOHOL, V58, P358, DOI 10.15288/jsa.1997.58.358; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Willenbring ML, 1999, ARCH INTERN MED, V159, P1946, DOI 10.1001/archinte.159.16.1946	68	1203	1222	1	104	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2003	2017		10.1001/jama.295.17.2003	http://dx.doi.org/10.1001/jama.295.17.2003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038MF	16670409	Bronze			2022-12-28	WOS:000237225100017
J	Biau, DJ; Tournoux, C; Katsahian, S; Schranz, PJ; Nizard, RS				Biau, DJ; Tournoux, C; Katsahian, S; Schranz, PJ; Nizard, RS			Bone-patellar tendon-bone autografts versus hamstring autografts for reconstruction of anterior cruciate ligament: meta-analysis	BRITISH MEDICAL JOURNAL			English	Article							2-YEAR FOLLOW-UP; ACL RECONSTRUCTION; GRACILIS TENDONS; SITE MORBIDITY; GRAFT TENSION; KNEE PAIN; SEMITENDINOSUS; ARTHROFIBROSIS; SURGERY; TRIAL	Objectives To compare bone-patellar tendon-bone autografts with hamstring autografts for reconstruction of the anterior cruciate ligament. Data sources Medline, WebSPIRS, Science Citation Index. Current Contents databases, and Cochrane Central Register of Controlled Trials. Review methods All randomised controlled trials reporting one or more outcome related to stability (instrumented measurement of knee laxity, Lachman test, or pivot shift test) and Morbidity (anterior knee pain, kneeling test, loss of extension, or graft. failure). Study quality was assessed by using a 5 point scale. Random effect models were used to pool the data. Heterogeneity in the effect of treatment was tested on the basis of study quality, randomisation status, and number of tendon strands used. Results 24 trials of 18 cohorts (1512 patients) met the inclusion criteria. study quality was poor for nine studies and Fair for nine studies. The weighted mean difference of die instrumented measurement of knee laxity was 0.36 (95% confidence interval 0.01 to 0.71 P=0.04). Relative risk of a positive Lachman test was 1.22 (1.01 to 1.47; P= 0.04), of anterior knee pain 0.57 (0.44 to 0.74; P < 0.0001), of a positive kneeling test 0.26 (0.14 to 0.48; P < 0.0001), and of loss of extension 0.52 (0.34 to 0.80; P = 0.003). Other results were not significant. Conclusion Morbidity was lower for hamstring autografts than for patellar tendon autografts. Evidence that patellar tendon autografts offer better stability was weak. The poor quality of the studies calls into question the robustness of the analyses.	Hop Cochin, Assistance Publ Hop Paris, Cerv Chirurg Orthoped & Traumatol, F-75679 Paris, France; Hop St Louis, Assistance Publ Hop Paris, Dept Biostat & Informat Med, F-75475 Paris, France; Hop Lariboisiere, Assistance Publ Hop Paris, Serv Chirurg Orthoped & Traumatol, F-75010 Paris, France; Royal Devon & Exeter Hosp, Princess Elizabeth Orthopaed Ctr, Exeter EX2 5DW, Devon, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Exeter	Biau, DJ (corresponding author), Hop Cochin, Assistance Publ Hop Paris, Cerv Chirurg Orthoped & Traumatol, F-75679 Paris, France.	djmbiau@yahoo.fr	Nizard, Remy/R-5845-2019; BIAU, DAVID/P-5355-2016	KATSAHIAN, Sandrine/0000-0002-7261-0671				Aglietti P, 1997, J SPORT TRAUMATOL, V19, P57; Aglietti P, 2004, J BONE JOINT SURG AM, V86A, P2143, DOI 10.2106/00004623-200410000-00004; AGLIETTI P, 1994, AM J SPORT MED, V22, P211, DOI 10.1177/036354659402200210; *AM AC ORTH SURG, 2005, REP ANT CIRC LIG; ANDERSON AF, 2001, AM J SPORTS MED, V29; Arnold MR, 2005, AM J SPORT MED, V33, P536, DOI 10.1177/0363546504269938; Aune AK, 2001, AM J SPORT MED, V29, P722, DOI 10.1177/03635465010290060901; Beard DJ, 2001, KNEE, V8, P45, DOI 10.1016/S0968-0160(01)00062-X; Beynnon BD, 2002, J BONE JOINT SURG AM, V84A, P1503, DOI 10.2106/00004623-200209000-00001; Bosch U, 2001, KNEE SURG SPORT TR A, V9, P282, DOI 10.1007/s001670100218; *BRIT ORTH ASS, ACL REC BEST PRACT; BYNUM EB, 1995, AM J SPORT MED, V23, P401, DOI 10.1177/036354659502300405; Callaway GH, 1994, ORTHOP T, V18, P1017; Carter TR, 1999, ARTHROSCOPY, V15, P169, DOI 10.1053/ar.1999.v15.0150161; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Ejerhed L, 2003, AM J SPORT MED, V31, P19, DOI 10.1177/03635465030310011401; Eriksson K, 2001, J BONE JOINT SURG BR, V83B, P348, DOI 10.1302/0301-620X.83B3.11685; Eriksson K, 2001, SCAND J MED SCI SPOR, V11, P170, DOI 10.1034/j.1600-0838.2001.110307.x; Feller JA, 2003, AM J SPORT MED, V31, P564, DOI 10.1177/03635465030310041501; Feller JA, 2001, KNEE SURG SPORT TR A, V9, P260, DOI 10.1007/s001670100216; FELLER JA, 2001, SPROTS MED ODISSEY C; Fithian DC, 2002, ORTHOP CLIN N AM, V33, P621, DOI 10.1016/S0030-5898(02)00015-9; Fleming BC, 2001, J ORTHOPAED RES, V19, P841, DOI 10.1016/S0736-0266(01)00020-1; Forster MC, 2005, KNEE, V12, P225, DOI 10.1016/j.knee.2004.06.008; Francis A, 2001, KNEE, V8, P13, DOI 10.1016/S0968-0160(00)00073-9; Gobbi A, 2003, ARTHROSCOPY, V19, P592, DOI 10.1016/S0749-8063(03)00393-1; HANTES M, 2004, 11 ESSKA 2000 C 4 WO, P128; Ibrahim SAR, 2005, ARTHROSCOPY, V21, P412, DOI 10.1016/j.arthro.2004.12.002; Jansson KA, 2003, AM J SPORT MED, V31, P12, DOI 10.1177/03635465030310010501; Jarvela T, 2001, AM J SPORT MED, V29, P18; JONES KG, 1970, J BONE JOINT SURG AM, VA 52, P838; Jonsson H, 2004, ACTA ORTHOP SCAND, V75, P594, DOI 10.1080/00016470410001484; Kartus J, 1999, KNEE SURG SPORT TR A, V7, P2, DOI 10.1007/s001670050112; Laxdal G, 2005, ARTHROSCOPY, V21, P34, DOI 10.1016/j.arthro.2004.09.014; LIPSCOMB AB, 1981, AM J SPORT MED, V9, P77; LYMAN CH, 2005, BMC MED RES METHODOL, V5, P14; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Malanga GA, 2003, ARCH PHYS MED REHAB, V84, P592, DOI 10.1053/apmr.2003.50026; MARDER RA, 1991, AM J SPORT MED, V19, P478, DOI 10.1177/036354659101900510; Marx RG, 2003, ARTHROSCOPY, V19, P762, DOI 10.1016/S0749-8063(03)00398-0; Mastrokalos DS, 2005, AM J SPORT MED, V33, P85, DOI 10.1177/0363546504265926; Mayr HO, 2004, ARCH ORTHOP TRAUM SU, V124, P518, DOI 10.1007/s00402-004-0718-x; Mikkelsen C, 2003, KNEE SURG SPORT TR A, V11, P318, DOI 10.1007/s00167-003-0406-3; MIYASAKA KC, 1991, AM J KNEE SURG, V4, P9; Nicholas SJ, 2004, AM J SPORT MED, V32, P1881, DOI 10.1177/0363546504265924; Nichols CG, 2004, ADV MOL CEL, V32, P1; Noyes FR, 2000, KNEE SURG SPORT TR A, V8, P196, DOI 10.1007/s001670000126; O'Neill DB, 2001, J BONE JOINT SURG AM, V83A, P1329, DOI 10.2106/00004623-200109000-00006; ONEILL DB, 1996, J BONE JOINT SURG AM, V78; *RIT ORTH ASS, ACL REC BEST PRACT; Ropke M, 2001, UNFALLCHIRURG, V104, P312, DOI 10.1007/s001130050733; RUBINSTEIN RA, 1994, AM J SPORT MED, V22, P324, DOI 10.1177/036354659402200305; Shaieb MD, 2002, AM J SPORT MED, V30, P214, DOI 10.1177/03635465020300021201; Shelbourne KD, 1997, AM J SPORT MED, V25, P41, DOI 10.1177/036354659702500108; Sherman OH, 2004, ARTHROSCOPY, V20, P974, DOI 10.1016/j.arthro.2004.08.001; Tomita F, 2001, ARTHROSCOPY, V17, P461, DOI 10.1053/jars.2001.24059; Tsuda E, 2001, AM J SPORT MED, V29, P450, DOI 10.1177/03635465010290041201; Webster KE, 2001, KNEE SURG SPORT TR A, V9, P86, DOI 10.1007/s001670100191; Yunes M, 2001, ARTHROSCOPY, V17, P248, DOI 10.1053/jars.2001.21242	59	179	194	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 29	2006	332	7548					995	998		10.1136/bmj.38784.384109.2F	http://dx.doi.org/10.1136/bmj.38784.384109.2F			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16603564	Green Published, Bronze			2022-12-28	WOS:000237403100013
J	Hu, EM; Cowie, LL				Hu, EM; Cowie, LL			High-redshift galaxy populations	NATURE			English	Review							LY-ALPHA EMITTERS; ULTRAVIOLET LUMINOSITY DENSITY; LYMAN-BREAK GALAXIES; PROBE WMAP OBSERVATIONS; STAR-FORMING GALAXIES; GUNN-PETERSON TROUGH; DIGITAL SKY SURVEY; HUBBLE DEEP FIELD; INTERGALACTIC MEDIUM; DROPOUT GALAXIES	We now see many galaxies as they were only 800 million years after the Big Bang, and that limit may soon be exceeded when wide-field infrared detectors are widely available. Multi-wavelength studies show that there was relatively little star formation at very early times and that star formation was at its maximum at about half the age of the Universe. A small number of high-redshift objects have been found by targeting X-ray and radio sources and most recently, gamma-ray bursts. The gamma-ray burst sources may provide a way to reach even higher-redshift galaxies in the future, and to probe the first generation of stars.	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	University of Hawaii System	Hu, EM (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	hu@ifa.hawaii.edu		Cowie, Lennox/0000-0002-6319-1575				Ajiki M, 2002, ASTROPHYS J, V576, pL25, DOI 10.1086/343026; Barger A. J., 2003, APJ, V584, P61; Barger AJ, 2000, ASTRON J, V119, P2092, DOI 10.1086/301341; Barger AJ, 1998, NATURE, V394, P248, DOI 10.1038/28338; Barkana R, 2004, ASTROPHYS J, V609, P474, DOI 10.1086/421079; Becker RH, 2001, ASTRON J, V122, P2850, DOI 10.1086/324231; BLAIN AW, 1993, MON NOT R ASTRON SOC, V264, P509, DOI 10.1093/mnras/264.2.509; Bouwens R, 2006, NEW ASTRON REV, V50, P152, DOI 10.1016/j.newar.2005.11.027; Bouwens R, 2003, ASTROPHYS J, V593, P640, DOI 10.1086/376588; BOUWENS R, IN PRESS ASTROPHYS J; Bouwens RJ, 2004, ASTROPHYS J, V616, pL79, DOI 10.1086/426503; Bremer MN, 2004, ASTROPHYS J, V615, pL1, DOI 10.1086/426019; Bromm V, 2002, ASTROPHYS J, V575, P111, DOI 10.1086/341189; BROMM V, IN PRESS ASTROPHYS J; Bunker A, 2006, NEW ASTRON REV, V50, P94, DOI 10.1016/j.newar.2005.11.006; Bunker AJ, 2003, MON NOT R ASTRON SOC, V342, pL47, DOI 10.1046/j.1365-8711.2003.06664.x; Bunker AJ, 2004, MON NOT R ASTRON SOC, V355, P374, DOI 10.1111/j.1365-2966.2004.08326.x; Cen RY, 2003, ASTROPHYS J, V591, P12, DOI 10.1086/375217; Chary RR, 2005, ASTROPHYS J, V635, pL5, DOI 10.1086/499205; Cole S, 2001, MON NOT R ASTRON SOC, V326, P255, DOI 10.1046/j.1365-8711.2001.04591.x; Cowie LL, 1998, ASTRON J, V115, P1319, DOI 10.1086/300309; Cuby JG, 2003, ASTRON ASTROPHYS, V405, pL19, DOI 10.1051/0004-6361:20030760; DEY A, 1998, APJ, V498, P93; Dickinson M, 2004, ASTROPHYS J, V600, pL99, DOI 10.1086/381119; Dickinson M, 2003, ESO ASTROPHY SYMP, P324, DOI 10.1007/10899892_78; Egami E, 2005, ASTROPHYS J, V618, pL5, DOI 10.1086/427550; Ellis R, 2001, ASTROPHYS J, V560, pL119, DOI 10.1086/324423; FAN X, ASTROPH0512082; Fan XH, 2002, ASTRON J, V123, P1247, DOI 10.1086/339030; Fan XH, 2001, ASTRON J, V122, P2833, DOI 10.1086/324111; Fan XH, 2003, ASTRON J, V125, P1649, DOI 10.1086/368246; Furlanetto SR, 2006, MON NOT R ASTRON SOC, V365, P1012, DOI 10.1111/j.1365-2966.2005.09785.x; GUNN JE, 1965, ASTROPHYS J, V142, P1633, DOI 10.1086/148444; Haiman Z, 1999, ASTROPHYS J, V518, P138, DOI 10.1086/307276; Haiman Z, 2002, ASTROPHYS J, V576, pL1, DOI 10.1086/343101; Hu EM, 1996, NATURE, V382, P231, DOI 10.1038/382231a0; Hu EM, 1999, ASTROPHYS J, V522, pL9, DOI 10.1086/312205; Hu EM, 2004, ASTRON J, V127, P563, DOI 10.1086/381302; Hu EM, 2002, ASTROPHYS J, V568, pL75, DOI 10.1086/340424; Hu EM, 1996, ASTROPHYS J, V459, pL53, DOI 10.1086/309958; HU EM, 2005, PROBING GALAXIES QUA, P363; HU EM, UNPUB ASTRON J; HU EM, 1998, ASTROPHYS J LETT, V502, P99; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Iwata I, 2003, PUBL ASTRON SOC JPN, V55, P415, DOI 10.1093/pasj/55.2.415; KAWAI N, IN PRESS NATURE; Kneib JP, 2004, ASTROPHYS J, V607, P697, DOI 10.1086/386281; Kodaira K, 2003, PUBL ASTRON SOC JPN, V55, pL17, DOI 10.1093/pasj/55.2.L17; Kogut A, 2003, ASTROPHYS J SUPPL S, V148, P161, DOI 10.1086/377219; Kurk JD, 2004, ASTRON ASTROPHYS, V422, pL13, DOI 10.1051/0004-6361:20040189; Loeb A, 1999, ASTROPHYS J, V524, P527, DOI 10.1086/307844; Malhotra S, 2005, ASTROPHYS J, V626, P666, DOI 10.1086/430047; Malhotra S, 2004, ASTROPHYS J, V617, pL5, DOI 10.1086/427182; MALHOTRA S, 2006, ASTROPH0511196; Manchester RN, 2005, ASTROPHYS J, V621, pL49, DOI 10.1086/429128; Miralda-Escude J, 1998, ASTROPHYS J, V501, P15, DOI 10.1086/305799; Miralda-Escude J, 1998, ASTROPHYS J, V497, P21, DOI 10.1086/305458; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833, DOI 10.1093/pasj/54.6.833; Mobasher B, 2005, ASTROPHYS J, V635, P832, DOI 10.1086/497626; Nagao T, 2005, ASTROPHYS J, V634, P142, DOI 10.1086/496956; Nagao T, 2004, ASTROPHYS J, V613, pL9, DOI 10.1086/424965; Ouchi M, 2005, ASTROPHYS J, V620, pL1, DOI 10.1086/428499; Pello R, 2004, ASTRON ASTROPHYS, V416, pL35, DOI 10.1051/0004-6361:20040065; Rhoads JE, 2004, ASTROPHYS J, V611, P59, DOI 10.1086/422094; Rhoads JE, 2003, ASTRON J, V125, P1006, DOI 10.1086/346272; Rhoads JE, 2000, ASTROPHYS J, V545, pL85, DOI 10.1086/317874; Santos MR, 2004, ASTROPHYS J, V606, P683, DOI 10.1086/383080; Schaerer D, 2003, ASTRON ASTROPHYS, V397, P527, DOI 10.1051/0004-6361:20021525; Schiminovich D, 2005, ASTROPHYS J, V619, pL47, DOI 10.1086/427077; Shimasaku K, 2004, ASTROPHYS J, V605, pL93, DOI 10.1086/420921; Shimasaku K, 2003, ASTROPHYS J, V586, pL111, DOI 10.1086/374880; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Songaila A, 2004, ASTRON J, V127, P2598, DOI 10.1086/383561; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; SPERGEL DN, 2006, ASTROPH0603449, P43502; Spinrad H, 2004, ASTROPHYSICS UPDATE: TOPICAL AND TIMELY REVIEWS ON ASTROPHYSICS, P155; Spinrad H, 2005, S-P B ASTRON PLANET, P1, DOI 10.1007/3-540-29007-9; Stanway ER, 2004, ASTROPHYS J, V604, pL13, DOI 10.1086/383523; Stanway ER, 2004, ASTROPHYS J, V607, P704, DOI 10.1086/383531; Stanway ER, 2003, MON NOT R ASTRON SOC, V342, P439, DOI 10.1046/j.1365-8711.2003.06546.x; Steffen AT, 2004, ASTRON J, V128, P1483, DOI 10.1086/423998; Steidel CC, 1999, ASTROPHYS J, V519, P1, DOI 10.1086/307363; Steidel CC, 2000, ASTROPHYS J, V532, P170, DOI 10.1086/308568; Stern D, 2005, ASTROPHYS J, V619, P12, DOI 10.1086/426423; Stiavelli M, 2004, ASTROPHYS J, V600, P508, DOI 10.1086/380110; Taniguchi Y, 2005, PUBL ASTRON SOC JPN, V57, P165, DOI 10.1093/pasj/57.1.165; TANIGUCHI Y, 2003, APJ, V585, P97; Treyer MA, 1998, MON NOT R ASTRON SOC, V300, P303, DOI 10.1046/j.1365-8711.1998.01909.x; van Breugel W, 1999, ASTROPHYS J, V518, pL61, DOI 10.1086/312080; Walter F, 2003, NATURE, V424, P406, DOI 10.1038/nature01821; WANG WH, IN PRESS ASTROPHYS J; Weatherley SJ, 2004, ASTRON ASTROPHYS, V428, pL29, DOI 10.1051/0004-6361:200400099; WEYMANN RJ, 1998, APJ, V505, P95; Willis JP, 2005, MON NOT R ASTRON SOC, V357, P1348, DOI 10.1111/j.1365-2966.2005.08755.x; Wilson G, 2002, ASTRON J, V124, P1258, DOI 10.1086/341818; Wyder TK, 2005, ASTROPHYS J, V619, pL15, DOI 10.1086/424735; Wyithe JSB, 2005, ASTROPHYS J, V625, P1, DOI 10.1086/429529; WYITHE JSB, IN PRESS ASTROPHYS J; Yan HJ, 2005, ASTROPHYS J, V634, P109, DOI 10.1086/491695; Yan HJ, 2004, ASTROPHYS J, V612, pL93, DOI 10.1086/424690	102	39	39	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1145	1150		10.1038/nature04806	http://dx.doi.org/10.1038/nature04806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641986				2022-12-28	WOS:000237080000035
J	Woywodt, A; Haubitz, M; Haller, H; Matteson, EL				Woywodt, A; Haubitz, M; Haller, H; Matteson, EL			Wegener's granulomatosis	LANCET			English	Article							NODOSA	A 63-year-old man presented with a 6-month history of recurrent epistaxis, impaired hearing, arthralgia, and constitutional symptoms. He had had a productive cough with scanty streaks of blood in his sputum, and deterioration of hearing. These symptoms were followed by muscle weakness in his finger flexors with acral paraesthesiae. The past medical history was unremarkable and he was not on any medication. On examination, the patient was pale but had no skin lesions or signs of arthritis; the chest was clear on auscultation. Laboratory tests revealed a serum haemoglobin concentration of 6.7 m mol/L (typical range 8.38-10.55 m mol/L) and serum creatinine concentration of 187 mu mol/L (59-104 mu mol/L). Dipstick testing of his urine was strongly positive for haemoglobin and protein, and phase contrast microscopy of a freshly voided sample showed many erythrocyte casts and dysmorphic erythrocytes. Chest radiograph revealed round shadows in both lung fields and a CT scan confirmed bilateral non-cavitating nodules. The nasal mucosa was moderately inflamed and the biopsy sample revealed necrotising granulomatous inflammation. Examination of the ear showed tympanic effusion. Neurological examination and nerve-conduction studies were consistent with mononeuritis multiplex. An immunofluorescence assay for anti neutrophil cytoplasmic antibodies was positive with a cytoplasmic fluorescence pattern, and proteinase-3 antibodies were high in an enzyme-linked immunoassay. Renal biopsy confirmed pauci-immune crescentic glomerulonephritis. A diagnosis of Wegeners granulomatosis with involvement of middle ear, nose, lungs, kidneys, and peripheral nervous system was made. He was treated with high-dose intravenous methylprednisolone (500 mg daily for 3 days), then by monthly pulses of intravenous cyclophosphamide (starting with 750 mg/m(2), later adjusted to leucocyte nadir), and tapering doses of corticosteroids (starting at 1 mg/kg). All pulmonary lesions had resolved within 6 months, and the urinanalysis had returned to normal, with serum creatinine of 96 mu mol/L.	Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany; Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN USA	Hannover Medical School; Mayo Clinic	Woywodt, A (corresponding author), Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany.	Woywodt.Alexander@MH-Hannover.de	Woywodt, Alexander/ABD-2711-2020	Woywodt, Alexander/0000-0002-3825-6955				[Anonymous], 1852, DENKSCHR KAIS AKAD W, V4, P1; BROWNING CR, 1988, HOLOCAUST GENOCIDE S, V3, P21, DOI 10.1093/hgs/3.1.21; *BUND ARCH BERL, 1938, 60 BUND ARCH BERL; DEREMEE RA, 1993, ADV EXP MED BIOL, V336, P1; FAUCI AS, 1971, NEW ENGL J MED, V285, P1493, DOI 10.1056/NEJM197112302852701; Ferrari E, 1903, BEITR PATHOL ANAT AL, V34, P350; Gaskin G, 1998, OXFORD TXB CLIN NEPH; GODMAN GC, 1954, AMA ARCH PATHOL, V58, P533; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; KERSHAW I, 1991, T R HIST SOC, V6, P51; KLEE E, 1985, DOCUMENTS REGARDING, P72; KLEE E, 1987, WHAT THEY DID WHAT B, P218; Klinger H, 1931, FRANKFURT Z PATHOL, V42, P455; Kussmaul A, 1866, DTSCH ARCH KLIN MED, P484; LAMPERT U, 1991, THESIS K MARX U LEIP; MITSCHERLICH A, 1987, MED HUMANITY DOCUMEN; SCHMIDT S, 1993, F WEGENER; STAEMMLER M, 1933, NURTURE RACE NATL ET; VANDERWOUDE FJ, 1985, LANCET, V1, P425; WEGENER E, 1941, MONTHLY REPORT, P85; WEGENER F, 1990, EUR ARCH OTO-RHINO-L, V247, P133; WEGENER F, 1941, MUNICIPAL HLTH AUTHO; WEGENER F, 1939, COMMUNICATION, P57; WEGENER F, 1947, COMMUNICATION, P7; WEGENER F, 1944, LETTER ENTITLED LITZ; Wegener F, 1936, VERHANDLUNGEN DTSCH, V29, P202; WEGENER F, 1939, BEITR PATHOL ANAT, V102, P30; WEGENER F, 1967, TXB PATHOLOGICAL ANA, P225; Wiesel E, 2005, NEW ENGL J MED, V352, P1511, DOI 10.1056/NEJMp058069; Wohlwill F, 1923, VIRCHOWS ARCH A, V246, P377, DOI 10.1007/BF01947911	30	75	79	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 22	2006	367	9519					1362	1366		10.1016/S0140-6736(06)68583-8	http://dx.doi.org/10.1016/S0140-6736(06)68583-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631915				2022-12-28	WOS:000237118500031
J	Kuiken, T; Holmes, EC; McCauley, J; Rimmelzwaan, GF; Williams, CS; Grenfell, BT				Kuiken, T; Holmes, EC; McCauley, J; Rimmelzwaan, GF; Williams, CS; Grenfell, BT			Host species barriers to influenza virus infections	SCIENCE			English	Editorial Material							H5N1 INFECTION; DISEASE; FITNESS; EPIDEMIOLOGY; DETERMINANTS; TRANSMISSION; EVOLUTION; VIRULENCE; DYNAMICS; IMMUNITY		Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Inst Anim Hlth, Comp Lab, Newbury RG20 7NN, Berks, England; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Kuiken, T (corresponding author), Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019	Holmes, Edward/0000-0001-9596-3552; Kuiken, Thijs/0000-0001-5501-9049				ANDERSON R M, 1991; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MURPHY BR, 1996, FIELDS VIROLOGY, V1, pCH46; Olofsson S, 2005, LANCET INFECT DIS, V5, P184, DOI 10.1016/S1473-3099(05)01311-3; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Slingenbergh J, 2004, REV SCI TECH OIE, V23, P467, DOI 10.20506/rst.23.2.1492; SMITH H, 1988, REV INFECT DIS, V10, P56; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x	38	286	306	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					394	397		10.1126/science.1122818	http://dx.doi.org/10.1126/science.1122818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627737				2022-12-28	WOS:000236941800038
J	Chosidow, O				Chosidow, O			Scabies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VIVO DETECTION; SARCOPTES-SCABIEI; PERMETHRIN CREAM; VAR HOMINIS; IVERMECTIN; LINDANE; VITRO; EFFICACY; CHILDREN; SAFETY		Univ Paris 06, Paris, France; Hop Tenon, Assistance Publ Hop Paris, Dept Dermatol & Allergy, F-75970 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Chosidow, O (corresponding author), Hop Tenon, Dept Dermatol & Allergy, 4 Rue Chine, F-75970 Paris 20, France.	chosidow@tnn.aphp.fr	Strong, Mark/A-4638-2010					[Anonymous], SEX TRANSM DIS TREAT; Argenziano G, 1997, ARCH DERMATOL, V133, P751, DOI 10.1001/archderm.133.6.751; ARLIAN LG, 1988, J AM ACAD DERMATOL, V19, P806, DOI 10.1016/S0190-9622(88)70237-6; ARLIAN LG, 1984, J AM ACAD DERMATOL, V11, P210, DOI 10.1016/S0190-9622(84)70151-4; Barkwell R, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63020-6; Bhalla M, 2004, PEDIATR DERMATOL, V21, P597, DOI 10.1111/j.0736-8046.2004.21515.x; Bigby M, 2000, ARCH DERMATOL, V136, P387, DOI 10.1001/archderm.136.3.387; Brooks PA, 2002, J PAEDIATR CHILD H, V38, P401, DOI 10.1046/j.1440-1754.2002.00015.x; Burkhart CG, 2001, J AM ACAD DERMATOL, V45, P637, DOI 10.1067/mjd.2001.113454; Centers for Disease Control and Prevention, 2005, SCAB FACT SHEET; Chosidow O, 2000, LANCET, V355, P819, DOI 10.1016/S0140-6736(99)09458-1; Chouela EN, 1999, ARCH DERMATOL, V135, P651, DOI 10.1001/archderm.135.6.651; Currie BJ, 2004, CLIN INFECT DIS, V39, pE8, DOI 10.1086/421776; del Giudice P, 1999, ARCH DERMATOL, V135, P351, DOI 10.1001/archderm.135.3.351; del Giudice Pascal, 2003, J Drugs Dermatol, V2, P13; Downs AMR, 1999, EPIDEMIOL INFECT, V122, P471, DOI 10.1017/S0950268899002277; Elston DM, 2002, J AM ACAD DERMATOL, V46, P794, DOI 10.1067/mjd.2002.121027; FALK ES, 1981, INT J DERMATOL, V20, P600, DOI 10.1111/j.1365-4362.1981.tb00844.x; Franz TJ, 1996, ARCH DERMATOL, V132, P901, DOI 10.1001/archderm.132.8.901; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; Macotela-Ruiz E, 1993, Gac Med Mex, V129, P201; Mahe A, 2005, T ROY SOC TROP MED H, V99, P39, DOI 10.1016/j.trstmh.2004.03.008; Meinking TL, 1996, ARCH DERMATOL, V132, P959, DOI 10.1001/archderm.132.8.959; MEINKING TL, 1995, NEW ENGL J MED, V333, P26, DOI 10.1056/NEJM199507063330105; ORKIN M, 1995, CURR PROBL DERMATOL, V22, P105; Otero L, 2004, SEX TRANSM DIS, V31, P761, DOI 10.1097/01.olq.0000145853.35574.18; Prins C, 2004, DERMATOLOGY, V208, P241, DOI 10.1159/000077310; Roulet A, 2003, EUR J PHARMACOL, V460, P85, DOI 10.1016/S0014-2999(02)02955-2; SCHULTZ MW, 1990, ARCH DERMATOL, V126, P167, DOI 10.1001/archderm.126.2.167; TAPLIN D, 1990, PEDIATR DERMATOL, V7, P67, DOI 10.1111/j.1525-1470.1990.tb01078.x; Usha V, 2000, J AM ACAD DERMATOL, V42, P236, DOI 10.1016/S0190-9622(00)90131-2; Walker G.J.A., 2000, COCHRANE DB SYST REV, V3; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 2000, T ROY SOC TROP MED H, V94, P92, DOI 10.1016/S0035-9203(00)90454-1; Walton SF, 1999, CLIN INFECT DIS, V29, P1226, DOI 10.1086/313466; Walton SF, 2004, ARCH DERMATOL, V140, P563, DOI 10.1001/archderm.140.5.563; 1999, SEX TRANSM INFECT S1, V75, pS76	38	279	292	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1718	1727		10.1056/NEJMcp052784	http://dx.doi.org/10.1056/NEJMcp052784			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16625010				2022-12-28	WOS:000236893900008
J	Freedman, SB; Adler, M; Seshadri, R; Powell, EC				Freedman, SB; Adler, M; Seshadri, R; Powell, EC			Oral ondansetron for gastroenteritis in a pediatric emergency department	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIAL; CHILDREN; DEHYDRATION; PROCHLORPERAZINE; PROMETHAZINE; REHYDRATION; PARAMETERS; THERAPY; NAUSEA; SIGNS	BACKGROUND: Vomiting limits the success of oral rehydration in children with gastroenteritis. We conducted a double-blind trial to determine whether a single oral dose of ondansetron, an antiemetic, would improve outcomes in children with gastroenteritis. METHODS: We enrolled 215 children 6 months through 10 years of age who were treated in a pediatric emergency department for gastroenteritis and dehydration. After being randomly assigned to treatment with orally disintegrating ondansetron tablets or placebo, the children received oral-rehydration therapy according to a standardized protocol. The primary outcome was the proportion who vomited while receiving oral rehydration. The secondary outcomes were the number of episodes of vomiting and the proportions who were treated with intravenous rehydration or hospitalized. RESULTS: As compared with children who received placebo, children who received ondansetron were less likely to vomit (14 percent vs. 35 percent; relative risk, 0.40; 95 percent confidence interval, 0.26 to 0.61), vomited less often (mean number of episodes per child, 0.18 vs. 0.65; P<0.001), had greater oral intake (239 ml vs. 196 ml, P=0.001), and were less likely to be treated by intravenous rehydration (14 percent vs. 31 percent; relative risk, 0.46; 95 percent confidence interval, 0.26 to 0.79). Although the mean length of stay in the emergency department was reduced by 12 percent in the ondansetron group, as compared with the placebo group (P=0.02), the rates of hospitalization (4 percent and 5 percent, respectively; P=1.00) and of return visits to the emergency department (19 percent and 22 percent, P=0.73) did not differ significantly between groups. CONCLUSIONS: In children with gastroenteritis and dehydration, a single dose of oral ondansetron reduces vomiting and facilitates oral rehydration and may thus be well suited for use in the emergency department.	Univ Toronto, Hosp Sick Children, Div Pediat Emergency Med, Toronto, ON M5G 1X8, Canada; Childrens Mem Hosp, Childrens Mem Res Ctr, Div Pediat Emergency Med, Chicago, IL 60614 USA; Childrens Mem Hosp, Childrens Mem Res Ctr, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Freedman, SB (corresponding author), Univ Toronto, Hosp Sick Children, Div Pediat Emergency Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	stephen.freedman@sickkids.ca	; Freedman, Stephen/H-9102-2012	Adler, Mark/0000-0003-1857-8639; Freedman, Stephen/0000-0003-2319-6192; Powell, Elizabeth/0000-0003-3147-9889	NCRR NIH HHS [M01 RR-00048] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000048] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Behrman RE, 2004, NELSON TXB PEDIAT, V17th; Chan-Tack KM, 1999, SOUTHERN MED J, V92, P1017, DOI 10.1097/00007611-199910000-00015; DAVIGNON A, 1980, PEDIATR CARDIOL, V1, P123, DOI 10.1007/BF02083144; DeGrandi T, 1987, Pediatr Emerg Care, V3, P91, DOI 10.1097/00006565-198706000-00007; Drotts DL, 1999, ANN EMERG MED, V34, P469, DOI 10.1016/S0196-0644(99)80048-1; Duggan C, 1996, J PEDIATR GASTR NUTR, V22, P56, DOI 10.1097/00005176-199601000-00009; Ernst AA, 2000, ANN EMERG MED, V36, P89, DOI 10.1067/mem.2000.108652; Freedman SB, 2004, PEDIATR EMERG CARE, V20, P625, DOI 10.1097/01.pec.0000139748.61838.ad; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Frifdman JN, 2004, J PEDIATR-US, V145, P201, DOI 10.1016/j.jpeds.2004.05.035; GINSBURG CM, 1980, J PEDIATR-US, V96, P767, DOI 10.1016/S0022-3476(80)80764-5; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; LANG TA, 1997, REPORT STAT MED ANNO; Li STT, 2003, ARCH PEDIAT ADOL MED, V157, P475, DOI 10.1001/archpedi.157.5.475; MACKENZIE A, 1989, LANCET, V2, P605; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MCMILLAN JA, 1999, OSKIS PEDIAT PRINCIP; Ozuah PO, 2002, PEDIATRICS, V109, P259, DOI 10.1542/peds.109.2.259; Ramsook C, 2002, ANN EMERG MED, V39, P397, DOI 10.1067/mem.2002.122706; Reeves JJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e62; REIS EC, 1994, PEDIATRICS, V93, P708; Rudolph CD, 2002, RUDOLPHS PEDIAT; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; Vega RM, 1997, PEDIATR EMERG CARE, V13, P179, DOI 10.1097/00006565-199706000-00001; World Health Organization, 2005, TREATM DIARRH MAN PH	26	157	162	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1698	1705		10.1056/NEJMoa055119	http://dx.doi.org/10.1056/NEJMoa055119			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16625009	Bronze			2022-12-28	WOS:000236893900006
J	Saleh, M; Mathison, JC; Wolinski, MK; Bensinger, SJ; Fitzgerald, P; Droin, N; Ulevitch, RJ; Green, DR; Nicholson, DW				Saleh, M; Mathison, JC; Wolinski, MK; Bensinger, SJ; Fitzgerald, P; Droin, N; Ulevitch, RJ; Green, DR; Nicholson, DW			Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice	NATURE			English	Article							STRESS-INDUCED APOPTOSIS; CELL-DEATH; ACTIVATION; SURVIVAL; BETA; DEFICIENT; CASPASE-4; ENZYME	Caspases function in both apoptosis and inflammatory cytokine processing and thereby have a role in resistance to sepsis(1). Here we describe a novel role for a caspase in dampening responses to bacterial infection. We show that in mice, gene-targeted deletion of caspase-12 renders animals resistant to peritonitis and septic shock. The resulting survival advantage was conferred by the ability of the caspase-12-deficient mice to clear bacterial infection more efficiently than wild-type littermates. Caspase-12 dampened the production of the pro-inflammatory cytokines interleukin (IL)-1 beta, IL- 18 (interferon (IFN)-gamma inducing factor) and IFN-gamma, but not tumour-necrosis factor-alpha and IL- 6, in response to various bacterial components that stimulate Toll-like receptor and NOD pathways. The IFN-gamma pathway was crucial in mediating survival of septic caspase-12-deficient mice, because administration of neutralizing antibodies to IFN-gamma receptors ablated the survival advantage that otherwise occurred in these animals. Mechanistically, caspase-12 associated with caspase-1 and inhibited its activity. Notably, the protease function of caspase-12 was not necessary for this effect, as the catalytically inactive caspase-12 mutant Cys299Ala also inhibited caspase-1 and IL-1 beta production to the same extent as wild-type caspase-12. In this regard, caspase-12 seems to be the cFLIP counterpart for regulating the inflammatory branch of the caspase cascade. In mice, caspase-12 deficiency confers resistance to sepsis and its presence exerts a dominant-negative suppressive effect on caspase-1, resulting in enhanced vulnerability to bacterial infection and septic mortality.	Merck Res Labs, Rahway, NJ 07065 USA; La Jolla Inst Allergy & Immunol, Dept Cellular Immunol, San Diego, CA 92121 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Merck & Company; La Jolla Institute for Immunology; Scripps Research Institute	Green, DR (corresponding author), Merck Res Labs, Rahway, NJ 07065 USA.	douglas.green@stjude.org; donald_nicholson@merck.com	Green, Douglas R/N-8083-2018; Ulevitch, Richard J/Q-3393-2017; Droin, Nathalie M/Y-5506-2018	Green, Douglas R/0000-0002-7332-1417; Droin, Nathalie M/0000-0002-6099-5324; Saleh, Maya/0000-0003-1538-9146				Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Kalai M, 2003, J CELL BIOL, V162, P457, DOI 10.1083/jcb.200303157; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	18	257	275	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1064	1068		10.1038/nature04656	http://dx.doi.org/10.1038/nature04656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625199				2022-12-28	WOS:000236906000039
J	Chung, SY				Chung, SY			Bladder tissue-engineering: a new practical solution?	LANCET			English	Editorial Material							SMALL-INTESTINAL SUBMUCOSA; STEM-CELLS; REGENERATION; GROWTH		Adv Urol Inst Illinois, Spring Valley, IL 61362 USA		Chung, SY (corresponding author), Adv Urol Inst Illinois, Spring Valley, IL 61362 USA.	chungsy@gmail.com						Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1; Chung SY, 2004, J UROLOGY, V171, P372, DOI 10.1097/01.ju.0000101696.20531.2b; De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034; Frimberger D, 2005, UROLOGY, V65, P827, DOI 10.1016/j.urology.2004.11.024; Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Lu SH, 2005, BIOMATERIALS, V26, P443, DOI 10.1016/j.biomaterials.2004.05.006; Lu SH, 2003, UROLOGY, V61, P1285, DOI 10.1016/S0090-4295(03)00020-7; Neal DE, 1999, LANCET, V353, pSL24; Vacanti JP, 1999, LANCET, V354, pSI32; Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054; Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x	13	27	32	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1215	1216		10.1016/S0140-6736(06)68481-X	http://dx.doi.org/10.1016/S0140-6736(06)68481-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631860				2022-12-28	WOS:000236913400004
J	Huang, WD; Ma, K; Zhang, J; Qatanani, M; Cuvillier, J; Liu, J; Dong, BN; Huang, XF; Moore, DD				Huang, WD; Ma, K; Zhang, J; Qatanani, M; Cuvillier, J; Liu, J; Dong, BN; Huang, XF; Moore, DD			Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration	SCIENCE			English	Article							RAT-LIVER; GENE-EXPRESSION; HEPATOCYTES; LIGANDS; IDENTIFICATION; HEPATECTOMY; MODULATION; SECRETION; PATHWAY; PHASE	Liver mass depends on one or more unidentified humoral signals that drive regeneration when liver functional capacity is diminished. Bile acids are important liver products, and their levels are tightly regulated. Here, we identify a role for nuclear receptor - dependent bile acid signaling in normal liver regeneration. Elevated bile acid levels accelerate regeneration, and decreased levels inhibit liver regrowth, as does the absence of the primary nuclear bile acid receptor FXR. We propose that FXR activation by increased bile acid flux is a signal of decreased functional capacity of the liver. FXR, and possibly other nuclear receptors, may promote homeostasis not only by regulating expression of appropriate metabolic target genes but also by driving homeotrophic liver growth.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, Duarte, CA 91010 USA	Baylor College of Medicine; City of Hope; Beckman Research Institute of City of Hope	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	moore@bcm.tmc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R01DK053366] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19 DK62434, R01 DK053366] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barone M, 1996, HEPATOLOGY, V23, P1159, DOI 10.1053/jhep.1996.v23.pm0008621149; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Chijiiwa K, 1996, BRIT J SURG, V83, P482, DOI 10.1002/bjs.1800830414; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; Columbano A, 2003, CELL DEATH DIFFER, V10, pS19, DOI 10.1038/sj.cdd.4401113; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; GARCIAMARIN JJ, 1990, CLIN SCI, V78, P55, DOI 10.1042/cs0780055; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200; Higgins GM, 1931, ARCH PATHOL, V12, P186; HUANG W, 2005, MOL ENDOCRINOL  0414; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kren BT, 2001, LIVER TRANSPLANT, V7, P321, DOI 10.1053/jlts.2001.23062; Kullak-Ublick G A, 2000, Clin Liver Dis, V4, P357, DOI 10.1016/S1089-3261(05)70114-8; LEONG GF, 1959, AM J PHYSIOL, V197, P880, DOI 10.1152/ajplegacy.1959.197.4.880; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; MELCHIORRI C, 1993, CARCINOGENESIS, V14, P1825, DOI 10.1093/carcin/14.9.1825; Monte MJ, 1997, BBA-MOL BASIS DIS, V1362, P56, DOI 10.1016/S0925-4439(97)00063-X; Monte MJ, 2002, J HEPATOL, V36, P534, DOI 10.1016/S0168-8278(01)00296-3; MOOLTEN FL, 1967, SCIENCE, V158, P272, DOI 10.1126/science.158.3798.272; Oe S, 2004, HEPATOLOGY, V40, P1098, DOI 10.1002/hep.20426; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sainz GR, 1997, INT J EXP PATHOL, V78, P109, DOI 10.1046/j.1365-2613.1997.d01-246.x; Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SOLOPAEV B P, 1957, Biull Eksp Biol Med, V43, P109; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Ueda JJ, 2002, SURGERY, V131, P564, DOI 10.1067/msy.2002.123008; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wiezer MJ, 2000, ANN SURG, V232, P208, DOI 10.1097/00000658-200008000-00010; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200	44	485	517	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					233	236		10.1126/science.1121435	http://dx.doi.org/10.1126/science.1121435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614213				2022-12-28	WOS:000236765300039
J	Chikashige, Y; Tsutsumi, C; Yamane, M; Kamasa, K; Haraguchi, T; Hiraoka, Y				Chikashige, Y; Tsutsumi, C; Yamane, M; Kamasa, K; Haraguchi, T; Hiraoka, Y			Meiotic proteins Bqt1 and Bqt2 tether telomeres to form the bouquet arrangement of chromosomes	CELL			English	Article							SPINDLE POLE BODY; YEAST SCHIZOSACCHAROMYCES-POMBE; OSCILLATORY NUCLEAR-MOVEMENT; FISSION YEAST; DOMAIN PROTEIN; LIVING CELLS; MEIOSIS; PROPHASE; GENE; RECOMBINATION	In many organisms, meiotic chromosomes are bundled at their telomeres to form a "bouquet" arrangement. The bouquet formation plays an important role in homologous chromosome pairing and therefore progression of meiosis. As meiotic telomere clustering occurs in response to mating pheromone signaling in fission yeast, we looked for factors essential for bouquet formation among genes induced under mating pheromone signaling. This genome-wide search identified two proteins, Bqt1 and Bqt2, that connect telomeres to the spindle-pole body (SPB; the centrosome equivalent in fungi). Neither Bqt1 nor Bqt2 alone functions as a connector, but together the two proteins form a bridge between Rap1 (a telomere protein) and Sad1 (an SPB protein). Significantly, when both Bqt1 and Bqt2 are ectopically expressed in mitotic cells, they also form a bridge between Rap1 and Sad1. Thus, a complex including Bqt1 and Bqt2 is essential for connecting telomeres to the SPB.	Natl Inst Informat & Commun Technol, Kansai Adv Res ctr, Cell Biol Grp, Nishi Ku, Kobe, Hyogo 6512492, Japan; Natl Inst Informat & Commun Technol, Kansai Adv Res ctr, CREST Res Project, Nishi Ku, Kobe, Hyogo 6512492, Japan; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 5600043, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Japan Science & Technology Agency (JST); National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Hiraoka, Y (corresponding author), Natl Inst Informat & Commun Technol, Kansai Adv Res ctr, Cell Biol Grp, Nishi Ku, 588-2 Iwaoka, Kobe, Hyogo 6512492, Japan.	yasushi@nict.go.jp	Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228				Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2004, GENES CELLS, V9, P671, DOI 10.1111/j.1356-9597.2004.00760.x; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Cooper JP, 2000, CURR OPIN GENET DEV, V10, P169; Cunliffe L, 2004, MOL GENET GENOMICS, V271, P60, DOI 10.1007/s00438-003-0956-6; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding DQ, 1998, J CELL SCI, V111, P701; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Goto B, 2001, J CELL SCI, V114, P2427; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; HAGAN IM, 1988, J CELL SCI, V89, P343; Haraguchi T, 1999, CELL STRUCT FUNCT, V24, P291, DOI 10.1247/csf.24.291; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; IMAI Y, 1994, GENE DEV, V8, P328, DOI 10.1101/gad.8.3.328; Jin Y, 2002, GENETICS, V160, P861; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Miki F, 2004, MOL GENET GENOMICS, V270, P449, DOI 10.1007/s00438-003-0938-8; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nickas ME, 2003, EUKARYOT CELL, V2, P431, DOI 10.1128/EC.2.3.431-445.2003; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2001, DEVELOPMENT, V128, P5039; SVOBODA A, 1995, CHROMOSOMA, V104, P203, DOI 10.1007/s004120050109; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wood V, 2003, NATURE, V421, P94, DOI 10.1038/nature01203; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamamoto A, 2001, BIOESSAYS, V23, P526, DOI 10.1002/bies.1072; Yamamoto TG, 2004, J CELL SCI, V117, P3875, DOI 10.1242/jcs.01248; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	46	260	271	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					59	69		10.1016/j.cell.2006.01.048	http://dx.doi.org/10.1016/j.cell.2006.01.048			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615890	Bronze			2022-12-28	WOS:000237314200014
J	Weinreich, DM; Delaney, NF; DePristo, MA; Hartl, DL				Weinreich, DM; Delaney, NF; DePristo, MA; Hartl, DL			Darwinian evolution can follow only very few mutational paths to fitter proteins	SCIENCE			English	Article							TEM BETA-LACTAMASE; IN-VITRO; ANTIBIOTIC-RESISTANCE; CEPHALOSPORINS; AGGREGATION; ADAPTATION; LANDSCAPE; STABILITY; SEQUENCE	Five point mutations in a particular beta-lactamase allele jointly increase bacterial resistance to a clinically important antibiotic by a factor of similar to 100,000. In principle, evolution to this high-resistance beta-lactamase might follow any of the 120 mutational trajectories linking these alleles. However, we demonstrate that 102 trajectories are inaccessible to Darwinian selection and that many of the remaining trajectories have negligible probabilities of realization, because four of these five mutations fail to increase drug resistance in some combinations. Pervasive biophysical pleiotropy within the beta-lactamase seems to be responsible, and because such pleiotropy appears to be a general property of missense mutations, we conclude that much protein evolution will be similarly constrained. This implies that the protein tape of life may be largely reproducible and even predictable.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Weinreich, DM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	dmw@post.harvard.edu	Weinreich, Dan/AAZ-6606-2021					AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Barlow M, 2002, GENETICS, V160, P823; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; GEORGIOU G, 1994, PROTEIN SCI, V3, P1953, DOI 10.1002/pro.5560031107; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; Gould S. J., 1989, WONDERFUL LIFE BURGE; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; Hall BG, 2002, ANTIMICROB AGENTS CH, V46, P3035, DOI 10.1128/AAC.46.9.3035-3038.2002; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; Jacoby GA, 2005, TEM EXTENDED SPECTRU; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MALCOLM BA, 1990, NATURE, V345, P86, DOI 10.1038/345086a0; MEDEIROS AA, 1997, CLIN INFECT DIS   S1, V24, P19; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2005, EVOLUTION, V59, P216; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; RAQUET X, 1994, J MOL BIOL, V244, P625, DOI 10.1006/jmbi.1994.1756; RAQUET X, 1995, PROTEINS, V23, P63, DOI 10.1002/prot.340230108; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; WATSON N, 1988, GENE, V70, P399, DOI 10.1016/0378-1119(88)90212-0; Weinreich DM, 2005, EVOLUTION, V59, P1165; WRIGHT S, 1932, P 6 INT C GEN, P356	26	899	908	2	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					111	114		10.1126/science.1123539	http://dx.doi.org/10.1126/science.1123539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601193				2022-12-28	WOS:000236584400043
J	Becker, S				Becker, S			Good news for Marburg virus workers	LANCET			English	Editorial Material							NONHUMAN-PRIMATES; HEMORRHAGIC-FEVER; VACCINE; INFECTION; EBOLA		Robert Koch Inst, D-13353 Berlin, Germany	Robert Koch Institute	Becker, S (corresponding author), Robert Koch Inst, D-13353 Berlin, Germany.	beckerst@rki.de						Chepurnov AA, 1995, VOP VIRUSOL+, V40, P257; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Geisbert TW, 2005, PLOS MED, V2, P537, DOI 10.1371/journal.pmed.0020183; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; Hevey M, 1997, VIROLOGY, V239, P206, DOI 10.1006/viro.1997.8883; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; PATTYN S, 1977, LANCET, V1, P573; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; SIEGERT R, 1967, DEUT MED WOCHENSCHR, V92, P2341, DOI 10.1055/s-0028-1106144; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108	11	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1373	1374		10.1016/S0140-6736(06)68547-4	http://dx.doi.org/10.1016/S0140-6736(06)68547-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650630	Bronze			2022-12-28	WOS:000237195600004
J	Hetz, C; Bernasconi, P; Fisher, J; Lee, AH; Bassik, MC; Antonsson, B; Brandt, GS; Iwakoshi, NN; Schinzel, A; Glimcher, LH; Korsmeyer, SJ				Hetz, C; Bernasconi, P; Fisher, J; Lee, AH; Bassik, MC; Antonsson, B; Brandt, GS; Iwakoshi, NN; Schinzel, A; Glimcher, LH; Korsmeyer, SJ			Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1 alpha	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER STRESS; TRANSCRIPTION FACTOR; CELL-DEATH; APOPTOSIS; XBP-1; IRE1; ACTIVATION; BIOGENESIS	Accumulation of misfolded protein in the endoplasmic reticulum (ER) triggers an adaptive stress response-termed the unfolded protein response (UPR)-mediated by the ER transmembrane protein kinase and endoribonuclease inositol-requiring enzyme-1 alpha (IRE1 alpha). We investigated UPR signaling events in mice in the absence of the proapoptotic BCL-2 family members BAX and BAK [double knockout (DKO)]. DKO mice responded abnormally to tunicamycin-induced ER stress in the liver, with extensive tissue damage and decreased expression of the IRE1 substrate X-box-binding protein 1 and its target genes. ER-stressed DKO cells showed deficient IRE1a signaling. BAX and BAK formed a protein complex with the cytosolic domain of IRE1 alpha that was essential for IRE1 alpha activation. Thus, BAX and BAK function at the ER membrane to activate IRE1 alpha signaling and to provide a physical link between members of the core apoptotic pathway and the UPR.	Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Serono Pharmaceut Res Inst, CH-1228 Plan Les Ouates, Switzerland; Brandeis Univ, Rosenstiel Ctr, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Rosenstiel Ctr, Dept Chem, Waltham, MA 02454 USA	Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Brandeis University; Brandeis University	Hetz, C (corresponding author), Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	chetz@hsph.harvard.edu; lglimche@hsph.harvard.edu	Hetz, Claudio/I-1900-2013; Hetz, Claudio/ABD-7514-2021; Longo, Kenneth A/A-5631-2010	Hetz, Claudio/0000-0001-7724-1767; Brandt, Gabriel/0000-0002-9148-8042	NCI NIH HHS [P01 CA92625, R37 CA50239, CA100707] Funding Source: Medline; NIAID NIH HHS [P01 AI56296, R01 AI32412] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625, P50CA100707, R37CA050239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056296, R01AI032412] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu ZG, 2003, MOL CELL, V12, P795, DOI 10.1016/S1097-2765(03)00399-X; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Reimold AM, 2000, GENE DEV, V14, P152; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	32	518	542	6	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					572	576		10.1126/science.1123480	http://dx.doi.org/10.1126/science.1123480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645094				2022-12-28	WOS:000237296700044
J	Nemecek, JC; Wuthrich, M; Klein, BS				Nemecek, JC; Wuthrich, M; Klein, BS			Global control of dimorphism and virulence in fungi	SCIENCE			English	Article							BLASTOMYCES-DERMATITIDIS; HISTOPLASMA-CAPSULATUM; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; HISTIDINE KINASE; HYPHAL DEVELOPMENT; PROTEIN-KINASE; YEAST; STRESS; COCCIDIOIDOMYCOSIS	Microbial pathogens that normally inhabit our environment can adapt to thrive inside mammalian hosts. There are six dimorphic fungi that cause disease worldwide, which switch from nonpathogenic molds in soil to pathogenic yeast after spores are inhaled and exposed to elevated temperature. Mechanisms that regulate this switch remain obscure. We show that a hybrid histidine kinase senses host signals and triggers the transition from mold to yeast. The kinase also regulates cell-wall integrity, sporulation, and expression of virulence genes in vivo. This global regulator shapes how dimorphic fungal pathogens adapt to the mammalian host, which has broad implications for treating and preventing systemic fungal disease.	Univ Wisconsin Hosp & Clin, Dept Med Microbiol & Immunol, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Dept Pediat, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Dept Internal Med, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Univ Wisconsin Sch Med, Ctr Comprehens Canc, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Klein, BS (corresponding author), Univ Wisconsin Hosp & Clin, Dept Med Microbiol & Immunol, Madison, WI 53792 USA.	bsklein@wisc.edu						Ajello L., 1971, Histoplasmosis. Proceedings of the Second National Conference., P103; Alex LA, 1998, P NATL ACAD SCI USA, V95, P7069, DOI 10.1073/pnas.95.12.7069; Brandhorst TT, 1999, J EXP MED, V189, P1207, DOI 10.1084/jem.189.8.1207; Chiller TM, 2003, INFECT DIS CLIN N AM, V17, P41, DOI 10.1016/S0891-5520(02)00040-5; Deschenes RJ, 1999, ANTIMICROB AGENTS CH, V43, P1700, DOI 10.1128/AAC.43.7.1700; Galgiani JN, 1999, ANN INTERN MED, V130, P293, DOI 10.7326/0003-4819-130-4-199902160-00015; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; Klein B S, 1986, Semin Respir Infect, V1, P29; KLEIN BS, 1990, J CLIN INVEST, V85, P152, DOI 10.1172/JCI114406; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; MARESCA B, 1989, MICROBIOL REV, V53, P186, DOI 10.1128/MMBR.53.2.186-209.1989; MEDOFF G, 1986, SCIENCE, V231, P476, DOI 10.1126/science.3001938; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rooney PJ, 2001, MOL MICROBIOL, V39, P875, DOI 10.1046/j.1365-2958.2001.02300.x; SALAZAR ME, 1988, INFECT IMMUN, V56, P711, DOI 10.1128/IAI.56.3.711-713.1988; SANTOS JL, 2001, SCI STKE, pRE1, DOI DOI 10.1126/J.STKE.2001.98.RE1; Sebghati TS, 2000, SCIENCE, V290, P1368, DOI 10.1126/science.290.5495.1368; Shieh JC, 1998, MOL BIOL CELL, V9, P311, DOI 10.1091/mbc.9.2.311; Stock J, 1999, CURR BIOL, V9, pR364, DOI 10.1016/S0960-9822(99)80228-0; Sullivan TD, 2002, EUKARYOT CELL, V1, P895, DOI 10.1128/EC.1.6.895-905.2002; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004; White S, 1997, CELL MOL LIFE SCI, V53, P744, DOI 10.1007/s000180050094; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243, DOI 10.1128/JB.181.23.7243-7247.1999	30	258	279	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					583	588		10.1126/science.1124105	http://dx.doi.org/10.1126/science.1124105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645097				2022-12-28	WOS:000237296700047
J	Kleiner, K				Kleiner, K			Crunch time for New Jersey Lab	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1111	1111		10.1038/4401111a	http://dx.doi.org/10.1038/4401111a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641969				2022-12-28	WOS:000237080000015
J	MacDonald, D; Demarre, G; Bouvier, M; Mazel, D; Gopaul, DN				MacDonald, D; Demarre, G; Bouvier, M; Mazel, D; Gopaul, DN			Structural basis for broad DNA-specificity in integron recombination	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; CRYSTAL-STRUCTURE; MECHANISM; GENOME; DOMAIN; BINDS; INTI1	Lateral DNA transfer-the movement of genetic traits between bacteria-has a profound impact on genomic evolution and speciation. The efficiency with which bacteria incorporate genetic information reflects their capacity to adapt to changing environmental conditions. Integron integrases are proteins that mediate site-specific DNA recombination between a proximal primary site (attI) and a secondary target site (attC) found within mobile gene cassettes encoding resistance or virulence factors. The lack of sequence conservation among attC sites has led to the hypothesis that a sequence-independent structural recognition determinant must exist within attC. Here we report the crystal structure of an integron integrase bound to an attC substrate. The structure shows that DNA target site recognition and high-order synaptic assembly are not dependent on canonical DNA but on the position of two flipped-out bases that interact in cis and in trans with the integrase. These extrahelical bases, one of which is required for recombination in vivo, originate from folding of the bottom strand of attC owing to its imperfect internal dyad symmetry. The mechanism reported here supports a new paradigm for how sequence-degenerate single-stranded genetic material is recognized and exchanged between bacteria.	Inst Pasteur, Dept Biol Struct & Chim, Lab Biochim & Biophys Macromol, F-75724 Paris 15, France; Inst Pasteur, CNRS,URA 2171, Dept Struct & Dynam Genomes, Unite Postulante Plast Genome Bacterien, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gopaul, DN (corresponding author), Inst Pasteur, Dept Biol Struct & Chim, Lab Biochim & Biophys Macromol, F-75724 Paris 15, France.	gopauld@pasteur.fr	Mazel, Didier/F-9200-2013	Mazel, Didier/0000-0001-6482-6002; Bouvier, Marie/0000-0002-2111-052X; GOPAUL, Deshmukh/0000-0003-1631-3303				Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Arciszewska L, 1997, EMBO J, V16, P3731, DOI 10.1093/emboj/16.12.3731; AZARO MA, 2002, MOBILE DNA, V2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biskri L, 2005, J BACTERIOL, V187, P1740, DOI 10.1128/JB.187.5.1740-1750.2005; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; CRAIG NL, 2002, MOBILE DNA, V2; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; Gopaul Deshmukh N., 1999, Current Opinion in Structural Biology, V9, P14, DOI 10.1016/S0959-440X(99)80003-7; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Gravel A, 1998, NUCLEIC ACIDS RES, V26, P4347, DOI 10.1093/nar/26.19.4347; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hansson K, 1997, MOL MICROBIOL, V26, P441, DOI 10.1046/j.1365-2958.1997.5401964.x; Hickman AB, 1997, CELL, V89, P227, DOI 10.1016/S0092-8674(00)80202-0; Johansson C, 2004, NUCLEIC ACIDS RES, V32, P4033, DOI 10.1093/nar/gkh730; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Messier N, 2001, J BACTERIOL, V183, P6699, DOI 10.1128/JB.183.22.6699-6706.2001; MEYERLEON L, 1990, MOL CELL BIOL, V10, P235, DOI 10.1128/MCB.10.1.235; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; STARK WM, 1989, TRENDS GENET, V5, P304, DOI 10.1016/0168-9525(89)90113-3; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; VANDUYNE G, 2002, MOBILE DNA, V2; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659	40	117	133	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1157	1162		10.1038/nature04643	http://dx.doi.org/10.1038/nature04643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641988	Green Submitted			2022-12-28	WOS:000237080000037
J	Muzny, DM; Scherer, SE; Kaul, R; Wang, J; Yu, J; Sudbrak, R; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Wei, S; Wheeler, DA; Wright, MW; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clendenning, J; Clerc-Blankenburg, KP; Chen, RS; Chen, Z; Davis, C; Delgado, O; Dinh, HH; Dong, W; Draper, H; Ernst, S; Fu, G; Gonzalez-Garay, ML; Garcia, DK; Gillett, W; Gu, J; Hao, BL; Haugen, E; Havlak, P; He, X; Hennig, S; Hu, SN; Huang, W; Jackson, LR; Jacob, LS; Kelly, SH; Kube, M; Levy, R; Li, ZW; Liu, B; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Palmeiri, A; Pasternak, S; Perez, LM; Phelps, KA; Plopper, FJH; Qiang, BQ; Raymond, C; Rodriguez, R; Saenphimmachak, C; Santibanez, J; Shen, H; Shen, Y; Subramanian, S; Tabor, PE; Verduzco, D; Waldron, L; Wang, J; Wang, J; Wang, QY; Williams, GA; Wong, GKS; Yao, ZJ; Zhang, JK; Zhang, XQ; Zhao, GP; Zhou, JL; Zhou, Y; Nelson, D; Lehrach, H; Reinhardt, R; Naylor, SL; Yang, HM; Olson, M; Weinstock, G; Gibbs, RA				Muzny, DM; Scherer, SE; Kaul, R; Wang, J; Yu, J; Sudbrak, R; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Wei, S; Wheeler, DA; Wright, MW; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clendenning, J; Clerc-Blankenburg, KP; Chen, RS; Chen, Z; Davis, C; Delgado, O; Dinh, HH; Dong, W; Draper, H; Ernst, S; Fu, G; Gonzalez-Garay, ML; Garcia, DK; Gillett, W; Gu, J; Hao, BL; Haugen, E; Havlak, P; He, X; Hennig, S; Hu, SN; Huang, W; Jackson, LR; Jacob, LS; Kelly, SH; Kube, M; Levy, R; Li, ZW; Liu, B; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Palmeiri, A; Pasternak, S; Perez, LM; Phelps, KA; Plopper, FJH; Qiang, BQ; Raymond, C; Rodriguez, R; Saenphimmachak, C; Santibanez, J; Shen, H; Shen, Y; Subramanian, S; Tabor, PE; Verduzco, D; Waldron, L; Wang, J; Wang, J; Wang, QY; Williams, GA; Wong, GKS; Yao, ZJ; Zhang, JK; Zhang, XQ; Zhao, GP; Zhou, JL; Zhou, Y; Nelson, D; Lehrach, H; Reinhardt, R; Naylor, SL; Yang, HM; Olson, M; Weinstock, G; Gibbs, RA			The DNA sequence, annotation and analysis of human chromosome 3	NATURE			English	Article							HUMAN GENOME; EVOLUTION; CHROMOSOME; REARRANGEMENTS; RECOMBINATION; DUPLICATION; INVERSION; MAP	After the completion of a draft human genome sequence(1), the International Human Genome Sequencing Consortium has proceeded to finish(2) and annotate each of the 24 chromosomes comprising the human genome. Here we describe the sequencing and analysis of human chromosome 3, one of the largest human chromosomes. Chromosome 3 comprises just four contigs, one of which currently represents the longest unbroken stretch of finished DNA sequence known so far. The chromosome is remarkable in having the lowest rate of segmental duplication in the genome. It also includes a chemokine receptor gene cluster as well as numerous loci involved in multiple human cancers such as the gene encoding FHIT, which contains the most common constitutive fragile site in the genome, FRA3B(3). Using genomic sequence from chimpanzee and rhesus macaque, we were able to characterize the breakpoints defining a large pericentric inversion that occurred some time after the split of Homininae from Ponginae, and propose an evolutionary history of the inversion.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Washington, Genome Ctr, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Chinese Acad Sci, Beijing Genom Inst, Beijing 101300, Peoples R China; Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310008, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Natl Human Genome Ctr, Beijing 100176, Peoples R China; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA; RZPD German Resource Ctr Genome Res, D-14059 Berlin, Germany	Baylor College of Medicine; University of Washington; University of Washington Seattle; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Zhejiang University; Max Planck Society; University of Kiel; University of London; University College London; University of Texas System; University of Texas Health San Antonio	Scherer, SE (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	sscherer@bcm.tmc.edu; yanghm@genomics.org.cn	Liu, Tao/AAO-6310-2021; Liu, Tao/G-3585-2010; Chen, Runsheng/S-9834-2017; Sudbrak, Ralf/HHZ-8821-2022; Wang, Jun/A-7261-2013; WONG, Gane Ka-Shu/G-5784-2013; Driemeier, David/H-3461-2012; Wright, Mathew/H-5394-2012; Li, Wei/A-8544-2009; Wheeler, David A/M-9740-2018; Weinstock, George M/C-6314-2013; 郑, 征/C-8514-2011; Wang, Jun/B-9503-2016; Hu, Songnian/C-6509-2013; Wang, Jun/C-8434-2016	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Chen, Runsheng/0000-0001-6049-8347; WONG, Gane Ka-Shu/0000-0001-6108-5560; Driemeier, David/0000-0003-3766-0654; Wright, Mathew/0000-0002-2650-2426; Wheeler, David A/0000-0002-9056-6299; Weinstock, George M/0000-0002-2997-4592; Delgado, Oliver/0000-0003-2547-5857; Wang, Jun/0000-0002-2113-5874; Hu, Songnian/0000-0003-3966-3111; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Wang, Jun/0000-0002-8540-8931; Worley, Kim/0000-0002-0282-1000; Zhao, Guo-Ping/0000-0002-7621-6620; Haugen, Eric/0000-0001-7444-8981; Reinhardt, Richard/0000-0001-9376-2132; Kaul, Rajinder/0000-0002-7895-9284; Liu, Tao/0000-0003-0446-9001	Medical Research Council [G0000107] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; MRC [G0000107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLDERDICE PW, 1975, AM J HUM GENET, V27, P699; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; CIGUDOSA RC, 1995, CANCER GENET CYTOGEN, V83, P119; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Jin YS, 2002, INT J CANCER, V98, P475, DOI 10.1002/ijc.10225; Jun Y, 2005, SCI CHINA SER C, V48, P311, DOI 10.1360/062005-173; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; KALITSIS P, 1993, GENOMICS, V16, P104, DOI 10.1006/geno.1993.1147; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARKKANEN A, 1982, HEREDITAS, V96, P317, DOI 10.1111/j.1601-5223.1982.tb00866.x; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; STINE SB, 1982, AM J MED GENET, V12, P57, DOI 10.1002/ajmg.1320120108; TAGARRO I, 1993, HISTOCHEMISTRY, V99, P453; Ventura M, 2004, GENOME RES, V14, P1696, DOI 10.1101/gr.2608804; Wienberg J, 2004, CURR OPIN GENET DEV, V14, P657, DOI 10.1016/j.gde.2004.10.001; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Yue Y, 2005, GENOMICS, V85, P36, DOI 10.1016/j.ygeno.2004.10.007; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	27	40	661	5	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1194	1198		10.1038/nature04728	http://dx.doi.org/10.1038/nature04728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641997	Bronze			2022-12-28	WOS:000237080000046
J	White, M; Herrera, DJG; Lim-Quizon, MC				White, M; Herrera, DJG; Lim-Quizon, MC			Joined-up public-health initiatives	LANCET			English	Editorial Material									Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Atlanta, GA 30309 USA; Inst Salud Carlos III, Madrid, Spain; Training Epidemiol & Publ Hlth & Intervent Networ, Tarlac, Philippines	Centers for Disease Control & Prevention - USA; Instituto de Salud Carlos III	White, M (corresponding author), Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Atlanta, GA 30309 USA.	markewhite@cdc.gov						*CDC, 2003, MMWR-MORBID MORTAL W, V52, P1042; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Goldsmith S., 2005, GOVERNING NETWORK NE; Goodwin N, 2004, MANAGING DIVERSE NET; Pablos-Mendez A, 2005, B WORLD HEALTH ORGAN, V83, P723; Rodgers E., 1995, DIFFUSION INNOVATION; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; White ME, 2001, AM J EPIDEMIOL, V154, P993, DOI 10.1093/aje/154.11.993; Zaza S, 2005, GUIDE COMMUNITY PREV; 2006, ECONOMIST S, V378, P1	11	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1301	1302		10.1016/S0140-6736(06)68556-5	http://dx.doi.org/10.1016/S0140-6736(06)68556-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631896				2022-12-28	WOS:000237118500008
J	Yao, SQ; Lum, L; Beachy, P				Yao, SQ; Lum, L; Beachy, P			The ihog cell-surface proteins bind hedgehog and mediate pathway activation	CELL			English	Article							IG SUPERFAMILY MEMBER; SUBCELLULAR-LOCALIZATION; DROSOPHILA ORTHOLOG; DALLY-LIKE; GENE; RECEPTOR; ROLES; CDO; IDENTIFICATION; MUTATIONS	The ihog gene (interference hedgehog), identified by RNA interference in Drosophila cultured cells, encodes a type 1 membrane protein shown here to bind and to mediate response to the active Hedgehog (Hh) protein signal. ihog mutations produce defects characteristic of Hh signaling loss in embryos and imaginal discs, and epistasis analysis places ihog action at or upstream of the negatively acting receptor component, Patched (Ptc). The first of two extracellular fibronectin type III (FNIII) domains of the lhog protein mediates a specific interaction with Hh protein in vitro, but the second FNIII domain is additionally required for in vivo signaling activity and for Ihog-enhanced binding of Hh protein to cells coexpressing Ptc. Other members of the Ihog family, including Drosophila Boi and mammalian CDO and BOC, also interact with Hh ligands via a specific FNIII domain, thus identifying an evolutionarily conserved family of membrane proteins that function in Hh signal response.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Oncol, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Beachy, P (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol, Baltimore, MD 21205 USA.	pbeachy@jhmi.edu						Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Borycki AG, 1999, DEVELOPMENT, V126, P4053; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chou TB, 1996, GENETICS, V144, P1673; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Connor RM, 2005, J COMP NEUROL, V485, P32, DOI 10.1002/cne.20503; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; FORBES AJ, 1993, DEVELOPMENT, P115; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Glise B, 2005, DEV CELL, V8, P255, DOI 10.1016/j.devcel.2005.01.003; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gorfinkiel N, 2005, DEV CELL, V8, P241, DOI 10.1016/j.devcel.2004.12.018; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mohler J, 2000, DEVELOPMENT, V127, P55; MUENKE M, 2001, METABOLIC MOL BASES, P6203; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; SAMPEDRO J, 1991, NATURE, V353, P187, DOI 10.1038/353187a0; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	48	174	188	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					343	357		10.1016/j.cell.2006.02.040	http://dx.doi.org/10.1016/j.cell.2006.02.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630821	Bronze			2022-12-28	WOS:000237241500023
J	Girguis, PR; Lee, RW				Girguis, PR; Lee, RW			Thermal preference and tolerance of alvinellids	SCIENCE			English	Article							POMPEII WORMS; TEMPERATURE		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Harvard University; Washington State University	Girguis, PR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	pgirguis@oeb.harvard.edu; rlee@mail.wsu.edu		Girguis, Peter/0000-0002-3599-8160				Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; Chevaldonne P, 2000, MAR ECOL PROG SER, V208, P293, DOI 10.3354/meps208293; COONEY D, 1964, THERMOPHILIC FUNGI, P63; HOCHACHKA P, 2002, BIOCH ADAPTATION MEC, P363; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1711, DOI 10.1016/0198-0149(88)90045-3; Le Bris N, 2005, DEEP-SEA RES PT I, V52, P1071, DOI 10.1016/j.dsr.2005.01.003; Sarrazin J, 2002, CAH BIOL MAR, V43, P275; Shillito B, 2004, HIGH PRESSURE RES, V24, P169, DOI 10.1080/08957950310001635774; WEHNER R, 1992, NATURE, V357, P586, DOI 10.1038/357586a0; WICKSTROM CE, 1973, SCIENCE, V181, P1063, DOI 10.1126/science.181.4104.1063	10	65	66	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					231	231		10.1126/science.1125286	http://dx.doi.org/10.1126/science.1125286			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614212				2022-12-28	WOS:000236765300038
J	Henrich, J				Henrich, J			Cooperation, punishment, and the evolution of human institutions	SCIENCE			English	Editorial Material							RECIPROCITY; NORMS		Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Emory University	Henrich, J (corresponding author), Emory Univ, Dept Anthropol, 1557 Dickey Dr, Atlanta, GA 30322 USA.	jhenric@emory.edu						Bowles S., 2004, ROUNDTABLE SER BEHAV; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; JOSHI NV, 1987, J GENET, V66, P69, DOI 10.1007/BF02934456; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Richerson P. J., 2005, NOT GENES ALONE CULT; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252	13	107	107	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					60	61		10.1126/science.1126398	http://dx.doi.org/10.1126/science.1126398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601179				2022-12-28	WOS:000236584400025
J	Parson, A				Parson, A			The long journey from stem cells to medical product	CELL			English	Editorial Material								There is much interest in developing stem cells and the cells derived from them as therapies for treating human disease and injury, but many biological, technological and regulatory hurdles have to be overcome before these cell therapies can be brought to commercial fruition.											0	23	23	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					9	11		10.1016/j.cell.2006.03.024	http://dx.doi.org/10.1016/j.cell.2006.03.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615881	Bronze			2022-12-28	WOS:000237314200005
J	Messer, H; Zinevich, A; Alpert, P				Messer, H; Zinevich, A; Alpert, P			Environmental monitoring by wireless communication networks	SCIENCE			English	Article									Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Geophys & Planetary Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Messer, H (corresponding author), Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel.							BEVIS M, 1992, J GEOPHYS RES-ATMOS, V97, P15787, DOI 10.1029/92JD01517; Morin E, 2003, J HYDROMETEOROL, V4, P782, DOI 10.1175/1525-7541(2003)004<0782:ERIFWR>2.0.CO;2; Raghavan S., 2003, RADAR METEOROLOGY	3	281	290	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					713	713		10.1126/science.1120034	http://dx.doi.org/10.1126/science.1120034			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675693				2022-12-28	WOS:000237312100040
J	Layard, R				Layard, R			Health policy - The case for psychological treatment centres	BRITISH MEDICAL JOURNAL			English	Editorial Material							SOCIAL PHOBIA; THERAPY; DEPRESSION; TRIAL	The government is committed to improved access to psychological therapy. How big an expansion is necessary to meet the NICE guidelines on depression and anxiety, and how should it be organised?	London Sch Econ, Ctr Econ Performance, London WC2A 2AE, England	University of London; London School Economics & Political Science	Layard, R (corresponding author), London Sch Econ, Ctr Econ Performance, London WC2A 2AE, England.	r.layard@lse.ac.uk						Andrade L, 2000, B WORLD HEALTH ORGAN, V78, P413; Clark DM, 2003, J CONSULT CLIN PSYCH, V71, P1058, DOI 10.1037/0022-006X.71.6.1058; CRAIGHEAD WE, 2002, GUIDE TREATMENTS WOR, P245; Department of Health and Human Services, 1999, MENT HLTH REP SURG G; Fava GA, 2004, AM J PSYCHIAT, V161, P1872, DOI 10.1176/appi.ajp.161.10.1872; HOLLON S, 2004, HDB PSYCHOTHERAPY BE; Layard R., 2005, PROSPECT, V108; LAYARD R, SAINSBURY CTR LECT T; LAYARD R, IMPLEMENTING NICE GU; LAYARD R, MENTAL HLTH BRITAINS; LEVENSON R, 2003, LONDONS STATE MIND, P86; Liebowitz MR, 1999, DEPRESS ANXIETY, V10, P89, DOI 10.1002/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.3.CO;2-X; Marks IM, 2003, BRIT J PSYCHIAT, V183, P57, DOI 10.1192/bjp.183.1.57; *NAT I CLIN EXC, 2004, AUX MAN ANX PAN DIS; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; National Institute of Clinical Excellence, 2005, POSTTR STRESS DIS PT; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; *OFF NAT STAT, 2000, PSYCH MORB SURV; Revicki DA, 1998, J AFFECT DISORDERS, V48, P25, DOI 10.1016/S0165-0327(97)00117-1; ROTH T, 2005, CLIN PSYCHOL FOR NOV, P47; Roy-Byrne PP, 2005, ARCH GEN PSYCHIAT, V62, P290, DOI 10.1001/archpsyc.62.3.290	21	182	186	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 29	2006	332	7548					1030	1032		10.1136/bmj.332.7548.1030	http://dx.doi.org/10.1136/bmj.332.7548.1030			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040TK	16644834	Green Accepted, Green Published			2022-12-28	WOS:000237403100026
J	Fitzsimmons, A				Fitzsimmons, A			Planetary science - Ice among the rocks	SCIENCE			English	Editorial Material							COMET; BELT		Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Fitzsimmons, A (corresponding author), Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland.	a.fitzsimmons@qub.ac.uk						EDGEWORTH KE, 1949, MON NOT R ASTRON SOC, V109, P600, DOI 10.1093/mnras/109.5.600; Elst E., 1996, 6456 IAU; FERNANDEZ JA, 1980, MON NOT R ASTRON SOC, V192, P481, DOI 10.1093/mnras/192.3.481; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; Hsieh HH, 2004, ASTRON J, V127, P2997, DOI 10.1086/383208; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Kuiper G.P., 1951, ASTROPHYSICS TOPICAL, P357; Meech KJ, 2005, SCIENCE, V310, P265, DOI 10.1126/science.1118978; MEECH KJ, 2005, SCIENCE         0908; Oort J. H., 1950, B ASTRON I NETH, V11, P91; Toth I, 2006, ASTRON ASTROPHYS, V446, P333, DOI 10.1051/0004-6361:20053550; WHIPPLE FL, 1987, ASTRON ASTROPHYS, V187, P852	13	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					535	536		10.1126/science.1126896	http://dx.doi.org/10.1126/science.1126896			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645082				2022-12-28	WOS:000237296700029
J	Brennan, RJ; Waldman, RJ				Brennan, RJ; Waldman, RJ			The South Asian earthquake six months later - An ongoing crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Int Rescue Comm, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Program Forced Migrat & Hlth, New York, NY USA	Columbia University	Brennan, RJ (corresponding author), Int Rescue Comm, New York, NY USA.							de Goyet CD, 2000, LANCET, V356, P762, DOI 10.1016/S0140-6736(00)02642-8; Male Serge, 1996, World Health Statistics Quarterly, V49, P221; *TERR FREE TOM, 2005, POLL MAJ CHANG PUBL; *WHO MIN HLTH PAK, 2005, WEEKL MORB MORT REP, V13; Wilder-Smith A, 2005, ANN ACAD MED SINGAP, V34, P625	5	32	33	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1769	1771		10.1056/NEJMp068017	http://dx.doi.org/10.1056/NEJMp068017			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641392	Bronze			2022-12-28	WOS:000237077100001
J	Bulatov, VV; Hsiung, LL; Tang, M; Arsenlis, A; Bartelt, MC; Cai, W; Florando, JN; Hiratani, M; Rhee, M; Hommes, G; Pierce, TG; de la Rubia, TD				Bulatov, VV; Hsiung, LL; Tang, M; Arsenlis, A; Bartelt, MC; Cai, W; Florando, JN; Hiratani, M; Rhee, M; Hommes, G; Pierce, TG; de la Rubia, TD			Dislocation multi-junctions and strain hardening	NATURE			English	Article								At the microscopic scale, the strength of a crystal derives from the motion, multiplication and interaction of distinctive line defects called dislocations. First proposed theoretically in 1934 (refs 1-3) to explain low magnitudes of crystal strength observed experimentally, the existence of dislocations was confirmed two decades later(4,5). Much of the research in dislocation physics has since focused on dislocation interactions and their role in strain hardening, a common phenomenon in which continued deformation increases a crystal's strength. The existing theory relates strain hardening to pair-wise dislocation reactions in which two intersecting dislocations form junctions that tie the dislocations together(6,7). Here we report that interactions among three dislocations result in the formation of unusual elements of dislocation network topology, termed 'multi-junctions'. We first predict the existence of multi-junctions using dislocation dynamics and atomistic simulations and then confirm their existence by transmission electron microscopy experiments in single-crystal molybdenum. In large-scale dislocation dynamics simulations, multi-junctions present very strong, nearly indestructible, obstacles to dislocation motion and furnish new sources for dislocation multiplication, thereby playing an essential role in the evolution of dislocation microstructure and strength of deforming crystals(8). Simulation analyses conclude that multi-junctions are responsible for the strong orientation dependence of strain hardening in body-centred cubic crystals.	Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Stanford University	Bulatov, VV (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	bulatov1@llnl.gov	Pierce, Tristan/HGD-5225-2022	Cai, Wei/0000-0001-5919-8734; Florando, Jeffrey/0000-0002-1592-5503; Arsenlis, Athanasios/0000-0003-4981-1157				Abraham FF, 2002, P NATL ACAD SCI USA, V99, P5783, DOI 10.1073/pnas.062054999; Basinski S. J., 1979, Dislocations in solids, vol.IV. Dislocations in metallurgy, P261; BULATOV VV, 2004, SUPERCOMPUTING; FINNIS MW, 1984, PHILOS MAG A, V50, P45, DOI 10.1080/01418618408244210; FRANCIOSI P, 1980, ACTA METALL MATER, V28, P273, DOI 10.1016/0001-6160(80)90162-5; FRANK FC, 1950, PHYS REV, V79, P722, DOI 10.1103/PhysRev.79.722; Ghoniem NM, 2002, PHIL MAG LETT, V82, P55, DOI 10.1080/09500830110103216; GUIU F, 1966, PHYS STATUS SOLIDI, V15, P539, DOI 10.1002/pssb.19660150214; Hahner P, 1999, MAT SCI ENG A-STRUCT, V272, P443, DOI 10.1016/S0921-5093(99)00527-4; HIRSCH PB, 1956, PHILOS MAG, V1, P677, DOI 10.1080/14786435608244003; HIRTH JP, 1982, THEORY DISLOCATIONS, P269; HIRTH JP, 1982, THEORY DISLOCATIONS, P9; KUBIN LP, 1992, SCRIPTA METALL MATER, V27, P957, DOI 10.1016/0956-716X(92)90456-O; Madec R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.255508; MUGHRABI H, 1983, ACTA METALL MATER, V31, P1367, DOI 10.1016/0001-6160(83)90007-X; NABARRO FRN, 1964, ADV PHYS, V13, P193, DOI 10.1080/00018736400101031; Orowan E, 1934, Z PHYS, V89, P605, DOI 10.1007/BF01341478; Polanyi W, 1934, Z PHYS, V89, P660; SAADA G, 1960, ACTA METALL MATER, V8, P841, DOI 10.1016/0001-6160(60)90150-4; Taylor GI, 1934, P R SOC A, V145, P363	20	220	227	9	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1174	1178		10.1038/nature04658	http://dx.doi.org/10.1038/nature04658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641992	Green Submitted			2022-12-28	WOS:000237080000041
J	Ferradini, L; Jeannin, A; Pinoges, L; Izopet, J; Odhiambo, D; Mankhambo, L; Karungi, G; Szumilin, E; Balandine, S; Fedida, G; Carrieri, MP; Spire, B; Ford, N; Tassie, JM; Guerin, PI; Brasher, C				Ferradini, L; Jeannin, A; Pinoges, L; Izopet, J; Odhiambo, D; Mankhambo, L; Karungi, G; Szumilin, E; Balandine, S; Fedida, G; Carrieri, MP; Spire, B; Ford, N; Tassie, JM; Guerin, PI; Brasher, C			Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment	LANCET			English	Article; Proceedings Paper	12th Conference on Retroviruses and Opportunistic Infections	FEB 22-25, 2005	Boston, MA				RESOURCE-POOR SETTINGS; DRUG-RESISTANCE; ADHERENCE; SURVIVAL; INTERRUPTION; KHAYELITSHA; COMBINATION; HIV/AIDS; ACCESS; SAFETY	Background The recording of outcomes from large-scale, simplified HAART (highly active antiretroviral therapy) programmes in sub-Saharan Africa is critical. We aimed to assess the effectiveness of such a programme held by Medecins Sans Fronteires (MSF) in the Chiradzulu district, Malawi. Methods We scaled up and simplified HAART in this programme since August, 2002. We analysed survival indicators, CD4 count evolution, virological response, and adherence to treatment. We included adults who all started HAART 6 months or more before the analysis. HIV-1 RNA plasma viral load and self-reported adherence were assessed on a subsample of patients, and antiretroviral resistance mutations were analysed in plasma with viral loads greater than 1000 copies per mL. Analysis was by intention to treat. Findings Of the 1308 patients who were eligible, 827 (64%) were female, the median age was 34.9 years (IQR 29.9-41.0), and 1023 (78%) received d4T/3TC/NVP (stavudine, lamivudine, and nevirapine) as a fixed-dose combination. At baseline, 1266 individuals (97%) were HAART-naive, 357 (27%) were at WHO stage IV, 311 (33%) had a body-mass index of less than 18.5 kg/m(2), and 208 (21%) had a CD4 count lower than 50 cells per mu L. At follow-up (median 8.3 months, IQR 5.5-13.1),967 (74%) were still on HAART, 243 (19%) had died, 91 (7%) were lost to follow-up, and seven (0.5%) discontinued treatment. Low body-mass index, WHO stage IV, male sex, and baseline CD4 count lower than 50 cells per mu L were independent determinants of death in the first 6 months. At 12 months, the probability of individuals still in care was 0.76 (95% CI 0.73-0.78) and the median CD4 gain was 165 (IQR 67-259) cells per mu L. In the cross-sectional survey (n = 398), 334 (84%) had a viral load of less than 400 copies per mL. Of several indicators measuring adherence, self-reported poor adherence (<80%) in the past 4 days was the best predictor of detectable viral load (odds ratio 5.4, 95% CI 1.9-15.6). Interpretation These data show that large numbers of people can rapidly benefit from antiretroviral therapy in rural resource-poor settings and strongly supports the implementation of such large-scale simplified programmes in Africa.	Epictr, Paris, France; Med Sans Frontieres, Paris, France; Purpan Hosp, Toulouse, France; Minist Hlth, Chiradzulu, Malawi; INSERM, U379, F-13258 Marseille, France	Doctors Without Borders; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ferradini, L (corresponding author), MSF F Mission Cambodge, 8 Rue St Sabin, F-75011 Paris, France.	msffr.comed@online.com.kh	Spire, Bruno/F-5546-2013; Brasher, Chris/Y-4488-2019; IZOPET, Jacques/L-5756-2014	Spire, Bruno/0000-0002-3546-8020; Brasher, Chris/0000-0003-1037-3604; Carrieri, Patrizia/0000-0002-6794-4837; Guerin, Philippe/0000-0002-6008-2963				Adje C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Calmy A, 2004, AIDS, V18, P2353; Carrieri MP, 2003, ANTIVIR THER, V8, P585; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chimzizi R, 2005, INT J TUBERC LUNG D, V9, P582; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Frater John, 2002, J HIV Ther, V7, P92; *FRENCH ANRS NAT A, AC11 RES GROUP HIV 1; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; Izopet J, 2000, AIDS, V14, P2247, DOI 10.1097/00002030-200010200-00005; Izopet J, 2002, J INFECT DIS, V185, P1506, DOI 10.1086/340215; *JOINT UN PROGR HI, 2004, UNAIDS REP GLOB AIDS; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Kumarasamy N, 2003, AIDS, V17, P2267, DOI 10.1097/00002030-200310170-00019; Kuritzkes DR, 2004, AIDS, V18, pS45, DOI 10.1097/00002030-200406003-00009; Lange JMA, 2004, AIDS, V18, pS69, DOI 10.1097/00002030-200406003-00013; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; *MED SANS FRONT CA, 2005, MSF HIV AIDS TREATM; Mekonnen Y, 2003, ETHIOPIAN MED J, V41, P61; *MIN HLTH POP MAL, 2004, TREATM AIDS 2 YEAR P; Moatti JP, 2004, AIDS, V18, pS55, DOI 10.1097/00002030-200406003-00011; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; *MSF WHO, 2004, ANT THER PRIM HLTH C; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Pasquier C, 1999, J VIROL METHODS, V81, P123, DOI 10.1016/S0166-0934(99)00057-9; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2005, PROGR GLOB ACC HIV A; *WHO, 2003, PREQ WHO LIST; *WHO, TREATING 3 MILLION 2; *WHO, GUID SURV HIV DRUG R; *WHO MSF UNAIDS, 2003, JOINT REP PROC ARVS; World Health Organization, 2004, SCAL ANT THER RES LT	46	363	368	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1335	1342		10.1016/S0140-6736(06)68580-2	http://dx.doi.org/10.1016/S0140-6736(06)68580-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	037AG	16631912				2022-12-28	WOS:000237118500028
J	Ali, MMU; Roe, SM; Vaughan, CK; Meyer, P; Panaretou, B; Piper, PW; Prodromou, C; Pearl, LH				Ali, MMU; Roe, SM; Vaughan, CK; Meyer, P; Panaretou, B; Piper, PW; Prodromou, C; Pearl, LH			Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex	NATURE			English	Article							HSP90 MOLECULAR CHAPERONE; N-TERMINAL DOMAIN; ESCHERICHIA-COLI HSP90; SHOCK-PROTEIN 90; ATPASE ACTIVITY; CLIENT PROTEIN; STEROID-RECEPTOR; BINDING SITE; IN-VIVO; P23	Hsp90 (heat shock protein of 90 kDa) is a ubiquitous molecular chaperone responsible for the assembly and regulation of many eukaryotic signalling systems and is an emerging target for rational chemotherapy of many cancers. Although the structures of isolated domains of Hsp90 have been determined, the arrangement and ATP-dependent dynamics of these in the full Hsp90 dimer have been elusive and contentious. Here we present the crystal structure of full-length yeast Hsp90 in complex with an ATP analogue and the co-chaperone p23/Sba1. The structure reveals the complex architecture of the 'closed' state of the Hsp90 chaperone, the extensive interactions between domains and between protein chains, the detailed conformational changes in the amino-terminal domain that accompany ATP binding, and the structural basis for stabilization of the closed state by p23/Sba1. Contrary to expectations, the closed Hsp90 would not enclose its client proteins but provides a bipartite binding surface whose formation and disruption are coupled to the chaperone ATPase cycle.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Kings Coll London, Pharmaceut Sci Res Div, London SE1 9NN, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; University of Sheffield	Pearl, LH (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	laurence.pearl@icr.ac.uk	Prodromou, Chrisostomos/ABA-9133-2021; Meyer, Philippe/AAC-6038-2019	Prodromou, Chrisostomos/0000-0003-4320-1147; Meyer, Philippe/0000-0002-6220-0679; Roe, Mark/0000-0002-7371-9855; Piper, Peter William/0000-0003-4019-2329; Pearl, Laurence/0000-0002-6910-1809	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Cheung KMJ, 2005, BIOORG MED CHEM LETT, V15, P3338, DOI 10.1016/j.bmcl.2005.05.046; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Huai Q, 2005, STRUCTURE, V13, P579, DOI 10.1016/j.str.2004.12.018; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Oxelmark E, 2003, J BIOL CHEM, V278, P36547, DOI 10.1074/jbc.M305960200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pratt WB, 1998, TRENDS ENDOCRIN MET, V9, P244, DOI 10.1016/S1043-2760(98)00059-9; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	44	691	712	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					1013	1017		10.1038/nature04716	http://dx.doi.org/10.1038/nature04716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625188	Green Accepted			2022-12-28	WOS:000236906000027
J	Kong, TK; To, WK				Kong, TK; To, WK			Bird-mite infestation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Princess Margaret Hosp, Hong Kong, Hong Kong, Peoples R China		Kong, TK (corresponding author), Princess Margaret Hosp, Hong Kong, Hong Kong, Peoples R China.		KONG, Tak-kwan/T-6061-2018	KONG, Tak-kwan/0000-0003-4340-7479					0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1728	1728		10.1056/NEJMicm050608	http://dx.doi.org/10.1056/NEJMicm050608			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16625011				2022-12-28	WOS:000236893900009
J	Johnstone, RE				Johnstone, RE			Last words	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												JohnstoneR@rcbhsc.wvu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1624	1624		10.1001/jama.295.14.1624	http://dx.doi.org/10.1001/jama.295.14.1624			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609075				2022-12-28	WOS:000236707300001
J	Bernat, JL				Bernat, JL			Chronic disorders of consciousness	LANCET			English	Review							PERSISTENT VEGETATIVE STATE; SEVERE BRAIN-INJURY; GLASGOW COMA SCALE; SOMATOSENSORY EVOKED-POTENTIALS; REGIONAL CEREBRAL METABOLISM; SENSORY MODALITY ASSESSMENT; MEDICAL DECISION-MAKING; DIFFUSE AXONAL INJURY; WESSEX HEAD-INJURY; LOCKED-IN SYNDROME	The vegetative state and the minimally conscious state are disorders of consciousness that can be acute and reversible or chronic and irreversible. Diffuse lesions of the thalami, cortical neurons, or the white-matter tracts that connect them cause the vegetative state, which is wakefulness without awareness. Functional imaging with PET and functional MRI shows activation of primary cortical areas with stimulation, but not of secondary areas or distributed neural networks that would indicate awareness. Vegetative state has a poor prognosis for recovery of awareness when present for more than a year in traumatic cases and for 3 months in non-traumatic cases. Patients in minimally conscious state are poorly responsive to stimuli, but show intermittent awareness behaviours. Indeed, findings of preliminary functional imaging studies suggest that some patients could have substantially intact awareness. The outcomes of minimally conscious state are variable. Stimulation treatments have been disappointing in vegetative state but occasionally improve minimally conscious state. Treatment decisions for patients in vegetative state or minimally conscious state should follow established ethical and legal principles and accepted practice guidelines of professional medical specialty societies.	Dartmouth Med Sch, Hanover, NH USA	Dartmouth College	Bernat, JL (corresponding author), Dartmouth Hitchcock Med Ctr, Neurol Sect, Lebanon, NH 03756 USA.	bernat@dartmouth.edu						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; Alkire MT, 1999, ANESTHESIOLOGY, V90, P701, DOI 10.1097/00000542-199903000-00011; Allain P, 1998, CORTEX, V34, P629, DOI 10.1016/S0010-9452(08)70520-3; Andrews K, 2004, NEUROREHABILITATION, V19, P299; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1992, BRIT MED J, V305, P486, DOI 10.1136/bmj.305.6852.486; ANDREWS K, 1993, BMJ-BRIT MED J, V300, P1597; Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; [Anonymous], 2003, Clin Med (Lond), V3, P249; [Anonymous], 2005, ANN INTERN MED, V142, P1019, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00013; [Anonymous], 1989, NEUROLOGY, V39, P125; [Anonymous], 1990, JAMA, V263, P426; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ARTS WFM, 1985, J NEUROL NEUROSUR PS, V48, P1300, DOI 10.1136/jnnp.48.12.1300; Asai A, 1999, J MED ETHICS, V25, P302, DOI 10.1136/jme.25.4.302; ASHWAL S, 1994, PEDIATR NEUROL, V10, P27, DOI 10.1016/0887-8994(94)90063-9; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ashwal S, 2004, NEUROREHABILITATION, V19, P349; Ashwal S, 2003, BRAIN DEV-JPN, V25, P535, DOI 10.1016/S0387-7604(03)00095-0; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; ASHWAL S, 1992, ANN NEUROL, V32, P570, DOI 10.1002/ana.410320414; Ashwal Stephen, 2002, Semin Pediatr Neurol, V9, P19, DOI 10.1053/spen.2002.30334; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P788, DOI 10.1136/jnnp.2003.034876; Beresford HR, 1997, ANN NY ACAD SCI, V835, P386, DOI 10.1111/j.1749-6632.1997.tb48644.x; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bernat J L, 1992, J Clin Ethics, V3, P176; Bernat JL, 2004, NEUROCRIT CARE, V1, P107, DOI 10.1385/NCC:1:1:107; Bernat JL, 2002, NEUROLOGY, V58, P337, DOI 10.1212/WNL.58.3.337; Bernat JL, 2001, NEUROLOGY, V56, P144, DOI 10.1212/WNL.56.2.144; BERNAT JL, 2002, ETHICAL ISSUES NEURO, P283; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Black D, 1996, J ROY COLL PHYS LOND, V30, P119; Block N, 1997, NATURE CONSCIOUSNESS; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Bonito V, 2002, NEUROL SCI, V23, P131, DOI 10.1007/s100720200040; Borthwick CJ, 2004, NEUROREHABILITATION, V19, P381; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRIERLEY JB, 1971, LANCET, V2, P560; *BRIT MED ASS, 1996, BMA GUID TREATM DEC; BRUNKO E, 1987, ELECTROEN CLIN NEURO, V66, P15, DOI 10.1016/0013-4694(87)90133-7; Bush MC, 2003, OBSTET GYNECOL SURV, V58, P738, DOI 10.1097/01.OGX.0000093268.20608.53; Cairns H, 1941, BRAIN, V64, P273, DOI 10.1093/brain/64.4.273; Carver AC, 1999, NEUROLOGY, V53, P284, DOI 10.1212/WNL.53.2.284; CELESIA, 1993, ANN NEUROL, V33, P386; Chalela JA, 2001, NEUROLOGY, V56, P481, DOI 10.1212/WNL.56.4.481; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman D, 2002, NEUROLOGY, V58, P506, DOI 10.1212/WNL.58.3.506; Coleman MR, 2005, J NEUROL NEUROSUR PS, V76, P432, DOI 10.1136/jnnp.2004.045930; DANZE F, 1989, Neurosurgical Review, V12, P477, DOI 10.1007/BF01790694; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Els T, 2004, ACTA NEUROL SCAND, V110, P361, DOI 10.1111/j.1600-0404.2004.00342.x; Farah MJ, 2005, TRENDS COGN SCI, V9, P34, DOI 10.1016/j.tics.2004.12.001; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; FRANK LM, 1985, NEUROLOGY, V35, P931, DOI 10.1212/WNL.35.6.931; Garrard P, 2002, J NEUROL NEUROSUR PS, V73, P191, DOI 10.1136/jnnp.73.2.191; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2005, PROG BRAIN RES, V150, P381, DOI 10.1016/S0079-6123(05)50027-X; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2003, J HEAD TRAUMA REHAB, V18, P4, DOI 10.1097/00001199-200301000-00003; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; Grubb A, 1996, LANCET, V348, P35, DOI 10.1016/S0140-6736(96)02030-2; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Hamel MB, 2002, CRIT CARE MED, V30, P1191, DOI 10.1097/00003246-200206000-00002; HANSOTIA PL, 1985, ARCH NEUROL-CHICAGO, V42, P1048, DOI 10.1001/archneur.1985.04060100030015; Hattori N, 2003, J NUCL MED, V44, P1709; HAWKES CH, 1974, NEUROLOGY, V24, P1015, DOI 10.1212/WNL.24.11.1015; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; Hook CC, 2005, MAYO CLIN PROC, V80, P1449, DOI 10.4065/80.11.1449; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; Howard RS, 1999, BLUE BOOK PRACT NEUR, V22, P91; HOWARD RS, 1995, BRIT MED J, V310, P341, DOI 10.1136/bmj.310.6976.341; Howsepian AA, 1996, ISSUES LAW MED, V12, P3; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; JENNETT B, 2002, VEGETATIVE STATE MED; Jones SJ, 2000, BRAIN, V123, P1007, DOI 10.1093/brain/123.5.1007; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Keown J, 1997, Law Q Rev, V113, P481; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kretschmer E, 1940, Z GESAMTE NEUROL PSY, V169, P576, DOI 10.1007/BF02871384; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; LAHRMANN H, 2004, PALLIATIVE CARE NEUR, P135; Laine C, 1996, JAMA-J AM MED ASSOC, V275, P152, DOI 10.1001/jama.275.2.152; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2002, ACTA NEUROL BELG, V102, P176; Laureys S., 2003, European Journal of Neurology, V10, P224; Laureys S, 2000, LANCET, V355, P1825, DOI 10.1016/S0140-6736(05)73084-1; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Lavrijsen JCM, 2005, J NEUROL NEUROSUR PS, V76, P1420, DOI 10.1136/jnnp.2004.058198; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Madl C, 1996, ARCH NEUROL-CHICAGO, V53, P512, DOI 10.1001/archneur.1996.00550060054017; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Majerus S, 2000, NEUROPSYCHOL REHABIL, V10, P167, DOI 10.1080/096020100389237; MAROSI M, 1993, LANCET, V341, P1473, DOI 10.1016/0140-6736(93)90914-3; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; MCQUILLEN MP, 1991, ISSUES LAW MED, V6, P373; *MED EX DISTR 6, 2005, PASC PIN COUNT FLOR; Mega MS, 1997, NEUROPSY NEUROPSY BE, V10, P254; Meisel Alan, 1992, Law Med Health Care, V20, P340; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Montane E, 2004, NEUROLOGY, V63, P1357; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; MULLIE A, 1988, LANCET, V1, P137; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; ODell MW, 1996, NEUROREHABILITATION, V6, P45, DOI 10.3233/NRE-1996-6106; Oksenberg A, 2000, SLEEP, V23, P953; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Papermaster DS, 2001, INVEST OPHTH VIS SCI, V42, P1; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; Payne K, 1996, ANN INTERN MED, V125, P104, DOI 10.7326/0003-4819-125-2-199607150-00004; Phipps E, 1999, AM J PHYS MED REHAB, V78, P77, DOI 10.1097/00002060-199901000-00020; Pilon M, 1996, BRAIN INJURY, V10, P421, DOI 10.1080/026990596124287; Plum F, 1980, DIAGNOSIS STUPOR COM, Vthird; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; ROSENBERG GA, 1977, ANN NEUROL, V2, P167, DOI 10.1002/ana.410020215; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; *ROYAL COLL PHYS, 2003, REH FOLL ACQ BRAIN I, P8; Rudolf J, 1999, J NEUROSURG ANESTH, V11, P17, DOI 10.1097/00008506-199901000-00004; Sandel ME, 1996, NEUROREHABILITATION, V6, P9, DOI 10.3233/NRE-1996-6103; Schaafsma A, 2003, J NEUROL SCI, V210, P23, DOI 10.1016/S0022-510X(03)00063-7; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2005, PROG BRAIN RES, V150, P473, DOI 10.1016/S0079-6123(05)50033-5; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Shewmon DA, 2004, NEUROREHABILITATION, V19, P343; Shewmon DA, 2002, NEUROLOGY, V58, P506; SHEWMON DA, 1989, NEUROL CLIN, V7, P823, DOI 10.1016/S0733-8619(18)30392-X; Shewmon DA, 1999, DEV MED CHILD NEUROL, V41, P364, DOI 10.1017/S0012162299000821; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shiel A, 2004, BRIT J NEUROSURG, V18, P5, DOI 10.1080/02688690410001660625; Showalter PEC, 2000, BRAIN INJURY, V14, P997; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; SNYDER BD, 1983, ANN NEUROL, V14, P152; Stepan C, 2004, EUR J NEUROL, V11, P461, DOI 10.1111/j.1468-1331.2004.00817.x; Strens LHA, 2004, BRAIN INJURY, V18, P213, DOI 10.1080/0269905031000149533; TEASDALE G, 1974, LANCET, V2, P81; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Volicer L, 1997, ARCH NEUROL-CHICAGO, V54, P1382, DOI 10.1001/archneur.1997.00550230051016; Wade DT, 2001, BMJ-BRIT MED J, V322, P352, DOI 10.1136/bmj.322.7282.352; WALSHE TM, 1985, ARCH NEUROL-CHICAGO, V42, P1045, DOI 10.1001/archneur.1985.04060100027014; *WHO, 1989, STAT PERS VEG STAT; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; Wijdicks Eelco F. M., 2001, BRAIN DEATH; Wijdicks EFM, 2005, MAYO CLIN PROC, V80, P1037, DOI 10.4065/80.8.1037; Wilson BA, 2001, BRAIN INJURY, V15, P1083, DOI 10.1080/02699050110082197; Wilson FC, 2002, NEUROREHABILITATION, V17, P231; Winslade WJ, 2004, J HEAD TRAUMA REHAB, V19, P178, DOI 10.1097/00001199-200403000-00008; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; Yamamoto T, 2003, ACTA NEUROCHIR SUPPL, V87, P15; Yingling CD, 2001, CLIN NEUROPHYSIOL, V112, P157, DOI 10.1016/S1388-2457(00)00507-1; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8; ZASLER ND, 1995, J HEAD TRAUMA REHAB, V10, P101, DOI 10.1097/00001199-199508000-00010; Zasler ND, 2004, NEUROREHABILITATION, V19, P285; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263; Zeman A, 1997, LANCET, V350, P795, DOI 10.1016/S0140-6736(97)06447-7; Zeman A., 2003, ADV CLIN NEUROSCI RE, V3, P12; [No title captured]	198	209	224	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1181	1192		10.1016/S0140-6736(06)68508-5	http://dx.doi.org/10.1016/S0140-6736(06)68508-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030ZH	16616561				2022-12-28	WOS:000236673400027
J	Loewenstein, G				Loewenstein, G			The pleasures and pains of information	SCIENCE			English	Editorial Material							NEUROECONOMICS; ECONOMICS		Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Loewenstein, G (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	gl20@andrew.cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474				Baumeister, 2003, TIME DECISION EC PSY, P441; BENABOU R, IN PRESS J AM EC REV; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Bodner R, 2002, COLLECTED ESSAYS PSY; Brunnermeier MK, 2005, AM ECON REV, V95, P1092, DOI 10.1257/0002828054825493; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; DITTO PH, 1992, J PERS SOC PSYCHOL, V63, P568, DOI 10.1037/0022-3514.63.4.568; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; HARE RD, 1966, J ABNORMAL SOCIAL PS, V70, P442; KARLSSON N, SOCIAL SCI RES NETWO; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; Loewenstein George, 1992, CHOICE TIME, P3, DOI DOI 10.1037/A0019486; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Rabin M, 1999, Q J ECON, V114, P37, DOI 10.1162/003355399555945; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Shiv B, 2005, PSYCHOL SCI, V16, P435; STIGLER GJ, 1961, J POLIT ECON, V69, P213, DOI 10.1086/258464	19	41	41	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					704	706		10.1126/science.1128388	http://dx.doi.org/10.1126/science.1128388			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039NF	16675688				2022-12-28	WOS:000237312100035
J	Gridi-Papp, M; Rand, AS; Ryan, MJ				Gridi-Papp, M; Rand, AS; Ryan, MJ			Animal communication: Complex call production in the tungara frog	NATURE			English	Article							PHYSALAEMUS-PUSTULOSUS; SEXUAL SELECTION; MORPHOLOGY; SYRINX		Smithsonian Trop Res Inst, Balboa, Panama; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Univ Estadual Paulista, Inst Biociencias, Dept Zool, BR-13506900 Sao Paulo, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Texas System; University of Texas Austin; Universidade de Sao Paulo; Universidade Estadual Paulista	Gridi-Papp, M (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA.	mryan@mail.utexas.edu						Boul KE, 2004, COPEIA, P624, DOI 10.1643/CH-03-153R2; DREWRY GE, 1982, COPEIA, P636, DOI 10.2307/1444664; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Greenwalt C.H., 1968, BIRD SONG ACOUSTICS; Ryan M. J., 1985, TUNGARA FROG STUDY S; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1990, BIOL J LINN SOC, V40, P37, DOI 10.1111/j.1095-8312.1990.tb00533.x; SUTHERS RA, 1990, NATURE, V347, P473, DOI 10.1038/347473a0	10	78	80	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					38	38		10.1038/441038a	http://dx.doi.org/10.1038/441038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672962				2022-12-28	WOS:000237248600025
J	Schmiedel, S; Ehrhardt, S; Moll, I; Burchard, GD				Schmiedel, S; Ehrhardt, S; Moll, I; Burchard, GD			A Thai patient with generalised inflammatory skin disease 18 years after migration to Europe	LANCET			English	Editorial Material							LEPROSY		Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Dermatol & Venereol, D-20246 Hamburg, Germany; Bernhard Nocht Hosp, Dept Med 1, D-20246 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg	Ehrhardt, S (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	ehrhardt@bni-hamburg.de	Ehrhardt, Stephan/D-8957-2017					Boggild AK, 2004, CAN MED ASSOC J, V170, P55; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Gill AL, 2005, QJM-INT J MED, V98, P505, DOI 10.1093/qjmed/hci079; Lockwood DNJ, 2001, QJM-INT J MED, V94, P207, DOI 10.1093/qjmed/94.4.207; Ooi WW, 2001, CLIN INFECT DIS, V32, P930, DOI 10.1086/319357	5	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1458	1458		10.1016/S0140-6736(06)68617-0	http://dx.doi.org/10.1016/S0140-6736(06)68617-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650656				2022-12-28	WOS:000237195600034
J	Watts, G				Watts, G			You need hands	LANCET			English	Editorial Material							TEACHERS GESTURES				Watts, G (corresponding author), 28 New End Sq, London NW3 1LS, England.	geoff@scileg.freeserve.co.uk						Goldin-Meadow S, 2003, HEARING GESTURE OUR; GOLDINMEADOW S, 2006, ADV SCI SERV SOC M S; NICOLADIS E, 2005, 10 INT ASS STUD CHIL; Perry M., 1995, CONT LEGAL ISSUES, V6, P213; Singer MA, 2005, PSYCHOL SCI, V16, P85, DOI 10.1111/j.0956-7976.2005.00786.x; Valenzeno L, 2003, CONTEMP EDUC PSYCHOL, V28, P187, DOI 10.1016/S0361-476X(02)00007-3; Wagner SM, 2004, J MEM LANG, V50, P395, DOI 10.1016/j.jml.2004.01.002	7	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1383	1384		10.1016/S0140-6736(06)68595-4	http://dx.doi.org/10.1016/S0140-6736(06)68595-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650637				2022-12-28	WOS:000237195600011
J	Eyre-Walker, A				Eyre-Walker, A			Evolution - Size does not matter for mitochondrial DNA	SCIENCE			English	Editorial Material									Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England	The National Evolutionary Synthesis Center; University of Sussex	Eyre-Walker, A (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC 27705 USA.	a.c.eyre-walker@sussex.ac.uks	Eyre-Walker, Adam/G-6216-2011	Eyre-Walker, Adam/0000-0001-5527-8729				Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Gillespie JH, 2000, GENETICS, V155, P909; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Lewontin RC, 1974, GENETIC BASIS EVOLUT	5	15	15	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					537	538		10.1126/science.1127182	http://dx.doi.org/10.1126/science.1127182			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645084				2022-12-28	WOS:000237296700031
J	Jahn, R				Jahn, R			Neuroscience - A neuronal receptor for botulinum toxin	SCIENCE			English	Editorial Material							PROTEIN; NEUROTOXIN		Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de		Jahn, Reinhard/0000-0003-1542-3498				AHNERTHILGER G, 1995, PROG NEUROBIOL, V46, P83, DOI 10.1016/0301-0082(95)00003-E; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; DONG M, 2006, SCIENCE         0316; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412	8	26	29	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					540	541		10.1126/science.1127236	http://dx.doi.org/10.1126/science.1127236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645086				2022-12-28	WOS:000237296700033
J	Mao, WL; Mao, HK; Sturhahn, W; Zhao, JY; Prakapenka, VB; Meng, Y; Shu, JF; Fei, YW; Hemley, RJ				Mao, WL; Mao, HK; Sturhahn, W; Zhao, JY; Prakapenka, VB; Meng, Y; Shu, JF; Fei, YW; Hemley, RJ			Iron-rich post-perovskite and the origin of ultralow-velocity zones	SCIENCE			English	Article							CORE-MANTLE BOUNDARY; SEISMIC EVIDENCE; CONSTRAINTS; DENSITY; BASE	The boundary layer between the crystalline silicate lower mantle and the liquid iron core contains regions with ultralow seismic velocities. Such low compressional and shear wave velocities and high Poisson's ratio are also observed experimentally in post-perovskite silicate phase containing up to 40 mol% FeSiO3 endmember. The iron-rich post-perovskite silicate is stable at the pressure-temperature and chemical environment of the core-mantle boundary and can be formed by core-mantle reaction. Mantle dynamics may lead to further accumulation of this material into the ultralow-velocity patches that are observable by seismology.	Los Alamos Natl Lab, Lujan Neutron Scattering Ctr, Los Alamos, NM 87545 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; Argonne Natl Lab, Adv Photon Source, Xray Operat & Res, Argonne, IL 60439 USA; Argonne Natl Lab, High Pressure Collaborat Access Team, Argonne, IL 60439 USA; Univ Chicago, Chicago, IL 60637 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Carnegie Institution for Science; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Mao, WL (corresponding author), Los Alamos Natl Lab, Lujan Neutron Scattering Ctr, POB 1663, Los Alamos, NM 87545 USA.	wmao@lanl.gov	Fei, Yingwei/F-3709-2011; Mao, Wendy/D-1885-2009	Fei, Yingwei/0000-0001-9955-5353; 				Bassett W. A., 1972, Physics of the Earth and Planetary Interiors, V6, P154, DOI 10.1016/0031-9201(72)90048-9; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fei YW, 1996, J GEOPHYS RES-SOL EA, V101, P11525, DOI 10.1029/96JB00408; Garnero EJ, 2004, SCIENCE, V304, P834, DOI 10.1126/science.1097849; Helmberger DV, 1998, NATURE, V396, P251, DOI 10.1038/24357; Hu MY, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094304; Ishii M, 1999, SCIENCE, V285, P1231, DOI 10.1126/science.285.5431.1231; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Mao WL, 2005, P NATL ACAD SCI USA, V102, P9751, DOI 10.1073/pnas.0503737102; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Petford N, 2005, EARTH PLANETS SPACE, V57, P459, DOI 10.1186/BF03351834; Rost S, 2005, NATURE, V435, P666, DOI 10.1038/nature03620; Rost S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001627; STURHAHN W, 1995, PHYS REV LETT, V74, P3832, DOI 10.1103/PhysRevLett.74.3832; Thorne MS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003010; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996; Wen LX, 1998, SCIENCE, V279, P1701, DOI 10.1126/science.279.5357.1701; Wen LX, 2001, EARTH PLANET SC LETT, V189, P141, DOI 10.1016/S0012-821X(01)00365-X; Wentzcovitch RM, 2006, P NATL ACAD SCI USA, V103, P543, DOI 10.1073/pnas.0506879103; Williams Q, 1998, SCIENCE, V281, P546, DOI 10.1126/science.281.5376.546; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528	21	184	191	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					564	565		10.1126/science.1123442	http://dx.doi.org/10.1126/science.1123442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645091				2022-12-28	WOS:000237296700041
J	Midorikawa, R; Takei, Y; Hirokawa, N				Midorikawa, R; Takei, Y; Hirokawa, N			KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity	CELL			English	Article							NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; NERVOUS-SYSTEM; DNA FRAGMENTATION; NUCLEAR CALCIUM; KINESIN; PROTEIN; TRANSCRIPTION; EXPRESSION; DEATH	In brain development, apoptosis is a physiological process that controls the final numbers of neurons. Here, we report that the activity-dependent prevention of apoptosis in juvenile neurons is regulated by kinesin superfamily protein 4 (KIF4), a microtubule-based molecular motor. The C-terminal domain of KIF4 is a module that suppresses the activity of poly (ADPribose) polymerase-1 (PARP-1), a nuclear enzyme known to maintain cell homeostasis by repairing DNA and serving as a transcriptional regulator. When neurons are stimulated by membrane depolarization, calcium signaling mediated by CaMKII induces dissociation of KIF4 from PARP-1, resulting in upregulation of PARP-1 activity, which supports neuron survival. After dissociation from PARP-1, KIF4 enters into the cytoplasm from the nucleus and moves to the distal part of neurites in a microtubule-dependent manner. We suggested that KIF4 controls the activity-dependent survival of postmitotic neurons by regulating PARP-1 activity in brain development.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Takei, Yosuke/I-1828-2015	Takei, Yosuke/0000-0002-5026-8027; Midorikawa, Ryosuke/0000-0002-5163-7744				AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Cohen-Armon M, 2004, SCIENCE, V304, P1820, DOI 10.1126/science.1096775; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DIDIER M, 1994, EUR J NEUROSCI, V6, P1536, DOI 10.1111/j.1460-9568.1994.tb00544.x; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLO V, 1992, J NEUROCHEM, V58, P406, DOI 10.1111/j.1471-4159.1992.tb09737.x; Garnier P, 2003, J NEUROSCI, V23, P7967; Gilliams-Francis KL, 2003, EXP NEUROL, V184, P359, DOI 10.1016/j.expneurol.2003.07.003; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; HORNBURG S, 2000, J CELL BIOL, V150, P293; Ikeuchi T, 1998, Hum Cell, V11, P125; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kawahara A, 1998, GENES CELLS, V3, P297, DOI 10.1046/j.1365-2443.1998.00189.x; KOCSIS JD, 1994, J NEUROBIOL, V25, P252, DOI 10.1002/neu.480250306; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Lin WW, 1997, J NEUROCHEM, V68, P2577; Macho B, 2002, SCIENCE, V298, P2388, DOI 10.1126/science.1077265; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Mandir AS, 2000, J NEUROSCI, V20, P8005; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nicoletti VG, 2003, NEUROCHEM RES, V28, P187, DOI 10.1023/A:1022316914492; Oh S, 2000, BBA-GENE STRUCT EXPR, V1493, P219, DOI 10.1016/S0167-4781(00)00151-2; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; SCHRAUFSTATTER IU, 1988, METHOD ENZYMOL, V163, P328; SCOVASSI AI, 1984, J BIOL CHEM, V259, P973; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; WANG SZ, 1995, J CELL BIOL, V128, P761, DOI 10.1083/jcb.128.5.761; Weller M, 1997, J NEURAL TRANSM-SUPP, P115; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	47	91	95	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					371	383		10.1016/j.cell.2006.02.039	http://dx.doi.org/10.1016/j.cell.2006.02.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630823	Bronze			2022-12-28	WOS:000237241500025
J	Bramstedt, KA				Bramstedt, KA			When pharmacists refuse to dispense prescriptions	LANCET			English	Editorial Material									Cleveland Clin Fdn, Cleveland Clin, Lerner Coll Med, Dept Bioeth, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Bramstedt, KA (corresponding author), Cleveland Clin Fdn, Cleveland Clin, Lerner Coll Med, Dept Bioeth, 9500 Euclid Ave, Cleveland, OH 44195 USA.	txbioethics@yahoo.com	Bramstedt, Katrina Andrea/J-4785-2019	Bramstedt, Katrina Andrea/0000-0001-5446-0123				*AM MED ASS, 2006, D120975 AM MED ASS; *AM MED ASS, 2004, COD ETH; *AM PHARM ASS, 2005, PHARM PRACT ACT CLAS; Cantor J, 2004, NEW ENGL J MED, V351, P2008, DOI 10.1056/NEJMsb042263; Drazen JM, 2004, NEW ENGL J MED, V350, P1561, DOI 10.1056/NEJMe048057; Greenberger MD, 2005, SCIENCE, V308, P1557, DOI 10.1126/science.1114466; Guerrero RM, 1996, AM J HEALTH-SYST PH, V53, P548, DOI 10.1093/ajhp/53.5.548; JOHNSON A, 2005, STATE PROBES DRUG RE; *REUT, 2004, TEX PHARM REF PILL W; WINCKLER SC, 2005, PREVENTION, V57, P170; WINCKLER SC, 2004, UNPUB COMMUNICA 0701	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1219	1220		10.1016/S0140-6736(06)68517-6	http://dx.doi.org/10.1016/S0140-6736(06)68517-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	034FC	16631862				2022-12-28	WOS:000236913400006
J	McKee, M; Atun, R				McKee, M; Atun, R			Beyond borders: public-health surveillance	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ London Imperial Coll Sci Technol & Med, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk	Atun, Rifat/AAH-5537-2021; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; McKee, Martin/0000-0002-0121-9683; Atun, Rifat/0000-0002-1531-5983				ATUN RA, 2004, FUNCTIONAL ANAL STEW; ATUN RA, 2005, REV HLTH SYSTEM NO C; Awad R., 2001, Eastern Mediterranean Health Journal, V7, P274; *BBC, 2006, TURK BATTL STEM BIRD; Bobbitt P, 2003, SHIELD ACHILLES WAR; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; CONDON RE, 1986, LANCET, V1, P159; Fidler D. P, 1999, INT LAW INFECT DIS; Merianos A, 2005, LANCET, V366, P1249, DOI 10.1016/S0140-6736(05)67508-3; SIEGEL J, 2005, JERUSALEM POST  1216, P6	10	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2006	367	9518					1224	1226		10.1016/S0140-6736(06)68520-6	http://dx.doi.org/10.1016/S0140-6736(06)68520-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	034FC	16631865				2022-12-28	WOS:000236913400009
J	Huang, XX; Hansen, N; Tsuji, N				Huang, XX; Hansen, N; Tsuji, N			Hardening by annealing and softening by deformation in nanostructured metals	SCIENCE			English	Article							LARGE STRAINS; STRENGTH; MICROSTRUCTURE; ALUMINUM; COPPER	We observe that a nanostructured metal can be hardened by annealing and softened when subsequently deformed, which is in contrast to the typical behavior of a metal. Microstructural investigation points to an effect of the structural scale on fundamental mechanisms of dislocation-dislocation and dislocation-interface reactions, such that heat treatment reduces the generation and interaction of dislocations, leading to an increase in strength and a reduction in ductility. A subsequent deformation step may restore the dislocation structure and facilitate the yielding process when the metal is stressed. As a consequence, the strength decreases and the ductility increases. These observations suggest that for materials such as the nanostructured aluminum studied here, deformation should be used as an optimizing procedure instead of annealing.	Riso Natl Lab, Mat Res Dept, Ctr Fundamental Res Met Struct 4 Dimens, DK-4000 Roskilde, Denmark; Osaka Univ, Grad Sch Engn, Dept Adapt Machine Syst, Suita, Osaka 5650871, Japan	Technical University of Denmark; Osaka University	Huang, XX (corresponding author), Riso Natl Lab, Mat Res Dept, Ctr Fundamental Res Met Struct 4 Dimens, DK-4000 Roskilde, Denmark.	xiaoxu.huang@risoe.dk	Hansen, Niels/B-2218-2018; Huang, Xiaoxu/AFV-2572-2022; Tsuji, Nobuhiro/F-7951-2010; Huang, Xiaoxu/N-2856-2017	Tsuji, Nobuhiro/0000-0002-2132-1327; Huang, Xiaoxu/0000-0002-4635-6112				Bowen JR, 2004, MAT SCI ENG A-STRUCT, V387, P235, DOI 10.1016/j.msea.2004.01.127; Ebrahimi F, 1998, SCRIPTA MATER, V39, P315, DOI 10.1016/S1359-6462(98)00164-X; FOUGERE GE, 1992, SCRIPTA METALL MATER, V26, P1879, DOI 10.1016/0956-716X(92)90052-G; Greer JR, 2005, ACTA MATER, V53, P1821, DOI 10.1016/j.actamat.2004.12.031; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Hasnaoui A, 2002, ACTA MATER, V50, P3927, DOI 10.1016/S1359-6454(02)00195-7; Hughes DA, 2000, ACTA MATER, V48, P2985, DOI 10.1016/S1359-6454(00)00082-3; Kamikawa N., 2005, THESIS OSAKA U; LANGUILLAUME J, 1993, ACTA METALL MATER, V41, P2953, DOI 10.1016/0956-7151(93)90110-E; Li BL, 2004, ACTA MATER, V52, P1069, DOI 10.1016/j.actamat.2003.10.040; Liu Q, 2002, ACTA MATER, V50, P3789, DOI 10.1016/S1359-6454(02)00174-X; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Tsuji N, 2003, MAT SCI ENG A-STRUCT, V350, P108, DOI 10.1016/S0921-5093(02)00709-8; Tsuji N, 2003, ADV ENG MATER, V5, P338, DOI 10.1002/adem.200310077; VALIEV RZ, 1992, SCRIPTA METALL MATER, V27, P855, DOI 10.1016/0956-716X(92)90405-4; Wang YM, 2004, SCRIPTA MATER, V51, P1023, DOI 10.1016/j.scriptamat.2004.08.015; Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133; Weertman J., 1993, SOLID STATE PHENOM, V35-36, P249; WEERTMAN JR, 1993, MAT SCI ENG A-STRUCT, V166, P161, DOI 10.1016/0921-5093(93)90319-A	20	566	588	15	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					249	251		10.1126/science.1124268	http://dx.doi.org/10.1126/science.1124268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614217				2022-12-28	WOS:000236765300043
J	Wilkinson, R; Pickett, KE				Wilkinson, R; Pickett, KE			Health inequalities and the UK presidency of the EU	LANCET			English	Editorial Material									Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England; Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Nottingham; University of York - UK	Wilkinson, R (corresponding author), Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England.	Richard.Wilkinson@Nottingham.ac.uk						BREWER M, 2005, 9 I FISC STUD; *DEP HLTH, 2005, TACKL HLTH IN STAT R; Department of Health, 2000, NHS PLAN PLAN INV PL; *EUR COMM, PROGR COMM ACT FIELD; Judge K., 2005, HLTH INEQUALITIES CH; MACKENBACH J, 2005, HLTH IN EUR PROF; Marmot M, 2004, STATUS SYNDROME; *OECD PROGR INT ST, 2004, LEARN TOM WORLD 1 RE; *UK PRES EU 2005, 2005, EMPL SOC POL HLTH CO; *UN DEV PROGR, 2003, HUM DEV REP; Wilkinson R, 2005, IMPACT INEQUALITY MA; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036	12	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1126	1128		10.1016/S0140-6736(06)68489-4	http://dx.doi.org/10.1016/S0140-6736(06)68489-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030ZH	16616546				2022-12-28	WOS:000236673400008
J	Kang, YS; Do, YY; Lee, HK; Park, SH; Cheong, C; Lynch, RM; Loeffler, JM; Steinman, RM; Park, CG				Kang, YS; Do, YY; Lee, HK; Park, SH; Cheong, C; Lynch, RM; Loeffler, JM; Steinman, RM; Park, CG			A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q	CELL			English	Article							MARGINAL-ZONE MACROPHAGES; MANNOSE-BINDING LECTIN; C-TYPE LECTIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; BLOOD-BORNE ANTIGENS; DC-SIGN; CAPSULAR POLYSACCHARIDE; ANTIBODY-RESPONSE; INNATE IMMUNITY; MEDIATES UPTAKE	The intricate system of serum complement proteins provides resistance to infection. A pivotal step in the complement pathway is the assembly of a C3 convertase, which digests the C3 complement component to form microbial binding C3 fragments recognized by leukocytes. The spleen and C3 provide resistance against blood-borne S. pneurnomae infection. To better understand the mechanisms involved, we studied SIGN-R1, a lectin that captures microbial polysaccharides in spleen. Surprisingly, conditional SIGN-R1 knockout mice developed deficits in C3 catabolism when given S. pneumoniae or its capsular polysaccharide intravenously. There were marked reductions in proteolysis of serum C3, deposition of C3 on organisms within SIGN-R1(+) spleen macrophages, and formation of C3 ligands. We found that SIGN-R1 directly bound the complement C1 subcomponent, C1q, and assembled a C3 convertase, but without the traditional requirement for either antibody or factor B. The transmembrane lectin SIGN-R1 therefore contributes to innate resistance by an unusual C3 activation pathway.	Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA; Rockefeller Univ, Lab Bacterial Pathogenesis, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University	Park, CG (corresponding author), Rockefeller Univ, Cellular Physiol & Immunol Lab, 1230 York Ave, New York, NY 10021 USA.	parkc@mail.rockefeller.edu	Loeffler, Jutta M/C-2747-2008; Do, Yoonkyung/F-5231-2010; Steinman, Ralph/F-7729-2012	Do, Yoonkyung/0000-0001-7947-4767; Park, Chae Gyu/0000-0003-1906-1308	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R37AI040045, R37AI013013, R01AI013013, R56AI040045, R01AI040045] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40045, AI13013, AI057158] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMLOT PL, 1985, LANCET, V1, P1008, DOI 10.1016/S0140-6736(85)91613-7; Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Banki Z, 2005, AIDS, V19, P481, DOI 10.1097/01.aids.0000162336.20439.8d; BROWN EJ, 1982, J CLIN INVEST, V69, P85, DOI 10.1172/JCI110444; BROWN EJ, 1983, REV INFECT DIS, V5, pS797; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; CAMPBELL JR, 1991, INFECT IMMUN, V59, P1978, DOI 10.1128/IAI.59.6.1978-1983.1991; Caraher EM, 1999, J ENDOCRINOL, V162, P143, DOI 10.1677/joe.0.1620143; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Cowell RM, 2003, J NEUROSCI, V23, P9459; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Garau J, 2002, LANCET INFECT DIS, V2, P404, DOI 10.1016/S1473-3099(02)00316-X; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Harms G, 1996, INFECT IMMUN, V64, P4220, DOI 10.1128/IAI.64.10.4220-4225.1996; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; HUMPHREY JH, 1981, EUR J IMMUNOL, V11, P221, DOI 10.1002/eji.1830110311; HUMPHREY JH, 1985, IMMUNOL LETT, V11, P149, DOI 10.1016/0165-2478(85)90161-0; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kars M, 2005, EUR J CLIN INVEST, V35, P531, DOI 10.1111/j.1365-2362.2005.01521.x; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; KRAAL G, 1986, IMMUNOLOGY, V58, P665; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kronborg G, 2002, J INFECT DIS, V185, P1517, DOI 10.1086/340216; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Law SKA, 1997, PROTEIN SCI, V6, P263; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Pozdnyakova O, 2003, J IMMUNOL, V170, P84, DOI 10.4049/jimmunol.170.1.84; SawantMane S, 1996, J NEUROIMMUNOL, V69, P63; Schutze GE, 2002, PEDIATR INFECT DIS J, V21, P278, DOI 10.1097/00006454-200204000-00004; SCHWAEBLE W, 1995, J IMMUNOL, V155, P4971; Stoiber H, 2001, IMMUNOL REV, V180, P168, DOI 10.1034/j.1600-065X.2001.1800115.x; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WINKELSTEIN JA, 1977, J IMMUNOL, V118, P451; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x	47	156	163	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					47	58		10.1016/j.cell.2006.01.046	http://dx.doi.org/10.1016/j.cell.2006.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615889	Bronze, Green Submitted			2022-12-28	WOS:000237314200013
J	Snyder, SH				Snyder, SH			Turning off neurotransmitters	CELL			English	Editorial Material							TRITIATED-NORADRENALINE	The historic discovery that the catecholamine neurotransmitters of the sympathetic nervous system, norepinephrine and epinephrine, are inactivated through their reuptake by presynaptic nerve terminals provided new insights into neurotransmitter action and paved the way for the development of modern antidepressant drugs.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Dept Neurosci, 725 N Wolfe St,WBSB 813, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu						AXELROD J, 1957, SCIENCE, V126, P400, DOI 10.1126/science.126.3270.400; DALE H, 1960, ADRENERGIC MECH; GLOWINSKI J, 1964, NATURE, V204, P1318, DOI 10.1038/2041318a0; HERTTING G, 1961, NATURE, V189, P66, DOI 10.1038/189066a0; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; HERTTING G, 1961, J PHARMACOL EXP THER, V134, P146	6	7	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					13	15		10.1016/j.cell.2006.03.023	http://dx.doi.org/10.1016/j.cell.2006.03.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615882	Bronze			2022-12-28	WOS:000237314200006
J	Wu, DS				Wu, DS			A glimpse backstage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Wu, DS (corresponding author), No Org, Seattle, WA USA.	wutoo@comcast.net		Wu, David/0000-0003-1973-7777					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					1979	1980		10.1001/jama.295.17.1979	http://dx.doi.org/10.1001/jama.295.17.1979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038MF	16670399				2022-12-28	WOS:000237225100001
J	Liu, PY; Swerdloff, RS; Christenson, PD; Handelsman, DJ; Wang, C				Liu, PY; Swerdloff, RS; Christenson, PD; Handelsman, DJ; Wang, C		Hormonal Male Contraception Summit	Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis	LANCET			English	Article							INTRAMUSCULAR TESTOSTERONE UNDECANOATE; EFFECTIVELY SUPPRESSES SPERMATOGENESIS; CYPROTERONE-ACETATE; LEVONORGESTREL IMPLANTS; ORAL DESOGESTREL; NORETHISTERONE ENANTHATE; ETONOGESTREL IMPLANTS; GONADOTROPIN-LEVELS; DEPOT TESTOSTERONE; ETHNIC-DIFFERENCES	Background Hormonal methods for safe, reliable, and reversible contraception based on the suppression of spermatogenesis could soon become available. We have investigated the rate, extent, and predictors of reversibility of hormonal male contraception. Methods We undertook an integrated multivariate time-to-event analysis of data from individual participants in 30 studies published in 1990-2005, in which sperm output was monitored every month until recovery. The primary outcome was the time for the sperm concentration to recover to a threshold of 20 million per mL, an indicator of fertility. We undertook univariate and multivariate analyses, using Kaplan-Meier and Cox's methods. Findings 1549 healthy eugonadal men who were white (n=965), Asian (almost all Chinese men; n=535), or of other origins (n=49) and aged 18-51 years underwent 1283.5 man-years of treatment and 705 man-years of post-treatment recovery. These data represented about 90% of all published data from individuals using androgen or androgen-progestagen regimens. The median times for sperm to recover to thresholds of 20, 10, and 3 million per mL were 3.4 months (95% CI 3.2-3.5), 3.0 months (2.9-3.1), and 2.5 months (2.4-2.7), respectively. Multivariate Cox's analysis showed higher rates of recovery with older age, Asian origin, shorter treatment duration, shorter-acting testosterone preparations, higher sperm concentrations at baseline, faster suppression of spermatogenesis, and lower blood concentrations of luteinising hormone at baseline. The typical probability of recovery to 20 million per mL was 67% (61-72) within 6 months, 90% (85-93) within 12 months, 96% (92-98) within 16 months, and 100% within 24 months. Interpretation Hormonal male contraceptive regimens show full reversibility within a predictable time course. Various covariables affect the rate but not the extent of recovery although their effect sizes are minor. These data are crucial for the further safe and practical development of such regimens.	Concord Hosp, Dept Androl, Sydney, NSW 2139, Australia; Univ Sydney, ANZAC Res Inst, Sydney, NSW 2139, Australia; Harbor UCLA Med Ctr, Torrance, CA 90509 USA; Los Angeles Biomed Res Inst, Torrance, CA USA	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Liu, PY (corresponding author), Concord Hosp, Dept Androl, Sydney, NSW 2139, Australia.	pliu@mail.usyd.edu.au	Research Institute, ANZAC/CAE-9030-2022; Handelsman, David/AAR-9580-2021	Handelsman, David/0000-0002-4200-7476	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NCRR NIH HHS [RR M01 00425] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amory JK, 2006, NAT CLIN PRACT ENDOC, V2, P32, DOI 10.1038/ncpendmet0069; Amory JK, 2001, J ANDROL, V22, P1053; Anawalt BD, 2000, FERTIL STERIL, V74, P707, DOI 10.1016/S0015-0282(00)01490-4; Anawalt BD, 1999, J ANDROL, V20, P407; Anawalt BD, 2005, J ANDROL, V26, P405, DOI 10.2164/jandrol.04135; Anderson RA, 2002, ENDOCR REV, V23, P735, DOI 10.1210/er.2002-0002; Anderson RA, 2002, J CLIN ENDOCR METAB, V87, P3640, DOI 10.1210/jc.87.8.3640; Anderson RA, 2002, HUM REPROD, V17, P2869, DOI 10.1093/humrep/17.11.2869; [Anonymous], 1990, Lancet, V336, P955; Aribarg A, 1996, FERTIL STERIL, V65, P821; ARIBARG A, 1995, INT J ANDROL, V18, P157; Bebb RA, 1996, J CLIN ENDOCR METAB, V81, P757, DOI 10.1210/jc.81.2.757; Berger G S, 1977, Int J Gynaecol Obstet, V15, P125; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; Brady BM, 2004, HUM REPROD, V19, P2658, DOI 10.1093/humrep/deh491; Farrow A, 2002, HUM REPROD, V17, P2754, DOI 10.1093/humrep/17.10.2754; GALLO M, 2005, COCHRANE DB SYST REV, V3; Glasier AF, 2000, HUM REPROD, V15, P646, DOI 10.1093/humrep/15.3.646; Goldzieher JW, 1995, CONTRACEPTION, V52, P327, DOI 10.1016/0010-7824(95)00222-7; Gonzalo ITG, 2002, J CLIN ENDOCR METAB, V87, P3562, DOI 10.1210/jc.87.8.3562; Gu XQ, 2003, J CLIN ENDOCR METAB, V88, P562, DOI 10.1210/jc.2002-020447; Gu YQ, 2004, J CLIN ENDOCR METAB, V89, P2254, DOI 10.1210/jc.2003-031307; Gui YL, 2004, J ANDROL, V25, P720; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hair WM, 2001, J CLIN ENDOCR METAB, V86, P5201, DOI 10.1210/jc.86.11.5201; Handelsman DJ, 2003, J CLIN ENDOCR METAB, V88, P559, DOI 10.1210/jc.2002-021997; Handelsman DJ, 1997, HUM REPROD, V12, P2701, DOI 10.1093/humrep/12.12.2701; HANDELSMAN DJ, 2005, ENDOCRINOLOGY, P3247; Hay CJ, 2005, J CLIN ENDOCR METAB, V90, P2042, DOI 10.1210/jc.2004-0895; Heinemann K, 2005, HUM REPROD, V20, P549, DOI 10.1093/humrep/deh574; Hikim APS, 1998, J CLIN ENDOCR METAB, V83, P152; HULL MGR, 1981, LANCET, V1, P1329; Johnson L, 1998, J ANDROL, V19, P348; Kamischke A, 2000, CLIN ENDOCRINOL, V53, P43, DOI 10.1046/j.1365-2265.2000.01024.x; Kamischke A, 2002, J CLIN ENDOCR METAB, V87, P530, DOI 10.1210/jc.87.2.530; Kamischke A, 2001, J CLIN ENDOCR METAB, V86, P303, DOI 10.1210/jc.86.1.303; Kinniburgh D, 2002, HUM REPROD, V17, P1490, DOI 10.1093/humrep/17.6.1490; Li X F, 1992, Adv Contracept, V8, P1, DOI 10.1007/BF01849342; Liu PY, 2004, J CLIN ENDOCR METAB, V89, P4789, DOI 10.1210/jc.2004-0807; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Liu PY, 2002, HUM REPROD, V17, P625, DOI 10.1093/humrep/17.3.625; London R S, 1993, J SOGC, V15, P925; LONDON RS, 1993, J SOGC, V15, P932; MACLEOD J, 1951, J UROLOGY, V66, P436, DOI 10.1016/S0022-5347(17)74358-3; Menon DK, 2003, FERTIL STERIL, V79, P1659, DOI 10.1016/S0015-0282(03)00365-0; Meriggiola MC, 1996, J CLIN ENDOCR METAB, V81, P3018, DOI 10.1210/jc.81.8.3018; Meriggiola MC, 1998, HUM REPROD, V13, P1225, DOI 10.1093/humrep/13.5.1225; Meriggiola MC, 2005, J CLIN ENDOCR METAB, V90, P2005, DOI 10.1210/jc.2004-1852; Meriggiola MC, 2003, J CLIN ENDOCR METAB, V88, P5818, DOI 10.1210/jc.2003-030574; Meriggiola MC, 2003, J ANDROL, V24, P466; Meriggiola MC, 2002, J ANDROL, V23, P684; Meriggiola MC, 1997, FERTIL STERIL, V68, P844; MOELOEK N, 1993, FERTIL STERIL, V60, P1062; Muller A, 2004, HUM REPROD, V19, P2838, DOI 10.1093/humrep/deh521; Nieschlag E, 2005, LANCET, V365, P554; Pollanen P, 2001, INT J ANDROL, V24, P369, DOI 10.1046/j.1365-2605.2001.00319.x; Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P414, DOI 10.1289/ehp.5927; Therneau TM, 2000, MODELING SURVIVAL DA; Turner L, 2003, J CLIN ENDOCR METAB, V88, P4659, DOI 10.1210/jc.2003-030107; von Eckardstein S, 2003, J CLIN ENDOCR METAB, V88, P5232, DOI 10.1210/jc.2002-022043; Waites GMH, 2003, FERTIL STERIL, V80, P1, DOI 10.1016/S0015-0282(03)00577-6; Wang C, 1998, J CLIN ENDOCR METAB, V83, P870, DOI 10.1210/jc.83.3.870; Wang C, 2006, J CLIN ENDOCR METAB, V91, P460, DOI 10.1210/jc.2005-1743; Wang C, 2004, AM J OBSTET GYNECOL, V190, pS60, DOI 10.1016/j.ajog.2004.01.057; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wu FCW, 1999, J CLIN ENDOCR METAB, V84, P112, DOI 10.1210/jc.84.1.112; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Wu FCW, 1996, FERTIL STERIL, V65, P626, DOI 10.1016/S0015-0282(16)58166-7; 2002, INT J ANDROL, V25, P375	69	148	152	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1412	1420		10.1016/S0140-6736(06)68614-5	http://dx.doi.org/10.1016/S0140-6736(06)68614-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650651				2022-12-28	WOS:000237195600029
J	Grottoli, AG; Rodrigues, LJ; Palardy, JE				Grottoli, AG; Rodrigues, LJ; Palardy, JE			Heterotrophic plasticity and resilience in bleached corals	NATURE			English	Article							REEF CORALS; TISSUE BIOMASS; CLIMATE-CHANGE; ZOOPLANKTON; HAWAIIAN; PATTERNS; CARBON; RATES	Mass coral bleaching events caused by elevated seawater temperatures(1,2) have resulted in extensive coral mortality throughout the tropics over the past few decades(3,4). With continued global warming, bleaching events are predicted to increase in frequency and severity, causing up to 60% coral mortality globally within the next few decades(4-6). Although some corals are able to recover and to survive bleaching(7,8), the mechanisms underlying such resilience are poorly understood. Here we show that the coral host has a significant role in recovery and resilience. Bleached and recovering Montipora capitata (branching) corals met more than 100% of their daily metabolic energy requirements by markedly increasing their feeding rates and CHAR (per cent contribution of heterotrophically acquired carbon to daily animal respiration), whereas Porites compressa (branching) and Porites lobata (mounding) corals did not. These findings suggest that coral species with high-CHAR capability during bleaching and recovery, irrespective of morphology, will be more resilient to bleaching events over the long term, could become the dominant coral species on reefs, and may help to safeguard affected reefs from potential local and global extinction.	Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA; Villanova Univ, Dept Biol, Villanova, PA 19085 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	University System of Ohio; Ohio State University; Villanova University; Brown University	Grottoli, AG (corresponding author), Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA.	grottoli.1@osu.edu	Grottoli, Andrea/C-9736-2009; Rodrigues, Lisa J/A-2541-2009; Palardy, James/L-9092-2019	Rodrigues, Lisa/0000-0002-0973-0451; Palardy, James/0000-0002-8347-7108				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Buddemeier R., 2004, CORAL REEFS GLOBAL C, V15, P17789; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Glynn PW, 2001, B MAR SCI, V69, P79; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Heidelberg KB, 2004, CORAL REEFS, V23, P263, DOI 10.1007/s00338-004-0375-0; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2004, MAR ECOL PROG SER, V282, P151, DOI 10.3354/meps282151; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Palardy JE, 2006, J EXP MAR BIOL ECOL, V331, P99, DOI 10.1016/j.jembe.2005.10.001; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; *SAS I, 1999, SAS STAT SOFTW VERS; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stimson J, 2002, CORAL REEFS, V21, P409, DOI 10.1007/s00338-002-0264-3; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Ward S, 2000, P 9 INT COR REEF S, V2, P1123; Wilkinson C, 1999, NATURE RESOUR, V35, P16; Wilkinson C, 2000, STATUS CORAL REEFS W	28	580	591	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1186	1189		10.1038/nature04565	http://dx.doi.org/10.1038/nature04565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641995				2022-12-28	WOS:000237080000044
J	Peterson, ED; Roe, MT; Mulgund, J; DeLong, ER; Lytle, BL; Brindis, RG; Smith, SC; Pollack, CV; Newby, LK; Harrington, RA; Gibler, WB; Ohman, EM				Peterson, ED; Roe, MT; Mulgund, J; DeLong, ER; Lytle, BL; Brindis, RG; Smith, SC; Pollack, CV; Newby, LK; Harrington, RA; Gibler, WB; Ohman, EM			Association between hospital process performance and outcomes among patients with acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; QUALITY-OF-CARE; AMERICAN-COLLEGE; CARDIOVASCULAR CARE; ELDERLY-PATIENTS; UNSTABLE ANGINA; GUIDELINES; CRUSADE; MANAGEMENT	Context Selected care processes are increasingly being used to measure hospital quality; however, data regarding the association between hospital process performance and outcomes are limited. Objectives To evaluate contemporary care practices consistent with the American College of Cardiology/American Heart Association (ACC/AHA) guideline recommendations, to examine how hospital performance varied among centers, to identify characteristics predictive of higher guideline adherence, and to assess whether hospitals' overall composite guideline adherence was associated with observed and risk-adjusted in-hospital mortality rates. Design, Setting, and Participants An observational analysis of hospital care in 350 academic and nonacademic US centers of 64 775 patients enrolled in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) National Quality Improvement Initiative between January 1, 2001, and September 30, 2003, presenting with chest pain and positive electrocardiographic changes or cardiac biomarkers consistent with non-ST-segment elevation acute coronary syndrome (ACS). Main Outcome Measures Use of 9 ACC/AHA class I guideline-recommended treatments and the correlation among hospitals' use of individual care processes as well as overall composite adherence rates. Results Overall, the 9 ACC/AHA guideline-recommended treatments were adhered to in 74% of eligible instances. There was modest correlation in hospital performance among the individual ACS process metrics. However, composite adherence performance varied widely (median [interquartile range] composite adherence scores from lowest to highest hospital quartiles, 63% [59%-66%] vs 82% [80%-84%]). Composite guideline adherence rate was significantly associated with in-hospital mortality, with observed mortality rates decreasing from 6.31% for the lowest adherence quartile to 4.15% for the highest adherence quartile (P<.001). After risk adjustment, every 10% increase in composite adherence at a hospital was associated with an analogous 10% decrease in its patients' likelihood of in-hospital mortality (adjusted odds ratio, 0.90; 95% confidence interval, 0.84-0.97; P<.001). Conclusion A significant association between care process and outcomes was found, supporting the use of broad, guideline-based performance metrics as a means of assessing and helping improve hospital quality.	Duke Univ, Ctr Med, Duke Clin Res Inst, Durham, NC 27705 USA; Kaiser Permanente Hlth Syst, San Francisco, CA USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Univ Penn, Penn Hosp, Philadelphia, PA USA; Univ Cincinnati, Sch Med, Cincinnati, OH USA	Duke University; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; University of Cincinnati	Peterson, ED (corresponding author), Duke Univ, Ctr Med, Duke Clin Res Inst, 2400 Pratt St,Room 7009, Durham, NC 27705 USA.	peter016@mc.duke.edu	Peterson, Eric David/ABF-5033-2021		NATIONAL INSTITUTE ON AGING [R01AG025312] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG025312-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander KP, 2005, J AM COLL CARDIOL, V46, P1479, DOI 10.1016/j.jacc.2005.05.084; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Braun BI, 1999, EVAL HEALTH PROF, V22, P283, DOI 10.1177/016327879902200301; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Centers for Medicare & Medicaid Services, HOSP COMP; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; *CTR MED MED SERV, HOSP QUAL ALL IMPR C; DAVIDIAN M, 1993, BIOMETRIKA, V80, P475, DOI 10.2307/2337169; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Granger CB, 2005, AM J MED, V118, P858, DOI 10.1016/j.amjmed.2005.01.070; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; *LEAPFR GROUP, 2004, FACT SHEET EV BAS HO; Lee TH, 2004, NEW ENGL J MED, V350, P2409, DOI 10.1056/NEJMsb041193; LOHR KN, 1990, NEW ENGL J MED, V322, P707, DOI 10.1056/NEJM199003083221031; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; *NAT COMM QUAL ASS, NQF END NAT VOL CONS; Rao S, 2003, J AM COLL CARDIOL, V41, P1948, DOI 10.1016/S0735-1097(03)00402-9; Roe MT, 2005, ARCH INTERN MED, V165, P1630, DOI 10.1001/archinte.165.14.1630; Roe MT, 2003, AM HEART J, V146, P605, DOI 10.1016/S0002-8703(03)00388-0; ROE MT, IN PRESS AM HEART J; Sonel AF, 2005, CIRCULATION, V111, P1225, DOI 10.1161/01.CIR.0000157732.03358.64; Spertus JA, 2005, CIRCULATION, V111, P1703, DOI 10.1161/01.CIR.0000157096.95223.D7; Spertus John A., 2003, Circulation, V107, P1681, DOI 10.1161/01.CIR.0000062026.90014.63; Staman Karen L, 2003, Crit Pathw Cardiol, V2, P34, DOI 10.1097/01.HPC.0000053684.59325.88; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2	34	514	530	0	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1912	1920		10.1001/jama.295.16.1912	http://dx.doi.org/10.1001/jama.295.16.1912			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639050	Green Published, Bronze			2022-12-28	WOS:000237059200026
J	Buszczak, M; Spradling, AC				Buszczak, M; Spradling, AC			Searching chromatin for stem cell identity	CELL			English	Review							SELF-RENEWAL; POLYCOMB; TRANSCRIPTION		Carnegie Inst Sci, Howard Hughes Labs, Baltimore, MD 21218 USA; Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Carnegie Institution for Science	Spradling, AC (corresponding author), Carnegie Inst Sci, Howard Hughes Labs, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu		Buszczak, Michael/0000-0001-6361-3654	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bielinska B, 2005, GENETICS, V169, P161, DOI 10.1534/genetics.104.033118; BOYER AL, 2006, NATURE, DOI DOI 10.1038/NATURE04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140	22	74	77	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					233	236		10.1016/j.cell.2006.04.004	http://dx.doi.org/10.1016/j.cell.2006.04.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630812	Bronze			2022-12-28	WOS:000237241500014
J	Walborn, SP; Ribeiro, PHS; Davidovich, L; Mintert, F; Buchleitner, A				Walborn, SP; Ribeiro, PHS; Davidovich, L; Mintert, F; Buchleitner, A			Experimental determination of entanglement with a single measurement	NATURE			English	Article							QUANTUM STATE	Nearly all protocols requiring shared quantum information(1) such as quantum teleportation(2) or key distribution(3)-rely on entanglement between distant parties. However, entanglement is difficult to characterize experimentally. All existing techniques for doing so, including entanglement witnesses(4,11,12) or Bell inequalities(5), disclose the entanglement of some quantum states but fail for other states; therefore, they cannot provide satisfactory results in general. Such methods are fundamentally different from entanglement measures that, by definition, quantify the amount of entanglement in any state. However, these measures suffer from the severe disadvantage that they typically are not directly accessible in laboratory experiments. Here we report a linear optics experiment in which we directly observe a pure-state entanglement measure, namely concurrence(6). Our measurement set-up includes two copies of a quantum state: these 'twin' states are prepared in the polarization and momentum degrees of freedom of two photons, and concurrence is measured with a single, local measurement on just one of the photons.	Univ Fed Rio de Janeiro, Inst Fis, BR-21941972 Rio De Janeiro, Brazil; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Universidade Federal do Rio de Janeiro; Harvard University; Max Planck Society	Walborn, SP (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Caixa Postal 68528, BR-21941972 Rio De Janeiro, Brazil.	swalborn@if.ufrj.br	Ribeiro, Paulo/GYA-1014-2022; Souto Ribeiro, PH/C-4893-2013; Souto Ribeiro, PH/GYA-0054-2022; Walborn, Stephen/P-9966-2019	Souto Ribeiro, PH/0000-0002-0060-1717; Souto Ribeiro, PH/0000-0002-0060-1717; Walborn, Stephen/0000-0002-3346-8625				Barbieri M, 2005, PHYS REV A, V72, DOI [10.1103/PhysRevA.72.052110, 10.1103/PhysREvA.72.052110]; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 1996, PHYS REV A, V54, P3824, DOI 10.1103/PhysRevA.54.3824; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Brun TA, 2004, QUANTUM INFORM COMPU, V4, P401; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Fiorentino M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070502; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Horodecki P, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.167901; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Kwiat PG, 1997, J MOD OPTIC, V44, P2173, DOI 10.1080/095003497152438; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Liang YC, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022324; Mintert F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260502; Nielsen Michael A., 2002, QUANTUM COMPUTATION; RARITY JG, 1990, PHYS REV LETT, V64, P2495, DOI 10.1103/PhysRevLett.64.2495; Sancho JMG, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042303; Vidal G, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032314; WHIE A, 1990, PHYS REV LETT, V83, P3103; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245	22	259	263	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1022	1024		10.1038/nature04627	http://dx.doi.org/10.1038/nature04627			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625190				2022-12-28	WOS:000236906000029
J	Enoch, S; Grey, JE; Harding, KG				Enoch, S; Grey, JE; Harding, KG			ABC of wound healing - Non-surgical and drug treatments	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Surgeons England, London WC2A 3PN, England; Cardiff Univ, Wound Healing Res Unit, Cardiff, S Glam, Wales; Cardiff & Vale NHS Trust, Univ Wales Hosp, Cardiff, Wales	Royal College of Surgeons of England; Cardiff University; Cardiff University	Enoch, S (corresponding author), Royal Coll Surgeons England, London WC2A 3PN, England.	joseph.grey@cardiffandvale.wales.nhs.uk	Harding, Keith/J-5605-2013	Harding, Keith/0000-0003-0048-3279				Berliner E, 2003, J VASC SURG, V37, P539, DOI 10.1067/mva.2003.103; Cullum N, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000265; Eginton MT, 2003, ANN VASC SURG, V17, P645, DOI 10.1007/s10016-003-0065-3; Karukonda SRK, 2000, INT J DERMATOL, V39, P321, DOI 10.1046/j.1365-4362.2000.00949.x; Kranke P, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004123.PUB2	5	63	73	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 15	2006	332	7546					900	903		10.1136/bmj.332.7546.900	http://dx.doi.org/10.1136/bmj.332.7546.900			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16613966	Green Published			2022-12-28	WOS:000237132100024
J	Ling, JQ; Li, T; Hu, JF; Vu, TH; Chen, HL; Qiu, XW; Cherry, AM; Hoffman, AR				Ling, JQ; Li, T; Hu, JF; Vu, TH; Chen, HL; Qiu, XW; Cherry, AM; Hoffman, AR			CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1	SCIENCE			English	Article							IMPRINTING CONTROL REGION; BETA-GLOBIN LOCUS; ENHANCER-BLOCKING ACTIVITY; CHROMOSOME TERRITORIES; GENE-REGULATION; H19 GENE; CHROMATIN; METHYLATION; SITES; TRANSCRIPTION	Gene transcription may be regulated by remote enhancer or insulator regions through chromosome looping. Using a modification of chromosome conformation capture (3C) and fluorescence in situ hybridization, we found that one allele of the insulin-like growth factor 2 (Igf2)/H19 imprinting control region (ICR) on chromosome 7 colocalized with one allele of Wsb1/Nf1 on chromosome 11. Omission of CCCTC-binding factor ( CTCF) or deletion of the maternal ICR abrogated this association and altered Wsb1/Nf1 gene expression. These findings demonstrate that CTCF mediates an interchromosomal association, perhaps by directing distant DNA segments to a common transcription factory, and the data provide a model for long-range allele-specific associations between gene regions on different chromosomes that suggest a framework for DNA recombination and RNA trans-splicing.	Palo Alto Hlth Care Syst, Dept Vet Affairs, Med Serv, Palo Alto, CA 94304 USA; Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University	Hoffman, AR (corresponding author), Palo Alto Hlth Care Syst, Dept Vet Affairs, Med Serv, Palo Alto, CA 94304 USA.	arhoffman@stanford.edu	Hu, Jifan/Q-3003-2019	HU, Jifan/0000-0002-2174-0361; Hoffman, Andrew/0000-0002-0145-1917	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK065283, R01DK036054] Funding Source: NIH RePORTER; NICHD NIH HHS [HD047013] Funding Source: Medline; NIDDK NIH HHS [DK036054, DK065283] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Grande MA, 1997, J CELL SCI, V110, P1781; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim A, 2004, P NATL ACAD SCI USA, V101, P7028, DOI 10.1073/pnas.0307985101; Lestou VS, 2002, CANCER GENET CYTOGEN, V138, P153, DOI 10.1016/S0165-4608(02)00583-6; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Puttaraju M, 1999, NAT BIOTECHNOL, V17, P246, DOI 10.1038/6986; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Walter J, 2003, HUM MOL GENET, V12, pR215, DOI 10.1093/hmg/ddg296; Weber M, 2003, MOL CELL BIOL, V23, P8953, DOI 10.1128/MCB.23.24.8953-8959.2003; Yang L, 2004, J BIOL CHEM, V279, P46253, DOI 10.1074/jbc.M408155200; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337	29	381	392	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					269	272		10.1126/science.1123191	http://dx.doi.org/10.1126/science.1123191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614224				2022-12-28	WOS:000236765300050
J	Nam, KT; Kim, DW; Yoo, PJ; Chiang, CY; Meethong, N; Hammond, PT; Chiang, YM; Belcher, AM				Nam, KT; Kim, DW; Yoo, PJ; Chiang, CY; Meethong, N; Hammond, PT; Chiang, YM; Belcher, AM			Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes	SCIENCE			English	Article							GENETICALLY-ENGINEERED VIRUSES; PARTICLES; PEPTIDES; PHASE; CO3O4	The selection and assembly of materials are central issues in the development of smaller, more flexible batteries. Cobalt oxide has shown excellent electrochemical cycling properties and is thus under consideration as an electrode for advanced lithium batteries. We used viruses to synthesize and assemble nanowires of cobalt oxide at room temperature. By incorporating gold-binding peptides into the filament coat, we formed hybrid gold - cobalt oxide wires that improved battery capacity. Combining virus-templated synthesis at the peptide level and methods for controlling two-dimensional assembly of viruses on polyelectrolyte multilayers provides a systematic platform for integrating these nanomaterials to form thin, flexible lithium ion batteries.	MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Inst Soldier Nanotechnol, Cambridge, MA 02139 USA; MIT, Inst Collaborat Biotechnol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Belcher, AM (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	belcher@mit.edu	Yoo, Pil J./A-1069-2012; Kim, Dong-Wan/E-5310-2010; Nam, Ki Tae/A-1866-2011; Ibrahim, Essam Hassan/G-1960-2018; Yoo, Pil J./T-2367-2019	Yoo, Pil J./0000-0002-5499-6566; Kim, Dong-Wan/0000-0002-1635-6082; Nam, Ki Tae/0000-0001-6353-8877; Ibrahim, Essam Hassan/0000-0003-0130-2257; Yoo, Pil J./0000-0002-5499-6566; Chiang, Yet-Ming/0000-0002-0833-7674				Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Armstrong AR, 2005, ADV MATER, V17, P862, DOI 10.1002/adma.200400795; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; Cassagneau T, 1998, ADV MATER, V10, P877, DOI 10.1002/(SICI)1521-4095(199808)10:11<877::AID-ADMA877>3.0.CO;2-1; Claye AS, 2000, J ELECTROCHEM SOC, V147, P2845, DOI 10.1149/1.1393615; DeLongchamp DM, 2003, CHEM MATER, V15, P1165, DOI 10.1021/cm020945a; Dogic Z, 1997, PHYS REV LETT, V78, P2417, DOI 10.1103/PhysRevLett.78.2417; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Guo ZP, 2005, J ELECTROCHEM SOC, V152, pA2211, DOI 10.1149/1.2051847; GYU D, 2004, ADV MATER, V16, P533; Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760; Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d; Joly S, 2000, LANGMUIR, V16, P1354, DOI 10.1021/la991089t; Larcher D, 2002, J ELECTROCHEM SOC, V149, pA234, DOI 10.1149/1.1435358; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; Long JW, 2004, CHEM REV, V104, P4463, DOI 10.1021/cr020740l; Mann S., 2001, BIOMINERALLIZATION P; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100; Massalski T.B., 1996, BINARY ALLOY PHASE D, Vsecond; Mui SC, 2002, J ELECTROCHEM SOC, V149, pA1610, DOI 10.1149/1.1518482; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; Nam KT, 2004, NANO LETT, V4, P23, DOI 10.1021/nl0347536; Peelle BR, 2005, LANGMUIR, V21, P6929, DOI 10.1021/la050261s; Poizot P, 2000, NATURE, V407, P496, DOI 10.1038/35035045; Sakamoto JS, 2002, J ELECTROCHEM SOC, V149, pA26, DOI 10.1149/1.1425791; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; TARASCON JM, 2004, CR CHIM, V8, P9; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596; Yuan ZY, 2003, MATER CHEM PHYS, V79, P1, DOI 10.1016/S0254-0584(02)00442-X; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	33	1613	1701	19	1171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					885	888		10.1126/science.1122716	http://dx.doi.org/10.1126/science.1122716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16601154	Green Submitted			2022-12-28	WOS:000237452900039
J	van Zelm, MC; Reisli, I; van der Burg, M; Castano, D; van Noesel, CJM; van Tol, MJD; Woellner, C; Grimbacher, B; Patino, PJ; van Dongen, JJM; Franco, JL				van Zelm, MC; Reisli, I; van der Burg, M; Castano, D; van Noesel, CJM; van Tol, MJD; Woellner, C; Grimbacher, B; Patino, PJ; van Dongen, JJM; Franco, JL			An antibody-deficiency syndrome due to mutations in the CD19 gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL DEVELOPMENT; COMMON VARIABLE IMMUNODEFICIENCY; X-LINKED AGAMMAGLOBULINEMIA; AUTOSOMAL RECESSIVE FORM; HYPER-IGM SYNDROME; LYMPHOCYTES-B; SIGNAL-TRANSDUCTION; POSITIVE SELECTION; RESIDUAL-DISEASE; TYROSINE KINASES	BACKGROUND: The CD19 protein forms a complex with CD21, CD81, and CD225 in the membrane of mature B cells. Together with the B-cell antigen receptor, this complex signals the B cell to decrease its threshold for activation by the antigen. METHODS: We evaluated four patients from two unrelated families who had increased susceptibility to infection, hypogammaglobulinemia, and normal numbers of mature B cells in blood. We found a mutation in the CD19 gene in all four patients. The CD19 gene in the patients and their first-degree relatives was sequenced, and flow-cytometric immunophenotyping of B cells, immunohistochemical staining of lymphoid tissues, and DNA and messenger RNA analysis were performed. B-cell responses on the triggering of the B-cell receptor were investigated by in vitro stimulation; the antibody response after vaccination with rabies vaccine was also studied. RESULTS: All four patients had homozygous mutations in the CD19 gene. Levels of CD19 were undetectable in one patient and substantially decreased in the other three. Levels of CD21 were decreased, whereas levels of CD81 and CD225 were normal, in all four patients. The composition of the precursor B-cell compartment in bone marrow and the total numbers of B cells in blood were normal. However, the numbers of CD27+ memory B cells and CD5+ B cells were decreased. Secondary follicles in lymphoid tissues were small to normal in size and had a normal cellular composition. The few B cells that showed molecular signs of switching from one immunoglobulin class to another contained V-H-C-alpha and V-H-C-gamma transcripts with somatic mutations. The response of the patients' B cells to in vitro stimulation through the B-cell receptor was impaired, and in all four patients, the antibody response to rabies vaccination was poor. CONCLUSIONS: Mutation of the CD19 gene causes a type of hypogammaglobulinemia in which the response of mature B cells to antigenic stimulation is defective.	Erasmus MC, Dept Immunol, Mol Immunol Unit, NL-3015 GE Rotterdam, Netherlands; Erasmus MC Sophia, Rotterdam, Netherlands; Selcuk Univ, Dept Pediat Immunol & Allergy, Meram Med Fac, Konya, Turkey; Univ Antioquia, Grp Primary Immunodeficiencies, Medellin, Colombia; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; Univ Hosp Freiburg, Div Rheumatol & Clin Immunol, Freiburg, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Selcuk University; Universidad de Antioquia; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Freiburg	van Dongen, JJM (corresponding author), Erasmus MC, Dept Immunol, Mol Immunol Unit, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	j.j.m.vandongen@erasmusmc.nl	van Zelm, Menno C/O-4404-2015; FRANCO, JOSE/AAK-1590-2020; van Dongen, Jacques J.M./F-8537-2015	van Zelm, Menno C/0000-0003-4161-1919; FRANCO, JOSE/0000-0001-5664-6415; van Dongen, Jacques J.M./0000-0001-7686-0021; Patino, Pablo/0000-0002-3234-0371; Castano, Diana/0000-0002-5697-5603; van Dongen, Jacques J.M./0000-0002-3650-7087				ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; AMETT FC, 1988, ARTHRITIS RHEUM, V31, P315; Ballow M, 2002, J ALLERGY CLIN IMMUN, V109, P581, DOI 10.1067/mai.2002.122466; Barrington RA, 2005, J IMMUNOL, V175, P2859, DOI 10.4049/jimmunol.175.5.2859; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; BRADBURY LE, 1993, J IMMUNOL, V151, P2915; Brinkman DMC, 2003, J CLIN IMMUNOL, V23, P528, DOI 10.1023/B:JOCI.0000010429.36461.6b; Brooks SR, 2004, J IMMUNOL, V172, P7556, DOI 10.4049/jimmunol.172.12.7556; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; Diamant E, 2005, BLOOD, V105, P3247, DOI 10.1182/blood-2004-08-3165; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; EVANS SS, 1990, BLOOD, V76, P2583; Fehr T, 1998, J EXP MED, V188, P145, DOI 10.1084/jem.188.1.145; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; Gary-Gouy H, 2000, J BIOL CHEM, V275, P548, DOI 10.1074/jbc.275.1.548; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Ikinciogullari A, 2004, TURKISH J PEDIATR, V46, P125; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Lefranc MP, 2003, LEUKEMIA, V17, P260, DOI 10.1038/sj.leu.2402637; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Noordzij JG, 2002, BLOOD, V100, P2145; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Shoham T, 2003, J IMMUNOL, V171, P4062, DOI 10.4049/jimmunol.171.8.4062; TEDDER TF, 1989, J IMMUNOL, V143, P712; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; VANNOESEL CJM, 1993, IMMUNOL TODAY, V14, P8, DOI 10.1016/0167-5699(93)90316-D; VETRIE D, 1993, NATURE, V364, P362, DOI 10.1038/364362a0; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003	44	395	404	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1901	1912		10.1056/NEJMoa051568	http://dx.doi.org/10.1056/NEJMoa051568			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672701				2022-12-28	WOS:000237239900006
J	Schildgen, O; Sirma, H; Funk, A; Olotu, C; Wend, UC; Hartmann, H; Helm, M; Rockstroh, JK; Willems, WR; Will, H; Gerlich, WH				Schildgen, O; Sirma, H; Funk, A; Olotu, C; Wend, UC; Hartmann, H; Helm, M; Rockstroh, JK; Willems, WR; Will, H; Gerlich, WH			Brief report: Variant of hepatitis B virus with primary resistance to adefovir	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; LAMIVUDINE; DIPIVOXIL; THERAPY; REPLICATION; MUTATIONS; SUSCEPTIBILITY; HIV	The reverse-transcriptase inhibitor lamivudine ( Zeffix, GlaxoSmithKline) is often treat chronic infection with hepatitis B virus ( HBV) until resistance develops. may then be switched to the reverse-transcriptase inhibitor adefovir Gilead), which has a lower frequency of resistance. Here, we describe cases of primary adefovir resistance that were sensitive to tenofovir ( Viread, All three cases involved a rare HBV variant with a valine at position 233 of transcriptase domain instead of isoleucine ( rtI233V), as in the wild-type This HBV variant also displayed resistance to adefovir and sensitivity to tenofovir vitro.	Univ Bonn, Inst Med Microbiol & Immunol, D-5300 Bonn, Germany; Univ Bonn, Dept Med 1, D-5300 Bonn, Germany; Heinrich Pette Inst, Hamburg, Germany; Inst Med Virol, D-35392 Giessen, Germany; Practice Gastroenterol & Hepatol, Herne, Germany; Practice Abelein Helm, Nurnberg, Germany	University of Bonn; University of Bonn; Heinrich Pette Institute	Gerlich, WH (corresponding author), Inst Med Virol, Frankfurterstr 107, D-35392 Giessen, Germany.	h.gerlich@viro.med.uni-giessen.de	Funk, Anneke/C-5688-2009; Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627				Angus P, 2003, GASTROENTEROLOGY, V125, P292, DOI 10.1016/S0016-5085(03)00939-9; Benhamou Y, 2003, NEW ENGL J MED, V348, P177, DOI 10.1056/NEJM200301093480218; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Dore GJ, 2004, J INFECT DIS, V189, P1185, DOI 10.1086/380398; Erhardt A, 2000, HEPATOLOGY, V31, P716, DOI 10.1002/hep.510310323; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GANEM D, 2004, NEW ENGL J MED, V351, P351; Grethe S, 2000, J VIROL, V74, P5377, DOI 10.1128/JVI.74.11.5377-5381.2000; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Jursch CA, 2002, MED MICROBIOL IMMUN, V190, P189, DOI 10.1007/s00430-001-0103-0; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Perrillo R, 2004, GASTROENTEROLOGY, V126, P81, DOI 10.1053/j.gastro.2003.10.050; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Rang A, 2002, J BIOL CHEM, V277, P7645, DOI 10.1074/jbc.C100729200; Schildgen O, 2004, AIDS, V18, P2325, DOI 10.1097/00002030-200411190-00014; Stuyver LJ, 2001, HEPATOLOGY, V33, P751, DOI 10.1053/jhep.2001.22166; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; Van Bommel F, 2005, HEPATOLOGY, V42, P239, DOI 10.1002/hep.20765; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Yang HL, 2004, ANTIVIR RES, V61, P27, DOI 10.1016/j.antiviral.2003.07.003; Ying C, 2000, J VIRAL HEPATITIS, V7, P161; Zhang JM, 2005, J MED VIROL, V77, P203, DOI 10.1002/jmv.20453	27	175	196	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1807	1812		10.1056/NEJMoa051214	http://dx.doi.org/10.1056/NEJMoa051214			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641397	Bronze			2022-12-28	WOS:000237077100006
J	Maisel, WH; Moynahan, M; Zuckerman, BD; Gross, TP; Tovar, OH; Tillman, DB; Schultz, DB				Maisel, WH; Moynahan, M; Zuckerman, BD; Gross, TP; Tovar, OH; Tillman, DB; Schultz, DB			Pacemaker and ICD generator malfunctions - Analysis of food and drug administration annual reports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; SAFETY; DEVICES; THERAPY	Context Pacemakers and implantable cardioverter-defibrillators (ICDs) are complex medical devices proven to reduce mortality in specific high-risk patient populations. It is not known if increasing device complexity is associated with decreased reliability. Objectives To analyze postapproval annual reports submitted to the US Food and Drug Administration (FDA) by manufacturers of pacemakers and ICDs to determine the reported number and rate of pacemaker and ICD malfunctions and to assess trends in device performance. Design and Setting Pacemaker and ICD annual reports submitted to the FDA for the years 1990-2002 were reviewed. A pacemaker or ICD generator was defined as having malfunctioned if it was explanted due to an observed malfunction, returned to the manufacturer, and confirmed by the manufacturer to be functioning inappropriately. Leads and biventricular devices were not included in the study. Deaths were attributed to device malfunction only if they were witnessed, the malfunction immediately led to the death, and the malfunction was confirmed by the manufacturer. Main Outcome Measures Number of implanted pacemaker and ICD generators; number of reported malfunctions; and annual malfunction replacement rates. Generator malfunction replacement rates were defined as the annual number of replacements due to confirmed malfunction divided by the annual number of implants. Results During the study period, 2.25 million pacemakers and 415780 ICDs were implanted in the United States. Overall, 17 323 devices (8834 pacemakers and 8489 ICDs) were explanted due to confirmed malfunction. Battery/capacitor abnormalities (4085 malfunctions [23.6%]) and electrical issues (4708 malfunctions [27.1%]) accounted for half of the total device failures. The annual pacemaker malfunction replacement rate per 1000 implants decreased significantly during the study, from a peak of 9.0 in 1993 to a low of 1.4 in 2002 (P=.006 for trend). In contrast, the ICD malfunction replacement rate per 1000 implants, after decreasing from 38.6 in 1993 to 7.9 in 1996, increased markedly during the latter half of the study, peaking in 2001 at 36.4 (P=.04 for trend). More than half of the reported ICD malfunctions occurred in the last 3 years of the study. Overall, the annual ICD malfunction replacement rate was significantly higher than the pacemaker malfunction replacement rate (mean [SD], 20.7 [11.6] vs 4.6 [2.2] replacements per 1000 implants; P<.001; rate ratio, 5.9 [95% confidence interval, 2.7-9.1]). Sixty-one deaths (30 pacemaker patients, 31 ICD patients) were attributable to device malfunction. Conclusions This study demonstrates that thousands of patients have been affected by pacemaker and ICD malfunctions, the pacemaker malfunction replacement rate has decreased, the ICD malfunction replacement rate increased during the latter half of the study, and the ICD malfunction replacement rate is significantly higher than that for pacemakers. Although pacemakers and ICDs are important life-sustaining devices that have saved many lives, careful monitoring of device performance is still required.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; US Food & Drug Administration (FDA)	Maisel, WH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc, 185 Pilgrim Rd,Baker 4, Boston, MA 02215 USA.	wmaisel@bidmc.harvard.edu						Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Buxton AE, 2000, NEW ENGL J MED, V342, P1937, DOI 10.1056/NEJM200006293422602; Eagle KA, 2001, JAMA-J AM MED ASSOC, V286, P843, DOI 10.1001/jama.286.7.843; Gregoratos G, 2002, ACC AHA NASPE 2002 G; *GUID CORP, 2004, GUID CARD RHYTHM MAN; Hauser R, 2001, PACE, V24, P82, DOI 10.1046/j.1460-9592.2001.00082.x; Kutalek SP, 2000, CLIN CARDIAC PACING, P645; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1929, DOI 10.1001/jama.295.16.1929; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P955, DOI 10.1001/jama.294.8.955; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Maisel WH, 2002, JAMA-J AM MED ASSOC, V287, P839; Maisel WH, 2002, PACE, V25, P1670, DOI 10.1046/j.1460-9592.2002.01670.x; Maisel WH, 2001, JAMA-J AM MED ASSOC, V286, P793, DOI 10.1001/jama.286.7.793; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; *MEDTR INC, 2004, MEDTR CRM PROD PERF; *MEDTR INC, OV HIST ICD THER; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Muni NI, 2004, NEW ENGL J MED, V351, P1593, DOI 10.1056/NEJMp048262; SONG SL, 1994, PACE, V17, P692, DOI 10.1111/j.1540-8159.1994.tb02410.x; *ST JUD MED INC, 2004, ST JUD MED PROD PERF; Stanton MS, 2002, JAMA-J AM MED ASSOC, V287, P839, DOI 10.1001/jama.287.7.839	21	224	226	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1901	1906		10.1001/jama.295.16.1901	http://dx.doi.org/10.1001/jama.295.16.1901			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639048	Bronze			2022-12-28	WOS:000237059200024
J	Bucksbaum, PH				Bucksbaum, PH			The first femtosecond in the life of a chemical reaction	SCIENCE			English	Editorial Material									Stanford Linear Accelerator Ctr, Photon Sci Div, Menlo Pk, CA 94025 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Bucksbaum, PH (corresponding author), Stanford Linear Accelerator Ctr, Photon Sci Div, Menlo Pk, CA 94025 USA.	phb@slac.stanford.edu		Bucksbaum, Philip/0000-0003-1258-5571				Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183	4	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					373	374		10.1126/science.1125514	http://dx.doi.org/10.1126/science.1125514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627727				2022-12-28	WOS:000236941800028
J	Ashlin, A; Ladle, RJ				Ashlin, A; Ladle, RJ			Science communication - Environmental science adrift in the blogosphere	SCIENCE			English	Editorial Material							BLOG		Univ Oxford, Ctr Environm, Oxford OX1 3QY, England	University of Oxford	Ashlin, A (corresponding author), Univ Oxford, Ctr Environm, S Parks Rd, Oxford OX1 3QY, England.	aashlin@ouce.ox.ac.uk	Ladle, Richard/E-4228-2014	Ladle, Richard/0000-0003-3200-3946				[Anonymous], 2005, OXFORD ENGLISH DICT; BUCKLEY D, 2005, TIMES ED SUPPL  0916, P11; Butler D, 2005, NATURE, V438, P548, DOI 10.1038/438548a; CHERKOFF J, 2005, INDEPENDENT     0627, P16; GIBSON O, 2005, GUARDIAN        1007, P1; Johnson TJ, 2004, JOURNALISM MASS COMM, V81, P622, DOI 10.1177/107769900408100310; Kerbel MR, 2005, HARV INT J PRESS-POL, V10, P3, DOI 10.1177/1081180X05281395; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; 2005, PR WEEK         0708, P7	9	24	24	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					201	201		10.1126/science.1124197	http://dx.doi.org/10.1126/science.1124197			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614201				2022-12-28	WOS:000236765300027
J	Huang, YH; Dass, RI; Xing, ZL; Goodenough, JB				Huang, YH; Dass, RI; Xing, ZL; Goodenough, JB			Double perovskites as anode materials for solid-oxide fuel cells	SCIENCE			English	Article							ELECTRICAL-PROPERTIES; POWER-DENSITY; SOFC ANODE; OXIDATION; TEMPERATURE; METHANE	Extensive efforts to develop a solid-oxide fuel cell for transportation, the bottoming cycle of a power plant, and distributed generation of electric energy are motivated by a need for greater fuel efficiency and reduced air pollution. Barriers to the introduction of hydrogen as the fuel have stimulated interest in developing an anode material that can be used with natural gas under operating temperatures 650 degrees C < T < 1000 degrees C. Here we report identification of the double perovskites Sr(2)Mg(1-x)Mn(x)MoO(6-delta) that meet the requirements for long-term stability with tolerance to sulfur and show a superior single-cell performance in hydrogen and methane.	Univ Texas, Texas Mat Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Goodenough, JB (corresponding author), Univ Texas, Texas Mat Inst, ETC 9-102, Austin, TX 78712 USA.	jgoodenough@mail.utexas.edu	Huang, Yunhui/C-3752-2014; huang, yao/GWR-5388-2022; Huang, Yunhui/L-6536-2019; Biradar, Nirmala/AAY-2295-2020	Huang, Yunhui/0000-0003-1687-1938; Goodenough, John Bannister/0000-0001-9350-3034				Atkinson A, 2004, NAT MATER, V3, P17, DOI 10.1038/nmat1040; Barnett S. A., 2003, HDB FUEL CELL TECHNO, V4, P98; Boukamp BA, 2003, NAT MATER, V2, P294, DOI 10.1038/nmat892; GOODENOUGH JB, 1988, SOLID STATE IONICS, V26, P87, DOI 10.1016/0167-2738(88)90019-7; He HP, 2005, ELECTROCHEM SOLID ST, V8, pA279, DOI 10.1149/1.1896469; Huang KQ, 2001, J ELECTROCHEM SOC, V148, pA788, DOI 10.1149/1.1378289; Huang KQ, 2000, J ALLOY COMPD, V303, P454, DOI 10.1016/S0925-8388(00)00626-5; Huang XJ, 1996, J CHEM SOC FARADAY T, V92, P2173, DOI 10.1039/ft9969202173; LEE AL, 1990, IND ENG CHEM RES, V29, P766, DOI 10.1021/ie00101a009; Marina OA, 1999, SOLID STATE IONICS, V123, P199, DOI 10.1016/S0167-2738(99)00111-3; Matsuzaki Y, 2000, SOLID STATE IONICS, V132, P261, DOI 10.1016/S0167-2738(00)00653-6; Murray EP, 1999, NATURE, V400, P649, DOI 10.1038/23220; Park SD, 2000, NATURE, V404, P265, DOI 10.1038/35005040; STEELE BCH, 1988, SOLID STATE IONICS, V28, P1547, DOI 10.1016/0167-2738(88)90417-1; Tao S, 2002, J SOLID STATE CHEM, V165, P12, DOI 10.1006/jssc.2001.9477; Tao SW, 2004, J ELECTROCHEM SOC, V151, pA252, DOI 10.1149/1.1639161; Tao SW, 2003, NAT MATER, V2, P320, DOI 10.1038/nmat871; Wan JH, 2005, J ELECTROCHEM SOC, V152, pA1511, DOI 10.1149/1.1943587; Zha SW, 2005, J SOLID STATE CHEM, V178, P1844, DOI 10.1016/j.jssc.2005.03.027; Zhan ZL, 2005, SCIENCE, V308, P844, DOI 10.1126/science.1109213	20	863	902	11	652	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					254	257		10.1126/science.1125877	http://dx.doi.org/10.1126/science.1125877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614219				2022-12-28	WOS:000236765300045
J	Potapova, TA; Daum, JR; Pittman, BD; Hudson, JR; Jones, TN; Satinover, DL; Stukenberg, PT; Gorbsky, GJ				Potapova, TA; Daum, JR; Pittman, BD; Hudson, JR; Jones, TN; Satinover, DL; Stukenberg, PT; Gorbsky, GJ			The reversibility of mitotic exit in vertebrate cells	NATURE			English	Article							CYCLIN-A; MITOSIS; DESTRUCTION; ANAPHASE; PHOSPHORYLATION; CYTOKINESIS; HYSTERESIS; DRIVES; CDC2	A guiding hypothesis for cell-cycle regulation asserts that regulated proteolysis constrains the directionality of certain cell-cycle transitions(1,2). Here we test this hypothesis for mitotic exit, which is regulated by degradation of the cyclin-dependent kinase 1 (Cdk1) activator, cyclin B3-5. Application of chemical Cdk1 inhibitors to cells in mitosis induces cytokinesis and other normal aspects of mitotic exit, including cyclin B degradation. However, chromatid segregation fails, resulting in entrapment of chromatin in the midbody. If cyclin B degradation is blocked with a proteasome inhibitor or by expression of non-degradable cyclin B, Cdk inhibitors will nonetheless induce mitotic exit and cytokinesis. However, if after mitotic exit, the Cdk1 inhibitor is washed free from cells in which cyclin B degradation is blocked, the cells can revert back to M phase. This reversal is characterized by chromosome recondensation, nuclear envelope breakdown, assembly of microtubules into a mitotic spindle, and in most cases, dissolution of the midbody, reopening of the cleavage furrow, and realignment of chromosomes at the metaphase plate. These findings demonstrate that proteasome-dependent degradation of cyclin B provides directionality for the M phase to G1 transition.	Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, Oklahoma City, OK 73104 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Oklahoma Medical Research Foundation; University of Virginia	Gorbsky, GJ (corresponding author), Oklahoma Med Res Fdn, Program Mol Cell & Dev Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	GJG@omrf.ouhsc.edu		Gorbsky, Gary/0000-0003-3076-4725; Stukenberg, Todd/0000-0002-6788-2111; Potapova, Tamara/0000-0003-2761-1795	NIGMS NIH HHS [R01 GM050412] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050412] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cross FR, 2005, MOL BIOL CELL, V16, P2129, DOI 10.1091/mbc.E04-10-0897; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; LOSIEWICZ MD, 1994, BIOCHEM BIOPH RES CO, V201, P589, DOI 10.1006/bbrc.1994.1742; MINSHULL J, 1989, J CELL SCI, P77; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5	22	148	149	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					954	958		10.1038/nature04652	http://dx.doi.org/10.1038/nature04652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612388	Green Accepted			2022-12-28	WOS:000236736700045
J	Saudek, CD; Derr, RL; Kalyani, RR				Saudek, CD; Derr, RL; Kalyani, RR			Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A(1c)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTENSIVE INSULIN THERAPY; HBA(1C) PREDICTS RISK; CARDIOVASCULAR-DISEASE; BIOLOGICAL VARIATION; PLASMA-GLUCOSE; GLYCOSYLATED HEMOGLOBIN; METABOLIC-CONTROL; IMPACT; MELLITUS; SYSTEM	Context With the increasing prevalence of diabetes, successful management of blood glucose control is increasingly important. Current approaches to assessing glycemia include the use of self-monitoring of blood glucose (SMBG) and hemoglobin A(1c) (HbA(1c)). Objectives To assess the evidence underlying the use of these 2 modalities, to evaluate confounders and sources of error in each test, to describe upcoming developments, and to reach evidence-based conclusions on their optimal use. Data Sources, Study Selection, and Data Extraction Reports identified from MEDLINE searches (1976-2005) using relevant terms were selected for quality and relevance to the stated questions. Particular attention was paid to larger cohort studies, clinical trials, meta-analyses, and established recommendations. Data Synthesis If used properly SMBG gives an acceptably accurate reflection of immediate plasma glucose levels. Study results vary, but in general, the evidence supports a positive effect of regular SMBG for improving glycemia, particularly in individuals treated with insulin. The best timing of SMBG and its frequency are controversial issues, but the clinical recommendation is for regular monitoring with frequency depending on the treatment and the instability of glycemia. In the relatively near term, SMBG could gradually be replaced by continuous glucose monitoring. HbA(1c) measures long-term glycemic control, reflecting a time-weighted mean over the previous 3 to 4 months. There are a number of physiologic and methodologic confounders that can affect HbA(1c), but standardization of assays has been well established. The main value of HbA(1c) is its use as a predictor of diabetic complications and the proven effect of improved control of HbA(1c) on complication risk. A reasonable target value for HbA(1c) is less than 7%. A new method for measuring HbA(1c) may cause significant changes in the recommended levels, the numbers reported, and even the name of the test. Conclusion Assessing glycemia in diabetes can be a challenge, but approaches are available that promote successful management of blood glucose and may thereby lead to a significant reduction in morbidity and mortality related to diabetes.	Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA	Johns Hopkins University	Saudek, CD (corresponding author), Johns Hopkins Univ Hosp, Osler 576,600 N Wolfe St, Baltimore, MD 21287 USA.	csaudek@jhu.edu; lauerm@ccf.org						Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; ALLEN BT, 1990, DIABETES CARE, V13, P1044, DOI 10.2337/diacare.13.10.1044; American Diabetes Association, 2001, Diabetes Care, V24, P775; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; [Anonymous], 1996, DIABETES, V45, P1289; [Anonymous], 1995, DIABETES, V44, P968; Barr RG, 2002, ANN INTERN MED, V137, P263, DOI 10.7326/0003-4819-137-4-200208200-00011; Bergenstal R, 2000, DIABETES EDUCATOR, V26, P981, DOI 10.1177/014572170002600610; Bina DM, 2003, DIABETES CARE, V26, P981, DOI 10.2337/diacare.26.4.981; Bliss M., 1982, DISCOVERY INSULIN; Blonde L, 2002, DIABETES CARE, V25, P245, DOI 10.2337/diacare.25.1.245; Bowker SL, 2004, CAN MED ASSOC J, V171, P39, DOI 10.1503/cmaj.1031830; Brunner GA, 1998, DIABETES CARE, V21, P585, DOI 10.2337/diacare.21.4.585; Bry L, 2001, CLIN CHEM, V47, P153; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Cagliero E, 1999, DIABETES CARE, V22, P1785, DOI 10.2337/diacare.22.11.1785; *CDCP, 1994, AG ADJ RAT ANN DIL E; CEFALU WT, 1994, CLIN CHEM, V40, P1317; CERIELLO A, 1991, DIABETES CARE, V14, P68, DOI 10.2337/diacare.14.1.68; Chachou A, 2000, CLIN CHEM LAB MED, V38, P321, DOI 10.1515/CCLM.2000.046; Chia CW, 2004, ENDOCRIN METAB CLIN, V33, P175, DOI 10.1016/j.ecl.2003.12.001; COHEN M, 1983, MED J AUSTRALIA, V2, P377, DOI 10.5694/j.1326-5377.1983.tb122531.x; Cohen Ohad, 2003, Diabetes Technol Ther, V5, P11, DOI 10.1089/152091503763816418; Colwell JA, 1996, DIABETES, V45, pS87, DOI 10.2337/diab.45.3.S87; Coster S, 2000, DIABETIC MED, V17, P755, DOI 10.1046/j.1464-5491.2000.00390.x; Davidson MB, 2005, DIABETES CARE, V28, P1531, DOI 10.2337/diacare.28.6.1531; Davidson MB, 2005, AM J MED, V118, P422, DOI 10.1016/j.amjmed.2004.12.006; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; Derr R, 2003, DIABETES CARE, V26, P2728, DOI 10.2337/diacare.26.10.2728; DEVECIANA M, 1995, NEW ENGL J MED, V333, P1237, DOI 10.1056/NEJM199511093331901; Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195; Ellison JM, 2002, DIABETES CARE, V25, P961, DOI 10.2337/diacare.25.6.961; Estey A L, 1990, Diabetes Educ, V16, P291, DOI 10.1177/014572179001600408; Faas A, 1997, DIABETES CARE, V20, P1482, DOI 10.2337/diacare.20.9.1482; FONTBONNE A, 1989, DIABETES METAB, V15, P255; Franciosi M, 2005, DIABETIC MED, V22, P900, DOI 10.1111/j.1464-5491.2005.01546.x; Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870; Genuth S, 2005, DIABETES CARE, V28, P233, DOI 10.2337/diacare.28.1.233; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Goldberg Philip A, 2004, Diabetes Technol Ther, V6, P339, DOI 10.1089/152091504774198034; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Guerci B, 2003, DIABETES METAB, V29, P587, DOI 10.1016/S1262-3636(07)70073-3; Hanas R, 2002, DIABETES CARE, V25, P2110, DOI 10.2337/diacare.25.11.2110; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Harris MI, 2001, DIABETES CARE, V24, P979, DOI 10.2337/diacare.24.6.979; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Jaber LA, 1996, ANN PHARMACOTHER, V30, P238, DOI 10.1177/106002809603000305; Jeppsson JO, 2002, CLIN CHEM LAB MED, V40, P78, DOI 10.1515/CCLM.2002.016; Johnson RN, 2001, CLIN CHIM ACTA, V307, P61, DOI 10.1016/S0009-8981(01)00433-8; Karter A, 2003, DIABETES CARE, V26, P2294, DOI 10.2337/diacare.26.8.2294; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; KISHIMOTO M, 1995, DIABETES CARE, V18, P1156, DOI 10.2337/diacare.18.8.1156; KLEIN CE, 1993, J GEN INTERN MED, V8, P597, DOI 10.1007/BF02599711; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Kwon HS, 2004, DIABETES CARE, V27, P478, DOI 10.2337/diacare.27.2.478; LARSEN ML, 1990, NEW ENGL J MED, V323, P1021, DOI 10.1056/NEJM199010113231503; LEWANDROWSKI K, 1992, AM J MED, V93, P419, DOI 10.1016/0002-9343(92)90172-8; Lindsey Cameron C, 2004, Diabetes Technol Ther, V6, P370, DOI 10.1089/152091504774198070; Manderson JG, 2003, AM J OBSTET GYNECOL, V189, P507, DOI 10.1067/S0002-9378(03)00497-6; Marks V, 1996, CLIN CHIM ACTA, V251, P3, DOI 10.1016/0009-8981(96)06330-9; McCarter RJ, 2004, DIABETES CARE, V27, P1259, DOI 10.2337/diacare.27.6.1259; McGill JRB, 2004, DIABETES CARE, V27, P1859, DOI 10.2337/diacare.27.8.1859; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Miller CD, 2003, DIABETES CARE, V26, P1158, DOI 10.2337/diacare.26.4.1158; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Monnier L, 2004, DIABETES METAB, V30, P113, DOI 10.1016/S1262-3636(07)70097-6; MUCHMORE DB, 1994, ACTA DIABETOL, V31, P215, DOI 10.1007/BF00571954; NATHAN DM, 1983, CLIN CHEM, V29, P466; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; NEWMAN WP, 1990, ARCH INTERN MED, V150, P107, DOI 10.1001/archinte.150.1.107; Nielsen LR, 2004, DIABETES CARE, V27, P1200, DOI 10.2337/diacare.27.5.1200; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Oki JC, 1997, DIABETES EDUCATOR, V23, P419, DOI 10.1177/014572179702300406; Peterson KP, 1998, CLIN CHEM, V44, P1951; PICKUP JC, 1982, DIABETOLOGIA, V22, P175; Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P2555, DOI 10.1016/j.bios.2004.10.002; RAHBAR S, 1969, BIOCHEM BIOPH RES CO, V36, P838, DOI 10.1016/0006-291X(69)90685-8; Rebrin K, 2000, Diabetes Technol Ther, V2, P461, DOI 10.1089/15209150050194332; Rebrin K, 1999, AM J PHYSIOL-ENDOC M, V277, pE561, DOI 10.1152/ajpendo.1999.277.3.E561; Rindone JP, 1997, AM J MANAG CARE, V3, P1335; Roberts WL, 2005, CLIN CHEM, V51, P776, DOI 10.1373/clinchem.2004.047142; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; RUTTEN G, 1990, FAM PRACT, V7, P273, DOI 10.1093/fampra/7.4.273; Sacks DB, 2002, CLIN CHEM, V48, P436; Sacks DB, 2005, CLIN CHEM, V51, P681, DOI 10.1373/clinchem.2004.047431; Salardi S, 2002, DIABETES CARE, V25, P1840, DOI 10.2337/diacare.25.10.1840; Sarol JN, 2005, CURR MED RES OPIN, V21, P173, DOI 10.1185/030079904X20286; SAUDEK CD, 2004, INT TXB DIABETES MEL, V2, P1037; Schwedes U, 2002, DIABETES CARE, V25, P1928, DOI 10.2337/diacare.25.11.1928; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Smith NL, 2002, ARCH INTERN MED, V162, P209, DOI 10.1001/archinte.162.2.209; SONKSEN PH, 1978, LANCET, V1, P729; Soumerai SB, 2004, ARCH INTERN MED, V164, P645, DOI 10.1001/archinte.164.6.645; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; TAHARA Y, 1993, DIABETES CARE, V16, P1313, DOI 10.2337/diacare.16.9.1313; Tanenberg R, 2004, MAYO CLIN PROC, V79, P1521, DOI 10.4065/79.12.1521; Tang ZP, 2000, AM J CLIN PATHOL, V113, P75, DOI 10.1309/QAW1-X5XW-BVRQ-5LKQ; Tansey Michael J, 2005, Diabetes Technol Ther, V7, P109; Tarim O, 1999, PEDIATR INT, V41, P357; TATTERSALL RB, 1991, DIABETIC MED, V8, P49, DOI 10.1111/j.1464-5491.1991.tb01516.x; Trajanoski Z, 1996, DIABETES CARE, V19, P1412, DOI 10.2337/diacare.19.12.1412; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UKPDS GROUP, 1998, LANCET, V352, P1557; WALFORD S, 1978, LANCET, V1, P732; Welschen LMC, 2005, DIABETES CARE, V28, P1510, DOI 10.2337/diacare.28.6.1510; Wen L, 2004, AM J HEALTH-SYST PH, V61, P2401, DOI 10.1093/ajhp/61.22.2401; Wieland LD, 1997, AM J HEALTH-SYST PH, V54, P1062, DOI 10.1093/ajhp/54.9.1062; WIENER K, 1991, DIABETIC MED, V8, P172, DOI 10.1111/j.1464-5491.1991.tb01566.x; WING RR, 1986, AM J MED, V81, P830, DOI 10.1016/0002-9343(86)90354-2; Wright AD, 1998, DIABETES CARE, V21, P87; WYSOCKI T, 1989, J BEHAV MED, V12, P183, DOI 10.1007/BF00846550	117	241	251	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1688	1697		10.1001/jama.295.14.1688	http://dx.doi.org/10.1001/jama.295.14.1688			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609091				2022-12-28	WOS:000236707300025
J	Hanashima, C; Molnar, Z; Fishell, G				Hanashima, C; Molnar, Z; Fishell, G			Building bridges to the cortex	CELL			English	Editorial Material						t	AXONS; DEFECTS; MICE	Innervation of the neocortex by the thalamus is dependent on the precise coordination of spatial and temporal guidance cues. In this issue of Cell, work by Lopez-Bendito et al. (2006) reveals that tangentially migrating cells within the ventral telencephalon are essential for axonal navigation between the thalamus and the neocortex, a process apparently mediated by Neuregulin-1/ErbB4 short- and long-range signaling.	Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; NYU Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA	University of Oxford; New York University; New York University	Molnar, Z (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Gros Clark Bldg,S Parks Rd, Oxford OX1 3QX, England.	zoltan.molnar@anat.ox.ac.uk; fishell@saturn.med.nyu.edu	Molnar, Zoltan/J-7281-2012	Molnar, Zoltan/0000-0002-6852-6004; Fishell, Gordon/0000-0002-9640-9278	Medical Research Council [G0300200] Funding Source: Medline; MRC [G0300200] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Metin C, 1996, J NEUROSCI, V16, P3219; MITROFANIS J, 1993, TRENDS NEUROSCI, V16, P240, DOI 10.1016/0166-2236(93)90163-G; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Tuttle R, 1999, DEVELOPMENT, V126, P1903	9	10	10	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					24	27		10.1016/j.cell.2006.03.021	http://dx.doi.org/10.1016/j.cell.2006.03.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615886	Bronze			2022-12-28	WOS:000237314200010
J	Suttmeier, RP; Cao, C; Simon, DF				Suttmeier, RP; Cao, C; Simon, DF			Priorities and funding - "Knowledge innovation" and the Chinese Academy of Sciences	SCIENCE			English	Editorial Material									Univ Oregon, Eugene, OR 97403 USA; SUNY, Neil D Levin Grad Inst Int Relat & Commerce, New York, NY 10036 USA	University of Oregon; State University of New York (SUNY) System; SUNY Community College; SUNY Maritime College; SUNY Optometry	Suttmeier, RP (corresponding author), Univ Oregon, Eugene, OR 97403 USA.	petesutt@uoregon.edu	Cao, Cong/U-1847-2019	Cao, Cong/0000-0002-3407-7837				Cao C., 2004, CHINAS SCI ELITE; Cyranoski D, 2004, NATURE, V430, P495, DOI 10.1038/430495b; LI H, 1998, SCIENCE, V279, P649; *NAT BUR STAT MIN, 2005, CHIN STAT YB SCI TEC; POO MM, 2004, NATURE S, V432, pA18; Rao Yi, 2004, NATURE S, V432, pA12; ZHU C, 2004, NATURE S2, V432, pA24; 2006, PEOPLES DAILY   0301	8	46	48	5	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					58	59		10.1126/science.1122280	http://dx.doi.org/10.1126/science.1122280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601178				2022-12-28	WOS:000236584400024
J	Komatsu, M; Waguri, S; Chiba, T; Murata, S; Iwata, J; Tanida, I; Ueno, T; Koike, M; Uchiyama, Y; Kominami, E; Tanaka, K				Komatsu, Masaaki; Waguri, Satoshi; Chiba, Tomoki; Murata, Shigeo; Iwata, Jun-ichi; Tanida, Isei; Ueno, Takashi; Koike, Masato; Uchiyama, Yasuo; Kominami, Eiki; Tanaka, Keiji			Loss of autophagy in the central nervous system causes neurodegeneration in mice	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; CELL-DEATH; DISEASE; CARDIOMYOPATHY; IMPAIRMENT; PATHWAYS; HOMOLOG	Protein quality-control, especially the removal of proteins with aberrant structures, has an important role in maintaining the homeostasis of non-dividing neural cells(1). In addition to the ubiquitin-proteasome system, emerging evidence points to the importance of autophagy-the bulk protein degradation pathway involved in starvation-induced and constitutive protein turnover-in the protein quality-control process(2,3). However, little is known about the precise roles of autophagy in neurons. Here we report that loss of Atg7 (autophagy-related 7), a gene essential for autophagy, leads to neurodegeneration. We found that mice lacking Atg7 specifically in the central nervous system showed behavioural defects, including abnormal limb-clasping reflexes and a reduction in coordinated movement, and died within 28 weeks of birth. Atg7 deficiency caused massive neuronal loss in the cerebral and cerebellar cortices. Notably, polyubiquitinated proteins accumulated in autophagy-deficient neurons as inclusion bodies, which increased in size and number with ageing. There was, however, no obvious alteration in proteasome function. Our results indicate that autophagy is essential for the survival of neural cells, and that impairment of autophagy is implicated in the pathogenesis of neurodegenerative disorders involving ubiquitin-containing inclusion bodies.	Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan	Tokyo Metropolitan Institute of Medical Science; Juntendo University; Osaka University	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan.	tanakak@rinshoken.or.jp	Kominami, Eiki/D-3802-2009; Komatsu, Masaaki/B-8321-2011; Murata, Shigeo/A-1426-2010; Koike, Masato/F-9584-2010; Tanida, Isei/C-8277-2009	Komatsu, Masaaki/0000-0001-7672-7722; Murata, Shigeo/0000-0002-3177-3503; Koike, Masato/0000-0002-3174-5684; Tanida, Isei/0000-0001-8999-3990				Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fortun J, 2003, J NEUROSCI, V23, P10672; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; WAGURI S, 1995, EUR J CELL BIOL, V67, P308; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	30	2716	2817	6	317	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					880	884		10.1038/nature04723	http://dx.doi.org/10.1038/nature04723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16625205				2022-12-28	WOS:000238254100044
J	Steinhardt, PJ; Turok, N				Steinhardt, PJ; Turok, N			Why the cosmological constant is small and positive	SCIENCE			English	Article							UNIVERSE; SUPERNOVAE; VACUUM; AXIONS; DECAY		Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Princeton University; University of Cambridge	Steinhardt, PJ (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	steinh@princeton.edu		Steinhardt, Paul/0000-0003-3488-1603				BANKS T, 1991, PHYS LETT B, V273, P105, DOI 10.1016/0370-2693(91)90561-4; Battefeld TJ, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.066006; Boyle LA, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.127302; BROWN JD, 1987, PHYS LETT B, V195, P177, DOI 10.1016/0370-2693(87)91190-7; COLEMAN S, 1988, NUCL PHYS B, V310, P643, DOI 10.1016/0550-3213(88)90097-1; COLEMAN S, 1980, PHYS REV D, V21, P3305, DOI 10.1103/PhysRevD.21.3305; Creminelli P, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.063505; Felder G, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.023507; HAWKING SW, 1984, PHYS LETT B, V134, P403, DOI 10.1016/0370-2693(84)91370-4; HAWKING SW, 1982, PHYS LETT B, V110, P35, DOI 10.1016/0370-2693(82)90946-7; Khoury J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.031302; Khoury J, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.123522; LEE K, 1987, PHYS REV D, V36, P1088, DOI 10.1103/PhysRevD.36.1088; LINDE A, 1991, PHYS LETT B, V259, P38, DOI 10.1016/0370-2693(91)90130-I; LINDE AD, 1988, PHYS LETT B, V200, P272, DOI 10.1016/0370-2693(88)90770-8; LINDE AD, 1987, 300 YEARS GRAVITATIO, P604; PARKE SJ, 1983, PHYS LETT B, V21, P313; PECCEI RD, 1977, PHYS REV LETT, V38, P1440, DOI 10.1103/PhysRevLett.38.1440; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Steinhardt PJ, 2002, SCIENCE, V296, P1436, DOI 10.1126/science.1070462; Steinhardt PJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.126003; Tegmark M, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.023505; TURNER MS, 1978, PHYS REV LETT, V40, P279; WEINBERG S, 1978, PHYS REV LETT, V40, P223, DOI 10.1103/PhysRevLett.40.223; WEINBERG S, 1987, PHYS REV LETT, V59, P2607, DOI 10.1103/PhysRevLett.59.2607; WILCZEK F, 1978, PHYS REV LETT, V40, P279, DOI 10.1103/PhysRevLett.40.279	28	96	97	3	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1180	1183		10.1126/science.1126231	http://dx.doi.org/10.1126/science.1126231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16675662	Green Submitted			2022-12-28	WOS:000237957400044
J	Strom, BL				Strom, BL			How the US drug safety system should be changed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania	Strom, BL (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, 824 Blockley Hall,423 guardian Dr, Philadelphia, PA 19104 USA.	bstrom@cceb.med.upenn.edu						BAKKE OM, 1995, CLIN PHARMACOL THER, V58, P108, DOI 10.1016/0009-9236(95)90078-0; Califf RM, 2002, PHARMACOEPIDEM DR S, V11, P319, DOI 10.1002/pds.699; Gelfand JM, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P337; HALPIN TJ, 1982, JAMA-J AM MED ASSOC, V248, P687, DOI 10.1001/jama.248.6.687; Hennessy S, 2004, PHARMACOEPIDEM DR S, V13, P503, DOI 10.1002/pds.995; Hennessy S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P281; HOLMES OW, 1861, WORKS, V9, P185; Joint Commission on Prescription Drug Use, 1980, FIN REP; Kramer JM, 2005, PHARMACOEPIDEM DR S, V14, P619, DOI 10.1002/pds.1060; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Mendelsohn AB, 2005, PHARMACOEPIDEM DR S, V14, P615, DOI 10.1002/pds.1111; *PHRMA, 2004, PHARM IND PROF 2004; Rawlins JW., 1977, TXB ADVERSE DRUG REA, P44; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; Spence MM, 2005, MED CARE RES REV, V62, P544, DOI 10.1177/1077558705279314; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P29; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P219; *US GEN ACC OFF, 1990, PUBL GAO, P24	19	83	87	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2072	2075		10.1001/jama.295.17.2072	http://dx.doi.org/10.1001/jama.295.17.2072			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038MF	16670415				2022-12-28	WOS:000237225100023
J	Holtz, TH; Sternberg, M; Kammerer, S; Laserson, KF; Riekstina, V; Zarovska, E; Skripconoka, V; Wells, CD; Leimane, V				Holtz, TH; Sternberg, M; Kammerer, S; Laserson, KF; Riekstina, V; Zarovska, E; Skripconoka, V; Wells, CD; Leimane, V			Time to sputum culture conversion in multidrug-resistant tuberculosis: Predictors and relationship to treatment outcome	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY TUBERCULOSIS; EXPERIENCE; RIFAMPIN; LATVIA	Background: Conversion of sputum mycobacterial cultures from positive growth to negative growth of Mycobacterium tuberculosis in patients with pulmonary tuberculosis (TB) is considered the most important interim indicator of the efficacy of anti-TB pharmacologic treatment for multidrug-resistant disease. Objective: To evaluate and compare time to and predictors of initial sputum culture conversion with predictors of treatment outcome for patients with multidrug-resistant TB. Design: Retrospective cohort study. Setting: Latvia. Patients: All civilian patients with multidrug-resistant TB treated with the DOTS-Plus strategy between 1 January and 31 December 2000. Intervention: Individualized treatment for confirmed sputum culture-positive pulmonary multidrug-resistant TB. Measurements: Time to initial sputum culture conversion and treatment outcome. Results: Among 167 patients who were sputum culture-positive at initiation of second-line therapy, 129 (77%) converted in a median time of 60 days (range, 4 to 462 days) and 38 (23%) did not convert. independent predictors of a longer sputum culture conversion time, using an accelerated failure time regression model, included previous treatment for multidrug-resistant TB, high initial sputum culture colony count, bilateral cavitations on chest radiography, and the number of drugs the initial isolate was resistant to at treatment initiation. Treatment outcomes were statistically significantly worse for patients who did not convert their sputum culture within 2 months. Limitations: Twenty-five percent of patients missed 5 or more monthly sputum collections. Conclusions: Under program conditions in Latvia, most patents with multidrug-resistant TB achieved sputum culture conversion within 12 weeks of starting treatment. Chest radiography and sputum culture drug susceptibility testing can assist physicians in predicting which patients will convert more slowly. Sputum culture conversion is a useful and appropriate interim indicator of treatment outcome in patients with multidrug-resistant TB.	Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; State Agcy TB & Lung Dis, Riga, Latvia	Centers for Disease Control & Prevention - USA	Holtz, TH (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, 1600 Clifton Rd NE,MS E-10, Atlanta, GA 30333 USA.	tholtz@cdc.gov			PHS HHS [U23 CCU021873] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM SOC SOC, 2003, MMWR MORB MORAL WKLY, V52; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Dominguez-Castellano A, 2003, INT J TUBERC LUNG D, V7, P432; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Johansen IS, 2003, INT J TUBERC LUNG D, V7, P899; Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Liu ZY, 1999, ARCH INTERN MED, V159, P1110, DOI 10.1001/archinte.159.10.1110; Maranetra KN, 1999, CHEMOTHERAPY, V45, P12, DOI 10.1159/000048477; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Narita M, 2001, CHEST, V120, P343, DOI 10.1378/chest.120.2.343; Organization WH, 1997, WHOTB97229; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Skenders G, 2005, EMERG INFECT DIS, V11, P1461, DOI 10.3201/eid1109.041236; Suo J, 1996, CHEMOTHERAPY, V42, P20, DOI 10.1159/000239510; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; *WHO, 2000, WHOCDSTB2000278; *WHO, 2002, WHOCDSTB2002307; *WHO, 2005, WHOHTMTB2004343; *WHO, 2000, WHOCDSTB2000279 GEN; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2010, GUIDELINES TREATMENT, V4; Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476	27	163	170	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					650	659		10.7326/0003-4819-144-9-200605020-00008	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039GJ	16670134				2022-12-28	WOS:000237293700004
J	Shannon, J				Shannon, J			Traffic fine	LANCET			English	Editorial Material									Univ Sydney, Nepean Canc Care Ctr, Sydney, NSW 2747, Australia	University of Sydney	Shannon, J (corresponding author), Univ Sydney, Nepean Canc Care Ctr, Sydney, NSW 2747, Australia.	shannoj@wahs.nsw.gov.au							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 29	2006	367	9520					1456	1457		10.1016/S0140-6736(06)68616-9	http://dx.doi.org/10.1016/S0140-6736(06)68616-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650655				2022-12-28	WOS:000237195600033
J	de Jong, T				de Jong, T			Computer simulations - Technological advances in inquiry learning	SCIENCE			English	Editorial Material							THEORETICAL FRAMEWORK; DISCOVERY; ENVIRONMENT; INSTRUCTION; STUDENTS; SUPPORT		Univ Twente, Fac Behav Sci, NL-7500 AE Enschede, Netherlands	University of Twente	de Jong, T (corresponding author), Univ Twente, Fac Behav Sci, POB 217, NL-7500 AE Enschede, Netherlands.	a.j.m.dejong@utwente.nl	van Joolingen, Wouter R/A-7148-2011	van Joolingen, Wouter R/0000-0002-4271-2861				BRUNER JS, 1961, HARVARD EDUC REV, V31, P21; CHINN CA, 1993, REV EDUC RES, V63, P1, DOI 10.3102/00346543063001001; Chinn CA, 2002, SCI EDUC, V86, P175, DOI 10.1002/sce.10001; de Jong T, 1998, REV EDUC RES, V68, P179, DOI 10.2307/1170753; de Jong T., 2006, DEALING COMPLEXITY L, P107; Dewey John, 1938, LOGIC THEORY INQUIRY; Hickey DT, 2003, AM EDUC RES J, V40, P495, DOI 10.3102/00028312040002495; Hulshof CD, 2005, INTERACT LEARN ENVIR, V13, P39, DOI 10.1080/10494820500224079; Keselman A, 2003, J RES SCI TEACH, V40, P898, DOI 10.1002/tea.10115; Klahr D, 2004, PSYCHOL SCI, V15, P661, DOI 10.1111/j.0956-7976.2004.00737.x; Lawson AE, 2002, J RES SCI TEACH, V39, P237, DOI 10.1002/tea.10019; Lewis E. L., 1993, Educational Technology, V33, P45; Lin XD, 1999, J RES SCI TEACH, V36, P837, DOI 10.1002/(SICI)1098-2736(199909)36:7<837::AID-TEA6>3.0.CO;2-U; Linn M.C., 2004, INTERNET ENV SCI ED, P315; Manlove S, 2006, J COMPUT ASSIST LEAR, V22, P87, DOI 10.1111/j.1365-2729.2006.00162.x; Mayer RE, 2004, AM PSYCHOL, V59, P14, DOI 10.1037/0003-066X.59.1.14; NSF, 2000, FDN INQ THOUGHTS VIE, V2, P1; OECD, 2004, LEARN TOM WORLD 1 RE; Okada T, 1997, COGNITIVE SCI, V21, P109, DOI 10.1016/S0364-0213(99)80020-2; Quintana C, 2004, J LEARN SCI, V13, P337, DOI 10.1207/s15327809jls1303_4; Schauble L, 1995, J LEARN SCI, V4, P131, DOI 10.1207/s15327809jls0402_1; Swaak J, 1998, LEARN INSTR, V8, P235, DOI 10.1016/S0959-4752(98)00018-8; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; Van Joolingen W.R., 2003, AUTHORING TOOLS ADV, P1; van Joolingen WR, 2005, COMPUT HUM BEHAV, V21, P671, DOI 10.1016/j.chb.2004.10.039; Veermans K, 2006, INT J SCI EDUC, V28, P341, DOI 10.1080/09500690500277615; White B, 2005, EDUC PSYCHOL-US, V40, P211, DOI 10.1207/s15326985ep4004_3	27	254	254	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					532	533		10.1126/science.1127750	http://dx.doi.org/10.1126/science.1127750			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039HN	16645080				2022-12-28	WOS:000237296700027
J	Sun, L; Peng, Y; Sharrow, AC; Iqbal, J; Zhang, Z; Papachristou, DJ; Zaidi, S; Zhu, LL; Yaroslavskiy, BB; Zhou, H; Zallone, A; Sairam, MR; Kumar, TR; Bo, W; Braun, J; Cardoso-Landa, L; Schaffler, MB; Moonga, BS; Blair, HC; Zaidi, M				Sun, L; Peng, Y; Sharrow, AC; Iqbal, J; Zhang, Z; Papachristou, DJ; Zaidi, S; Zhu, LL; Yaroslavskiy, BB; Zhou, H; Zallone, A; Sairam, MR; Kumar, TR; Bo, W; Braun, J; Cardoso-Landa, L; Schaffler, MB; Moonga, BS; Blair, HC; Zaidi, M			FSH directly regulates bone mass	CELL			English	Article							FOLLICLE-STIMULATING-HORMONE; OSTEOCLAST FORMATION; ESTROGEN DEFICIENCY; CD38/ADP-RIBOSYL CYCLASE; BIOCHEMICAL MARKERS; RECEPTOR FUNCTION; TURNOVER MARKERS; MENSTRUAL-CYCLE; FEMALE MICE; IN-VITRO	Postmenopausal osteoporosis, a global public health problem, has for decades been attributed solely to declining estrogen levels. Although FSH levels rise sharply in parallel, a direct effect of FSH on the skeleton has never been explored. We show that FSH is required for hypogonadal bone loss. Neither FSH beta nor FSH receptor (FSHR) null mice have bone loss despite severe hypogonadism. Bone mass is increased and osteoclastic resorption is decreased in haploin-sufficient FSHD+/- mice with normal ovarian function, suggesting that the skeletal action of FSH is estrogen independent. Osteoclasts and their precursors possess G(i2 alpha)-COupled FSHRs that activate MEK/Erk, NF-kappa B, and Akt to result in enhanced osteoclast formation and function. We suggest that high circulating FSH causes hypogonadal bone loss.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; CUNY Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Orthopaed, New York, NY 10029 USA; VA Med Ctr, Pittsburgh, PA 15261 USA; Univ Bari, Dept Anat & Histol, I-70124 Bari, Italy; Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; Univ Kansas, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Universita degli Studi di Bari Aldo Moro; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Kansas; University of California System; University of California Los Angeles	Blair, HC (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA.	hcblair@imap.upitt.edu; mone.zaidi@mssm.edu	Cardoso, Luis/F-1234-2013	Cardoso, Luis/0000-0002-2252-7802; Sharrow, Allison/0000-0002-4611-6020; Braun, Jonathan/0000-0003-1646-2974	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041210, R01AR047700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG014907, R01AG012951, R01AG023176] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41010, AR47700, R01 AR041210] Funding Source: Medline; NIA NIH HHS [AG12951, AG23176, AG14907] Funding Source: Medline; NIDDK NIH HHS [DK70526] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Blair HC, 2004, J BONE MINER RES, V19, P1329, DOI 10.1359/JBMR.040403; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Chiu KM, 1999, J BONE MINER RES, V14, P609, DOI 10.1359/jbmr.1999.14.4.609; CLAYTON RN, 1993, HUM REPROD, V8, P29, DOI 10.1093/humrep/8.suppl_2.29; Conti M, 2002, BIOL REPROD, V67, P1653, DOI 10.1095/biolreprod.102.004952; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; Danilovich N, 2000, ENDOCRINOLOGY, V141, P4295, DOI 10.1210/en.141.11.4295; Devleta B, 2004, J BONE MINER METAB, V22, P360, DOI 10.1007/s00774-004-0495-1; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; GORAI I, 1995, CALCIFIED TISSUE INT, V57, P100, DOI 10.1007/BF00298428; Kawai Haruko, 2004, Archives of Gynecology and Obstetrics, V269, P192; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Lindsay R, 2004, ENDOCRINE, V24, P223, DOI 10.1385/ENDO:24:3:223; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; McCauley LK, 2002, CRIT REV EUKAR GENE, V12, P89, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.10; MINEGISH T, 1991, BIOCHEM BIOPH RES CO, V175, P1125, DOI 10.1016/0006-291X(91)91682-3; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Oz OK, 2000, J BONE MINER RES, V15, P507, DOI 10.1359/jbmr.2000.15.3.507; Oz OK, 2001, J STEROID BIOCHEM, V79, P49, DOI 10.1016/S0960-0760(01)00130-3; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; PADMANABHAN V, 1989, J CLIN ENDOCR METAB, V69, P968, DOI 10.1210/jcem-69-5-968; Prior JC, 1998, ENDOCR REV, V19, P397, DOI 10.1210/er.19.4.397; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Robker RL, 1998, BIOL REPROD, V59, P476, DOI 10.1095/biolreprod59.3.476; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Sairam M. R., 1999, ENCYC REPROD, P552; Sairam MR, 1996, BIOCHEM BIOPH RES CO, V226, P717, DOI 10.1006/bbrc.1996.1419; Saltarelli D, 1999, CELL SIGNAL, V11, P415, DOI 10.1016/S0898-6568(99)00012-1; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Sowers MR, 2003, OSTEOPOROSIS INT, V14, P191, DOI 10.1007/s00198-002-1329-4; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; STEPNICK LS, 2004, BONE HLTH OSTEOPOROS, P68; Sun L, 1999, J CELL BIOL, V146, P1161, DOI 10.1083/jcb.146.5.1161; Sun L, 2003, FASEB J, V17, P369, DOI 10.1096/fj.02-0205com; Sun L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0705com; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yeh JK, 1997, BONE, V20, P413, DOI 10.1016/S8756-3282(97)00027-6; Yeh JK, 1996, BONE, V18, P443, DOI 10.1016/8756-3282(96)00045-2; ZAIDI M, 1993, BIOL REV, V68, P197, DOI 10.1111/j.1469-185X.1993.tb00996.x; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212; Zittermann A, 2000, J CLIN ENDOCR METAB, V85, P95, DOI 10.1210/jc.85.1.95	50	489	552	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					247	260		10.1016/j.cell.2006.01.051	http://dx.doi.org/10.1016/j.cell.2006.01.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630814	Bronze			2022-12-28	WOS:000237241500016
J	Aharonian, F; Akhperjanian, AG; Bazer-Bachi, AR; Beilicke, M; Benbow, W; Berge, D; Bernlohr, K; Boisson, C; Bolz, O; Borrel, V; Braun, I; Breitling, F; Brown, AM; Chadwick, PM; Chounet, LM; Cornils, R; Costamante, L; Degrange, B; Dickinson, HJ; Djannati-Atai, A; Drury, LO; Dubus, G; Emmanoulopoulos, D; Espigat, P; Feinstein, F; Fontaine, G; Fuchs, Y; Funk, S; Gallant, YA; Giebels, B; Gillessen, S; Glicenstein, JF; Goret, P; Hadjichristidis, C; Hauser, D; Hauser, M; Heinzelmann, G; Henri, G; Hermann, G; Hinton, JA; Hofmann, W; Holleran, M; Horns, D; Jacholkowska, A; de Jager, OC; Khelifi, B; Klages, S; Komin, N; Konopelko, A; Latham, IJ; Le Gallou, R; Lemiere, A; Lemoine-Goumard, M; Leroy, N; Lohse, T; Martin, JM; Martineau-Huynh, O; Marcowith, A; Masterson, C; McComb, TJL; de Naurois, M; Nolan, SJ; Noutsos, A; Orford, KJ; Osborne, JL; Ouchrif, M; Panter, M; Pelletier, G; Pita, S; Puhlhofer, G; Punch, M; Raubenheimer, BC; Raue, M; Raux, J; Rayner, SM; Reimer, A; Reimer, O; Ripken, J; Rob, L; Rolland, L; Rowell, G; Sahakian, V; Sauge, L; Schlenker, S; Schlickeiser, R; Schuster, C; Schwanke, U; Siewert, M; Sol, H; Spangler, D; Steenkamp, R; Stegmann, C; Tavernet, JP; Terrier, R; Theoret, CG; Tluczykont, M; van Eldik, C; Vasileiadis, G; Venter, C; Vincent, P; Volk, HJ; Wagner, SJ				Aharonian, F; Akhperjanian, AG; Bazer-Bachi, AR; Beilicke, M; Benbow, W; Berge, D; Bernlohr, K; Boisson, C; Bolz, O; Borrel, V; Braun, I; Breitling, F; Brown, AM; Chadwick, PM; Chounet, LM; Cornils, R; Costamante, L; Degrange, B; Dickinson, HJ; Djannati-Atai, A; Drury, LO; Dubus, G; Emmanoulopoulos, D; Espigat, P; Feinstein, F; Fontaine, G; Fuchs, Y; Funk, S; Gallant, YA; Giebels, B; Gillessen, S; Glicenstein, JF; Goret, P; Hadjichristidis, C; Hauser, D; Hauser, M; Heinzelmann, G; Henri, G; Hermann, G; Hinton, JA; Hofmann, W; Holleran, M; Horns, D; Jacholkowska, A; de Jager, OC; Khelifi, B; Klages, S; Komin, N; Konopelko, A; Latham, IJ; Le Gallou, R; Lemiere, A; Lemoine-Goumard, M; Leroy, N; Lohse, T; Martin, JM; Martineau-Huynh, O; Marcowith, A; Masterson, C; McComb, TJL; de Naurois, M; Nolan, SJ; Noutsos, A; Orford, KJ; Osborne, JL; Ouchrif, M; Panter, M; Pelletier, G; Pita, S; Puhlhofer, G; Punch, M; Raubenheimer, BC; Raue, M; Raux, J; Rayner, SM; Reimer, A; Reimer, O; Ripken, J; Rob, L; Rolland, L; Rowell, G; Sahakian, V; Sauge, L; Schlenker, S; Schlickeiser, R; Schuster, C; Schwanke, U; Siewert, M; Sol, H; Spangler, D; Steenkamp, R; Stegmann, C; Tavernet, JP; Terrier, R; Theoret, CG; Tluczykont, M; van Eldik, C; Vasileiadis, G; Venter, C; Vincent, P; Volk, HJ; Wagner, SJ			A low level of extragalactic background light as revealed by gamma-rays from blazars	NATURE			English	Article							MKN 501; TELESCOPE; SPACE; ABSORPTION; SPECTRUM; 2MASS; DIRBE	The diffuse extragalactic background light consists of the sum of the starlight emitted by galaxies through the history of the Universe, and it could also have an important contribution from the 'first stars', which may have formed before galaxy formation began. Direct measurements are difficult and not yet conclusive, owing to the large uncertainties caused by the bright foreground emission associated with zodiacal light(1). An alternative approach(2-5) is to study the absorption features imprinted on the gamma-ray spectra of distant extragalactic objects by interactions of those photons with the background light photons(6). Here we report the discovery of gamma-ray emission from the blazars(7) H 2356-309 and 1ES 1101-232, at redshifts z=0.165 and z=0.186, respectively. Their unexpectedly hard spectra provide an upper limit on the background light at optical/near-infrared wavelengths that appears to be very close to the lower limit given by the integrated light of resolved galaxies(8). The background flux at these wavelengths accordingly seems to be strongly dominated by the direct starlight from galaxies, thus excluding a large contribution from other sources-in particular from the first stars formed(9). This result also indicates that intergalactic space is more transparent to gamma-rays than previously thought.	Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; Yerevan Phys Inst, Yerevan 375036, Armenia; UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31029 Toulouse 4, France; Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; Observ Paris, Sect Meudon, LUTH, CNRS,UMR 8102, F-92195 Meudon, France; Univ Durham, Dept Phys, Durham DH1 3LE, England; Ecole Polytech, Lab Leprince Ringuet, CNRS, IN2P3, F-91128 Palaiseau, France; APC, F-75231 Paris 05, France; Dublin Inst Adv Studies, Dublin 2, Ireland; Landessternwarte Konigstuhl, D-69117 Heidelberg, Germany; Univ Montpellier 2, Lab Phys Theor & Astroparticules, CNRS, IN2P3, F-34095 Montpellier 5, France; Univ Grenoble 1, Lab Astrophys Grenoble, CNRS, INSU, F-38041 Grenoble 9, France; Ctr Etud Saclay, CEA, DSM, DAPNIA, F-91191 Gif Sur Yvette, France; North West Univ, Unit Space Phys, ZA-2520 Potchefstroom, South Africa; Univ Paris 06, Lab Phys Nucl & Hautes Energies, CNRS, IN2P3, F-75252 Paris 5, France; Univ Paris 07, Lab Phys Nucl & Hautes Energies, CNRS, IN2P3, F-75252 Paris 5, France; Ruhr Univ Bochum, Inst Theoret Phys, Lehrstuhl Weltraum & Astrophys 4, D-44780 Bochum, Germany; Charles Univ Prague, Inst Nucl & Particle Phys, CR-18000 Prague 8, Czech Republic; Univ Namibia, Windhoek, Namibia	Max Planck Society; Yerevan Physics Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hamburg; Humboldt University of Berlin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Durham University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Centre National de la Recherche Scientifique (CNRS); Dublin Institute for Advanced Studies; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay; North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ruhr University Bochum; Charles University Prague; University of Namibia	Costamante, L (corresponding author), Max Planck Inst Kernphys, POB 103980, D-69029 Heidelberg, Germany.	luigi.costamante@mpi-hd.mpg.de	Berge, David/P-2179-2017; Venter, Christo/E-6884-2011; Hadjichristidis, Christos/G-7284-2012; Reimer, Olaf/A-3117-2013; Reimer, Anita/K-5822-2015; Drury, Luke O'C/B-1916-2017; Braun, Isabel V/C-9373-2012; Funk, Stefan/AAI-1568-2021; Fontaine, Gerard/D-6420-2014; Marcowith, Alexandre/ABH-1254-2020; Funk, Stefan/B-7629-2015; Djannati-Atai, Arache/ABA-9249-2021; Horns, Dieter/C-9727-2011; Pühlhofer, Gerd/Q-2336-2018; van Eldik, Christopher/C-3901-2013; Horns, Dieter/ABE-9516-2020; Komin, Nukri/J-6781-2015	Berge, David/0000-0002-2918-1824; Venter, Christo/0000-0002-2666-4812; Hadjichristidis, Christos/0000-0002-5933-0755; Reimer, Olaf/0000-0001-6953-1385; Reimer, Anita/0000-0001-8604-7077; Drury, Luke O'C/0000-0002-9257-2270; Braun, Isabel V/0000-0002-9389-0502; Funk, Stefan/0000-0002-2012-0080; Fontaine, Gerard/0000-0002-6443-5025; Marcowith, Alexandre/0000-0002-3971-0910; Funk, Stefan/0000-0002-2012-0080; van Eldik, Christopher/0000-0001-9669-645X; Horns, Dieter/0000-0003-1945-0119; Chadwick, Paula/0000-0002-1468-2685; Punch, Michael/0000-0002-4710-2165; Komin, Nukri/0000-0003-3280-0582; Rowell, Gavin/0000-0002-9516-1581; Brown, Anthony/0000-0003-0259-3148; Hermann, German/0000-0002-4595-1032; Martineau-Huynh, Olivier/0000-0001-5334-8244				Aharonian F, 2005, ASTRON ASTROPHYS, V430, P865, DOI 10.1051/0004-6361:20041853; Aharonian F, 2003, ASTRON ASTROPHYS, V403, P523, DOI 10.1051/0004-6361:20030326; Aharonian FA, 1999, ASTRON ASTROPHYS, V349, P11; AHARONIAN FA, 2001, P 27 ICRC HAMB, P250; Bernstein RA, 2002, ASTROPHYS J, V571, P56, DOI 10.1086/339422; Cambresy L, 2001, ASTROPHYS J, V555, P563, DOI 10.1086/321470; Costamante L, 2002, ASTRON ASTROPHYS, V384, P56, DOI 10.1051/0004-6361:20011749; Djannati-Atai A, 1999, ASTRON ASTROPHYS, V350, P17; Dwek E, 2005, ASTROPHYS J, V635, P784, DOI 10.1086/497569; Dwek E, 2005, ASTROPHYS J, V618, P657, DOI 10.1086/426010; Dwek E, 1998, ASTROPHYS J, V508, pL9, DOI 10.1086/311714; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P39, DOI 10.1086/422585; GOULD RJ, 1966, PHYS REV LETT, V16, P252, DOI 10.1103/PhysRevLett.16.252; Hauser MG, 2001, ANNU REV ASTRON ASTR, V39, P249, DOI 10.1146/annurev.astro.39.1.249; JELLEY JV, 1966, PHYS REV LETT, V16, P479, DOI 10.1103/PhysRevLett.16.479; Kashlinsky A, 2005, PHYS REP, V409, P361, DOI 10.1016/j.physrep.2004.12.005; KRENNRICH F, 2002, APJ, V575, P9; Madau P, 2005, MON NOT R ASTRON SOC, V359, pL37, DOI 10.1111/j.1745-3933.2005.00031.x; Madau P, 2000, MON NOT R ASTRON SOC, V312, pL9, DOI 10.1046/j.1365-8711.2000.03268.x; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Matsumoto T, 2005, ASTROPHYS J, V626, P31, DOI 10.1086/429383; Mattila K, 2003, ASTROPHYS J, V591, P119, DOI 10.1086/375182; NIKISHOV AI, 1962, SOV PHYS JETP-USSR, V14, P393; Primack JR, 2005, AIP CONF PROC, V745, P23, DOI 10.1063/1.1878394; Primack JR, 2001, AIP CONF PROC, V558, P463, DOI 10.1063/1.1370813; Protheroe RJ, 2000, PHYS LETT B, V493, P1, DOI 10.1016/S0370-2693(00)01113-8; Santos MR, 2002, MON NOT R ASTRON SOC, V336, P1082, DOI 10.1046/j.1365-8711.2002.05895.x; STECKER FW, 1992, ASTROPHYS J, V390, pL49, DOI 10.1086/186369; Totani T, 2001, ASTROPHYS J, V550, pL137, DOI 10.1086/319646; Wright EL, 2001, ASTROPHYS J, V553, P538, DOI 10.1086/320942	30	464	468	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1018	1021		10.1038/nature04680	http://dx.doi.org/10.1038/nature04680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625189	Green Submitted, Green Accepted			2022-12-28	WOS:000236906000028
J	Clayton, TA; Lindon, JC; Cloarec, O; Antti, H; Charuel, C; Hanton, G; Provost, JP; Le Net, JL; Baker, D; Walley, RJ; Everett, JR; Nicholson, JK				Clayton, TA; Lindon, JC; Cloarec, O; Antti, H; Charuel, C; Hanton, G; Provost, JP; Le Net, JL; Baker, D; Walley, RJ; Everett, JR; Nicholson, JK			Pharmaco-metabonomic phenotyping and personalized drug treatment	NATURE			English	Article							URINARY-EXCRETION; ACETAMINOPHEN; SPECTROSCOPY; VARIABILITY; TAURINE; SYSTEMS	There is a clear case for drug treatments to be selected according to the characteristics of an individual patient, in order to improve efficacy and reduce the number and severity of adverse drug reactions(1,2). However, such personalization of drug treatments requires the ability to predict how different individuals will respond to a particular drug/dose combination. After initial optimism, there is increasing recognition of the limitations of the pharmacogenomic approach, which does not take account of important environmental influences on drug absorption, distribution, metabolism and excretion(3-5). For instance, a major factor underlying inter-individual variation in drug effects is variation in metabolic phenotype, which is influenced not only by genotype but also by environmental factors such as nutritional status, the gut microbiota, age, disease and the co- or pre-administration of other drugs(6,7). Thus, although genetic variation is clearly important, it seems unlikely that personalized drug therapy will be enabled for a wide range of major diseases using genomic knowledge alone. Here we describe an alternative and conceptually new 'pharmaco-metabonomic' approach to personalizing drug treatment, which uses a combination of pre-dose metabolite profiling and chemometrics to model and predict the responses of individual subjects. We provide proof-of-principle for this new approach, which is sensitive to both genetic and environmental influences, with a study of paracetamol (acetaminophen) administered to rats. We show pre-dose prediction of an aspect of the urinary drug metabolite profile and an association between pre-dose urinary composition and the extent of liver damage sustained after paracetamol administration.	Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biomed Sci, London SW7 2AZ, England; Umea Univ, Dept Chem, S-90187 Umea, Sweden; Pfizer Global Res & Dev, Ctr Rech, F-37401 Amboise, France; Pfizer Inc, Ann Arbor, MI 48105 USA; Pfizer Ltd, Global Res & Dev, Sandwich CT13 9NJ, Kent, England	Imperial College London; Umea University; Pfizer; Pfizer; Pfizer	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biomed Sci, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Everett, Jeremy/B-5613-2012; Nicholson, Jeremy K/B-3395-2012	Everett, Jeremy/0000-0003-1550-4482; Nicholson, Jeremy K/0000-0002-8123-8349; Lindon, John/0000-0002-0916-6360; Walley, Rosalind/0000-0002-4990-2377	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALES JR, 1984, CLIN CHEM, V30, P1631; Claridge T. D. W., 1999, TETR ORG CH, V19, P285; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; COOMES MW, 1997, TXB BIOCH CLIN CORRE, P473; Grant DM, 2004, BRIT J CLIN PHARMACO, V58, pS788, DOI 10.1111/j.1365-2125.2004.02297.x; GREGUS Z, 1988, J PHARMACOL EXP THER, V244, P91; Ingelman-Sundberg M, 2001, TOXICOL LETT, V120, P259, DOI 10.1016/S0378-4274(01)00278-8; Lenz EM, 2004, J PHARMACEUT BIOMED, V36, P841, DOI 10.1016/j.jpba.2004.08.002; Lindon JC, 2005, PHARMACOGENOMICS, V6, P691, DOI 10.2217/14622416.6.7.691; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Liu L, 1996, TOXICOL APPL PHARM, V139, P128, DOI 10.1006/taap.1996.0151; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Nicholls AW, 2003, CHEM RES TOXICOL, V16, P1395, DOI 10.1021/tx0340293; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Pagliarulo Vincenzo, 2002, Current Issues in Molecular Biology, V4, P101; Rang H.P., 1995, PHARMACOLOGY; Rawson ES, 2002, ACTA PHYSIOL SCAND, V174, P57, DOI 10.1046/j.1365-201x.2002.00924.x; Shockcor John P., 2002, Current Topics in Medicinal Chemistry, V2, P35, DOI 10.2174/1568026023394498; SMITH JL, 1994, TOXICOL APPL PHARM, V125, P296, DOI 10.1006/taap.1994.1076; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Tannock G.W., 1995, NORMAL MICROFLORA IN; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; van Aken Jan, 2003, Am J Pharmacogenomics, V3, P149, DOI 10.2165/00129785-200303030-00001; WATERFIELD CJ, 1993, TOXICOLOGY, V77, P1, DOI 10.1016/0300-483X(93)90132-C; Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274; Zoratti R, 1998, EUR J EPIDEMIOL, V14, P9, DOI 10.1023/A:1007492202045; Zuppi C, 1997, CLIN CHIM ACTA, V265, P85, DOI 10.1016/S0009-8981(97)00110-1	30	631	687	6	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1073	1077		10.1038/nature04648	http://dx.doi.org/10.1038/nature04648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625200	Green Accepted			2022-12-28	WOS:000236906000041
J	Brandes, JL				Brandes, JL			The influence of estrogen on migraine - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MENSTRUALLY ASSOCIATED MIGRAINE; REPRODUCTIVE LIFE EVENTS; SHORT-TERM PROPHYLAXIS; DOUBLE-BLIND; WITHDRAWAL MIGRAINE; POPULATION-SAMPLE; OVARIAN-STEROIDS; UNITED-STATES; FOLLOW-UP	Context Menstrual migraine affects approximately 50% to 60% of female migraineurs, but knowledge regarding the role of hormones, especially estrogen, appears incomplete. Objective To conduct a systematic review to determine the role of hormones on menstrual migraine. Evidence Acquisition MEDLINE ( January 1966 through September 1, 2005) and EMBASE Drugs and Pharmacology ( January 1991 through September 1, 2005) were searched for articles published in the English language using the keywords migraine, estrogen, menstrual migraine, pure menstrual migraine, true menstrual migraine, menstrually-associated migraine, menstrually-related migraine, pregnancy, breast-feeding, perimenopause, menopause, nitric oxide, and estrogen receptors. A total of 643 unique articles were reviewed for relevance, scientific rigor, and generalizability. For each relevant citation, the bibliography was reviewed to identify additional sources of pertinent data. Evidence Synthesis The influence of estrogen on migraine is evident by a 3-fold greater prevalence among women compared with men, and by significant changes in migraine incidence with changes in female reproductive status. Menstrual migraines are usually more resistant to treatment, generally not associated with aura, of longer duration, and associated with more functional disability compared with attacks at other times of the month. Biochemical and genetic evidence suggest central and peripheral roles for estrogen in the pathophysiology of menstrual migraine, with potential interactions with excitatory circuits, including serotonergic components. Although evidence for estrogen as a preventive treatment for menstrual migraine is inconsistent, serotonin receptor agonists (triptans) provide acute relief and also may have a role in prevention. Conclusions Epidemiological, pathophysiological, and clinical evidence link estrogen to migraine headaches. Triptans appear to provide acute relief and also may be useful for headache prevention. Clear, focused, and evidence-based treatment algorithms are needed to support primary care physicians, neurologists, and gynecologists in the treatment of this common condition.	Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA	Vanderbilt University	Brandes, JL (corresponding author), 300 20th Ave N,Suite 603, Nashville, TN 37203 USA.	jbrandes@nashvilleneuroscience.com						Amir Ben-Yehuda, 2005, Headache, V45, P215, DOI 10.1111/j.1526-4610.2005.05047.x; Benedetto C, 1997, CEPHALALGIA, V17, P32, DOI 10.1177/0333102497017S2010; Bille B, 1997, CEPHALALGIA, V17, P488, DOI 10.1046/j.1468-2982.1997.1704488.x; Calhoun AH, 2004, SOUTH MED J, V97, P819, DOI 10.1097/01.SMJ.0000129924.15619.D9; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Colson NJ, 2005, NEUROGENETICS, V6, P17, DOI 10.1007/s10048-004-0205-0; Colson NJ, 2004, NEUROGENETICS, V5, P129, DOI 10.1007/s10048-004-0181-4; Couturier EGM, 2003, CEPHALALGIA, V23, P302, DOI 10.1046/j.1468-2982.2003.00516.x; DELIGNIERES B, 1986, BMJ-BRIT MED J, V293, P1540, DOI 10.1136/bmj.293.6561.1540; DENNERSTEIN L, 1988, GYNECOL ENDOCRINOL, V2, P113, DOI 10.3109/09513598809023619; Dzoljic E, 2002, HEADACHE, V42, P185, DOI 10.1046/j.1526-4610.2002.02050.x; FACCHINETTI F, 1990, CEPHALALGIA, V10, P51, DOI 10.1046/j.1468-2982.1990.1001051.x; FACCHINETTI F, 1995, OBSTET GYNECOL, V86, P911, DOI 10.1016/0029-7844(95)00288-3; Facchinetti F, 2002, HEADACHE, V42, P924, DOI 10.1046/j.1526-4610.2002.02215.x; Facchinetti F, 2000, FUNCT NEUROL, V15, P137; FACCHINETTI F, 1993, CEPHALALGIA, V13, P422, DOI 10.1046/j.1468-2982.1993.1306422.x; Ferrari MD, 2002, CEPHALALGIA, V22, P633, DOI 10.1046/j.1468-2982.2002.00404.x; FIORONI L, 1995, CEPHALALGIA, V15, P297, DOI 10.1046/j.1468-2982.1995.1504297.x; Geraud G, 2004, CLIN THER, V26, P1305; Gervil M, 1999, NEUROLOGY, V53, P995, DOI 10.1212/WNL.53.5.995; Granella F, 2004, CEPHALALGIA, V24, P707, DOI 10.1111/j.1468-2982.2004.00741.x; GRANELLA F, 1993, HEADACHE, V33, P385, DOI 10.1111/j.1526-4610.1993.hed3307385.x; Granella F, 2000, CEPHALALGIA, V20, P701, DOI 10.1046/j.1468-2982.2000.00112.x; JOHANNES CB, 1995, NEUROLOGY, V45, P1076, DOI 10.1212/WNL.45.6.1076; Kara I, 2003, MOL BRAIN RES, V111, P84, DOI 10.1016/S0169-328X(02)00672-1; Kowa H, 2000, AM J MED GENET, V96, P762, DOI 10.1002/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-X; KUDROW L, 1993, FEMALE PATIENT TOTAL, V18, P33; Landy S, 2004, INT J CLIN PRACT, V58, P913, DOI 10.1111/j.1368-5031.2004.00295.x; Lichten EM, 1996, HEADACHE, V36, P367, DOI 10.1046/j.1526-4610.1996.3606367.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Loder E, 2004, HEADACHE, V44, P120, DOI 10.1111/j.1526-4610.2004.04027.x; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; MacGregor A, 2000, FUNCT NEUROL, V15, P143; MacGregor EA, 2004, NEUROLOGY, V63, P351, DOI 10.1212/01.WNL.0000133134.68143.2E; MACGREGOR EA, 1990, CEPHALALGIA, V10, P305, DOI 10.1046/j.1468-2982.1990.1006305.x; MacGregor EA, 2000, CEPHALALGIA, V20, P170, DOI 10.1046/j.1468-2982.2000.00038.x; Marcus DA, 1999, HEADACHE, V39, P21, DOI 10.1046/j.1526-4610.1999.3901021.x; Martin Vincent T, 2004, Curr Pain Headache Rep, V8, P229, DOI 10.1007/s11916-004-0057-1; Martin VT, 2006, HEADACHE, V46, P3, DOI 10.1111/j.1526-4610.2006.00309.x; Martin VT, 2006, HEADACHE, V46, P125, DOI 10.1111/j.1526-4610.2006.00306.x; Mattsson P, 2003, HEADACHE, V43, P27, DOI 10.1046/j.1526-4610.2003.03005.x; Misakian AL, 2003, J WOMENS HEALTH, V12, P1027, DOI 10.1089/154099903322643956; Moschiano F, 2005, NEUROL SCI, V26, pS162, DOI 10.1007/s10072-005-0435-4; Nappi RE, 2005, HUM REPROD, V20, P3423, DOI 10.1093/humrep/dei260; NERI I, 1993, MATURITAS, V17, P31, DOI 10.1016/0378-5122(93)90121-W; Newman L, 2001, HEADACHE, V41, P248, DOI 10.1046/j.1526-4610.2001.111006248.x; Newman LC, 1998, NEUROLOGY, V51, P307, DOI 10.1212/WNL.51.1.307; Oterino A, 2004, CEPHALALGIA, V24, P491, DOI 10.1111/j.1468-2982.2004.00692.x; Puri V, 2006, CEPHALALGIA, V26, P33, DOI 10.1111/j.1468-2982.2005.00987.x; Puri V, 2005, NEUROPEPTIDES, V39, P409, DOI 10.1016/j.npep.2005.04.002; SANCES G, 1990, HEADACHE, V30, P705, DOI 10.1111/j.1526-4610.1990.hed3011705.x; Sances G, 2003, CEPHALALGIA, V23, P197, DOI 10.1046/j.1468-2982.2003.00480.x; Sarchielli P, 1996, CEPHALALGIA, V16, P468, DOI 10.1046/j.1468-2982.1996.1607468.x; Scharff L, 1997, HEADACHE, V37, P203, DOI 10.1046/j.1526-4610.1997.3704203.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2004, NEUROLOGY, V63, P261, DOI 10.1212/01.WNL.0000134620.30129.D6; Silberstein SD, 2000, OBSTET GYNECOL, V96, P237, DOI 10.1016/S0029-7844(00)00880-2; SILBERSTIEN SD, PRACTICE PARAMETER E; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Smith LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2035, DOI 10.1038/sj.npp.1300510; SMITS MG, 1994, HEADACHE, V34, P103, DOI 10.1111/j.1526-4610.1994.hed3402103.x; Snow V, 2002, ANN INTERN MED, V137, P840, DOI 10.7326/0003-4819-137-10-200211190-00014; SOLBACH MP, 1993, OBSTET GYNECOL, V82, P769; SOMERVIL.BW, 1972, NEUROLOGY, V22, P355, DOI 10.1212/WNL.22.4.355; SOMERVILLE BW, 1975, NEUROLOGY, V25, P239, DOI 10.1212/WNL.25.3.239; SOMERVILLE BW, 1975, NEUROLOGY, V25, P245, DOI 10.1212/WNL.25.3.245; SOMERVILLE BW, 1972, NEUROLOGY, V22, P824, DOI 10.1212/WNL.22.8.824; SOMERVILLE BW, 1971, NEUROLOGY, V21, P853, DOI 10.1212/WNL.21.8.853; Splett CL, 2003, ENDOCRINOLOGY, V144, P484, DOI 10.1210/en.2002-220855; Stang PE, 2004, AM J MANAG CARE, V10, P313; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stewart WF, 2000, NEUROLOGY, V55, P1517, DOI 10.1212/WNL.55.10.1517; Swartz KL, 2000, ARCH GEN PSYCHIAT, V57, P945, DOI 10.1001/archpsyc.57.10.945; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; Wall V R, 1992, J Hum Lact, V8, P209, DOI 10.1177/089033449200800422; WELCH K, 1984, CEPHALALGIA, V4, P227, DOI 10.1046/j.1468-2982.1984.0404227.x	76	168	176	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1824	1830		10.1001/jama.295.15.1824	http://dx.doi.org/10.1001/jama.295.15.1824			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622144	Bronze			2022-12-28	WOS:000236886900025
J	Gauthier, S; Reisberg, B; Zaudig, M; Petersen, RC; Ritchie, K; Broich, K; Belleville, S; Brodaty, H; Bennett, D; Chertkow, H; Cummings, JL; de Leon, M; Feldman, H; Ganguli, M; Hampel, H; Scheltens, P; Tierney, MC; Whitehouse, P; Winblad, B				Gauthier, S; Reisberg, B; Zaudig, M; Petersen, RC; Ritchie, K; Broich, K; Belleville, S; Brodaty, H; Bennett, D; Chertkow, H; Cummings, JL; de Leon, M; Feldman, H; Ganguli, M; Hampel, H; Scheltens, P; Tierney, MC; Whitehouse, P; Winblad, B		Int Psychogeriatric Assoc Expert C	Mild cognitive impairment	LANCET			English	Review							SUBJECTIVE MEMORY COMPLAINTS; INCIDENT ALZHEIMERS-DISEASE; MINI-MENTAL-STATE; APOLIPOPROTEIN-E; INSTRUMENTAL ACTIVITIES; CLINICAL ENTITY; WORKING GROUP; VITAMIN-E; DEMENTIA; PREDICTION	Mild cognitive impairment is a syndrome defined as cognitive decline greater than expected for an individual's age and education level but that does not interfere notably with activities of daily life. Prevalence in population-based epidemiological studies ranges from 3% to 19% in adults older than 65 years. Some people with mild cognitive impairment seem to remain stable or return to normal over time, but more than half progress to dementia within 5 years. Mild cognitive impairment can thus be regarded as a risk state for dementia, and its identification could lead to secondary prevention by controlling risk factors such as systolic hypertension. The amnestic subtype of mild cognitive impairment has a high risk of progression to Alzheimer's disease, and it could constitute a prodromal stage of this disorder. Other definitions and subtypes of mild cognitive impairment need to be studied as potential prodromes of Alzheimer's disease and other types of dementia.	Douglas Hosp, McGill Ctr Studies Aging, Montreal, PQ, Canada; NYU, Sch Med, New York, NY USA; Windach Hosp Psychosomat Med, Windach, Germany; Mayo Clin, Coll Med, Rochester, MN USA; INSERM, Montpellier, France; Fed Inst Drugs & Med Devices, Bonn, Germany; Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; Univ New S Wales, Sydney, NSW, Australia; Rush Univ, Med Ctr, Chicago, IL 60612 USA; McGill Univ, Lady Davis Inst, Montreal, PQ, Canada; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC V5Z 1M9, Canada; Univ Pittsburgh, Pittsburgh, PA USA; Univ Munich, Munich, Germany; Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; Case Western Reserve Univ, Cleveland, OH 44106 USA; Karolinska Inst, Stockholm, Sweden	McGill University; New York University; Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montreal; University of New South Wales Sydney; Rush University; Lady Davis Institute; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Case Western Reserve University; Karolinska Institutet	Gauthier, S (corresponding author), Douglas Hosp, McGill Ctr Studies Aging, Montreal, PQ, Canada.	serge.gauthier@mcgill.ca	Ancelin, Marie-Laure/L-1198-2019; Ritchie, Karen/G-3571-2013; MORAN, CATHERINE L/C-9539-2015; Brodaty, Henry/E-2753-2010; Ganguli, Mary/A-3638-2013; Scheltens, Philip/AAL-9631-2020; Ancelin, Marie-Laure/F-3079-2013; Scheltens, Philip/E-1205-2012; de Leon, Mony/AAP-7890-2021	Ancelin, Marie-Laure/0000-0002-1149-4320; Ritchie, Karen/0000-0002-0688-8982; Brodaty, Henry/0000-0001-9487-6617; Scheltens, Philip/0000-0002-1046-6408; Ancelin, Marie-Laure/0000-0002-1149-4320; de Leon, Mony/0000-0003-2245-4380; Hampel, Harald/0000-0003-0894-8982; Reisberg, Barry/0000-0002-9104-7423; Feldman, Howard/0000-0002-9258-4538				Aggarwal NT, 2005, NEUROCASE, V11, P3, DOI 10.1080/13554790490903038; *AM PSYCH ASS, 1980, DIAGN STAT MAN MENT, P124; Artero S, 2003, ACTA PSYCHIAT SCAND, V107, P390, DOI 10.1034/j.1600-0447.2003.00081.x; Backman L, 2001, BRAIN, V124, P96, DOI 10.1093/brain/124.1.96; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barberger-Gateau P, 1999, J AM GERIATR SOC, V47, P456, DOI 10.1111/j.1532-5415.1999.tb07239.x; BELLEVILLE S, P 9 COGN AG C APR 20, P4; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Blacker D, 2005, NEW ENGL J MED, V352, P2439, DOI 10.1056/NEJMe058086; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buerger K, 2002, NEUROLOGY, V59, P627, DOI 10.1212/WNL.59.4.627; Burns A, 2002, LANCET, V360, P1963, DOI 10.1016/S0140-6736(02)11920-9; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Clare L., 2003, COCHRANE DB SYST REV, V4, P1, DOI [https://doi.org/10.1002/14651858.CD003260, DOI 10.1002/14651858.CD003260]; Copeland MP, 2003, ALZ DIS ASSOC DIS, V17, P1, DOI 10.1097/00002093-200301000-00001; Crook T, 1986, DEV NEUROPSYCHOL, V2, P261, DOI 10.1080/87565648609540348; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; de Leon MJ, 2002, NEUROSCI LETT, V333, P183, DOI 10.1016/S0304-3940(02)01038-8; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; DELEON MJ, 1989, LANCET, V2, P672; Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0; Feldman H, 2004, NEUROLOGY, V62, P1199, DOI 10.1212/01.WNL.0000118301.92105.EE; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank RA, 2003, NEUROBIOL AGING, V24, P521, DOI 10.1016/S0197-4580(03)00002-2; Franssen EH, 1999, J AM GERIATR SOC, V47, P463, DOI 10.1111/j.1532-5415.1999.tb07240.x; Galasko DR, 2005, NEUROLOGY, V64, pA144; Galluzzi S, 2005, DEMENT GERIATR COGN, V19, P196, DOI 10.1159/000083499; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Garand L, 2005, INT J GERIATR PSYCH, V20, P512, DOI 10.1002/gps.1318; Gauthier S, 2005, ARCH NEUROL-CHICAGO, V62, P1164, DOI 10.1001/archneur.62.7.1164; Gauthier Serge, 2004, Dialogues Clin Neurosci, V6, P391; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Gold M, 2003, INT PSYCHOGERIATR, V15, P259; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Gunther VK, 2003, AGING MENT HEALTH, V7, P200, DOI 10.1080/1360786031000101175; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; HUANG T, 2004, ALZHEIMERS DIS RELAT, P71; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hunderfund ANL, 2005, NEUROLOGY, V64, pA166; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jelic V, 1996, DEMENTIA, V7, P314, DOI 10.1159/000106897; Jorm AF, 2001, PSYCHOL MED, V31, P441, DOI 10.1017/S0033291701003245; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kluger A, 1999, J GERIATR PSYCH NEUR, V12, P168, DOI 10.1177/089198879901200402; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; KRAL VA, 1962, CAN MED ASSOC J, V86, P257; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mintzer J, 2000, J ROY SOC MED, V93, P457, DOI 10.1177/014107680009300903; Mitchell TW, 2002, ANN NEUROL, V51, P182, DOI 10.1002/ana.10086; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Mufson EJ, 1999, EXP NEUROL, V158, P469, DOI 10.1006/exnr.1999.7086; Mufson Elliott J., 2000, Journal of Comparative Neurology, V427, P19, DOI 10.1002/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nygard L, 2003, ACTA NEUROL SCAND, V107, P42, DOI 10.1034/j.1600-0404.107.s179.8.x; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2003, MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER'S DISEASE, P1; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Poirier J, 2005, NEUROBIOL AGING, V26, P355, DOI 10.1016/j.neurobiolaging.2004.09.003; Prichard JC, 1837, TREATISE INSANITY; PRICHEP LS, 1994, NEUROBIOL AGING, V15, P85, DOI 10.1016/0197-4580(94)90147-3; PRICHEP LS, 2005, NEUROBIOL AGING 1006, DOI DOI 10.1016/J.NEUROBIOLAGING.2005.07021; Reisberg B, 2001, INT PSYCHOGERIATR, V13, P163, DOI 10.1017/S1041610201007566; Reisberg B, 2005, NEUROPSYCHOPHARMACOL, V30, pS81; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Reisberg B., 2004, COMPREHENSIVE TXB GE, V3rd ed., P449; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Schofield PW, 1997, AM J PSYCHIAT, V154, P609; Sperling R, 2005, NEUROLOGY, V64, pA285; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Tabert MH, 2002, NEUROLOGY, V58, P758, DOI 10.1212/WNL.58.5.758; Tierney MC, 2003, J AM GERIATR SOC, V51, P813, DOI 10.1046/j.1365-2389.2003.51262.x; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; TOBIANSKY R, 1995, PSYCHOL MED, V25, P779, DOI 10.1017/S0033291700035029; Unverzagt FW, 2001, NEUROLOGY, V57, P1655, DOI 10.1212/WNL.57.9.1655; Visser PJ, 2005, J NEUROL NEUROSUR PS, V76, P1348, DOI 10.1136/jnnp.2004.047720; Whitehouse PJ, 2005, J AM GERIATR SOC, V53, P1417, DOI 10.1111/j.1532-5415.2005.53411.x; Wimo A, 2003, ACTA NEUROL SCAND, V107, P94, DOI 10.1034/j.1600-0404.107.s179.13.x; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wolf OT, 2005, NEUROBIOL AGING, V26, P1357, DOI 10.1016/j.neurobiolaging.2004.11.003; ZAUDIG M, 2005, EARLY DETECTION MANA, P276	96	1737	1834	16	302	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1262	1270		10.1016/S0140-6736(06)68542-5	http://dx.doi.org/10.1016/S0140-6736(06)68542-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	034FC	16631882				2022-12-28	WOS:000236913400031
J	Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; Smith, AJH; Withers, DJ; Vanhaesebroeck, B				Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; Smith, AJH; Withers, DJ; Vanhaesebroeck, B			Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; HYPOTHALAMIC NEURONS; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; INDUCED ANOREXIA; MICE LACKING; PI 3-KINASE; CELL-SIZE; INSULIN; P110-BETA	The eight catalytic subunits of the mammalian phosphoinositide-3- OH kinase ( PI( 3) K) family form the backbone of an evolutionarily conserved signalling pathway; however, the roles of most PI( 3) K isoforms in organismal physiology and disease are unknown. To delineate the role of p110 alpha, a ubiquitously expressed PI( 3) K involved in tyrosine kinase and Ras signalling, here we generated mice carrying a knockin mutation (D933A) that abrogates p110 alpha kinase activity. Homozygosity for this kinase-dead p110 alpha led to embryonic lethality. Mice heterozygous for this mutation were viable and fertile, but displayed severely blunted signalling via insulin-receptor substrate (IRS) proteins, key mediators of insulin, insulin-like growth factor-1 and leptin action. Defective responsiveness to these hormones led to reduced somatic growth, hyperinsulinaemia, glucose intolerance, hyperphagia and increased adiposity in mice heterozygous for the D933A mutation. This signalling function of p110 alpha derives from its highly selective recruitment and activation to IRS signalling complexes compared to p110 beta, the other broadly expressed PI( 3) K isoform, which did not contribute to IRS-associated PI( 3) K activity. p110 alpha was the principal IRS-associated PI( 3) K in cancer cell lines. These findings demonstrate a critical role for p110 alpha in growth factor and metabolic signalling and also suggest an explanation for selective mutation or overexpression of p110 alpha in a variety of cancers(1,2).	Ludwig Inst Canc Res, London W1W 7BS, England; UCL, Rayne Inst, Ctr Diabet & Endocrinol, London WC1E 6JJ, England; Univ Edinburgh, Inst Stem Cell Res, Gene Targeting Lab, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	Ludwig Institute for Cancer Research; University of London; King's College London; University College London; University of Edinburgh; University of Fribourg; University of London; University College London	Vanhaesebroeck, B (corresponding author), Ludwig Inst Canc Res, 91 Riding House St, London W1W 7BS, England.	bartvanh@ludwig.ucl.ac.uk	Withers, Dominic J/D-7671-2014; Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019	Withers, Dominic J/0000-0002-8009-7521; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Pearce, Wayne/0000-0001-5407-4767; Peskett, Emma/0000-0002-0978-5401; Claret, Marc/0000-0001-7766-9296	MRC [G0300058] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C505659/1] Funding Source: Medline; Medical Research Council [G0300058] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Asano T, 2000, J BIOL CHEM, V275, P17671, DOI 10.1074/jbc.M910391199; Beeton CA, 2000, BIOCHEM J, V350, P353, DOI 10.1042/0264-6021:3500353; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Drees BE, 2004, EXPERT OPIN THER PAT, V14, P703, DOI 10.1517/13543776.14.5.703; Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Hooshmand-Rad R, 2000, J CELL SCI, V113, P207; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kubo H, 2005, BIOCHEM J, V392, P607, DOI 10.1042/BJ20050671; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Withers DJ, 2001, BIOCHEM SOC T, V29, P525, DOI 10.1042/BST0290525; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301	30	368	385	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					366	370		10.1038/nature04694	http://dx.doi.org/10.1038/nature04694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16625210				2022-12-28	WOS:000237593200052
J	Chang, JT; Hays, RD; Shekelle, PG; MacLean, CH; Solomon, DH; Reuben, DB; Roth, CP; Kamberg, CJ; Adams, J; Young, RT; Wenger, NS				Chang, JT; Hays, RD; Shekelle, PG; MacLean, CH; Solomon, DH; Reuben, DB; Roth, CP; Kamberg, CJ; Adams, J; Young, RT; Wenger, NS			Patients' global ratings of their health care are not associated with the technical quality of their care	ANNALS OF INTERNAL MEDICINE			English	Article							CONSUMER ASSESSMENT; VULNERABLE ELDERS; OF-CARE; SATISFACTION; COMMUNICATION; PLANS; PEOPLE	Background: Patient global ratings of care are commonly used to assess health care. However, the extent to which these assessments of care are related to the technical quality of care received is not well understood. objective: To investigate the relationship between patient-reported global ratings of health care and the quality of providers' communication and technical quality of care. Design: Observational cohort study. Setting: 2 managed care organizations, Patients: Vulnerable older patients identified by brief interviews of a random sample of community-dwelling adults 65 years of age or older who received care in 2 managed care organizations during a 13-month period. Measurements: Survey questions from the second stage of the Consumer Assessment of Healthcare Providers and Systems program were used to determine patients' global rating of health care and provider communication. A set of 236 quality indicators, defined by the Assessing Care of Vulnerable Elders project, were used to measure technical quality of care given for 22 clinical conditions; 207 quality indicators were evaluated by using data from chart abstraction or patient interview. Results: Data on the global rating item, communication scale, and technical quality of care score were available for 236 vulnerable older patients. In a multivariate logistic regression model that included patient and clinical factors, better communication was associated with higher global ratings of health care. Technical quality of care was not significantly associated with the global rating of care. Limitations: Findings were limited to vulnerable elders who were enrolled in managed care organizations and may not be generalizable to other age groups or types of insurance coverage. Conclusions: Vulnerable elders' global ratings of care should not be used as a marker of technical quality of care. Assessments of quality of care should include both patient evaluations and independent assessments of technical quality.	Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med, Los Angeles, CA 90095 USA; Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA USA; RAND Hlth, Santa Monica, CA USA; RAND Hlth, Arlington, VA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; RAND Corporation	Chang, JT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med, 911 Broxton Ave,3rd Floor, Los Angeles, CA 90095 USA.	johnchang@mednet.ucla.edu	Chang, John T./L-7840-2019; Hays, Ronald/D-5629-2013	Hays, Ronald/0000-0001-6697-907X	NIA NIH HHS [AG-02-004] Funding Source: Medline; NIMHD NIH HHS [P20-MD00148-01] Funding Source: Medline; BHP HRSA HHS [PE-19001] Funding Source: Medline; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000148] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); BHP HRSA HHS; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		[Anonymous], 1980, EXPLORATIONS QUALITY; Breen A, 2003, CLIN J PAIN, V19, P263, DOI 10.1097/00002508-200307000-00010; BUCHNER DM, 1993, J AM GERIATR SOC, V41, P297, DOI 10.1111/j.1532-5415.1993.tb06708.x; BULLER MK, 1987, J HEALTH SOC BEHAV, V28, P375, DOI 10.2307/2136791; CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25; Crofton C, 1999, MED CARE, V37, pMS1, DOI 10.1097/00005650-199903001-00001; DIMATTEO MR, 1980, MED CARE, V18, P376, DOI 10.1097/00005650-198004000-00003; Druss BG, 1999, PSYCHIATR SERV, V50, P1053, DOI 10.1176/ps.50.8.1053; Edlund MJ, 2003, HEALTH SERV RES, V38, P631, DOI 10.1111/1475-6773.00137; Elliott MN, 2001, HEALTH SERV RES, V36, P555; Fleishman JA, 2003, MED CARE, V41, P75, DOI 10.1097/01.MLR.0000076052.42628.CF; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Gross R, 2003, FAM PRACT, V20, P563, DOI 10.1093/fampra/cmg512; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; Hargraves JL, 2003, HEALTH SERV RES, V38, P1509; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; *I MED, 2000, ERR HUM BUILD SAF HL; Iezzoni LI, 2003, ARCH INTERN MED, V163, P2085, DOI 10.1001/archinte.163.17.2085; Jackson JL, 2001, SOC SCI MED, V52, P609, DOI 10.1016/S0277-9536(00)00164-7; Jung Hans Peter, 2003, Health Expect, V6, P160; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Lied TR, 2003, HEALTH CARE FINANC R, V25, P55; Marshall GN, 1996, J CONSULT CLIN PSYCH, V64, P380; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Meredith LS, 2001, MED CARE, V39, P349, DOI 10.1097/00005650-200104000-00006; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Orlando M, 2002, MED CARE, V40, P696, DOI 10.1097/00005650-200208000-00009; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Schmittdiel J, 1997, JAMA-J AM MED ASSOC, V278, P1596, DOI 10.1001/jama.278.19.1596; Schneider EC, 2001, MED CARE, V39, P1313, DOI 10.1097/00005650-200112000-00007; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Sloss EM, 2000, J AM GERIATR SOC, V48, P363, DOI 10.1111/j.1532-5415.2000.tb04691.x; Tai-Seale M, 2004, MED CARE RES REV, V61, P171, DOI 10.1177/1077558704263797; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Williams S, 1998, FAM PRACT, V15, P480, DOI 10.1093/fampra/15.5.480	38	215	218	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					665	672		10.7326/0003-4819-144-9-200605020-00010	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	039GJ	16670136				2022-12-28	WOS:000237293700006
J	Weir, P; Suttner, NJ; Flynn, P; McAuley, D				Weir, P; Suttner, NJ; Flynn, P; McAuley, D			Lesson of the week - Normal skull suture variant mimicking intentional injury	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FRACTURES		Royal Victoria Hosp, Dept Neurosurg, Belfast BT12 6BA, Antrim, North Ireland; Royal Victoria Hosp, Dept Neuroradiol, Belfast, Antrim, North Ireland		Suttner, NJ (corresponding author), Royal Victoria Hosp, Dept Neurosurg, Belfast BT12 6BA, Antrim, North Ireland.	nsuttner@doctors.org.uk						ALLEN WE, 1973, RADIOL CLIN N AM, V10, P479; Arnholz D, 1998, J TRAUMA, V45, P172, DOI 10.1097/00005373-199807000-00039; HISS J, 1995, J TRAUMA, V38, P32, DOI 10.1097/00005373-199501000-00010; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; KEATS TE, ATLAS NORMAL ROENTGE	5	16	16	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1020	1021		10.1136/bmj.332.7548.1020	http://dx.doi.org/10.1136/bmj.332.7548.1020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16644830	Green Published			2022-12-28	WOS:000237403100023
J	McDonnell, S; Clark, M				McDonnell, S; Clark, M			Sudden enlargement of the neck	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northampton Gen Hosp, Northampton NN1 5DD, England		McDonnell, S (corresponding author), Northampton Gen Hosp, Northampton NN1 5DD, England.			McDonnell, Stephen/0000-0002-3181-4192					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1827	1827		10.1056/NEJMicm050402	http://dx.doi.org/10.1056/NEJMicm050402			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641399				2022-12-28	WOS:000237077100009
J	Jeffcoate, WJ				Jeffcoate, WJ			Should eponyms be actively detached from diseases?	LANCET			English	Editorial Material									The Lancet, London NE1 7BY, England		Jeffcoate, WJ (corresponding author), The Lancet, London NE1 7BY, England.							Lu DW, 2005, J AM ACAD DERMATOL, V53, P720, DOI 10.1016/j.jaad.2005.06.048; Wallace DJ, 2003, SEMIN ARTHRITIS RHEU, V32, P208, DOI 10.1053/sarh.2003.49995; Woywodt A, 2006, LANCET, V367, P1362, DOI 10.1016/S0140-6736(06)68583-8	3	12	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 22	2006	367	9519					1296	1297		10.1016/S0140-6736(06)68553-X	http://dx.doi.org/10.1016/S0140-6736(06)68553-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631893				2022-12-28	WOS:000237118500005
J	Chen, JH; Costan, E; van Huis, MA; Xu, Q; Zandbergen, HW				Chen, JH; Costan, E; van Huis, MA; Xu, Q; Zandbergen, HW			Atomic pillar-based nanoprecipitates strengthen AlMgSi alloys	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PHASE-RETRIEVAL; FOCUS-VARIATION; AL; TRANSMISSION; RESOLUTION; PRECIPITATION; ALUMINUM; COPPER	Atomic-resolution electron microscopy reveals that pillarlike silicon double columns exist in the hardening nanoprecipitates of AlMgSi alloys, which vary in structure and composition. Upon annealing, the Si, pillars provide the skeleton for the nanoparticles to evolve in composition, structure, and morphology. We show that they begin as tiny nuclei with a composition close to Mg2Si2Al7 and a minimal mismatch with the aluminum matrix. They subsequently undergo a one-dimensional growth in association with compositional change, becoming elongated particles. During the evolution toward the final Mg5Si6 particles, the compositional change is accompanied by a characteristic structural change. Our study explains the nanoscopic reasons that the alloys make excellent automotive materials.	Delft Univ Technol, Netherlands Inst Met Res, NL-2628 CJ Delft, Netherlands; Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Delft University of Technology; Delft University of Technology	Chen, JH (corresponding author), Delft Univ Technol, Netherlands Inst Met Res, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	j.h.chen@tnw.tudelft.nl	van Huis, Marijn A/E-9916-2011	van Huis, Marijn A/0000-0002-8039-2256				Andersen SJ, 1998, ACTA MATER, V46, P3283, DOI 10.1016/S1359-6454(97)00493-X; Chen JH, 2004, ULTRAMICROSCOPY, V98, P81, DOI 10.1016/j.ultramic.2003.08.003; COENE W, 1992, PHYS REV LETT, V69, P3743, DOI 10.1103/PhysRevLett.69.3743; COENE W, 1992, SCANNING MICROSCOPY, V6, P379; Coene WMJ, 1996, ULTRAMICROSCOPY, V64, P109, DOI 10.1016/0304-3991(96)00010-1; Cowley J. M., 1981, DIFFRACTION PHYS; Edwards GA, 1998, ACTA MATER, V46, P3893, DOI 10.1016/S1359-6454(98)00059-7; Guinier A, 1938, NATURE, V142, P569, DOI 10.1038/142569b0; GUINIER A, 1959, SOLID STATE PHYS, V9, P293, DOI 10.1016/S0081-1947(08)60568-8; Jia CL, 1999, PHYS REV LETT, V82, P5052, DOI 10.1103/PhysRevLett.82.5052; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Marioara CD, 2001, ACTA MATER, V49, P321, DOI 10.1016/S1359-6454(00)00302-5; Murayama M, 1999, ACTA MATER, V47, P1537, DOI 10.1016/S1359-6454(99)00033-6; OKEEFE MA, 1988, SCANNING MICROSCOPY, P225; PASHLEY DW, 1967, PHILOS MAG, V16, P51, DOI 10.1080/14786436708229257; Perovic A, 1999, SCRIPTA MATER, V41, P703, DOI 10.1016/S1359-6462(99)00204-3; Preston GD, 1938, PHILOS MAG, V26, P855; Ravi C, 2004, ACTA MATER, V52, P4213, DOI 10.1016/j.actamat.2004.05.037; Ringer SP, 2000, MATER CHARACT, V44, P101, DOI 10.1016/S1044-5803(99)00051-0; Saxton W. O., 1978, COMPUTER TECHNIQUES; THOMAS G, 1961, J I MET, V90, P57; Zandbergen HW, 1997, SCIENCE, V277, P1221, DOI 10.1126/science.277.5330.1221; Zhuang L, 2001, ALUMINUM 2001: PROCEEDINGS OF THE TMS 2001 ANNUAL MEETING ALUMINUM AUTOMOTIVE AND JOINING SYMPOSIA, P77	23	239	276	10	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					416	419		10.1126/science.1124199	http://dx.doi.org/10.1126/science.1124199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627740				2022-12-28	WOS:000236941800044
J	Zody, MC; Garber, M; Adams, DJ; Sharpe, T; Harrow, J; Lupski, JR; Nicholson, C; Searle, SM; Wilming, L; Young, SK; Abouelleil, A; Allen, NR; Bi, WM; Bloom, T; Borowsky, ML; Bugalter, BE; Butler, J; Chang, JL; Chen, CK; Cook, A; Corum, B; Cuomo, CA; de Jong, PJ; DeCaprio, D; Dewar, K; FitzGerald, M; Gilbert, J; Gibson, R; Gnerre, S; Goldstein, S; Grafham, DV; Grocock, R; Hafez, N; Hagopian, DS; Hart, E; Norman, CH; Humphray, S; Jaffe, DB; Jones, M; Kamal, M; Khodiyar, VK; LaButti, K; Laird, G; Lehoczky, J; Liu, XH; Lokyitsang, T; Loveland, J; Lui, A; Macdonald, P; Major, JE; Matthews, L; Mauceli, E; McCarroll, SA; Mihalev, AH; Mudge, J; Nguyen, C; Nicol, R; O'Leary, SB; Osoegawa, K; Schwartz, DC; Shaw-Smith, C; Stankiewicz, P; Steward, C; Swarbreck, D; Venkataraman, V; Whittaker, CA; Yang, XP; Zimmer, AR; Bradley, A; Hubbard, T; Birren, BW; Rogers, J; Lander, ES; Nusbaum, C				Zody, MC; Garber, M; Adams, DJ; Sharpe, T; Harrow, J; Lupski, JR; Nicholson, C; Searle, SM; Wilming, L; Young, SK; Abouelleil, A; Allen, NR; Bi, WM; Bloom, T; Borowsky, ML; Bugalter, BE; Butler, J; Chang, JL; Chen, CK; Cook, A; Corum, B; Cuomo, CA; de Jong, PJ; DeCaprio, D; Dewar, K; FitzGerald, M; Gilbert, J; Gibson, R; Gnerre, S; Goldstein, S; Grafham, DV; Grocock, R; Hafez, N; Hagopian, DS; Hart, E; Norman, CH; Humphray, S; Jaffe, DB; Jones, M; Kamal, M; Khodiyar, VK; LaButti, K; Laird, G; Lehoczky, J; Liu, XH; Lokyitsang, T; Loveland, J; Lui, A; Macdonald, P; Major, JE; Matthews, L; Mauceli, E; McCarroll, SA; Mihalev, AH; Mudge, J; Nguyen, C; Nicol, R; O'Leary, SB; Osoegawa, K; Schwartz, DC; Shaw-Smith, C; Stankiewicz, P; Steward, C; Swarbreck, D; Venkataraman, V; Whittaker, CA; Yang, XP; Zimmer, AR; Bradley, A; Hubbard, T; Birren, BW; Rogers, J; Lander, ES; Nusbaum, C			DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage	NATURE			English	Article							HUMAN-GENOME; SEGMENTAL DUPLICATIONS; HOMOLOGOUS RECOMBINATION; EVOLUTION; GENE; ARCHITECTURE; MECHANISM; REGION	Chromosome 17 is unusual among the human chromosomes in many respects. It is the largest human autosome with orthology to only a single mouse chromosome(1), mapping entirely to the distal half of mouse chromosome 11. Chromosome 17 is rich in protein-coding genes, having the second highest gene density in the genome(2,3). It is also enriched in segmental duplications, ranking third in density among the autosomes(4). Here we report a finished sequence for human chromosome 17, as well as a structural comparison with the finished sequence for mouse chromosome 11, the first finished mouse chromosome. Comparison of the orthologous regions reveals striking differences. In contrast to the typical pattern seen in mammalian evolution(5,6), the human sequence has undergone extensive intrachromosomal rearrangement, whereas the mouse sequence has been remarkably stable. Moreover, although the human sequence has a high density of segmental duplication, the mouse sequence has a very low density. Notably, these segmental duplications correspond closely to the sites of structural rearrangement, demonstrating a link between duplication and rearrangement. Examination of the main classes of duplicated segments provides insight into the dynamics underlying expansion of chromosome-specific, low-copy repeats in the human genome.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Univ Wisconsin, Lab Mol & Computat Genom, Madison, WI 53706 USA; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Wellcome Trust Sanger Institute; Baylor College of Medicine; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London	Zody, MC (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	mczody@broad.mit.edu; chad@broad.mit.edu	Hubbard, Tim J/C-2567-2008; Stankiewicz, Paweł/AAP-7906-2021; Cuomo, Christina/L-2222-2019; Hubbard, Tim J.P./AAT-4571-2020; McCarroll, Steven A/A-8433-2009	Hubbard, Tim J/0000-0002-1767-9318; Stankiewicz, Paweł/0000-0002-6456-7490; Cuomo, Christina/0000-0002-5778-960X; Hubbard, Tim J.P./0000-0002-1767-9318; Wass, Elizabeth/0000-0002-8605-9921; Whittaker, Charles/0000-0002-2400-0094; Gilbert, James/0000-0001-8079-3159; DeCaprio, Dave/0000-0001-8931-9461; Loveland, Jane/0000-0002-7669-2934; Swarbreck, David/0000-0002-5453-1013; Adams, David/0000-0001-9490-0306; Harrow, Jennifer/0000-0003-0338-3070; Mudge, Jonathan/0000-0003-4789-7495; Nicol, Robert/0000-0003-1932-1392; Khodiyar, Varsha/0000-0002-2743-6918; Steward, Charles/0000-0001-8829-5349; Gibson, Richard Charles/0000-0001-5412-1965; Wilming, Laurens/0000-0002-4154-7358; Bradley, Allan/0000-0002-2349-8839	Medical Research Council [G0000107] Funding Source: Medline; Wellcome Trust [077187] Funding Source: Medline; MRC [G0000107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 2001, METABOLIC MOL BASES, P5759; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Nusbaum C, 2006, NATURE, V439, P331, DOI 10.1038/nature04406; Nusbaum C, 2005, NATURE, V437, P551, DOI 10.1038/nature03983; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601	27	108	799	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1045	1049		10.1038/nature04689	http://dx.doi.org/10.1038/nature04689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625196	Green Accepted, Bronze			2022-12-28	WOS:000236906000035
J	Fisher, J				Fisher, J			Patient counseling and education: Should doctors be doing more?	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org		Wilson, Jennifer/0000-0003-4025-3136					0	10	10	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					621	624		10.7326/0003-4819-144-8-200604180-00021	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00021			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618961				2022-12-28	WOS:000237017900017
J	Brubaker, L; Cundiff, GW; Fine, P; Nygaard, I; Richter, HE; Visco, AG; Zyczynski, H; Brown, MB; Weber, AM				Brubaker, L; Cundiff, GW; Fine, P; Nygaard, I; Richter, HE; Visco, AG; Zyczynski, H; Brown, MB; Weber, AM		Pelvic Floor Disorders Network	Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC ORGAN PROLAPSE; FREE VAGINAL TAPE; FOLLOW-UP; SURGICAL-PROCEDURES; RANDOMIZED-TRIAL; CONTINENT WOMEN; REPAIR; SURGERY; PREVALENCE; SYMPTOMS	BACKGROUND: We designed this trial to assess whether the addition of standardized Burch colposuspension to abdominal sacrocolpopexy for the treatment of pelvic-organ prolapse decreases postoperative stress urinary incontinence in women without preoperative symptoms of stress incontinence. METHODS: Women who did not report symptoms of stress incontinence and who chose to undergo sacrocolpopexy to treat prolapse were randomly assigned to concomitant Burch colposuspension or to no Burch colposuspension (control) and were evaluated in a blinded fashion three months after the surgery. The primary outcomes included measures of stress incontinence (symptoms, stress testing, or treatment) and measures of urge symptoms. Enrollment was stopped after the first interim analysis because of a significantly lower frequency of stress incontinence in the group that underwent the Burch colposuspension. RESULTS: Of 322 women who underwent randomization, 157 were assigned to Burch colposuspension and 165 to the control group. Three months after surgery, 23.8 percent of the women in the Burch group and 44.1 percent of the controls met one or more of the criteria for stress incontinence (P<0.001). There was no significant difference between the Burch group and the control group in the frequency of urge incontinence (32.7 percent vs. 38.4 percent, P=0.48). After surgery, women in the control group were more likely to report bothersome symptoms of stress incontinence than those in the Burch group who had stress incontinence (24.5 percent vs. 6.1 percent, P<0.001). CONCLUSIONS: In women without stress incontinence who are undergoing abdominal sacrocolpopexy for prolapse, Burch colposuspension significantly reduced postoperative symptoms of stress incontinence without increasing other lower urinary tract symptoms.	Loyola Univ, Med Ctr, Dept Obstet & Gynecol, Maywood, IL 60153 USA; Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD USA; Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; Univ Pittsburgh, Dept Obstet & Gynecol, Pittsburgh, PA USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; NICHHD, Contracept & Reprod Hlth Branch, Populat Res Ctr, NIH, Bethesda, MD 20892 USA	Loyola University Chicago; Johns Hopkins University; Baylor College of Medicine; University of Iowa; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Brubaker, L (corresponding author), Loyola Univ, Med Ctr, Dept Obstet & Gynecol, 2160 S 1st Ave, Maywood, IL 60153 USA.		Cundiff, Geoffrey/HGD-1512-2022; Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Richter, Holly E/0000-0001-7741-5771; Cundiff, Geoffrey/0000-0002-5777-7836	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD041267, U10HD041261, U10HD041250] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD041269, U10HD041263, U10HD041268, U10HD041248, U01HD041249] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; BERGMAN A, 1995, AM J OBSTET GYNECOL, V173, P66, DOI 10.1016/0002-9378(95)90171-X; Bradley CS, 2005, J WOMENS HEALTH, V14, P128, DOI 10.1089/jwh.2005.14.128; Brown JS, 2002, AM J OBSTET GYNECOL, V186, P712, DOI 10.1067/mob.2002.121897; Brubaker L, 2003, CONTROL CLIN TRIALS, V24, P629, DOI 10.1016/S0197-2456(03)00073-4; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Chaikin DC, 2000, J UROLOGY, V163, P531, DOI 10.1016/S0022-5347(05)67918-9; Colombo M, 1996, AM J OBSTET GYNECOL, V175, P78, DOI 10.1016/S0002-9378(96)70254-5; Cross CA, 1997, J UROLOGY, V158, P431, DOI 10.1016/S0022-5347(01)64495-1; DIOKNO AC, 1986, J UROLOGY, V136, P1022; Fitzgerald MP, 2003, AM J OBSTET GYNECOL, V189, P1241, DOI 10.1067/S0002-9378(03)00642-2; Gordon D, 2001, UROLOGY, V58, P547, DOI 10.1016/S0090-4295(01)01327-9; HUNSKAAR S, 1992, J AM GERIATR SOC, V40, P976, DOI 10.1111/j.1532-5415.1992.tb02002.x; Kenton K, 2002, AM J OBSTET GYNECOL, V187, P107, DOI 10.1067/mob.2002.125706; Klutke JJ, 2000, AM J OBSTET GYNECOL, V182, P1378, DOI 10.1067/mob.2000.106176; Kulseng-Hanssen S, 2002, NEUROUROL URODYNAM, V21, P100, DOI 10.1002/nau.10011; Langer R, 2001, INT UROGYNECOL J PEL, V12, P323, DOI 10.1007/s001920170034; LAPITAN MC, 2005, COCHRANE DB SYST REV, V3; Lefranc JP, 2002, J AM COLL SURGEONS, V195, P352, DOI 10.1016/S1072-7515(02)01234-6; Liang CC, 2004, OBSTET GYNECOL, V104, P795, DOI 10.1097/01.AOG.0000140689.90131.01; Meschia M, 2004, AM J OBSTET GYNECOL, V190, P609, DOI 10.1016/j.ajog.2003.09.027; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Nygaard IE, 2004, OBSTET GYNECOL, V104, P805, DOI 10.1097/01.AOG.0000139514.90897.07; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; RICHARDSON DA, 1983, AM J OBSTET GYNECOL, V146, P901, DOI 10.1016/0002-9378(83)90961-4; ROSENZWEIG BA, 1992, OBSTET GYNECOL, V79, P539; Ward KL, 2004, AM J OBSTET GYNECOL, V190, P324, DOI 10.1016/j.ajog.2003.07.029; Wren PA, 2005, AM J OBSTET GYNECOL, V192, P780, DOI 10.1016/j.ajog.2004.10.603	28	372	384	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1557	1566		10.1056/NEJMoa054208	http://dx.doi.org/10.1056/NEJMoa054208			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611949	Bronze			2022-12-28	WOS:000236736900004
J	Poehling, KA; Talbot, TR; Griffin, MR; Craig, AS; Whitney, CG; Zell, E; Lexau, CA; Thomas, AR; Harrison, LH; Reingold, AL; Hadler, JL; Farley, MM; Anderson, BJ; Schaffner, W				Poehling, KA; Talbot, TR; Griffin, MR; Craig, AS; Whitney, CG; Zell, E; Lexau, CA; Thomas, AR; Harrison, LH; Reingold, AL; Hadler, JL; Farley, MM; Anderson, BJ; Schaffner, W			Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTIONS; CHILDREN; IMMUNIZATION; EPIDEMIOLOGY; SURVEILLANCE; RESISTANCE; PROGRAM; IMPACT	Context Streptococcus pneumoniae is a serious infection in young infants. A heptavalent pneumococcal conjugate vaccine (PCV7) was licensed in 2000 and recommended for all children aged 2 to 23 months. Objective To determine the rates of invasive pneumococcal disease (IPD) in young infants before and after PCV7 was incorporated into the childhood immunization schedule in June 2000. Design, Setting, and Participants A prospective, population-based study of infants aged 0 to 90 days who resided in areas in 8 US states with active laboratory surveillance for invasive S pneumoniae infections from July 1, 1997, to June 30, 2004. Main Outcome Measures Rates of laboratory-confirmed IPD before (July 1, 1997-June 30, 2000) and after (July 1, 2001-June 30, 2004) PCV7 introduction, excluding a transition year (July 1, 2000-June 30, 2001). Results There were 146 cases of IPD, 89 before and 57 after PCV7 introduction. Isolated bacteremia occurred in 94 cases (64%), pneumonia in 27 (18%), meningitis in 22 (15%), and septic arthritis and/or osteomyelitis in 3 (2%). Mean rates of IPD for infants aged 0 to 90 days decreased 40% from 11.8 (95% confidence interval [CI], 9.6-14.5) to 7.2 (95% CI, 5.6-9.4; P = .004) per 100 000 live births following PCV7 introduction. Among black infants, mean rates of IPD decreased significantly from 17.1 (95% CI, 11.9-24.6) to 5.3 (95% CI, 2.8-10.1; P = .001) per 100 000 live births, with a nonsignificant decrease from 9.6 (95% CI, 7.3-12.7) to 6.8 (95% CI, 4.9-9.4) per 100 000 live births for white infants. Rates of PCV7-serotype isolates decreased significantly from 7.3 (95% CI, 5.3-10.1) to 2.4 (95% CI, 1.6-3.8; P < .001) per 100 000 live births, while rates of non-PCV7 serotypes remained stable (P = .55). Conclusions Since PCV7 introduction, rates of IPD in young infants have decreased significantly, providing evidence that vaccinating children aged 2 to 23 months has led to changes in pneumococcal carriage in infants too young to receive PCV7. With a significant decrease in rates of IPD among black infants, the previous racial difference has been eliminated.	Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37232 USA; Tennessee Dept Hlth, Nashville, TN USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Minnesota Dept Hlth, Minneapolis, MN USA; Oregon Dept Human Serv, Off Dis Prevent & Epidemiol, Portland, OR USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Connecticut Dept Hlth, Infect Dis Sect, Hartford, CT USA; Emory Univ, Sch Med, Atlanta, GA USA; Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; New York State Dept Hlth, Emerging Infect Program, Albany, NY USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tennessee Department Health; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; State University of New York (SUNY) System	Poehling, KA (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, AA-0216 Med Ctr N, Nashville, TN 37232 USA.	katherine.poehling@vanderbilt.edu		Talbot, Thomas/0000-0002-6139-212X	PHS HHS [U50/CCU416123] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Bradley JS, 1998, PEDIATRICS, V102, P1376, DOI 10.1542/peds.102.6.1376; *CDCP, 2001, NAT IMM SURV; Centers for Disease Control and Prevention, ACT BACT COR SURV RE; *CT DEP PUBL HLTH, 1997, CONN LIV BIRTH DAT; *CTR HLTH STAT OFF, 1997, CAL LIV BIRTH DAT; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Dagan R, 1999, VACCINE, V17, P134, DOI 10.1016/S0264-410X(98)00165-0; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Freed GL, 2002, PEDIATRICS, V110, P399, DOI 10.1542/peds.110.2.399; *GA DIV PUBL HLTH, 1997, GEORG LIV BIRTH DAT; Gomez M, 1999, PEDIATR INFECT DIS J, V18, P1014, DOI 10.1097/00006454-199911000-00016; Hausdorff WP, 2002, EUR J PEDIATR, V161, pS135, DOI 10.1007/s00431-002-1066-x; Hoffman JA, 2003, PEDIATRICS, V112, P1095, DOI 10.1542/peds.112.5.1095; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Hyde TB, 2002, PEDIATRICS, V110, P690, DOI 10.1542/peds.110.4.690; McDonald LC, 2003, J CLIN MICROBIOL, V41, P2258, DOI 10.1128/JCM.41.5.2258-2260.2003; McEllistrem MC, 2005, EMERG INFECT DIS, V11, P969; *MN DEP HLTH, 1997, MINN LIV BIRTH DAT; *NAT COMM CLIN LAB, 2002, PERF STAND ANT SUSC, V22; O'Brien KL, 2004, AM J EPIDEMIOL, V159, P634, DOI 10.1093/aje/kwh082; PAVIS A, 1995, EUR J CLIN MICROBIOL, V14, P68, DOI 10.1007/BF02112625; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Rubin DB., 1987, SOCIOL METHODOL, V17, P131, DOI DOI 10.2307/271031; Sadow KB, 1999, ARCH PEDIAT ADOL MED, V153, P611, DOI 10.1001/archpedi.153.6.611; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; SIMPSON JM, 1995, EUR J PEDIATR, V154, P563, DOI 10.1007/s004310050343; *STAT OR PUBL HLTH, 1997, OR LIV BIRTH DAT; Talbot TR, 2004, PEDIATR INFECT DIS J, V23, P726, DOI 10.1097/01.inf.0000133046.60555.de; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; *TN DEP HLTH, 1997, TENN LIV BIRTH DAT; *VIT STAT ADM, 1997, MAR LIV BIRTH DAT; *VIT STAT NY STAT, 1997, NEW YORK LIV BIRTH D; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; 2002, NAT VITAL STAT REPOR	36	322	341	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1668	1674		10.1001/jama.295.14.1668	http://dx.doi.org/10.1001/jama.295.14.1668			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609088	Bronze			2022-12-28	WOS:000236707300022
J	Lopez-Bendito, G; Cautinat, A; Sanchez, JA; Bielle, F; Flames, N; Garratt, AN; Talmage, DA; Role, LW; Charnay, P; Marin, O; Garel, S				Lopez-Bendito, G; Cautinat, A; Sanchez, JA; Bielle, F; Flames, N; Garratt, AN; Talmage, DA; Role, LW; Charnay, P; Marin, O; Garel, S			Tangential neuronal migration controls axon guidance: A role for neuregulin-1 in thalamocortical axon navigation	CELL			English	Article							LATERAL OLFACTORY TRACT; INTERMEDIATE TARGET; BASAL TELENCEPHALON; CONNECTIONS; PROJECTIONS; MICE; FOREBRAIN; CORTEX; MECHANISMS; NETRIN-1	Neuronal migration and axon guidance constitute fundamental processes in brain development that are generally studied independently. Although both share common mechanisms of cell biology and biochemistry, little is known about their coordinated integration in the formation of neural circuits. Here we show that the development of the thalamocortical projection, one of the most prominent tracts in the mammalian brain, depends on the early tangential migration of a population of neurons derived from the ventral telencephalon. This tangential migration contributes to the establishment of a permissive corridor that is essential for thalamocortical axon pathfinding. Our results also demonstrate that in this process two different products of the Neuregulin-1 gene, CRD-NRG1 and lg-NRG1, mediate the guidance of thalamocortical axons. These results show that neuronal tangential migration constitutes a novel mechanism to control the timely arrangement of guidance cues required for axonal tract formation in the mammalian brain.	CSIC, Inst Neurosci Alicante, St Joan DAlacant 03550, Spain; Univ Miguel Hernandez, St Joan DAlacant 03550, Spain; Ecole Normale Super, U368, INSERM, F-75230 Paris 05, France; Max Delbrueck Ctr, D-13125 Berlin, Germany; Columbia Univ, Med Ctr, New York, NY 10032 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Columbia University	Marin, O (corresponding author), CSIC, Inst Neurosci Alicante, St Joan DAlacant 03550, Spain.	o.marin@umh.es; garel@biologie.ens.fr	Garratt, Alistair/AAG-2715-2021; Marin, Oscar/F-3856-2012; Garratt, Alistair N/D-9893-2013; Garratt, Alistair/HGC-0774-2022; Role, LW/Q-7371-2018; Garel, Sonia/P-4538-2017; Sanchez-Alcaniz, Juan A/U-2285-2018; Flames, Nuria/L-2290-2017; Lopez-Bendito, Guillermina/E-4028-2014; Sanchez-Alcaniz, Juan Antonio/A-8173-2017	Marin, Oscar/0000-0001-6264-7027; Garratt, Alistair N/0000-0001-9631-3041; Role, LW/0000-0001-5851-212X; Garel, Sonia/0000-0003-2984-3645; Flames, Nuria/0000-0003-0961-0609; Bielle, Franck/0000-0001-6564-6388; Lopez-Bendito, Guillermina/0000-0002-8965-6836; Sanchez-Alcaniz, Juan Antonio/0000-0002-4900-5086; Charnay, Patrick/0000-0002-3847-6042; Talmage, David/0000-0003-4627-3007	NINDS NIH HHS [R01 NS029071, R01 NS029071-17, NS29071] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Bystron I, 2005, J NEUROSCI, V25, P2781, DOI 10.1523/JNEUROSCI.4770-04.2005; Casarosa S, 1999, DEVELOPMENT, V126, P525; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fukuda T, 1997, J COMP NEUROL, V382, P141; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jones L, 2002, DEVELOPMENT, V129, P5041; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Marin O, 2002, DEVELOPMENT, V129, P761; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Metin C, 1996, J NEUROSCI, V16, P3219; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MITROFANIS J, 1993, J COMP NEUROL, V338, P575, DOI 10.1002/cne.903380407; Molnar Z, 1999, J COMP NEUROL, V413, P1, DOI 10.1002/(SICI)1096-9861(19991011)413:1<1::AID-CNE1>3.0.CO;2-5; Molnar Z, 1998, J NEUROSCI, V18, P5723; Powell EM, 2003, DEV NEUROSCI-BASEL, V25, P197, DOI 10.1159/000072268; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sato Y, 1998, J NEUROSCI, V18, P7800; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sussel L, 1999, DEVELOPMENT, V126, P3359; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tomioka N, 2000, J NEUROSCI, V20, P5802, DOI 10.1523/JNEUROSCI.20-15-05802.2000; Tuttle R, 1999, DEVELOPMENT, V126, P1903; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9	50	286	289	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					127	142		10.1016/j.cell.2006.01.042	http://dx.doi.org/10.1016/j.cell.2006.01.042			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615895	Bronze, Green Accepted			2022-12-28	WOS:000237314200019
J	Bachmann, LM; Puhan, MA; ter Riet, G; Bossuyt, PM				Bachmann, LM; Puhan, MA; ter Riet, G; Bossuyt, PM			Sample sizes of studies on diagnostic accuracy: literature survey	BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine sample sizes in studies on diagnostic accuracy and the proportion of studies that report calculations of sample size. Design Literature survey. Data sources All issues of eight leading journals published in 2002. Methods Sample sizes, number of subgroup analyses, and how often studies reported calculations of sample size were extracted. Results 43 of 8999 articles were non-screening studies on diagnostic accuracy. The median sample size was 118 (interquartile range 71-350) and the median prevalence of the target condition was 43% (27-61%). The median number of patients with the target condition-needed to calculate a test's sensitivity-was 49 (28-91). The median number of patients without the target condition-needed to determine a test's specificity-was 76 (27-209). Two of the 43 studies (5%) reported a priori calculations of sample size. Twenty articles (47%) reported results for patient subgroups. The number of subgroups ranged from two to 19 (median four). No studies reported that sample size was calculated on the basis of preplanned analyses of subgroups. Conclusion Few studies on diagnostic accuracy report considerations of sample size. The number of participants in most studies on diagnostic accuracy is probably too small to analyse variability of measures of accuracy across patient subgroups.	Univ Bern, Dept Social & Prevent Med, Div Epidemiol & Biostat, CH-3012 Bern, Switzerland; Univ Zurich, Horten Ctr, CH-8091 Zurich, Switzerland; Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	University of Bern; University of Zurich; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bachmann, LM (corresponding author), Univ Bern, Dept Social & Prevent Med, Div Epidemiol & Biostat, CH-3012 Bern, Switzerland.	lucas.bachmann@evimed.ch	Riet, Gerben ter/A-6943-2011; Bachmann, Lucas M/C-9686-2011; Bossuyt, Patrick M./B-4557-2016; Bossuyt, Patrick M/AAR-1183-2021; Puhan, Milo/ABE-6298-2020	Riet, Gerben ter/0000-0002-2231-7637; Bossuyt, Patrick M./0000-0003-4427-0128; Bossuyt, Patrick M/0000-0003-4427-0128; Puhan, Milo/0000-0003-4721-1879; , Lucas/0000-0002-9868-154X				Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Pepe MS, 2003, STAT EVALUATION MED; PEPE MS, 2003, STAT EVALUATION MED, P214; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3	5	106	106	1	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 13	2006	332	7550					1127	1129		10.1136/bmj.38793.637789.2F	http://dx.doi.org/10.1136/bmj.38793.637789.2F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16627488	Green Published, Bronze			2022-12-28	WOS:000237682700018
J	Kato, H; Takeuchi, O; Sato, S; Yoneyama, M; Yamamoto, M; Matsui, K; Uematsu, S; Jung, A; Kawai, T; Ishii, KJ; Yamaguchi, O; Otsu, K; Tsujimura, T; Koh, CS; Sousa, CRE; Matsuura, Y; Fujita, T; Akira, S				Kato, H; Takeuchi, O; Sato, S; Yoneyama, M; Yamamoto, M; Matsui, K; Uematsu, S; Jung, A; Kawai, T; Ishii, KJ; Yamaguchi, O; Otsu, K; Tsujimura, T; Koh, CS; Sousa, CRE; Matsuura, Y; Fujita, T; Akira, S			Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses	NATURE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; IFN-BETA; ANTIVIRAL RESPONSE; SIGNALING PATHWAY; VIRAL REPLICATION; IMMUNE-RESPONSES; ADAPTER PROTEIN; INTERFERON; ACTIVATION	The innate immune system senses viral infection by recognizing a variety of viral components (including double-stranded (ds) RNA) and triggers antiviral responses(1,2). The cytoplasmic helicase proteins RIG-I (retinoic-acid-inducible protein I, also known as Ddx58) and MDA5 (melanoma-differentiation-associated gene 5, also known as Ifih1 or Helicard) have been implicated in viral dsRNA recognition(3-7). In vitro studies suggest that both RIG-I and MDA5 detect RNA viruses and polyinosine-polycytidylic acid (poly(I:C)), a synthetic dsRNA analogue(3). Although a critical role for RIG-I in the recognition of several RNA viruses has been clarified(8), the functional role of MDA5 and the relationship between these dsRNA detectors in vivo are yet to be determined. Here we use mice deficient in MDA5 (MDA5(-/-)) to show that MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs. RNA viruses are also differentially recognized by RIG-I and MDA5. We find that RIG-I is essential for the production of interferons in response to RNA viruses including paramyxo-viruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection. Furthermore, RIG-I-/- and MDA5(-/-) mice are highly susceptible to infection with these respective RNA viruses compared to control mice. Together, our data show that RIG-I and MDA5 distinguish different RNA viruses and are critical for host antiviral responses.	Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, ERATO, Suita, Osaka 5650871, Japan; Kyoto Univ, Dept Genet & Mol Biol, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; Hyogo Med Univ, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Shinshu Univ, Sch Allied Med Sci, Dept Med Technol, Matsumoto, Nagano 3908621, Japan; Lincolns Inn Fields Labs, Immunobiol Lab, Canc Res UK London Res Inst, London WC2A 3PX, England	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Kyoto University; Osaka University; Hyogo College of Medicine; University of Hyogo; Shinshu University; Cancer Research UK	Akira, S (corresponding author), Osaka Univ, Dept Host Def, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Reis e Sousa, Caetano/O-1657-2014; Akira, Shizuo/C-3134-2009; Yoneyama, Mitsutoshi/D-8244-2017; Takeuchi, Osamu/D-6007-2011; Ishii, Ken J/B-1685-2012; Takeuchi, Osamu/AAG-9359-2019; Reis e Sousa, Caetano/ABD-7322-2021	Reis e Sousa, Caetano/0000-0001-7392-2119; Yoneyama, Mitsutoshi/0000-0001-9512-0408; Ishii, Ken J/0000-0002-6728-3872; Takeuchi, Osamu/0000-0002-1260-6232; Reis e Sousa, Caetano/0000-0001-7392-2119; Yamaguchi, Osamu/0000-0002-7461-369X; Sato, Shintaro/0000-0001-5156-3354; Kawai, Taro/0000-0001-7510-4662				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	28	2734	2898	10	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					101	105		10.1038/nature04734	http://dx.doi.org/10.1038/nature04734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16625202				2022-12-28	WOS:000237248600041
J	Jeong, KH; Kim, J; Lee, LP				Jeong, KH; Kim, J; Lee, LP			Biologically inspired artificial compound eyes	SCIENCE			English	Article							WAVE-GUIDES; FACET LENS; OPTICS; BEE; SENSITIVITY; RHABDOMERE; ARRAY	This work presents the fabrication of biologically inspired artificial compound eyes. The artificial ommatidium, like that of an insect's compound eyes, consists of a refractive polymer microlens, a light-guiding polymer cone, and a self-aligned waveguide to collect light with a small angular acceptance. The ommatidia are omnidirectionally arranged along a hemispherical polymer dome such that they provide a wide field of view similar to that of a natural compound eye. The spherical configuration of the microlenses is accomplished by reconfigurable microtemplating, that is, polymer replication using the deformed elastomer membrane with microlens patterns. The formation of polymer waveguides self-aligned with microlenses is also realized by a self-writing process in a photosensitive polymer resin. The angular acceptance is directly measured by three-dimensional optical sectioning with a confocal microscope, and the detailed optical characteristics are studied in comparison with a natural compound eye.	Univ Calif Berkeley, Biomol Nanotechnol Ctr, Berkeley Sensor & Actuator Ctr, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lee, LP (corresponding author), Univ Calif Berkeley, Biomol Nanotechnol Ctr, Berkeley Sensor & Actuator Ctr, Dept Bioengn, 485 Evans Hall 1762, Berkeley, CA 94720 USA.	lplee@socrates.berkeley.edu	Kim, Jaeyoun/B-5291-2012; Lee, Luke/AAN-6695-2021; Jeong, Ki-Hun/C-1667-2011	Jeong, Ki-Hun/0000-0003-4799-7816				BEERSMA DGM, 1982, J OPT SOC AM, V72, P583, DOI 10.1364/JOSA.72.000583; Duparre J, 2005, APPL OPTICS, V44, P2949, DOI 10.1364/AO.44.002949; Feng R, 2003, J MICROMECH MICROENG, V13, P80, DOI 10.1088/0960-1317/13/1/312; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Hamanaka K, 1996, OPT REV, V3, P264, DOI 10.1007/s10043-996-0264-6; HARDIE R, 1989, J INSECT PHYSIOL, V35, P423, DOI 10.1016/0022-1910(89)90117-0; Kagami M, 2001, APPL PHYS LETT, V79, P1079, DOI 10.1063/1.1389516; Kewitsch AS, 1996, OPT LETT, V21, P24, DOI 10.1364/OL.21.000024; Kim JY, 2005, OPT LETT, V30, P5, DOI 10.1364/OL.30.000005; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAUGHLIN SB, 1971, Z VERGL PHYSIOL, V74, P329, DOI 10.1007/BF00297733; Lee LP, 2005, SCIENCE, V310, P1148, DOI 10.1126/science.1115248; OGATA S, 1994, OPT ENG, V33, P3649, DOI 10.1117/12.179889; Ottoson D, 1985, PROGR SENSORY PHYSL, P1; SANDERS JS, 1995, OPT ENG, V34, P222, DOI 10.1117/12.183393; Shoji S, 2002, OPT LETT, V27, P185, DOI 10.1364/OL.27.000185; Snyder A. W., 1979, COMP PHYSL EVOLUTION, P225, DOI DOI 10.1007/978-3-642-66999-6_5; SNYDER AW, 1972, J COMP PHYSIOL, V80, P51, DOI 10.1007/BF00694327; STAVENGA DG, 1991, J OPT SOC AM A, V8, P14, DOI 10.1364/JOSAA.8.000014; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; Streppel U, 2003, APPL OPTICS, V42, P3570, DOI 10.1364/AO.42.003570; Tanida J, 2001, APPL OPTICS, V40, P1806, DOI 10.1364/AO.40.001806; van Hateren J.H., 1989, P74; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Yamashita K, 2004, IEEE PHOTONIC TECH L, V16, P801, DOI 10.1109/LPT.2004.823752	25	508	538	17	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					557	561		10.1126/science.1123053	http://dx.doi.org/10.1126/science.1123053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645090				2022-12-28	WOS:000237296700039
J	Copelan, EA				Copelan, EA			Medical progress: Hematopoietic stem-cell transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; UMBILICAL-CORD BLOOD; ACUTE MYELOID-LEUKEMIA; HEPATIC VENOOCCLUSIVE-DISEASE; KIR LIGAND INCOMPATIBILITY; TOTAL-BODY IRRADIATION; PREPARATIVE REGIMEN; TARGETED BUSULFAN; RISK-FACTOR		Ohio State Univ, Arthur G James Canc Hosp, Columbus, OH 43210 USA; Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Copelan, EA (corresponding author), A-437 Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	edward.copelan@osumc.edu						Anderlini P, 2001, BONE MARROW TRANSPL, V27, P689, DOI 10.1038/sj.bmt.1702875; Attal M, 2004, NEW ENGL J MED, V350, P1467; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Berger C, 2003, BLOOD, V101, P476, DOI 10.1182/blood-2002-07-2142; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Bornhauser M, 2003, BLOOD, V102, P820, DOI 10.1182/blood-2002-11-3567; BRENNER MK, 1993, LANCET, V341, P85, DOI 10.1016/0140-6736(93)92560-G; Burt RK, 2004, J EXP MED, V199, P895, DOI 10.1084/jem.20031916; CLIFT RA, 1990, BLOOD, V76, P1867; Clouthier SG, 2003, BIOL BLOOD MARROW TR, V9, P592, DOI 10.1016/S1083-8791(03)00230-1; Cooke KR, 2004, BONE MARROW TRANSPL, V34, P753, DOI 10.1038/sj.bmt.1704629; Curtis RE, 1997, NEW ENGL J MED, V336, P897, DOI 10.1056/NEJM199703273361301; Cutler C, 2001, J CLIN ONCOL, V19, P3685, DOI 10.1200/JCO.2001.19.16.3685; Dann EJ, 2005, HUM REPROD, V20, P2247, DOI 10.1093/humrep/dei018; Davies SM, 2002, BLOOD, V100, P3825, DOI 10.1182/blood-2002-04-1197; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dykewicz CA, 2000, BIOL BLOOD MARROW TR, V6, P659; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Fernandez MN, 2003, EXP HEMATOL, V31, P535, DOI 10.1016/S0301-472X(03)00067-5; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Flomenberg N, 2005, BLOOD, V106, P1867, DOI 10.1182/blood-2005-02-0468; *GAO, 2002, GAO03182; GATTI RA, 1968, LANCET, V2, P1366; Giebel S, 2003, BLOOD, V102, P814, DOI 10.1182/blood-2003-01-0091; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gratwohl A, 2002, BRIT J HAEMATOL, V117, P451, DOI 10.1046/j.1365-2141.2002.03440.x; Guglielmi C, 2001, HAEMATOLOGICA, V86, P941; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Hogan WJ, 2004, BLOOD, V103, P78, DOI 10.1182/blood-2003-04-1311; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; HOROWITZ MM, 1990, BLOOD, V75, P555; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Kallianpur AR, 2005, BONE MARROW TRANSPL, V35, P1155, DOI 10.1038/sj.bmt.1704943; Kashyap A, 2002, BIOL BLOOD MARROW TR, V8, P493, DOI 10.1053/bbmt.2002.v8.pm12374454; Krishnan A, 2000, BLOOD, V95, P1588, DOI 10.1182/blood.V95.5.1588.005k38_1588_1593; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lan FS, 2003, BIOL BLOOD MARROW TR, V9, P355, DOI 10.1016/S1083-8791(03)00108-3; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lass A, 2001, HUM REPROD UPDATE, V7, P370, DOI 10.1093/humupd/7.4.370; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levesque JP, 2004, BLOOD, V104, P65, DOI 10.1182/blood-2003-05-1589; Levine JE, 2003, BIOL BLOOD MARROW TR, V9, P189, DOI 10.1053/bbmt.2003.50012; Lin M, 2003, NEW ENGL J MED, V349, P2201, DOI 10.1056/NEJMoa022060; LORENZ E, 1951, J NATL CANCER I, V12, P197; Lowsky R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMoa050642; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701; MANNICK JA, 1960, BLOOD, V15, P255, DOI 10.1182/blood.V15.2.255.255; Matthews DC, 1999, BLOOD, V94, P1237, DOI 10.1182/blood.V94.4.1237.416k34_1237_1247; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; McSweeney PA, 2001, BLOOD, V97, P3390, DOI 10.1182/blood.V97.11.3390; Metayer C, 2003, BLOOD, V101, P2015, DOI 10.1182/blood-2002-04-1261; MEYERS JD, 1982, REV INFECT DIS, V4, P1119; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Mitchell JM, 1997, J CLIN ONCOL, V15, P2644, DOI 10.1200/JCO.1997.15.7.2644; Molldrem JJ, 1997, BLOOD, V90, P2529, DOI 10.1182/blood.V90.7.2529.2529_2529_2534; Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879; Murai M, 2003, NAT IMMUNOL, V4, P497, DOI 10.1038/ni0503-497; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PAIVANAS T, 2005, ONCOLOGY NEWS INT, V14, P73; PAIVANAS T, 2005, ONCOLOGY NEWS INT, V14, P51; Peggs KS, 2004, BLOOD, V103, P1548, DOI 10.1182/blood-2003-05-1513; PHILIP T, 1987, NEW ENGL J MED, V316, P1493, DOI 10.1056/NEJM198706113162401; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; Radeva JI, 2005, BONE MARROW TRANSPL, V36, P397, DOI 10.1038/sj.bmt.1705077; Radich JP, 2003, BLOOD, V102, P31, DOI 10.1182/blood-2002-08-2619; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Rocha V, 2002, BLOOD, V100, P3908, DOI 10.1182/blood-2002-04-1033; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sanders JE, 2005, BLOOD, V105, P1348, DOI 10.1182/blood-2004-07-2528; SANDMAIER BM, 2004, THOMAS HEMATOPOIETIC, P1164; SANTOS GW, 1983, NEW ENGL J MED, V309, P1347, DOI 10.1056/NEJM198312013092202; SANTOS GW, 1969, TRANSPLANT P, V1, P44; SLATTERY JT, 1995, BONE MARROW TRANSPL, V16, P31; Slattery JT, 1996, BONE MARROW TRANSPL, V18, P829; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Srivastava A, 2004, BLOOD, V104, P1574, DOI 10.1182/blood-2003-11-3778; Stewart AK, 2001, J CLIN ONCOL, V19, P3771, DOI 10.1200/JCO.2001.19.17.3771; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; STORB R, 1989, BLOOD, V73, P1729; STORB R, 1970, TRANSPLANTATION, V9, P240, DOI 10.1097/00007890-197003000-00007; Subbiah K, 2003, J NUCL MED, V44, P437; SULLIVAN KM, 1986, BLOOD, V67, P1172; Sykes M, 2005, NATURE, V435, P620, DOI 10.1038/nature03728; Syrjala KL, 2005, J CLIN ONCOL, V23, P6596, DOI 10.1200/JCO.2005.12.674; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; THOMAS ED, 1979, NEW ENGL J MED, V301, P597, DOI 10.1056/NEJM197909133011109; THOMAS ED, 1959, J CLIN INVEST, V38, P1709, DOI 10.1172/JCI103949; THOMAS ED, 1977, BLOOD, V49, P511; Tivol E, 2005, BLOOD, V105, P4885, DOI 10.1182/blood-2004-12-4980; TUTSCHKA PJ, 1987, BLOOD, V70, P1382; Vogt MHJ, 2002, BLOOD, V99, P3027, DOI 10.1182/blood.V99.8.3027; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Yanik G, 2002, BIOL BLOOD MARROW TR, V8, P395, DOI 10.1053/bbmt.2002.v8.pm12171486	102	1538	1599	7	143	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1813	1826		10.1056/NEJMra052638	http://dx.doi.org/10.1056/NEJMra052638			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641398				2022-12-28	WOS:000237077100007
J	Freedman, B; Bartal, G; Segev, M; Lifshitz, R; Christodoulides, DN; Fleischer, JW				Freedman, B; Bartal, G; Segev, M; Lifshitz, R; Christodoulides, DN; Fleischer, JW			Wave and defect dynamics in nonlinear photonic quasicrystals	NATURE			English	Article							SOLITONS; DISLOCATIONS; PHASONS	Quasicrystals are unique structures with long-range order but no periodicity. Their properties have intrigued scientists ever since their discovery(1) and initial theoretical analysis(2,3). The lack of periodicity excludes the possibility of describing quasicrystal structures with well-established analytical tools, including common notions like Brillouin zones and Bloch's theorem. New and unique features such as fractal-like band structures(4-7) and 'phason' degrees of freedom(8) are introduced. In general, it is very difficult to directly observe the evolution of electronic waves in solid-state atomic quasicrystals, or the dynamics of the structure itself. Here we use optical induction(9-11) to create two-dimensional photonic quasicrystals, whose macroscopic nature allows us to explore wave transport phenomena. We demonstrate that light launched at different quasicrystal sites travels through the lattice in a way equivalent to quantum tunnelling of electrons in a quasiperiodic potential. At high intensity, lattice solitons are formed. Finally, we directly observe dislocation dynamics when crystal sites are allowed to interact with each other. Our experimental results apply not only to photonics, but also to other quasiperiodic systems such as matter waves in quasiperiodic traps(12), generic pattern-forming systems as in parametrically excited surface waves(13), liquid quasicrystals(14), and the more familiar atomic quasicrystals.	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Solid State, IL-32000 Haifa, Israel; Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Cent Florida, Coll Opt & Photon, Orlando, FL 32816 USA; Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA; Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University; State University System of Florida; University of Central Florida; Princeton University; Princeton University	Segev, M (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	msegev@techunix.technion.ac.il	Lifshitz, Ron/A-7775-2008	Lifshitz, Ron/0000-0002-8829-5506				Barak G, 2006, PHILOS MAG, V86, P1059, DOI 10.1080/14786430500256383; Bartal G, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.053904; Bratfalean RT, 2005, OPT LETT, V30, P424, DOI 10.1364/OL.30.000424; Chan YS, 1998, PHYS REV LETT, V80, P956, DOI 10.1103/PhysRevLett.80.956; CHRISTODOULIDES DN, 1995, J OPT SOC AM B, V12, P1628, DOI 10.1364/JOSAB.12.001628; Christodoulides DN, 2003, NATURE, V424, P817, DOI 10.1038/nature01936; CHRISTODOULIDES DN, 1988, OPT LETT, V13, P794, DOI 10.1364/OL.13.000794; Clausen CB, 1999, PHYS REV LETT, V83, P4740, DOI 10.1103/PhysRevLett.83.4740; Dal Negro L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.055501; Edagawa K, 2000, PHYS REV LETT, V85, P1674, DOI 10.1103/PhysRevLett.85.1674; Efremidis NK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.213906; Efremidis NK, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046602; Eisenberg HS, 1998, PHYS REV LETT, V81, P3383, DOI 10.1103/PhysRevLett.81.3383; Fleischer JW, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.023902; Fleischer JW, 2003, NATURE, V422, P147, DOI 10.1038/nature01452; Guidoni L, 1997, PHYS REV LETT, V79, P3363, DOI 10.1103/PhysRevLett.79.3363; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Kaliteevski MA, 2000, NANOTECHNOLOGY, V11, P274, DOI 10.1088/0957-4484/11/4/316; LEVINE D, 1985, PHYS REV LETT, V54, P1520, DOI 10.1103/PhysRevLett.54.1520; Lifshitz R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.133901; Lifshitz R, 1997, PHYS REV LETT, V79, P1261, DOI 10.1103/PhysRevLett.79.1261; Man WN, 2005, NATURE, V436, P993, DOI 10.1038/nature03977; Martin H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.123902; Rotenberg E, 2000, NATURE, V406, P602, DOI 10.1038/35020519; RUSSELL PS, 1986, APPL PHYS B-PHOTO, V39, P231, DOI 10.1007/BF00697490; SEGEV M, 1994, PHYS REV LETT, V73, P3211, DOI 10.1103/PhysRevLett.73.3211; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; SOCOLAR JES, 1986, PHYS REV B, V34, P3345, DOI 10.1103/PhysRevB.34.3345; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368; Zoorob ME, 2000, NATURE, V404, P740, DOI 10.1038/35008023	30	209	211	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1166	1169		10.1038/nature04722	http://dx.doi.org/10.1038/nature04722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641990				2022-12-28	WOS:000237080000039
J	Gibbs, MJ; Gibbs, AJ				Gibbs, MJ; Gibbs, AJ			Molecular virology - Was the 1918 pandemic caused by a bird flu?	NATURE			English	Letter							GENE; EVOLUTION; VIRUSES; SEGMENT; ORIGIN		Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia	Australian National University	Gibbs, MJ (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	mark.gibbs@anu.edu.au						Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Fanning TG, 2002, J VIROL, V76, P7860, DOI 10.1128/JVI.76.15.7860-7862.2002; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Reid AH, 2002, J VIROL, V76, P10717, DOI 10.1128/JVI.76.21.10717-10723.2002; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	8	50	55	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					E8	E8		10.1038/nature04823	http://dx.doi.org/10.1038/nature04823			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641948	Bronze			2022-12-28	WOS:000237080000028
J	Scher, HD; Martin, EE				Scher, HD; Martin, EE			Timing and climatic consequences of the opening of Drake Passage	SCIENCE			English	Article							FOSSIL FISH TEETH; SOUTHERN-OCEAN; EVOLUTION; EOCENE; CIRCULATION; ND; GLACIATION; ISOTOPES; SEAWATER; INPUTS	Age estimates for the opening of Drake Passage range from 49 to 17 million years ago (Ma), complicating interpretations of the relationship between ocean circulation and global cooling. Secular variations of neodymium isotope ratios at Agulhas Ridge (Southern Ocean, Atlantic sector) suggest an influx of shallow Pacific seawater approximately 41 Ma. The timing of this connection and the subsequent deepening of the passage coincide with increased biological productivity and abrupt climate reversals. Circulation/productivity linkages are proposed as a mechanism for declining atmospheric carbon dioxide. These results also indicate that Drake Passage opened before the Tasmanian Gateway, implying the late Eocene establishment of a complete circum-Antarctic pathway.	Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Scher, HD (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	howie@earth.rochester.edu	Scher, Howie/C-4927-2013	Scher, Howie/0000-0002-7778-6772				ANDERSON LC, COMMUNICATION; Anderson LD, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001043; Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; Barker PF, 2001, EARTH-SCI REV, V55, P1, DOI 10.1016/S0012-8252(01)00055-1; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Cooke PJ, 2002, PALAEOGEOGR PALAEOCL, V188, P73, DOI 10.1016/S0031-0182(02)00531-X; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DiesterHaass L, 1996, GEOLOGY, V24, P163, DOI 10.1130/0091-7613(1996)024<0163:EOTITS>2.3.CO;2; Frank M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000919; Frank M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000606; Goldstein S.L., 2003, TREATISE GEOCHEMISTR, P453, DOI [10.1016/B0-08-043751-6/06179-X, DOI 10.1016/B0-08-043751-6/06179-X]; GOLDSTEIN SL, 1984, EARTH PLANET SC LETT, V70, P221, DOI 10.1016/0012-821X(84)90007-4; HUBBERTEN HW, 1991, P OCEAN DRILLING PRO, V0114; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Latimer JC, 2002, PALAEOGEOGR PALAEOCL, V182, P151, DOI 10.1016/S0031-0182(01)00493-X; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Ling HF, 1997, EARTH PLANET SC LETT, V146, P1, DOI 10.1016/S0012-821X(96)00224-5; Livermore R, 2005, EARTH PLANET SC LETT, V236, P459, DOI 10.1016/j.epsl.2005.03.027; Martin EE, 2004, EARTH PLANET SC LETT, V220, P25, DOI 10.1016/S0012-821X(04)00030-5; MEAD GA, 1993, ANTAR RES S, V60, P27; Miller K.G., 1992, EOCENE OLIGOCENE CLI, P160, DOI [10.1515/9781400862924.160, DOI 10.1515/9781400862924.160]; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; PALMER MR, 1986, GEOCHIM COSMOCHIM AC, V50, P409, DOI 10.1016/0016-7037(86)90194-8; Scher HD, 2004, EARTH PLANET SC LETT, V228, P391, DOI 10.1016/j.epsl.2004.10.016; Scher HD, 2002, GEOCHIM COSMOCHIM AC, V66, pA677; Stickley CE, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001022; Tachikawa K, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/1999JC000285; Thomas DJ, 2003, EARTH PLANET SC LETT, V209, P309, DOI 10.1016/S0012-821X(03)00096-7; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1992, INDIAN OCEAN SYNTHES, P351	31	386	402	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					428	430		10.1126/science.1120044	http://dx.doi.org/10.1126/science.1120044			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627741				2022-12-28	WOS:000236941800047
J	Lagakos, SW				Lagakos, SW			The challenge of subgroup analyses - Reporting without distorting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLINICAL-TRIALS		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Lagakos, SW (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bailar JC., 1992, MED USES STAT; Parker AB, 2000, AM HEART J, V139, P952, DOI 10.1067/mhj.2000.106610; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	5	373	379	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1667	1669		10.1056/NEJMp068070	http://dx.doi.org/10.1056/NEJMp068070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16625007				2022-12-28	WOS:000236893900003
J	Conde-Agudelo, A; Rosas-Bermudez, A; Kafury-Goeta, AC				Conde-Agudelo, A; Rosas-Bermudez, A; Kafury-Goeta, AC			Birth spacing and risk of adverse perinatal outcomes - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SHORT INTERPREGNANCY INTERVALS; INTRAUTERINE GROWTH-RETARDATION; FOR-GESTATIONAL-AGE; DOSE-RESPONSE DATA; PRETERM BIRTH; PREGNANCY INTERVAL; MATERNAL DEPLETION; SUBSEQUENT RISK; NEONATAL DEATH; BLACK-WOMEN	Context Both short and long interpregnancy intervals have been associated with an increased risk of adverse perinatal outcomes. However, whether this possible association is confounded by maternal characteristics or socioeconomic status is uncertain. Objective To examine the association between birth spacing and relative risk of adverse perinatal outcomes. Data Sources Studies published in any language were retrieved by searching MEDLINE ( 1966 through January 2006), EMBASE, ECLA, POPLINE, CINAHL, and LILACS, proceedings of meetings on birth spacing, and bibliographies of retrieved articles, and by contact with relevant researchers in the field. Study Selection Included studies were cohort, cross-sectional, and case-control studies with results adjusted for at least maternal age and socioeconomic status, reporting risk estimates and 95% confidence intervals ( or data to calculate them) of birth spacing and perinatal outcomes. Of 130 articles identified in the search, 67 (52%) were included. Data Extraction Information on study design, participant characteristics, measure of birth spacing used, measures of outcome, control for potential confounding factors, and risk estimates was abstracted independently by 2 investigators using a standardized protocol. Data Synthesis A random-effects model and meta-regression analyses were used to pool data from individual studies. Compared with interpregnancy intervals of 18 to 23 months, interpregnancy intervals shorter than 6 months were associated with increased risks of preterm birth, low birth weight, and small for gestational age ( pooled adjusted odds ratios [ 95% confidence intervals]: 1.40 [1.24- 1.58], 1.61 [1.39- 1.86], and 1.26 [1.18-1.33], respectively). Intervals of 6 to 17 months and longer than 59 months were also associated with a significantly greater risk for the 3 adverse perinatal outcomes. Conclusions Interpregnancy intervals shorter than 18 months and longer than 59 months are significantly associated with increased risk of adverse perinatal outcomes. These data suggest that spacing pregnancies appropriately could help prevent such adverse perinatal outcomes.	Fdn Santa Fe Bogota, Ctr Estud & Invest Salud, Bogota, Colombia; Fdn Santa Fe Bogota, Dept Obstet & Gynecol, Bogota, Colombia; Univ Autonoma Occidente, Dept Biostat, Cali, Colombia; Clin Materno Infantil Los Farallones, Cali, Colombia	Universidad Autonoma de Occidente	Conde-Agudelo, A (corresponding author), MPH, Calle 58 26-60, Palmira Valle, Colombia.	condeagu@uniweb.net.co						Adams MM, 1997, PAEDIATR PERINAT EP, V11, P48, DOI 10.1046/j.1365-3016.11.s1.8.x; Al-Jasmi F, 2002, B WORLD HEALTH ORGAN, V80, P871; Arafa MA, 2004, PAEDIATR PERINAT EP, V18, P248, DOI 10.1111/j.1365-3016.2004.00564.x; Arif M A, 1998, J Obstet Gynaecol Res, V24, P215; Bakewell JM, 1997, PAEDIATR PERINAT EP, V11, P119, DOI 10.1046/j.1365-3016.11.s1.4.x; BARROS FC, 1992, PEDIATRICS, V90, P238; BARTLETT AV, 1991, ACTA PAEDIATR SCAND, V80, P288, DOI 10.1111/j.1651-2227.1991.tb11851.x; Basso O, 1998, AM J OBSTET GYNECOL, V178, P259, DOI 10.1016/S0002-9378(98)80010-0; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; BRODY DJ, 1987, AM J PERINAT, V4, P50, DOI 10.1055/s-2007-999736; CASTERLINE JB, 1989, SOC BIOL, V36, P186; Conde-Agudelo A, 2005, OBSTET GYNECOL, V106, P359, DOI 10.1097/01.AOG.0000171118.79529.a3; Dafopoulos KC, 2002, EUR J OBSTET GYN R B, V103, P14, DOI 10.1016/S0301-2115(02)00007-6; DAVANZO J, 1984, SOC SCI MED, V18, P387; DAVANZO J, 2005, TECHN CONS REV SCI E; DEBARROS EP, 2004, S INT CES AV PROP AC; DECHERING W H J C, 1991, Ceylon Medical Journal, V36, P52; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshmukh J S, 1998, Indian Pediatr, V35, P33; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EISNER V, 1979, AM J PUBLIC HEALTH, V69, P887, DOI 10.2105/AJPH.69.9.887; Ekwo EE, 1998, INT J EPIDEMIOL, V27, P68, DOI 10.1093/ije/27.1.68; ERICKSON JD, 1979, LANCET, V1, P52; FEDRICK J, 1973, BMJ-BRIT MED J, V4, P753, DOI 10.1136/bmj.4.5895.753; FERRAZ EM, 1988, AM J EPIDEMIOL, V128, P1111; FIKREE FF, 1994, B WORLD HEALTH ORGAN, V72, P581; FORTNEY JA, 1984, PUBLIC HEALTH, V98, P73, DOI 10.1016/S0033-3506(84)80099-2; Fourn L, 1996, Med Trop (Mars), V56, P163; Fuentes-Afflick E, 2000, OBSTET GYNECOL, V95, P383, DOI 10.1016/S0029-7844(99)00583-9; Grau Espinosa M A, 1999, Rev Panam Salud Publica, V6, P95, DOI 10.1590/S1020-49891999000700003; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENWOOD R, 1994, PAEDIATR PERINAT EP, V8, P40, DOI 10.1111/j.1365-3016.1994.tb00490.x; GRIBBLE JN, 1993, POP STUD-J DEMOG, V47, P133, DOI 10.1080/0032472031000146776; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOSAIN GM, 2005, J TROP PEDIATRICS, P662; Hsieh TT, 2005, J SOC GYNECOL INVEST, V12, P202, DOI 10.1016/j.jsgi.2004.12.004; HUTTLY SRA, 1992, PEDIATRICS, V89, P1049; KALLAN JE, 1992, SOC BIOL, V39, P231; Kallan JE, 1997, SOC BIOL, V44, P205; Khan Nusrat, 2003, J Coll Physicians Surg Pak, V13, P25; Khoshnood B, 1998, AM J EPIDEMIOL, V148, P798; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; KLEBANOFF MA, 1988, AM J PUBLIC HEALTH, V78, P667, DOI 10.2105/AJPH.78.6.667; Klebanoff MA, 1999, NEW ENGL J MED, V340, P643, DOI 10.1056/NEJM199902253400809; Kleijer ME, 2005, J MATERN-FETAL NEO M, V18, P23, DOI 10.1080/14767050500127674; Klerman LV, 1998, AM J PUBLIC HEALTH, V88, P1182, DOI 10.2105/AJPH.88.8.1182; KUMAR R, 1992, Indian Journal of Pediatrics, V59, P455, DOI 10.1007/BF02751561; LANG JM, 1990, AM J EPIDEMIOL, V132, P304, DOI 10.1093/oxfordjournals.aje.a115659; LEONG WP, 1993, J BIOSOC SCI, V25, P465, DOI 10.1017/S0021932000021842; LEVINE M, 1994, JAMA-J AM MED ASSOC, V271, P1615, DOI 10.1001/jama.271.20.1615; LIEBERMAN E, 1989, OBSTET GYNECOL, V74, P1; Mafina-Mienandi M C, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P500; MAVALANKAR DV, 1991, AM J EPIDEMIOL, V133, P958, DOI 10.1093/oxfordjournals.aje.a115976; MAVALANKAR DV, 1992, INT J EPIDEMIOL, V21, P263, DOI 10.1093/ije/21.2.263; MILLER JE, 1994, J BIOSOC SCI, V26, P243, DOI 10.1017/S0021932000021271; MILLER JE, 1991, FAM PLANN PERSPECT, V23, P62, DOI 10.2307/2135451; MILLER JE, 1989, J BIOSOC SCI, V21, P235, DOI 10.1017/S0021932000017922; NEEL N R, 1991, Boletin de la Oficina Sanitaria Panamericana, V110, P93; Ochoa Sangrador C, 1996, ANAL ESPANIOLES PEDI, V45, P67; Orji E O, 2004, East Afr Med J, V81, P388; RAWLINGS JS, 1995, NEW ENGL J MED, V332, P69, DOI 10.1056/NEJM199501123320201; Rousham EK, 2002, ANN HUM BIOL, V29, P363, DOI 10.1080/03014460110088798; Rousso D, 2002, EUR J OBSTET GYN R B, V105, P4, DOI 10.1016/S0301-2115(02)00077-5; Ruelas-Orozco G, 1985, Bol Med Hosp Infant Mex, V42, P153; RUTSTEIN O, 2005, TECHN CONS REV SCI E; Sachar RK, 2000, J TROP PEDIATRICS, V46, P43, DOI 10.1093/tropej/46.1.43; Sener T, 1997, J MATERN-FETAL INVES, V7, P145; Shults RA, 1999, EPIDEMIOLOGY, V10, P250, DOI 10.1097/00001648-199905000-00010; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Smits LJM, 2001, LANCET, V358, P2074, DOI 10.1016/S0140-6736(01)07105-7; SPRATLEY E, 1981, VITAL HLTH STAT 21, V39, P1; Stephansson O, 2003, OBSTET GYNECOL, V102, P101, DOI 10.1016/S0029-7844(03)00366-1; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SWENSON I, 1978, SOC BIOL, V25, P251, DOI 10.1080/19485565.1978.9988344; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; Wang PD, 1999, PUBLIC HEALTH, V113, P27, DOI 10.1016/S0033-3506(99)00109-2; WINIKOFF B, 1983, STUD FAMILY PLANN, V14, P231, DOI 10.2307/1965748; WINKVIST A, 1992, AM J PUBLIC HEALTH, V82, P691, DOI 10.2105/AJPH.82.5.691; Zhu Bao-Ping, 2003, Matern Child Health J, V7, P169, DOI 10.1023/A:1025184304391; Zhu BP, 2001, AM J OBSTET GYNECOL, V185, P1403, DOI 10.1067/mob.2001.118307; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	82	715	727	1	69	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1809	1823		10.1001/jama.295.15.1809	http://dx.doi.org/10.1001/jama.295.15.1809			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033XG	16622143				2022-12-28	WOS:000236886900024
J	D'Cruz, DP				D'Cruz, DP			Systemic lupus erythematosus	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRIMARY ANTIPHOSPHOLIPID SYNDROME; NEUROPSYCHIATRIC MANIFESTATIONS; RECURRENT THROMBOSIS; DISEASE-ACTIVITY; THERAPY; PREVALENCE; TRIAL; PREVENTION; DEPLETION; WARFARIN		St Thomas Hosp, Louise Coote Lupus Unit, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	D'Cruz, DP (corresponding author), St Thomas Hosp, Louise Coote Lupus Unit, London SE1 7EH, England.	david.d'cruz@kcl.ac.uk						Anolik JH, 2003, ARTHRITIS RHEUM, V48, P455, DOI 10.1002/art.10764; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Asherson RA, 2003, LUPUS, V12, P530, DOI 10.1191/0961203303lu394oa; Baron MA, 2005, ANN RHEUM DIS, V64, P144, DOI 10.1136/ard.2003.016204; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Crowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241; Cuadrado MJ, 2000, MEDICINE, V79, P57, DOI 10.1097/00005792-200001000-00006; D'Cruz D, 2001, LUPUS, V10, P148, DOI 10.1191/096120301669779293; de Carvalho MRP, 2005, ARTHRIT RHEUM-ARTHR, V53, P838, DOI 10.1002/art.21605; El-Magadmi M, 2004, CIRCULATION, V110, P399, DOI 10.1161/01.CIR.0000136807.78534.50; ESDAILE J, 1991, NEW ENGL J MED, V324, P150; Finazzi G, 2005, J THROMB HAEMOST, V3, P848, DOI 10.1111/j.1538-7836.2005.01340.x; Galie N, 2005, LUPUS, V14, P713, DOI 10.1191/0961203305lu2206oa; Ginzler EM, 2005, NEW ENGL J MED, V353, P2219, DOI 10.1056/NEJMoa043731; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; Houssiau FA, 2004, ARTHRITIS RHEUM-US, V50, P3934, DOI 10.1002/art.20666; HUGHES GRV, 1983, BRIT MED J, V287, P1088, DOI 10.1136/bmj.287.6399.1088; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Jump RL, 2005, J RHEUMATOL, V32, P1699; Lampropoulos CE, 2004, RHEUMATOLOGY, V43, P1383, DOI 10.1093/rheumatology/keh325; Lampropoulos CE, 2005, ARTHRITIS RHEUM-US, V52, P841, DOI 10.1002/art.20957; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ruiz-Irastorza G, 2005, ANN NY ACAD SCI, V1051, P606, DOI 10.1196/annals.1361.105; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Sanchez-Guerrero J, 2005, NEW ENGL J MED, V353, P2539, DOI 10.1056/NEJMoa050817; Sangle S, 2004, ANN RHEUM DIS, V63, P1241, DOI 10.1136/ard.2003.016105; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136/ard.62.10.999; Sanna G, 2003, J RHEUMATOL, V30, P985; Shoenfeld Y, 2004, J RHEUMATOL, V31, P1344; Tektonidou MG, 2003, ARTHRITIS RHEUM-US, V48, P732, DOI 10.1002/art.10835; Tench CM, 2003, RHEUMATOLOGY, V42, P1050, DOI 10.1093/rheumatology/keg289; Tlacuilo-Parra A, 2005, RHEUMATOLOGY, V44, P1564, DOI 10.1093/rheumatology/kei093; Zandman-Goddard G, 2005, CLIN REV ALLERG IMMU, V29, P219, DOI 10.1385/CRIAI:29:3:219	38	54	56	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2006	332	7546					890	894B		10.1136/bmj.332.7546.890	http://dx.doi.org/10.1136/bmj.332.7546.890			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16613963	Green Published			2022-12-28	WOS:000237132100021
J	Harper, DM; Franco, EL; Wheeler, CM; Moscicki, AB; Romonowski, B; Roteli-Martins, CM; Jenkins, D; Schuind, A; Clemens, SAC; Dubin, G				Harper, DM; Franco, EL; Wheeler, CM; Moscicki, AB; Romonowski, B; Roteli-Martins, CM; Jenkins, D; Schuind, A; Clemens, SAC; Dubin, G		HPV Vaccine Study Grp	Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial	LANCET			English	Article							HEPATITIS-B-VACCINE; NATURAL-HISTORY; CLINICAL-TRIALS; CERVICAL-CANCER; YOUNG-WOMEN; INFECTION; IMMUNOGENICITY; WORLDWIDE; PROFILE; DESIGN	Background Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will require a high level of sustained protection against infection and precancerous lesions. Our aim was to assess the long-term efficacy, immunogenicity, and safety of a bivalent HPV-16/18 L1 virus-like particle AS04 vaccine against incident and persistent infection with HPV 16 and HPV 18 and their associated cytological and histological outcomes. Methods We did a follow-up study of our multicentre, double-blind, randomised, placebo-controlled trial reported in 2004. We included women who originally received all three doses of bivalent HPV-16/18 virus-like particle AS04 vaccine (0.5 mL; n=393) or placebo (n=383). We assessed HPV DNA, using cervical samples, and did yearly cervical cytology assessments. We also studied the long-term immunogenicity and safety of the vaccine. Findings More than 98% seropositivity was maintained for HPV-16/18 antibodies during the extended follow-up phase. We noted significant vaccine efficacy against HPV-16 and HPV-18 endpoints: incident infection, 96.9% (95% CI 81.3-99.9); persistent infection: 6 month definition, 94.3 (63.2-99.9); 12 month definition, 100% (33.6-100). In a combined analysis of the initial efficacy and extended follow-up studies, vaccine efficacy of 100% (42.4-100) against cervical intraepithelial neoplasia (CIN) lesions associated with vaccine types. We noted broad protection against cytohistological outcomes beyond that anticipated for HPV 16/18 and protection against incident infection with HPV 45 and HPV 31. The vaccine has a good long-term safety profile. Interpretation Up to 4.5 years, the HPV-16/18 L1 virus-like particle AS04 vaccine is highly immunogenic and safe, and induces a high degree of protection against HPV-16/18 infection and associated cervical lesions. There is also evidence of cross protection.	Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Obstet & Gynecol, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Community & Family Med, Lebanon, NH 03756 USA; McGill Univ, Dept Oncol, Montreal, PQ, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Alberta, Edmonton, AB, Canada; Nove Julho Hosp, Sao Paulo, Brazil; GlaxoSmithKline Biol, Rixensart, Belgium; GlaxoSmithKline Biol, King Of Prussia, PA USA; GlaxoSmithKline Biol, Rio De Janeiro, Brazil	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; McGill University; McGill University; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of California System; University of California San Francisco; University of Alberta; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Harper, DM (corresponding author), Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Obstet & Gynecol, Rubin 880,1 Med Ctr Dr, Lebanon, NH 03756 USA.	diane.m.harper@dartmouth.edu	Harper, Diane M./I-2180-2014; Moscicki, Anna-Barbara/AAP-3806-2021; Franco, Eduardo/C-6445-2014	Harper, Diane M./0000-0001-7648-883X; Costa Clemens, Sue Ann/0000-0001-9576-0878; Franco, Eduardo/0000-0002-4409-8084				Boland G, 2004, VACCINE, V23, P316, DOI 10.1016/j.vaccine.2004.06.006; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; COGLIANO V, 2005, LANCET ONCOL, V6, P931; Combita AL, 2002, INT J CANCER, V97, P796, DOI 10.1002/ijc.10153; Garcon Nathalie, 2006, P161, DOI 10.1016/B978-012088403-2/50011-3; Goldie SJ, 2003, INT J CANCER, V106, P896, DOI 10.1002/ijc.11334; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Jacques P, 2002, VACCINE, V20, P3644, DOI 10.1016/S0264-410X(02)00397-3; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Marais D, 2000, J MED VIROL, V60, P331, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;331::AID-JMV12&gt;3.0.CO;2-A; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; STANLEY M, 2005, VACCINE, DOI DOI 10.1016/J.VACCINE2005.09.002; TANG DI, 1993, BIOMETRICS, V49, P23, DOI 10.2307/2532599; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wideroff L, 1999, J INFECT DIS, V180, P1424, DOI 10.1086/315055; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	24	1177	1249	5	123	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1247	1255		10.1016/S0140-6736(06)68439-0	http://dx.doi.org/10.1016/S0140-6736(06)68439-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631880				2022-12-28	WOS:000236913400029
J	Samarasekera, S; Dorman, PJ				Samarasekera, S; Dorman, PJ			The case of the forgotten address	LANCET			English	Editorial Material							THALAMUS		Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Samarasekera, S (corresponding author), Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	shani@doctors.org.uk						Carrera E, 2004, STROKE, V35, P2826, DOI 10.1161/01.STR.0000147039.49252.2f; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; WINSLOW F, 1868, OBSCURE DIS BRAIN DI	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1290	1290		10.1016/S0140-6736(06)68544-9	http://dx.doi.org/10.1016/S0140-6736(06)68544-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631885				2022-12-28	WOS:000236913400034
J	Silove, D; Zwi, AB; le Touze, D				Silove, D; Zwi, AB; le Touze, D			Do truth commissions heal? The East Timor experience	LANCET			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; RECONCILIATION COMMISSION; HUMAN-RIGHTS; SURVIVORS; EXPOSURE		Liverpool Hosp, Mental Hlth Ctr, Psychiat Res & Teaching Unit, Liverpool, NSW 2170, Australia; Sydney S W Area Hlth Serv, Ctr Populat Mental Hlth Res, Sydney, NSW, Australia; Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	Liverpool Hospital; University of New South Wales Sydney; University of New South Wales Sydney	Silove, D (corresponding author), Liverpool Hosp, Mental Hlth Ctr, Psychiat Res & Teaching Unit, Liverpool, NSW 2170, Australia.	d.silove@unsw.edu.au	Zwi, Anthony/AAP-7026-2021; Zwi, Anthony/AAP-8731-2020	Zwi, Anthony/0000-0001-6902-6602; 				Becker DF, 1999, J AM ACAD CHILD PSY, V38, P775, DOI 10.1097/00004583-199906000-00027; Bryant RA, 2003, J CONSULT CLIN PSYCH, V71, P706, DOI 10.1037/0022-006X.71.4.706; Kaminer D, 2001, BRIT J PSYCHIAT, V178, P373, DOI 10.1192/bjp.178.4.373; LEOPOLD E, 2006, WEEKEND AUSTR   0121; LETOUZE D, 2005, INTERVENTION, V3, P192; Modvig J, 2000, LANCET, V356, P1763, DOI 10.1016/S0140-6736(00)03218-9; Neuner F, 2004, J CONSULT CLIN PSYCH, V72, P579, DOI 10.1037/0022-006X.72.4.579; RICHET C, 1905, ARCH INT PHYSL, V3, P203; Silove D, 1999, LANCET, V353, P2067, DOI 10.1016/S0140-6736(99)00105-1; Swartz L, 2000, ETHNIC HEALTH, V5, P205, DOI 10.1080/713667455	10	19	19	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2006	367	9518					1222	1224		10.1016/S0140-6736(06)68519-X	http://dx.doi.org/10.1016/S0140-6736(06)68519-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631864				2022-12-28	WOS:000236913400008
J	von Boehmer, H				von Boehmer, H			Immunology - Thoracic thymus, exclusive no longer	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu						Boehm T, 2003, IMMUNOL REV, V195, P15, DOI 10.1034/j.1600-065X.2003.00070.x; GOOD RA, 1962, J EXP MED, V116, P733; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; LAW LW, 1962, WIST I S PHIL PA; MATSUYAMA M, 1966, J EXP MED, V123, P559, DOI 10.1084/jem.123.3.559; MILLER JF, 1961, LANCET, V2, P748; Miller JFAP, 2006, NAT IMMUNOL, V7, P3, DOI 10.1038/ni0106-3; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9	9	5	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					206	207		10.1126/science.1126403	http://dx.doi.org/10.1126/science.1126403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614204				2022-12-28	WOS:000236765300030
J	Berry, DA; Cirrincione, C; Henderson, IC; Citron, ML; Budman, DR; Goldstein, LJ; Martino, S; Perez, EA; Muss, HB; Norton, L; Hudis, C; Winer, EP				Berry, DA; Cirrincione, C; Henderson, IC; Citron, ML; Budman, DR; Goldstein, LJ; Martino, S; Perez, EA; Muss, HB; Norton, L; Hudis, C; Winer, EP			Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; TAMOXIFEN THERAPY; TRASTUZUMAB; RECURRENCE; COMBINATION; EXPRESSION; EFFICACY	Context Breast cancer estrogen-receptor (ER) status is useful in predicting benefit from endocrine therapy. It may also help predict which patients benefit from advances in adjuvant chemotherapy. Objective To compare differences in benefits from adjuvant chemotherapy achieved by patients with ER-negative vs ER-positive tumors. Design, Setting, and Patients Trial data from the Cancer and Leukemia Group B and US Breast Cancer Intergroup analyzed; patient outcomes by ER status compared using hazards over time and multivariate models. Randomized trials comparing (1): 3 regimens of cyclophosphamide, doxorubicin, and fluorouracil (January 1985 to April 1991); (2) 3 doses of doxorubicin concurrent with cyclophosphamide, with or without subsequent paclitaxel (May 1994 to April 1997); (3) sequential doxorubicin, paclitaxel, and cyclophosphamide with concurrent doxorubicin and cyclophosphamide followed by paclitaxel, and also 3-week vs 2-week cycles (September 1997 to March 1999). A total of 6644 node-positive breast cancer patients received adjuvant treatment. Main Outcome Measures Disease-free and overall survival. Results For ER-negative tumors, chemotherapy improvements reduced the relative risk of recurrence by 21%, 25%, and 23% in the 3 studies, respectively, and 55% comparing the lowest dose in the first study with biweekly cycles in the third study. Corresponding relative risk reductions for ER-positive tumors treated with tamoxifen were 9%, 12%, and 8% in the 3 studies, and 26% overall. The overall mortality rate reductions associated with chemotherapy improvements were 55% and 23% among ER-negative and ER-positive patients, respectively. All individual ER-negative comparisons and no ER-positive comparisons were statistically significant. Absolute benefits due to chemotherapy were greater for patients with ER-negative compared with ER-positive tumors: 22.8% more ER-negative patients survived to 5 years disease-free if receiving chemotherapy vs 7.0% for ER-positive patients; corresponding improvements for overall survival were 16.7% vs 4.0%. Conclusion Among patients with node-positive tumors, ER-negative breast cancer, biweekly doxorubicin/cyclophosphamide plus paclitaxel lowers the rate of recurrence and death by more than 50% in comparison with low-dose cyclophosphamide, doxorubicin, and fluorouracil as used in the first study.	Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA; Canc & Leukemia Grp B Stat Ctr, Durham, NC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Albert Einstein Coll Med, Lake Success, NY USA; N Shore Univ Hosp, Manhasset, NY USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Angeles Clin & Res Inst, Santa Monica, CA USA; Mayo Clin & Mayo Fdn, Jacksonville, FL USA; Univ Vermont, Vermont Reg Canc Ctr, Burlington, VT USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Yeshiva University; Northwell Health; North Shore University Hospital; Fox Chase Cancer Center; Angeles Clinic & Research Institute; Mayo Clinic; University of Vermont; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Berry, DA (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, 1515 Holcombe Blvd,Unit 447, Houston, TX 77030 USA.	dberry@mdanderson.org	Hudis, Clifford/AAW-9482-2021; Wardley, Andrew/N-8135-2015	Hudis, Clifford/0000-0001-7144-8791; Wardley, Andrew/0000-0002-9639-0888; Norton, Larry/0000-0003-3701-9250	NCI NIH HHS [U10 CA031946, U10 CA033601, U01 CA088278, CA31946] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA031946, U01CA088278, U10CA033601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ALBAIN K, 2004, BREAST CANC RES T S1, V88; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Ballesteros J, 2005, J CLIN PSYCHOPHARM, V25, P127, DOI 10.1097/01.jcp.0000155826.05327.c1; Baum M, 2002, LANCET, V359, P2131; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry DA, 2003, AM HEART J, V145, P1036, DOI 10.1016/S0002-8703(03)00106-6; BERRY DA, 1990, BIOMETRICS, V46, P1227; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; BUZDAR AU, 2003, 26 ANN SAN ANT BREAS; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; DOMINICI F, 2000, METANALYSIS MED HLTH, P112; Emens LA, 2004, ONCOLOGY-NY, V18, P1117; GIANNI L, 2004, J CLIN ONCOL S14, V22; Goldhirsch A, 2002, JNCI-J NATL CANCER I, V94, P1054; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; Jones Robin L, 2004, Expert Opin Drug Saf, V3, P317, DOI 10.1517/14740338.3.4.317; Mann GB, 2005, J CLIN ONCOL, V23, P5148, DOI 10.1200/JCO.2005.02.076; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; Paik S, 2004, BREAST CANCER RES TR, V88, pS15; Perez EA, 2005, J CLIN ONCOL, V23, p17S; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; ROBINSON A, 2005, J CLIN ONCOL, V23, P500; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rueckert S, 2005, EXPERT OPIN BIOL TH, V5, P853, DOI 10.1517/14712598.5.6.853; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; Tan AR, 2003, SEMIN ONCOL, V30, P54, DOI 10.1053/j.seminoncol.2003.08.008; Thor AD, 1998, JNCI-J NATL CANCER I, V90, P1346, DOI 10.1093/jnci/90.18.1346	34	535	570	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1658	1667		10.1001/jama.295.14.1658	http://dx.doi.org/10.1001/jama.295.14.1658			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609087	Bronze, Green Accepted			2022-12-28	WOS:000236707300021
J	Beasley, R; McNaughton, A; Robinson, G				Beasley, R; McNaughton, A; Robinson, G			New look at the oxyhaemoglobin dissociation curve	LANCET			English	Editorial Material							SUPPLEMENTAL OXYGEN; MYOCARDIAL-INFARCTION; ACUTE EXACERBATIONS; CONTROLLED-TRIAL; HYPEROXIA; VENTILATION; INFANTS; AUDIT; AIR		Med Res Inst New Zealand, Wellington 6001, New Zealand; Univ Southampton, Sch Med, Southampton, Hants, England	Medical Research Institute Of New Zealand; University of Southampton	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6001, New Zealand.	richard.beasley@mrinz.ac.nz	Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X				ALBIN RJ, 1992, CHEST, V102, P1672, DOI 10.1378/chest.102.6.1672; BARON JF, 1990, AM J PHYSIOL, V258, pH1388, DOI 10.1152/ajpheart.1990.258.5.H1388; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Denniston AKO, 2002, CLIN MED, V2, P449, DOI 10.7861/clinmedicine.2-5-449; Dodd ME, 2000, BRIT MED J, V321, P864, DOI 10.1136/bmj.321.7265.864; Downs JB, 1999, CRIT CARE MED, V27, P2844, DOI 10.1097/00003246-199912000-00050; Downs John B, 2003, Respir Care, V48, P611; GARNER WL, 1989, SURGERY, V105, P747; Haque WA, 1996, J AM COLL CARDIOL, V27, P353, DOI 10.1016/0735-1097(95)00474-2; KENMURE ACF, 1968, BMJ-BRIT MED J, V4, P360, DOI 10.1136/bmj.4.5627.360; Kor A. C., 2000, Annals Academy of Medicine Singapore, V29, P177; NIIJIMA S, 1988, ARCH DIS CHILD-FETAL, V63, P1126, DOI 10.1136/adc.63.10_Spec_No.1126; Plant PK, 2000, THORAX, V55, P550, DOI 10.1136/thorax.55.7.550; RAWLES JM, 1976, BMJ-BRIT MED J, V1, P1121, DOI 10.1136/bmj.1.6018.1121; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Thomson AJ, 2002, BMJ-BRIT MED J, V324, P1406, DOI 10.1136/bmj.324.7351.1406; WAGNER PD, 1974, J CLIN INVEST, V54, P54, DOI 10.1172/JCI107750	17	23	23	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2006	367	9517					1124	1126		10.1016/S0140-6736(06)68488-2	http://dx.doi.org/10.1016/S0140-6736(06)68488-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616545				2022-12-28	WOS:000236673400007
J	de Pater, I; Hammel, HB; Gibbard, SG; Showalter, MR				de Pater, I; Hammel, HB; Gibbard, SG; Showalter, MR			New dust belts of Uranus: One ring, two ring, red ring, blue ring	SCIENCE			English	Article							SATURNS E-RING; PHOTOMETRY; SATELLITES	We compared near-infrared observations of the recently discovered outer rings of Uranus with Hubble Space Telescope results. We find that the inner ring, R/2003 U 2, is red, whereas the outer ring, R/2003 U 1, is very blue. Blue is an unusual color for rings; Saturn's enigmatic E ring is the only other known example. By analogy to the E ring, R/2003 U 1 is probably produced by impacts into the embedded moon Mab, which apparently orbits at a location where nongravitational perturbations favor the survival and spreading of submicron-sized dust. R/2003 U 2 more closely resembles Saturn's G ring, which is red, a typical color for dusty rings.	Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Space Sci Inst, Boulder, CO 80301 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; SETI Inst, Mountain View, CA 94043 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	de Pater, I (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	imke@astron.berkeley.edu						Burns JA, 2001, ASTR AST LI, P641; de Pater I, 2006, ICARUS, V180, P186, DOI 10.1016/j.icarus.2005.08.011; de Pater I, 2004, ICARUS, V172, P446, DOI 10.1016/j.icarus.2004.07.012; French R. G., 1991, URANUS, P327; Gibbard SG, 2005, ICARUS, V174, P253, DOI 10.1016/j.icarus.2004.09.008; HEDMAN MM, 2005, BAAS, V37; HORANYI M, 1992, ICARUS, V97, P248, DOI 10.1016/0019-1035(92)90131-P; JOHNSON T, 2005, AM GEOPH UN FALL M S; JUHASZ A, 2002, J GEOPHYS RES, V107, P1, DOI DOI 10.1029/2001JA000182; Karkoschka E, 2001, ICARUS, V151, P51, DOI 10.1006/icar.2001.6596; SHOWALTER MR, 1993, ICARUS, V103, P124, DOI 10.1006/icar.1993.1062; Showalter MR, 2006, SCIENCE, V311, P973, DOI 10.1126/science.1122882; SHOWALTER MR, 1991, ICARUS, V94, P451, DOI 10.1016/0019-1035(91)90241-K; Throop HB, 1998, ICARUS, V131, P152, DOI 10.1006/icar.1997.5851; VANALLEN JA, 1980, SCIENCE, V207, P415, DOI 10.1126/science.207.4429.415	15	33	33	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					92	94		10.1126/science.1125110	http://dx.doi.org/10.1126/science.1125110			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601188	Green Submitted			2022-12-28	WOS:000236584400037
J	Vig, M; Peinelt, C; Beck, A; Koomoa, DL; Rabah, D; Koblan-Huberson, M; Kraft, S; Turner, H; Fleig, A; Penner, R; Kinet, JP				Vig, M.; Peinelt, C.; Beck, A.; Koomoa, D. L.; Rabah, D.; Koblan-Huberson, M.; Kraft, S.; Turner, H.; Fleig, A.; Penner, R.; Kinet, J. -P.			CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry	SCIENCE			English	Article							CALCIUM CURRENT; T-LYMPHOCYTES; MAST-CELLS; DEPLETION; CHANNELS; STIM1; ACTIVATION; INFLUX; SENSOR	Store-operited Ca2+ entry is mediated by Ca2+ release-activated Ca2+ (CRAC) channels following Ca2+ release from intracellular stores. We performed a genome-wide RNA interference (RNAi) screen in Drosophila cells to identify proteins that inhibit store-operated Ca2+ influx. A secondary patch-clamp screen identified CRACM1 and CRACM2 (CRAC modulators 1 and 2) as modulators of Drosophila CRAC currents. We characterized the human ortholog of CRACM1, a plasma membrane-resident protein encoded by gene FLJ14466. Although overexpression of CRACM1 did not affect CRAC currents, RNAi-mediated knockdown disrupted its activation. CRACM1 could be the CRAC channel itself, a subunit of it, or a component of the CRAC signaling machinery.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Honolulu, HI 96813 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Hawaii System; The Queen's Medical Center; University of Hawaii System	Vig, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	mvig@bidmc.harvard.edu; rpenner@hawaii.edu; jkinet@bidmc.harvard.edu	Peinelt, Christine/ABH-5292-2020	Fleig, Andrea/0000-0001-8396-7249; Vig, Monika/0000-0002-4770-8853; Penner, Reinhold/0000-0002-5366-1537; Peinelt, Christine/0000-0002-3474-6893	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065360, R37GM053950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050200, R01-AI050200] Funding Source: Medline; NIGMS NIH HHS [R37 GM053950, 5-R37-GM053950, R01 GM065360, R01-GM065360] Funding Source: Medline; NINDS NIH HHS [R01 NS040927, R01-NS040927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	15	1056	1096	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1220	1223		10.1126/science.1127883	http://dx.doi.org/10.1126/science.1127883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16645049	Green Accepted			2022-12-28	WOS:000237957400056
J	Bohlenius, H; Huang, T; Charbonnel-Campaa, L; Brunner, AM; Jansson, S; Strauss, SH; Nilsson, O				Bohlenius, H; Huang, T; Charbonnel-Campaa, L; Brunner, AM; Jansson, S; Strauss, SH; Nilsson, O			CO/FT regulatory module controls timing of flowering and seasonal growth cessation in trees	SCIENCE			English	Article							ASPEN POPULUS-TREMULA; BUD SET; BLACK COTTONWOOD; CANDIDATE GENE; SHOOT APEX; ARABIDOPSIS; PHYTOCHROME; FT; INDUCTION; PROTEIN	Forest trees display a perennial growth behavior characterized by a multiple-year delay in flowering and, in temperate regions, an annual cycling between growth and dormancy. We show here that the CO/FT regulatory module, which controls flowering time in response to variations in daylength in annual plants, controls flowering in aspen trees. Unexpectedly, however, it also controls the short-day-induced growth cessation and bud set occurring in the fall. This regulatory mechanism can explain the ecogenetic variation in a highly adaptive trait: the critical daylength for growth cessation displayed by aspen trees sampled across a latitudinal gradient spanning northern Europe.	Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; Virginia Polytech Inst & State Univ, Virginia Tech, Dept Forestry, Blacksburg, VA 24061 USA; Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, S-90187 Umea, Sweden; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA	Swedish University of Agricultural Sciences; Umea University; Virginia Polytechnic Institute & State University; Umea University; Oregon State University	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden.	Ove.Nilsson@genfys.slu.se	Jansson, Stefan/A-1119-2009	Jansson, Stefan/0000-0002-7906-6891; Nilsson, Ove/0000-0002-1033-1909				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Frewen BE, 2000, GENETICS, V154, P837; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Howe GT, 1996, PHYSIOL PLANTARUM, V97, P95, DOI 10.1111/j.1399-3054.1996.tb00484.x; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Howe GT, 1998, MOL BIOL EVOL, V15, P160, DOI 10.1093/oxfordjournals.molbev.a025912; Huang T, 2005, SCIENCE, V309, P1694, DOI 10.1126/science.1117768; Ingvarsson PK, 2006, GENETICS, V172, P1845, DOI 10.1534/genetics.105.047522; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Olsen JE, 1997, PLANT J, V12, P1339, DOI 10.1046/j.1365-313x.1997.12061339.x; PAULEY S. S., 1954, Journal of the Arnold Arboretum, V35, P167; Pineiro M, 2003, PLANT CELL, V15, P1552, DOI 10.1105/tpc.012153; Rottmann WH, 2000, PLANT J, V22, P235, DOI 10.1046/j.1365-313x.2000.00734.x; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; WEISER CJ, 1970, SCIENCE, V169, P1299; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	21	745	837	27	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1040	1043		10.1126/science.1126038	http://dx.doi.org/10.1126/science.1126038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16675663				2022-12-28	WOS:000237628800042
J	Wisniewska, J; Xu, J; Seifertova, D; Brewer, PB; Ruzicka, K; Blilou, I; Rouquie, D; Benkova, E; Scheres, B; Friml, J				Wisniewska, J; Xu, J; Seifertova, D; Brewer, PB; Ruzicka, K; Blilou, I; Rouquie, D; Benkova, E; Scheres, B; Friml, J			Polar PIN localization directs auxin flow in plants	SCIENCE			English	Article							ARABIDOPSIS; GRAVITROPISM; GRADIENTS; TRANSPORT		Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland	Eberhard Karls University of Tubingen; Utrecht University; Nicolaus Copernicus University	Friml, J (corresponding author), Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany.	jiri.friml@zmbp.uni-tuebingen.de	Ruzicka, Kamil/AAT-1798-2020; Ruzicka, Kamil/E-3727-2012; Xu, Jian/I-2921-2012; Wisniewska, Justyna/D-4351-2009; Brewer, Philip B/C-6562-2008; Friml, Jiri/D-9511-2012; Benkova, Eva/E-2910-2012	Ruzicka, Kamil/0000-0002-0602-2046; Ruzicka, Kamil/0000-0002-0602-2046; Xu, Jian/0000-0001-6194-6316; Brewer, Philip B/0000-0003-4871-9260; Friml, Jiri/0000-0002-8302-7596; Scheres, Ben/0000-0001-5400-9578				Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Kepinski S, 2005, CURR BIOL, V15, pR208, DOI 10.1016/j.cub.2005.03.012; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Swarup R, 2003, DEV CELL, V5, P824, DOI 10.1016/S1534-5807(03)00370-8	7	640	677	4	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					883	883		10.1126/science.1121356	http://dx.doi.org/10.1126/science.1121356			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16601151				2022-12-28	WOS:000237452900038
J	Roberts, DM; Nanda, A; Havenga, MJE; Abbink, P; Lynch, DM; Ewald, BA; Liu, J; Thorner, AR; Swanson, PE; Gorgone, DA; Lifton, MA; Lemckert, AAC; Holterman, L; Chen, B; Dilraj, A; Carville, A; Mansfield, KG; Goudsmit, J; Barouch, DH				Roberts, DM; Nanda, A; Havenga, MJE; Abbink, P; Lynch, DM; Ewald, BA; Liu, J; Thorner, AR; Swanson, PE; Gorgone, DA; Lifton, MA; Lemckert, AAC; Holterman, L; Chen, B; Dilraj, A; Carville, A; Mansfield, KG; Goudsmit, J; Barouch, DH			Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity	NATURE			English	Article							NEUTRALIZING ANTIBODIES; RECOMBINANT ADENOVIRUS; RHESUS-MONKEYS; VACCINE VECTOR; PROTEIN; GENE; IMMUNOGENICITY; VIRUS; RESOLUTION; INFECTION	A common viral immune evasion strategy involves mutating viral surface proteins in order to evade host neutralizing antibodies. Such immune evasion tactics have not previously been intentionally applied to the development of novel viral gene delivery vectors that overcome the critical problem of anti-vector immunity. Recombinant, replication-incompetent adenovirus serotype 5 (rAd5) vector-based vaccines for human immunodeficiency virus type 1 and other pathogens have proved highly immunogenic in preclinical studies(1,2) but will probably be limited by the high prevalence of pre-existing anti-Ad5 immunity in human populations, particularly in the developing world(3-6). Here we show that rAd5 vectors can be engineered to circumvent anti-Ad5 immunity. We constructed novel chimaeric rAd5 vectors in which the seven short hypervariable regions (HVRs) on the surface of the Ad5 hexon protein were replaced with the corresponding HVRs from the rare adenovirus serotype Ad48. These HVR-chimaeric rAd5 vectors were produced at high titres and were stable through serial passages in vitro. HVR-chimaeric rAd5 vectors expressing simian immunodeficiency virus Gag proved comparably immunogenic to parental rAd5 vectors in naive mice and rhesus monkeys. In the presence of high levels of pre-existing anti-Ad5 immunity, the immunogenicity of HVR-chimaeric rAd5 vectors was not detectably suppressed, whereas the immunogenicity of parental rAd5 vectors was abrogated. These data demonstrate that functionally relevant Ad5-specific neutralizing antibodies are focused on epitopes located within the hexon HVRs. Moreover, these studies show that recombinant viral vectors can be engineered to circumvent pre-existing anti-vector immunity by removing key neutralizing epitopes on the surface of viral capsid proteins. Such chimaeric viral vectors may have important practical implications for vaccination and gene therapy.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; Crucell Holland BV, NL-2301 CA Leiden, Netherlands; Harvard Univ, Sch Med, Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; S African MRC, ZA-4001 Durban, South Africa; New England Reg Primate Res Ctr, Southborough, MA 01772 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johnson & Johnson; Harvard University; Boston Children's Hospital; Harvard Medical School; South African Medical Research Council	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019					ATHAPPILLY FK, 1994, J MOL BIOL, V242, P430, DOI 10.1006/jmbi.1994.1593; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Gahery-Segard H, 1998, J VIROL, V72, P2388; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Havenga MJE, 2001, J VIROL, V75, P3335, DOI 10.1128/JVI.75.7.3335-3342.2001; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988; Youil R, 2002, HUM GENE THER, V13, P311, DOI 10.1089/10430340252769824	22	373	412	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					239	243		10.1038/nature04721	http://dx.doi.org/10.1038/nature04721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16625206				2022-12-28	WOS:000237418800051
J	Marty, B				Marty, B			The primordial porridge	SCIENCE			English	Editorial Material							SOLAR-SYSTEM; NITROGEN		Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France	Universite de Lorraine	Marty, B (corresponding author), Ctr Rech Petrog & Geochim, BP 20, F-54501 Vandoeuvre Les Nancy, France.	bmarty@crpg.cnrs-nancy.fr						Aleon J, 2005, NATURE, V437, P385, DOI 10.1038/nature03947; BROWNLEE DE, 2006, 37 LUN PLAN SCI C 13; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Messenger S, 2003, SPACE SCI REV, V106, P155, DOI 10.1023/A:1024637704533; Remusat L, 2006, EARTH PLANET SC LETT, V243, P15, DOI 10.1016/j.epsl.2005.12.010; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x	8	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					706	707		10.1126/science.1125967	http://dx.doi.org/10.1126/science.1125967			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675689				2022-12-28	WOS:000237312100036
J	Bonetta, L				Bonetta, L			An expression of interest	NATURE			English	Article																			0	5	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1233	+		10.1038/4401233a	http://dx.doi.org/10.1038/4401233a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16642003	Bronze			2022-12-28	WOS:000237080000054
J	Cowan, JJ; Sneden, C				Cowan, JJ; Sneden, C			Heavy element synthesis in the oldest stars and the early Universe	NATURE			English	Review							EXTREMELY METAL-POOR; NEUTRON-CAPTURE ELEMENTS; CORE-COLLAPSE SUPERNOVAE; R-PROCESS; MASSIVE STARS; MILKY-WAY; SPECTROSCOPIC ANALYSIS; CHEMICAL-COMPOSITION; ABUNDANCE PATTERN; SURVEY HERES	The first stars in the Universe were probably quite different from those born today. Composed almost entirely of hydrogen and helium (plus a tiny trace of lithium), they lacked the heavier elements that determine the formation and evolution of younger stars. Although we cannot observe the very first stars-they died long ago in supernovae explosions-they created heavy elements that were incorporated into the next generation. Here we describe how observations of heavy elements in the oldest surviving stars in our Galaxy's halo help us understand the nature of the first stars-those responsible for the chemical enrichment of our Galaxy and Universe.	Univ Oklahoma, Homer L Dodge Dept Phys & Astron, Norman, OK 73019 USA; Univ Texas, Dept Astron, Austin, TX 78712 USA; Univ Texas, McDonald Observ, Austin, TX 78712 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Cowan, JJ (corresponding author), Univ Oklahoma, Homer L Dodge Dept Phys & Astron, Norman, OK 73019 USA.	cowan@nhn.ou.edu; chris@verdi.as.utexas.edu						Aoki W, 2002, ASTROPHYS J, V576, pL141, DOI 10.1086/343761; Aoki W, 2003, ASTROPHYS J, V586, P506, DOI 10.1086/367540; Argast D, 2004, ASTRON ASTROPHYS, V416, P997, DOI 10.1051/0004-6361:20034265; Arnone E, 2005, ASTRON ASTROPHYS, V430, P507, DOI 10.1051/0004-6361:20041034; Barklem PS, 2005, ASTRON ASTROPHYS, V439, P129, DOI 10.1051/0004-6361:20052967; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Burris DL, 2000, ASTROPHYS J, V544, P302, DOI 10.1086/317172; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; CAMERON AGW, 1957, PUBL ASTRON SOC PAC, V69, P201, DOI 10.1086/127051; Cayrel R, 2004, ASTRON ASTROPHYS, V416, P1117, DOI 10.1051/0004-6361:20034074; Cayrel R, 2001, NATURE, V409, P691, DOI 10.1038/35055507; Christlieb N, 2004, ASTRON ASTROPHYS, V428, P1027, DOI 10.1051/0004-6361:20041536; Cowan J. J, 2004, CARNEGIE OBSERVATORI, V4, P27; Cowan JJ, 1999, ASTROPHYS J, V521, P194, DOI 10.1086/307512; Cowan JJ, 2005, ASTROPHYS J, V627, P238, DOI 10.1086/429952; COWAN JJ, 1995, ASTROPHYS J, V439, pL51, DOI 10.1086/187742; Cowan JJ, 2004, PHYS TODAY, V57, P47, DOI 10.1063/1.1825268; COWAN JJ, 1991, PHYS REP, V208, P267, DOI 10.1016/0370-1573(91)90070-3; Cowan JJ, 2002, ASTROPHYS J, V572, P861, DOI 10.1086/340347; Dauphas N, 2005, NATURE, V435, P1203, DOI 10.1038/nature03645; Depagne E, 2002, ASTRON ASTROPHYS, V390, P187, DOI 10.1051/0004-6361:20020687; FRANCOIS P, 1993, ASTRON ASTROPHYS, V274, P821; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; FROHLICH C, 2005, ASTROPH0511376; GILROY KK, 1988, ASTROPHYS J, V327, P298, DOI 10.1086/166191; GRATTON RG, 1994, ASTRON ASTROPHYS, V287, P927; Hill V, 2002, ASTRON ASTROPHYS, V387, P560, DOI 10.1051/0004-6361:20020434; Honda S, 2004, ASTROPHYS J, V607, P474, DOI 10.1086/383406; Ishimaru Y, 1999, ASTROPHYS J, V511, pL33, DOI 10.1086/311829; IVANS I, IN PRESS ASTROPHYS J; Iwamoto N, 2005, SCIENCE, V309, P451, DOI 10.1126/science.1112997; Jimenez R, 2003, ASTROPHYS J, V593, P622, DOI 10.1086/376595; Johnson JA, 2002, ASTROPHYS J, V579, P616, DOI 10.1086/342829; Johnson JA, 2001, ASTROPHYS J, V554, P888, DOI 10.1086/321386; Kratz KL, 2004, NEW ASTRON REV, V48, P105, DOI 10.1016/j.newar.2003.11.014; KURUCZ RL, 1984, NAT SOL OBS ALTAS; Lambert DL, 2002, MON NOT R ASTRON SOC, V335, P325, DOI 10.1046/j.1365-8711.2002.05643.x; Langanke K, 2003, REV MOD PHYS, V75, P819, DOI 10.1103/RevModPhys.75.819; Lawler JE, 2004, ASTROPHYS J, V604, P850, DOI 10.1086/382068; LAWLER JE, IN PRESS ASTROPHYS J; MATHEWS GJ, 1992, ASTROPHYS J, V391, P719, DOI 10.1086/171383; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; Norris JE, 2001, ASTROPHYS J, V561, P1034, DOI 10.1086/323429; O'Brien S, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.035801; PAGEL BEJ, 1989, EVOLUTIONARY PHENOMENA IN GALAXIES, P201; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pfeiffer B, 1997, Z PHYS A-HADRON NUCL, V357, P235, DOI 10.1007/s002180050237; Plez B, 2004, ASTRON ASTROPHYS, V428, pL9, DOI 10.1051/0004-6361:200400094; Prochaska JX, 2003, NATURE, V423, P57, DOI 10.1038/nature01524; Qian YZ, 2002, ASTROPHYS J, V567, P515, DOI 10.1086/338277; Qian YZ, 2002, ASTROPHYS J, V569, pL61, DOI 10.1086/340641; Ryan SG, 1996, ASTROPHYS J, V471, P254, DOI 10.1086/177967; Schatz H, 2002, ASTROPHYS J, V579, P626, DOI 10.1086/342939; Shetrone M, 2003, ASTRON J, V125, P684, DOI 10.1086/345966; SNEDEN C, 1983, ASTROPHYS J, V267, P757, DOI 10.1086/160913; SNEDEN C, 1985, ASTROPHYS J, V288, pL55, DOI 10.1086/184421; Sneden C, 1996, ASTROPHYS J, V467, P819, DOI 10.1086/177656; Sneden C, 2003, ASTROPHYS J, V591, P936, DOI 10.1086/375491; Sneden C, 2000, ASTROPHYS J, V536, pL85, DOI 10.1086/312742; Sneden C, 2003, SCIENCE, V299, P70, DOI 10.1126/science.1077506; Sneden C, 2002, ASTROPHYS J, V566, pL25, DOI 10.1086/339471; SNEDEN C, 2000, APJ, V533, P139; SPITE M, 1978, ASTRON ASTROPHYS, V67, P23; Tegmark M, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.103501; Thielemann F.-K., 2000, Memorie della Societa Astronomica Italiana, V71, P483; Thompson TA, 2003, ASTROPHYS J, V585, pL33, DOI 10.1086/374261; Travaglio C, 2004, ASTROPHYS J, V601, P864, DOI 10.1086/380507; Truran JW, 2002, PUBL ASTRON SOC PAC, V114, P1293, DOI 10.1086/344585; Wanajo S, 2002, ASTROPHYS J, V577, P853, DOI 10.1086/342230; Wasserburg GJ, 2000, ASTROPHYS J, V529, pL21, DOI 10.1086/312455; WASSERBURG GJ, 1996, APJ, V466, P109; Westin J, 2000, ASTROPHYS J, V530, P783, DOI 10.1086/308407; WHEELER JC, 1998, APJ, V493, P101; WOOLF VM, 1995, ASTROPHYS J, V453, P660, DOI 10.1086/176428; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1994, ASTROPHYS J, V433, P229, DOI 10.1086/174638	82	101	104	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1151	1156		10.1038/nature04807	http://dx.doi.org/10.1038/nature04807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641987				2022-12-28	WOS:000237080000036
J	Maisel, WH				Maisel, WH			Pacemaker and ICD generator reliability - Meta-analysis of device registries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review								Context Despite there being millions of pacemaker and implantable cardioverter-defibrillator (ICD) generator implants worldwide, little is known about device reliability. Objectives To perform a meta-analysis of prospective pacemaker and ICD registries to determine annual rates of pacemaker and ICD malfunction and to identify trends in these rates. Data Sources MEDLINE (January 1966 to April 2005), the Cochrane Central Register of Controlled Trials (through second quarter 2005), the Cochrane Database of Systematic Reviews (through second quarter 2005), and a bibliographic review of secondary sources. Search terms included pacemaker, artificial; defibrillators, implantable; registries; performance; and malfunction. Study Selection Eligible registries were prospective; reported the number of patients with pacemaker, ICD, or both; and allowed determination of the annual number of device malfunctions. Of 1007 references screened, 3 registries meeting the selection criteria were identified and included 2.1 million pacemaker person-years and 14821 ICD person-years of observation. Data Extraction Included the annual number of patients with pacemakers and ICDs at risk of device failure and the annual number of generator malfunctions (1983-2004 for pacemakers, 1988-2004 for ICDs). A device malfunction was defined as an integral component failure that required device explantation prior to reaching elective replacement. Failures of pacemaker and ICD electrodes were not included in the study. Data Synthesis There were 2981 pacemaker and 384 ICD generator malfunctions. Pacemaker reliability improved markedly during the 1980s (P for trend <.001) and the pacemaker malfunction rate remained low during the remainder of the study. Implantable cardioverter-defibrillator reliability improved during the first 10 study years (P for trend <.001). From 1998-2002, however, the ICD malfunction rate increased more than 4-fold (P for trend <.001), before decreasing substantially in the latter 2 years of the study. Overall, the mean (SE) annual ICD malfunction rate was about 20-fold higher than the pacemaker malfunction rate (26.5 [3.8] vs 1.3 [0.1] malfunctions per 1000 person-years, P<.001). Battery malfunctions were the most common cause of device failure. Conclusions Pacemaker reliability has improved markedly. In contrast, after more than a decade of improving device reliability, the ICD malfunction rate transiently increased before experiencing substantial reductions in the latter 2 study years. Whether increasing device sophistication accounts for the observed decrease in reliability is not known. Continued monitoring of pacemaker and ICD performance is required.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Maisel, WH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc, 185 Pilgrim Rd,Baker 4, Boston, MA 02215 USA.	wmaisel@bidmc.harvard.edu						BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; *DAN PAC REG, 2002, DAN PAC ICD REG 2004; *GUID CORP, PHYS COMM PROV IMP S; JEFFREY K, 2001, MACHINES OUR HEARTS, P223; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P955, DOI 10.1001/jama.294.8.955; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Maisel WH, 2002, PACE, V25, P1670, DOI 10.1046/j.1460-9592.2002.01670.x; Maisel WH, 2001, JAMA-J AM MED ASSOC, V286, P793, DOI 10.1001/jama.286.7.793; MEIER B, 2005, NY TIMES        0524, P1; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; *NAT PAC DAT, 2001, NAT PAC ICD DAT ANN; SONG SL, 1994, PACE, V17, P692, DOI 10.1111/j.1540-8159.1994.tb02410.x; *US FDA, MEDTR ISS NOT REG CE; 2005, MED DEVICES DIAGNOST, V31, P5	15	113	114	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1929	1934		10.1001/jama.295.16.1929	http://dx.doi.org/10.1001/jama.295.16.1929			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639052				2022-12-28	WOS:000237059200028
J	Blakemore, C; Davidson, J				Blakemore, C; Davidson, J			Putting a value on medical research	LANCET			English	Editorial Material									MRC, London W1B 1AL, England		Blakemore, C (corresponding author), MRC, London W1B 1AL, England.	colin.blakemore@headoffice.mrc.ac.uk		Blakemore, Colin/0000-0003-2659-7899				*AC MED SERV MED R, IN PRESS MED RES ASS; Access Economics, 2003, ACC EC EXC RET VAL I; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; CROFTON J, 2004, MRC RANDOMISED TRIAL; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; FREDRICKSON DS, 1980, CONTROL CLIN TRIALS, V1, P263, DOI 10.1016/0197-2456(80)90006-9; *FUND FIRST, 2000, EXC RET EC VAL AM IN; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; LEWIS CA, 1992, ANN NY ACAD SCI, V669, P360; Martin J A, 1999, Natl Vital Stat Rep, V47, P1; Oakley GP, 2002, BRIT MED J, V324, P1348, DOI 10.1136/bmj.324.7350.1348; Rosenberg LE, 2002, MED J AUSTRALIA, V177, P368, DOI 10.5694/j.1326-5377.2002.tb04840.x; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Topel R, 2003, MEASURING GAINS MED; Tuberculosis Trials Committee iMRCS, 1948, BMJ, V2, P769	17	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1293	1295		10.1016/S0140-6736(06)68552-8	http://dx.doi.org/10.1016/S0140-6736(06)68552-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631892				2022-12-28	WOS:000237118500004
J	Lapsley, P				Lapsley, P			Commentary: The double benefits of educational programmes for patients with eczema	BRITISH MEDICAL JOURNAL			English	Editorial Material									Skin Care Campaign, London N19 5NA, England		Lapsley, P (corresponding author), Skin Care Campaign, Highgate Hill, London N19 5NA, England.	plapsley@eczema.org						*ALL PART PARL GRO, 2004, ENQ DERM TRAIN HLTH; Beattie PE, 2003, CLIN EXP DERMATOL, V28, P549, DOI 10.1046/j.1365-2230.2003.01357.x; Charman CR, 2000, BRIT J DERMATOL, V142, P931, DOI 10.1046/j.1365-2133.2000.03473.x; STABB D, 2006, BMJ-BRIT MED J, V332, P933	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 22	2006	332	7547					936	936		10.1136/bmj.332.7547.936	http://dx.doi.org/10.1136/bmj.332.7547.936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627510	Green Published, Bronze			2022-12-28	WOS:000237143900013
J	DeRouen, TA; Martin, MD; Leroux, BG; Townes, BD; Woods, JS; Leitao, J; Castro-Caldas, A; Luis, H; Bernardo, M; Rosenbaum, G; Martins, IP				DeRouen, TA; Martin, MD; Leroux, BG; Townes, BD; Woods, JS; Leitao, J; Castro-Caldas, A; Luis, H; Bernardo, M; Rosenbaum, G; Martins, IP			Neurobehavioral effects of dental amalgam in children - A randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONGITUDINAL DATA; RESTORATIONS; MERCURY; SAMPLES; DESIGN; URINE; TEETH	Context Dental ( silver) amalgam is a widely used restorative material containing 50% elemental mercury that emits small amounts of mercury vapor. No randomized clinical trials have determined whether there are significant health risks associated with this low-level mercury exposure. Objective To assess the safety of dental amalgam restorations in children. Design A randomized clinical trial in which children requiring dental restorative treatment were randomized to either amalgam for posterior restorations or resin composite instead of amalgam. Enrollment commenced February 1997, with annual follow-up for 7 years concluding in July 2005. Setting and Participants A total of 507 children in Lisbon, Portugal, aged 8 to 10 years with at least 1 carious lesion on a permanent tooth, no previous exposure to amalgam, urinary mercury level < 10 mu g/L, blood lead level < 15 mu g/dL, Comprehensive Test of Nonverbal Intelligence IQ >= 67, and with no interfering health conditions. Intervention Routine, standard-of-care dental treatment, with one group receiving amalgam restorations for posterior lesions (n= 253) and the other group receiving resin composite restorations instead of amalgam ( n= 254). Main Outcome Measures Neurobehavioral assessments of memory, attention/ concentration, and motor/visuomotor domains, as well as nerve conduction velocities. Results During the 7-year trial period, children had a mean of 18.7 tooth surfaces ( median, 16) restored in the amalgam group and 21.3 ( median, 18) restored in the composite group. Baseline mean creatinine-adjusted urinary mercury levels were 1.8 mu g/g in the amalgam group and 1.9 mu g/g in the composite group, but during follow-up were 1.0 to 1.5 mu g/g higher in the amalgam group than in the composite group ( P <. 001). There were no statistically significant differences in measures of memory, attention, visuomotor function, or nerve conduction velocities ( average z scores were very similar, near zero) for the amalgam and composite groups over all 7 years of follow-up, with no statistically significant differences observed at any time point ( P values from .29 to .91). Starting at 5 years after initial treatment, the need for additional restorative treatment was approximately 50% higher in the composite group. Conclusions In this study, children who received dental restorative treatment with amalgam did not, on average, have statistically significant differences in neurobehavioral assessments or in nerve conduction velocity when compared with children who received resin composite materials without amalgam. These findings, combined with the trend of higher treatment need later among those receiving composite, suggest that amalgam should remain a viable dental restorative option for children.	Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Oral Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; Battelle Ctr Publ Hlth Res & Evaluat, Seattle, WA USA; Univ Lisbon, Fac Med Dent, P-1699 Lisbon, Portugal; Univ Lisbon, Fac Med, P-1699 Lisbon, Portugal; Univ Catolica Portuguesa, Inst Hlth Sci, Lisbon, Portugal	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universidade de Lisboa; Universidade de Lisboa; Universidade Catolica Portuguesa	DeRouen, TA (corresponding author), Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Box 357480, Seattle, WA 98195 USA.	derouen@u.washington.edu	Leroux, Brian G/H-2254-2015; Martins, Isabel Pavao/ABF-9729-2020; Bernardo, Mário/C-6675-2018; Castro-Caldas, Alexandre/M-4156-2013; Luis, Henrique/I-7551-2018	Martins, Isabel Pavao/0000-0002-9611-7400; Bernardo, Mário/0000-0002-9204-7230; Castro-Caldas, Alexandre/0000-0002-9148-3719; Luis, Henrique/0000-0002-1092-7825	NIDCR NIH HHS [U01 DE11894, U01 DE011894] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE011894] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Agency for Toxic Substances and Disease Registry, 1999, TOX PROF MERC; BOWERS MA, 1992, J LAB CLIN MED, V120, P272; Brown R, 2005, POLYM TEST, V24, P1, DOI 10.1016/j.polymertesting.2004.10.001; CORNS WT, 1994, ANALYST, V119, P2481, DOI 10.1039/an9941902481; DeRouen TA, 2002, CONTROL CLIN TRIALS, V23, P301, DOI 10.1016/S0197-2456(01)00206-9; Dye BA, 2005, OCCUP ENVIRON MED, V62, P368, DOI 10.1136/oem.2004.016832; FRIBERG L, 1973, MERCURY MERCURIALS M; HARRISON DJ, 1989, J CLIN PATHOL, V42, P624, DOI 10.1136/jcp.42.6.624; Leroux BG, 2005, STAT METHODS MED RES, V14, P591, DOI 10.1191/0962280205sm421oa; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mackert JR, 1997, CRIT REV ORAL BIOL M, V8, P410, DOI 10.1177/10454411970080040401; Martin MD, 2005, ORAL SURG ORAL MED O, V99, P429; Martins IP, 2005, INT J NEUROSCI, V115, P1687, DOI 10.1080/00207450590958556; McKinlay SM, 2003, CONTROL CLIN TRIALS, V24, P795, DOI 10.1016/S0197-2456(03)00105-3; Mjor IA, 2002, ACTA ODONTOL SCAND, V60, P25, DOI 10.1080/000163502753471961; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Ritchie KA, 2004, BRIT DENT J, V197, P625, DOI 10.1038/sj.bdj.4811831; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sjogren P, 2002, SWED DENT J, V26, P59; Townes B. D., 2003, PSYCHOLOGICA, V34, P177; Van Nieuwenhuysen JP, 2003, J DENT, V31, P395, DOI 10.1016/S0300-5712(03)00084-8; Wada H, 2004, J DENT RES, V83, P222, DOI 10.1177/154405910408300307; *WHO, 1991, WHO CRIT EH, V118	23	165	168	1	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1784	1792		10.1001/jama.295.15.1784	http://dx.doi.org/10.1001/jama.295.15.1784			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622140				2022-12-28	WOS:000236886900021
J	Giepmans, BNG; Adams, SR; Ellisman, MH; Tsien, RY				Giepmans, BNG; Adams, SR; Ellisman, MH; Tsien, RY			Review - The fluorescent toolbox for assessing protein location and function	SCIENCE			English	Review							IN-VIVO; QUANTUM DOTS; LIVING CELLS; CORRELATION SPECTROSCOPY; FLOW-CYTOMETRY; LIGHT; FRET; MICROSCOPY; MOLECULES; PHOTOOXIDATION	Advances in molecular biology, organic chemistry, and materials science have recently created several new classes of fluorescent probes for imaging in cell biology. Here we review the characteristic benefits and limitations of fluorescent probes to study proteins. The focus is on protein detection in live versus fixed cells: determination of protein expression, localization, activity state, and the possibility for combination of fluorescent light microscopy with electron microscopy. Small organic fluorescent dyes, nanocrystals ("quantum dots''), autofluorescent proteins, small genetic encoded tags that can be complexed with fluorochromes, and combinations of these probes are highlighted.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	rtsien@ucsd.edu	Giepmans, Ben N.G./R-4564-2016	Giepmans, Ben N.G./0000-0001-5105-5915	NCRR NIH HHS [RR04050] Funding Source: Medline; NIGMS NIH HHS [GM 72033] Funding Source: Medline; NINDS NIH HHS [NS27177] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Andresen M, 2004, MOL BIOL CELL, V15, P5616, DOI 10.1091/mbc.E04-06-0454; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Clemons PA, 2004, CURR OPIN CHEM BIOL, V8, P334, DOI 10.1016/j.cbpa.2004.04.002; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Danna EA, 2006, CURR OPIN CHEM BIOL, V10, P20, DOI 10.1016/j.cbpa.2005.12.021; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Egner A, 2005, TRENDS CELL BIOL, V15, P207, DOI 10.1016/j.tcb.2005.02.003; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gronemeyer T, 2005, CURR OPIN BIOTECH, V16, P453, DOI 10.1016/j.copbio.2005.06.001; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Haugland R.P., 2005, HDB GUIDE FLUORESCEN; Haustein E, 2004, CURR OPIN STRUC BIOL, V14, P531, DOI 10.1016/j.sbi.2004.09.004; He LS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni057; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Jaiswal JK, 2004, TRENDS CELL BIOL, V14, P497, DOI 10.1016/j.tcb.2004.07.012; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; JAY DG, 1999, BIOCHIM BIOPHYS ACTA, V1424, P39; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KAETHER C, 1995, FEBS LETT, V369, P267, DOI 10.1016/0014-5793(95)00765-2; Keller PJ, 2006, CURR OPIN CELL BIOL, V18, P117, DOI 10.1016/j.ceb.2005.12.012; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lee TH, 2005, ACCOUNTS CHEM RES, V38, P534, DOI 10.1021/ar040146t; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Magliery TJ, 2006, METHOD BIOCHEM ANAL, V47, P391; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Marks KM, 2004, P NATL ACAD SCI USA, V101, P9982, DOI 10.1073/pnas.0401609101; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Matz MV, 2006, METHOD BIOCHEM ANAL, V47, P139; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Miller LW, 2005, CURR OPIN CHEM BIOL, V9, P56, DOI 10.1016/j.cbpa.2004.12.007; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; O'Rourke NA, 2005, CURR OPIN CHEM BIOL, V9, P82, DOI 10.1016/j.cbpa.2004.12.002; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Rice MC, 2001, MOL MICROBIOL, V40, P857, DOI 10.1046/j.1365-2958.2001.02407.x; Rice MC, 2001, NAT BIOTECHNOL, V19, P321, DOI 10.1038/86701; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shah Khalid, 2005, NeuroRx, V2, P215, DOI 10.1007/BF03206667; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Stockholm D, 2005, J MOL BIOL, V346, P215, DOI 10.1016/j.jmb.2004.11.039; Tanabe T, 2005, NAT METHODS, V2, P503, DOI 10.1038/NMETH770; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; Tour O, 2003, NAT BIOTECHNOL, V21, P1505, DOI 10.1038/nbt914; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Waggoner A, 2006, CURR OPIN CHEM BIOL, V10, P62, DOI 10.1016/j.cbpa.2006.01.005; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Ward TH, 2006, METHOD BIOCHEM ANAL, V47, P305; Waterman-Storer CM, 2002, CURR BIOL, V12, pR633, DOI 10.1016/S0960-9822(02)01139-9; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wiseman PW, 2000, J MICROSC-OXFORD, V200, P14, DOI 10.1046/j.1365-2818.2000.00736.x; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	86	2129	2221	38	1807	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					217	224		10.1126/science.1124618	http://dx.doi.org/10.1126/science.1124618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614209				2022-12-28	WOS:000236765300035
J	Novelli, V				Novelli, V			BCG vaccination gets a boost	LANCET			English	Editorial Material							TUBERCULOUS MENINGITIS; EFFICACY; CHILDREN		Great Ormond St Hosp Sick Children, Clin Infect Dis Unit, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Novelli, V (corresponding author), Great Ormond St Hosp Sick Children, Clin Infect Dis Unit, Great Ormond St, London WC1N 3JH, England.	NovelV@gosh.nhs.uk						Chief Medical Officer, 2005, CHANG BCG VACC PROGR; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMSTOCK GW, 1994, CLIN INFECT DIS, V19, P528, DOI 10.1093/clinids/19.3.528; Farinha NJ, 2000, J INFECTION, V41, P61, DOI 10.1053/jinf.2000.0692; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Jordan Jimenez A, 2005, An Pediatr (Barc), V62, P215; Kumar P, 2005, NATL MED J INDIA, V18, P7; Kumar R, 2005, J NEUROL NEUROSUR PS, V76, P1550, DOI 10.1136/jnnp.2005.065201; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; WILSON ME, 1995, CLIN INFECT DIS, V20, P982, DOI 10.1093/clinids/20.4.982	12	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1122	1124		10.1016/S0140-6736(06)68487-0	http://dx.doi.org/10.1016/S0140-6736(06)68487-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616544				2022-12-28	WOS:000236673400006
J	Bridgham, JT; Carroll, SM; Thornton, JW				Bridgham, JT; Carroll, SM; Thornton, JW			Evolution of hormone-receptor complexity by molecular exploitation	SCIENCE			English	Article							MINERALOCORTICOID RECEPTOR; INTERRENAL GLAND; ORIGIN; GENE; ADAPTATION; SELECTION; PATTERNS; FISH; EYE	According to Darwinian theory, complexity evolves by a stepwise process of elaboration and optimization under natural selection. Biological systems composed of tightly integrated parts seem to challenge this view, because it is not obvious how any element's function can be selected for unless the partners with which it interacts are already present. Here we demonstrate how an integrated molecular system-the specific functional interaction between the steroid hormone aldosterone and its partner the mineralocorticoid receptor-evolved by a stepwise Darwinian process. Using ancestral gene resurrection, we show that, long before the hormone evolved, the receptor's affinity for aldosterone was present as a structural by-product of its partnership with chemically similar, more ancient ligands. Introducing two amino acid changes into the ancestral sequence recapitulates the evolution of present-day receptor specificity. Our results indicate that tight interactions can evolve by molecular exploitation-recruitment of an older molecule, previously constrained for a different role, into a new functional complex.	Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Thornton, JW (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022		NICHD NIH HHS [T32 HD007348] Funding Source: Medline; NIGMS NIH HHS [F32-GM074398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074398] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bentley P., 1998, COMP VERTEBRATE ENDO; Bulow HE, 2002, EUR J BIOCHEM, V269, P3838, DOI 10.1046/j.1432-1033.2002.03076.x; Darwin C., 1877, ORIGIN SPECIES; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; FISHER RA, 1930, GENETICAL HIST NATUR; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Greenwood AK, 2003, ENDOCRINOLOGY, V144, P4226, DOI 10.1210/en.2003-0566; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; NONAKA Y, 1995, EUR J BIOCHEM, V229, P249, DOI 10.1111/j.1432-1033.1995.tb20462.x; Nunez S, 1999, J EXP ZOOL, V284, P517, DOI 10.1002/(SICI)1097-010X(19991001)284:5<517::AID-JEZ7>3.0.CO;2-S; Piatigorsky J, 1998, ANN NY ACAD SCI, V842, P7, DOI 10.1111/j.1749-6632.1998.tb09626.x; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; SIMPSON TH, 1970, J ENDOCRINOL, V46, P261, DOI 10.1677/joe.0.0460261; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; WEISBART M, 1977, J STEROID BIOCHEM, V8, P1249, DOI 10.1016/0022-4731(77)90109-1; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	29	410	417	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					97	101		10.1126/science.1123348	http://dx.doi.org/10.1126/science.1123348			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601189				2022-12-28	WOS:000236584400039
J	Capone, DG; Popa, R; Flood, B; Nealson, KH				Capone, DG; Popa, R; Flood, B; Nealson, KH			Follow the nitrogen	SCIENCE			English	Editorial Material							ENCELADUS		Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Portland State Univ, Dept Biol, Portland, OR 97207 USA	University of Southern California; University of Southern California; Portland State University	Capone, DG (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	knealson@usc.edu						Brandes JA, 1998, NATURE, V395, P365, DOI 10.1038/26450; CHICARELLI MI, 1993, GEOCHIM COSMOCHIM AC, V57, P1307, DOI 10.1016/0016-7037(93)90067-7; Galloway J. N., 2004, TREATISE GEOCHEMISTR, V8, P557; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Kargel JS, 2006, SCIENCE, V311, P1389, DOI 10.1126/science.1124495; Mancinelli RL., 2003, INT J ASTROBIOL, V2, P217, DOI DOI 10.1017/S1473550403001599; McElroy M. B., 1977, Journal of Geophysical Research, V82, P4379, DOI 10.1029/JS082i028p04379; PLUMB RC, 1989, NATURE, V338, P633, DOI 10.1038/338633a0; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Smil V., 2001, ENRICHING THE EARTH; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002	15	45	47	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					708	709		10.1126/science.1111863	http://dx.doi.org/10.1126/science.1111863			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675690				2022-12-28	WOS:000237312100037
J	Demers, G; Griffin, G; De Vroey, G; Haywood, JR; Zurlo, J; Bedard, M				Demers, G; Griffin, G; De Vroey, G; Haywood, JR; Zurlo, J; Bedard, M			Harmonization of animal care and use guidance	SCIENCE			English	Editorial Material									ICLAS, Quebec City, PQ J3H 4W1, Canada; Canadian Council Anim Care, Ottawa, ON K1P 5G4, Canada; Johnson & Johnson, B-2340 Beerse, Belgium; Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; Natl Acad Sci, Inst Lab Anim Res, Washington, DC 20001 USA	Johnson & Johnson; Michigan State University; National Academies of Sciences, Engineering & Medicine	Demers, G (corresponding author), ICLAS, Quebec City, PQ J3H 4W1, Canada.	gdemers@ccac.ca						*AVMA PAN EUTH, 2000 REP AM VET MED; Bankowski Z, 1986, INT GUIDING PRINCIPL; CCAC, 1998, CCAC GUID CHOOS APPR; *ESF POL RIEF, 2001, US AN RES; *FELASA, 2005, P 9 FELASA S SECT 2; GRIFFIN G, 2002, ILAR J S, V43; *ICLAS, 2005, INT HARM GUID HUM EN; *ICLAS, 2004, INT HARM GUID EUTH; *NAT RES COUNC, 1996, GUID CAR US LAB; *NAT RES COUNC, 2004, DEV SCI GUID LAB AN; OECD [Organisation for Economic Co-operation and Development], 2000, GUID DOC REC ASS US; Russell WMS., 1959, MED J AUSTRALIA; 1996 1997 EC RECOMME	13	85	87	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					700	701		10.1126/science.1124036	http://dx.doi.org/10.1126/science.1124036			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675685				2022-12-28	WOS:000237312100032
J	Lancaster, N				Lancaster, N			Linear dunes on Titan	SCIENCE			English	Editorial Material									Desert Res Inst, Reno, NV 89512 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Lancaster, N (corresponding author), Desert Res Inst, Reno, NV 89512 USA.	nick@dri.edu		Lancaster, Nicholas/0000-0003-1585-5282				Bristow CS, 2000, NATURE, V406, P56, DOI 10.1038/35017536; GREELEY R, 1992, J GEOPHYS RES-PLANET, V97, P13319, DOI 10.1029/92JE00980; GREELEY R, 1981, MEM SOC ASTRON ITAL, V52, P409; Greeley R., 1985, WIND GEOLOGICAL PROC, DOI 10.1017/CBO9780511573071; Kocurek G, 1999, SEDIMENTOLOGY, V46, P505, DOI 10.1046/j.1365-3091.1999.00227.x; Lancaster N., 1995, GEOMORPHOLOGY DESERT; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; MCCAULEY JF, 1973, J GEOPHYS RES, V78, P4123, DOI 10.1029/JB078i020p04123; SULLIVAN R, 2005, NATURE, P436	9	31	34	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					702	703		10.1126/science.1126292	http://dx.doi.org/10.1126/science.1126292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675686				2022-12-28	WOS:000237312100033
J	Bejerano, G; Lowe, CB; Ahituv, N; King, B; Siepel, A; Salama, SR; Rubin, EM; Kent, WJ; Haussler, D				Bejerano, G; Lowe, CB; Ahituv, N; King, B; Siepel, A; Salama, SR; Rubin, EM; Kent, WJ; Haussler, D			A distal enhancer and an ultraconserved exon are derived from a novel retroposon	NATURE			English	Article							ELEMENTS; MOTOR; VERTEBRATE; GENE; RNAS	Hundreds of highly conserved distal cis-regulatory elements have been characterized so far in vertebrate genomes(1). Many thousands more are predicted on the basis of comparative genomics(2,3). However, in stark contrast to the genes that they regulate, in invertebrates virtually none of these regions can be traced by using sequence similarity, leaving their evolutionary origins obscure. Here we show that a class of conserved, primarily non-coding regions in tetrapods originated from a previously unknown short interspersed repetitive element (SINE) retroposon family that was active in the Sarcopterygii (lobe-finned fishes and terrestrial vertebrates) in the Silurian period at least 410 million years ago (ref. 4), and seems to be recently active in the 'living fossil' Indonesian coelacanth, Latimeria menadoensis. Using a mouse enhancer assay we show that one copy, 0.5 million bases from the neuro-developmental gene ISL1, is an enhancer that recapitulates multiple aspects of Isl1 expression patterns. Several other copies represent new, possibly regulatory, alternatively spliced exons in the middle of pre-existing Sarcopterygian genes. One of these, a more than 200-base-pair ultraconserved region(5), 100% identical in mammals, and 80% identical to the coelacanth SINE, contains a 31-amino-acid-residue alternatively spliced exon of the messenger RNA processing gene PCBP2 (ref. 6). These add to a growing list of examples(7) in which relics of transposable elements have acquired a function that serves their host, a process termed 'exaptation'(8), and provide an origin for at least some of the many highly conserved vertebrate-specific genomic sequences.	Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Bejerano, G (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	jill@soe.ucsc.edu	Salama, Sofie/K-6412-2019	Ahituv, Nadav/0000-0002-7434-8144; Salama, Sofie/0000-0001-6999-7193; Siepel, Adam/0000-0002-3557-7219				Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Brosius J, 2003, GENETICA, V118, P99, DOI 10.1023/A:1024141306559; Caton A, 2000, DEVELOPMENT, V127, P1751; Chkheidze AN, 2003, MOL CELL BIOL, V23, P8405, DOI 10.1128/MCB.23.23.8405-8415.2003; Danke J, 2004, J EXP ZOOL PART A, V301A, P228, DOI 10.1002/jez.a.20024; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Gunduz E, 2005, INT J ONCOL, V26, P201; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li YH, 2005, BIOCHEM BIOPH RES CO, V333, P868, DOI 10.1016/j.bbrc.2005.05.170; Makalowski W, 2003, SCIENCE, V300, P1246, DOI 10.1126/science.1085690; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	30	379	388	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					87	90		10.1038/nature04696	http://dx.doi.org/10.1038/nature04696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16625209				2022-12-28	WOS:000237248600038
J	Bonilla, MF; Kaul, DR; Saint, S; Isada, CM; Brotman, DJ				Bonilla, MF; Kaul, DR; Saint, S; Isada, CM; Brotman, DJ			Ring around the diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS LIVER-BIOPSY; Q-FEVER; BONE-MARROW; COMPLICATIONS; HEPATITIS; ORIGIN		Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA; Cleveland Clin Fdn, Dept Internal Med, Cleveland, OH USA; Cleveland Clin Fdn, Dept Infect Dis, Cleveland, OH USA; Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Johns Hopkins University; Johns Hopkins Medicine	Brotman, DJ (corresponding author), Johns Hopkins Univ Hosp, Hospitalist Program, Jefferson 242,600 N Wolfe St, Baltimore, MD 21287 USA.	brotman@jhmi.edu	Saint, Sanjay/AAF-5126-2019					DERRICK E. H., 1937, Medical Journal of Australia, V2, P281; Eid A, 1996, WESTERN J MED, V164, P510; ENDE N, 1957, ARCH INTERN MED, V100, P793, DOI 10.1001/archinte.1957.00260110109015; HOFMANN CE, 1982, GASTROENTEROLOGY, V83, P474; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MCGILL DB, 1990, GASTROENTEROLOGY, V99, P1396, DOI 10.1016/0016-5085(90)91167-5; Mcquiston JH, 2002, VECTOR-BORNE ZOONOT, V2, P179, DOI 10.1089/15303660260613747; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; OKUN DB, 1979, AM J CLIN PATHOL, V71, P117; PELLEGRIN M, 1980, HUM PATHOL, V11, P51, DOI 10.1016/S0046-8177(80)80105-5; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; SRIGLEY JR, 1985, AM J SURG PATHOL, V9, P752, DOI 10.1097/00000478-198510000-00007; TOBKES AI, 1995, DIGEST DIS, V13, P267, DOI 10.1159/000171507; TRAVIS LB, 1986, ARCH PATHOL LAB MED, V110, P1017	15	10	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1937	1942		10.1056/NEJMcps053094	http://dx.doi.org/10.1056/NEJMcps053094			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672706				2022-12-28	WOS:000237239900012
J	Qvarnstrom, A; Brommer, JE; Gustafsson, L				Qvarnstrom, A; Brommer, JE; Gustafsson, L			Testing the genetics underlying the co-evolution of mate choice and ornament in the wild	NATURE			English	Article							SECONDARY SEXUAL CHARACTER; COLLARED FLYCATCHER; MATING PREFERENCES; FEMALE PREFERENCE; MALE COMPETITION; BADGE SIZE; SELECTION; EVOLUTION; FITNESS; HERITABILITY	One of the most debated questions in evolutionary biology is whether female choice of males with exaggerated sexual displays can evolve as a correlated response to selection acting on genes coding for male attractiveness or high overall viability. To date, empirical studies have provided support for parts of this scenario(1), but evidence for all key genetic components in a natural population is lacking. Here we use animal-model quantitative genetic analysis(2,3) on data from over 8,500 collared flycatchers (Ficedula albicollis) followed for 24 years to quantify all of the key genetic requirements of both fisherian(4,5) and 'good-genes' models(6,7) on sexual selection in the wild. We found significant additive genetic variances of all the main components: male ornament (forehead patch size), female mate choice for this ornament, male fitness and female fitness. However, when the necessary genetic correlations between these components were taken into account, the estimated strength of indirect sexual selection on female mate choice was negligible. Our results show that the combined effect of environmental influences on several components reduces the potential for indirect sexual selection in the wild. This study provides insight into the field of sexual selection by showing that genes coding for mate choice for an ornament probably evolve by their own pathways instead of 'hitchhiking' with genes coding for the ornament.	Uppsala Univ, Dept Ecol & Evolut, SE-75236 Uppsala, Sweden; Univ Helsinki, Bird Ecol Unit, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	Uppsala University; University of Helsinki	Qvarnstrom, A (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Norbyvagen 18D, SE-75236 Uppsala, Sweden.		Gustafsson, Lars/A-7634-2012; Gustafsson, Lars/O-8056-2019; Brommer, Jon E/C-3613-2008	Gustafsson, Lars/0000-0001-6566-2863; Gustafsson, Lars/0000-0001-6566-2863; Brommer, Jon E/0000-0002-2435-2612; Qvarnstrom, Anna/0000-0002-1178-4053				ANDERSSOPN M, 1994, SEXUAL SELECTION; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; Bakker TCM, 1999, BEHAVIOUR, V136, P1237, DOI 10.1163/156853999501748; Brooks R, 1999, AM NAT, V154, P37, DOI 10.1086/303219; BURT A, 1995, EVOLUTION, V49, P1, DOI 10.1111/j.1558-5646.1995.tb05954.x; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; DALE S, 1992, BEHAV ECOL SOCIOBIOL, V30, P165, DOI 10.1007/BF00166699; Fisher R.A., 1930, GENETICAL THEORY NAT; Garant D, 2004, EVOLUTION, V58, P634, DOI 10.1111/j.0014-3820.2004.tb01685.x; Hine E, 2002, P ROY SOC B-BIOL SCI, V269, P2215, DOI 10.1098/rspb.2002.2149; HOGLUND J, 1995, TEKS; HOUDE AE, 1994, P ROY SOC B-BIOL SCI, V256, P125, DOI 10.1098/rspb.1994.0059; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lesna I, 1999, NATURE, V401, P581, DOI 10.1038/44125; LYNCH M, 1996, GENETICS ANAL QUANTI; Part T, 1997, ANIM BEHAV, V54, P893, DOI 10.1006/anbe.1997.0514; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Qvarnstrom A, 1999, EVOLUTION, V53, P1564, DOI 10.1111/j.1558-5646.1999.tb05419.x; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; SERVICE PM, 1985, EVOLUTION, V39, P943, DOI [10.2307/2408694, 10.1111/j.1558-5646.1985.tb00436.x]; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	30	172	173	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					84	86		10.1038/nature04564	http://dx.doi.org/10.1038/nature04564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672970				2022-12-28	WOS:000237248600037
J	Weatherhead, EC; Andersen, SB				Weatherhead, EC; Andersen, SB			The search for signs of recovery of the ozone layer	NATURE			English	Review							STRATOSPHERIC WATER-VAPOR; TROPOPAUSE HEIGHT CHANGES; TOTAL COLUMN OZONE; HETEROGENEOUS CHEMISTRY; ANTARCTIC OZONE; NORTHERN MIDLATITUDES; ATMOSPHERIC CHEMISTRY; VERTICAL-DISTRIBUTION; 2-DIMENSIONAL MODEL; GREENHOUSE-GAS	Evidence of mid-latitude ozone depletion and proof that the Antarctic ozone hole was caused by humans spurred policy makers from the late 1980s onwards to ratify the Montreal Protocol and subsequent treaties, legislating for reduced production of ozone-depleting substances. The case of anthropogenic ozone loss has often been cited since as a success story of international agreements in the regulation of environmental pollution. Although recent data suggest that total column ozone abundances have at least not decreased over the past eight years for most of the world, it is still uncertain whether this improvement is actually attributable to the observed decline in the amount of ozone-depleting substances in the Earth's atmosphere. The high natural variability in ozone abundances, due in part to the solar cycle as well as changes in transport and temperature, could override the relatively small changes expected from the recent decrease in ozone-depleting substances. Whatever the benefits of the Montreal agreement, recovery of ozone is likely to occur in a different atmospheric environment, with changes expected in atmospheric transport, temperature and important trace gases. It is therefore unlikely that ozone will stabilize at levels observed before 1980, when a decline in ozone concentrations was first observed.	Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80307 USA; Danish Meteorol Inst, DK-2100 Copenhagen, Denmark	University of Colorado System; University of Colorado Boulder; Danish Meteorological Institute DMI	Weatherhead, EC (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Campus Box 216, Boulder, CO 80307 USA.	betsy.weatherhead@cires.colorado.edu	andersen, signe/C-4809-2013; Weatherhead, Elizabeth/I-7091-2015	andersen, signe/0000-0002-8216-0141; Weatherhead, Elizabeth/0000-0002-9252-4228				Andersen SB, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006091; Appenzeller C, 2000, GEOPHYS RES LETT, V27, P1131, DOI 10.1029/1999GL010854; Austin J, 2003, ATMOS CHEM PHYS, V3, P1, DOI 10.5194/acp-3-1-2003; Austin J, 2002, J ATMOS SCI, V59, P218, DOI 10.1175/1520-0469(2002)059<0218:ATDCCC>2.0.CO;2; Bojkov RD, 2002, METEOROL ATMOS PHYS, V79, P127, DOI 10.1007/s007030200000; Chipperfield MP, 1999, NATURE, V400, P551, DOI 10.1038/22999; CRUTZEN PJ, 1971, J GEOPHYS RES, V76, P7311, DOI 10.1029/JC076i030p07311; DESSLER AE, 1993, GEOPHYS RES LETT, V20, P2527, DOI 10.1029/93GL02419; FAHEY DW, 1993, NATURE, V363, P509, DOI 10.1038/363509a0; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Fioletov VE, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016739; Fleming EL, 1999, J GEOPHYS RES-ATMOS, V104, P23911, DOI 10.1029/1999JD900332; Forster PMF, 2001, J GEOPHYS RES-ATMOS, V106, P12241, DOI 10.1029/2000JD900813; Fusco AC, 1999, J CLIMATE, V12, P1619, DOI 10.1175/1520-0442(1999)012<1619:IVOTOA>2.0.CO;2; Grooss JU, 1998, ATMOS ENVIRON, V32, P3173, DOI 10.1016/S1352-2310(98)00016-8; Hadjinicolaou P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022476; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; Hofmann DJ, 1997, J GEOPHYS RES-ATMOS, V102, P8931, DOI 10.1029/96JD03749; HOFMANN DJ, 1994, GEOPHYS RES LETT, V21, P65, DOI 10.1029/93GL02526; Hood L, 1999, J GEOPHYS RES-ATMOS, V104, P24321, DOI 10.1029/1999JD900401; Jackman CH, 2000, J GEOPHYS RES-ATMOS, V105, P11659, DOI 10.1029/2000JD900010; JOHNSTON HS, 1974, CAN J CHEM, V52, P1415, DOI 10.1139/v74-214; Kirk-Davidoff DB, 1999, NATURE, V402, P399, DOI 10.1038/46521; Langematz U, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002069; Logan JA, 1999, J GEOPHYS RES-ATMOS, V104, P26373, DOI 10.1029/1999JD900300; Manney GL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005367; Miller AJ, 1996, J GEOPHYS RES-ATMOS, V101, P9017, DOI 10.1029/96JD00229; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; Montzka SA, 1999, NATURE, V398, P690, DOI 10.1038/19499; Newchurch MJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003471; Newman PA, 2000, J GEOPHYS RES-ATMOS, V105, P12485, DOI 10.1029/1999JD901191; Oltmans SJ, 2000, GEOPHYS RES LETT, V27, P3453, DOI 10.1029/2000GL012133; Pawson S, 1999, J GEOPHYS RES-ATMOS, V104, P14209, DOI 10.1029/1999JD900211; Petropavlovskikh I, 2001, GEOPHYS RES LETT, V28, P255, DOI 10.1029/1999GL011251; PITARI G, 1993, J ATMOS SCI, V50, P3260, DOI 10.1175/1520-0469(1993)050<3260:AEOTCA>2.0.CO;2; Portmann RW, 1999, GEOPHYS RES LETT, V26, P2387, DOI 10.1029/1999GL900499; PRATHER M, 1990, J GEOPHYS RES-ATMOS, V95, P3473, DOI 10.1029/JD095iD04p03473; PRATHER M, 1992, J GEOPHYS RES-ATMOS, V97, P10187, DOI 10.1029/92JD00845; Ramaswamy V, 2001, REV GEOPHYS, V39, P71, DOI 10.1029/1999RG000065; Randall CE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022003; Randel WJ, 1999, SCIENCE, V285, P1689, DOI 10.1126/science.285.5434.1689; Randel WJ, 2004, J ATMOS SCI, V61, P2133, DOI 10.1175/1520-0469(2004)061<2133:ICOSWV>2.0.CO;2; Randeniya LK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014295; Reinsel GC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014716; Reinsel GC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000500; Reinsel GC, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004662; Rex M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018844; Rinsland CP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002965; Rosenfield JE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000824; Salawitch RJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021504; SALBY ML, 1993, J GEOPHYS RES-ATMOS, V98, P2715, DOI 10.1029/92JD01814; SANDER SP, 2003, JPL PUBL, V225; Santer BD, 2003, SCIENCE, V301, P479, DOI 10.1126/science.1084123; Schnadt C, 2002, CLIM DYNAM, V18, P501, DOI 10.1007/s00382-001-0190-z; SCHOEBERL MR, 1993, GEOPHYS RES LETT, V20, P29, DOI 10.1029/92GL02637; Shindell DT, 1998, NATURE, V392, P589, DOI 10.1038/33385; Shindell DT, 2001, GEOPHYS RES LETT, V28, P1551, DOI 10.1029/1999GL011197; Shine KP, 2003, Q J ROY METEOR SOC, V129, P1565, DOI 10.1256/QJ.02.186; Sinnhuber M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017265; Smyshlyaev SP, 1998, J GEOPHYS RES-ATMOS, V103, P28373, DOI 10.1029/98JD02354; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Solomon S, 1996, J GEOPHYS RES-ATMOS, V101, P6713, DOI 10.1029/95JD03353; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; Staehelin J, 2001, REV GEOPHYS, V39, P231, DOI 10.1029/1999RG000059; Steinbrecht W, 1998, J GEOPHYS RES-ATMOS, V103, P19183, DOI 10.1029/98JD01929; STEPHENSON JAE, 1991, NATURE, V352, P137, DOI 10.1038/352137a0; STOLARSKI RS, 1974, CAN J CHEM, V52, P1610, DOI 10.1139/v74-233; STORDAL F, 1985, J GEOPHYS RES-ATMOS, V90, P5757, DOI 10.1029/JD090iD03p05757; Tabazadeh A, 2004, ATMOS ENVIRON, V38, P647, DOI 10.1016/j.atmosenv.2003.10.024; Thomason LW, 1997, J GEOPHYS RES-ATMOS, V102, P8967, DOI 10.1029/96JD02962; THRUSH BA, 1988, REP PROG PHYS, V51, P1341, DOI 10.1088/0034-4885/51/10/002; VELDERS GJM, 1995, 722201006 RIVM NAT I; Waugh DW, 1999, J GEOPHYS RES-ATMOS, V104, P27191, DOI 10.1029/1999JD900795; Weatherhead EC, 2000, J GEOPHYS RES-ATMOS, V105, P22201, DOI 10.1029/2000JD900063; Weisenstein DK, 1998, J GEOPHYS RES-ATMOS, V103, P1527, DOI 10.1029/97JD02930; WOFSY SC, 1975, GEOPHYS RES LETT, V2, P215, DOI 10.1029/GL002i006p00215; World Meteorological Organization, 2003, SCI ASS OZ DEPL 2002; Wuebbles DJ, 2001, J GEOPHYS RES-ATMOS, V106, P14551, DOI 10.1029/2001JD900008; Zerefos CS, 1997, J GEOPHYS RES-ATMOS, V102, P1561, DOI 10.1029/96JD02395; Zhou ST, 2001, GEOPHYS RES LETT, V28, P4107, DOI 10.1029/2001GL013660	80	209	230	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					39	45		10.1038/nature04746	http://dx.doi.org/10.1038/nature04746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672963				2022-12-28	WOS:000237248600028
J	Briel, M; Schwartz, GG; Thompson, PL; de Lemos, JA; Blazing, MA; van Es, GA; Kayikcioglu, M; Arntz, HR; den Hartog, FR; Veeger, NJGM; Colivicchi, F; Dupuis, J; Okazaki, S; Wright, RS; Bucher, HC; Nordmann, AJ				Briel, M; Schwartz, GG; Thompson, PL; de Lemos, JA; Blazing, MA; van Es, GA; Kayikcioglu, M; Arntz, HR; den Hartog, FR; Veeger, NJGM; Colivicchi, F; Dupuis, J; Okazaki, S; Wright, RS; Bucher, HC; Nordmann, AJ			Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes - A meta-analysis of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA-PECTORIS; LIPID-LOWERING THERAPY; ATORVASTATIN 80 MG; HEART-DISEASE; PRAVASTATIN; FLUVASTATIN; INTERVENTION; CERIVASTATIN; CHOLESTEROL	Context The short-term effects of early treatment with statins in patients after the onset of acute coronary syndromes (ACS) for the outcomes of death, myocardial infarction (MI), and stroke are unclear. Objective To evaluate relevant outcomes of patients from randomized controlled trials comparing early statin therapy with placebo or usual care at 1 and 4 months following ACS. Data Sources and Study Selection Systematic search of electronic databases ( MEDLINE, EMBASE, PASCAL, Cochrane Central Register) from their inception to August 2005, which was supplemented by contact with experts in the field. Two reviewers independently determined the eligibility of randomized controlled trials that compared treatment with statins with a control, were initiated within 14 days after onset of ACS, and had a minimal follow-up of 30 days. Trials with cerivastatin were only included in a sensitivity analysis. Data Extraction Information on baseline characteristics of included trials and patients, reported methodological quality, lipid levels, and clinical outcome was independently extracted by 2 investigators. Investigators from each included trial contributed additional data if necessary. Data Synthesis Twelve trials involving 13 024 patients with ACS were included in the meta-analysis. The risk ratios for the combined end point of death, MI, and stroke for patients treated with early statin therapy compared with control therapy were 0.93 (95% confidence interval [CI], 0.80-1.09; P=. 39) at 1 month and 0.93 ( 95% CI, 0.81-1.07; P=. 30) at 4 months following ACS. There were no statistically significant risk reductions from statins for total death, total MI, total stroke, cardiovascular death, fatal or nonfatal MI, or revascularization procedures ( percutaneous coronary intervention or coronary artery bypass graft surgery). Sensitivity analyses with restriction to trials of high quality or with additional data from a large trial using cerivastatin indicated summary risk ratios even closer to 1. Conclusion Based on available evidence, initiation of statin therapy within 14 days following onset of ACS does not reduce death, MI, or stroke up to 4 months.	Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; Ege Univ, Sch Med, Izmir, Turkey; Cardialysis BV, Rotterdam, Netherlands; Duke Clin Res Inst, Durham, NC USA; Univ Texas, SW Med Sch, Dallas, TX 75235 USA; Univ Western Australia, Sir Charles Gairdner Hosp, Perth, WA 6009, Australia; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; VA Med Ctr, Denver, CO USA; Mayo Clin, Rochester, MN USA; Juntendo Univ, Sch Med, Tokyo 113, Japan; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; S Filippo Neri Hosp, Rome, Italy; Univ Groningen, Med Ctr, Groningen, Netherlands; Gelderse Vallei Hosp, Ede, Netherlands	University of Basel; Ege University; Cardialysis; Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Western Australia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Mayo Clinic; Juntendo University; Universite de Montreal; San Filippo Neri Hospital; University of Groningen; Gelderse Vallei Hospital	Bucher, HC (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol, Hebelstr 10, CH-4031 Basel, Switzerland.	hbucher@uhbs.ch	Thompson, Peter L/P-1071-2014; Dupuis, Jocelyn/B-3898-2009; de Lemos, James/ABD-6669-2021; Briel, Matthias/AAT-9284-2021; KAYIKCIOGLU, Meral/AAH-6687-2020; Dupuis, Jocelyn/C-6613-2013; Veeger, Nic JGM/F-2966-2013	Dupuis, Jocelyn/0000-0002-3193-1014; Veeger, Nic JGM/0000-0002-1492-7937; Colivicchi, Furio/0000-0001-7187-2234; Briel, Matthias/0000-0002-2070-5230				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Arntz HR, 2000, AM J CARDIOL, V86, P1293, DOI 10.1016/S0002-9149(00)01230-3; Aronow HD, 2001, LANCET, V357, P1063, DOI 10.1016/S0140-6736(00)04257-4; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Colivicchi F, 2002, AM J CARDIOL, V90, P872, DOI 10.1016/S0002-9149(02)02711-X; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Correia LCL, 2002, AM J CARDIOL, V90, P162, DOI 10.1016/S0002-9149(02)02443-8; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; den Hartog FR, 2001, INT J CLIN PRACT, V55, P300; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; *EUR SOC CARD, 2004, PRINCESS PREV ISCH E; Fonarow GC, 2005, AM J CARDIOL, V96, P611, DOI 10.1016/j.amjcard.2005.04.029; Foody JM, 2005, AM J CARDIOL, V95, P483, DOI 10.1016/j.amjcard.2004.09.060; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE149, DOI 10.1161/01.ATV.0000133317.49796.0E; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kayikcioglu M, 2002, ACTA CARDIOL, V57, P295, DOI 10.2143/AC.57.4.2005430; Kesteloot H, 1997, ACTA CARDIOL, V52, P107; Lachin J. M., 2000, WILEY SER PROB STAT; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Laupacis A, 2004, ANN INTERN MED, V140, P923, DOI 10.7326/0003-4819-140-11-200406010-00014; Liem AH, 2002, EUR HEART J, V23, P1931, DOI 10.1053/euhj.2002.3291; Newby LK, 2002, JAMA-J AM MED ASSOC, V287, P3087, DOI 10.1001/jama.287.23.3087; Nordmann, 2000, Eur J Intern Med, V11, P309, DOI 10.1016/S0953-6205(00)00110-2; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; Ostadal P, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-4; Ostadal P, 2003, MOL CELL BIOCHEM, V246, P45, DOI 10.1023/A:1023499727477; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2000, CLIN THER, V22, P949, DOI 10.1016/S0149-2918(00)80066-1; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Smith CS, 2005, AM HEART J, V149, P444, DOI 10.1016/j.ahj.2004.06.033; Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006; Sposito AC, 2002, ARTERIOSCL THROM VAS, V22, P1524, DOI 10.1161/01.ATV.0000032033.39301.6A; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Studer M, 2005, ARCH INTERN MED, V165, P725, DOI 10.1001/archinte.165.7.725; Thompson PL, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2003.10.052; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Walter DH, 2004, CURR PHARM DESIGN, V10, P369, DOI 10.2174/1381612043453360; Walter SD, 2000, J CLIN EPIDEMIOL, V53, P931, DOI 10.1016/S0895-4356(00)00210-9; Wood D, 1998, EUR HEART J, V19, P1434	51	122	132	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2046	2056		10.1001/jama.295.17.2046	http://dx.doi.org/10.1001/jama.295.17.2046			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038MF	16670413				2022-12-28	WOS:000237225100021
J	Janvier, P; Desbiens, S; Willett, JA; Arsenault, M				Janvier, P; Desbiens, S; Willett, JA; Arsenault, M			Lamprey-like gills in a gnathostome-related Devonian jawless vertebrate	NATURE			English	Article							ANATOMY	So far, the Palaeozoic fossil jawless vertebrates have not provided any direct evidence for the organization of the gills, apart from vague impressions-supposedly left by gill filaments-on the bony surface of the gill chamber in certain armoured forms or 'ostracoderms' (for example, osteostracans and heterostracans)(1). The latter are currently regarded as more closely related to the living jawed vertebrates (crown gnathostomes) than to the living jawless vertebrates (hagfish and lampreys, or cyclostomes)(2,3). Here we report the first direct evidence for the position of the gill filaments-possibly supported by gill rays-enclosed by gill pouches in a 370-million year (Myr)-old jawless vertebrate, Endeiolepis, from the Late Devonian fossil fish site of Miguasha, Quebec, Canada. This extinct jawless fish has much the same gill organization as living lampreys, although it possesses an unusually large number of gill pouches-a condition unlike that in any extant vertebrates and that raises questions about gill development(4). Endeiolepis is currently regarded as a close relative of anaspids(3), a group of 410-430-Myr-old 'ostracoderms'. Assuming that current vertebrate phylogeny is correct, this discovery demonstrates that pouches enclosing the gills are primitive for vertebrates, but have been subsequently lost in jawed vertebrates.	Museum Natl Hist Nat, CNRS, UMR 5143, F-75231 Paris 05, France; Nat Hist Museum, London SW7 5BD, England; Parc Natl Miguasha, Nouvelle, PQ G0C 2E0, Canada	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Natural History Museum London	Janvier, P (corresponding author), Museum Natl Hist Nat, CNRS, UMR 5143, CP38,57 Rue Cuvier, F-75231 Paris 05, France.	janvier@mnhn.fr						Arsenault M., 2004, RECENT ADV ORIGIN EA, P439; Arsenault Marius, 1991, P19; Clemens S, 2001, RESP PHYSIOL, V128, P299, DOI 10.1016/S0034-5687(01)00308-5; Donoghue PCJ, 2000, BIOL REV, V75, P191, DOI 10.1017/S0006323199005472; Donoghue PCJ, 2001, T ROY SOC EDIN-EARTH, V92, P15, DOI 10.1017/S026359330000002X; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; Hou XG, 2002, P ROY SOC B-BIOL SCI, V269, P1865, DOI 10.1098/rspb.2002.2104; Janvier P, 2002, NATURE, V417, P609, DOI 10.1038/417609a; Janvier P., 1996, EARLY VERTEBRATES; Janvier P., 2004, RECENT ADV ORIGIN EA, P29; Janvier Philippe, 1996, P134; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Maisey J.G., 1989, Journal of Vertebrate Paleontology, V9, P174; Mallatt J, 1996, ZOOL J LINN SOC-LOND, V117, P329, DOI 10.1111/j.1096-3642.1996.tb01658.x; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; MARINELLI W, 1954, VERGLEICHENDE ANATOM, V1; Prichonnet G., 1996, DEVONIAN FISHES PLAN, P23; Quinlan R, 2004, DEVELOPMENT, V131, P593, DOI 10.1242/dev.00950; STENSIO E, 1964, TRAITE PALEONTOLOGIE, V4; Stensio EA., 1939, K SVENSKA VET AKAD H, V18, P1; Watson D. M. S., 1954, PHIL T R SOC B, V238, P1, DOI [10.1098/rstb.1954.0004, DOI 10.1098/RSTB.1954.0004]	22	36	37	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1183	1185		10.1038/nature04471	http://dx.doi.org/10.1038/nature04471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641994				2022-12-28	WOS:000237080000043
J	Reznik, D; Pintschovius, L; Ito, M; Iikubo, S; Sato, M; Goka, H; Fujita, M; Yamada, K; Gu, GD; Tranquada, JM				Reznik, D; Pintschovius, L; Ito, M; Iikubo, S; Sato, M; Goka, H; Fujita, M; Yamada, K; Gu, GD; Tranquada, JM			Electron-phonon coupling reflecting dynamic charge inhomogeneity in copper oxide superconductors	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; DISPERSION; MAGNETISM; YBA2CU3O7; STRIPES	The attempt to understand copper oxide superconductors is complicated by the presence of multiple strong interactions in these systems. Many believe that antiferromagnetism is important for superconductivity, but there has been renewed interest in the possible role of electron-lattice coupling(1-4). The conventional superconductor MgB2 has a very strong electron-lattice coupling, involving a particular vibrational mode (phonon) that was predicted by standard theory and confirmed quantitatively by experiment(5). Here we present inelastic scattering measurements that show a similarly strong anomaly in the Cu-O bond-stretching phonon in the copper oxide superconductors La2-xSrxCuO4 (with x=0.07, 0.15). Conventional theory does not predict such behaviour. The anomaly is strongest in La1.875Ba0.125CuO4 and La1.48Nd0.4Sr0.12CuO4, compounds that exhibit spatially modulated charge and magnetic order, often called stripe order(6); it occurs at a wave vector corresponding to the charge order. These results suggest that this giant electron-phonon anomaly, which is absent in undoped and over-doped non-superconductors, is associated with charge inhomogeneity. It follows that electron-phonon coupling may be important to our understanding of superconductivity, although its contribution is likely to be indirect.	Forschungszentrum Karlsruhe, Inst Festkorperphys, D-76021 Karlsruhe, Germany; Ctr Etud Saclay, Leon Brillouin Lab, F-91191 Gif Sur Yvette, France; Nagoya Univ, Dept Phys, Div Sci Mat, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci, Upton, NY 11973 USA	Helmholtz Association; Karlsruhe Institute of Technology; CEA; Centre National de la Recherche Scientifique (CNRS); Nagoya University; Tohoku University; United States Department of Energy (DOE); Brookhaven National Laboratory	Reznik, D (corresponding author), Forschungszentrum Karlsruhe, Inst Festkorperphys, POB 3640, D-76021 Karlsruhe, Germany.	Reznik@llb.saclay.cea.fr	Yamada, Kazuyoshi/C-2728-2009; Tranquada, John M./A-9832-2009; Gu, Genda/D-5410-2013; Fujita, Masaki/D-8430-2013	Tranquada, John M./0000-0003-4984-8857; Gu, Genda/0000-0002-9886-3255; 				Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Baron AQR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.197004; Bohnen KP, 2003, EUROPHYS LETT, V64, P104, DOI 10.1209/epl/i2003-00143-x; CHAPLOT SL, 1995, PHYS REV B, V52, P7230, DOI 10.1103/PhysRevB.52.7230; Chung JH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014517; Devereaux TP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.117004; Falter C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054516; Fujita M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104517; Fukuda T, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.060501; Hinkov V, 2004, NATURE, V430, P650, DOI 10.1038/nature02774; Hiraka H, 2001, J PHYS SOC JPN, V70, P853, DOI 10.1143/JPSJ.70.853; Ishihara S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144520; Ito M, 2003, J PHYS SOC JPN, V72, P1627, DOI 10.1143/JPSJ.72.1627; Kaneshita E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.115501; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; MACHIDA K, 1989, PHYSICA C, V158, P192, DOI 10.1016/0921-4534(89)90316-X; McQueeney RJ, 1999, PHYS REV LETT, V82, P628, DOI 10.1103/PhysRevLett.82.628; Pintschovius L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.037001; Pintschovius L, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214506; Pintschovius L, 1999, PHYS REV B, V60, pR15039, DOI 10.1103/PhysRevB.60.R15039; PINTSCHOVIUS L, 1991, PHYSICA C, V185, P156, DOI 10.1016/0921-4534(91)91965-7; PINTSCHOVIUS L, 2003, EVIDENCE DYNAMIC CHA; REZNIK D, 1995, PHYS REV LETT, V75, P2396, DOI 10.1103/PhysRevLett.75.2396; Rosch O, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.146403; Tranquada JM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.075505; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Uchiyama H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.197005; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zhou XJ, 1999, SCIENCE, V286, P268, DOI 10.1126/science.286.5438.268	30	263	265	7	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1170	1173		10.1038/nature04704	http://dx.doi.org/10.1038/nature04704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641991	Green Submitted			2022-12-28	WOS:000237080000040
J	Woods, NB; Bottero, V; Schmidt, M; von Kalle, C; Verma, IM				Woods, NB; Bottero, V; Schmidt, M; von Kalle, C; Verma, IM			Therapeutic gene causing lymphoma	NATURE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; COMMON GAMMA-CHAIN; CYTOKINE RECEPTOR; BONE-MARROW; MICE; LYMPHOCYTES; CELLS; MODEL		Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Natl Ctr Tumor Dis Heidelberg, D-69120 Heidelberg, Germany; German Canc Res Ctr, Dept Translat Oncol, Otto Meyerhof Zentrum, D-69120 Heidelberg, Germany; Univ Hosp, Dept Internal Med 1, D-79106 Freiburg, Germany; Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	Salk Institute; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg	Woods, NB (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu	Woods, Niels-Bjarne/B-7390-2019	Woods, Niels-Bjarne/0000-0001-6052-922X				An DS, 2001, J VIROL, V75, P3547, DOI 10.1128/JVI.75.8.3547-3555.2001; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kersseboom R, 2003, J EXP MED, V198, P91, DOI 10.1084/jem.20030615; LARSON RC, 1995, ONCOGENE, V11, P853; Lo M, 1999, BLOOD, V94, P3027, DOI 10.1182/blood.V94.9.3027.421k11_3027_3036; Mendoza GJA, 2001, MOL THER, V3, P565, DOI 10.1006/mthe.2001.0292; Otsu M, 2000, HUM GENE THER, V11, P2051, DOI 10.1089/10430340050143462; Otsu M, 2000, MOL THER, V1, P145, DOI 10.1006/mthe.1999.0020; Otsu M, 2001, BLOOD, V97, P1618, DOI 10.1182/blood.V97.6.1618; Soudais C, 2000, BLOOD, V95, P3071, DOI 10.1182/blood.V95.10.3071.010k06_3071_3077; Whitwam T, 1998, BLOOD, V92, P1565, DOI 10.1182/blood.V92.5.1565.417k12_1565_1575	12	219	230	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1123	1123		10.1038/4401123a	http://dx.doi.org/10.1038/4401123a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641981	Bronze			2022-12-28	WOS:000237080000027
J	Trojer, P; Reinberg, D				Trojer, P; Reinberg, D			Histone lysine demethylases and their impact on epigenetics	CELL			English	Editorial Material							METHYLATION; BINDING; PROTEINS; REQUIRES; ZESTE; MARKS		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucle Acids Enzymol, Dept Biochem,Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucle Acids Enzymol, Dept Biochem,Howard Hughes Med Inst, Piscataway, NJ 08854 USA.	reinbedf@umdnj.edu		Reinberg, Danny/0000-0003-4288-2016				Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Reinberg D, 2004, COLD SPRING HARB SYM, V69, P171, DOI 10.1101/sqb.2004.69.171; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waddington C., 1957, STRATEGY GENES; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	22	163	171	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					213	217		10.1016/j.cell.2006.04.003	http://dx.doi.org/10.1016/j.cell.2006.04.003			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630806	Bronze			2022-12-28	WOS:000237241500008
J	Apesteguia, S; Zaher, H				Apesteguia, S; Zaher, H			A Cretaceous terrestrial snake with robust hindlimbs and a sacrum	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PACHYRHACHIS-PROBLEMATICUS; LIMBLESSNESS; EVOLUTION; SQUAMATA; LEGS	It has commonly been thought that snakes underwent progressive loss of their limbs by gradual diminution of their use(1). However, recent developmental and palaeontological discoveries suggest a more complex scenario of limb reduction, still poorly documented in the fossil record(2-5). Here we report a fossil snake with a sacrum supporting a pelvic girdle and robust, functional legs outside the ribcage. The new fossil, from the Upper Cretaceous period of Patagonia, fills an important gap in the evolutionary progression towards limblessness because other known fossil snakes with developed hindlimbs, the marine Haasiophis, Pachyrhachis and Eupodophis, lack a sacral region. Phylogenetic analysis shows that the new fossil is the most primitive (basal) snake known and that all other limbed fossil snakes are closer to the more advanced macrostomatan snakes, a group including boas, pythons and colubroids. The new fossil retains several features associated with a subterranean or surface dwelling life that are also present in primitive extant snake lineages, supporting the hypothesis of a terrestrial rather than marine origin of snakes.	Museo Argentino Ciencias Nat Bernardino Rivadavia, RA-1405 Buenos Aires, DF, Argentina; Univ Maimonides, Fdn Hist Nat Felix de Azara CEBBAD, RA-1405 Buenos Aires, DF, Argentina; Univ Sao Paulo, Museu Zool, BR-04263000 Sao Paulo, Brazil	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidade de Sao Paulo	Apesteguia, S (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, A Gallardo 470, RA-1405 Buenos Aires, DF, Argentina.	paleoninja@yahoo.com.ar; hzaher@ib.usp.br	Apesteguía, Sebastian/F-4034-2018; Fapesp, Biota/F-8655-2017; Zaher, Hussam/D-4000-2012; Zaher, Hussam/ABC-1701-2021	Apesteguía, Sebastian/0000-0002-0414-0524; Fapesp, Biota/0000-0002-9887-8449; Zaher, Hussam/0000-0002-6994-489X; Zaher, Hussam/0000-0002-6994-489X				Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Caldwell MW, 1997, NATURE, V386, P705, DOI 10.1038/386705a0; Caldwell MW, 2002, J VERTEBR PALEONTOL, V22, P861, DOI 10.1671/0272-4634(2002)022[0861:EPSOTC]2.0.CO;2; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Corbella Hugo, 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P227; Lee MSY, 1999, NATURE, V400, P655, DOI 10.1038/23236; Lee MSY, 2002, BIOL REV, V77, P333, DOI 10.1017/S1464793102005924; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Polcyn Michael J., 2005, Palaeontologia Electronica, V8, P1; Rage JC, 2000, CR ACAD SCI II A, V330, P513, DOI 10.1016/S1251-8050(00)00146-4; Rieppel O, 2002, J VERTEBR PALEONTOL, V22, P812, DOI 10.1671/0272-4634(2002)022[0812:TTPROT]2.0.CO;2; RIEPPEL O, 2000, FIELDIANA GEOL, V43, P1, DOI DOI 10.5962/BHL.TITLE.3584; Rieppel Olivier, 2004, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V32, P1; Scanlon JD, 2005, ACTA PALAEONTOL POL, V50, P139; Swofford D.L., 2003, PAUP VERSION 40 B10; Tchernov E, 2000, SCIENCE, V287, P2010, DOI 10.1126/science.287.5460.2010; Underwood G., 1977, C INTX CENT NATL REC, V266, P341; Zaher H, 2002, J VERTEBR PALEONTOL, V22, P104, DOI 10.1671/0272-4634(2002)022[0104:OTPROT]2.0.CO;2; Zaher H, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011029; Zaher H, 1999, CR ACAD SCI II A, V329, P831, DOI 10.1016/S1251-8050(00)88639-5	20	124	132	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1037	1040		10.1038/nature04413	http://dx.doi.org/10.1038/nature04413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625194				2022-12-28	WOS:000236906000033
J	Kesselheim, AS; Ferris, TG; Studdert, DM				Kesselheim, AS; Ferris, TG; Studdert, DM			Will physician-level measures of clinical performance be used in medical malpractice litigation?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIAC-SURGERY; JURORS; CARE		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Partners MGH Inst Hlth Policy, Div Gen Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Studdert, DM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	studdert@hsph.harvard.edu	Studdert, David/AAF-3116-2021; Kesselheim, Aaron/R-6793-2017	Studdert, David/0000-0003-0585-5537; Kesselheim, Aaron/0000-0002-8867-2666				[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Bowie Gavin M., 2002, S CAROLINA LAW REV, V54, P495; *CMS, 2004, CMS DOCT OFF QUAL PR; *CMS PHYS FOC QUAL, 2005, CHRON DIS PREV MEAS; COBLE Y, 2004, COMM FUND QUAL IMPR; Donohue Sharon King, 2002, Ann Health Law, V11, P147; GASH J, 2004, UTAH LAW REV, P1191; Hibbard Judith, 2004, Jt Comm J Qual Saf, V30, P347; *I MED, 2006, COMM RED HLTH INS PE; IMWINKELRIED EJ, 2003, UNCHARGED MISCONDUCT, V2, P4; Krumholz HM, 2002, JAMA-J AM MED ASSOC, V287, P1277, DOI 10.1001/jama.287.10.1277; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Lee TH, 2004, NEW ENGL J MED, V350, P2409, DOI 10.1056/NEJMsb041193; *NCQA, 2005, NCQA LAUDS NAT QUAL; PENNSYLVANIAS GUID, 2003, PENNS GUID COR ART B; ROBEZNIEKS A, 2004, ED CALLED KEY ACCEPT; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; SUE S, 1973, J APPL SOC PSYCHOL, V3, P345, DOI 10.1111/j.1559-1816.1973.tb02401.x; TEITELBAUM LE, 1983, WISC LAW REV, P1147; Terry Ken, 2004, Med Econ, V81, P45; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; WISSLER RL, 1985, LAW HUMAN BEHAV, V9, P37, DOI 10.1007/BF01044288	24	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1831	1834		10.1001/jama.295.15.1831	http://dx.doi.org/10.1001/jama.295.15.1831			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622145				2022-12-28	WOS:000236886900026
J	Smith-Bindman, R; Miglioretti, DL; Lurie, N; Abraham, L; Barbash, RB; Strzelczyk, J; Dignan, M; Barlow, WE; Beasley, CM; Kerlikowske, K				Smith-Bindman, R; Miglioretti, DL; Lurie, N; Abraham, L; Barbash, RB; Strzelczyk, J; Dignan, M; Barlow, WE; Beasley, CM; Kerlikowske, K			Does utilization of screening mammography explain racial and ethnic differences in breast cancer?	ANNALS OF INTERNAL MEDICINE			English	Article							WHITE WOMEN; BLACK-WOMEN; SOCIOECONOMIC-FACTORS; CARCINOMA SURVIVAL; AMERICAN WOMEN; UNITED-STATES; RACE; DIAGNOSIS; STAGE; DISPARITIES	Background: Reasons for persistent differences in breast cancer mortality rates among various racial and ethnic groups have been difficult to ascertain. Objective: To determine reasons for disparities in breast cancer outcomes across racial and ethnic groups. Design: Prospective cohort. Setting: The authors pooled data from 7 mammography registries that participate in the National Cancer Institute-funded'Breast Cancer Surveillance Consortium. Cancer diagnoses were ascertained through linkage with pathology databases; Surveillance, Epidemiology, and End Results programs; and state tumor registries. Participants: 1010515 women 40 years of age and older who had at least 1 mammogram between 1996 and 2002; 17558 of these women had diagnosed breast cancer. Measurements: Patterns of mammography and the probability of inadequate mammography screening were examined. The authors evaluated whether overall and advanced cancer rates were similar across racial and ethnic groups and whether these rates were affected by the use of mammography. Results: African-American, Hispanic, Asian, and Native American women were more likely than white women to have received inadequate mammographic screening (relative risk, 1.2 [95% Cl, 1.2 to 1.2], 1.3 [Cl, 1.2 to 1.3], 1.4 [Cl, 1.3 to 1.4], and 1.2 [Cl, 1.1 to 1.2) respectively). African-American women were more likely than white, Asian, and Native American women to have large, advanced-stage, high-grade, and lymph node-positive tumors of the breast. The observed differences in advanced cancer rates between African American and white women were attenuated or eliminated after the cohort was stratified by screening history. Among women who were previously screened at intervals of 4 to 41 months, African -American women were no more likely to have large, advanced-stage tumors or lymph node involvement than white women with the same screening history. African-American women had higher rates of high-grade tumors than white women regardless of screening history. The lower rates of advanced cancer among Asian and Native American women persisted when the cohort was stratified by mammography history. Limitations: Results are based on a cohort of women who had received mammographic evaluations. Conclusions: African-American women are less likely to receive adequate mammographic screening than white women, which may explain the higher prevalence of advanced breast tumors among African-American women. Tumor characteristics may also contribute to differences in cancer outcomes because African-American women have higher-grade tumors than white women regardless of screening. These results suggest that adherence to recommended mammography screening intervals may reduce breast cancer mortality rates.	Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94115 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; RAND Corp, Arlington, VA USA; NCI, Bethesda, MD 20892 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Kentucky, Prevent Res Ctr, Lexington, KY USA; Canc Res & Biostat, Seattle, WA USA; Univ N Carolina, Pembroke, NC USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Group Health Cooperative; RAND Corporation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Kentucky; Cancer Research & Biostatistics; University of North Carolina	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol, 1600 Divisadero St, San Francisco, CA 94115 USA.	Rebecca.Smith-Bindman@Radiology.UCSF.edu		Beasley, Cherry/0000-0002-2848-994X	NCI NIH HHS [U01CA86076, U01CA70040, U01CA70013, U01CA69976, U01CA63740, U01CA63736, U01CA63731, K07 CA86032, U01CA86082] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA086032, U01CA063731, U01CA086082, U01CA063736, U01CA070040, U01CA070013, U01CA063740, U01CA086076, U01CA069976] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; [Anonymous], 1997, AJCC CANC STAGING MA; Bach PB, 2002, JAMA-J AM MED ASSOC, V287, P2106, DOI 10.1001/jama.287.16.2106; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Breen N, 1996, BREAST CANCER RES TR, V40, P105, DOI 10.1007/BF01806006; Burns RB, 1996, ANN INTERN MED, V125, P173, DOI 10.7326/0003-4819-125-3-199608010-00002; Champion VL, 1998, AM J PREV MED, V14, P111, DOI 10.1016/S0749-3797(97)00021-4; Chang SW, 1996, CANCER, V78, P1395, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1395::AID-CNCR5>3.0.CO;2-K; CHEN VW, 1994, CANCER EPIDEM BIOMAR, V3, P127; Chu KC, 2003, CANCER, V97, P2853, DOI 10.1002/cncr.11411; Chu KC, 1996, JNCI-J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; DEGNAN D, 1992, AM J PUBLIC HEALTH, V82, P1386, DOI 10.2105/AJPH.82.10.1386; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Ernster VL, 2002, J NATL CANCER I, V94, P1546; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; FOX SA, 1991, MED CARE, V29, P1065, DOI 10.1097/00005650-199111000-00001; Gill KS, 2004, CANCER, V100, P139, DOI 10.1002/cncr.11878; GORDON NH, 1992, AM J EPIDEMIOL, V135, P609, DOI 10.1093/oxfordjournals.aje.a116340; GORDON NP, 1993, J NATL CANCER I, V85, P566, DOI 10.1093/jnci/85.7.566; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Haggstrom DA, 2005, CANCER, V104, P2347, DOI 10.1002/cncr.21443; Hankey, 1973, SEER CANC STAT REV; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; JONES BA, 1995, CANCER, V75, P2103, DOI 10.1002/1097-0142(19950415)75:8<2103::AID-CNCR2820750813>3.0.CO;2-2; Joslyn SA, 2000, CANCER-AM CANCER SOC, V88, P114, DOI 10.1002/(SICI)1097-0142(20000101)88:1<114::AID-CNCR16>3.0.CO;2-J; Kerlikowske K, 2005, ARCH INTERN MED, V165, P1862, DOI 10.1001/archinte.165.16.1862; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; May DS, 1998, ANN EPIDEMIOL, V8, P439, DOI 10.1016/S1047-2797(98)00010-6; McCarthy EP, 1998, ANN INTERN MED, V128, P729, DOI 10.7326/0003-4819-128-9-199805010-00005; NATARAJAN N, 1985, CANCER-AM CANCER SOC, V56, P1704, DOI 10.1002/1097-0142(19851001)56:7<1704::AID-CNCR2820560740>3.0.CO;2-L; Pearlman DN, 1996, AM J PREV MED, V12, P327, DOI 10.1016/S0749-3797(18)30287-3; Peek ME, 2004, J GEN INTERN MED, V19, P184, DOI 10.1111/j.1525-1497.2004.30254.x; Rosenberg J, 2005, BREAST CANCER RES TR, V89, P47, DOI 10.1007/s10549-004-1470-1; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; Singh GK, 2002, JNCI-J NATL CANCER I, V94, P916, DOI 10.1093/jnci/94.12.916; STEIN JA, 1991, J HEALTH SOC BEHAV, V32, P101, DOI 10.2307/2137146; Torck BJ, 1996, BREAST CANCER RES TR, V40, P11, DOI 10.1007/BF01805999; Tu SP, 2003, CANCER, V97, P1293, DOI 10.1002/cncr.11169; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; WELLS BL, 1992, AM J PUBLIC HEALTH, V82, P1383, DOI 10.2105/AJPH.82.10.1383; Yood MU, 1999, J NATL CANCER I, V91, P1487, DOI 10.1093/jnci/91.17.1487; Zapka JG, 1996, AM J PUBLIC HEALTH, V86, P1016, DOI 10.2105/AJPH.86.7.1016; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	256	260	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					541	553		10.7326/0003-4819-144-8-200604180-00004	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035QZ	16618951				2022-12-28	WOS:000237017900001
J	Egred, M; Andron, M; Morrison, WL				Egred, M; Andron, M; Morrison, WL			Nicorandil may be associated with gastrointestmal ulceration	BRITISH MEDICAL JOURNAL			English	Article									Ctr Cardiothorac, Liverpool L14 3PE, Merseyside, England		Egred, M (corresponding author), Ctr Cardiothorac, Liverpool L14 3PE, Merseyside, England.	m.egred@ctc.nhs.uk						Agbo-Godeau S, 1998, LANCET, V352, P1598, DOI 10.1016/S0140-6736(05)61045-8; Healy CM, 2004, HEART, V90, DOI 10.1136/hrt.2003.031831; King PM, 2004, SURG-J R COLL SURG E, V2, P56, DOI 10.1016/S1479-666X(04)80140-9; Reichert S, 1997, EUR J DERMATOL, V7, P132; Watson A, 2002, LANCET, V360, P546, DOI 10.1016/S0140-6736(02)09710-6	5	24	25	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 15	2006	332	7546					889	889		10.1136/bmj.332.7546.889	http://dx.doi.org/10.1136/bmj.332.7546.889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16613962	Bronze, Green Published			2022-12-28	WOS:000237132100020
J	Vonkeman, HE; Brouwers, JRBJ; van de Laar, MAFJ				Vonkeman, HE; Brouwers, JRBJ; van de Laar, MAFJ			Practice pointer - Understanding the NSAID related risk of vascular events	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; UPPER GASTROINTESTINAL TOXICITY; CONGESTIVE-HEART-FAILURE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; ROFECOXIB; NAPROXEN; CELECOXIB; CYCLOOXYGENASE-2		Med Spectrum Twente Hosp, Dept Rheumatol & Clin Immunol, Enschede, Netherlands; Univ Twente, NL-7500 AE Enschede, Netherlands; Univ Groningen, Inst Drug Explorat, Groningen, Netherlands; Groningen Res Inst Pharm, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, Groningen, Netherlands	Medical Spectrum Twente; University of Twente; University of Groningen; University of Groningen	Vonkeman, HE (corresponding author), Med Spectrum Twente Hosp, Dept Rheumatol & Clin Immunol, Enschede, Netherlands.	H.Vonkeman@ziekenhuis-mst.nl						Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; Fischer LM, 2004, ARCH INTERN MED, V164, P2472, DOI 10.1001/archinte.164.22.2472; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1065, DOI 10.1056/NEJM198404263101701; Fitzgerald GA, 2002, AM J CARDIOL, V89, p26D; *FOOD DRUG ADM, 2005, FDA AL PRACT CEL MAR; *FOOD DRUG ADM, 2005, BRIEF PACK NDA 21 CL; *FOOD DRUG ADM, 2005, FDA ANN SER CHANG CL; Furberg CD, 2005, CIRCULATION, V111, P249, DOI 10.1161/01.CIR.0000155081.76164.17; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Heerdink ER, 1998, ARCH INTERN MED, V158, P1108, DOI 10.1001/archinte.158.10.1108; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Knijff-Dutmer EAJ, 1999, ANN RHEUM DIS, V58, P257, DOI 10.1136/ard.58.4.257; KNIJFFDUTMER EAJ, 2004, RHEUMATOLOGY, V41, P458; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; *NIH, 2004, US NONST ANT DRUGS S; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Page J, 2000, ARCH INTERN MED, V160, P777, DOI 10.1001/archinte.160.6.777; Schonbeck U, 1999, AM J PATHOL, V155, P1281, DOI 10.1016/S0002-9440(10)65230-3; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; TANAKA Y, 1987, J BIOL CHEM, V262, P1374; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417	27	28	29	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2006	332	7546					895	898		10.1136/bmj.332.7546.895	http://dx.doi.org/10.1136/bmj.332.7546.895			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16613964	Green Published, Green Submitted			2022-12-28	WOS:000237132100022
J	Kling, MF; Siedschlag, C; Verhoef, AJ; Khan, JI; Schultze, M; Uphues, T; Ni, Y; Uiberacker, M; Drescher, M; Krausz, F; Vrakking, MJJ				Kling, MF; Siedschlag, C; Verhoef, AJ; Khan, JI; Schultze, M; Uphues, T; Ni, Y; Uiberacker, M; Drescher, M; Krausz, F; Vrakking, MJJ			Control of electron localization in molecular dissociation	SCIENCE			English	Article							INTENSE LASER FIELDS; WAVE-PACKET; DYNAMICS; H-2(+); PULSE	We demonstrated how the subcycle evolution of the electric field of light can be used to control the motion of bound electrons. Results are presented for the dissociative ionization of deuterium molecules (D(2) --> D(+) + D), where asymmetric ejection of the ionic fragment reveals that light-driven intramolecular electronic motion before dissociation localizes the electron on one of the two D(+) ions in a controlled way. The results extend subfemtosecond electron control to molecules and provide evidence of its usefulness in controlling reaction dynamics.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Univ Bielefeld, Fak Phys, D-33615 Bielefeld, Germany; Univ Munich, Dept Phys, D-85748 Garching, Germany; Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany	AMOLF; Max Planck Society; University of Bielefeld; University of Munich; University of Hamburg	Kling, MF (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.		Kling, Matthias F/D-3742-2014; Vrakking, Marc JJ/F-6770-2014; Uphues, Thorsten/D-1373-2014; Kling, Matthias Friedrich/AHH-0080-2022	Vrakking, Marc JJ/0000-0002-3249-1663; Uphues, Thorsten/0000-0003-3423-4510; Kling, Matthias Friedrich/0000-0002-1710-0775; Verhoef, Aart/0000-0003-2691-214X; Schultze, Martin/0000-0003-0438-9255				Alnaser AS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.183202; Alnaser AS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.163002; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bandrauk AD, 2004, INT J QUANTUM CHEM, V100, P834, DOI 10.1002/qua.20252; BUCKSBAUM PH, 1990, PHYS REV LETT, V64, P1883, DOI 10.1103/PhysRevLett.64.1883; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; Ivanov MY, 1993, LASER PHYS, V3, P375; Kawata I, 1999, J CHEM PHYS, V110, P11152, DOI 10.1063/1.478002; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Lindner F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040401; Niikura H, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.021402; Niikura H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.083003; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Paulus GG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.253004; Posthumus JH, 2004, REP PROG PHYS, V67, P623, DOI 10.1088/0034-4885/67/5/R01; Roudnev V, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163601; Sakai H, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.063404; Sandig K, 2000, PHYS REV LETT, V85, P4876, DOI 10.1103/PhysRevLett.85.4876; Yudin GL, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.051401	22	608	616	3	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					246	248		10.1126/science.1126259	http://dx.doi.org/10.1126/science.1126259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614216				2022-12-28	WOS:000236765300042
J	Mishra, G; Zhang, WH; Deng, F; Zhao, J; Wang, XM				Mishra, G; Zhang, WH; Deng, F; Zhao, J; Wang, XM			A bifurcating pathway directs abscisic acid effects on stomatal closure and opening in Arabidopsis	SCIENCE			English	Article							PROTEIN PHOSPHATASE 2C; CELL SIGNAL-TRANSDUCTION; GUARD-CELLS; PHOSPHOLIPASE-D; ALPHA-SUBUNIT; CA2+ SIGNALS; INTERACTS; PLANTS; ABA; CHANNELS	Terrestrial plants lose water primarily through stomata, pores on the leaves. The hormone abscisic acid (ABA) decreases water loss by regulating opening and closing of stomata. Here, we show that phospholipase D alpha 1 (PLD alpha 1) mediates the ABA effects on stomata through interaction with a protein phosphatase 2C (PP2C) and a heterotrimeric GTP-binding protein ( G protein) in Arabidopsis. PLD alpha 1-produced phosphatidic acid (PA) binds to the ABI1 PP2C to signal ABA-promoted stomatal closure, whereas PLD alpha 1 and PA interact with the G alpha subunit of heterotrimeric G protein to mediate ABA inhibition of stomatal opening. The results reveal a bifurcating signaling pathway that regulates plant water loss.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Zhao, Jian/Q-8591-2019; Wang, Xuemin/M-2853-2013; Zhao, Jian/A-2336-2008	Zhao, Jian/0000-0002-4416-7334; wang, xuemin/0000-0002-6251-6745				Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Hunt L, 2003, PLANT J, V34, P47, DOI 10.1046/j.1365-313X.2003.01698.x; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Lein W, 2001, BBA-MOL CELL BIOL L, V1530, P172, DOI 10.1016/S1388-1981(00)00182-7; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Sanchez JP, 2004, PLANT J, V38, P381, DOI 10.1111/j.1365-313X.2004.02055.x; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Wang XM, 2005, PLANT PHYSIOL, V139, P566, DOI 10.1104/pp.105.068809; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200	24	302	342	6	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2006	312	5771					264	266		10.1126/science.1123769	http://dx.doi.org/10.1126/science.1123769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614222				2022-12-28	WOS:000236765300048
J	Castellino, F; Huang, AY; Altan-Bonnet, G; Stoll, S; Scheinecker, C; Germain, RN				Castellino, F; Huang, AY; Altan-Bonnet, G; Stoll, S; Scheinecker, C; Germain, RN			Chemokines enhance immunity by guiding naive CD8(+) T cells to sites of CD4 T cell-dendritic cell interaction	NATURE			English	Article							LYMPH-NODES; IN-VIVO; CD8-T-CELL MEMORY; CD4-T-CELL HELP; LYMPHOCYTES; EXPRESSION; ANTIGEN; MIGRATION; GENERATION; MOTILITY	CD8(+) T cells have a crucial role in resistance to pathogens and can kill malignant cells; however, some critical functions of these lymphocytes depend on helper activity provided by a distinct population of CD4(+) T cells. Cooperation between these lymphocyte subsets involves recognition of antigens co-presented by the same dendritic cell, but the frequencies of such antigen-bearing cells early in an infection and of the relevant naive T cells are both low. This suggests that an active mechanism facilitates the necessary cell-cell associations. Here we demonstrate that after immunization but before antigen recognition, naive CD8(+) T cells in immunogen-draining lymph nodes upregulate the chemokine receptor CCR5, permitting these cells to be attracted to sites of antigen-specific dendritic cell-CD4(+) T cell interaction where the cognate chemokines CCL3 and CCL4 (also known as MIP-1 alpha and MIP-1 beta) are produced. Interference with this actively guided recruitment markedly reduces the ability of CD4(+) T cells to promote memory CD8(+) T-cell generation, indicating that an orchestrated series of differentiation events drives nonrandom cell-cell interactions within lymph nodes, optimizing CD8(+) T-cell immune responses involving the few antigen-specific precursors present in the naive repertoire.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Johannes Gutenberg Univ Mainz, Dept Dermatol, D-55131 Mainz, Germany; Med Univ Vienna, Dept Rheumatol, Gen Hosp Vienna, A-1090 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Memorial Sloan Kettering Cancer Center; Johannes Gutenberg University of Mainz; Medical University of Vienna	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Huang, Alex Y./ABG-8182-2021; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Huang, Alex Y./0000-0002-5701-4521; Altan-Bonnet, Gregoire/0000-0002-7283-3162	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000758, Z01AI000758] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; GERMAIN RN, IN PRESS ANN REV IMM; Guan E, 2001, J BIOL CHEM, V276, P12404, DOI 10.1074/jbc.M006327200; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; HALL JG, 1965, BRIT J EXP PATHOL, V46, P450; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nagorsen D, 2004, CYTOKINE, V25, P31, DOI 10.1016/j.cyto.2003.08.012; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SHERRY B, 1988, J EXP MED, V168, P2251, DOI 10.1084/jem.168.6.2251; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160	38	578	597	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					890	895		10.1038/nature04651	http://dx.doi.org/10.1038/nature04651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612374				2022-12-28	WOS:000236736700031
J	Thorens, B				Thorens, B			A toggle for type 2 diabetes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSULIN-SECRETION; MICE		Univ Lausanne, Dept Physiol, Lausanne, Switzerland; Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Thorens, B (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.							Guillam MT, 1997, NAT GENET, V17, P503, DOI 10.1038/ng1297-503b; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1636	1638		10.1056/NEJMcibr060422	http://dx.doi.org/10.1056/NEJMcibr060422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611957	Green Published			2022-12-28	WOS:000236736900017
J	Hara, T; Nakamura, K; Matsui, M; Yamamoto, A; Nakahara, Y; Suzuki-Migishima, R; Yokoyama, M; Mishima, K; Saito, I; Okano, H; Mizushima, N				Hara, Taichi; Nakamura, Kenji; Matsui, Makoto; Yamamoto, Akitsugu; Nakahara, Yohko; Suzuki-Migishima, Rika; Yokoyama, Minesuke; Mishima, Kenji; Saito, Ichiro; Okano, Hideyuki; Mizushima, Noboru			Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice	NATURE			English	Article							CEREBELLAR PURKINJE-CELLS; TRANSGENIC MICE; NEURONAL DEATH; MUTANT MOUSE; POLYGLUTAMINE; AGGRESOMES; HUNTINGTIN; PROTEIN; GENE; DEGRADATION	Autophagy is an intracellular bulk degradation process through which a portion of the cytoplasm is delivered to lysosomes to be degraded(1-4). Although the primary role of autophagy in many organisms is in adaptation to starvation, autophagy is also thought to be important for normal turnover of cytoplasmic contents, particularly in quiescent cells such as neurons. Autophagy may have a protective role against the development of a number of neurodegenerative diseases(5-8). Here we report that loss of autophagy causes neurodegeneration even in the absence of any disease-associated mutant proteins. Mice deficient for Atg5 (autophagy-related 5) specifically in neural cells develop progressive deficits in motor function that are accompanied by the accumulation of cytoplasmic inclusion bodies in neurons. In Atg5(-/-) cells, diffuse, abnormal intracellular proteins accumulate, and then form aggregates and inclusions. These results suggest that the continuous clearance of diffuse cytosolic proteins through basal autophagy is important for preventing the accumulation of abnormal proteins, which can disrupt neural function and ultimately lead to neurodegeneration.	Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan; Mitsubishi Kagaku Inst Life Sci, Mouse Genome Technol Lab, Tokyo, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan; Niigata Univ, Brain Res Inst, Niigata 9518510, Japan; Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa 2308501, Japan; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan; Japan Sci & Technol Agcy, SORST, Kawaguchi 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Niigata University; Tsurumi University; Keio University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Mizushima, N (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan.	nmizu@rinshoken.or.jp	Mizushima, Noboru/C-3635-2009; Okano, Hideyuki/I-7584-2019	Mizushima, Noboru/0000-0002-6258-6444; 				Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Fortun J, 2003, J NEUROSCI, V23, P10672; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KIKUCHI T, 1990, ACTA NEUROPATHOL, V80, P145, DOI 10.1007/BF00308917; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuemmerle S, 1999, ANN NEUROL, V46, P842; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lossi L, 2002, NEUROSCIENCE, V112, P509, DOI 10.1016/S0306-4522(02)00112-4; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SOTELO C, 1990, J NEUROCYTOL, V19, P737, DOI 10.1007/BF01188042; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; YAMAMOTO A, 1991, CELL STRUCT FUNCT, V16, P419, DOI 10.1247/csf.16.419	30	2963	3071	19	407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					885	889		10.1038/nature04724	http://dx.doi.org/10.1038/nature04724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16625204				2022-12-28	WOS:000238254100045
J	Newman, TB; Liljestrand, P; Jeremy, RJ; Ferriero, DM; Wu, YW; Hudes, ES; Escobar, GJ				Newman, TB; Liljestrand, P; Jeremy, RJ; Ferriero, DM; Wu, YW; Hudes, ES; Escobar, GJ		Jaunde Infant Feeding Study	Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	56th Annual Meeting of the American-Academy-of-Pediatrics	OCT 08-10, 2004	San Francisco, CA	Amer Acad Pediat			NEONATAL HYPERBILIRUBINEMIA; CEREBRAL-PALSY; FOLLOW-UP; ERYTHROBLASTOSIS FETALIS; TERM; HEALTH; INTELLIGENCE; PERFORMANCE; CHILDREN; INFANTS	BACKGROUND: The neurodevelopmental risks associated with high total serum bilirubin levels in newborns are not well defined. METHODS: We identified 140 infants with neonatal total serum bilirubin levels of at least 25 mg per deciliter (428 micromol per liter) and 419 randomly selected controls from a cohort of 106,627 term and near-term infants born from 1995 through 1998 in Kaiser Permanente hospitals in northern California. Data on outcomes were obtained from electronic records, interviews, responses to questionnaires, and neurodevelopmental evaluations that had been performed in a blinded fashion. RESULTS: Peak bilirubin levels were between 25 and 29.9 mg per deciliter (511 micromol per liter) in 130 of the newborns with hyperbilirubinemia and 30 mg per deciliter (513 micromol per liter) or more in 10 newborns; treatment involved phototherapy in 136 cases and exchange transfusion in 5. Follow-up data to the age of at least two years were available for 132 of 140 children with a history of hyperbilirubinemia (94 percent) and 372 of 419 controls (89 percent) and included formal evaluation at a mean (+/-SD) age of 5.1+/-0.12 years for 82 children (59 percent) and 168 children (40 percent), respectively. There were no cases of kernicterus. Neither crude nor adjusted scores on cognitive tests differed significantly between the two groups; on most tests, 95 percent confidence intervals excluded a 3-point (0.2 SD) decrease in adjusted scores in the hyperbilirubinemia group. There was no significant difference between groups in the proportion of children with abnormal neurologic findings on physical examination or with documented diagnoses of neurologic abnormalities. Fourteen of the children with hyperbilirubinemia (17 percent) had ``questionable'' or abnormal findings on neurologic examination, as compared with 48 controls (29 percent; P=0.05; adjusted odds ratio, 0.47; 95 percent confidence interval, 0.23 to 0.98; P=0.04). The frequencies of parental concern and reported behavioral problems also were not significantly different between the two groups. Within the hyperbilirubinemia group, those with positive direct antiglobulin tests had lower scores on cognitive testing but not more neurologic or behavioral problems. CONCLUSIONS: When treated with phototherapy or exchange transfusion, total serum bilirubin levels in the range included in this study were not associated with adverse neurodevelopmental outcomes in infants born at or near term.	Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; Kaiser Permanente Med Ctr, Dept Pediat, Walnut Creek, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente	Newman, TB (corresponding author), Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.				NCRR NIH HHS [M01 RR01271] Funding Source: Medline; NINDS NIH HHS [R01 NS39683] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039683] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; *AM AC PED SUBC HY, 2004, PEDIATRICS, V0114, P01138; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Atkinson LR, 2003, PEDIATRICS, V111, pE555, DOI 10.1542/peds.111.5.e555; BEERY KE, 1997, BEERYBUKTENICA DEV T; Civic D, 2000, Matern Child Health J, V4, P215, DOI 10.1023/A:1026667720478; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; DAY R, 1954, PEDIATRICS, V13, P333; Escobar GJ, 2002, ARCH PEDIAT ADOL MED, V156, P155, DOI 10.1001/archpedi.156.2.155; Glascoe FP, 1998, COLLABORATING PARENT; Grimmer I, 1999, ACTA PAEDIATR, V88, P661, DOI 10.1080/08035259950169341; Gwynne K, 2004, J PAEDIATR CHILD H, V40, P369, DOI 10.1111/j.1440-1754.2004.00404.x; HOLMES GE, 1968, AM J DIS CHILD, V116, P37, DOI 10.1001/archpedi.1968.02100020039005; HYMAN CB, 1969, AM J DIS CHILD, V117, P395, DOI 10.1001/archpedi.1969.02100030397002; Ip S, 2004, PEDIATRICS, V114, pE130, DOI 10.1542/peds.114.1.e130; JOHNSTON WH, 1967, PEDIATRICS, V39, P88; MADAN A, 2004, AVERYS DIS NEWBORN, P1247; Maisels MJ, 2004, PEDIATRICS, V114, P297; NEWMAN TB, 1993, PEDIATRICS, V92, P651; NEWMAN TB, 1990, CLIN PERINATOL, V17, P331, DOI 10.1016/S0095-5108(18)30571-2; Newman TB, 2003, PEDIATRICS, V111, P1303, DOI 10.1542/peds.111.6.1303; Newman TB, 2002, PEDIATRICS, V110, P1032, DOI 10.1542/peds.110.5.1032; Newman TB, 2000, ARCH PEDIAT ADOL MED, V154, P1140, DOI 10.1001/archpedi.154.11.1140; Newman TB, 1999, PEDIATRICS, V104, P1198; NILSEN ST, 1984, ACTA PAEDIATR SCAND, V73, P176, DOI 10.1111/j.1651-2227.1984.tb09924.x; Ozmert E, 1996, ACTA PAEDIATR, V85, P1440, DOI 10.1111/j.1651-2227.1996.tb13949.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SCHEIDT PC, 1991, PEDIATRICS, V87, P797; SEIDMAN DS, 1991, PEDIATRICS, V88, P828; Soorani-Lunsing I, 2001, PEDIATR RES, V50, P701, DOI 10.1203/00006450-200112000-00012; Watchko JF, 2005, PEDIATRICS, V115, P1747, DOI 10.1542/peds.2004-1748; Wechsler D., 2014, WECHSLER PRESCHOOL P; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wu YW, 2005, J PEDIATR NEUROL, V3, P141; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677; Yilmaz Y, 2001, Indian Pediatr, V38, P165	36	126	140	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1889	1900		10.1056/NEJMoa054244	http://dx.doi.org/10.1056/NEJMoa054244			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	038RE	16672700				2022-12-28	WOS:000237239900005
J	Mounier-Jack, S; Coker, RJ				Mounier-Jack, S; Coker, RJ			How prepared is Europe for pandemic influenza? Analysis of national plans	LANCET			English	Article								Background The threat of a human pandemic of influenza has prompted urgent development of national preparedness plans. We assessed these plans, to judge Europe's preparedness for pandemic influenza. Methods Published national pandemic influenza preparedness plans from the European Union countries, the two acceding countries (Bulgaria and Romania), Norway, and Switzerland, were evaluated against criteria taken from a WHO checklist. Plans were eligible for inclusion if formally published between Jan 1, 2002, and Nov 30, 2005. Findings 21 national plans were eligible for inclusion for analysis. Although preparation for surveillance, planning and coordination, and communication were good, maintenance of essential services, putting plans into action, and public-health interventions were probably inadequate. Few countries have addressed in their plans the need for collaboration with adjacent countries, despite this being an acknowledged imperative. Similarly, plans for the timely distribution of available medical supplies are notably absent. Interpretation Governmental commitment in most European countries is strong, and levels of preparedness are broadly good. However, gaps in preparedness planning remain, and substantial variations exist between countries, with important implications for the region and nation states. improved cooperation between countries may be needed to share experience, and to ensure coherence of approaches.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, RJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	richard.coker@lshtm.ac.uk						CIOTTI M, 2005, EUROSURVEILL WKLY, V10, P136; *EU AG, 2005, EU PAND PREP BE COMP; Mounier-Jack S, 2006, EUR J PUBLIC HEALTH, V16, P119, DOI 10.1093/eurpub/ckl034; MOUNIERJACK S, PREPARED IS EUROPE P; Paget W J, 2001, Euro Surveill, V6, P136; Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A; University of Toronto Joint Center for Bioethics, 2005, STAND GUARD THEE ETH; WHO, 2004, WHOCDSCSRRMD20048; *WHO, 2005, WHOCDSCSRGIP20058; WHO, 2005, WHOCDSCSRGIP20054; *WHO EC, 2005, 2 JOINT WHO EC WORKS; World Health Organization, 2005, WHO GLOB INFL PREP P; 2005, LANCET INFECT DIS, V5, P191	13	129	132	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1405	1411		10.1016/S0140-6736(06)68511-5	http://dx.doi.org/10.1016/S0140-6736(06)68511-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650650				2022-12-28	WOS:000237195600028
J	Gattinoni, L; Caironi, P; Cressoni, M; Chiumello, D; Ranieri, VM; Quintel, M; Russo, S; Patroniti, N; Cornejo, R; Bugedo, G				Gattinoni, L; Caironi, P; Cressoni, M; Chiumello, D; Ranieri, VM; Quintel, M; Russo, S; Patroniti, N; Cornejo, R; Bugedo, G			Lung recruitment in patients with the acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							END-EXPIRATORY PRESSURES; MECHANICAL VENTILATION; PROTECTIVE-VENTILATION; FAILURE; MANEUVERS; MORTALITY; INJURY; ARDS	Background: In the acute respiratory distress syndrome (ARDS), positive end-expiratory pressure (PEEP) may decrease ventilator-induced lung injury by keeping lung regions open that otherwise would be collapsed. Since the effects of PEEP probably depend on the recruitability of lung tissue, we conducted a study to examine the relationship between the percentage of potentially recruitable lung, as indicated by computed tomography (CT), and the clinical and physiological effects of PEEP. Methods: Sixty-eight patients with acute lung injury or ARDS underwent whole-lung CT during breath-holding sessions at airway pressures of 5, 15, and 45 cm of water. The percentage of potentially recruitable lung was defined as the proportion of lung tissue in which aeration was restored at airway pressures between 5 and 45 cm of water. Results: The percentage of potentially recruitable lung varied widely in the population, accounting for a mean (+/-SD) of 13+/-11 percent of the lung weight, and was highly correlated with the percentage of lung tissue in which aeration was maintained after the application of PEEP (r(sup 2)=0.72, P < 0.001). On average, 24 percent of the lung could not be recruited. Patients with a higher percentage of potentially recruitable lung (greater than the median value of 9 percent) had greater total lung weights (P < 0.001), poorer oxygenation (defined as a ratio of partial pressure of arterial oxygen to fraction of inspired oxygen) (P < 0.001) and respiratory-system compliance (P=0.002), higher levels of dead space (P=0.002), and higher rates of death (P=0.02) than patients with a lower percentage of potentially recruitable lung. The combined physiological variables predicted, with a sensitivity of 71 percent and a specificity of 59 percent, whether a patient's proportion of potentially recruitable lung was higher or lower than the median. Conclusions: In ARDS, the percentage of potentially recruitable lung is extremely variable and is strongly associated with the response to PEEP.	Univ Milan, Fdn IRCCS, Osped Maggiore Policlin, I-20122 Milan, Italy; Univ Turin, Azienda Osped San Giovanni Battista Molinette, Dipartimento Anestesia, Turin, Italy; Univ Klinikum Gottingen, Gottingen, Germany; Univ Studi Milano Bicocca, Azienda Osped San Gerardo Monza, Dipartimento Med Perioperat & Terapia Intens, Milan, Italy; Pontificia Univ Catolica Chile, Fac Med, Dept Anestesiol & Med Intens, Santiago, Chile	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Gottingen; University of Milano-Bicocca; Pontificia Universidad Catolica de Chile	Gattinoni, L (corresponding author), Univ Milan, Fdn IRCCS, Osped Maggiore Policlin, Via F Sforza 35, I-20122 Milan, Italy.	gattinon@policlinico.mi.it	Ranieri, Marco/AFX-8152-2022; Cressoni, Massimo/B-7315-2017; Patroniti, Nicolo/K-6347-2016	Cressoni, Massimo/0000-0002-0089-2905; Gattinoni, Luciano/0000-0001-5380-2494; Patroniti, Nicolo/0000-0003-3600-193X; Caironi, Pietro/0000-0003-0490-0818; CHIUMELLO, DAVIDE ALBERTO/0000-0001-9260-3930				*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; ASHBAUGH DG, 1967, LANCET, V2, P319; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2004, CRIT CARE MED, V32, P907; Crotti S, 2001, AM J RESP CRIT CARE, V164, P131, DOI 10.1164/ajrccm.164.1.2007011; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; GATTINONI L, 1980, LANCET, V2, P292; GATTINONI L, 1993, JAMA-J AM MED ASSOC, V269, P2122, DOI 10.1001/jama.269.16.2122; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; GATTINONI L, 1993, JAMA-J AM MED ASSOC, V270, P1814; Gattinoni L, 2003, EUR RESPIR J, V22, p15S, DOI 10.1183/09031936.03.00021303; Grasso S, 2005, AM J RESP CRIT CARE, V171, P1002, DOI 10.1164/rccm.200407-940OC; Grasso S, 2002, ANESTHESIOLOGY, V96, P795, DOI 10.1097/00000542-200204000-00005; HICKLING KG, 1990, INTENS CARE MED, V16, P372, DOI 10.1007/BF01735174; KOLOBOW T, 1987, AM REV RESPIR DIS, V135, P312; LACHMANN B, 1992, INTENS CARE MED, V18, P319, DOI 10.1007/BF01694358; Lapinsky SE, 2005, CRIT CARE, V9, P60, DOI 10.1186/cc2934; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2004, NEW ENGL J MED, V351, P389, DOI 10.1056/NEJMe048103; Papadakos PJ, 2002, MT SINAI J MED, V69, P73; PELOSI P, 1994, AM J RESP CRIT CARE, V149, P8, DOI 10.1164/ajrccm.149.1.8111603; Piacentini E, 2004, CRIT CARE, V8, P115, DOI 10.1186/cc2364; PONTOPPIDAN H, 1972, NEW ENGL J MED, V287, P799, DOI 10.1056/NEJM197210192871605; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Terashima T, 1996, AM J RESP CRIT CARE, V153, P1600, DOI 10.1164/ajrccm.153.5.8630608; Villagra A, 2002, AM J RESP CRIT CARE, V165, P165, DOI 10.1164/ajrccm.165.2.2104092; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	30	932	999	2	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1775	1786		10.1056/NEJMoa052052	http://dx.doi.org/10.1056/NEJMoa052052			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641394				2022-12-28	WOS:000237077100003
J	Springel, V; Frenk, CS; White, SDM				Springel, V; Frenk, CS; White, SDM			The large-scale structure of the Universe	NATURE			English	Review							LYMAN-ALPHA FOREST; GALAXY REDSHIFT SURVEY; DIGITAL SKY SURVEY; COLD DARK-MATTER; MICROWAVE BACKGROUND ANISOTROPY; QSO ABSORPTION-SPECTRA; POWER-SPECTRUM; COSMOLOGICAL PARAMETERS; INFLATIONARY-UNIVERSE; GRAVITATIONAL LENSES	Research over the past 25 years has led to the view that the rich tapestry of present-day cosmic structurearose during the first instants of creation, where weak ripples were imposed on the otherwise uniform and rapidly expanding primordial soup. Over 14 billion years of evolution, these ripples have been amplified to enormous proportions by gravitational forces, producing ever-growing concentrations of dark matter in which ordinary gases cool, condense and fragment to make galaxies. This process can be faithfully mimicked in large computer simulations, and tested by observations that probe the history of the Universe starting from just 400,000 years after the Big Bang.	Max Planck Inst Astrophys, D-85740 Garching, Germany; Univ Durham, Dept Phys, Inst Computat Cosmol, Durham DH1 3LE, England	Max Planck Society; Durham University	Springel, V (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85740 Garching, Germany.	vspringel@mpa-garching.mpg.de	Frenk, Carlos/Z-3084-2019; White, Simon/Y-2399-2019	White, Simon/0000-0002-1061-6154; Frenk, Carlos/0000-0002-2338-716X; Springel, Volker/0000-0001-5976-4599				Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Adelberger KL, 1998, ASTROPHYS J, V505, P18, DOI 10.1086/306162; Aguirre A, 2005, ASTROPHYS J, V620, pL13, DOI 10.1086/428498; Aguirre A, 2001, ASTROPHYS J, V561, P550, DOI 10.1086/323376; Aharonian F, 2004, ASTRON ASTROPHYS, V425, pL13, DOI 10.1051/0004-6361:200400055; ALLEN B, 1988, PHYS REV D, V37, P2078, DOI 10.1103/PhysRevD.37.2078; Allen SW, 2003, MON NOT R ASTRON SOC, V342, P287, DOI 10.1046/j.1365-8711.2003.06550.x; Angulo R, 2005, MON NOT R ASTRON SOC, V362, pL25, DOI 10.1111/j.1745-3933.2005.00067.x; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; Baugh CM, 1998, ASTROPHYS J, V498, P504, DOI 10.1086/305563; Bekenstein JD, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.083509; Benson AJ, 2000, MON NOT R ASTRON SOC, V311, P793, DOI 10.1046/j.1365-8711.2000.03101.x; Benson AJ, 2002, MON NOT R ASTRON SOC, V333, P177, DOI 10.1046/j.1365-8711.2002.05388.x; Bergstrom L, 1998, ASTROPART PHYS, V9, P137, DOI 10.1016/S0927-6505(98)00015-2; Blanchard A, 2003, ASTRON ASTROPHYS, V412, P35, DOI 10.1051/0004-6361:20031425; Bond JR, 1996, NATURE, V380, P603, DOI 10.1038/380603a0; Borgani S, 2001, ASTROPHYS J, V561, P13, DOI 10.1086/323214; Boyle LA, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.127302; Bullock JS, 2001, ASTROPHYS J, V548, P33, DOI 10.1086/318681; CEN R, 1994, APJ, V437, P9; Chiang LY, 2003, ASTROPHYS J, V590, pL65, DOI 10.1086/376822; Ciardi B, 2003, MON NOT R ASTRON SOC, V344, pL7, DOI 10.1046/j.1365-8711.2003.06976.x; Clowe D, 2000, ASTROPHYS J, V539, P540, DOI 10.1086/309242; Cole S, 2005, MON NOT R ASTRON SOC, V362, P505, DOI 10.1111/j.1365-2966.2005.09318.x; Colless M, 2001, MON NOT R ASTRON SOC, V328, P1039, DOI 10.1046/j.1365-8711.2001.04902.x; Contaldi CR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.221303; Croft RAC, 2002, ASTROPHYS J, V581, P20, DOI 10.1086/344099; Croft RAC, 1998, ASTROPHYS J, V495, P44, DOI 10.1086/305289; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; DAVIS M, 1985, ASTROPHYS J, V292, P371, DOI 10.1086/163168; de Bernardis P, 2000, NATURE, V404, P955, DOI 10.1038/35010035; de Blok WJG, 2001, ASTROPHYS J, V552, pL23, DOI 10.1086/320262; De Lucia G, 2006, MON NOT R ASTRON SOC, V366, P499, DOI 10.1111/j.1365-2966.2005.09879.x; de Oliveira-Costa A, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.063516; Eke VR, 1998, MON NOT R ASTRON SOC, V298, P1145, DOI 10.1046/j.1365-8711.1998.01713.x; Eriksen HK, 2004, ASTROPHYS J, V605, P14, DOI 10.1086/382267; Evrard AE, 2002, ASTROPHYS J, V573, P7, DOI 10.1086/340551; Fischer P, 2000, ASTRON J, V120, P1198, DOI 10.1086/301540; Gallagher JS, 2005, ASTROPHYS J, V634, P210, DOI 10.1086/491664; GELLER MJ, 1989, SCIENCE, V246, P897, DOI 10.1126/science.246.4932.897; Giavalisco M, 1998, ASTROPHYS J, V503, P543, DOI 10.1086/306027; Gott JR, 2005, ASTROPHYS J, V624, P463, DOI 10.1086/428890; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; Haiman Z, 2001, ASTROPHYS J, V553, P545, DOI 10.1086/320939; Hamuy M, 1996, ASTRON J, V112, P2438, DOI 10.1086/118193; Hanany S, 2000, ASTROPHYS J, V545, pL5, DOI 10.1086/317322; Hayashi E, 2004, MON NOT R ASTRON SOC, V355, P794, DOI 10.1111/j.1365-2966.2004.08359.x; Hernquist L, 1996, ASTROPHYS J, V457, pL51, DOI 10.1086/309899; Hoflich P, 1998, ASTROPHYS J, V495, P617, DOI 10.1086/305327; HUETSI G, 2005, ARXIVASTROPH0512201; Jaffe TR, 2005, ASTROPHYS J, V629, pL1, DOI 10.1086/444454; KAISER N, 1992, ASTROPHYS J, V388, P272, DOI 10.1086/171151; KAISER N, 1984, ASTROPHYS J, V284, pL9, DOI 10.1086/184341; Kim TS, 2004, MON NOT R ASTRON SOC, V347, P355, DOI 10.1111/j.1365-2966.2004.07221.x; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Kochanek CS, 2004, ASTROPHYS J, V610, P69, DOI 10.1086/421436; Kovac JM, 2002, NATURE, V420, P772, DOI 10.1038/nature01269; LACEY C, 1993, MON NOT R ASTRON SOC, V262, P627, DOI 10.1093/mnras/262.3.627; Land K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.071301; Leitch EM, 2002, NATURE, V420, P763, DOI 10.1038/nature01271; Lyth DH, 1997, PHYS REV LETT, V78, P1861, DOI 10.1103/PhysRevLett.78.1861; MANDELBAUM R, 2005, ARXIVASTROPH0511164; MASJEDI M, 2005, ARXIVASTROPH0512166; McDonald P, 2005, MON NOT R ASTRON SOC, V360, P1471, DOI 10.1111/j.1365-2966.2005.09141.x; Mo HJ, 1996, ASTROPHYS J, V467, pL9, DOI 10.1086/310190; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Netterfield CB, 2002, ASTROPHYS J, V571, P604, DOI 10.1086/340118; Oguri M, 2005, ASTROPHYS J, V632, P841, DOI 10.1086/452629; PEEBLES PJE, 1970, ASTROPHYS J, V162, P815, DOI 10.1086/150713; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pierce A, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.075006; PRESS WH, 1974, ASTROPHYS J, V187, P425, DOI 10.1086/152650; Reed DS, 2005, MON NOT R ASTRON SOC, V363, P393, DOI 10.1111/j.1365-2966.2005.09416.x; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Sanchez AG, 2006, MON NOT R ASTRON SOC, V366, P189, DOI [10.1111/j.1365-2966.2005.09833.x, 10.1111/J.1365-2966.2005.09833.X]; SAUNDERS W, 1991, NATURE, V349, P32, DOI 10.1038/349032a0; Seljak U, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.103515; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; STAROBINSKY AA, 1982, PHYS LETT B, V117, P175, DOI 10.1016/0370-2693(82)90541-X; SUNYAEV RA, 1970, ASTROPHYS SPACE SCI, V7, P3; Tegmark M, 2004, ASTROPHYS J, V606, P702, DOI 10.1086/382125; Travaglio C, 2005, ASTRON ASTROPHYS, V443, P1007, DOI 10.1051/0004-6361:20052883; Van Waerbeke L, 2005, ASTRON ASTROPHYS, V429, P75, DOI 10.1051/0004-6361:20041513; Van Waerbeke L, 2001, ASTRON ASTROPHYS, V374, P757, DOI 10.1051/0004-6361:20010766; Viel M, 2004, MON NOT R ASTRON SOC, V355, pL23, DOI 10.1111/j.1365-2966.2004.08498.x; Viel M, 2004, MON NOT R ASTRON SOC, V354, P684, DOI 10.1111/j.1365-2966.2004.08224.x; WEINBERG S, 1989, REV MOD PHYS, V61, P1, DOI 10.1103/RevModPhys.61.1; WHITE SDM, 1993, NATURE, V366, P429, DOI 10.1038/366429a0; WHITE SDM, 1983, ASTROPHYS J, V274, pL1, DOI 10.1086/184139; Wilson G, 2001, ASTROPHYS J, V555, P572, DOI 10.1086/321441; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Zwicky F, 1937, PHYS REV, V51, P290, DOI 10.1103/PhysRev.51.290; Zwicky F., 1933, HELV PHYS ACTA, V6, P110, DOI [DOI 10.1007/S10714-008-0707-4, 10.1007/s10714-008-0707-4]	101	477	480	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1137	1144		10.1038/nature04805	http://dx.doi.org/10.1038/nature04805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641985	Green Submitted			2022-12-28	WOS:000237080000034
J	Zink, TM				Zink, TM			Dog pals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												Zink0003@umn.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1877	1878		10.1001/jama.295.16.1877	http://dx.doi.org/10.1001/jama.295.16.1877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639037				2022-12-28	WOS:000237059200001
J	Partridge, J				Partridge, J			Patient's journey - From burns unit to boardroom	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Changing Faces, London WC1E 6JN, England		Partridge, J (corresponding author), Changing Faces, London WC1E 6JN, England.	jamesp@changingfaces.org.uk							0	13	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					956	959		10.1136/bmj.332.7547.956	http://dx.doi.org/10.1136/bmj.332.7547.956			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627513	Green Published			2022-12-28	WOS:000237143900020
J	Tesmer, JJG				Tesmer, JJG			Hitting the hot spots of cell signaling cascades	SCIENCE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS; BETA-GAMMA-SUBUNITS; HETEROTRIMERIC G-PROTEIN; BINDING; INTERFACES; EFFECTORS		Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), Univ Michigan, Inst Life Sci, Dept Pharmacol, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	tesmerjj@umich.edu		Tesmer, John/0000-0003-1125-3727				Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; BUCK E, 2003, SCI STKE; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Iaccarino G, 2003, ASSAY DRUG DEV TECHN, V1, P347, DOI 10.1089/154065803321204484; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; Sidhu SS, 2003, CHEMBIOCHEM, V4, P14, DOI 10.1002/cbic.200390008; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	19	21	22	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					377	378		10.1126/science.1126903	http://dx.doi.org/10.1126/science.1126903			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627730				2022-12-28	WOS:000236941800031
J	Loscalzo, J				Loscalzo, J			The NIH budget and the future of biomedical research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Loscalzo, Joseph/ABD-8980-2021					Korn D, 2002, SCIENCE, V296, P1401, DOI 10.1126/science.1072486; *OFF BUDG, 2006, FY 2007 BUDG BRIEF A	2	52	52	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1665	1667		10.1056/NEJMp068050	http://dx.doi.org/10.1056/NEJMp068050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	033ZP	16625006	Bronze			2022-12-28	WOS:000236893900002
J	Schneidman, E; Berry, MJ; Segev, R; Bialek, W				Schneidman, E; Berry, MJ; Segev, R; Bialek, W			Weak pairwise correlations imply strongly correlated network states in a neural population	NATURE			English	Article							MOVEMENT DIRECTION; CORTICAL-NEURONS; EXPRESSION DATA; GANGLION-CELLS; SPIKE TRAINS; INFORMATION; PATTERNS; RETINA; VARIABILITY; ADAPTATION	Biological networks have so many possible states that exhaustive sampling is impossible. Successful analysis thus depends on simplifying hypotheses, but experiments on many systems hint that complicated, higher-order interactions among large groups of elements have an important role. Here we show, in the vertebrate retina, that weak correlations between pairs of neurons coexist with strongly collective behaviour in the responses of ten or more neurons. We find that this collective behaviour is described quantitatively by models that capture the observed pairwise correlations but assume no higher-order interactions. These maximum entropy models are equivalent to Ising models, and predict that larger networks are completely dominated by correlation effects. This suggests that the neural code has associative or error-correcting properties, and we provide preliminary evidence for such behaviour. As a first test for the generality of these ideas, we show that similar results are obtained from networks of cultured cortical neurons.	Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Schneidman, E (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	elads@princeton.edu		schneidman, elad/0000-0001-8653-9848; Segev, Ronen/0000-0002-8109-1076	NATIONAL EYE INSTITUTE [R01EY014196] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BRILLOUIN L, 1962, SCI INFORMATION THEO; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DARROCH JN, 1980, ANN STAT, V43, P1470; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eytan D, 2003, J NEUROSCI, V23, P9349; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Grun S, 2002, NEURAL COMPUT, V14, P43, DOI 10.1162/089976602753284455; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Landau L.D, 2013, STAT PHYS; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Martignon L, 2000, NEURAL COMPUT, V12, P2621, DOI 10.1162/089976600300014872; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Mezard M., 1987, WORLD SCI LECT NOT P, V9; *NIPS, 2003, NIPS 2003 WORKSH EST; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rieke F., 1997, SPIKES EXPLORING NEU; Schneidman E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.238701; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	43	1056	1065	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1007	1012		10.1038/nature04701	http://dx.doi.org/10.1038/nature04701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625187	Green Submitted, Green Accepted			2022-12-28	WOS:000236906000026
J	Yan, LJL; Liu, K; Daviglus, ML; Colangelo, LA; Kiefe, CI; Sidney, S; Matthews, KA; Greenland, P				Yan, LJL; Liu, K; Daviglus, ML; Colangelo, LA; Kiefe, CI; Sidney, S; Matthews, KA; Greenland, P			Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age - The Coronary Artery Risk Development in Young Adults study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; HEART-DISEASE; CAROTID ATHEROSCLEROSIS; SUBCLINICAL ATHEROSCLEROSIS; FACTORS EXPLAIN; FOLLOW-UP; CALCIFICATION; ASSOCIATION	Context The inverse association between education and cardiovascular disease is well established, but little is known about the relationship between education and subclinical disease, which is free from medical access and treatment-related influences, or about possible mediating pathways for these relationships. Objective To examine the association of education with coronary artery calcium (CAC), an indicator of subclinical atherosclerosis, and cardiovascular risk factors, and their changes as potential mediators. Design, Setting, and Participants A population-based, prospective, observational study ( Coronary Artery Risk Development in Young Adults [ CARDIA]) of 2913 eligible participants (44.9% black; 53.9% women) recruited from 4 metropolitan areas ( Birmingham, Ala; Chicago, Ill; Minneapolis, Minn; and Oakland, Calif) in both the baseline (1985-1986, ages 18-30 years) and year 15 examinations (2000-2001, ages 33-45 years). Education ( year 15) was classified into less than high school (n= 128), high school graduate ( n= 498), some college ( n= 902), college graduate ( n= 764), and more than college ( n= 621). Main Outcome Measure Presence of CAC, measured twice by computed tomography ( mean total Agatston score > 0) at year 15. Results Overall CAC prevalence in this sample was 9.3%. After adjusting for age, race, and sex, the odds ratios (ORs) for having CAC were 4.14 (95% confidence interval [CI], 2.33- 7.35) for less than high school education, 1.89 ( 95% CI, 1.23- 2.91) for high school graduate, 1.47 ( 95% CI, 0.99-2.19) for some college, and 1.24 ( 95% CI, 0.84-1.85) for college graduate compared with those participants with more than a college education ( P for trend <. 001). This was also consistent within each of the 4 race-sex groups. Adjustment for baseline systolic blood pressure, smoking, waist circumference, physical activity, and total cholesterol reduced the ORs to 2.61 ( 95% CI, 1.40-4.85) for less than high school, 1.38 ( 95% CI, 0.88-2.17) for high school graduate, 1.17 ( 95% CI, 0.78-1.77) for some college, and 1.13 ( 95% CI, 0.76-1.69) for college graduate compared with more than a college education ( P for trend=. 01), and only slightly attenuated by further adjustment for 15-year changes in risk factors. Conclusion Education was inversely associated with the prevalence of CAC, an association partially explained by baseline risk factors and minimally by 15-year changes in risk factors.	Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; Peking Univ, Dept Hlth Econ & Management, Guanghua Sch Management, Beijing 100871, Peoples R China; Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; Kaiser Permanente, Div Res, Oakland, CA USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Northwestern University; Feinberg School of Medicine; Peking University; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yan, LJL (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	lijing@northwestern.edu	Greenland, Philip/ABD-5528-2021		NHLBI NIH HHS [N01-HC-48048, N01-HC-48047, N01-HC-95095, N01-HC-48050, N01-HC-48049] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048047, N01HC048050, N01HC048049, N01HC095095, N01HC048048] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler N.E., 1999, SOCIOECONOMIC STATUS; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Bild D E, 1993, Ann Epidemiol, V3, P636; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bild DE, 2001, ARTERIOSCL THROM VAS, V21, P852, DOI 10.1161/01.ATV.21.5.852; Budoff MJ, 2005, J AM COLL CARDIOL, V46, P383, DOI [10.1016/j.jacc.2005.04.033, 10.1161/CIRCULATIONAHA.105.168237]; Burke G L, 1996, Ethn Health, V1, P327; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chambless LE, 2002, AM J EPIDEMIOL, V155, P38, DOI 10.1093/aje/155.1.38; Chang CL, 2002, J CLIN EPIDEMIOL, V55, P749, DOI 10.1016/S0895-4356(02)00414-6; Cirera L, 1998, EUR J EPIDEMIOL, V14, P755, DOI 10.1023/A:1007596222217; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DIEZROUX AV, 1995, AM J EPIDEMIOL, V141, P960, DOI 10.1093/oxfordjournals.aje.a117363; Din-Dzietham R, 2000, AM J EPIDEMIOL, V152, P617, DOI 10.1093/aje/152.7.617; Franks P, 2002, MED CARE, V40, P717, DOI 10.1097/00005650-200208000-00011; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gallo LC, 2001, PSYCHOSOM MED, V63, P925, DOI 10.1097/00006842-200111000-00011; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Iribarren C, 1997, ARCH INTERN MED, V157, P873, DOI 10.1001/archinte.157.8.873; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kilander L, 2001, INT J EPIDEMIOL, V30, P1119, DOI 10.1093/ije/30.5.1119; Kitagawa EM, 1973, DIFFERENTIAL MORTALI; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; LEIGH JP, 1983, SOC SCI MED, V17, P227, DOI 10.1016/0277-9536(83)90120-X; Leino M, 1999, INT J EPIDEMIOL, V28, P667, DOI 10.1093/ije/28.4.667; Lenfant C, 1996, CIRCULATION, V94, P2041, DOI 10.1161/01.CIR.94.9.2041; LIU K, 1982, CIRCULATION, V66, P1308, DOI 10.1161/01.CIR.66.6.1308; Loria CM, 2002, CIRCULATION, V105, pE90; Lynch J, 1997, ARTERIOSCL THROM VAS, V17, P513, DOI 10.1161/01.ATV.17.3.513; LYNCH J, 1995, CIRCULATION, V92, P1786, DOI 10.1161/01.CIR.92.7.1786; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; MATTHEWS KA, 1989, AM J EPIDEMIOL, V129, P1132, DOI 10.1093/oxfordjournals.aje.a115235; Nordstrom CK, 2004, SOC SCI MED, V59, P2139, DOI 10.1016/j.socscimed.2004.03.017; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Ranjit N, 2006, ARTERIOSCL THROM VAS, V26, P411, DOI 10.1161/01.ATV.0000198245.16342.3d; Rosvall M, 2006, SOC SCI MED, V62, P1785, DOI 10.1016/j.socscimed.2005.08.037; Rosvall M, 2000, AM J EPIDEMIOL, V152, P334, DOI 10.1093/aje/152.4.334; Schmermund A, 1998, J AM COLL CARDIOL, V31, P1267, DOI 10.1016/S0735-1097(98)00082-5; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Sutton-Tyrrell K, 2002, ATHEROSCLEROSIS, V160, P407, DOI 10.1016/S0021-9150(01)00591-3; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Terry JG, 2005, ARTERIOSCL THROM VAS, V25, P1723, DOI 10.1161/01.ATV.0000173418.42264.19; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Tyroler HA, 1999, PREV MED, V29, pS36, DOI 10.1006/pmed.1998.0441; van Rossum CTM, 1999, AM J EPIDEMIOL, V150, P142; Wagenknecht LE, 2004, STROKE, V35, pE97, DOI 10.1161/01.STR.0000127081.99767.1d; Warnick G R, 1986, Methods Enzymol, V129, P101; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Winkleby MA, 1997, ANN EPIDEMIOL, V7, pS96, DOI 10.1016/S1047-2797(97)80012-9	51	65	70	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1793	1800		10.1001/jama.295.15.1793	http://dx.doi.org/10.1001/jama.295.15.1793			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622141				2022-12-28	WOS:000236886900022
J	Atala, A; Bauer, SB; Soker, S; Yoo, JJ; Retik, AB				Atala, A; Bauer, SB; Soker, S; Yoo, JJ; Retik, AB			Tissue-engineered autologous bladders for patients needing cystoplasty	LANCET			English	Article							LONG-TERM COMPLICATIONS; SMOOTH-MUSCLE-CELLS; URINARY-BLADDER; IN-VITRO; UROTHELIAL CELLS; ACELLULAR MATRIX; ALLOPLASTIC REPLACEMENT; PRESERVED BLADDER; RECONSTRUCTION; BIOMATERIALS	Background Patients with end-stage bladder disease can be treated with cystoplasty using gastrointestinal segments. The presence of such segments in the urinary tract has been associated with many complications. We explored an alternative approach using autologous engineered bladder tissues for reconstruction. Methods Seven patients with myelomeningocele, aged 4-19 years, with high-pressure or poorly compliant bladders, were identified as candidates for cystoplasty. A bladder biopsy was obtained from each patient. Urothelial and muscle cells were grown in culture, and seeded on a biodegradable bladder-shaped scaffold made of Collagen, or a composite of Collagen and polyglycolic acid. About 7 weeks after the biopsy, the autologous engineered bladder constructs were used for reconstruction and implanted either with or without an omental wrap. Serial urodynamics, cystograms, ultrasounds, bladder biopsies, and serum analyses were done. Results Follow-up range was 22-61 months (mean 46 months). Post-operatively, the mean bladder leak point pressure decrease at capacity, and the volume and compliance increase was greatest in the composite engineered bladders with an omental wrap (56%, 1.58-fold, and 2.79-fold, respectively). Bowel function returned promptly after surgery. No metabolic consequences were noted, urinary calculi did not form, mucus production was normal, and renal function was preserved. The engineered bladder biopsies showed an adequate structural architecture and phenotype. Conclusions Engineered bladder tissues, created with autologous cells seeded on collagen-polyglycolic acid scaffolds, and wrapped in omentum after implantation, can be used in patients who need cystoplasty.	Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; Childrens Hosp, Dept Urol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Atala, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	aatala@wfubmc.edu	Yoo, James J./L-4850-2017	Atala, Anthony/0000-0001-8186-2160				ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1; Atala Anthony, 1997, P149; Bona A. V, 1966, MINERVA UROL, V18, P43; Brown AL, 2005, BIOMATERIALS, V26, P529, DOI 10.1016/j.biomaterials.2004.02.055; Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950; CHENG E, 1994, J UROLOGY, V152, P2252, DOI 10.1016/S0022-5347(17)31652-X; CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9; Danielsson C, 2006, BIOMATERIALS, V27, P1054, DOI 10.1016/j.biomaterials.2005.07.027; De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034; Fraser M, 2004, BJU INT, V93, P609, DOI 10.1111/j.1464-410X.2003.04675.x; FUJITA K, 1978, INVEST UROL, V15, P355; Gilbert SM, 2005, J UROLOGY, V173, P1080, DOI 10.1097/01.ju.0000155248.57049.4e; GLASSBERG KI, 1985, UROL CLIN N AM, V12, P175; GLEESON MJ, 1992, J UROLOGY, V148, P1377, DOI 10.1016/S0022-5347(17)36916-1; Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a; KELAMI A, 1970, EUR SURG RES, V2, P195, DOI 10.1159/000127514; Kiddoo DA, 2004, UROL CLIN N AM, V31, P417, DOI 10.1016/j.ucl.2004.04.023; KUDISH HG, 1957, J UROLOGY, V78, P232, DOI 10.1016/S0022-5347(17)66428-0; Lai JY, 2002, J UROLOGY, V168, P1853, DOI 10.1016/S0022-5347(05)64429-1; MCDOUGAL WS, 1992, J UROLOGY, V147, P1199, DOI 10.1016/S0022-5347(17)37517-1; Mingin GC, 1999, J UROLOGY, V162, P1122, DOI 10.1016/S0022-5347(01)68092-3; MONSOUR MJ, 1987, UROL RES, V15, P235; Nakanishi Y, 2003, J PEDIATR SURG, V38, P1781, DOI 10.1016/j.jpedsurg.2003.08.034; NEUHOF H, 1917, SURG GYNECOL OBSTET, V25, P383; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2; Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z; Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011; Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x; Rohrmann D, 1996, J UROLOGY, V156, P2094, DOI 10.1016/S0022-5347(01)65442-9; Schoeller T, 2001, J UROLOGY, V165, P980, DOI 10.1016/S0022-5347(05)66588-3; Schultheiss D, 2005, J UROLOGY, V173, P276, DOI 10.1097/01.ju.0000145882.80339.18; Sievert KD, 2006, WORLD J UROL, V24, P101, DOI 10.1007/s00345-006-0052-8; Snodgrass WT, 2004, UROL CLIN N AM, V31, P427, DOI 10.1016/j.ucl.2004.04.001; Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56; Southgate J, 2003, P I MECH ENG H, V217, P311, DOI 10.1243/095441103322060776; TSUJI I, 1967, J UROLOGY, V98, P91, DOI 10.1016/S0022-5347(17)62828-3; TSUJI I, 1961, J UROLOGY, V85, P42, DOI 10.1016/S0022-5347(17)65279-0; Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1; Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4	43	1291	1402	1	219	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2006	367	9518					1241	1246		10.1016/S0140-6736(06)68438-9	http://dx.doi.org/10.1016/S0140-6736(06)68438-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631879				2022-12-28	WOS:000236913400028
J	Peterson, DM; Hummel, CA; Pauls, TA; Armstrong, JT; Benson, JA; Gilbreath, GC; Hindsley, RB; Hutter, DJ; Johnston, KJ; Mozurkewich, D; Schmitt, HR				Peterson, DM; Hummel, CA; Pauls, TA; Armstrong, JT; Benson, JA; Gilbreath, GC; Hindsley, RB; Hutter, DJ; Johnston, KJ; Mozurkewich, D; Schmitt, HR			Vega is a rapidly rotating star	NATURE			English	Article							PROTOTYPE OPTICAL INTERFEROMETER; A-TYPE STARS; MODEL ATMOSPHERES; CALIBRATION; PHOTOMETRY; CONTINUUM; ALTAIR; FLUX	Vega, the second brightest star in the northern hemisphere, serves as a primary spectral type standard(1). Although its spectrum is dominated by broad hydrogen lines, the narrower lines of the heavy elements suggested slow to moderate rotation, giving confidence that the ground-based calibration of its visible spectrum could be safely extrapolated into the ultraviolet and near-infrared (through atmosphere models(2)), where it also serves as the primary photometric calibrator. But there have been problems: the star is too bright compared to its peers(3) and it has unusually shaped absorption line profiles, leading some(4,5) to suggest that it is a distorted, rapidly rotating star seen pole-on. Here we report optical interferometric observations that show that Vega has the asymmetric brightness distribution of the bright, slightly offset polar axis of a star rotating at 93 per cent of its breakup speed. In addition to explaining the unusual brightness and line shape peculiarities, this result leads to the prediction of an excess of near-infrared emission compared to the visible, in agreement with observations(6,7). The large temperature differences predicted across its surface call into question composition determinations, adding uncertainty to Vega's age and opening the possibility that its debris disk(8) could be substantially older than previously thought(9,10).	SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; European So Observ, Santiago 19, Chile; USN Observ, Washington, DC 20392 USA; USN, Res Lab, Washington, DC 20375 USA; US Naval Observ, Flagstaff Stn, Flagstaff, AZ 86001 USA; Seabrook Engn, Seabrook, MD 20706 USA; Interferomet Inc, Herndon, VA USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; European Southern Observatory; United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; Naval Research Laboratory	Peterson, DM (corresponding author), SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA.	dpeterson@astro.sunysb.edu		Hummel, Christian/0000-0002-4308-0763				Armstrong JT, 1998, ASTROPHYS J, V496, P550, DOI 10.1086/305365; Aumann H. H., 1984, ASTROPHYS J, V278, P23, DOI 10.1086/184214; BALDWIN JE, 1996, ASTRON ASTROPHYS, V306, P13; Bessell MS, 1998, ASTRON ASTROPHYS, V333, P231; BLACKWELL DE, 1983, MON NOT R ASTRON SOC, V205, P897, DOI 10.1093/mnras/205.3.897; Bohlin RC, 2004, ASTRON J, V127, P3508, DOI 10.1086/420715; CASTELLI F, 1994, ASTRON ASTROPHYS, V281, P817; COLLINS GW, 1963, ASTROPHYS J, V138, P1134, DOI 10.1086/147712; de Souza AD, 2005, ASTRON ASTROPHYS, V442, P567, DOI 10.1051/0004-6361:20042476; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; GRAY RO, 1988, J ROY ASTRON SOC CAN, V82, P336; GULLIVER AF, 1994, ASTROPHYS J, V429, pL81, DOI 10.1086/187418; Habing HJ, 1999, NATURE, V401, P456, DOI 10.1038/46749; HARDORP J, 1968, ASTROPHYS J, V151, P1057, DOI 10.1086/149505; Kurucz R. L., 1993, ATLAS9 STELLAR ATMOS; LEGGETT SK, 1985, ASTRON ASTROPHYS, V153, P273; LEGGETT SK, 1986, MON NOT R ASTRON SOC, V223, P443, DOI 10.1093/mnras/223.3.443; MORGAN WW, 1973, ANNU REV ASTRON ASTR, V11, P29, DOI 10.1146/annurev.aa.11.090173.000333; Ohishi N, 2004, ASTROPHYS J, V612, P463, DOI 10.1086/422422; Peterson DM, 2006, ASTROPHYS J, V636, P1087, DOI 10.1086/497981; Petrie R. M., 1965, PUBL DOMINION ASTROP, V12, P317; PRESS WH, 1992, NUMERICAL RECIPES; Song I, 2001, ASTROPHYS J, V546, P352, DOI 10.1086/318269; Su KYL, 2005, ASTROPHYS J, V628, P487, DOI 10.1086/430819; THOMPSON RA, 2004, INTERFEROMETRY SYNTH; VANHAMME W, 1993, ASTRON J, V106, P2096, DOI 10.1086/116788; Zeipel H.V., 1924, MNRAS, V84, P684; [No title captured]	29	136	136	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2006	440	7086					896	899		10.1038/nature04661	http://dx.doi.org/10.1038/nature04661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612375				2022-12-28	WOS:000236736700032
J	Willig, KI; Rizzoli, SO; Westphal, V; Jahn, R; Hell, SW				Willig, KI; Rizzoli, SO; Westphal, V; Jahn, R; Hell, SW			STED microscopy reveals that synaptotagmin remains clustered after synaptic vesicle exocytosis	NATURE			English	Article							FROG NEUROMUSCULAR JUNCTION; HIPPOCAMPAL SYNAPSES; FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; ENDOCYTOSIS; RESOLUTION; MEMBRANE; TRANSMITTER; RELEASE; DOMAIN	Synaptic transmission is mediated by neurotransmitters that are stored in synaptic vesicles and released by exocytosis upon activation. The vesicle membrane is then retrieved by endocytosis, and synaptic vesicles are regenerated and re-filled with neurotransmitter(1). Although many aspects of vesicle recycling are understood, the fate of the vesicles after fusion is still unclear. Do their components diffuse on the plasma membrane, or do they remain together? This question has been difficult to answer because synaptic vesicles are too small (similar to 40 nm in diameter) and too densely packed to be resolved by available fluorescence microscopes. Here we use stimulated emission depletion (STED)(2) to reduce the focal spot area by about an order of magnitude below the diffraction limit, thereby resolving individual vesicles in the synapse. We show that synaptotagmin I, a protein resident in the vesicle membrane, remains clustered in isolated patches on the presynaptic membrane regardless of whether the nerve terminals are mildly active or intensely stimulated. This suggests that at least some vesicle constituents remain together during recycling. Our study also demonstrates that questions involving cellular structures with dimensions of a few tens of nanometres can be resolved with conventional far-field optics and visible light.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Willig, Katrin/AAH-5418-2020; Rizzoli, Silvio/ABG-2227-2020	Willig, Katrin/0000-0002-1860-334X; Rizzoli, Silvio/0000-0002-1667-7839; Jahn, Reinhard/0000-0003-1542-3498				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hell S.W., 1997, T FLUOR SP, P361; Hell SW, 2004, PHYS LETT A, V326, P140, DOI 10.1016/j.physleta.2004.03.082; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Torok P, 2004, OPT EXPRESS, V12, P3605, DOI 10.1364/OPEX.12.003605; Westphal V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.143903; Wilson T., 1984, THEORY PRACTICE SCAN; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	26	799	835	17	408	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					935	939		10.1038/nature04592	http://dx.doi.org/10.1038/nature04592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612384				2022-12-28	WOS:000236736700041
J	Stefanick, ML; Anderson, GL; Margolis, KL; Hendrix, SL; Rodabough, RJ; Paskett, ED; Lane, DS; Hubbell, FA; Assaf, AR; Sarto, GE; Schenken, RS; Yasmeen, S; Lessin, L; Chlebowski, RT				Stefanick, ML; Anderson, GL; Margolis, KL; Hendrix, SL; Rodabough, RJ; Paskett, ED; Lane, DS; Hubbell, FA; Assaf, AR; Sarto, GE; Schenken, RS; Yasmeen, S; Lessin, L; Chlebowski, RT		WHI Investigators	Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE-REPLACEMENT THERAPY; INITIATIVE RANDOMIZED-TRIAL; INTERVAL FOLLOW-UP; PLUS-PROGESTIN; CLINICAL-TRIAL; GROWTH-RATE; RISK; TAMOXIFEN; CELLS; WITHDRAWAL	Context The Women's Health Initiative Estrogen-Aone trial comparing conjugated equine estrogens (CEE) with placebo was stopped early because of an increased stroke incidence and no reduction in risk of coronary heart disease. Preliminary results suggesting possible reduction in breast cancers warranted more detailed analysis. Objective To determine the effects of CEE on breast cancers and mammographic findings. Design, Setting, and Participants Following breast cancer risk assessment, 10 739 postmenopausal women aged 50 to 79 years with prior hysterectomy were randomized to CEE or placebo at 40 US clinical centers from 1993 through 1998. Mammography screenings and clinical breast examinations were performed at baseline and annually. All breast cancers diagnosed through February 29, 2004, are included. Intervention A dose of 0.625 mg/d of CEE or an identical-appearing placebo. Main Outcome Measures Breast cancer incidence, tumor characteristics, and mammogram findings. Results After a mean (SD) follow-up of 7.1 (1.6) years, the invasive breast cancer hazard ratio (HR) for women assigned to CEE vs placebo was 0.80 (95% confidence interval [CI], 0.62-1.04; P = .09) with annualized rates of 0.28% (104 cases in the CEE group) and 0.34% (133 cases in the placebo group). In exploratory analyses, ductal carcinomas (HR, 0.71; 95% CI, 0.52-0.99) were reduced in the CEE group vs placebo group; however, the test for interaction by tumor type was not significant (P = .054). At 1 year, 9.2% of women in the CEE group had mammograms with abnormalities requiring follow-up vs 5.5% in the placebo group (P < .001), a pattern that continued through the trial to reach a cumulative percentage of 36.2% vs 28.1%, respectively (P < .001); however, this difference was primarily in assessments requiring short interval follow-up. Conclusions Treatment with CEE alone for 7.1 years does not increase breast cancer incidence in postmenopausal women with prior hysterectomy. However, treatment with CEE increases the frequency of mammography screening requiring short interval follow-up. Initiation of CEE should be based on consideration of the individual woman's potential risks and benefits.	Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Womens Hlth Initiat Clin Coordinating Ctr, Seattle, WA 98104 USA; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Wayne State Univ, Sch Med, Hutzel Womens Hosp, Dept Obstet & Gynecol, Detroit, MI USA; Ohio State Univ, Sch Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; Brown Univ, Mem Hosp Rhode Isl, Ctr Primary Care & Prevent, Pawtucket, RI 02860 USA; Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; Univ Texas, Hlth Sci Ctr, Dept Obstet & Gynecol, San Antonio, TX 78284 USA; Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; Medstar Res Inst, Washington, DC USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	Stanford University; Fred Hutchinson Cancer Center; Hennepin County Medical Center; Wayne State University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Irvine; Brown University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Davis; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Stefanick, ML (corresponding author), Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Hoover Pavil,Room N229,211 Quarry Rd, Stanford, CA 94305 USA.	stefanick@stanford.edu		Anderson, Garnet/0000-0001-5087-7837; Margolis, Karen/0000-0003-1862-7402				ALLEN DS, 2002, PHARMACOEPIDEMIOL S1, V1, P296; *AM COLL RAD, 1993, BREAST IM REP DAT SY; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1111/j.1525-1497.2001.00329.x; Baum Michael, 2004, Breast Cancer, V11, P15, DOI 10.1007/BF02967995; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Berstein LM, 2004, CLIN CANCER RES, V10, P1530, DOI 10.1158/1078-0432.CCR-0433-03; Bhide SA, 2004, BREAST, V13, P66, DOI 10.1016/j.breast.2003.09.009; Chen W, 2005, BRIT J CANCER, V93, P392, DOI 10.1038/sj.bjc.6602701; Chlebowski Rowan T, 2005, Clin Breast Cancer, V6, P235, DOI 10.3816/CBC.2005.n.025; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Greendale GA, 1999, ANN INTERN MED, V130, P262, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00003; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; HOWELL A, 1992, ANN ONCOL, V3, P611, DOI 10.1093/oxfordjournals.annonc.a058286; Hulley SB, 2004, JAMA-J AM MED ASSOC, V291, P1769, DOI 10.1001/jama.291.14.1769; Ingle JN, 2002, BREAST CANCER RES, V4, P133, DOI 10.1186/bcr436; INGLE JN, 1981, NEW ENGL J MED, V304, P16, DOI 10.1056/NEJM198101013040104; Jordan VC, 2003, BREAST, V12, P432, DOI 10.1016/S0960-9776(03)00149-8; Kerlikowske K, 2005, RADIOLOGY, V234, P684, DOI 10.1148/radiol.2343031976; Kerlikowske K, 2003, J CLIN ONCOL, V21, P4314, DOI 10.1200/JCO.2003.05.151; KRECKE KN, 1993, AM J ROENTGENOL, V161, P957, DOI 10.2214/ajr.161.5.8273634; KUROISHI T, 1990, JPN J CANCER RES, V81, P454, DOI 10.1111/j.1349-7006.1990.tb02591.x; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Liu H, 2003, J NATL CANCER I, V95, P1586, DOI 10.1093/jnci/djg080; Lonning PE, 2001, BREAST CANCER RES TR, V67, P111, DOI 10.1023/A:1010619225209; Lowe JB, 1999, CANCER, V85, P1114, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1114::AID-CNCR15>3.0.CO;2-Y; McTiernan A, 2005, JNCI-J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279; Morimoto LM, 2002, CANCER CAUSE CONTROL, V13, P741, DOI 10.1023/A:1020239211145; National Cancer Institute, AB SEER; OLSSON HL, 2004, P AN M AM SOC CLIN, P2049; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Prasad R, 2003, CANCER, V98, P2539, DOI 10.1002/cncr.11836; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Song RXD, 2001, J NATL CANCER I, V93, P1714, DOI 10.1093/jnci/93.22.1714; Stefanick ML, 2003, ANN EPIDEMIOL, V13, pS78, DOI 10.1016/S1047-2797(03)00045-0; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; Thorne Sally E., 1999, Breast J, V5, P42, DOI 10.1046/j.1524-4741.1999.005001042.x; Thurfjell E, 2002, NEW ENGL J MED, V347, P866, DOI 10.1056/NEJMp020093; Tilanus-Linthorst MMA, 2005, EUR J CANCER, V41, P1610, DOI 10.1016/j.ejca.2005.02.034; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yasmeen S, 2003, JNCI-J NATL CANCER I, V95, P429, DOI 10.1093/jnci/95.6.429	51	409	424	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2006	295	14					1647	1657		10.1001/jama.295.14.1647	http://dx.doi.org/10.1001/jama.295.14.1647			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031LY	16609086	Bronze			2022-12-28	WOS:000236707300020
J	Bloom, K				Bloom, K			NoCut: Cytokinesis ien check	CELL			English	Editorial Material							SPINDLE STABILITY; YEAST; MITOSIS	In this issue of Cell, Norden et al. (2006) describe a new pathway, NoCut, that links the completion of chromosome segregation to the onset of cytokinesis in budding yeast. In NoCut, Aurora kinase (Ipl1) at the spindle midzone negatively regulates cytokinesis through two proteins previously identified to be involved in cell polarity, Boi1 and Boi2.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Bloom, K (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	kbloom@email.unc.edu	Bloom, Kerry/AAE-5336-2019	Bloom, Kerry/0000-0002-3457-004X				Bouck D, 2005, BIOCHEM CELL BIOL, V83, P696, DOI 10.1139/O05-161; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865; Melo JA, 2001, GENE DEV, V15, P2809; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X	9	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					17	18		10.1016/j.cell.2006.03.016	http://dx.doi.org/10.1016/j.cell.2006.03.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615883	Bronze			2022-12-28	WOS:000237314200007
J	Cohen, SM; Brennecke, J				Cohen, SM; Brennecke, J			Mixed messages in early development	SCIENCE			English	Editorial Material							MESSENGER-RNAS; MICRORNAS; ZEBRAFISH; DEADENYLATION; EVOLUTION; BODIES; IMPACT		European Mol Biol Lab, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	cohen@embl.de	Cohen, Stephen M/G-9930-2011; Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019	Cohen, Stephen M/0000-0003-2858-9163; Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	17	8	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2006	312	5770					65	66		10.1126/science.1126400	http://dx.doi.org/10.1126/science.1126400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601183				2022-12-28	WOS:000236584400029
J	Godula, K; Sames, D				Godula, K; Sames, D			C-H bond functionalization in complex organic synthesis	SCIENCE			English	Review							PALLADIUM-CATALYZED ARYLATION; TRANSITION-METAL COMPLEXES; ACTIVATION; INSERTION; NITROGEN; OLEFINS; ELABORATION; MECHANISMS; EFFICIENT; HALIDES	Direct and selective replacement of carbon-hydrogen bonds with new bonds (such as C-C, C-O, and C-N) represents an important and long-standing goal in chemistry. These transformations have broad potential in synthesis because C-H bonds are ubiquitous in organic substances. At the same time, achieving selectivity among many different C-H bonds remains a challenge. Here, we focus on the functionalization of C-H bonds in complex organic substrates catalyzed by transition metal catalysts. We outline the key concepts and approaches aimed at achieving selectivity in complex settings and discuss the impact these reactions have on synthetic planning and strategy in organic synthesis.	Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Sames, D (corresponding author), Columbia Univ, Dept Chem, 3000 Broadway, New York, NY 10027 USA.	sames@chem.columbia.edu						Ahrendt KA, 2003, ORG LETT, V5, P1301, DOI 10.1021/ol034228d; BARTON DH, 1961, J AM CHEM SOC, V83, P4083, DOI 10.1021/ja01480a031; Beller M., 2004, TRANSITION METALS OR, P271; BRESLOW R, 1983, J AM CHEM SOC, V105, P6728, DOI 10.1021/ja00360a039; BUCHSCHACHER P, 1958, J AM CHEM SOC, V80, P2905, DOI 10.1021/ja01544a080; Chatani N, 1997, J ORG CHEM, V62, P2604, DOI 10.1021/jo970131r; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; COREY EJ, 1958, J AM CHEM SOC, V80, P2903, DOI 10.1021/ja01544a078; Dangel BD, 2002, J AM CHEM SOC, V124, P11856, DOI 10.1021/ja027311p; Dangel BD, 2001, J AM CHEM SOC, V123, P8149, DOI 10.1021/ja016280f; Davies HML, 2003, CHEM REV, V103, P2861, DOI 10.1021/cr0200217; Davies HML, 2003, J AM CHEM SOC, V125, P6462, DOI 10.1021/ja0290072; Davies HML, 1997, J AM CHEM SOC, V119, P9075, DOI 10.1021/ja971915p; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Doyle M. P., 1995, COMPREHENSIVE ORGANO, VII; Doyle MP, 1996, J AM CHEM SOC, V118, P8837, DOI 10.1021/ja961682m; Dyker G., 2000, HDB C H TRANSFORMATI; Espino CG, 2001, J AM CHEM SOC, V123, P6935, DOI 10.1021/ja011033x; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; HEUSLER K, 1964, ANGEW CHEM INT EDIT, V3, P525, DOI 10.1002/anie.196405251; Hinman A, 2003, J AM CHEM SOC, V125, P11510, DOI 10.1021/ja0368305; HOFFMANN AW, 1885, BERICHTE, V18, P105; Holland HL, 2000, CURR OPIN BIOTECH, V11, P547, DOI 10.1016/S0958-1669(00)00142-7; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Johnson JA, 2000, J AM CHEM SOC, V122, P6321, DOI 10.1021/ja0003223; Jun CH, 1997, J ORG CHEM, V62, P1200, DOI 10.1021/jo961887d; Kakiuchi F, 2003, ADV SYNTH CATAL, V345, P1077, DOI 10.1002/adsc.200303094; KLEINMAN DF, 1991, COMPREHENSIVE ORGANI, V2, pCH4; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Lane BS, 2004, ORG LETT, V6, P2897, DOI 10.1021/ol0490072; Lawrence JD, 2004, J AM CHEM SOC, V126, P15334, DOI 10.1021/ja044933x; Lewis JC, 2004, ORG LETT, V6, P35, DOI 10.1021/ol035985e; Loffler K, 1909, BER DTSCH CHEM GES, V42, P3431, DOI 10.1002/cber.19090420378; Miura M, 2002, TOP CURR CHEM, V219, P211; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Mori A, 2003, J AM CHEM SOC, V125, P1700, DOI 10.1021/ja0289189; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Oi S, 2005, J ORG CHEM, V70, P3113, DOI 10.1021/jo050031i; Park CH, 2004, ORG LETT, V6, P1159, DOI 10.1021/ol049866q; Pivsa-Art S, 1998, B CHEM SOC JPN, V71, P467, DOI 10.1246/bcsj.71.467; RYABOV AD, 1990, CHEM REV, V90, P403, DOI 10.1021/cr00100a004; Sato T, 1998, CHEM LETT, P893, DOI 10.1246/cl.1998.893; Shilov A.E., 2000, ACTIVATION CATALYTIC; Shilov AE, 1997, CHEM REV, V97, P2879, DOI 10.1021/cr9411886; Taber DF, 1998, CHEM-EUR J, V4, P990, DOI 10.1002/(SICI)1521-3765(19980615)4:6<990::AID-CHEM990>3.0.CO;2-U; Thalji RK, 2004, J AM CHEM SOC, V126, P7192, DOI 10.1021/ja0394986; TROST BM, 1995, J AM CHEM SOC, V117, P5371, DOI 10.1021/ja00124a025; Wang X, 2005, J AM CHEM SOC, V127, P4996, DOI 10.1021/ja050279p; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u	50	1803	1812	13	571	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					67	72		10.1126/science.1114731	http://dx.doi.org/10.1126/science.1114731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601184				2022-12-28	WOS:000236584400030
J	Kostelansky, MS; Sun, J; Lee, SH; Kim, J; Ghirlando, R; Hierro, A; Emr, SD; Hurley, JH				Kostelansky, MS; Sun, J; Lee, SH; Kim, J; Ghirlando, R; Hierro, A; Emr, SD; Hurley, JH			Structural and functional organization of the ESCRT-I trafficking complex	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; SORTING COMPLEX; POLYCISTRONIC EXPRESSION; PROTEIN-TRANSPORT; CRYSTAL-STRUCTURE; HIV-1 P6; UBIQUITIN; TSG101; BINDING; DOMAIN	The endosomal sorting complex required for transport (ESCRT) complexes are central to receptor downregulation, lysosome biogenesis, and budding of HIV. The yeast ESCRT-I complex contains the Vps23, Vps28, and Vps37 proteins, and its assembly is directed by the C-terminal steadiness box of Vps23, the N-terminal half of Vps28, and the C-terminal half of Vps37. The crystal structures of a Vps23:Vps28 core sub-complex and the Vps23:Vps28:Vps37 core were solved at 2.1 and 2.8 angstrom resolution. Each subunit contains a structurally similar pair of helices that form the core. The N-terminal domain of Vps28 has a hydrophobic binding site on its surface that is conformationally dynamic. The C-terminal domain of Vps28 binds the ESCRT-II complex. The structure shows how ESCRT-I is assembled by a compact core from which the Vps23 UEV domain, the Vps28 C domain, and other domains project to bind their partners.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Chem & Biochem, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Ghirlando, Rodolfo/A-8880-2009; Hierro, Aitor/F-9998-2011; Lee, Sangho/P-4204-2018	Hierro, Aitor/0000-0002-7721-1581; Lee, Sangho/0000-0003-3886-4579	NIDDK NIH HHS [Z01 DK036118-12] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036123, Z01DK036123, R01DK036118, Z01DK033007, R37DK036118, Z01DK036118, ZIADK033007] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2002, MOL CELL, V10, P215, DOI 10.1016/S1097-2765(02)00601-9; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Feng GH, 2000, CANCER RES, V60, P1736; Freeman D, 2003, OIL GAS J, V101, P56; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Gonzalez A, 1999, ACTA CRYSTALLOGR D, V55, P1449, DOI 10.1107/S0907444999006745; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hierro A, 2005, METHOD ENZYMOL, V403, P322, DOI 10.1016/S0076-6879(05)03027-2; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; HURLEY JH, 2006, IN PRESS ANN REV BIO; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1	60	73	79	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					113	126		10.1016/j.cell.2006.01.049	http://dx.doi.org/10.1016/j.cell.2006.01.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615894	Green Accepted, Bronze			2022-12-28	WOS:000237314200018
J	Sato, J; Omori, T; Oikawa, K; Ohnuma, I; Kainuma, R; Ishida, K				Sato, J; Omori, T; Oikawa, K; Ohnuma, I; Kainuma, R; Ishida, K			Cobalt-base high-temperature alloys	SCIENCE			English	Article							SUPERALLOYS; PHASE	We have identified cobalt-base superalloys showing a high-temperature strength greater than those of conventional nickel-base superalloys. The cobalt-base alloys are strengthened by a ternary compound with the L1(2) structure, gamma ' Co-3( Al,W), which precipitates in the disordered gamma face-centered cubic cobalt matrix with high coherency and with high melting points. We also identified a ternary compound, gamma ' Ir-3(Al, W), with the L1(2) structure, which suggests that the Co-Ir-Al-W-base systems with gamma + gamma ' (Co, Ir)(3)(Al, W) structures offer great promise as candidates for next-generation high-temperature materials.	Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan	Tohoku University	Ishida, K (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan.	ishida@material.tohoku.ac.jp	Kainuma, Ryosuke/I-6482-2013; Oikawa, Katsunari/C-6660-2009; Omori, Toshihiro/A-4478-2017; OHNUMA, Ikuo/J-4253-2015	Oikawa, Katsunari/0000-0002-5269-8426; Omori, Toshihiro/0000-0001-9174-0239; 				Blaise J. M., 1970, Cobalt, P192; Bradley AJ, 1939, J I MET, V64, P81; Decker R.F., 1972, SUPERALLOYS, P33; Drapier J., 1965, COBALT, V27, P59; Drapier J. M., 1968, COBALT, V39, P63; Edwards OS, 1941, J I MET, V67, P67; Feng Q, 2003, ACTA MATER, V51, P269, DOI 10.1016/S1359-6454(02)00397-X; Hagel W. C., 1972, SUPERALLOYS, P145; JIA CC, 1994, METALL MATER TRANS A, V25, P473, DOI 10.1007/BF02651589; NAIDU SVN, 1970, BINARY ALLOY PHASE D, P1257; OMORI T, 2005, INT C MART TRANSF IC; Sato J, 2005, MATER TRANS, V46, P1199, DOI 10.2320/matertrans.46.1199; Stoloff NS, 1990, METALS HDB, V1, P950; Viatour P, 1973, COBALT, V3, P67; Volek A, 2005, SCRIPTA MATER, V52, P141, DOI 10.1016/j.scriptamat.2004.09.013; Yamabe-Mitarai Y, 2004, JOM-US, V56, P34, DOI 10.1007/s11837-004-0198-z	16	733	782	24	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					90	91		10.1126/science.1121738	http://dx.doi.org/10.1126/science.1121738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16601187				2022-12-28	WOS:000236584400036
J	Houston, TK; Person, SD; Pletcher, MJ; Liu, K; Iribarren, C; Kiefe, CI				Houston, TK; Person, SD; Pletcher, MJ; Liu, K; Iribarren, C; Kiefe, CI			Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEPENDENT DIABETES-MELLITUS; CIGARETTE-SMOKING; RISK DEVELOPMENT; RECRUITMENT; PATTERNS; ALCOHOL	Objective To assess whether active and passive smokers are more likely than non-smokers to develop clinically relevant glucose intolerance or diabetes. Design Coronary artery risk development in Young adults (CARDIA) is a prospective cohort study begun in 1985-6 with 15 years of follow-up. Setting Participants recruited from Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California, USA. Participants Black and white men and women aged 18-30 years with no glucose intolerance at baseline, including 1386 current smokers, 621 previous smokers, 1452 never smokers with reported exposure to secondhand smoke (validated by serum cotinine concentrations 1-15 ng/ml), and 1113 never smokers with no exposure to secondhand smoke. Main outcome measure Time to development of glucose intolerance (glucose >= 100 mg/dl or taking antidiabetic drugs) during 15 years of follow-up. Results Median age at baseline was 25, 55% of participants were women, and 50% were African-American. During follow-up, 16.7% of participants developed glucose intolerance. A graded association existed between smoking exposure and the development of glucose intolerance. The 15 year incidence of glucose intolerance was highest among smokers (21.8%), followed by never smokers with passive smoke exposure (17.2%), and then previous smokers (14.4%); it was lowest for never smokers with no passive smoke exposure (11.5%). Current smokers (hazard ratio 1.65, 95% confidence interval 1.27 to 2.13) and never smokers with passive smoke exposure (1.35, 1.06 to 1.71) remained at higher risk than never smokers without passive smoke exposure after adjustment for multiple baseline sociodemographic, biological, and behavioural factors, but risk in previous smokers was similar to that in never smokers without passive smoke exposure. Conclusion These findings support a role of both active and passive smoking in the development of glucose intolerance in young adulthood.	Univ Alabama Birmingham, Div Gen Internal Med, Birmingham, AL 35294 USA; Kaiser Permanente, Oakland, CA USA; Northwestern Univ, Evanston, IL USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Birmingham Vet Affairs Med Ctr, Deep S Ctr Effectiveness Res, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; Northwestern University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Houston, TK (corresponding author), Univ Alabama Birmingham, Div Gen Internal Med, 510 20th St S,FOT 720, Birmingham, AL 35294 USA.	thouston@uabmc.edu	Houston, Thomas/F-2469-2013		NHLBI NIH HHS [N01-HC-05187, N01-HC-45134, N01-HC-48050, N01-HC-95095, N01-HC48048, N01-HC-48047] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC045134, N01HC048047, N01HC048050, N01HC095095, N01HC005187] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderssen N, 1996, AM J EPIDEMIOL, V143, P351, DOI 10.1093/oxfordjournals.aje.a008749; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011; Chan-Yeung M, 2003, RESPIROLOGY, V8, P131, DOI 10.1046/j.1440-1843.2003.00453.x; DYER AR, 1990, J CLIN EPIDEMIOL, V43, P1, DOI 10.1016/0895-4356(90)90050-Y; FIORE C, 2000, TREATING TOBACCO USE; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Haire-Joshu D, 1999, DIABETES CARE, V22, P1887, DOI 10.2337/diacare.22.11.1887; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; JANZON L, 1983, DIABETOLOGIA, V25, P86; Kawakami N, 1997, AM J EPIDEMIOL, V145, P103; Kiefe CI, 1998, AM J PREV MED, V15, P146, DOI 10.1016/S0749-3797(98)00044-0; Kiefe CI, 2001, AM J PUBLIC HEALTH, V91, P213, DOI 10.2105/AJPH.91.2.213; MEDALIE JH, 1975, ARCH INTERN MED, V135, P811, DOI 10.1001/archinte.135.6.811; National Cancer Institute, 1999, HLTH EFF EXP ENV TOB, P12; [Office of Research and Development Office of Health Environmental Assessment United States Environmental Protection Agency], 1992, RESP HLTH EFF PASS S; RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Talamini G, 1999, DIGEST DIS SCI, V44, P1303, DOI 10.1023/A:1026670911955; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; WAGENKNECHT LE, 1992, AM J PUBLIC HEALTH, V82, P33, DOI 10.2105/AJPH.82.1.33; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; WILSON PWF, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90532-2	25	154	163	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1064	1067		10.1136/bmj.38779.584028.55	http://dx.doi.org/10.1136/bmj.38779.584028.55			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16603565	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000237518400017
J	Ross, JS; Bradley, EH; Busch, SH				Ross, JS; Bradley, EH; Busch, SH			Use of health care services by lower-income and higher-income uninsured adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSURANCE; COVERAGE; CANCER; POPULATION; NEEDS	Context More than 45 million individuals in the United States lack health insurance, potentially limiting their access to and use of appropriate health care services. Although the uninsured comprise a range of income levels, little attention has been directed at higher-income uninsured adults and their patterns of care. Objective To examine whether having higher income attenuates the association between being uninsured and using fewer recommended health care services. Design, Setting, and Participants Cross-sectional analysis of data from the 2002 Behavioral Risk Factor Surveillance System, drawn from a nationally representative sample of households. Participants were community-dwelling adults (n= 194 943; 50% women) aged 18 to 64 years in 2002. Main Outcome Measures Self-reported use of screening for cervical, breast, and colorectal cancer; serum cholesterol screening and measurement, aspirin use, and tobacco cessation and weight loss counseling for cardiovascular risk reduction; and serum cholesterol and glycosylated hemoglobin measurement, eye and foot examination, and influenza and pneumococcal vaccination for diabetes management. Results Among eligible adults, use of cancer prevention services ranged from 51% for colorectal cancer screening to 88% for cervical cancer screening, while use of cardiovascular risk reduction services ranged from 38% for weight loss counseling to 81% for aspirin use, and use of services for diabetes management ranged from 33% for pneumococcal vaccination to 88% for serum glycosylated hemoglobin measurement. In bivariate analyses, health insurance and annual household income were both strongly associated with use of nearly all examined health care services ( P values <. 01). Using multivariable analysis, increased annual household income did not significantly increase the likelihood of uninsured compared with insured adults receiving recommended health care services for cancer prevention, cardiovascular risk reduction, or diabetes management ( P values >. 05). Conclusions Even among higher-income adults, lack of health care insurance was associated with significantly decreased use of recommended health care services; increased income did not attenuate the difference in use between uninsured and insured adults. Efforts to improve the use of recommended health care services among the uninsured should focus on patient education and expanding insurance eligibility for both lower-income and higher-income adults.	Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Epidemiol & Publ Hlth, Div Hlth Policy & Adm, New Haven, CT 06520 USA	Yale University; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Internal Med, 333 Cedar St,Room IE-61 SHM,POB 208088, New Haven, CT 06520 USA.	joseph.s.ross@yale.edu		Ross, Joseph/0000-0002-9218-3320				Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; American Association of Clinical Endocrinologists (AACE) Lipid Guidelines, 2000, ENDOCR PRACT, V6, P162; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS15; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Blendon RJ, 1999, HEALTH AFFAIR, V18, P203, DOI 10.1377/hlthaff.18.6.203; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; BROWN JB, 1992, MED CARE, V30, P400, DOI 10.1097/00005650-199205000-00003; *CDCP, DAT QUAL REP BHEH RI; *CDCP, QUEST BEH RISK FACT; *CDCP, TECHN DOC SURV DAT; *CDCP, SURV OV BEH RISK FAC; Collins S., 2004, WAGES HLTH BENEFITS; Cooper PF, 1997, HEALTH AFFAIR, V16, P142, DOI 10.1377/hlthaff.16.6.142; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; FRANE J, 1989, SUDAAN PROFESSIONAL; HOLAHAN J, 2005, HLTH AFF MILLWOOD, V5, P498; Institute of Medicine, 2004, INS AM HLTH PRINC RE; Johnson TP, 2005, MED CARE, V43, P565, DOI 10.1097/01.mlr.0000163648.26493.70; LaVange L M, 1996, Stat Methods Med Res, V5, P311, DOI 10.1177/096228029600500306; Leape LL, 1999, ANN INTERN MED, V130, P183, DOI 10.7326/0003-4819-130-3-199902020-00003; LITTLE RJA, 1982, AM STAT, V36, P38, DOI 10.2307/2684091; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Newell SA, 1999, AM J PREV MED, V17, P211, DOI 10.1016/S0749-3797(99)00069-0; Newhouse JP, 1996, FREE ALL LESSONS RAN; Office of the Federal Register, 2002, FED REGISTER, V67, P6931; Powell-Griner E, 1999, AM J PUBLIC HEALTH, V89, P882, DOI 10.2105/AJPH.89.6.882; Robinson JC, 2005, NEW ENGL J MED, V353, P1199, DOI 10.1056/NEJMp058097; SAVER BG, 1993, AM J PUBLIC HEALTH, V83, P1583, DOI 10.2105/AJPH.83.11.1583; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Turrell G, 2000, J EPIDEMIOL COMMUN H, V54, P207, DOI 10.1136/jech.54.3.207; U. S. Preventive Services Task Force, SCREEN COL CANC; U.S. Preventive Services Task Force, 2011, SCREEN BREAST CANC; *US PREV SERV TASK, SCREEN OB AD; *US PREV SERV TASK, COUNS TOB US; *US PREV SERV TASK, SCREEN LIP DIS AD; US Preventive Service Task Force, SCREEN CERV CANC; ABOUT HLTH PEOPL	40	134	135	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2027	2036		10.1001/jama.295.17.2027	http://dx.doi.org/10.1001/jama.295.17.2027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038MF	16670411	Bronze			2022-12-28	WOS:000237225100019
J	Gilbody, S; Sheldon, T; Wessely, S				Gilbody, S; Sheldon, T; Wessely, S			Health policy - Should we screen for depression?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; MAJOR DEPRESSION; MENTAL-DISORDERS; GENERAL-PRACTICE; OUTCOMES; MANAGEMENT; DIAGNOSIS; ANXIETY; UTILITY; IMPACT	The quality and outcomes framework will soon reward primary care doctors who screen for depression in England and Wales. This article scrutinises the rationale and evidence to support such screening.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Inst Psychiat, Guys Kings & St Thomass Sch Med, Acad Dept Psychol Med, London SE5 8AF, England	University of York - UK; University of London; King's College London	Gilbody, S (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	sg519@york.ac.uk	Gilbody, Simon/E-6543-2010; Sheldon, Trevor/AAK-7088-2021; Gilbody, Simon/AAY-3720-2021; Wessely, Simon C/A-8713-2008	Sheldon, Trevor/0000-0002-7479-5913; Gilbody, Simon/0000-0002-8236-6983; Wessely, Simon Charles/0000-0002-6743-9929				*AG HLTH CAR POL R, 2000, 5 US DEP HHS PUBL HL; Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Andrews Gavin, 2000, J Ment Health Policy Econ, V3, P175, DOI 10.1002/mhp.96; Arroll B, 2005, BRIT MED J, V331, P884, DOI 10.1136/bmj.38607.464537.7C; Coyne JC, 1997, J CONSULT CLIN PSYCH, V65, P161, DOI 10.1037/0022-006X.65.1.161; Coyne JC, 2003, ANN INTERN MED, V138, P767, DOI 10.7326/0003-4819-138-9-200305060-00017; Coyne JC, 1997, GEN HOSP PSYCHIAT, V19, P333, DOI 10.1016/S0163-8343(97)00055-8; COYNE JC, 1994, GEN HOSP PSYCHIAT, V16, P267, DOI 10.1016/0163-8343(94)90006-X; DOWRICK C, 1995, BMJ-BRIT MED J, V311, P1274, DOI 10.1136/bmj.311.7015.1274; FLETCHER J, 2004, ENHANCED SERVICES SP; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; GILODY S, 2002, EFFECTIVE HLTH CARE, V7; Goldberg D, 1998, BRIT J GEN PRACT, V48, P1840; Goldberg DP., 1992, COMMON MENTAL DISORD; GRAY JAM, 1997, EVIDENCE BASED HEALT; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hickie IB, 2001, MED J AUSTRALIA, V175, pS52; HOEPER EW, 1984, LANCET, V1, P33; Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Kessler D, 2002, BRIT MED J, V325, P1016, DOI 10.1136/bmj.325.7371.1016; Kessler D, 1999, BRIT MED J, V318, P436, DOI 10.1136/bmj.318.7181.436; Klinkman MS, 1998, ARCH FAM MED, V7, P451, DOI 10.1001/archfami.7.5.451; Lenzer J, 2004, BRIT MED J, V328, P1458, DOI 10.1136/bmj.328.7454.1458; Leon AC, 1999, INT J PSYCHIAT MED, V29, P1; MANT D, 1990, BRIT MED J, V300, P916, DOI 10.1136/bmj.300.6729.916; Meltzer H, 1995, OPCS SURVEYS PSYCHIA; National Institute for Clinical Excellence, 2004, DEPR COR INT MAN DEP; National Screening Committee, 2003, UK NAT SCREEN COMM C; New Freedom Commission on Mental Health, 2003, DHHS PUB; PIGMONE MP, 2002, ANN INTERN MED, V136, P65; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Simon GE, 1999, GEN HOSP PSYCHIAT, V21, P97, DOI 10.1016/S0163-8343(98)00072-3; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; StewartBrown S, 1997, BRIT MED J, V314, P533, DOI 10.1136/bmj.314.7080.533; Thomas CM, 2003, BRIT J PSYCHIAT, V183, P514, DOI 10.1192/bjp.183.6.514; Valenstein M, 1997, J GEN INTERN MED, V12, P679, DOI 10.1046/j.1525-1497.1997.07141.x; Valenstein M, 2001, ANN INTERN MED, V134, P345, DOI 10.7326/0003-4819-134-5-200103060-00007; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; WRIGHT AF, 1994, BRIT J GEN PRACT, V44, P132	45	134	137	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1027	1030		10.1136/bmj.332.7548.1027	http://dx.doi.org/10.1136/bmj.332.7548.1027			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040TK	16644833	Green Published			2022-12-28	WOS:000237403100025
J	Veneault-Fourrey, C; Barooah, M; Egan, M; Wakley, G; Talbot, NJ				Veneault-Fourrey, C; Barooah, M; Egan, M; Wakley, G; Talbot, NJ			Autophagic fungal cell death is necessary for infection by the rice blast fungus	SCIENCE			English	Article							MAGNAPORTHE-GRISEA; ASPERGILLUS-NIDULANS; TURGOR; MONODANSYLCADAVERINE; PENETRATION; BIOLOGY; PROTEIN; KINASE; GENE	Rice blast is caused by the fungus Magnaporthe grisea, which elaborates specialized infection cells called appressoria to penetrate the tough outer cuticle of the rice plant Oryza sativa. We found that the formation of an appressorium required, sequentially, the completion of mitosis, nuclear migration, and death of the conidium (fungal spore) from which the infection originated. Genetic intervention during mitosis prevented both appressorium development and conidium death. Impairment of autophagy, by the targeted mutation of the MgATG8 gene, arrested conidial cell death but rendered the fungus nonpathogenic. Thus, the initiation of rice blast requires autophagic cell death of the conidium.	Univ Exeter, Sch Biosci, Washington Singer Labs, Exeter EX4 4QG, Devon, England	University of Exeter	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	N.J.Talbot@exeter.ac.uk	Talbot, Nicholas J/I-5618-2019; Talbot, Nicholas J/I-9584-2014	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757; Barooah, Madhumita/0000-0002-3768-5336				BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Folco HD, 2003, EUKARYOT CELL, V2, P341, DOI 10.1128/EC.2.2.341-350.2003; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; MORRIS NR, 1976, EXP CELL RES, V98, P204, DOI 10.1016/0014-4827(76)90480-8; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; PU RT, 1995, J BIOL CHEM, V270, P18110, DOI 10.1074/jbc.270.30.18110; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696	17	356	388	8	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					580	583		10.1126/science.1124550	http://dx.doi.org/10.1126/science.1124550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645096				2022-12-28	WOS:000237296700046
J	Partridge, T				Partridge, T			Disciplining the stem cell into myogenesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MYOFIBERS		Genethon, Evry, France		Partridge, T (corresponding author), Genethon, Evry, France.							Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023	5	3	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1844	1845		10.1056/NEJMcibr053168	http://dx.doi.org/10.1056/NEJMcibr053168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641403				2022-12-28	WOS:000237077100014
J	Durso, SC				Durso, SC			Using clinical guidelines designed for older adults with diabetes mellitus and complex health status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; URINARY-INCONTINENCE; PATIENTS PREFERENCES; PATIENT; PEOPLE; FALLS; METAANALYSIS; MORTALITY; THERAPY; WOMEN	Increasingly, adults are living to an advanced age. While many enjoy good health, nearly 50% of adults older than 65 years have 3 or more chronic medical conditions. Furthermore, within any age-sex cohort, older adults exhibit widely heterogeneous health status-ranging from robust to frail. This heterogeneity and individual medical complexity makes care for older patients particularly challenging and requires both careful medical judgment and a clear understanding of the patient's personal values and goals. Most current health care guidelines are disease-specific and do not address this complexity and heterogeneity, thus limiting their utility for guiding physicians in the care of older adult patients. The "Guidelines for Improving the Care of Older Persons With Diabetes Mellitus" are the first guidelines to specifically address this complexity and provide guidance to physicians who must prioritize therapies and goals for older adults with diabetes, comorbid medical conditions, and geriatric syndromes. By providing a rationale for prioritizing recommendations and the inclusion of geriatric syndromes that impact the patient's overall health and diabetic care, these guidelines may serve as a model for the development of other guidelines targeting older adults with complex health status.	Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD 21224 USA	Johns Hopkins University	Durso, SC (corresponding author), Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, 5505 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	sdurso@jhmi.edu						Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; American Diabetes Association, 2004, DIABETES CARE, V27, pS15; [Anonymous], 2005, DIABETES CARE, V28, pS4; Barry MJ, 1999, JAMA-J AM MED ASSOC, V282, P2356, DOI 10.1001/jama.282.24.2356; Blaum CS, 2003, J AM GERIATR SOC, V51, P745, DOI 10.1046/j.1365-2389.2003.51256.x; Blaum CS, 2002, J AM GERIATR SOC, V50, P581, DOI 10.1046/j.1532-5415.2002.50130.x; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Brown JS, 1996, OBSTET GYNECOL, V87, P715, DOI 10.1016/0029-7844(96)00013-0; Clausen TD, 2005, DIABETES CARE, V28, P990; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; Dealberto MJ, 1997, J CLIN EPIDEMIOL, V50, P357, DOI 10.1016/S0895-4356(96)00339-3; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Godolphin W, 2003, BRIT MED J, V327, P692, DOI 10.1136/bmj.327.7417.692; Greene Douglas A., 1999, American Journal of Medicine, V107, p2S; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; Harris R, 2003, ANN INTERN MED, V138, P215, DOI 10.7326/0003-4819-138-3-200302040-00015; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Huang ES, 2005, J AM GERIATR SOC, V53, P306, DOI 10.1111/j.1532-5415.2005.53119.x; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; KELSEY JL, 1992, AM J EPIDEMIOL, V135, P477, DOI 10.1093/oxfordjournals.aje.a116314; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40, DOI 10.1111/j.1532-5415.1999.tb01899.x; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Maty SC, 2004, J GERONTOL A-BIOL, V59, P148; Morley JE, 1998, DIABETIC MED, V15, pS41, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S41::AID-DIA747>3.3.CO;2-5; Newman SC, 1999, J GERONTOL A-BIOL, V54, pM527, DOI 10.1093/gerona/54.10.M527; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Papapoulos SE, 2005, OSTEOPOROSIS INT, V16, P468, DOI 10.1007/s00198-004-1725-z; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; Salkeld G, 2000, BMJ-BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Shaughnessy AF, 2003, BRIT MED J, V327, P266, DOI 10.1136/bmj.327.7409.266; Stansby G, 2003, EUR J VASC ENDOVASC, V26, P1, DOI 10.1053/ejvs.2002.1927; Tilvis RS, 1996, J AM GERIATR SOC, V44, P809, DOI 10.1111/j.1532-5415.1996.tb03738.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ueda T, 2000, INT J UROL, V7, P95, DOI 10.1046/j.1442-2042.2000.00147.x; Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x; Vinik Aaron I., 1999, American Journal of Medicine, V107, p17S; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750	45	91	93	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1935	1940		10.1001/jama.295.16.1935	http://dx.doi.org/10.1001/jama.295.16.1935			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639053				2022-12-28	WOS:000237059200029
J	Rossi, DJ; Weissman, IL				Rossi, DJ; Weissman, IL			Pten, tumorigenesis, and stem cell self-renewal	CELL			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; CANCER; IDENTIFICATION; CAPACITY		Stanford Univ, Sch Med, Beckman Ctr B259, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B259, Inst Stem Cell Biol & Regenerat Med & Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Rossi, DJ (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B259, Dept Pathol, 279 Campus Dr, Stanford, CA 94305 USA.	drossi@stanford.edu; irv@stanford.edu						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	13	77	81	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					229	231		10.1016/j.cell.2006.04.006	http://dx.doi.org/10.1016/j.cell.2006.04.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630811	Bronze			2022-12-28	WOS:000237241500013
J	Thompson, JN				Thompson, JN			Mutualistic webs of species	SCIENCE			English	Editorial Material									Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA	University of California System; University of California Santa Cruz	Thompson, JN (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.	thompson@biology.ucsc.edu	Thompson, Jessica/GXW-0323-2022					Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Thompson J.N., 2005, INTERSPEC INTERACT; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Waser NM., 2006, PLANT POLLINATOR INT	9	72	75	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					372	373		10.1126/science.1126904	http://dx.doi.org/10.1126/science.1126904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627726				2022-12-28	WOS:000236941800027
J	Mermin, J; Ekwaru, JP; Liechty, CA; Were, W; Downing, R; Ransom, R; Weidle, P; Lule, J; Coutinho, A; Solberg, P				Mermin, J; Ekwaru, JP; Liechty, CA; Were, W; Downing, R; Ransom, R; Weidle, P; Lule, J; Coutinho, A; Solberg, P			Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study	LANCET			English	Article							CD4 CELL COUNT; PLASMODIUM-FALCIPARUM; RANDOMIZED-TRIAL; HIV-INFECTION; RURAL UGANDA; TRANSMISSION; EPISODES; AFRICA; REGION; KENYA	Background HIV-1 and malaria are common infections in Africa, and cause substantial morbidity and mortality. HIV infection has been associated with an increased incidence of malaria, and more severe disease. Our aim was to assess the effect of antiretroviral treatment (ART) on the frequency of clinical malaria in people with HIV, and to measure the additive effects of co-trimoxazole (trimethoprim and sulfamethoxazole) prophylaxis, ART, and insecticide-treated bednets. Methods In 2001, we enrolled 466 HIV-infected individuals aged 18 years or older in Uganda in a prospective cohort study that provided co-trimoxazole prophylaxis to 399 participants after 5 months of no intervention. In 2003, we enrolled 138 survivors from the initial study, and 897 new participants from the same community, to take antiretroviral therapy (ART) in addition to co-trimoxazole prophylaxis. The ART was in most cases a combination of stavudine, lamivudine, and nevirapine or efavirenz. In 2004, we also gave participants insecticide-treated bednets. Households were visited weekly by study staff to record fever, illness, or death in the preceding 7 days. In cases of reported fever in the previous 2 days, we took blood to test for malaria parasites. We compared the frequency of clinical malaria, adjusting for CD4-cell count, age, sex, and season. Findings 1035 individuals were given co-trimoxazole and ART (median age 38 years, 74% female, and median CD4-cell count 124 cells/mu L); 985 of these, plus four new participants, received co-trimoxazole, ART, and bednets. There were 166 cases of clinical malaria in the study. Compared with a baseline malaria incidence of 50.8 episodes per 100 person-years, co-trimoxazole prophylaxis was associated with 9.0 episodes per 100 person-years (adjusted incidence rate ratio [IRR] 0.24, 95% CI 0.15-0.38); ART and co-trimoxazole with 3.5 episodes per 100 person-years (0.08, 0.04-0.17); and co-trimoxazole, ART, and bednets with 2.1 episodes per 100 person-years (0.05, 0.03-0.08). Malaria incidence was significantly lower during ART and co-trimoxazole than during co-trimoxazole alone (IRR 0.36 [95% CI 0.18-0.74], p=0.0056). Interpretation A combination of co-trimoxazole, antiretroviral therapy, and insecticide-treated bednets substantially reduced the frequency of malaria in adults with HIV.	CDC Uganda, Uganda Virus Res Inst, Global AIDS Program,Ctr Dis Control & Prevent CD, Natl Ctr HIV STD & TB Prevent, Entebbe, Uganda; CDC, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; AIDS Support Org, Kampala, Uganda	Uganda Virus Research Institute; Centers for Disease Control & Prevention - USA	Mermin, J (corresponding author), CDC Uganda, Uganda Virus Res Inst, Global AIDS Program,Ctr Dis Control & Prevent CD, Natl Ctr HIV STD & TB Prevent, POB 49, Entebbe, Uganda.	jhm7@cdc.gov	Mermin, Jonathan/J-9847-2012					Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Francesconi P, 2001, AIDS, V15, P2445, DOI 10.1097/00002030-200112070-00013; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Grimwade K, 2003, PEDIATR INFECT DIS J, V22, P1057, DOI 10.1097/01.inf.0000101188.95433.60; Hawley WA, 2003, AM J TROP MED HYG, V68, P168, DOI 10.4269/ajtmh.2003.68.168; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Kilian AHD, 1998, T ROY SOC TROP MED H, V92, P197, DOI 10.1016/S0035-9203(98)90748-9; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Ladner J, 2003, AIDS, V17, P275, DOI 10.1097/00002030-200301240-00025; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; *MARA, UG MAL DISTR GRAD MA; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; *UG MIN HLTH, 2001, HLTH MAN INF SYST DA; *UG MIN HLTH, 2006, UG HIV AIDS IND SURV; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Whitworth JAG, 2005, LANCET, V365, P196; *WHO UNAIDS, PROV WHO UNAIDS SECR; World Health Organization, 2002, US ANT THER SIMPL AP	28	145	149	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1256	1261		10.1016/S0140-6736(06)68541-3	http://dx.doi.org/10.1016/S0140-6736(06)68541-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631881				2022-12-28	WOS:000236913400030
J	Rennard, SI; Vestbo, J				Rennard, SI; Vestbo, J			COPD: the dangerous underestimate of 15%	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; VENTILATORY FUNCTION; MORTALITY; OXYGEN; RISK		Univ Nebraska, Med Ctr, Omaha, NE 68198 USA; Univ Manchester, Manchester, Lancs, England; Hvidovre Univ Hosp, DK-2650 Hvidovre, Denmark	University of Nebraska System; University of Nebraska Medical Center; University of Manchester; University of Copenhagen	Rennard, SI (corresponding author), Univ Nebraska, Med Ctr, 600 S 42nd St, Omaha, NE 68198 USA.	srennard@unmc.edu	Vestbo, Jorgen/Y-2912-2019	Vestbo, Jorgen/0000-0001-6355-6362				*AM THOR SOC EUR R, 2005, STAND DIAGN MAN PAT; Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Emtner M, 2003, AM J RESP CRIT CARE, V168, P1034, DOI 10.1164/rccm.200212-1525OC; Fletcher CM, 1976, NATURAL HIST CHRONIC; *GLOB IN CHRON OBS, 2003, GLOB STRAT DIAGN MAN; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; HUMERFELT S, 1993, EUR RESPIR J, V6, P1095; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; LANGE P, 1991, EUR RESPIR J, V4, P1080; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Postma Dirkje S, 2004, Chest, V126, p96S, DOI 10.1378/chest.126.2_suppl_1.96S; Silverman EK, 2001, NOVART FDN SYMP, V234, P45; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Somfay A, 2001, EUR RESPIR J, V18, P77, DOI 10.1183/09031936.01.00082201	18	147	155	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2006	367	9518					1216	1219		10.1016/S0140-6736(06)68516-4	http://dx.doi.org/10.1016/S0140-6736(06)68516-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631861				2022-12-28	WOS:000236913400005
J	Domon, B; Aebersold, R				Domon, B; Aebersold, R			Review - Mass spectrometry and protein analysis	SCIENCE			English	Review							ELECTROSPRAY-IONIZATION; SACCHAROMYCES-CEREVISIAE; SELECTIVE DETECTION; PROTEOMICS; PEPTIDE; IDENTIFICATION; DISSOCIATION; QUANTIFICATION; CHROMATOGRAPHY; FRAGMENTATION	Mass spectrometry is a central analytical technique for protein research and for the study of biomolecules in general. Driven by the need to identify, characterize, and quantify proteins at ever increasing sensitivity and in ever more complex samples, a wide range of new mass spectrometry based analytical platforms and experimental strategies have emerged. Here we review recent advances in mass spectrometry instrumentation in the context of current and emerging research strategies in protein science.	ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland; Inst Mol Syst Biol, Seattle, WA 98103 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Domon, B (corresponding author), ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.				DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-28179] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Baldwin MA, 2004, MOL CELL PROTEOMICS, V3, P1, DOI 10.1074/mcp.R300012-MCP200; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Carr SA, 1996, ANAL BIOCHEM, V239, P180, DOI 10.1006/abio.1996.0313; COOKS RG, 1991, CHEM ENG NEWS, V69, P26, DOI 10.1021/cen-v069n012.p026; Desiere F, 2005, GENOME BIOL, V6; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hager JW, 2002, RAPID COMMUN MASS SP, V16, P512, DOI 10.1002/rcm.607; Hardman M, 2003, ANAL CHEM, V75, P1699, DOI 10.1021/ac0258047; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Hu S, 2004, ANAL CHEM, V76, P4044, DOI 10.1021/ac0498314; HUDDLESTON MJ, 1993, ANAL CHEM, V65, P877, DOI 10.1021/ac00055a009; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kearney P, 2003, J Bioinform Comput Biol, V1, P183, DOI 10.1142/S021972000300023X; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Le Blanc JCY, 2003, PROTEOMICS, V3, P859, DOI 10.1002/pmic.200300415; Li XJ, 2004, ANAL CHEM, V76, P3856, DOI 10.1021/ac035375s; Medzihradszky KF, 2000, ANAL CHEM, V72, P552, DOI 10.1021/ac990809y; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Senko MW, 1997, J AM SOC MASS SPECTR, V8, P970, DOI 10.1016/S1044-0305(97)00126-8; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	36	1434	1532	27	978	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					212	217		10.1126/science.1124619	http://dx.doi.org/10.1126/science.1124619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614208				2022-12-28	WOS:000236765300034
J	Hoshino, K; Sugiyama, T; Matsumoto, M; Tanaka, T; Saito, M; Hemmi, H; Ohara, O; Akira, S; Kaisho, T				Hoshino, K; Sugiyama, T; Matsumoto, M; Tanaka, T; Saito, M; Hemmi, H; Ohara, O; Akira, S; Kaisho, T			I kappa B kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9	NATURE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; IKK-ALPHA; ANTIVIRAL RESPONSE; VIRAL-INFECTION; MICE LACKING; IFN-ALPHA; ACTIVATION; INDUCTION; IMMUNITY	The Toll-like receptor (TLR) family has important roles in microbial recognition and dendritic cell activation(1,2). TLRs 7 and 9 can recognize nucleic acids(3-6) and trigger signalling cascades that activate plasmacytoid dendritic cells to produce interferon-alpha (IFN-alpha) (refs 7, 8). TLR7/9-mediated dendritic cell activation is critical for antiviral immunity but also contributes to the pathogenesis of systemic lupus erythematosus, a disease in which serum IFN-alpha levels are elevated owing to plasmacytoid dendritic cell activation(8,9). TLR7/9-induced IFN-alpha induction depends on a molecular complex that contains a TLR adaptor, MyD88, and IFN regulatory factor 7 (IRF-7) (refs 10-14), but the underlying molecular mechanisms are as yet unknown. Here we show that I kappa B kinase-alpha (IKK-alpha) is critically involved in TLR7/9-induced IFN-alpha production. TLR7/9-induced IFN-alpha production was severely impaired in IKK-alpha-deficient plasmacytoid dendritic cells, whereas inflammatory cytokine induction was decreased but still occurred. Kinase-deficient IKK-alpha inhibited the ability of MyD88 to activate the Ifna promoter in synergy with IRF-7. Furthermore, IKK-alpha associated with and phosphorylated IRF-7. Our results identify a role for IKK-alpha in TLR7/9 signalling, and highlight IKK-alpha as a potential target for manipulating TLR-induced IFN-alpha production.	RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Tsurumi Ku, Kanagawa 2300045, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Immunogenom, Tsurumi Ku, Kanagawa 2300045, Japan; Univ Tokushima, Div Mol Immunol, Inst Enzyme Res, Tokushima 7708503, Japan; Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; ERATO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; Kazusa DNA Res Inst, Chiba 2920818, Japan	RIKEN; RIKEN; Tokushima University; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute	Kaisho, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Host Def Lab, Tsurumi Ku, Suehirocho 1-7-22, Kanagawa 2300045, Japan.	tkaisho@rcai.riken.jp	Akira, Shizuo/C-3134-2009; Hoshino, Katsuaki/L-9162-2014; Kaisho, Tsuneyasu/B-4130-2012; Tanaka, Takashi/O-8254-2015; Hoshino, Katsuaki/AAE-2830-2022; Ohara, Osamu/G-5448-2015; Ohara, Osamu/A-9119-2012	Hoshino, Katsuaki/0000-0003-0493-4815; Hoshino, Katsuaki/0000-0003-0493-4815; Ohara, Osamu/0000-0002-3328-9571; 				Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011	30	277	296	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					949	953		10.1038/nature04641	http://dx.doi.org/10.1038/nature04641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612387				2022-12-28	WOS:000236736700044
J	Houstis, N; Rosen, ED; Lander, ES				Houstis, N; Rosen, ED; Lander, ES			Reactive oxygen species have a causal role in multiple forms of insulin resistance	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; TNF-ALPHA; GLUT4 TRANSLOCATION; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; OBESITY; JNK; EXPRESSION; PREGNANCY	Insulin resistance is a cardinal feature of type 2 diabetes and is characteristic of a wide range of other clinical and experimental settings. Little is known about why insulin resistance occurs in so many contexts. Do the various insults that trigger insulin resistance act through a common mechanism? Or, as has been suggested(1), do they use distinct cellular pathways? Here we report a genomic analysis of two cellular models of insulin resistance, one induced by treatment with the cytokine tumour-necrosis factor-alpha and the other with the glucocorticoid dexamethasone. Gene expression analysis suggests that reactive oxygen species (ROS) levels are increased in both models, and we confirmed this through measures of cellular redox state. ROS have previously been proposed to be involved in insulin resistance, although evidence for a causal role has been scant. We tested this hypothesis in cell culture using six treatments designed to alter ROS levels, including two small molecules and four transgenes; all ameliorated insulin resistance to varying degrees. One of these treatments was tested in obese, insulin-resistant mice and was shown to improve insulin sensitivity and glucose homeostasis. Together, our findings suggest that increased ROS levels are an important trigger for insulin resistance in numerous settings.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02214 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rosen, ED (corresponding author), MIT, Broad Inst, Cambridge, MA 02141 USA.	erosen@bidmc.harvard.edu; lander@broad.mit.edu						BALM PH, 2000, STREE PHYSL ANIMALS; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HORNNES PJ, 1985, DIABETES METAB, V11, P310; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; KUSUNOKI M, 1995, DIABETES, V44, P718, DOI 10.2337/diabetes.44.6.718; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; MCCALL JL, 1992, BRIT J SURG, V79, P1361, DOI 10.1002/bjs.1800791240; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Moini H, 2002, ARCH BIOCHEM BIOPHYS, V397, P384, DOI 10.1006/abbi.2001.2680; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; STONER HB, 1983, BRIT J SURG, V70, P32, DOI 10.1002/bjs.1800700113; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANPUTTEN JPM, 1985, DIABETOLOGIA, V28, P445, DOI 10.1007/BF00280889; VAUGHAN GM, 1982, J TRAUMA, V22, P263, DOI 10.1097/00005373-198204000-00001; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829	30	1820	1914	3	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					944	948		10.1038/nature04634	http://dx.doi.org/10.1038/nature04634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	031WU	16612386				2022-12-28	WOS:000236736700043
J	Mozaffarian, D; Katan, MB; Ascherio, A; Stampfer, MJ; Willett, WC				Mozaffarian, D; Katan, MB; Ascherio, A; Stampfer, MJ; Willett, WC			Medical progress - Trans fatty acids and cardiovascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-HEART-DISEASE; CONJUGATED LINOLEIC-ACID; TYPE-2 DIABETES-MELLITUS; HYDROGENATED SOYBEAN OIL; C-REACTIVE PROTEIN; LIPOPROTEIN CHOLESTEROL LEVELS; SUDDEN CARDIAC DEATH; FED CONTROLLED DIETS; MYOCARDIAL-INFARCTION; ADIPOSE-TISSUE		Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; Wageningen Ctr Food Sci, Wageningen, Netherlands	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Wageningen University & Research; Wageningen University & Research	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2,Rm 315, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008; Robles-Sardin, Alma E/M-7714-2015	Robles-Sardin, Alma E/0000-0003-2044-7793	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL075628] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08-HL-075628] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 2002, CIRCULATION, V105, P2595, DOI 10.1161/01.CIR.0000017493.03108.1C; Allison DB, 1999, J AM DIET ASSOC, V99, P166, DOI 10.1016/S0002-8223(99)00041-3; ALMENDINGEN K, 1995, J LIPID RES, V36, P1370; American Heart Association, 2005, HEART DIS STROKE STA; ARO A, 1995, LANCET, V345, P273, DOI 10.1016/S0140-6736(95)90273-2; Aro A, 1997, AM J CLIN NUTR, V65, P1419, DOI 10.1093/ajcn/65.5.1419; ARO A, 2005, 1 INT S TRANS FATT A; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Baylin A, 2003, J NUTR, V133, P1186, DOI 10.1093/jn/133.4.1186; Center for Science in the Public Interest to US Food and Drug Administration, 2004, PET RUL REV AUTH IND; Christiansen E, 1997, DIABETES CARE, V20, P881, DOI 10.2337/diacare.20.5.881; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Clifton PM, 2004, J NUTR, V134, P874, DOI 10.1093/jn/134.4.874; Dashti N, 2002, J NUTR, V132, P2651, DOI 10.1093/jn/132.9.2651; de Roos NM, 2001, ARTERIOSCL THROM VAS, V21, P1233, DOI 10.1161/hq0701.092161; de Roos NM, 2002, METABOLISM, V51, P1534, DOI 10.1053/meta.2002.36305; de Roos NM, 2001, J NUTR, V131, P242, DOI 10.1093/jn/131.2.242; *DEP HLTH HUM SERV, DIET GUID AM 2005; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dietary Guidelines Advisory Committee, 2005, NUTR YOUR HLTH DIET; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; *FOOD DRUG ADM, FREQ ASK QUEST GRAS; *FOOD DRUG ADM, 2005, FDA ACTS PROV BETT I; *FRIT LAY, 2005, PROD CONT ZER GRAMS; Han SN, 2002, J LIPID RES, V43, P445; Hites RA, 2004, SCIENCE, V303, P226, DOI 10.1126/science.1091447; *HLTH CAN, 2005, GOV RESP INT REC TRA; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Innis SM, 1999, J AM COLL NUTR, V18, P255, DOI 10.1080/07315724.1999.10718860; JAKOBSEN MU, IN PRESS AM J CLIN N; JENSEN HG, 2005, 1 INT S TRANS FATT A; Judd JT, 2002, LIPIDS, V37, P123, DOI 10.1007/s11745-002-0871-9; JUDD JT, 1994, AM J CLIN NUTR, V59, P861, DOI 10.1093/ajcn/59.4.861; Judd JT, 1998, AM J CLIN NUTR, V68, P768, DOI 10.1093/ajcn/68.4.768; LAINE DC, 1982, AM J CLIN NUTR, V35, P683, DOI 10.1093/ajcn/35.4.683; Lemaitre RN, 2002, CIRCULATION, V105, P697, DOI 10.1161/hc0602.103583; LETH T, 2005, 1 INT S TRANS FATT A; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lichtenstein AH, 2003, ATHEROSCLEROSIS, V171, P97, DOI 10.1016/j.atherosclerosis.2003.07.005; Lichtenstein AH, 1999, NEW ENGL J MED, V340, P1933, DOI 10.1056/NEJM199906243402501; Lock AL, 2004, LIPIDS, V39, P1197, DOI 10.1007/s11745-004-1348-6; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Louheranta AM, 1999, METABOLISM, V48, P870, DOI 10.1016/S0026-0495(99)90221-4; Lovejoy JC, 2002, DIABETES CARE, V25, P1283, DOI 10.2337/diacare.25.8.1283; Matthan NR, 2004, ARTERIOSCL THROM VAS, V24, P1092, DOI 10.1161/01.ATV.0000128410.23161.be; Matthan NR, 2001, J LIPID RES, V42, P1841; Mauger JF, 2003, AM J CLIN NUTR, V78, P370, DOI 10.1093/ajcn/78.3.370; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Mitmesser SH, 2005, J NUTR BIOCHEM, V16, P178, DOI 10.1016/j.jnutbio.2004.11.004; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Mozaffarian D, 2004, AM J CLIN NUTR, V80, P1521, DOI 10.1093/ajcn/80.6.1521; Mozaffarian D, 2005, ALTERN THER HEALTH M, V11, P24; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; Muller H, 2001, ATHEROSCLEROSIS, V155, P467, DOI 10.1016/S0021-9150(00)00591-8; Muller H, 1998, LIPIDS, V33, P879, DOI 10.1007/s11745-998-0284-9; NIELSEN K, 2005, 1 INT S TRANS FATT A; Nugent AP, 2005, EUR J CLIN NUTR, V59, P742, DOI 10.1038/sj.ejcn.1602132; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; Oomen CM, 2001, LANCET, V357, P746, DOI 10.1016/S0140-6736(00)04166-0; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Riserus U, 2004, AM J CLIN NUTR, V79, p1146S; Roach C, 2004, BIOCHEMISTRY-US, V43, P6344, DOI 10.1021/bi049917r; ROBERTS TL, 1995, LANCET, V345, P278, DOI 10.1016/S0140-6736(95)90274-0; Saravanan N, 2005, EUR J ENDOCRINOL, V153, P159, DOI 10.1530/eje.1.01946; Smedman A, 2004, CLIN SCI, V106, P67, DOI 10.1042/CS20030105; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; Vanden Heuvel John P, 2004, Curr Atheroscler Rep, V6, P432, DOI 10.1007/s11883-004-0083-9; VANTOL A, 1995, ATHEROSCLEROSIS, V115, P129, DOI 10.1016/0021-9150(94)05509-H; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; ZOCK PL, 1992, J LIPID RES, V33, P399; 2005, NY TIMES        0625, pA14	81	1100	1166	2	185	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1601	1613		10.1056/NEJMra054035	http://dx.doi.org/10.1056/NEJMra054035			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16611951				2022-12-28	WOS:000236736900008
J	Ro, DK; Paradise, EM; Ouellet, M; Fisher, KJ; Newman, KL; Ndungu, JM; Ho, KA; Eachus, RA; Ham, TS; Kirby, J; Chang, MCY; Withers, ST; Shiba, Y; Sarpong, R; Keasling, JD				Ro, DK; Paradise, EM; Ouellet, M; Fisher, KJ; Newman, KL; Ndungu, JM; Ho, KA; Eachus, RA; Ham, TS; Kirby, J; Chang, MCY; Withers, ST; Shiba, Y; Sarpong, R; Keasling, JD			Production of the antimalarial drug precursor artemisinic acid in engineered yeast	NATURE			English	Article							CATALYZES 3 STEPS; GIBBERELLIN BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; EXPRESSION; MALARIA; PATHWAY; CYTOCHROME-P450; IDENTIFICATION; REDUCTASE; OXIDASE	Malaria is a global health problem that threatens 300-500 million people and kills more than one million people annually(1). Disease control is hampered by the occurrence of multi-drug-resistant strains of the malaria parasite Plasmodium falciparum(2,3). Synthetic antimalarial drugs and malarial vaccines are currently being developed, but their efficacy against malaria awaits rigorous clinical testing(4,5). Artemisinin, a sesquiterpene lactone endoperoxide extracted from Artemisia annua L (family Asteraceae; commonly known as sweet wormwood), is highly effective against multi-drug-resistant Plasmodium spp., but is in short supply and unaffordable to most malaria sufferers(6). Although total synthesis of artemisinin is difficult and costly(7), the semi-synthesis of artemisinin or any derivative from microbially sourced artemisinic acid, its immediate precursor, could be a cost-effective, environmentally friendly, high-quality and reliable source of artemisinin(8,9). Here we report the engineering of Saccharomyces cerevisiae to produce high titres (up to 100 mg l(-1)) of artemisinic acid using an engineered mevalonate pathway, amorphadiene synthase, and a novel cytochrome P450 monooxygenase (CYP71AV1) from A. annua that performs a three-step oxidation of amorpha-4,11-diene to artemisinic acid. The synthesized artemisinic acid is transported out and retained on the outside of the engineered yeast, meaning that a simple and inexpensive purification process can be used to obtain the desired product. Although the engineered yeast is already capable of producing artemisinic acid at a significantly higher specific productivity than A. annua, yield optimization and industrial scale-up will be required to raise artemisinic acid production to a level high enough to reduce artemisinin combination therapies to significantly below their current prices.	Univ Calif Berkeley, Lawrence Berkeley Lab, Calif Inst Quantitat Biomed Res, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Synth Biol, Berkeley, CA 94720 USA; Amyris Biotechnol Inc, Emeryville, CA 94608 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Calif Inst Quantitat Biomed Res, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012; Ro, Dae-Kyun/G-9289-2012	Keasling, Jay D/0000-0003-4170-6088; Ro, Dae-Kyun/0000-0003-1288-5347; Sarpong, Richmond/0000-0002-0028-6323				ACTON N, 1992, J ORG CHEM, V57, P3610, DOI 10.1021/jo00039a020; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Davies BSJ, 2005, MOL CELL BIOL, V25, P7375, DOI 10.1128/MCB.25.16.7375-7385.2005; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341, DOI 10.1128/AEM.63.9.3341-3344.1997; ELMARAKBY SA, 1988, PHYTOCHEMISTRY, V27, P3089, DOI 10.1016/0031-9422(88)80006-2; Enserink M, 2005, SCIENCE, V307, P33, DOI 10.1126/science.307.5706.33; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Haynes R. K., 1994, U.S. Patent, Patent No. 5310946; Helliwell CA, 1999, PLANT PHYSIOL, V119, P507, DOI 10.1104/pp.119.2.507; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Hoffman S, 2004, NATURE, V430, P940, DOI 10.1038/430940a; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Kim SU, 1996, PLANTA MED, V62, P480, DOI 10.1055/s-2006-957948; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Lupien S, 1999, ARCH BIOCHEM BIOPHYS, V368, P181, DOI 10.1006/abbi.1999.1298; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mercke P, 2000, ARCH BIOCHEM BIOPHYS, V381, P173, DOI 10.1006/abbi.2000.1962; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; SCHMID G, 1983, J AM CHEM SOC, V105, P624, DOI 10.1021/ja00341a054; SEAMAN FC, 1982, BOT REV, V48, P121, DOI 10.1007/BF02919190; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Wang EM, 2001, NAT BIOTECHNOL, V19, P371, DOI 10.1038/86770; WHO UNICEF, 2005, WORLD MALARIA REPORT	26	1804	2121	76	1392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2006	440	7086					940	943		10.1038/nature04640	http://dx.doi.org/10.1038/nature04640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	031WU	16612385				2022-12-28	WOS:000236736700042
J	Gewin, V				Gewin, Virginia			Nanotech's big issue	NATURE			English	News Item								Lack of regulation and risk assessment could hamper the nanotechnology sector. As nanotechnological products start to reach the market place, concerns are being raised about the potential risk to health if the nanoparticles are inhaled or ingested. Companies have had to act on their own initiative because there are no regulations anywhere in the world to govern nanotech-related products. The greatest concern focuses on nano-sized particles used in consumer products, such as cosmetics or mineral supplements.										Brumfiel G, 2006, NATURE, V440, P262, DOI 10.1038/440262a	1	16	16	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 14	2006	443	7108					137	137		10.1038/443137a	http://dx.doi.org/10.1038/443137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	083OB	16607694	Bronze			2022-12-28	WOS:000240467000013
J	Wang, ZL; Song, JH				Wang, ZL; Song, JH			Piezoelectric nanogenerators based on zinc oxide nanowire arrays	SCIENCE			English	Article							SINGLE-CRYSTAL NANORINGS; NANOBELTS; EMISSION; GAN	We have converted nanoscale mechanical energy into electrical energy by means of piezoelectric zinc oxide nanowire ( NW) arrays. The aligned NWs are deflected with a conductive atomic force microscope tip in contact mode. The coupling of piezoelectric and semiconducting properties in zinc oxide creates a strain field and charge separation across the NW as a result of its bending. The rectifying characteristic of the Schottky barrier formed between the metal tip and the NW leads to electrical current generation. The efficiency of the NW-based piezoelectric power generator is estimated to be 17 to 30%. This approach has the potential of converting mechanical, vibrational, and/or hydraulic energy into electricity for powering nanodevices.	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China; Natl Ctr Nanosci & Technol, Beijing 100080, Peoples R China	University System of Georgia; Georgia Institute of Technology; Peking University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zhong.wang@mse.gatech.edu	Song, Jinhui/C-7524-2013; wang, jie/GRS-0942-2022; Dee, Chang Fu/G-4842-2010; Wang, Zhong Lin/E-2176-2011	Song, Jinhui/0000-0002-0042-2014; Dee, Chang Fu/0000-0003-1015-9181; Wang, Zhong Lin/0000-0002-5530-0380				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Duan XF, 2003, NATURE, V421, P241, DOI 10.1038/nature01353; Gao PX, 2005, SCIENCE, V309, P1700, DOI 10.1126/science.1116495; Hasegawa S, 2005, J CERAM PROCESS RES, V6, P245; He JH, 2005, J AM CHEM SOC, V127, P16376, DOI 10.1021/ja0559193; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Hughes WL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1853514; Hughes WL, 2004, J AM CHEM SOC, V126, P6703, DOI 10.1021/ja049266m; Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356; Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Park WI, 2003, APPL PHYS LETT, V82, P4358, DOI 10.1063/1.1584089; PIERRET RF, 1996, SEMICONDUCTOR DEVICE, pCH14; Song JH, 2005, NANO LETT, V5, P1954, DOI 10.1021/nl051334v; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang XD, 2004, NANO LETT, V4, P423, DOI 10.1021/nl035102c; Wang ZL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185502; Zhao MH, 2004, NANO LETT, V4, P587, DOI 10.1021/nl035198a; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; ZHOU J, 2001, ADV MATER, V13, P113	22	5956	6150	284	4029	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					242	246		10.1126/science.1124005	http://dx.doi.org/10.1126/science.1124005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16614215				2022-12-28	WOS:000236765300041
J	Ferraris, VA; Bridges, CR; Anderson, RP				Ferraris, VA; Bridges, CR; Anderson, RP		Blood Conservation Guideline	Aprotinin in cardiac surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							OUTCOMES		Univ Kentucky, Albert B Chandler Med Ctr, Lexington, KY 40536 USA; Univ Penn Hlth Syst, Philadelphia, PA 19106 USA; Virginia Mason Clin, Seattle, WA 98102 USA	University of Kentucky; University of Pennsylvania; Virginia Mason Medical Center	Ferraris, VA (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Lexington, KY 40536 USA.	ferraris@earthlink.net						Henry DA, 2001, COCHRANE DB SYST REV, V1; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041	5	46	49	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1953	1954						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672711				2022-12-28	WOS:000237239900021
